PMID,Title,Authors,Citation,First Author,Journal/Book,Publication Year,Create Date,PMCID,NIHMS ID,DOI
40486952,Translational Medicine in Alzheimer's Disease: The Journey of Donanemab From Discovery to Clinical Application,"Jayaprakash N, Elumalai K.",Chronic Dis Transl Med. 2024 Dec 16;11(2):105-116. doi: 10.1002/cdt3.155. eCollection 2025 Jun.,Jayaprakash N,Chronic Dis Transl Med,2024,09-06-2025,PMC12142702,,10.1002/cdt3.155
40190514,Research progress on the role of ginsenoside Rd in central nervous system diseases,"Ma X, Wang J.",Afr Health Sci. 2024 Dec;24(4):325-331. doi: 10.4314/ahs.v24i4.41.,Ma X,Afr Health Sci,2024,07-04-2025,PMC11970185,,10.4314/ahs.v24i4.41
40153582,1953-2023. Seventy Years of the Nerve Growth Factor: A Potential Novel Treatment in Neurological Diseases?,"Norata D, Capone F, Motolese F, Marano M, Rossi M, Calandrelli R, Sacchetti M, Mantelli F, Di Lazzaro V, Pilato F.",Aging Dis. 2024 Jul 15;16(4):2293-2314. doi: 10.14336/AD.2024.0573.,Norata D,Aging Dis,2024,28-03-2025,PMC12221384,,10.14336/AD.2024.0573
40086910,Correlation between changes in apathy and cognition in Alzheimer's disease associated apathy: Analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2),"Sankhe K, Tumati S, Perin J, Rivet L, Vieira D, Rosenberg PB, Herrmann N, Shade D, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey AI, Mintzer J, Lanctôt KL.",Int Psychogeriatr. 2025 Mar;37(2):100012. doi: 10.1016/j.inpsyc.2024.100012. Epub 2024 Dec 4.,Sankhe K,Int Psychogeriatr,2025,14-03-2025,,,10.1016/j.inpsyc.2024.100012
40046004,Assessing the role of vascular risk factors in dementia: Mendelian randomization meta-analysis and comparison with observational estimates,"Lee L, Walker R, Whiteley W.",F1000Res. 2025 Feb 7;11:565. doi: 10.12688/f1000research.121604.2. eCollection 2022.,Lee L,F1000Res,2025,06-03-2025,PMC11880757,,10.12688/f1000research.121604.2
39990823,[Radiological Identification and Evaluation of Amyloid-Related Imaging Abnormalities in Alzheimer's Disease],"Yang X, Li W, Yang X, Chen Q, Li H, Lyu S, Hu N.",Sichuan Da Xue Xue Bao Yi Xue Ban. 2024 Nov 20;55(6):1364-1370. doi: 10.12182/20241160201.,Yang X,Sichuan Da Xue Xue Bao Yi Xue Ban,2024,24-02-2025,PMC11839357,,10.12182/20241160201
39949865,Improving cognitive impairment through chronic consumption of natural compounds/extracts: a systematic review and meta-analysis of randomized controlled trials,"Hoang LN, Lee H, Lee SJ.",Front Aging Neurosci. 2025 Jan 30;16:1531278. doi: 10.3389/fnagi.2024.1531278. eCollection 2024.,Hoang LN,Front Aging Neurosci,2025,14-02-2025,PMC11821934,,10.3389/fnagi.2024.1531278
39945003,"Comparative the efficacy and safety of Gosuranemab, Semorinemab, Tilavonemab, and Zagotenemab in patients with Alzheimer's disease: a systematic review and network meta-analysis of randomized controlled trials","Cai W, Zhang H, Wu Y, Yao Y, Zhang J.",Front Aging Neurosci. 2025 Jan 29;16:1465871. doi: 10.3389/fnagi.2024.1465871. eCollection 2024.,Cai W,Front Aging Neurosci,2025,13-02-2025,PMC11814219,,10.3389/fnagi.2024.1465871
39929585,Neutral sphingomyelinase 2: A promising drug target for CNS disease,"Huang M, Stremlau M, Zavras J, Zivko C, Thomas AG, Pietri P, Machairaki V, Slusher BS.",Adv Pharmacol. 2025;102:65-101. doi: 10.1016/bs.apha.2024.10.015. Epub 2024 Oct 28.,Huang M,Adv Pharmacol,2025,10-02-2025,PMC12172027,NIHMS2079308,10.1016/bs.apha.2024.10.015
39830554,Aducanumab in Alzheimer's Disease: A Comparative Study of Its Effects on Dementia and Mild Cognitive Impairment,"Medel Sánchez A, Ortiz Hernández A, Moreno Moreno RA, Salas López D, Madrigal Gómez LE, Dominguez Ibarra AK, Gutiérrez Rojas BA, Garcia Navarro CO, Moreno Becerril GT, Montelongo Quevedo M, Flores Valdés JR.",Cureus. 2024 Dec 17;16(12):e75907. doi: 10.7759/cureus.75907. eCollection 2024 Dec.,Medel Sánchez A,Cureus,2024,20-01-2025,PMC11740155,,10.7759/cureus.75907
39787544,Sound and Alzheimer's Disease-From Harmful Noise to Beneficial Soundscape Augmentation and Music Therapy,Belojević G.,Noise Health. 2024 Oct-Dec 01;26(123):445-448. doi: 10.4103/nah.nah_162_24. Epub 2024 Dec 30.,Belojević G,Noise Health,2024,09-01-2025,PMC11813243,,10.4103/nah.nah_162_24
39776519,Mitochondrial protective potential of fucoxanthin in brain disorders,"Ferdous KA, Jansen J, Amjad E, Pray E, Bloch R, Benoit A, Callahan M, Park HA.",J Nutr Sci. 2024 Jul 25;13:e21. doi: 10.1017/jns.2024.16. eCollection 2024.,Ferdous KA,J Nutr Sci,2024,08-01-2025,PMC11704942,,10.1017/jns.2024.16
39770989,Mechanisms and Potential Benefits of Neuroprotective Agents in Neurological Health,"Pekdemir B, Raposo A, Saraiva A, Lima MJ, Alsharari ZD, BinMowyna MN, Karav S.",Nutrients. 2024 Dec 18;16(24):4368. doi: 10.3390/nu16244368.,Pekdemir B,Nutrients,2024,08-01-2025,PMC11677798,,10.3390/nu16244368
39766387,The Association Between Traumatic Brain Injury and the Risk of Cognitive Decline: An Umbrella Systematic Review and Meta-Analysis,"Mavroudis I, Kazis D, Petridis FE, Balmus IM, Papaliagkas V, Ciobica A.",Brain Sci. 2024 Nov 26;14(12):1188. doi: 10.3390/brainsci14121188.,Mavroudis I,Brain Sci,2024,08-01-2025,PMC11674444,,10.3390/brainsci14121188
39758348,Studying targeted oxidation in diabetic cognitive dysfunction based on scientometrics analysis: research progress of natural product approaches,"Tu W, Xu F, Li J, Tian X, Cao L, Wang L, Qu Y.",Front Endocrinol (Lausanne). 2024 Dec 20;15:1445750. doi: 10.3389/fendo.2024.1445750. eCollection 2024.,Tu W,Front Endocrinol (Lausanne),2024,06-01-2025,PMC11695123,,10.3389/fendo.2024.1445750
39746672,CROI 2024: Neuropsychiatric Complications in People With HIV,"Corley MJ, Letendre SL, Nightingale S.",Top Antivir Med. 2024 Aug 12;32(4):513-522.,Corley MJ,Top Antivir Med,2024,02-01-2025,PMC11361754,,
39746645,Statins for vascular dementia: A hype or hope,"Rajab HA, Al-Kuraishy HM, Shokr MM, Al-Gareeb AI, Al-Harchan NA, Alruwaili M, Papadakis M, Alexiou A, Batiha GE.",Neuroscience. 2025 Feb 16;567:45-55. doi: 10.1016/j.neuroscience.2024.12.059. Epub 2024 Dec 31.,Rajab HA,Neuroscience,2025,02-01-2025,,,10.1016/j.neuroscience.2024.12.059
39733844,The AβA2V paradigm: From molecular insights to therapeutic strategies in Alzheimer's disease and primary tauopathies,"Diomede L, Conz A, Mosconi M, Stoilova T, Paloni M, Salvalaglio M, Cagnotto A, Colombo L, Catania M, Di Fede G, Tagliavini F, Salmona M.",Pharmacol Res. 2025 Jan;211:107563. doi: 10.1016/j.phrs.2024.107563. Epub 2024 Dec 27.,Diomede L,Pharmacol Res,2025,29-12-2024,,,10.1016/j.phrs.2024.107563
39728750,New Insights into the Role of SGLT-2 Inhibitors in the Prevention of Dementia,"Hung CH, Lu LY.",Neurol Int. 2024 Dec 5;16(6):1717-1730. doi: 10.3390/neurolint16060124.,Hung CH,Neurol Int,2024,27-12-2024,PMC11676485,,10.3390/neurolint16060124
39719687,"Microglial Depletion, a New Tool in Neuroinflammatory Disorders: Comparison of Pharmacological Inhibitors of the CSF-1R","Guenoun D, Blaise N, Sellam A, Roupret-Serzec J, Jacquens A, Steenwinckel JV, Gressens P, Bokobza C.",Glia. 2025 Apr;73(4):686-700. doi: 10.1002/glia.24664. Epub 2024 Dec 24.,Guenoun D,Glia,2025,25-12-2024,PMC11845850,,10.1002/glia.24664
39719518,Molecular Signaling Pathways of Quercetin in Alzheimer's Disease: A Promising Arena,"Alsaleem MA, Al-Kuraishy HM, Al-Gareeb AI, Albuhadily AK, Alrouji M, Yassen ASA, Alexiou A, Papadakis M, Batiha GE.",Cell Mol Neurobiol. 2024 Dec 24;45(1):8. doi: 10.1007/s10571-024-01526-w.,Alsaleem MA,Cell Mol Neurobiol,2024,24-12-2024,PMC11668837,,10.1007/s10571-024-01526-w
39717349,Therapeutic agents for Alzheimer's disease: a critical appraisal,Weinstock M.,Front Aging Neurosci. 2024 Dec 9;16:1484615. doi: 10.3389/fnagi.2024.1484615. eCollection 2024.,Weinstock M,Front Aging Neurosci,2024,24-12-2024,PMC11663918,,10.3389/fnagi.2024.1484615
39716328,Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials,"Li Z, Lin C, Cai X, Lv F, Yang W, Ji L.",Alzheimers Res Ther. 2024 Dec 23;16(1):272. doi: 10.1186/s13195-024-01645-y.,Li Z,Alzheimers Res Ther,2024,24-12-2024,PMC11668108,,10.1186/s13195-024-01645-y
39711072,Overview of Alzheimer's Disease Neuroimaging Initiative and future clinical trials,"Weiner MW, Kanoria S, Miller MJ, Aisen PS, Beckett LA, Conti C, Diaz A, Flenniken D, Green RC, Harvey DJ, Jack CR Jr, Jagust W, Lee EB, Morris JC, Nho K, Nosheny R, Okonkwo OC, Perrin RJ, Petersen RC, Rivera-Mindt M, Saykin AJ, Shaw LM, Toga AW, Tosun D, Veitch DP; Alzheimer's Disease Neuroimaging Initiative.",Alzheimers Dement. 2025 Jan;21(1):e14321. doi: 10.1002/alz.14321. Epub 2024 Dec 22.,Weiner MW,Alzheimers Dement,2025,23-12-2024,PMC11775462,,10.1002/alz.14321
39711065,"ADNI Private Partners Scientific Board (PPSB) Diversity, Equity, and Inclusion (DE&I) Working Group: A new collaboration that crosses boundaries for industry, academia, and under-represented patients","Croney R, Fristed E, Masterman D, Meyer M, Sachdev P, Vasanthakumar A, Weber CJ, Devins T.",Alzheimers Dement. 2025 Jan;21(1):e14248. doi: 10.1002/alz.14248. Epub 2024 Dec 22.,Croney R,Alzheimers Dement,2025,23-12-2024,PMC11772309,,10.1002/alz.14248
39702132,"Effects of Probucol on plasma amyloid-β transport in patients with hyperlipidemia: a 12-week randomized, double-blind, placebo-controlled trial","Dang L, Wei S, Zhao Y, Zhou R, Shang S, Gao F, Wang J, Wang J, Qu Q.",Lipids Health Dis. 2024 Dec 19;23(1):410. doi: 10.1186/s12944-024-02398-1.,Dang L,Lipids Health Dis,2024,20-12-2024,PMC11657980,,10.1186/s12944-024-02398-1
39697158,Defining benefit: Clinically and biologically meaningful outcomes in the next-generation Alzheimer's disease clinical care pathway,"Elhage A, Cohen S, Cummings J, van der Flier WM, Aisen P, Cho M, Bell J, Hampel H.",Alzheimers Dement. 2025 Feb;21(2):e14425. doi: 10.1002/alz.14425. Epub 2024 Dec 19.,Elhage A,Alzheimers Dement,2025,19-12-2024,PMC11848336,,10.1002/alz.14425
39696300,"The double life of glucose metabolism: brain health, glycemic homeostasis, and your patients with type 2 diabetes","Schwartz SS, Herman ME, Tun MTH, Barone E, Butterfield DA.",BMC Med. 2024 Dec 18;22(1):582. doi: 10.1186/s12916-024-03763-8.,Schwartz SS,BMC Med,2024,19-12-2024,PMC11657227,,10.1186/s12916-024-03763-8
39695988,Exploring the gut-brain axis in alzheimer's disease treatment via probiotics: evidence from animal studies-a systematic review and meta-analysis,"Siripaopradit Y, Chatsirisakul O, Ariyapaisalkul T, Sereemaspun A.",BMC Neurol. 2024 Dec 19;24(1):481. doi: 10.1186/s12883-024-03978-5.,Siripaopradit Y,BMC Neurol,2024,19-12-2024,PMC11657461,,10.1186/s12883-024-03978-5
39690983,Role of Nonsteroidal Anti-Inflammatory Drugs as a Protective Factor in Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Asthana A, Tripathi S, Agarwal R.",Neurol India. 2024 Nov 1;72(6):1144-1151. doi: 10.4103/ni.ni_1073_22. Epub 2024 Dec 17.,Asthana A,Neurol India,2024,18-12-2024,,,10.4103/ni.ni_1073_22
39686614,Comparison of visit-to-visit blood pressure variability and time in target range in predicting risk for cognitive outcomes in the SPRINT trial,"Sible IJ, Nation DA.",J Alzheimers Dis. 2025 Jan;103(2):396-405. doi: 10.1177/13872877241303378. Epub 2024 Dec 16.,Sible IJ,J Alzheimers Dis,2025,17-12-2024,PMC11957754,NIHMS2063428,10.1177/13872877241303378
39684561,Medication Exposure and Risk of Dementia and Alzheimer's Disease,"Sharma N, An SSA, Kim SY.",Int J Mol Sci. 2024 Nov 29;25(23):12850. doi: 10.3390/ijms252312850.,Sharma N,Int J Mol Sci,2024,17-12-2024,PMC11641710,,10.3390/ijms252312850
39684447,Current and Potential Use of Biologically Active Compounds Derived from Cannabis sativa L. in the Treatment of Selected Diseases,Bukowska B.,Int J Mol Sci. 2024 Nov 27;25(23):12738. doi: 10.3390/ijms252312738.,Bukowska B,Int J Mol Sci,2024,17-12-2024,PMC11641728,,10.3390/ijms252312738
39684308,Magnesium (Mg) and Neurodegeneration: A Comprehensive Overview of Studies on Mg Levels in Biological Specimens in Humans Affected Some Neurodegenerative Disorders with an Update on Therapy and Clinical Trials Supplemented with Selected Animal Studies,"Ścibior A, Llopis J, Dobrakowski PP, Męcik-Kronenberg T.",Int J Mol Sci. 2024 Nov 23;25(23):12595. doi: 10.3390/ijms252312595.,Ścibior A,Int J Mol Sci,2024,17-12-2024,PMC11641227,,10.3390/ijms252312595
39683904,"Glutamate: Molecular Mechanisms and Signaling Pathway in Alzheimer's Disease, a Potential Therapeutic Target","Puranik N, Song M.",Molecules. 2024 Dec 5;29(23):5744. doi: 10.3390/molecules29235744.,Puranik N,Molecules,2024,17-12-2024,PMC11643865,,10.3390/molecules29235744
39683859,Potential Protective Effects of Pungent Flavor Components in Neurodegenerative Diseases,"Guo F, Qin X, Mao J, Xu Y, Xie J.",Molecules. 2024 Dec 2;29(23):5700. doi: 10.3390/molecules29235700.,Guo F,Molecules,2024,17-12-2024,PMC11643850,,10.3390/molecules29235700
39683463,"Dietary Phytic Acid, Dephytinization, and Phytase Supplementation Alter Trace Element Bioavailability-A Narrative Review of Human Interventions","Chondrou T, Adamidi N, Lygouras D, Hirota SA, Androutsos O, Svolos V.",Nutrients. 2024 Nov 27;16(23):4069. doi: 10.3390/nu16234069.,Chondrou T,Nutrients,2024,17-12-2024,PMC11643945,,10.3390/nu16234069
39683391,Food Functional Factors in Alzheimer's Disease Intervention: Current Research Progress,"Nie RZ, Luo HM, Liu YP, Wang SS, Hou YJ, Chen C, Wang H, Lv HL, Tao XY, Jing ZH, Zhang HK, Li PF.",Nutrients. 2024 Nov 22;16(23):3998. doi: 10.3390/nu16233998.,Nie RZ,Nutrients,2024,17-12-2024,PMC11643887,,10.3390/nu16233998
39678681,Effects of Probiotics on Neurodegenerative Disease-Related Symptoms and Systemic Inflammation: A Systematic Review,"Zhu F, Yin S, Wang Y, Zhong Y, Ji Q, Wu J.",Int J Gen Med. 2024 Dec 10;17:5941-5958. doi: 10.2147/IJGM.S499406. eCollection 2024.,Zhu F,Int J Gen Med,2024,16-12-2024,PMC11645901,,10.2147/IJGM.S499406
39676256,Unlocking the potential of melanotransferrin (CD228): implications for targeted drug development and novel therapeutic avenues,"Zhang Y, Song D, Han X, Liu H, Wang Y, Wang X, Dou C.",Expert Opin Ther Targets. 2024 Dec;28(12):1117-1129. doi: 10.1080/14728222.2024.2441705. Epub 2024 Dec 19.,Zhang Y,Expert Opin Ther Targets,2024,16-12-2024,,,10.1080/14728222.2024.2441705
39675366,Associations between adverse pregnancy outcomes and cognitive impairment and dementia: a systematic review and meta-analysis,"Miller EC, Conley P, Alirezaei M, Wolfova K, Gonzales MM, Tan ZS, Tom SE, Yee LM, Brickman AM, Bello NA.",Lancet Healthy Longev. 2024 Dec;5(12):100660. doi: 10.1016/j.lanhl.2024.100660. Epub 2024 Dec 12.,Miller EC,Lancet Healthy Longev,2024,15-12-2024,PMC11726346,NIHMS2044849,10.1016/j.lanhl.2024.100660
39670449,"Cognition, Depression, Pain, and Exercise Motives as Predictors of Longitudinal Profiles of Physical Activity During a Seven-Year Follow-Up Among Older Adults","Kyrönlahti S, Lehtisalo J, Ngandu T, Kivipelto M, Strandberg T, Antikainen R, Laatikainen T, Soininen H, Tuomilehto J, Havulinna S, Kulmala J.",Scand J Med Sci Sports. 2024 Dec;34(12):e14777. doi: 10.1111/sms.14777.,Kyrönlahti S,Scand J Med Sci Sports,2024,13-12-2024,PMC11638919,,10.1111/sms.14777
39667708,Discovery of the microbiota-gut-brain axis mechanisms of acupuncture for amnestic mild cognitive impairment based on multi-omics analyses: A pilot study,"Yin ZH, Bao QN, Li YQ, Liu YW, Wang ZQ, Ye F, He X, Zhang XY, Zhong WQ, Wu KX, Yao J, Chen ZW, Zhao L, Liang FR.",Complement Ther Med. 2025 Mar;88:103118. doi: 10.1016/j.ctim.2024.103118. Epub 2024 Dec 10.,Yin ZH,Complement Ther Med,2025,12-12-2024,,,10.1016/j.ctim.2024.103118
39666629,Effects of rivastigmine on gait in patients with neurodegenerative disorders: A systematic review and meta-analysis,"Shim SR, Kim JY, Kwon KY, Shin J, Lee Y, Lee SM.",PLoS One. 2024 Dec 12;19(12):e0310900. doi: 10.1371/journal.pone.0310900. eCollection 2024.,Shim SR,PLoS One,2024,12-12-2024,PMC11637393,,10.1371/journal.pone.0310900
39664530,A meta-analysis of the efficacy of physical exercise interventions on activities of daily living in patients with Alzheimer's disease,"Xiao Y, Fan Y, Feng Z.",Front Public Health. 2024 Nov 27;12:1485807. doi: 10.3389/fpubh.2024.1485807. eCollection 2024.,Xiao Y,Front Public Health,2024,12-12-2024,PMC11631704,,10.3389/fpubh.2024.1485807
39664391,Broadening horizons: the multifaceted role of ferroptosis in breast cancer,"Ge A, Xiang W, Li Y, Zhao D, Chen J, Daga P, Dai CC, Yang K, Yan Y, Hao M, Zhang B, Xiao W.",Front Immunol. 2024 Nov 27;15:1455741. doi: 10.3389/fimmu.2024.1455741. eCollection 2024.,Ge A,Front Immunol,2024,12-12-2024,PMC11631881,,10.3389/fimmu.2024.1455741
39663901,Oxidative stress and chronic cerebral hypoperfusion: An overview from preclinical rodent models,"Kimura S, Iwata M, Takase H, Lo EH, Arai K.",J Cereb Blood Flow Metab. 2025 Mar;45(3):381-395. doi: 10.1177/0271678X241305899. Epub 2024 Dec 12.,Kimura S,J Cereb Blood Flow Metab,2025,12-12-2024,PMC11635795,,10.1177/0271678X241305899
39659348,The Role of Omega-3 Fatty Acid Supplementation in Slowing Cognitive Decline Among Elderly Patients With Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials,"Deshmukh GV, Niaz H, Bai R, Kim DH, Kim JW, Asghar J, Ramzan T, Maqbool M, Abushalha NB, Arif S, Khan S.",Cureus. 2024 Nov 10;16(11):e73390. doi: 10.7759/cureus.73390. eCollection 2024 Nov.,Deshmukh GV,Cureus,2024,11-12-2024,PMC11630619,,10.7759/cureus.73390
39644533,The need for personalization when sharing results of amyloid imaging for Alzheimer's disease: Insights from a randomized experimental study,"Fruijtier AD, van der Flier WM, van Maurik I, van der Schaar J, Pijnenburg YAL, Smets EMA, Visser LNC.",Patient Educ Couns. 2025 Feb;131:108587. doi: 10.1016/j.pec.2024.108587. Epub 2024 Nov 28.,Fruijtier AD,Patient Educ Couns,2025,07-12-2024,,,10.1016/j.pec.2024.108587
39626378,A preclinical and phase I clinical study of ex vivo-expanded amyloid beta-specific human regulatory T cells in Alzheimer's disease,"Yang H, Byun MS, Ha NY, Yang J, Park SY, Park JE, Yi D, Chang YT, Jung WS, Kim JY, Kim J, Lee DY, Bae H.",Biomed Pharmacother. 2024 Dec;181:117721. doi: 10.1016/j.biopha.2024.117721. Epub 2024 Dec 2.,Yang H,Biomed Pharmacother,2024,03-12-2024,,,10.1016/j.biopha.2024.117721
39623197,Emerging Pharmacological Approaches for Psychosis and Agitation in Alzheimer's Disease,"Imbimbo C, Cotta Ramusino M, Leone S, Mazzacane F, De Franco V, Gatti A, Perini G, Costa A.",CNS Drugs. 2025 Feb;39(2):143-160. doi: 10.1007/s40263-024-01133-9. Epub 2024 Dec 2.,Imbimbo C,CNS Drugs,2025,02-12-2024,PMC11769872,,10.1007/s40263-024-01133-9
39617303,Clinical evidence of acupuncture for amnestic mild cognitive impairment: A systematic review and meta-analysis of randomized controlled trials,"Lin G, Yie SLJ, Guo S, Li X, Xu L.",Complement Ther Med. 2025 Mar;88:103114. doi: 10.1016/j.ctim.2024.103114. Epub 2024 Nov 30.,Lin G,Complement Ther Med,2025,01-12-2024,,,10.1016/j.ctim.2024.103114
39614040,Effect of transcranial direct current stimulation with cognitive training on executive functions in healthy older adults: a secondary analysis from the ACT trial,"Aksu S, Indahlastari A, O'Shea A, Marsiske M, Cohen R, Alexander GE, DeKosky ST, Hishaw GA, Dai Y, Wu SS, Woods AJ.",Geroscience. 2025 Feb;47(1):1361-1380. doi: 10.1007/s11357-024-01455-y. Epub 2024 Nov 30.,Aksu S,Geroscience,2025,29-11-2024,PMC11872955,,10.1007/s11357-024-01455-y
39600165,[New Alzheimer's treatments - a need for national preparations and coordination],"Granberg T, Börjesson Hanson A, Fällmar D, Basun H, Wahlund LO.",Lakartidningen. 2024 Nov 20;121:24067.,Granberg T,Lakartidningen,2024,27-11-2024,,,
39599527,Infectious Disease as a Modifiable Risk Factor for Dementia: A Narrative Review,"Farrer TJ, Moore JD, Chase M, Gale SD, Hedges DW.",Pathogens. 2024 Nov 7;13(11):974. doi: 10.3390/pathogens13110974.,Farrer TJ,Pathogens,2024,27-11-2024,PMC11597442,,10.3390/pathogens13110974
39598703,New Insights into the Development of Donepezil-Based Hybrid and Natural Molecules as Multi-Target Drug Agents for Alzheimer's Disease Treatment,"Angelova VT, Stoyanov BP, Simeonova R.",Molecules. 2024 Nov 11;29(22):5314. doi: 10.3390/molecules29225314.,Angelova VT,Molecules,2024,27-11-2024,PMC11596391,,10.3390/molecules29225314
39596657,Assessing the Impact and Cost-Effectiveness of Exposome Interventions on Alzheimer's Disease: A Review of Agent-Based Modeling and Other Data Science Methods for Causal Inference,"Liu SH, Weber ES, Manz KE, McCarthy KJ, Chen Y, Schüffler PJ, Zhu CW, Tracy M.",Genes (Basel). 2024 Nov 12;15(11):1457. doi: 10.3390/genes15111457.,Liu SH,Genes (Basel),2024,27-11-2024,PMC11593565,,10.3390/genes15111457
39596544,The Role of Alpha-Linolenic Acid and Other Polyunsaturated Fatty Acids in Mental Health: A Narrative Review,"Bertoni C, Pini C, Mazzocchi A, Agostoni C, Brambilla P.",Int J Mol Sci. 2024 Nov 20;25(22):12479. doi: 10.3390/ijms252212479.,Bertoni C,Int J Mol Sci,2024,27-11-2024,PMC11594615,,10.3390/ijms252212479
39596098,"Therapeutic Challenges Derived from the Interaction Among Apolipoprotein E, Cholesterol, and Amyloid in Alzheimer's Disease",Menendez-Gonzalez M.,Int J Mol Sci. 2024 Nov 8;25(22):12029. doi: 10.3390/ijms252212029.,Menendez-Gonzalez M,Int J Mol Sci,2024,27-11-2024,PMC11593474,,10.3390/ijms252212029
39596082,Caffeine: A Multifunctional Efficacious Molecule with Diverse Health Implications and Emerging Delivery Systems,"Song X, Singh M, Lee KE, Vinayagam R, Kang SG.",Int J Mol Sci. 2024 Nov 8;25(22):12003. doi: 10.3390/ijms252212003.,Song X,Int J Mol Sci,2024,27-11-2024,PMC11593559,,10.3390/ijms252212003
39595941,Mechanism of Metal Complexes in Alzheimer's Disease,"Liu Y, Ma J, Zhang Q, Wang Y, Sun Q.",Int J Mol Sci. 2024 Nov 5;25(22):11873. doi: 10.3390/ijms252211873.,Liu Y,Int J Mol Sci,2024,27-11-2024,PMC11593898,,10.3390/ijms252211873
39595543,"Exposure to Metals, Pesticides, and Air Pollutants: Focus on Resulting DNA Methylation Changes in Neurodegenerative Diseases","Stoccoro A, Coppedè F.",Biomolecules. 2024 Oct 27;14(11):1366. doi: 10.3390/biom14111366.,Stoccoro A,Biomolecules,2024,27-11-2024,PMC11591912,,10.3390/biom14111366
39595507,Dementia and Video Games: Systematic and Bibliographic Review,"Eckert M, Ostermann T, Ehlers JP, Hohenberg G.",Healthcare (Basel). 2024 Nov 19;12(22):2310. doi: 10.3390/healthcare12222310.,Eckert M,Healthcare (Basel),2024,27-11-2024,PMC11593771,,10.3390/healthcare12222310
39591666,Roflumilast and cognition enhancement: A translational perspective,"Prickaerts J, Kerckhoffs J, Possemis N, van Overveld W, Verbeek F, Grooters T, Sambeth A, Blokland A.",Biomed Pharmacother. 2024 Dec;181:117707. doi: 10.1016/j.biopha.2024.117707. Epub 2024 Nov 25.,Prickaerts J,Biomed Pharmacother,2024,26-11-2024,,,10.1016/j.biopha.2024.117707
39588869,Communication Bridge-2 randomized controlled trial: Recruitment and baseline features,"Rogalski E, Bona M, Esparza M, Mooney A, Fried-Oken M, Rademaker A, Roberts A.",Alzheimers Dement. 2025 Jan;21(1):e14168. doi: 10.1002/alz.14168. Epub 2024 Nov 26.,Rogalski E,Alzheimers Dement,2025,26-11-2024,PMC11771146,,10.1002/alz.14168
39587504,"Efficacy and safety of Neurocognitive Adaptive Training for Depression combined with SSRIs for treating cognitive impairment among patients with late-life depression: a 12-week, randomized controlled study","Wang X, Zhou J, Zhu K, Wang Y, Ma X, Ren L, Guo C, Zhang Z, Lu P, Zhang Q.",BMC Psychiatry. 2024 Nov 25;24(1):848. doi: 10.1186/s12888-024-06276-z.,Wang X,BMC Psychiatry,2024,26-11-2024,PMC11590405,,10.1186/s12888-024-06276-z
39585065,Utilization of Single-Pulse Transcranial-Evoked Potentials in Neurological and Psychiatric Clinical Practice: A Narrative Review,"Fogel H, Zifman N, Hallett M.",Neurol Int. 2024 Nov 11;16(6):1421-1437. doi: 10.3390/neurolint16060106.,Fogel H,Neurol Int,2024,25-11-2024,PMC11587110,,10.3390/neurolint16060106
39582467,Protective Activity of Melatonin Combinations and Melatonin-Based Hybrid Molecules in Neurodegenerative Diseases,"Galvani F, Cammarota M, Vacondio F, Rivara S, Boscia F.",J Pineal Res. 2024 Nov;76(8):e70008. doi: 10.1111/jpi.70008.,Galvani F,J Pineal Res,2024,25-11-2024,PMC11586835,,10.1111/jpi.70008
39580468,"Post hoc analysis of ADAMANT, a phase 2 clinical trial of active tau immunotherapy with AADvac1 in patients with Alzheimer's disease, positive for plasma p-tau217","Kovacech B, Cullen NC, Novak P, Hanes J, Kontsekova E, Katina S, Parrak V, Fresser M, Vanbrabant J, Feldman HH, Winblad B, Stoops E, Vanmechelen E, Zilka N.",Alzheimers Res Ther. 2024 Nov 23;16(1):254. doi: 10.1186/s13195-024-01620-7.,Kovacech B,Alzheimers Res Ther,2024,23-11-2024,PMC11585249,,10.1186/s13195-024-01620-7
39575854,Plasma pTau217 ratio predicts continuous regional brain tau accumulation in amyloid-positive early Alzheimer's disease,"Devanarayan V, Charil A, Horie K, Doherty T, Llano DA, Andreozzi E, Sachdev P, Ye Y, Murali LK, Zhou J, Reyderman L, Hampel H, Kramer LD, Dhadda S, Irizarry MC; Alzheimer's Disease Neuroimaging Initiative (ADNI).",Alzheimers Dement. 2025 Feb;21(2):e14411. doi: 10.1002/alz.14411. Epub 2024 Nov 22.,Devanarayan V,Alzheimers Dement,2025,22-11-2024,PMC11848419,,10.1002/alz.14411
39574800,"Alcohol consumption and its association with cancer, cardiovascular, liver and brain diseases: a systematic review of Mendelian randomization studies","Bouajila N, Domenighetti C, Aubin HJ, Naassila M.",Front Epidemiol. 2024 Nov 7;4:1385064. doi: 10.3389/fepid.2024.1385064. eCollection 2024.,Bouajila N,Front Epidemiol,2024,22-11-2024,PMC11578756,,10.3389/fepid.2024.1385064
39574193,"A digitally supported multimodal lifestyle program to promote brain health among older adults (the LETHE randomized controlled feasibility trial): study design, progress, and first results","Rosenberg A, Untersteiner H, Guazzarini AG, Bödenler M, Bruinsma J, Buchgraber-Schnalzer B, Colombo M, Crutzen R, Diaz A, Fotiadis DI, Hilberger H, Huber S, Kaartinen N, Kassiotis T, Kivipelto M, Lehtisalo J, Loukas VS, Lötjönen J, Pirani M, Thunborg C, Hanke S, Mangialasche F, Mecocci P, Stögmann E, Ngandu T; on behaf of the LETHE Consortium.",Alzheimers Res Ther. 2024 Nov 21;16(1):252. doi: 10.1186/s13195-024-01615-4.,Rosenberg A,Alzheimers Res Ther,2024,22-11-2024,PMC11580696,,10.1186/s13195-024-01615-4
39572023,"A Comprehensive Review of Naringenin, a Promising Phytochemical with Therapeutic Potential","Shin JH, Shin SH.",J Microbiol Biotechnol. 2024 Dec 28;34(12):2425-2438. doi: 10.4014/jmb.2410.10006. Epub 2024 Nov 22.,Shin JH,J Microbiol Biotechnol,2024,21-11-2024,PMC11733549,,10.4014/jmb.2410.10006
39567981,Systematic review of Mendelian randomization studies on antihypertensive drugs,"Fan B, Zhang J, Zhao JV.",BMC Med. 2024 Nov 20;22(1):547. doi: 10.1186/s12916-024-03760-x.,Fan B,BMC Med,2024,20-11-2024,PMC11580643,,10.1186/s12916-024-03760-x
39567607,The effect of resistance training on patients with secondary sarcopenia: a systematic review and meta-analysis,"Cheng F, Li N, Yang J, Yang J, Yang W, Ran J, Sun P, Liao Y.",Sci Rep. 2024 Nov 20;14(1):28784. doi: 10.1038/s41598-024-79958-z.,Cheng F,Sci Rep,2024,20-11-2024,PMC11579013,,10.1038/s41598-024-79958-z
39567405,Heavy metals: toxicity and human health effects,"Jomova K, Alomar SY, Nepovimova E, Kuca K, Valko M.",Arch Toxicol. 2025 Jan;99(1):153-209. doi: 10.1007/s00204-024-03903-2. Epub 2024 Nov 20.,Jomova K,Arch Toxicol,2025,20-11-2024,PMC11742009,,10.1007/s00204-024-03903-2
39564918,Centiloid recommendations for clinical context-of-use from the AMYPAD consortium,"Collij LE, Bollack A, La Joie R, Shekari M, Bullich S, Roé-Vellvé N, Koglin N, Jovalekic A, Garciá DV, Drzezga A, Garibotto V, Stephens AW, Battle M, Buckley C, Barkhof F, Farrar G, Gispert JD; AMYPAD consortium.",Alzheimers Dement. 2024 Dec;20(12):9037-9048. doi: 10.1002/alz.14336. Epub 2024 Nov 20.,Collij LE,Alzheimers Dement,2024,20-11-2024,PMC11667534,,10.1002/alz.14336
39559905,Long-term effects of collaborative dementia care on quality of life and caregiver well-being,"Possin KL, Dulaney S, Sideman AB, Wood AJ, Allen IE, Bonasera SJ, Merrilees JJ, Lee K, Chiong W, Braley TL, Hooper S, Kanzawa M, Gearhart R, Medsger H, Harrison KL, Hunt LJ, Kiekhofer RE, Chow C, Miller BL, Guterman EL.",Alzheimers Dement. 2025 Jan;21(1):e14370. doi: 10.1002/alz.14370. Epub 2024 Nov 19.,Possin KL,Alzheimers Dement,2025,19-11-2024,PMC11782176,,10.1002/alz.14370
39559892,A Pilot Electroencephalography Study of the Effect of CT1812 Treatment on Synaptic Activity in Patients with Mild to Moderate Alzheimer's Disease,"Vijverberg E, de Haan W, Scheijbeler E, Hamby ME, Catalano S, Scheltens P, Grundman M, Caggiano AO.",J Prev Alzheimers Dis. 2024;11(6):1809-1817. doi: 10.14283/jpad.2024.154.,Vijverberg E,J Prev Alzheimers Dis,2024,19-11-2024,PMC11573871,,10.14283/jpad.2024.154
39559877,Examining the Role of Community Engagement in Enhancing the Participation of Racial and Ethnic Minoritized Communities in Alzheimer's Disease Clinical Trials; A Rapid Review,"Dabiri S, Raman R, Grooms J, Molina-Henry D.",J Prev Alzheimers Dis. 2024;11(6):1647-1672. doi: 10.14283/jpad.2024.149.,Dabiri S,J Prev Alzheimers Dis,2024,19-11-2024,PMC11573826,,10.14283/jpad.2024.149
39559872,Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease,"Galpern WR, Triana-Baltzer G, Li L, Van Kolen K, Timmers M, Haeverans K, Janssens L, Kolb H, Nandy P, Aida K, Shimizu H, Mercken M, Sun H.",J Prev Alzheimers Dis. 2024;11(6):1592-1603. doi: 10.14283/jpad.2024.163.,Galpern WR,J Prev Alzheimers Dis,2024,19-11-2024,PMC11573813,,10.14283/jpad.2024.163
39559708,Towards a Non-pharmacological Intervention on Apathy in Korsakoff's Syndrome: A Systematic Narrative Review Across Different Clinical Conditions,"van Dorst MEG, Rensen YCM, Nijsten JMH, Janssen GTL, Kessels RPC.",Neuropsychiatr Dis Treat. 2024 Nov 13;20:2125-2144. doi: 10.2147/NDT.S483470. eCollection 2024.,van Dorst MEG,Neuropsychiatr Dis Treat,2024,19-11-2024,PMC11570530,,10.2147/NDT.S483470
39550530,Effect of an 18-month meditation training on cardiovascular risk in older adults: a secondary analysis of the Age-Well randomized controlled trial,"Garnier-Crussard A, Gonneaud J, Felisatti F, Palix C, Ferrand Devouge E, Chocat A, Rauchs G, de la Sayette V, Vivien D, Demnitz-King H, Lutz A, Chételat G, Poisnel G; Medit-Ageing Research Group.",BMC Geriatr. 2024 Nov 16;24(1):954. doi: 10.1186/s12877-024-05550-9.,Garnier-Crussard A,BMC Geriatr,2024,16-11-2024,PMC11568626,,10.1186/s12877-024-05550-9
39547823,Testing the Efficacy of a Culturally Adapted Family Dementia Caregiver Intervention (REACH VN): Results From a Cluster Randomized Controlled Trial in Northern Vietnam,"Nguyen H, Nguyen HT, Nguyen NB, Tran D, Harvey DJ, Nguyen BT, Nguyen BTT, Nguyen AN, Nguyen CTH, Nguyen TTH, Nguyen TL, Nguyen ATP, Nguyen NH, Nguyen AL, Luong YH, Nguyen BH, Nguyen PQ, Gitlin LN, Nguyen TA, Pham T, Hinton L.",Am J Geriatr Psychiatry. 2025 May;33(5):535-545. doi: 10.1016/j.jagp.2024.10.011. Epub 2024 Oct 23.,Nguyen H,Am J Geriatr Psychiatry,2025,15-11-2024,PMC11903202,NIHMS2036050,10.1016/j.jagp.2024.10.011
39544560,"Osteoarthritis and Neurological Disorder Diagnoses in Adults: A Meta-Analysis Examining Associations With Parkinson's Disease, Multiple Sclerosis, and Alzheimer's Disease","Peoples BM, Harrison KD, Renfrow G, Bethea D, Santamaria Guzman KG, Wilson AE, Samaan MA, Roper JA.",Cureus. 2024 Oct 14;16(10):e71458. doi: 10.7759/cureus.71458. eCollection 2024 Oct.,Peoples BM,Cureus,2024,15-11-2024,PMC11560400,,10.7759/cureus.71458
39542035,Person Profile Dementia Intervention in Long-Term Care: A Stepped-Wedge Cluster-Randomized Trial,"Spichiger F, Koppitz AL, Riese F, Kipfer S, Nagl-Cupal M, Büscher A, Volken T, Larkin P, Meichtry A.",J Am Med Dir Assoc. 2025 Jan;26(1):105351. doi: 10.1016/j.jamda.2024.105351. Epub 2024 Nov 12.,Spichiger F,J Am Med Dir Assoc,2025,14-11-2024,,,10.1016/j.jamda.2024.105351
39533696,"The phospho-tau cascade, basal forebrain neurodegeneration, and dementia in Alzheimer's disease: Anti-neurodegenerative benefits of acetylcholinesterase inhibitors","Moss DE, Perez RG.",J Alzheimers Dis. 2024 Dec;102(3):617-626. doi: 10.1177/13872877241289602. Epub 2024 Nov 12.,Moss DE,J Alzheimers Dis,2024,13-11-2024,,,10.1177/13872877241289602
39531433,Impact of remote social interaction during the COVID-19 pandemic on the cognitive and psychological status of older adults with and without cognitive impairment: A randomized controlled study,"Vives-Rodriguez AL, Marin A, Schiloski KA, Hajos GP, Di Crosta A, Ceccato I, La Malva P, Anderson DC, Lahdo N, Donnelly K, Dong J, Kasha S, Rooney C, Dayaw J, Marton G, Wack A, Hanger V, DeCaro R, Di Domenico A, Turk KW, Palumbo R, Budson AE.",PLoS One. 2024 Nov 12;19(11):e0311792. doi: 10.1371/journal.pone.0311792. eCollection 2024.,Vives-Rodriguez AL,PLoS One,2024,12-11-2024,PMC11556722,,10.1371/journal.pone.0311792
39531391,"The Effect of the ""Safety in Dementia"" Online Tool to Assist Decision Making for Caregivers of Persons With Dementia and Access to Firearms : A Randomized Trial","Betz ME, Portz J, Knoepke C, Ranney ML, Fischer SM, Peterson RA, Johnson RL, Omeragic F, Castaneda M, Greenway E, Matlock D.",Ann Intern Med. 2024 Dec;177(12):1630-1640. doi: 10.7326/ANNALS-24-00763. Epub 2024 Oct 22.,Betz ME,Ann Intern Med,2024,12-11-2024,,,10.7326/ANNALS-24-00763
39529357,Alzheimer's disease: part 2 - the present,Nitrini R.,Arq Neuropsiquiatr. 2024 Jun;82(6):1-9. doi: 10.1055/s-0044-1791755. Epub 2024 Nov 11.,Nitrini R,Arq Neuropsiquiatr,2024,12-11-2024,,,10.1055/s-0044-1791755
39521443,Dual inhibition of butyrylcholinesterase and p38α mitogen-activated protein kinase: A new approach for the treatment of Alzheimer's disease,"Ferjančič Benetik S, Knez D, Obreza A, Košak U, Gobec S.",Pharmacol Ther. 2024 Dec;264:108748. doi: 10.1016/j.pharmthera.2024.108748. Epub 2024 Nov 7.,Ferjančič Benetik S,Pharmacol Ther,2024,09-11-2024,,,10.1016/j.pharmthera.2024.108748
39519769,Recent Advances in Therapeutics for the Treatment of Alzheimer's Disease,"Thawabteh AM, Ghanem AW, AbuMadi S, Thaher D, Jaghama W, Karaman D, Karaman R.",Molecules. 2024 Oct 30;29(21):5131. doi: 10.3390/molecules29215131.,Thawabteh AM,Molecules,2024,09-11-2024,PMC11547905,,10.3390/molecules29215131
39519549,Functional Foods in Preventing Human Blood Platelet Hyperactivity-Mediated Diseases-An Updated Review,Duttaroy AK.,Nutrients. 2024 Oct 30;16(21):3717. doi: 10.3390/nu16213717.,Duttaroy AK,Nutrients,2024,09-11-2024,PMC11547462,,10.3390/nu16213717
39519189,The Importance of Phosphoinositide 3-Kinase in Neuroinflammation,"Wright B, King S, Suphioglu C.",Int J Mol Sci. 2024 Oct 30;25(21):11638. doi: 10.3390/ijms252111638.,Wright B,Int J Mol Sci,2024,09-11-2024,PMC11546674,,10.3390/ijms252111638
39518362,Predictive and Explainable Artificial Intelligence for Neuroimaging Applications,"Lee S, Lee KS.",Diagnostics (Basel). 2024 Oct 27;14(21):2394. doi: 10.3390/diagnostics14212394.,Lee S,Diagnostics (Basel),2024,09-11-2024,PMC11545799,,10.3390/diagnostics14212394
39514119,Does Sleep Moderate the Effects of Exercise Training or Complex Mental and Social Activities on Cognitive Function in Adults With Chronic Stroke? Secondary Analysis of a Randomized Trial,"Falck RS, Stein RG, Davis JC, Eng JJ, Middleton LE, Hall PA, Liu-Ambrose T.",J Gerontol A Biol Sci Med Sci. 2024 Dec 11;80(1):glae264. doi: 10.1093/gerona/glae264.,Falck RS,J Gerontol A Biol Sci Med Sci,2024,08-11-2024,PMC11632229,,10.1093/gerona/glae264
39513754,Pharmacodynamic effects of semorinemab on plasma and CSF biomarkers of Alzheimer's disease pathophysiology,"Schauer SP, Toth B, Lee J, Honigberg LA, Ramakrishnan V, Jiang J, Kollmorgen G, Bayfield A, Wild N, Hoffman J, Ceniceros R, Dolton M, Bohórquez SMS, Hoogenraad CC, Wildsmith KR, Teng E, Monteiro C, Anania V, Yeh FL.",Alzheimers Dement. 2024 Dec;20(12):8855-8866. doi: 10.1002/alz.14346. Epub 2024 Nov 8.,Schauer SP,Alzheimers Dement,2024,08-11-2024,PMC11667501,,10.1002/alz.14346
39508315,Prevention and Treatment of Alzheimer's Disease Via the Regulation of the Gut Microbiota With Traditional Chinese Medicine,"Long J, Zhang J, Zeng X, Wang M, Wang N.",CNS Neurosci Ther. 2024 Nov;30(11):e70101. doi: 10.1111/cns.70101.,Long J,CNS Neurosci Ther,2024,07-11-2024,PMC11541599,,10.1111/cns.70101
39505779,Amyloid-beta antibody treatment in Alzheimer's disease : An update on recent data and outlook on implementation in clinical routine,"Stögmann E, Schmidt R.",Wien Klin Wochenschr. 2025 Mar;137(5-6):182-188. doi: 10.1007/s00508-024-02466-7. Epub 2024 Nov 6.,Stögmann E,Wien Klin Wochenschr,2025,06-11-2024,PMC11926045,,10.1007/s00508-024-02466-7
39504064,Neurocognitive effects of proanthocyanidin in Alzheimer's disease: a systematic review of preclinical evidence,"Reshma A, Subramanian A, Kumarasamy V, Tamilanban T, Sekar M, Gan SH, Subramaniyan V, Wong LS, Rani NNIM, Wu YS.",Braz J Med Biol Res. 2024 Nov 4;57:e13587. doi: 10.1590/1414-431X2024e13587. eCollection 2024.,Reshma A,Braz J Med Biol Res,2024,06-11-2024,PMC11540257,,10.1590/1414-431X2024e13587
39501255,Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease,"Hong CT, Chen JH, Hu CJ.",J Biomed Sci. 2024 Nov 5;31(1):102. doi: 10.1186/s12929-024-01090-x.,Hong CT,J Biomed Sci,2024,05-11-2024,PMC11539687,,10.1186/s12929-024-01090-x
39494329,Targeting Neurological Disorders with Stilbenes: Bridging the Preclinical-Clinical Gap,"Begh MZA, Khan J, Zehravi M, Sweilam SH, Raja AD, Muthukumar A, Haque MA, Kar NR, Singh LP, Priya BD, Alshehri MA, Ahmad I, Kang S, Moon S, Park MN, Emran TB, Kim B.",Int J Biol Sci. 2024 Oct 7;20(14):5474-5494. doi: 10.7150/ijbs.102032. eCollection 2024.,Begh MZA,Int J Biol Sci,2024,04-11-2024,PMC11528462,,10.7150/ijbs.102032
39490557,Verbal training can improve neurocognitive and reading performance by increasing white matter integrity and grey matter volume,"Hsu CC, Wu YH, Lee KS, Shih PC, Liu TY, Wei JC, Chu WM, Nakai T, Yang FG.",Exp Gerontol. 2024 Dec;198:112625. doi: 10.1016/j.exger.2024.112625. Epub 2024 Nov 9.,Hsu CC,Exp Gerontol,2024,03-11-2024,,,10.1016/j.exger.2024.112625
39484364,Systematic review and meta-analysis of the association between ABCA7 common variants and Alzheimer's disease in non-Hispanic White and Asian cohorts,"Liu D, Zhang H, Liu C, Liu J, Liu Y, Bai N, Zhou Q, Xu Z, Li L, Liu H.",Front Aging Neurosci. 2024 Oct 17;16:1406573. doi: 10.3389/fnagi.2024.1406573. eCollection 2024.,Liu D,Front Aging Neurosci,2024,01-11-2024,PMC11524920,,10.3389/fnagi.2024.1406573
39908392,"Dietary Patterns and Risk of Cognitive Decline, Dementia, Alzheimer's Disease, and Mild Cognitive Impairment: A Systematic Review","Booth S, Talegawkar S, Fung T, Hoelscher DM, Anderson CAM, Deierlein A, Gardner C, Giovannucci E, Raynor H, Stanford FC, Taylor C, Tobias D, Reigh N, English LK, Higgins M, Butera G, Terry N, Obbagy J.",Alexandria (VA): USDA Nutrition Evidence Systematic Review; 2024 Nov.,Booth S,"Dietary Patterns and Risk of Cognitive Decline, Dementia, Alzheimer's Disease, and Mild Cognitive Impairment: A Systematic Review",2024,01-11-2024,,,10.52570/NESR.DGAC2025.SR20
39476248,Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels,"Gonzalo R, Minguet C, Ortiz AM, Bravo MI, López OL, Boada M, Ruiz A, Costa M.",Ann Clin Transl Neurol. 2024 Dec;11(12):3280-3291. doi: 10.1002/acn3.52235. Epub 2024 Oct 30.,Gonzalo R,Ann Clin Transl Neurol,2024,30-10-2024,PMC11651178,,10.1002/acn3.52235
39468148,Critical assessment of anti-amyloid-β monoclonal antibodies effects in Alzheimer's disease: a systematic review and meta-analysis highlighting target engagement and clinical meaningfulness,"Avgerinos KI, Manolopoulos A, Ferrucci L, Kapogiannis D.",Sci Rep. 2024 Oct 28;14(1):25741. doi: 10.1038/s41598-024-75204-8.,Avgerinos KI,Sci Rep,2024,29-10-2024,PMC11520896,,10.1038/s41598-024-75204-8
39459209,Olive Oil Industry By-Products as a Novel Source of Biophenols with a Promising Role in Alzheimer Disease Prevention,"Gonçalves M, Costa M, Paiva-Martins F, Silva P.",Molecules. 2024 Oct 12;29(20):4841. doi: 10.3390/molecules29204841.,Gonçalves M,Molecules,2024,26-10-2024,PMC11510978,,10.3390/molecules29204841
39458561,Supplementation and Mitigating Cognitive Decline in Older Adults With or Without Mild Cognitive Impairment or Dementia: A Systematic Review,"Fu Q, DeJager J, Gardner EM.",Nutrients. 2024 Oct 21;16(20):3567. doi: 10.3390/nu16203567.,Fu Q,Nutrients,2024,26-10-2024,PMC11509913,,10.3390/nu16203567
39457003,Natural Products and Their Neuroprotective Effects in Degenerative Brain Diseases: A Comprehensive Review,"Lim DW, Lee JE, Lee C, Kim YT.",Int J Mol Sci. 2024 Oct 18;25(20):11223. doi: 10.3390/ijms252011223.,Lim DW,Int J Mol Sci,2024,26-10-2024,PMC11508681,,10.3390/ijms252011223
39456822,"Anti-Inflammatory and Neuroprotective Polyphenols Derived from the European Olive Tree, Olea europaea L., in Long COVID and Other Conditions Involving Cognitive Impairment","Papadopoulou P, Polissidis A, Kythreoti G, Sagnou M, Stefanatou A, Theoharides TC.",Int J Mol Sci. 2024 Oct 14;25(20):11040. doi: 10.3390/ijms252011040.,Papadopoulou P,Int J Mol Sci,2024,26-10-2024,PMC11507169,,10.3390/ijms252011040
39456229,Unveiling the Potential of Phytocannabinoids: Exploring Marijuana's Lesser-Known Constituents for Neurological Disorders,"Basavarajappa BS, Subbanna S.",Biomolecules. 2024 Oct 13;14(10):1296. doi: 10.3390/biom14101296.,Basavarajappa BS,Biomolecules,2024,26-10-2024,PMC11506053,,10.3390/biom14101296
39456145,"The Imbalance of Homocysteine, Vitamin B12 and Folic Acid in Parkinson Plus Syndromes: A Review beyond Parkinson Disease","Poulidou V, Liampas I, Arnaoutoglou M, Dardiotis E, Siokas V.",Biomolecules. 2024 Sep 26;14(10):1213. doi: 10.3390/biom14101213.,Poulidou V,Biomolecules,2024,26-10-2024,PMC11506381,,10.3390/biom14101213
39451238,The Emerging Role of Phosphodiesterase 5 Inhibition in Neurological Disorders: The State of the Art,"Crescioli C, Paronetto MP.",Cells. 2024 Oct 17;13(20):1720. doi: 10.3390/cells13201720.,Crescioli C,Cells,2024,25-10-2024,PMC11506759,,10.3390/cells13201720
39449020,Geospatial analysis of environmental atmospheric risk factors in neurodegenerative diseases: a systematic review update,"Oliveira M, Padrão A, Teodoro AC, Freitas A, Gonçalves H.",Syst Rev. 2024 Oct 24;13(1):267. doi: 10.1186/s13643-024-02637-7.,Oliveira M,Syst Rev,2024,25-10-2024,PMC11515500,,10.1186/s13643-024-02637-7
39444037,"Preclinical and first-in-human evaluation of AL002, a novel TREM2 agonistic antibody for Alzheimer's disease","Long H, Simmons A, Mayorga A, Burgess B, Nguyen T, Budda B, Rychkova A, Rhinn H, Tassi I, Ward M, Yeh F, Schwabe T, Paul R, Kenkare-Mitra S, Rosenthal A.",Alzheimers Res Ther. 2024 Oct 23;16(1):235. doi: 10.1186/s13195-024-01599-1.,Long H,Alzheimers Res Ther,2024,24-10-2024,PMC11515656,,10.1186/s13195-024-01599-1
39443463,Long-term cognitive training enhances fluid cognition and brain connectivity in individuals with MCI,"Gozdas E, Avelar-Pereira B, Fingerhut H, Dacorro L, Jo B, Williams L, O'Hara R, Hosseini SMH.",Transl Psychiatry. 2024 Oct 23;14(1):447. doi: 10.1038/s41398-024-03153-x.,Gozdas E,Transl Psychiatry,2024,23-10-2024,PMC11500385,,10.1038/s41398-024-03153-x
39439251,Assessing clinical progression measures in Alzheimer's disease trials: A systematic review and meta-analysis,"McLaughlin J, Scotton WJ, Ryan NS, Hardy JA, Shoai M.",Alzheimers Dement. 2024 Dec;20(12):8673-8683. doi: 10.1002/alz.14314. Epub 2024 Oct 22.,McLaughlin J,Alzheimers Dement,2024,23-10-2024,PMC11667530,,10.1002/alz.14314
39436867,The neuropharmacological and clinical effects of lutein: a systematic review,"Firozjae AA, Shiran MR, Rashidi M.",Horm Mol Biol Clin Investig. 2024 Oct 23;46(1):27-38. doi: 10.1515/hmbci-2024-0053. eCollection 2025 Mar 1.,Firozjae AA,Horm Mol Biol Clin Investig,2024,22-10-2024,,,10.1515/hmbci-2024-0053
39434821,Prevalence of Antibiotic Resistance in Older Adults and Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis,"Gohil NV, Gandara FF, Gohil H, Gurajala S, Innocent DC, Tesfaye T, Praticò D.",J Alzheimers Dis Rep. 2024 Sep 10;8(1):1241-1251. doi: 10.3233/ADR-240057. eCollection 2024.,Gohil NV,J Alzheimers Dis Rep,2024,22-10-2024,PMC11491939,,10.3233/ADR-240057
39431763,"Effects of Family Audio Recordings on Depression, Cognitive Function, and Sleep Quality of Individuals With Alzheimer's Disease: A Randomized Controlled Trial","Hu X, Wu Y, Zhang L, Jiang X.",J Gerontol Nurs. 2025 Jan;51(1):42-48. doi: 10.3928/00989134-20241010-02. Epub 2024 Oct 21.,Hu X,J Gerontol Nurs,2025,21-10-2024,,,10.3928/00989134-20241010-02
39429811,Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease,"Wise-Brown A, Brangman SA, Henderson JN, Willis-Parker M, Monroe S, Mintzer JE, Grundman M, Smith J, Doody RS, Lin H, Assman B, Rippon GA, Gonzales R, Assunção SS.",EClinicalMedicine. 2024 Jul 13;73:102693. doi: 10.1016/j.eclinm.2024.102693. eCollection 2024 Jul.,Wise-Brown A,EClinicalMedicine,2024,21-10-2024,PMC11490654,,10.1016/j.eclinm.2024.102693
39428764,Research Progress of Novel Inorganic Nanomaterials in the Diagnosis and Treatment of Alzheimer's Disease,"Ding N, Lei Y, Hu Y, Wei J, Wang W, Zhang R, Cai F.",Neurol India. 2024 Sep 1;72(5):943-950. doi: 10.4103/neurol-india.Neurol-India-D-23-00592. Epub 2024 Oct 19.,Ding N,Neurol India,2024,21-10-2024,,,10.4103/neurol-india.Neurol-India-D-23-00592
39422953,"Amyloid-Directed Antibodies: Past, Present, and Future","Noorda K, Noorda K, Sabbagh MN, Bertelson J, Singer J, Decourt B.",J Alzheimers Dis. 2024;101(s1):S3-S22. doi: 10.3233/JAD-240189.,Noorda K,J Alzheimers Dis,2024,18-10-2024,PMC12312309,NIHMS2097083,10.3233/JAD-240189
39422949,Conquering Insulin Network Dysfunctions in Alzheimer's Disease: Where Are We Today?,de la Monte SM.,J Alzheimers Dis. 2024;101(s1):S317-S343. doi: 10.3233/JAD-240069.,de la Monte SM,J Alzheimers Dis,2024,18-10-2024,PMC11807374,NIHMS2052156,10.3233/JAD-240069
39422935,A Randomized-Controlled Trial Targeting Cognition in Early Alzheimer's Disease by Improving Sleep with Trazodone (REST),"Eyob E, Shaw JS, Bakker A, Munro C, Spira A, Wu M, Rabinowitz JA, Peters M, Wanigatunga S, Zipunnikov V, Thompson R, Burhanullah MH, Leoutsakos JM, Rosenberg P, Greenberg B.",J Alzheimers Dis. 2024;101(s1):S205-S215. doi: 10.3233/JAD-230635.,Eyob E,J Alzheimers Dis,2024,18-10-2024,PMC12279255,NIHMS2097790,10.3233/JAD-230635
39422361,Decreased Brain pH Correlated With Progression of Alzheimer Disease Neuropathology: A Systematic Review and Meta-Analyses of Postmortem Studies,"Hagihara H, Miyakawa T.",Int J Neuropsychopharmacol. 2024 Oct 1;27(10):pyae047. doi: 10.1093/ijnp/pyae047.,Hagihara H,Int J Neuropsychopharmacol,2024,18-10-2024,PMC11511658,,10.1093/ijnp/pyae047
39421964,Two weeks of exercise alters neuronal extracellular vesicle insulin signaling proteins and pro-BDNF in older adults with prediabetes,"Malin SK, Battillo DJ, Beeri MS, Mustapic M, Delgado-Peraza F, Kapogiannis D.",Aging Cell. 2025 Jan;24(1):e14369. doi: 10.1111/acel.14369. Epub 2024 Oct 18.,Malin SK,Aging Cell,2025,18-10-2024,PMC11709104,,10.1111/acel.14369
39408961,Intrathecal Immunoselective Nanopheresis for Alzheimer's Disease: What and How? Why and When?,Menendez-Gonzalez M.,Int J Mol Sci. 2024 Oct 2;25(19):10632. doi: 10.3390/ijms251910632.,Menendez-Gonzalez M,Int J Mol Sci,2024,16-10-2024,PMC11476806,,10.3390/ijms251910632
39403057,Gut Microbiome in Alzheimer's Disease: from Mice to Humans,"Liang C, Pereira R, Zhang Y, Rojas OL.",Curr Neuropharmacol. 2024;22(14):2314-2329. doi: 10.2174/1570159X22666240308090741.,Liang C,Curr Neuropharmacol,2024,15-10-2024,PMC11451315,,10.2174/1570159X22666240308090741
39400823,Therapeutic Potentials of Near-Infrared II Photobiomodulation to Treat Cerebrovascular Diseases via Nitric Oxide Signalling,"Kashiwagi S, Yokomizo S, Bragin DE, Perle SJ, Kastanenka KV, Gerashchenko D, Atochin DN.",Adv Exp Med Biol. 2024;1463:195-200. doi: 10.1007/978-3-031-67458-7_33.,Kashiwagi S,Adv Exp Med Biol,2024,14-10-2024,PMC11670881,NIHMS2040884,10.1007/978-3-031-67458-7_33
39400461,"Safety, tolerability, and efficacy outcomes of the Investigation of Levetiracetam in Alzheimer's disease (ILiAD) study: a pilot, double-blind placebo-controlled crossover trial","Sen A, Toniolo S, Tai XY, Akinola M, Symmonds M, Mura S, Galloway J, Hallam A, Chan JYC, Koychev I, Butler C, Geddes J, Jones GD, Tabi Y, Maio R, Frangou E, Love S, Thompson S, Van Der Putt R, Manohar SG, McShane R, Husain M.",Epilepsia Open. 2024 Dec;9(6):2353-2364. doi: 10.1002/epi4.13070. Epub 2024 Oct 14.,Sen A,Epilepsia Open,2024,14-10-2024,PMC11633694,,10.1002/epi4.13070
39399866,Regional health priorities for dementia: a roadmap for the Western Pacific,"Timmins HC, Mok VCT, Kim SH, Shahrizaila N, Sung JY, Sobue G, Agustini S, Ward S, Anstey KJ, Talbot DL, Mazumder S, Tu S, Tan RH, Shin-Yi Lin C, O'Callaghan C, Michaelian JC, Jeon YH, Foxe D, Naismith SL, Piguet O, Ahmed R, Devenney E, Park SB, Kiernan MC.",Lancet Reg Health West Pac. 2024 Sep 16;50:101179. doi: 10.1016/j.lanwpc.2024.101179. eCollection 2024 Sep.,Timmins HC,Lancet Reg Health West Pac,2024,14-10-2024,PMC11471056,,10.1016/j.lanwpc.2024.101179
39392675,Intervention for the Management of Neuropsychiatric Symptoms to Reduce Caregiver Stress: Protocol for the Mindful and Self-Compassion Care Intervention for Caregivers of Persons Living With Dementia,"Travis A, O'Donnell A, Giraldo-Santiago N, Stone SM, Torres D, Adler SR, Vranceanu AM, Ritchie CS.",JMIR Res Protoc. 2024 Oct 11;13:e58356. doi: 10.2196/58356.,Travis A,JMIR Res Protoc,2024,11-10-2024,PMC11512127,,10.2196/58356
39390616,"Safety, tolerability, pharmacokinetics and pharmacodynamics of a single intravenous dose of SHR-1707 in healthy adult subjects: two randomized, double-blind, single-ascending-dose, phase 1 studies","Yang Y, Qiu H, Fan Y, Zhang Q, Qin H, Wu J, Zhang X, Liu Y, Zhou R, Zhang Q, Ye Z, Ma J, Xu Y, Feng S, Fei Y, Li N, Cui X, Dong F, Wang Q, Shen K, Shakib S, Williams J, Hu W.",Alzheimers Res Ther. 2024 Oct 10;16(1):218. doi: 10.1186/s13195-024-01584-8.,Yang Y,Alzheimers Res Ther,2024,10-10-2024,PMC11465679,,10.1186/s13195-024-01584-8
39390439,The efficacy of socially assistive robots in improving children's pain and negative affectivity during needle-based invasive treatment: A systematic review and meta-analysis,"Pan XY, Bi XY, Nong YN, Ye XC, Yan Y, Shang J, Zhou YM, Yao YZ.",BMC Pediatr. 2024 Oct 10;24(1):643. doi: 10.1186/s12887-024-05116-z.,Pan XY,BMC Pediatr,2024,10-10-2024,PMC11465713,,10.1186/s12887-024-05116-z
39379282,Impact of Mouthwash-Induced Oral Microbiome Disruption on Alzheimer's Disease Risk: A Perspective Review,"Boulares A, Jdidi H, Bragazzi NL.",Int Dent J. 2025 Feb;75(1):45-50. doi: 10.1016/j.identj.2024.07.005. Epub 2024 Oct 8.,Boulares A,Int Dent J,2025,08-10-2024,PMC11806309,,10.1016/j.identj.2024.07.005
39378469,Systematic Review and Meta-Analysis Confirm the Moderate Efficacy of High-Frequency r-TMS in Alzheimer's Disease: Mediating Effects of Anhedonia-Apathy and Add-On Motor-Cognitive Excersizes,"Chigareva O, Astafeva D, Bikbaeva K, Berezhnaya K, Sheifer M, Gayduk A, Khairedinova I, Zakharov A, Sack A, Koutsoumistros T, Cumming P, Sinha S, Smirnova D, Syunyakov T.",Psychiatr Danub. 2024 Sep;36(Suppl 2):188-202.,Chigareva O,Psychiatr Danub,2024,08-10-2024,,,
39376152,LEAP! Rx: A randomized trial of a pragmatic approach to lifestyle medicine,"Watts A, Szabo-Reed A, Baker J, Morris JK, Vacek J, Clutton J, Mahnken J, Key MN, Vidoni ED, Burns JM.",Alzheimers Dement. 2024 Dec;20(12):8374-8386. doi: 10.1002/alz.14265. Epub 2024 Oct 8.,Watts A,Alzheimers Dement,2024,08-10-2024,PMC11667554,,10.1002/alz.14265
39370055,Free radicals in Alzheimer's disease: From pathophysiology to clinical trial results,"Viña J, Borrás C, Mas-Bargues C.",Free Radic Biol Med. 2024 Nov 20;225:296-301. doi: 10.1016/j.freeradbiomed.2024.09.051. Epub 2024 Oct 5.,Viña J,Free Radic Biol Med,2024,06-10-2024,,,10.1016/j.freeradbiomed.2024.09.051
39369280,Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized study,"Nakamura Y, Adachi J, Hirota N, Iba K, Shimizu K, Nakai M, Takahashi K, Mori N.",Alzheimers Dement. 2024 Nov;20(11):8002-8011. doi: 10.1002/alz.14282. Epub 2024 Oct 6.,Nakamura Y,Alzheimers Dement,2024,06-10-2024,PMC11567808,,10.1002/alz.14282
39366844,Insights into the use of biomarkers in clinical trials in Alzheimer's disease,"Pascoal TA, Aguzzoli CS, Lussier FZ, Crivelli L, Suemoto CK, Fortea J, Rosa-Neto P, Zimmer ER, Ferreira PCL, Bellaver B.",EBioMedicine. 2024 Oct;108:105322. doi: 10.1016/j.ebiom.2024.105322. Epub 2024 Oct 3.,Pascoal TA,EBioMedicine,2024,04-10-2024,PMC11663755,,10.1016/j.ebiom.2024.105322
39367211,Exogenous and endogenous formaldehyde-induced DNA damage in the aging brain: mechanisms and implications for brain diseases,"Tian Z, Huang K, Yang W, Chen Y, Lyv W, Zhu B, Yang X, Ma P, Tong Z.",Cell Biol Toxicol. 2024 Oct 5;40(1):83. doi: 10.1007/s10565-024-09926-w.,Tian Z,Cell Biol Toxicol,2024,04-10-2024,PMC11452425,,10.1007/s10565-024-09926-w
39365407,Orexin Receptor Antagonists for the Prevention and Treatment of Alzheimer's Disease and Associated Sleep Disorders,"Carpi M, Mercuri NB, Liguori C.",Drugs. 2024 Nov;84(11):1365-1378. doi: 10.1007/s40265-024-02096-3. Epub 2024 Oct 4.,Carpi M,Drugs,2024,04-10-2024,PMC11602839,,10.1007/s40265-024-02096-3
39364856,Effectiveness of a 14-week protocol for cognitive stimulation therapy for mild dementia: results from a pragmatic study using routinely collected clinical data,"Abdelkhalek H, Elliott K, Whitfield T, Pazvantova K, Zabihi S, Wenborn J, Walker Z.",Aging Ment Health. 2025 Mar;29(3):549-557. doi: 10.1080/13607863.2024.2410256. Epub 2024 Oct 4.,Abdelkhalek H,Aging Ment Health,2025,04-10-2024,,,10.1080/13607863.2024.2410256
39358806,Inflammatory proteins associated with Alzheimer's disease reduced by a GLP1 receptor agonist: a post hoc analysis of the EXSCEL randomized placebo controlled trial,"Koychev I, Reid G, Nguyen M, Mentz RJ, Joyce D, Shah SH, Holman RR.",Alzheimers Res Ther. 2024 Oct 2;16(1):212. doi: 10.1186/s13195-024-01573-x.,Koychev I,Alzheimers Res Ther,2024,02-10-2024,PMC11448378,,10.1186/s13195-024-01573-x
39358355,Davunetide sex-dependently boosts memory in prodromal Alzheimer's disease,"Gozes I, Blatt J, Lobyntseva A.",Transl Psychiatry. 2024 Oct 2;14(1):412. doi: 10.1038/s41398-024-03118-0.,Gozes I,Transl Psychiatry,2024,02-10-2024,PMC11446927,,10.1038/s41398-024-03118-0
39350371,"Japanese Subgroup Analyses from EMERGE and ENGAGE, Phase 3 Clinical Trials of Aducanumab in Patients with Early Alzheimer's Disease","Toda Y, Iwatsubo T, Nakamura Y, Matsuda N, Miyata M, Jin M, Chen T, Kuribayashi K, Tian Y, Hughes R, Yamamoto J, Muralidharan KK, Rubel C, Hutchison RM, Budd Haeberlein S.",J Prev Alzheimers Dis. 2024;11(5):1260-1269. doi: 10.14283/jpad.2024.106.,Toda Y,J Prev Alzheimers Dis,2024,01-10-2024,PMC11436400,,10.14283/jpad.2024.106
39350368,A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer's Disease,"Chen T, Hutchison RM, Rubel C, Murphy J, Xie J, Montenigro P, Cheng W, Fraser K, Dent G, Hendrix S, Hansson O, Aisen P, Tian Y, O'Gorman J.",J Prev Alzheimers Dis. 2024;11(5):1228-1240. doi: 10.14283/jpad.2024.126.,Chen T,J Prev Alzheimers Dis,2024,01-10-2024,PMC11436399,,10.14283/jpad.2024.126
39348087,"mGlu4R, mGlu7R, and mGlu8R allosteric modulation for treating acute and chronic neurodegenerative disorders","Domin H, Burnat G.",Pharmacol Rep. 2024 Dec;76(6):1219-1241. doi: 10.1007/s43440-024-00657-7. Epub 2024 Sep 30.,Domin H,Pharmacol Rep,2024,30-09-2024,PMC11582148,,10.1007/s43440-024-00657-7
39344050,A critical review of brexpiprazole oral tablets as the first drug approved to treat agitation symptoms associated with dementia due to Alzheimer's disease,"Zhong K, Cummings J.",Expert Rev Neurother. 2025 Jan;25(1):5-13. doi: 10.1080/14737175.2024.2407836. Epub 2024 Sep 29.,Zhong K,Expert Rev Neurother,2025,30-09-2024,PMC12025908,NIHMS2027226,10.1080/14737175.2024.2407836
39341443,Effects of a 6-Week Treadmill Training With and Without Virtual Reality on Frailty in People With Multiple Sclerosis,"Zanotto T, Galperin I, Pradeep Kumar D, Mirelman A, Yehezkyahu S, Regev K, Karni A, Schmitz-Hübsch T, Paul F, Lynch SG, Akinwuntan AE, He J, Troen BR, Devos H, Hausdorff JM, Sosnoff JJ.",Arch Phys Med Rehabil. 2025 Feb;106(2):187-194. doi: 10.1016/j.apmr.2024.09.010. Epub 2024 Sep 26.,Zanotto T,Arch Phys Med Rehabil,2025,28-09-2024,,,10.1016/j.apmr.2024.09.010
39340935,"Lipids, lipoproteins, and apolipoproteins: Associations with cognition and dementia","Juul Rasmussen I, Luo J, Frikke-Schmidt R.",Atherosclerosis. 2024 Nov;398:118614. doi: 10.1016/j.atherosclerosis.2024.118614. Epub 2024 Sep 21.,Juul Rasmussen I,Atherosclerosis,2024,28-09-2024,,,10.1016/j.atherosclerosis.2024.118614
39339756,Whole Plant Extracts for Neurocognitive Disorders: A Narrative Review of Neuropsychological and Preclinical Studies,"Piva A, Benvegnù G, Negri S, Commisso M, Ceccato S, Avesani L, Guzzo F, Chiamulera C.",Nutrients. 2024 Sep 18;16(18):3156. doi: 10.3390/nu16183156.,Piva A,Nutrients,2024,28-09-2024,PMC11434991,,10.3390/nu16183156
39339348,p38α Mitogen-Activated Protein Kinase-An Emerging Drug Target for the Treatment of Alzheimer's Disease,"Detka J, Płachtij N, Strzelec M, Manik A, Sałat K.",Molecules. 2024 Sep 13;29(18):4354. doi: 10.3390/molecules29184354.,Detka J,Molecules,2024,28-09-2024,PMC11433989,,10.3390/molecules29184354
39337560,Emerging Role of Extracellular Vesicles as Biomarkers in Neurodegenerative Diseases and Their Clinical and Therapeutic Potential in Central Nervous System Pathologies,"Malaguarnera M, Cabrera-Pastor A.",Int J Mol Sci. 2024 Sep 19;25(18):10068. doi: 10.3390/ijms251810068.,Malaguarnera M,Int J Mol Sci,2024,28-09-2024,PMC11432603,,10.3390/ijms251810068
39335404,Apolipoprotein E and Alzheimer's Disease in Italian Population: Systematic Review and Meta-Analysis,"Abrego-Guandique DM, Saraceno GF, Cannataro R, Manzzo de Burnside M, Caroleo MC, Cione E.",Brain Sci. 2024 Sep 7;14(9):908. doi: 10.3390/brainsci14090908.,Abrego-Guandique DM,Brain Sci,2024,28-09-2024,PMC11430190,,10.3390/brainsci14090908
39332901,"What's in It for Me? Contextualizing the Potential Clinical Impacts of Lecanemab, Donanemab, and Other Anti-β-amyloid Monoclonal Antibodies in Early Alzheimer's Disease","Jin M, Noble JM.",eNeuro. 2024 Sep 27;11(9):ENEURO.0088-24.2024. doi: 10.1523/ENEURO.0088-24.2024. Print 2024 Sep.,Jin M,eNeuro,2024,27-09-2024,PMC11439562,,10.1523/ENEURO.0088-24.2024
39332547,"Central effects of acute intranasal insulin on neuroimaging, cognitive, and behavioural outcomes: A systematic review","Tabassum A, Badulescu S, Singh E, Asoro R, McIntyre RS, Teopiz KM, Llach CD, Shah H, Mansur RB.",Neurosci Biobehav Rev. 2024 Dec;167:105907. doi: 10.1016/j.neubiorev.2024.105907. Epub 2024 Sep 25.,Tabassum A,Neurosci Biobehav Rev,2024,27-09-2024,,,10.1016/j.neubiorev.2024.105907
39331931,The role and mechanism of dapagliflozin in Alzheimer disease: A review,"Chen P, Liang L, Dai Y, Hui S.",Medicine (Baltimore). 2024 Sep 27;103(39):e39687. doi: 10.1097/MD.0000000000039687.,Chen P,Medicine (Baltimore),2024,27-09-2024,PMC11441869,,10.1097/MD.0000000000039687
39329711,Immunotherapy for Parkinson's Disease and Alzheimer's Disease: A Promising Disease-Modifying Therapy,"Mahboob A, Ali H, AlNaimi A, Yousef M, Rob M, Al-Muhannadi NA, Senevirathne DKL, Chaari A.",Cells. 2024 Sep 12;13(18):1527. doi: 10.3390/cells13181527.,Mahboob A,Cells,2024,27-09-2024,PMC11429902,,10.3390/cells13181527
39323633,"Cannabidiol, a plant-derived compound, is an emerging strategy for treating cognitive impairments: comprehensive review of randomized trials","Yndart Arias A, Vadell K, Vashist A, Kolishetti N, Lakshmana MK, Nair M, Liuzzi JP.",Front Pharmacol. 2024 Sep 11;15:1403147. doi: 10.3389/fphar.2024.1403147. eCollection 2024.,Yndart Arias A,Front Pharmacol,2024,26-09-2024,PMC11422111,,10.3389/fphar.2024.1403147
39320017,Reversibility of cognitive worsening observed with BACE inhibitor umibecestat in the Alzheimer's Prevention Initiative (API) Generation Studies,"Tariot PN, Riviere ME, Salloway S, Burns JM, Snaedal JG, Borowsky B, Lopez CL, Liu F, Rouzade-Dominguez ML, Cazorla P, Mousseau MC, Arkuszewski M, Ricart J, Viglietta V, Sui Y, Caputo A, Langbaum JB, Reiman EM, Graf A.",Alzheimers Dement. 2024 Nov;20(11):7745-7761. doi: 10.1002/alz.14237. Epub 2024 Sep 25.,Tariot PN,Alzheimers Dement,2024,25-09-2024,PMC11567862,,10.1002/alz.14237
39316411,A framework for translating tauopathy therapeutics: Drug discovery to clinical trials,"Feldman HH, Cummings JL, Boxer AL, Staffaroni AM, Knopman DS, Sukoff Rizzo SJ, Territo PR, Arnold SE, Ballard C, Beher D, Boeve BF, Dacks PA, Diaz K, Ewen C, Fiske B, Gonzalez MI, Harris GA, Hoffman BJ, Martinez TN, McDade E, Nisenbaum LK, Palma JA, Quintana M, Rabinovici GD, Rohrer JD, Rosen HJ, Troyer MD, Kim DY, Tanzi RE, Zetterberg H, Ziogas NK, May PC, Rommel A.",Alzheimers Dement. 2024 Nov;20(11):8129-8152. doi: 10.1002/alz.14250. Epub 2024 Sep 24.,Feldman HH,Alzheimers Dement,2024,24-09-2024,PMC11567863,,10.1002/alz.14250
39316339,Molecular Therapeutics in Development to Treat Alzheimer's Disease,"Tartaglia MC, Ingelsson M.",Mol Diagn Ther. 2025 Jan;29(1):9-24. doi: 10.1007/s40291-024-00738-6. Epub 2024 Sep 24.,Tartaglia MC,Mol Diagn Ther,2025,24-09-2024,PMC11748464,,10.1007/s40291-024-00738-6
39315325,Effects of sodium benzoate on cognitive function in neuropsychiatric disorders: a systematic review and meta-analysis,"Liang CW, Cheng HY, Tseng MM.",Front Psychiatry. 2024 Sep 9;15:1370431. doi: 10.3389/fpsyt.2024.1370431. eCollection 2024.,Liang CW,Front Psychiatry,2024,24-09-2024,PMC11416944,,10.3389/fpsyt.2024.1370431
39313800,Limitations and potential strategies of immune checkpoint blockade in age-related neurodegenerative disorders,"Lasheen NN, Allam S, Elgarawany A, Aswa DW, Mansour R, Farouk Z.",J Physiol Sci. 2024 Sep 23;74(1):46. doi: 10.1186/s12576-024-00933-4.,Lasheen NN,J Physiol Sci,2024,24-09-2024,PMC11421184,,10.1186/s12576-024-00933-4
39312316,Effect of long-term pharmacological treatments on Alzheimer disease: A systematic review and network meta-analysis,"Deng X, Li D.",Medicine (Baltimore). 2024 Sep 20;103(38):e39753. doi: 10.1097/MD.0000000000039753.,Deng X,Medicine (Baltimore),2024,23-09-2024,PMC11419515,,10.1097/MD.0000000000039753
39300341,Efficacy and safety of choline alphoscerate for amnestic mild cognitive impairment: a randomized double-blind placebo-controlled trial,"Jeon J, Lee SY, Lee S, Han C, Park GD, Kim SJ, Chang JG, Kim WJ.",BMC Geriatr. 2024 Sep 19;24(1):774. doi: 10.1186/s12877-024-05366-7.,Jeon J,BMC Geriatr,2024,19-09-2024,PMC11412009,,10.1186/s12877-024-05366-7
39297292,Measuring clinically relevant change in apathy symptoms in ADMET and ADMET 2,"Tumati S, Herrmann N, Perin J, Rosenberg PB, Lerner AJ, Mintzer J, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Shade D, Lanctôt KL.",Int Psychogeriatr. 2024 Dec;36(12):1232-1244. doi: 10.1017/S1041610224000711. Epub 2024 Sep 19.,Tumati S,Int Psychogeriatr,2024,19-09-2024,PMC11695175,NIHMS2001593,10.1017/S1041610224000711
39285266,Dose-response relationship of high-intensity training on global cognition in older adults with mild cognitive impairment or dementia: a systematic review with meta-analysis - the ACHIEVE-Study,"Afanador-Restrepo DF, Casanova-Correa A, Martín-Ojeda RI, Aibar-Almazán A, González-Martín AM, Hita-Contreras F, Del Carmen Carcelén-Fraile M, Castellote-Caballero Y.",Eur Rev Aging Phys Act. 2024 Sep 16;21(1):23. doi: 10.1186/s11556-024-00358-3.,Afanador-Restrepo DF,Eur Rev Aging Phys Act,2024,16-09-2024,PMC11407012,,10.1186/s11556-024-00358-3
39276955,Role of histone deacetylases and their inhibitors in neurological diseases,"Zhang LY, Zhang SY, Wen R, Zhang TN, Yang N.",Pharmacol Res. 2024 Oct;208:107410. doi: 10.1016/j.phrs.2024.107410. Epub 2024 Sep 12.,Zhang LY,Pharmacol Res,2024,14-09-2024,,,10.1016/j.phrs.2024.107410
39275022,Pomegranate (Punica granatum L.) Extract Effects on Inflammaging,"Cordiano R, Gammeri L, Di Salvo E, Gangemi S, Minciullo PL.",Molecules. 2024 Sep 3;29(17):4174. doi: 10.3390/molecules29174174.,Cordiano R,Molecules,2024,14-09-2024,PMC11396831,,10.3390/molecules29174174
39274904,Latest Perspectives on Alzheimer's Disease Treatment: The Role of Blood-Brain Barrier and Antioxidant-Based Drug Delivery Systems,"Daraban BS, Popa AS, Stan MS.",Molecules. 2024 Aug 27;29(17):4056. doi: 10.3390/molecules29174056.,Daraban BS,Molecules,2024,14-09-2024,PMC11397357,,10.3390/molecules29174056
39273435,Psychobiotic Properties of Lactiplantibacillus plantarum in Neurodegenerative Diseases,"Di Chiano M, Sallustio F, Fiocco D, Rocchetti MT, Spano G, Pontrelli P, Moschetta A, Gesualdo L, Gadaleta RM, Gallone A.",Int J Mol Sci. 2024 Aug 31;25(17):9489. doi: 10.3390/ijms25179489.,Di Chiano M,Int J Mol Sci,2024,14-09-2024,PMC11394828,,10.3390/ijms25179489
39273288,Unveiling the Therapeutic Potential of Folate-Dependent One-Carbon Metabolism in Cancer and Neurodegeneration,"Sobral AF, Cunha A, Silva V, Gil-Martins E, Silva R, Barbosa DJ.",Int J Mol Sci. 2024 Aug 28;25(17):9339. doi: 10.3390/ijms25179339.,Sobral AF,Int J Mol Sci,2024,14-09-2024,PMC11395277,,10.3390/ijms25179339
39272986,Anti-Inflammatory Role of the Klotho Protein and Relevance to Aging,"Prud'homme GJ, Wang Q.",Cells. 2024 Aug 24;13(17):1413. doi: 10.3390/cells13171413.,Prud'homme GJ,Cells,2024,14-09-2024,PMC11394293,,10.3390/cells13171413
39267112,TRanscranial AlterNating current stimulation FOR patients with mild Alzheimer's Disease (TRANSFORM-AD): a randomized controlled clinical trial,"Tang Y, Xing Y, Sun L, Wang Z, Wang C, Yang K, Zhu W, Shi X, Xie B, Yin Y, Mi Y, Wei T, Tong R, Qiao Y, Yan S, Wei P, Yang Y, Shan Y, Zhang X, Jia J, Teipel SJ, Howard R, Lu J, Li C, Zhao G.",Alzheimers Res Ther. 2024 Sep 12;16(1):203. doi: 10.1186/s13195-024-01570-0.,Tang Y,Alzheimers Res Ther,2024,12-09-2024,PMC11395938,,10.1186/s13195-024-01570-0
39258164,A systematic review of clinical efficacy and safety of cell-based therapies in Alzheimer's disease,"Feizi H, Hosseini MS, Seyedi-Sahebari S, Karimi H, Mosaddeghi-Heris R, Sadigh-Eteghad S, Sadeghi-Ghyassi F, Talebi M, Naseri A, Salehi-Pourmehr H, Roshangar L.",Dement Neuropsychol. 2024 Sep 6;18:e20240147. doi: 10.1590/1980-5764-DN-2024-0147. eCollection 2024.,Feizi H,Dement Neuropsychol,2024,11-09-2024,PMC11386524,,10.1590/1980-5764-DN-2024-0147
39257940,The impact of empowerment theory-based health education on Alzheimer's disease informal caregivers: a randomized controlled trial,"Liu X, Wang S, Wei L, Liu Y, Bian J, Wang S, Du X.",Front Public Health. 2024 Aug 27;12:1393823. doi: 10.3389/fpubh.2024.1393823. eCollection 2024.,Liu X,Front Public Health,2024,11-09-2024,PMC11385866,,10.3389/fpubh.2024.1393823
39255800,Fluid biomarkers in the context of amyloid-targeting disease-modifying treatments in Alzheimer's disease,"Hu Y, Cho M, Sachdev P, Dage J, Hendrix S, Hansson O, Bateman RJ, Hampel H.",Med. 2024 Oct 11;5(10):1206-1226. doi: 10.1016/j.medj.2024.08.004. Epub 2024 Sep 9.,Hu Y,Med,2024,10-09-2024,,,10.1016/j.medj.2024.08.004
39246604,"Modifying Alzheimer's disease pathophysiology with photobiomodulation: model, evidence, and future with EEG-guided intervention",Lim L.,Front Neurol. 2024 Aug 23;15:1407785. doi: 10.3389/fneur.2024.1407785. eCollection 2024.,Lim L,Front Neurol,2024,09-09-2024,PMC11377238,,10.3389/fneur.2024.1407785
39241934,GPCR-mediated natural products and compounds: Potential therapeutic targets for the treatment of neurological diseases,"Wang XX, Ji X, Lin J, Wong IN, Lo HH, Wang J, Qu L, Wong VKW, Chung SK, Law BYK.",Pharmacol Res. 2024 Oct;208:107395. doi: 10.1016/j.phrs.2024.107395. Epub 2024 Sep 4.,Wang XX,Pharmacol Res,2024,06-09-2024,,,10.1016/j.phrs.2024.107395
39241907,[Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)): Relevant biomarker and therapeutic target?],Bonnefont-Rousselot D.,Ann Pharm Fr. 2025 Jan;83(1):45-57. doi: 10.1016/j.pharma.2024.08.011. Epub 2024 Sep 4.,Bonnefont-Rousselot D,Ann Pharm Fr,2025,06-09-2024,,,10.1016/j.pharma.2024.08.011
39240280,Insulin-Like Growth Factor Signaling in Alzheimer's Disease: Pathophysiology and Therapeutic Strategies,"Miao J, Zhang Y, Su C, Zheng Q, Guo J.",Mol Neurobiol. 2025 Mar;62(3):3195-3225. doi: 10.1007/s12035-024-04457-1. Epub 2024 Sep 6.,Miao J,Mol Neurobiol,2025,06-09-2024,PMC11790777,,10.1007/s12035-024-04457-1
39240044,Pathways to personalized medicine-Embracing heterogeneity for progress in clinical therapeutics research in Alzheimer's disease,"Arnold SE, Hyman BT, Betensky RA, Dodge HH.",Alzheimers Dement. 2024 Oct;20(10):7384-7394. doi: 10.1002/alz.14063. Epub 2024 Sep 6.,Arnold SE,Alzheimers Dement,2024,06-09-2024,PMC11485305,,10.1002/alz.14063
39238639,Single-domain antibodies and aptamers drive new opportunities for neurodegenerative disease research,"Shoemaker RL, Larsen RJ, Larsen PA.",Front Immunol. 2024 Aug 22;15:1426656. doi: 10.3389/fimmu.2024.1426656. eCollection 2024.,Shoemaker RL,Front Immunol,2024,06-09-2024,PMC11374656,,10.3389/fimmu.2024.1426656
39236857,Dysfunctional mitochondria in age-related neurodegeneration: Utility of melatonin as an antioxidant treatment,"Reiter RJ, Sharma RN, Manucha W, Rosales-Corral S, Almieda Chuffa LG, Loh D, Luchetti F, Balduini W, Govitrapong P.",Ageing Res Rev. 2024 Nov;101:102480. doi: 10.1016/j.arr.2024.102480. Epub 2024 Sep 3.,Reiter RJ,Ageing Res Rev,2024,05-09-2024,,,10.1016/j.arr.2024.102480
39226946,"A randomized, placebo-controlled trial of purified anthocyanins on cognitive function in individuals at elevated risk for dementia: Analysis of inflammatory biomarkers toward personalized interventions","Borda MG, Barreto GE, Baldera JP, de Lucia C, Khalifa K, Bergland AK, Pola I, Botero-Rodríguez F, Siow RC, Kivipelto M, Zetterberg H, Ashton NJ, Ballard C, Aarsland D; NJ FINGER.",Exp Gerontol. 2024 Oct 15;196:112569. doi: 10.1016/j.exger.2024.112569. Epub 2024 Sep 9.,Borda MG,Exp Gerontol,2024,03-09-2024,,,10.1016/j.exger.2024.112569
39223534,Air pollution: a latent key driving force of dementia,"Mohammadzadeh M, Khoshakhlagh AH, Grafman J.",BMC Public Health. 2024 Sep 2;24(1):2370. doi: 10.1186/s12889-024-19918-4.,Mohammadzadeh M,BMC Public Health,2024,02-09-2024,PMC11367863,,10.1186/s12889-024-19918-4
39221402,Navigating Prevention: A Systematic Review of Strategies for Alzheimer's Disease in High-Risk and Affected Individuals,"Guanín Cabrera CL, Jaramillo AP, Vallejo MP, Cueva MG, Grandes X, Navarro Grijalva M, Hidalgo Guerrero OJ.",Cureus. 2024 Aug 1;16(8):e65972. doi: 10.7759/cureus.65972. eCollection 2024 Aug.,Guanín Cabrera CL,Cureus,2024,02-09-2024,PMC11365738,,10.7759/cureus.65972
39217739,Forget me not: The effect of doxycycline on human declarative memory,"Wehrli JM, Xia Y, Meister L, Tursunova S, Kleim B, Bach DR, Quednow BB.",Eur Neuropsychopharmacol. 2024 Dec;89:1-9. doi: 10.1016/j.euroneuro.2024.08.006. Epub 2024 Aug 31.,Wehrli JM,Eur Neuropsychopharmacol,2024,01-09-2024,,,10.1016/j.euroneuro.2024.08.006
40424434,Evidence Map on Home- and Community-Based Services and Person-Centered Care for Older Adults,"Wang Z, Chen CYY, Njeru JW, Nayfeh T, Saadi S, Farah MH, Viola KE, Prokop LJ, Murad MH.",Rockville (MD): Agency for Healthcare Research and Quality (US); 2024 Sep. Report No.: 25-EHC023.,Wang Z,Evidence Map on Home- and Community-Based Services and Person-Centered Care for Older Adults,2024,01-09-2024,,,
39213688,Perceptions of bias and credibility of male and female clinical psychologist and psychiatrist expert witnesses presenting clinical information in the courtroom,"Kipoulas E, Edwards I, Radakovic R, Beazley PI.",Int J Law Psychiatry. 2024 Sep-Oct;96:102016. doi: 10.1016/j.ijlp.2024.102016. Epub 2024 Aug 29.,Kipoulas E,Int J Law Psychiatry,2024,30-08-2024,,,10.1016/j.ijlp.2024.102016
39213264,Effect of matcha green tea on cognitive functions and sleep quality in older adults with cognitive decline: A randomized controlled study over 12 months,"Uchida K, Meno K, Korenaga T, Liu S, Suzuki H, Baba Y, Tagata C, Araki Y, Tsunemi S, Aso K, Inagaki S, Nakagawa S, Kobayashi M, Kakuma T, Asada T, Ota M, Takihara T, Arai T.",PLoS One. 2024 Aug 30;19(8):e0309287. doi: 10.1371/journal.pone.0309287. eCollection 2024.,Uchida K,PLoS One,2024,30-08-2024,PMC11364242,,10.1371/journal.pone.0309287
39201762,Estrogen Receptors: A New Frontier in Alzheimer's Disease Therapy,"Cipriano GL, Mazzon E, Anchesi I.",Int J Mol Sci. 2024 Aug 21;25(16):9077. doi: 10.3390/ijms25169077.,Cipriano GL,Int J Mol Sci,2024,29-08-2024,PMC11354998,,10.3390/ijms25169077
39201735,Advances in Cholinesterase Inhibitor Research-An Overview of Preclinical Studies of Selected Organoruthenium(II) Complexes,Žužek MC.,Int J Mol Sci. 2024 Aug 21;25(16):9049. doi: 10.3390/ijms25169049.,Žužek MC,Int J Mol Sci,2024,29-08-2024,PMC11354293,,10.3390/ijms25169049
39201668,Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease,"Flieger J, Forma A, Flieger W, Flieger M, Gawlik PJ, Dzierżyński E, Maciejewski R, Teresiński G, Baj J.",Int J Mol Sci. 2024 Aug 18;25(16):8982. doi: 10.3390/ijms25168982.,Flieger J,Int J Mol Sci,2024,29-08-2024,PMC11354426,,10.3390/ijms25168982
39201317,A Comprehensive Exploration of the Multifaceted Neuroprotective Role of Cannabinoids in Alzheimer's Disease across a Decade of Research,"Tyrakis P, Agridi C, Kourti M.",Int J Mol Sci. 2024 Aug 7;25(16):8630. doi: 10.3390/ijms25168630.,Tyrakis P,Int J Mol Sci,2024,29-08-2024,PMC11354546,,10.3390/ijms25168630
39192378,Hybrid nanostructures for neurodegenerative disease theranostics: the art in the combination of biomembrane and non-biomembrane nanostructures,"Gao C, Xiong R, Zhang ZY, Peng H, Gu YK, Xu W, Yang WT, Liu Y, Gao J, Yin Y.",Transl Neurodegener. 2024 Aug 27;13(1):43. doi: 10.1186/s40035-024-00436-7.,Gao C,Transl Neurodegener,2024,27-08-2024,PMC11348682,,10.1186/s40035-024-00436-7
39192044,Tetrameric Transthyretin as a Protective Factor Against Alzheimer's Disease,"Corino C, Aimo A, Luigetti M, Ciccone L, Ferrari Chen YF, Panichella G, Musetti V, Castiglione V, Vergaro G, Emdin M, Franzini M.",Mol Neurobiol. 2025 Mar;62(3):2945-2954. doi: 10.1007/s12035-024-04442-8. Epub 2024 Aug 27.,Corino C,Mol Neurobiol,2025,27-08-2024,PMC11790689,,10.1007/s12035-024-04442-8
39191071,Neurosurgical gene therapy for central nervous system diseases,"Patel RV, Nanda P, Richardson RM.",Neurotherapeutics. 2024 Jul;21(4):e00434. doi: 10.1016/j.neurot.2024.e00434. Epub 2024 Aug 26.,Patel RV,Neurotherapeutics,2024,27-08-2024,PMC11445594,,10.1016/j.neurot.2024.e00434
39185459,Alzheimer's disease: a review on the current trends of the effective diagnosis and therapeutics,"Abdul Manap AS, Almadodi R, Sultana S, Sebastian MG, Kavani KS, Lyenouq VE, Shankar A.",Front Aging Neurosci. 2024 Aug 9;16:1429211. doi: 10.3389/fnagi.2024.1429211. eCollection 2024.,Abdul Manap AS,Front Aging Neurosci,2024,26-08-2024,PMC11341404,,10.3389/fnagi.2024.1429211
39177596,"Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)","Neve A, Das B, Wojtowicz J, Huang Z, Bullain S, Watkin M, Lott D, Bittner T, Delmar P, Klein G, Hofmann C, Kerchner GA, Smith J, Baudler M, Fontoura P, Doody RS.",J Alzheimers Dis. 2024;101(1):353-367. doi: 10.3233/JAD-240221.,Neve A,J Alzheimers Dis,2024,23-08-2024,PMC11380290,,10.3233/JAD-240221
39176335,The Impact of Hypertension on Cognitive Decline and Alzheimer's Disease and Its Management: A Systematic Review,"Khan AD, Elnagar S, Eltayeb M, Baluch SK, Kumar A, Kumari M, Kumari M, Fareed MU, Rehman A, Shehryar A.",Cureus. 2024 Jul 23;16(7):e65194. doi: 10.7759/cureus.65194. eCollection 2024 Jul.,Khan AD,Cureus,2024,23-08-2024,PMC11340657,,10.7759/cureus.65194
39175422,Understanding the impact of slowing disease progression for individuals with biomarker-confirmed early symptomatic Alzheimer's disease,"Desai U, Gomes DA, Chandler J, Ye W, Daly M, Kirson N, Dennehy EB.",Curr Med Res Opin. 2024 Oct;40(10):1719-1725. doi: 10.1080/03007995.2024.2394602. Epub 2024 Sep 1.,Desai U,Curr Med Res Opin,2024,23-08-2024,,,10.1080/03007995.2024.2394602
39174535,"Recent advances in Alzheimer's disease: Mechanisms, clinical trials and new drug development strategies","Zhang J, Zhang Y, Wang J, Xia Y, Zhang J, Chen L.",Signal Transduct Target Ther. 2024 Aug 23;9(1):211. doi: 10.1038/s41392-024-01911-3.,Zhang J,Signal Transduct Target Ther,2024,22-08-2024,PMC11344989,,10.1038/s41392-024-01911-3
39166791,CT1812 biomarker signature from a meta-analysis of CSF proteomic findings from two Phase 2 clinical trials in Alzheimer's disease,"Lizama BN, Williams C, North HA, Pandey K, Duong D, Di Caro V, Mecca AP, Blennow K, Zetterberg H, Levey AI, Grundman M, van Dyck CH, Caggiano AO, Seyfried NT, Hamby ME.",Alzheimers Dement. 2024 Oct;20(10):6860-6880. doi: 10.1002/alz.14152. Epub 2024 Aug 21.,Lizama BN,Alzheimers Dement,2024,21-08-2024,PMC11485314,,10.1002/alz.14152
39164933,Cognitive behavioural treatment for mild Alzheimer's patients and their caregivers (CBTAC): results of a randomised controlled trial,"Forstmeier S, Maercker A, Bohli L, Savaskan E, Roth T.",Aging Ment Health. 2025 Feb;29(2):359-368. doi: 10.1080/13607863.2024.2393748. Epub 2024 Aug 20.,Forstmeier S,Aging Ment Health,2025,21-08-2024,,,10.1080/13607863.2024.2393748
39164754,Cancer research provides a model for advancing clinical trials in dementia in the era of disease-modifying Alzheimer's-type dementia therapies,"Jicha GA, Tucker TC, Arnold SM, Nelson PT.",Alzheimers Res Ther. 2024 Aug 21;16(1):184. doi: 10.1186/s13195-024-01532-6.,Jicha GA,Alzheimers Res Ther,2024,20-08-2024,PMC11337902,,10.1186/s13195-024-01532-6
39162889,"Fish consumption, cognitive impairment and dementia: an updated dose-response meta-analysis of observational studies","Godos J, Micek A, Currenti W, Franchi C, Poli A, Battino M, Dolci A, Ricci C, Ungvari Z, Grosso G.",Aging Clin Exp Res. 2024 Aug 20;36(1):171. doi: 10.1007/s40520-024-02823-6.,Godos J,Aging Clin Exp Res,2024,20-08-2024,PMC11335789,,10.1007/s40520-024-02823-6
39161876,"""Let's talk about sex, inflammaging, and cognition, baby"": A meta-analysis and meta-regression of 106 case-control studies on mild cognitive impairment and Alzheimer's disease","Childs R, Karamacoska D, Lim CK, Steiner-Lim GZ.",Brain Behav Immun Health. 2024 Jul 20;40:100819. doi: 10.1016/j.bbih.2024.100819. eCollection 2024 Oct.,Childs R,Brain Behav Immun Health,2024,20-08-2024,PMC11331696,,10.1016/j.bbih.2024.100819
39140601,Contributions of the ADNI Biostatistics Core,"Beckett LA, Saito N, Donohue MC, Harvey DJ; Alzheimer's Disease Neuroimaging Initiative.",Alzheimers Dement. 2024 Oct;20(10):7331-7339. doi: 10.1002/alz.14159. Epub 2024 Aug 14.,Beckett LA,Alzheimers Dement,2024,14-08-2024,PMC11485306,,10.1002/alz.14159
39136045,The Alzheimer's Disease Neuroimaging Initiative Clinical Core,"Aisen PS, Donohue MC, Raman R, Rafii MS, Petersen RC; Alzheimer's Disease Neuroimaging Initiative.",Alzheimers Dement. 2024 Oct;20(10):7361-7368. doi: 10.1002/alz.14167. Epub 2024 Aug 13.,Aisen PS,Alzheimers Dement,2024,13-08-2024,PMC11485391,,10.1002/alz.14167
39129397,Natural compounds from herbs and nutraceuticals as glycogen synthase kinase-3β inhibitors in Alzheimer's disease treatment,"Zhao Z, Yuan Y, Li S, Wang X, Yang X.",CNS Neurosci Ther. 2024 Aug;30(8):e14885. doi: 10.1111/cns.14885.,Zhao Z,CNS Neurosci Ther,2024,12-08-2024,PMC11317746,,10.1111/cns.14885
39129252,Are we ready to cure post-stroke cognitive impairment? Many key prerequisites can be achieved quickly and easily,"Godefroy O, Aarabi A, Béjot Y, Biessels GJ, Glize B, Mok VC, Schotten MT, Sibon I, Chabriat H, Roussel M.",Eur Stroke J. 2025 Mar;10(1):22-35. doi: 10.1177/23969873241271651. Epub 2024 Aug 11.,Godefroy O,Eur Stroke J,2025,12-08-2024,PMC11569528,,10.1177/23969873241271651
39128995,Melatonin: A potential nighttime guardian against Alzheimer's,"Zhang Z, Xue P, Bendlin BB, Zetterberg H, De Felice F, Tan X, Benedict C.",Mol Psychiatry. 2025 Jan;30(1):237-250. doi: 10.1038/s41380-024-02691-6. Epub 2024 Aug 11.,Zhang Z,Mol Psychiatry,2025,11-08-2024,PMC11649572,,10.1038/s41380-024-02691-6
39126772,Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut-brain axis,"Kim Y, Lim J, Oh J.",Biomed Pharmacother. 2024 Sep;178:117277. doi: 10.1016/j.biopha.2024.117277. Epub 2024 Aug 9.,Kim Y,Biomed Pharmacother,2024,10-08-2024,,,10.1016/j.biopha.2024.117277
39125389,"Methylsulfinyl Hexyl Isothiocyanate (6-MSITC) from Wasabi Is a Promising Candidate for the Treatment of Cancer, Alzheimer's Disease, and Obesity","Bartkowiak-Wieczorek J, Malesza M, Malesza I, Hadada T, Winkler-Galicki J, Grzelak T, Mądry E.",Nutrients. 2024 Aug 1;16(15):2509. doi: 10.3390/nu16152509.,Bartkowiak-Wieczorek J,Nutrients,2024,10-08-2024,PMC11313713,,10.3390/nu16152509
39125356,Nebulized Glutathione as a Key Antioxidant for the Treatment of Oxidative Stress in Neurodegenerative Conditions,"Lana JV, Rios A, Takeyama R, Santos N, Pires L, Santos GS, Rodrigues IJ, Jeyaraman M, Purita J, Lana JF.",Nutrients. 2024 Jul 31;16(15):2476. doi: 10.3390/nu16152476.,Lana JV,Nutrients,2024,10-08-2024,PMC11314501,,10.3390/nu16152476
39124919,Naturally Inspired Coumarin Derivatives in Alzheimer's Disease Drug Discovery: Latest Advances and Current Challenges,"Orioli R, Belluti F, Gobbi S, Rampa A, Bisi A.",Molecules. 2024 Jul 26;29(15):3514. doi: 10.3390/molecules29153514.,Orioli R,Molecules,2024,10-08-2024,PMC11313984,,10.3390/molecules29153514
39122565,Exploration of Alzheimer's disease-related gene expression following high-intensity and moderate-intensity exercise interventions,"Marston KJ, de Frutos-Lucas J, Porter T, Milicic L, Vacher M, Sewell KR, Peiffer JJ, Laws SM, Brown BM.",J Sci Med Sport. 2024 Dec;27(12):828-833. doi: 10.1016/j.jsams.2024.07.017. Epub 2024 Jul 30.,Marston KJ,J Sci Med Sport,2024,09-08-2024,,,10.1016/j.jsams.2024.07.017
39120318,The Potential of Metabolomics to Find Proper Biomarkers for Addressing the Neuroprotective Efficacy of Drugs Aimed at Delaying Parkinson's and Alzheimer's Disease Progression,"Franco R, Garrigós C, Lillo J, Rivas-Santisteban R.",Cells. 2024 Jul 31;13(15):1288. doi: 10.3390/cells13151288.,Franco R,Cells,2024,09-08-2024,PMC11311351,,10.3390/cells13151288
39113808,Transcranial blood-brain barrier opening in Alzheimer's disease patients using a portable focused ultrasound system with real-time 2-D cavitation mapping,"Bae S, Liu K, Pouliopoulos AN, Ji R, Jiménez-Gambín S, Yousefian O, Kline-Schoder AR, Batts AJ, Tsitsos FN, Kokossis D, Mintz A, Honig LS, Konofagou EE.",Theranostics. 2024 Jul 22;14(11):4519-4535. doi: 10.7150/thno.94206. eCollection 2024.,Bae S,Theranostics,2024,08-08-2024,PMC11303073,,10.7150/thno.94206
39104606,Efficacy of 5 and 10 mg donepezil in improving cognitive function in patients with dementia: a systematic review and meta-analysis,"Sheikh M, Ammar M.",Front Neurosci. 2024 Jul 22;18:1398952. doi: 10.3389/fnins.2024.1398952. eCollection 2024.,Sheikh M,Front Neurosci,2024,06-08-2024,PMC11298496,,10.3389/fnins.2024.1398952
39101248,"Nanomaterials that Aid in the Diagnosis and Treatment of Alzheimer's Disease, Resolving Blood-Brain Barrier Crossing Ability","Song Q, Li J, Li T, Li HW.",Adv Sci (Weinh). 2024 Oct;11(38):e2403473. doi: 10.1002/advs.202403473. Epub 2024 Aug 5.,Song Q,Adv Sci (Weinh),2024,05-08-2024,PMC11481234,,10.1002/advs.202403473
39099195,Using Synbiotics as a Therapy to Protect Mental Health in Alzheimer's Disease,"Ngoc APT, Zahoor A, Kim DG, Yang SH.",J Microbiol Biotechnol. 2024 Sep 28;34(9):1739-1747. doi: 10.4014/jmb.2403.03021. Epub 2024 Jun 21.,Ngoc APT,J Microbiol Biotechnol,2024,05-08-2024,PMC11485767,,10.4014/jmb.2403.03021
39094545,Therapeutic potential of plant-derived natural compounds in Alzheimer's disease: Targeting microglia-mediated neuroinflammation,"Shen Y, Liu F, Zhang M.",Biomed Pharmacother. 2024 Sep;178:117235. doi: 10.1016/j.biopha.2024.117235. Epub 2024 Aug 1.,Shen Y,Biomed Pharmacother,2024,02-08-2024,,,10.1016/j.biopha.2024.117235
39090680,Association between treatment with sacubitril/valsartan and the risk of Alzheimer's disease: a clinical update,Garnier-Crussard A.,Alzheimers Res Ther. 2024 Aug 1;16(1):177. doi: 10.1186/s13195-024-01547-z.,Garnier-Crussard A,Alzheimers Res Ther,2024,01-08-2024,PMC11293045,,10.1186/s13195-024-01547-z
39088965,Molecular mechanism and therapeutic strategy of bile acids in Alzheimer's disease from the emerging perspective of the microbiota-gut-brain axis,"Wu M, Cheng Y, Zhang R, Han W, Jiang H, Bi C, Zhang Z, Ye M, Lin X, Liu Z.",Biomed Pharmacother. 2024 Sep;178:117228. doi: 10.1016/j.biopha.2024.117228. Epub 2024 Jul 31.,Wu M,Biomed Pharmacother,2024,01-08-2024,,,10.1016/j.biopha.2024.117228
39088212,ω-3 PUFA for Secondary Prevention of White Matter Lesions and Neuronal Integrity Breakdown in Older Adults: A Randomized Clinical Trial,"Shinto LH, Murchison CF, Silbert LC, Dodge HH, Lahna D, Rooney W, Kaye J, Quinn JF, Bowman GL.",JAMA Netw Open. 2024 Aug 1;7(8):e2426872. doi: 10.1001/jamanetworkopen.2024.26872.,Shinto LH,JAMA Netw Open,2024,01-08-2024,PMC11294966,,10.1001/jamanetworkopen.2024.26872
39084596,Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease,"Kamath AP, Nayak PG, John J, Mutalik S, Balaraman AK, Krishnadas N.",Neuropharmacology. 2024 Nov 15;259:110096. doi: 10.1016/j.neuropharm.2024.110096. Epub 2024 Jul 29.,Kamath AP,Neuropharmacology,2024,31-07-2024,,,10.1016/j.neuropharm.2024.110096
39083796,Effects of Electronic Serious Games on Older Adults With Alzheimer's Disease and Mild Cognitive Impairment: Systematic Review With Meta-Analysis of Randomized Controlled Trials,"Zuo X, Tang Y, Chen Y, Zhou Z.",JMIR Serious Games. 2024 Jul 31;12:e55785. doi: 10.2196/55785.,Zuo X,JMIR Serious Games,2024,31-07-2024,PMC11324188,,10.2196/55785
39083787,Assessing the Effectiveness of eHealth Interventions to Manage Multiple Lifestyle Risk Behaviors Among Older Adults: Systematic Review and Meta-Analysis,"Shi B, Li G, Wu S, Ge H, Zhang X, Chen S, Pan Y, He Q.",J Med Internet Res. 2024 Jul 31;26:e58174. doi: 10.2196/58174.,Shi B,J Med Internet Res,2024,31-07-2024,PMC11325121,,10.2196/58174
39081782,Characteristics and Effectiveness of Physical Therapist-Supervised Exercise Interventions for Nursing Home Residents With Dementia: A Systematic Review,"Boer D, Schmidt C, Sterke S, Schoones J, Elbers R, Vliet Vlieland T.",Innov Aging. 2024 Jun 20;8(7):igae061. doi: 10.1093/geroni/igae061. eCollection 2024.,Boer D,Innov Aging,2024,31-07-2024,PMC11287766,,10.1093/geroni/igae061
39081600,Efficacy and safety of acupuncture for cognitive impairment in Alzheimer's disease: a systematic review and meta-analysis,"Guo R, Shen X, Ealing J, Zhou J, Lu J, Ning Y.",Front Dement. 2024 Jul 3;3:1380221. doi: 10.3389/frdem.2024.1380221. eCollection 2024.,Guo R,Front Dement,2024,31-07-2024,PMC11285646,,10.3389/frdem.2024.1380221
39081336,Advancements and Challenges in Antiamyloid Therapy for Alzheimer's Disease: A Comprehensive Review,"Beshir SA, Hussain N, Menon VB, Al Haddad AHI, Al Zeer RAK, Elnour AA.",Int J Alzheimers Dis. 2024 Jul 23;2024:2052142. doi: 10.1155/2024/2052142. eCollection 2024.,Beshir SA,Int J Alzheimers Dis,2024,31-07-2024,PMC11288696,,10.1155/2024/2052142
39080741,Dementia with Lewy bodies and gait neural basis: a cross-sectional study,"Sainsily-Cesarus A, Schmitt E, Landre L, Botzung A, Rauch L, Demuynck C, Philippi N, de Sousa PL, Mutter C, Cretin B, Martin-Hunyadi C, Blanc F.",Alzheimers Res Ther. 2024 Jul 30;16(1):170. doi: 10.1186/s13195-024-01539-z.,Sainsily-Cesarus A,Alzheimers Res Ther,2024,31-07-2024,PMC11287986,,10.1186/s13195-024-01539-z
39079148,Aducanumab: A look two years after its approval,"Torres A, Camargo L, López N.",Biomedica. 2024 May 31;44(Sp. 1):42-46. doi: 10.7705/biomedica.6967.,Torres A,Biomedica,2024,30-07-2024,PMC11349330,,10.7705/biomedica.6967
39069384,Standard versus High Cardiopulmonary Bypass Flow Rate: A Randomized Controlled Subtrial Comparing Brain Injury Biomarker Release,"Keiller AC, Axelsson M, Bragadottir G, Lannemyr L, Wijk J, Blennow K, Zetterberg H, Bagge RO.",J Cardiothorac Vasc Anesth. 2024 Oct;38(10):2204-2212. doi: 10.1053/j.jvca.2024.07.017. Epub 2024 Jul 14.,Keiller AC,J Cardiothorac Vasc Anesth,2024,28-07-2024,,,10.1053/j.jvca.2024.07.017
39068924,"Multicenter, Open-Label, Prospective Study Shows Safety and Therapeutic Benefits of a Defined Ginkgo Biloba Extract for Adults with Major Neurocognitive Disorder","Chowdhury D, Roy AK, Reddy VR, Gupta YK, Nigam P, Hoerr R.",Dement Geriatr Cogn Disord. 2024;53(6):299-309. doi: 10.1159/000540385. Epub 2024 Jul 26.,Chowdhury D,Dement Geriatr Cogn Disord,2024,28-07-2024,,,10.1159/000540385
39064687,"Postbiotics as Molecules Targeting Cellular Events of Aging Brain-The Role in Pathogenesis, Prophylaxis and Treatment of Neurodegenerative Diseases","Głowacka P, Oszajca K, Pudlarz A, Szemraj J, Witusik-Perkowska M.",Nutrients. 2024 Jul 12;16(14):2244. doi: 10.3390/nu16142244.,Głowacka P,Nutrients,2024,27-07-2024,PMC11279795,,10.3390/nu16142244
39063194,Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment,"Choi EH, Kim MH, Park SJ.",Int J Mol Sci. 2024 Jul 21;25(14):7952. doi: 10.3390/ijms25147952.,Choi EH,Int J Mol Sci,2024,27-07-2024,PMC11277296,,10.3390/ijms25147952
39063016,Adaptive and Maladaptive DNA Breaks in Neuronal Physiology and Alzheimer's Disease,"Roberts A, Swerdlow RH, Wang N.",Int J Mol Sci. 2024 Jul 16;25(14):7774. doi: 10.3390/ijms25147774.,Roberts A,Int J Mol Sci,2024,27-07-2024,PMC11277458,,10.3390/ijms25147774
39058809,"A phase 2, open-label study of anti-inflammatory NE3107 in patients with dementias","Haroon J, Jordan K, Mahdavi K, Rindner E, Becerra S, Surya JR, Zielinski M, Venkatraman V, Goodenowe D, Hofmeister K, Zhang J, Ahlem C, Reading C, Palumbo J, Pourat B, Kuhn T, Jordan S.",Medicine (Baltimore). 2024 Jul 26;103(30):e39027. doi: 10.1097/MD.0000000000039027.,Haroon J,Medicine (Baltimore),2024,26-07-2024,PMC11272329,,10.1097/MD.0000000000039027
39058448,A Framework for Best Practices and Readiness in the Advent of Anti-Amyloid Therapy for Early Alzheimer's Disease in Asia,"Lee JH, Jia J, Ji Y, Kandiah N, Kim S, Mok V, Pai MC, Senanarong V, Suh CH, Chen C.",J Alzheimers Dis. 2024;101(1):1-12. doi: 10.3233/JAD-240684.,Lee JH,J Alzheimers Dis,2024,26-07-2024,PMC11380317,,10.3233/JAD-240684
39055498,Molecular mechanisms and therapeutic potential of lithium in Alzheimer's disease: repurposing an old class of drugs,"Shen Y, Zhao M, Zhao P, Meng L, Zhang Y, Zhang G, Taishi Y, Sun L.",Front Pharmacol. 2024 Jul 11;15:1408462. doi: 10.3389/fphar.2024.1408462. eCollection 2024.,Shen Y,Front Pharmacol,2024,26-07-2024,PMC11269163,,10.3389/fphar.2024.1408462
39052288,Low-Dose Aspirin and Progression of Age-Related Hearing Loss: A Secondary Analysis of the ASPREE Randomized Clinical Trial,"Clark DPQ, Zhou Z, Hussain SM, Tran C, Britt C, Storey E, Lowthian JA, Shah RC, Dillon H, Wolfe R, Woods RL, Rance G, McNeil JJ.",JAMA Netw Open. 2024 Jul 1;7(7):e2424373. doi: 10.1001/jamanetworkopen.2024.24373.,Clark DPQ,JAMA Netw Open,2024,25-07-2024,PMC11273233,,10.1001/jamanetworkopen.2024.24373
39050670,Causal relationships involving brain imaging-derived phenotypes based on UKB imaging cohort: a review of Mendelian randomization studies,"Wang M, Wang Z, Wang Y, Zhou Q, Wang J.",Front Neurosci. 2024 Jul 10;18:1436223. doi: 10.3389/fnins.2024.1436223. eCollection 2024.,Wang M,Front Neurosci,2024,25-07-2024,PMC11266110,,10.3389/fnins.2024.1436223
39044511,Effectiveness of Resistance Exercise on Cognitive Function in Animal Models of Alzheimer Disease: A Systematic Review and Meta-Analysis,"de Andrade Santos FO, Passos AA, Arida RM, Teixeira-Machado L.",J Prev Alzheimers Dis. 2024;11(4):998-1012. doi: 10.14283/jpad.2024.75.,de Andrade Santos FO,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266263,,10.14283/jpad.2024.75
39044500,Novel Blood-Based Biomarkers and Disease Modifying Therapies for Alzheimer's Disease. Are We Ready for the New Era?,"Korologou-Linden R, Kalsi J, Kafetsouli D, Olawale A, Iwata A, Wingfield D, Mummery D, Hayhoe B, Robinson O, Majeed A, Middleton LT.",J Prev Alzheimers Dis. 2024;11(4):897-902. doi: 10.14283/jpad.2024.83.,Korologou-Linden R,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266440,,10.14283/jpad.2024.83
39044498,Maximizing the Utility of Alzheimer's Disease Trial Data: Sharing of Baseline A4 and LEARN Data,"Jimenez-Maggiora GA, Schulz AP, Donohue MC, Qiu H, Jaiswal SN, Adegoke O, Gallardo R, Baryshnikava O, Rissman RA, Abdel-Latif S, Sperling RA, Aisen PS.",J Prev Alzheimers Dis. 2024;11(4):889-894. doi: 10.14283/jpad.2024.120.,Jimenez-Maggiora GA,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266269,,10.14283/jpad.2024.120
39044496,Pre-Randomization Predictors of Study Discontinuation in a Preclinical Alzheimer's Disease Randomized Controlled Trial,"Raman R, Hussen K, Donohue MC, Ernstrom K, Holdridge KC, Langford O, Molina-Henry DP, Pierce AL, Sims JR, Smith A, Yaari R, Aisen PS, Sperling R, Grill JD.",J Prev Alzheimers Dis. 2024;11(4):874-880. doi: 10.14283/jpad.2024.136.,Raman R,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266258,,10.14283/jpad.2024.136
39044495,Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease,"Shirzadi Z, Schultz AP, Properzi M, Yaari R, Yau WW, Brickman AM, Rafii MS, Donohue MC, Ernstrom K, Wang S, Jack CR Jr, Greenberg SM, Raman R, Aisen P, Sperling RA, Chhatwal JP.",J Prev Alzheimers Dis. 2024;11(4):869-873. doi: 10.14283/jpad.2024.139.,Shirzadi Z,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266366,,10.14283/jpad.2024.139
39044494,Safety Profile of a Cognitively Unimpaired Older Population with Elevated Cerebral Amyloid in a 4.5-Year Clinical Trial,"Yaari R, Holdridge KC, Mancini M, Rafii MS, Case M, Battioui C, Sims JR, Aisen PS, Sperling RA.",J Prev Alzheimers Dis. 2024;11(4):857-868. doi: 10.14283/jpad.2024.138.,Yaari R,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266256,,10.14283/jpad.2024.138
39044493,Change in Digital Cognitive Test Performance between Solanezumab and Placebo Groups in Preclinical Alzheimer's Disease: Secondary Analyses from the A4 Study,"Papp KV, Maruff P, Rentz DM, Donohue MC, Liu A, Aisen PS, Sperling RA.",J Prev Alzheimers Dis. 2024;11(4):846-856. doi: 10.14283/jpad.2024.137.,Papp KV,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266374,,10.14283/jpad.2024.137
39044492,Longitudinal Trajectories of the Cognitive Function Index in the A4 Study,"Amariglio RE, Grill JD, Rentz DM, Marshall GA, Donohue MC, Liu A, Aisen PS, Sperling RA.",J Prev Alzheimers Dis. 2024;11(4):838-845. doi: 10.14283/jpad.2024.125.,Amariglio RE,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266220,,10.14283/jpad.2024.125
39044490,Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer's Disease,"Rissman RA, Donohue MC, Langford O, Raman R, Abdel-Latif S, Yaari R, Holdridge KC, Sims JR, Molina-Henry D, Jimenez-Maggiora G, Johnson KA, Aisen PS, Sperling RA.",J Prev Alzheimers Dis. 2024;11(4):823-830. doi: 10.14283/jpad.2024.134.,Rissman RA,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266279,,10.14283/jpad.2024.134
39044489,Characterizing Clinical Progression in Cognitively Unimpaired Older Individuals with Brain Amyloid: Results from the A4 Study,"Rentz DM, Rosenberg PB, Sperling RA, Donohue MC, Raman R, Liu A, Aisen PS.",J Prev Alzheimers Dis. 2024;11(4):814-822. doi: 10.14283/jpad.2024.123.,Rentz DM,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266445,,10.14283/jpad.2024.123
39044488,Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies,"Sperling RA, Donohue MC, Rissman RA, Johnson KA, Rentz DM, Grill JD, Heidebrink JL, Jenkins C, Jimenez-Maggiora G, Langford O, Liu A, Raman R, Yaari R, Holdridge KC, Sims JR, Aisen PS.",J Prev Alzheimers Dis. 2024;11(4):802-813. doi: 10.14283/jpad.2024.122.,Sperling RA,J Prev Alzheimers Dis,2024,24-07-2024,PMC11266444,,10.14283/jpad.2024.122
39043619,(Poly)phenols and brain health - beyond their antioxidant capacity,"Hunt T, Pontifex MG, Vauzour D.",FEBS Lett. 2024 Dec;598(24):2949-2962. doi: 10.1002/1873-3468.14988. Epub 2024 Jul 23.,Hunt T,FEBS Lett,2024,23-07-2024,PMC11665953,,10.1002/1873-3468.14988
39031970,The neuroinflammatory role of microglia in Alzheimer's disease and their associated therapeutic targets,"AmeliMojarad M, AmeliMojarad M.",CNS Neurosci Ther. 2024 Jul;30(7):e14856. doi: 10.1111/cns.14856.,AmeliMojarad M,CNS Neurosci Ther,2024,20-07-2024,PMC11259573,,10.1111/cns.14856
39031354,Effect of Multimodal Intervention in Individuals with Mild Cognitive Impairment: A Randomized Clinical Trial in Shanghai,"Fan M, Li Q, Yang T, Yang Y, Chen Z, Xuan G, Ruan Y, Sun S, Wang M, Chen X, Huang Y, Yang Z, Wang Y.",J Alzheimers Dis. 2024;101(1):235-248. doi: 10.3233/JAD-231370.,Fan M,J Alzheimers Dis,2024,20-07-2024,PMC11380217,,10.3233/JAD-231370
39012443,An Expanded Narrative Review of Neurotransmitters on Alzheimer's Disease: The Role of Therapeutic Interventions on Neurotransmission,"Akyuz E, Arulsamy A, Aslan FS, Sarisözen B, Guney B, Hekimoglu A, Yilmaz BN, Retinasamy T, Shaikh MF.",Mol Neurobiol. 2025 Feb;62(2):1631-1674. doi: 10.1007/s12035-024-04333-y. Epub 2024 Jul 16.,Akyuz E,Mol Neurobiol,2025,16-07-2024,PMC11772559,,10.1007/s12035-024-04333-y
39009081,Magnesium and Cognitive Health in Adults: A Systematic Review and Meta-Analysis,"Chen F, Wang J, Cheng Y, Li R, Wang Y, Chen Y, Scott T, Tucker KL.",Adv Nutr. 2024 Aug;15(8):100272. doi: 10.1016/j.advnut.2024.100272. Epub 2024 Jul 14.,Chen F,Adv Nutr,2024,15-07-2024,PMC11362647,,10.1016/j.advnut.2024.100272
39004063,Phytochemicals targeting mitophagy: Therapeutic opportunities and prospects for treating Alzheimer's disease,"Yang J, Zhao H, Qu S.",Biomed Pharmacother. 2024 Aug;177:117144. doi: 10.1016/j.biopha.2024.117144. Epub 2024 Jul 14.,Yang J,Biomed Pharmacother,2024,14-07-2024,,,10.1016/j.biopha.2024.117144
39003871,"Targeting calciumopathy for neuroprotection: focus on calcium channels Cav1, Orai1 and P2X7","Torres-Rico M, García-Calvo V, Gironda-Martínez A, Pascual-Guerra J, García AG, Maneu V.",Cell Calcium. 2024 Nov;123:102928. doi: 10.1016/j.ceca.2024.102928. Epub 2024 Jul 6.,Torres-Rico M,Cell Calcium,2024,14-07-2024,,,10.1016/j.ceca.2024.102928
39000142,Protein Tyrosine Phosphatase 1B (PTP1B): A Comprehensive Review of Its Role in Pathogenesis of Human Diseases,"Kołodziej-Sobczak D, Sobczak Ł, Łączkowski KZ.",Int J Mol Sci. 2024 Jun 27;25(13):7033. doi: 10.3390/ijms25137033.,Kołodziej-Sobczak D,Int J Mol Sci,2024,13-07-2024,PMC11241624,,10.3390/ijms25137033
39000036,From Inhalation to Neurodegeneration: Air Pollution as a Modifiable Risk Factor for Alzheimer's Disease,"Olloquequi J, Díaz-Peña R, Verdaguer E, Ettcheto M, Auladell C, Camins A.",Int J Mol Sci. 2024 Jun 25;25(13):6928. doi: 10.3390/ijms25136928.,Olloquequi J,Int J Mol Sci,2024,13-07-2024,PMC11241587,,10.3390/ijms25136928
38999294,"All GLP-1 Agonists Should, Theoretically, Cure Alzheimer's Dementia but Dulaglutide Might Be More Effective Than the Others",Fessel J.,J Clin Med. 2024 Jun 26;13(13):3729. doi: 10.3390/jcm13133729.,Fessel J,J Clin Med,2024,13-07-2024,PMC11242057,,10.3390/jcm13133729
38993656,The Black Book of Psychotropic Dosing and Monitoring,"DeBattista C, Schatzberg AF.",Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.,DeBattista C,Psychopharmacol Bull,2024,12-07-2024,PMC11235576,,
38988035,"Dalzanemdor (SAGE-718), a novel, investigational N-methyl-D-aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose-finding studies in healthy participants and an open-label study in participants with Huntington's disease","Koenig A, Lewis M, Wald J, Li S, Varoglu M, Dai J, Sankoh A, Paumier K, Doherty J, Quirk M.",Clin Transl Sci. 2024 Jul;17(7):e13852. doi: 10.1111/cts.13852.,Koenig A,Clin Transl Sci,2024,11-07-2024,PMC11236904,,10.1111/cts.13852
38986050,Blood Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-Analysis,"Holper S, Loveland P, Churilov L, Italiano D, Watson R, Yassi N.",Neurology. 2024 Aug 13;103(3):e209537. doi: 10.1212/WNL.0000000000209537. Epub 2024 Jul 10.,Holper S,Neurology,2024,10-07-2024,PMC11314950,,10.1212/WNL.0000000000209537
38981775,The anti-inflammatory effects of itaconate and its derivatives in neurological disorders,"Kong X, Xu L, Mou Z, Lyu W, Shan K, Wang L, Liu F, Rong F, Li J, Wei P.",Cytokine Growth Factor Rev. 2024 Aug;78:37-49. doi: 10.1016/j.cytogfr.2024.07.001. Epub 2024 Jul 6.,Kong X,Cytokine Growth Factor Rev,2024,09-07-2024,,,10.1016/j.cytogfr.2024.07.001
38976044,Cognition and Activity of Daily Living Function in people with Parkinson's disease,"Bode M, Kalbe E, Liepelt-Scarfone I.",J Neural Transm (Vienna). 2024 Oct;131(10):1159-1186. doi: 10.1007/s00702-024-02796-w. Epub 2024 Jul 8.,Bode M,J Neural Transm (Vienna),2024,08-07-2024,PMC11489248,,10.1007/s00702-024-02796-w
38970802,Targeting Microglial Immunoproteasome: A Novel Approach in Neuroinflammatory-Related Disorders,"Malek N, Gladysz R, Stelmach N, Drag M.",ACS Chem Neurosci. 2024 Jul 17;15(14):2532-2544. doi: 10.1021/acschemneuro.4c00099. Epub 2024 Jul 6.,Malek N,ACS Chem Neurosci,2024,06-07-2024,PMC11258690,,10.1021/acschemneuro.4c00099
38970141,Macro and micro structural preservation of grey matter integrity after 24 weeks of rTMS in Alzheimer's disease patients: a pilot study,"Mencarelli L, Torso M, Borghi I, Assogna M, Pezzopane V, Bonnì S, Di Lorenzo F, Santarnecchi E, Giove F, Martorana A, Bozzali M, Ridgway GR, Chance SA, Koch G.",Alzheimers Res Ther. 2024 Jul 5;16(1):152. doi: 10.1186/s13195-024-01501-z.,Mencarelli L,Alzheimers Res Ther,2024,05-07-2024,PMC11225141,,10.1186/s13195-024-01501-z
38970127,"A multicenter, randomized, double-blind, placebo-controlled ascending dose study to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) effects of Posiphen in subjects with early Alzheimer's Disease","Galasko D, Farlow MR, Lucey BP, Honig LS, Elbert D, Bateman R, Momper J, Thomas RG, Rissman RA, Pa J, Aslanyan V, Balasubramanian A, West T, Maccecchini M, Feldman HH.",Alzheimers Res Ther. 2024 Jul 5;16(1):151. doi: 10.1186/s13195-024-01490-z.,Galasko D,Alzheimers Res Ther,2024,05-07-2024,PMC11225352,,10.1186/s13195-024-01490-z
38968479,Comparative efficacy and safety of olanzapine and risperidone in the treatment of psychiatric and behavioral symptoms of Alzheimer's disease: Systematic review and meta-analysis,"Zhang Z, Zhang X, Xu L.",Medicine (Baltimore). 2024 Jul 5;103(27):e35663. doi: 10.1097/MD.0000000000035663.,Zhang Z,Medicine (Baltimore),2024,05-07-2024,PMC11224812,,10.1097/MD.0000000000035663
38967926,Clinical Outcomes and Cost-Effectiveness of Collaborative Dementia Care: A Secondary Analysis of a Cluster Randomized Clinical Trial,"Michalowsky B, Blotenberg I, Platen M, Teipel S, Kilimann I, Portacolone E, Bohlken J, Rädke A, Buchholz M, Scharf A, Muehlichen F, Xie F, Thyrian JR, Hoffmann W.",JAMA Netw Open. 2024 Jul 1;7(7):e2419282. doi: 10.1001/jamanetworkopen.2024.19282.,Michalowsky B,JAMA Netw Open,2024,05-07-2024,PMC11227088,,10.1001/jamanetworkopen.2024.19282
38965464,Implementation and evaluation of a community-based mindful walking randomized controlled trial to sustain cognitive health in older African Americans at risk for dementia,"Yang CH, Lee J, Wilcox S, Rudisill AC, Friedman DB, Hakun JG, Neils-Strunjas J, Wei J, Miller MC, Byers MD.",BMC Geriatr. 2024 Jul 4;24(1):579. doi: 10.1186/s12877-024-05090-2.,Yang CH,BMC Geriatr,2024,04-07-2024,PMC11225163,,10.1186/s12877-024-05090-2
38963798,"Consideration of T-Cell Profile in the Examination of Statin Efficacy in Inflammatory Diseases, Neurodegeneration, and Neurocognitive Performance","Hintermayer MA, Mendelson D, Byun JH.",J Gerontol A Biol Sci Med Sci. 2024 Aug 1;79(8):glae156. doi: 10.1093/gerona/glae156.,Hintermayer MA,J Gerontol A Biol Sci Med Sci,2024,04-07-2024,PMC11293203,,10.1093/gerona/glae156
38962958,Effect of gamification with a support partner to increase physical activity in older adults at risk for Alzheimer's disease: The STEP 4Life randomized clinical trial,"Greysen SR, Oon AL, Harkins K, Rareshide C, Mondal A, Patel MS, Grill JD, Karlawish J.",Alzheimers Dement. 2024 Aug;20(8):5450-5459. doi: 10.1002/alz.14058. Epub 2024 Jul 4.,Greysen SR,Alzheimers Dement,2024,04-07-2024,PMC11350015,,10.1002/alz.14058
38962803,The role of Foxo3a in neuron-mediated cognitive impairment,"Liu QQ, Wu GH, Wang XC, Xiong XW, Rui-Wang, Yao BL.",Front Mol Neurosci. 2024 Jun 19;17:1424561. doi: 10.3389/fnmol.2024.1424561. eCollection 2024.,Liu QQ,Front Mol Neurosci,2024,04-07-2024,PMC11220205,,10.3389/fnmol.2024.1424561
38961421,Nutrition guidance within a multimodal intervention improves diet quality in prodromal Alzheimer's disease: Multimodal Preventive Trial for Alzheimer's Disease (MIND-AD(mini)),"Levak N, Lehtisalo J, Thunborg C, Westman E, Andersen P, Andrieu S, Broersen LM, Coley N, Hartmann T, Irving GF, Mangialasche F, Ngandu T, Pantel J, Rosenberg A, Sindi S, Soininen H, Solomon A, Wang R, Kivipelto M.",Alzheimers Res Ther. 2024 Jul 3;16(1):147. doi: 10.1186/s13195-024-01522-8.,Levak N,Alzheimers Res Ther,2024,03-07-2024,PMC11221015,,10.1186/s13195-024-01522-8
38947104,Natural Bioactive Compounds from Macroalgae and Microalgae for the Treatment of Alzheimer's Disease: A Review,"Lee JY, Wong CY, Koh RY, Lim CL, Kok YY, Chye SM.",Yale J Biol Med. 2024 Jun 28;97(2):205-224. doi: 10.59249/JNKB9714. eCollection 2024 Jun.,Lee JY,Yale J Biol Med,2024,01-07-2024,PMC11202106,,10.59249/JNKB9714
38945937,Clinical Pipelines for Alzheimer's Disease Psychosis and Agitation,"Oguma T, Jino K.",Chem Pharm Bull (Tokyo). 2024;72(7):610-617. doi: 10.1248/cpb.c23-00416.,Oguma T,Chem Pharm Bull (Tokyo),2024,30-06-2024,,,10.1248/cpb.c23-00416
38943982,Effects of ketogenic diet on cognitive function of patients with Alzheimer's disease: a systematic review and meta-analysis,"Rong L, Peng Y, Shen Q, Chen K, Fang B, Li W.",J Nutr Health Aging. 2024 Aug;28(8):100306. doi: 10.1016/j.jnha.2024.100306. Epub 2024 Jun 28.,Rong L,J Nutr Health Aging,2024,29-06-2024,,,10.1016/j.jnha.2024.100306
38943006,"Impact of periodontal disease on cognitive disorders, dementia, and depression: a systematic review and meta-analysis","Dibello V, Custodero C, Cavalcanti R, Lafornara D, Dibello A, Lozupone M, Daniele A, Pilotto A, Panza F, Solfrizzi V.",Geroscience. 2024 Oct;46(5):5133-5169. doi: 10.1007/s11357-024-01243-8. Epub 2024 Jun 28.,Dibello V,Geroscience,2024,28-06-2024,PMC11336026,,10.1007/s11357-024-01243-8
38939962,"Amyloid-related imaging abnormalities (ARIA): diagnosis, management, and care in the setting of amyloid-modifying therapy",Vukmir RB.,Ann Clin Transl Neurol. 2024 Jul;11(7):1669-1680. doi: 10.1002/acn3.52042. Epub 2024 Jun 28.,Vukmir RB,Ann Clin Transl Neurol,2024,28-06-2024,PMC11251480,,10.1002/acn3.52042
38937382,Alzheimer's Disease: Combination Therapies and Clinical Trials for Combination Therapy Development,"Cummings JL, Osse AML, Kinney JW, Cammann D, Chen J.",CNS Drugs. 2024 Aug;38(8):613-624. doi: 10.1007/s40263-024-01103-1. Epub 2024 Jun 27.,Cummings JL,CNS Drugs,2024,27-06-2024,PMC11258156,NIHMS2007119,10.1007/s40263-024-01103-1
38935105,"A systematic review on the impact of nutrition and possible supplementation on the deficiency of vitamin complexes, iron, omega-3-fatty acids, and lycopene in relation to increased morbidity in women after menopause","Wylenzek F, Bühling KJ, Laakmann E.",Arch Gynecol Obstet. 2024 Oct;310(4):2235-2245. doi: 10.1007/s00404-024-07555-6. Epub 2024 Jun 27.,Wylenzek F,Arch Gynecol Obstet,2024,27-06-2024,PMC11393286,,10.1007/s00404-024-07555-6
38933275,Air pollution accelerates the development of obesity and Alzheimer's disease: the role of leptin and inflammation - a mini-review,"Campolim CM, Schimenes BC, Veras MM, Kim YB, Prada PO.",Front Immunol. 2024 Jun 12;15:1401800. doi: 10.3389/fimmu.2024.1401800. eCollection 2024.,Campolim CM,Front Immunol,2024,27-06-2024,PMC11199417,,10.3389/fimmu.2024.1401800
38932758,Anti-amyloid Antibody Therapies for Alzheimer's Disease,Park KW.,Nucl Med Mol Imaging. 2024 Jun;58(4):227-236. doi: 10.1007/s13139-024-00848-3. Epub 2024 Feb 20.,Park KW,Nucl Med Mol Imaging,2024,27-06-2024,PMC11196435,,10.1007/s13139-024-00848-3
38929542,Effect of Treatment of the Cholinergic Precursor Choline Alphoscerate in Mild Cognitive Dysfunction: A Randomized Controlled Trial,"Carotenuto A, Andreone V, Amenta F, Traini E.",Medicina (Kaunas). 2024 Jun 1;60(6):925. doi: 10.3390/medicina60060925.,Carotenuto A,Medicina (Kaunas),2024,27-06-2024,PMC11205363,,10.3390/medicina60060925
38929140,The Involvement of Antioxidants in Cognitive Decline and Neurodegeneration: Mens Sana in Corpore Sano,"Nazzi C, Avenanti A, Battaglia S.",Antioxidants (Basel). 2024 Jun 7;13(6):701. doi: 10.3390/antiox13060701.,Nazzi C,Antioxidants (Basel),2024,27-06-2024,PMC11200558,,10.3390/antiox13060701
38929090,Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer's Dementia: Clinical Trial Systematic Review,"Pagotto GLO, Santos LMOD, Osman N, Lamas CB, Laurindo LF, Pomini KT, Guissoni LM, Lima EP, Goulart RA, Catharin VMCS, Direito R, Tanaka M, Barbalho SM.",Antioxidants (Basel). 2024 May 27;13(6):651. doi: 10.3390/antiox13060651.,Pagotto GLO,Antioxidants (Basel),2024,27-06-2024,PMC11201198,,10.3390/antiox13060651
38928415,Potential of CBD Acting on Cannabinoid Receptors CB(1) and CB(2) in Ischemic Stroke,"Raïch I, Lillo J, Rivas-Santisteban R, Rebassa JB, Capó T, Santandreu M, Cubeles-Juberias E, Reyes-Resina I, Navarro G.",Int J Mol Sci. 2024 Jun 18;25(12):6708. doi: 10.3390/ijms25126708.,Raïch I,Int J Mol Sci,2024,27-06-2024,PMC11204117,,10.3390/ijms25126708
38928395,Engineered Antibodies to Improve Efficacy against Neurodegenerative Disorders,"Niazi SK, Mariam Z, Magoola M.",Int J Mol Sci. 2024 Jun 18;25(12):6683. doi: 10.3390/ijms25126683.,Niazi SK,Int J Mol Sci,2024,27-06-2024,PMC11203520,,10.3390/ijms25126683
38928248,Emerging Therapeutic Potential of Fluoxetine on Cognitive Decline in Alzheimer's Disease: Systematic Review,"Bougea A, Angelopoulou E, Vasilopoulos E, Gourzis P, Papageorgiou S.",Int J Mol Sci. 2024 Jun 13;25(12):6542. doi: 10.3390/ijms25126542.,Bougea A,Int J Mol Sci,2024,27-06-2024,PMC11203451,,10.3390/ijms25126542
38927999,Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives,"Gallo A, Lipari A, Di Francesco S, Ianuà E, Liperoti R, Cipriani MC, Martone AM, De Candia E, Landi F, Montalto M.",Int J Mol Sci. 2024 Jun 7;25(12):6292. doi: 10.3390/ijms25126292.,Gallo A,Int J Mol Sci,2024,27-06-2024,PMC11203688,,10.3390/ijms25126292
38924283,"The effects of omega-3, DHA, EPA, Souvenaid® in Alzheimer's disease: A systematic review and meta-analysis","Calderon Martinez E, Zachariah Saji S, Salazar Ore JV, Borges-Sosa OA, Srinivas S, Mareddy NSR, Manzoor T, Di Vanna M, Al Shanableh Y, Taneja R, Arruarana VS.",Neuropsychopharmacol Rep. 2024 Sep;44(3):545-556. doi: 10.1002/npr2.12455. Epub 2024 Jun 25.,Calderon Martinez E,Neuropsychopharmacol Rep,2024,26-06-2024,PMC11544444,,10.1002/npr2.12455
38919471,Repurposing Metformin for the Treatment of Atrial Fibrillation: Current Insights,"Sarkar A, Fanous KI, Marei I, Ding H, Ladjimi M, MacDonald R, Hollenberg MD, Anderson TJ, Hill MA, Triggle CR.",Vasc Health Risk Manag. 2024 Jun 21;20:255-288. doi: 10.2147/VHRM.S391808. eCollection 2024.,Sarkar A,Vasc Health Risk Manag,2024,26-06-2024,PMC11198029,,10.2147/VHRM.S391808
38914414,Exploring the gut-brain Axis: Potential therapeutic impact of Psychobiotics on mental health,"Cocean AM, Vodnar DC.",Prog Neuropsychopharmacol Biol Psychiatry. 2024 Aug 30;134:111073. doi: 10.1016/j.pnpbp.2024.111073. Epub 2024 Jun 22.,Cocean AM,Prog Neuropsychopharmacol Biol Psychiatry,2024,24-06-2024,,,10.1016/j.pnpbp.2024.111073
38914170,An interim exploratory proteomics biomarker analysis of a phase 2 clinical trial to assess the impact of CT1812 in Alzheimer's disease,"Lizama BN, North HA, Pandey K, Williams C, Duong D, Cho E, Di Caro V, Ping L, Blennow K, Zetterberg H, Lah J, Levey AI, Grundman M, Caggiano AO, Seyfried NT, Hamby ME.",Neurobiol Dis. 2024 Sep;199:106575. doi: 10.1016/j.nbd.2024.106575. Epub 2024 Jun 22.,Lizama BN,Neurobiol Dis,2024,24-06-2024,,,10.1016/j.nbd.2024.106575
38909933,Neuromodulatory effects of leukotriene receptor antagonists: A comprehensive review,"Sood R, Anoopkumar-Dukie S, Rudrawar S, Hall S.",Eur J Pharmacol. 2024 Sep 5;978:176755. doi: 10.1016/j.ejphar.2024.176755. Epub 2024 Jun 21.,Sood R,Eur J Pharmacol,2024,23-06-2024,,,10.1016/j.ejphar.2024.176755
38908296,"The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly individuals with mild cognitive impairment: a randomized controlled trial","Baltic S, Nedeljkovic D, Todorovic N, Ranisavljev M, Korovljev D, Cvejic J, Ostojic J, LeBaron TW, Timmcke J, Stajer V, Ostojic SM.",J Nutr Health Aging. 2024 Aug;28(8):100287. doi: 10.1016/j.jnha.2024.100287. Epub 2024 Jun 21.,Baltic S,J Nutr Health Aging,2024,22-06-2024,,,10.1016/j.jnha.2024.100287
38906479,Adeno-associated virus vector delivery to the brain: Technology advancements and clinical applications,"Ye D, Chukwu C, Yang Y, Hu Z, Chen H.",Adv Drug Deliv Rev. 2024 Aug;211:115363. doi: 10.1016/j.addr.2024.115363. Epub 2024 Jun 19.,Ye D,Adv Drug Deliv Rev,2024,21-06-2024,PMC11892011,NIHMS2061552,10.1016/j.addr.2024.115363
38905047,A Critical Review of Noninvasive Brain Stimulation Technologies in Alzheimer's Dementia and Primary Progressive Aphasia,"LoBue C, McClintock SM, Chiang HS, Helphrey J, Thakkar VJ, Hart J.",J Alzheimers Dis. 2024;100(3):743-760. doi: 10.3233/JAD-240230.,LoBue C,J Alzheimers Dis,2024,21-06-2024,PMC11959453,NIHMS2062411,10.3233/JAD-240230
38904713,Luteolin for neurodegenerative diseases: a review,"Jayawickreme DK, Ekwosi C, Anand A, Andres-Mach M, Wlaź P, Socała K.",Pharmacol Rep. 2024 Aug;76(4):644-664. doi: 10.1007/s43440-024-00610-8. Epub 2024 Jun 21.,Jayawickreme DK,Pharmacol Rep,2024,21-06-2024,PMC11294387,,10.1007/s43440-024-00610-8
38902572,"Analysis of Cerebrospinal Fluid, Plasma β-Amyloid Biomarkers, and Cognition from a 2-Year Phase 2 Trial Evaluating Oral ALZ-801/Valiltramiprosate in APOE4 Carriers with Early Alzheimer's Disease Using Quantitative Systems Pharmacology Model","Hey JA, Yu JY, Abushakra S, Schaefer JF, Power A, Kesslak P, Tolar M.",Drugs. 2024 Jul;84(7):825-839. doi: 10.1007/s40265-024-02068-7. Epub 2024 Jun 20.,Hey JA,Drugs,2024,20-06-2024,PMC11289344,,10.1007/s40265-024-02068-7
38902571,"Effects of Oral ALZ-801/Valiltramiprosate on Plasma Biomarkers, Brain Hippocampal Volume, and Cognition: Results of 2-Year Single-Arm, Open-Label, Phase 2 Trial in APOE4 Carriers with Early Alzheimer's Disease","Hey JA, Abushakra S, Blennow K, Reiman EM, Hort J, Prins ND, Sheardova K, Kesslak P, Shen L, Zhu X, Albayrak A, Paul J, Schaefer JF, Power A, Tolar M.",Drugs. 2024 Jul;84(7):811-823. doi: 10.1007/s40265-024-02067-8. Epub 2024 Jun 20.,Hey JA,Drugs,2024,20-06-2024,PMC11289173,,10.1007/s40265-024-02067-8
38902546,Target engagement and immunogenicity of an active immunotherapeutic targeting pathological α-synuclein: a phase 1 placebo-controlled trial,"Eijsvogel P, Misra P, Concha-Marambio L, Boyd JD, Ding S, Fedor L, Hsieh YT, Sun YS, Vroom MM, Farris CM, Ma Y, de Kam ML, Radanovic I, Vissers MFJM, Mirski D, Shareghi G, Shahnawaz M, Singer W, Kremer P, Groeneveld GJ, Yu HJ, Dodart JC.",Nat Med. 2024 Sep;30(9):2631-2640. doi: 10.1038/s41591-024-03101-8. Epub 2024 Jun 20.,Eijsvogel P,Nat Med,2024,20-06-2024,PMC11405261,,10.1038/s41591-024-03101-8
38901423,Brain responses to intermittent fasting and the healthy living diet in older adults,"Kapogiannis D, Manolopoulos A, Mullins R, Avgerinos K, Delgado-Peraza F, Mustapic M, Nogueras-Ortiz C, Yao PJ, Pucha KA, Brooks J, Chen Q, Haas SS, Ge R, Hartnell LM, Cookson MR, Egan JM, Frangou S, Mattson MP.",Cell Metab. 2024 Aug 6;36(8):1668-1678.e5. doi: 10.1016/j.cmet.2024.05.017. Epub 2024 Jun 19.,Kapogiannis D,Cell Metab,2024,20-06-2024,PMC11305918,NIHMS2001320,10.1016/j.cmet.2024.05.017
38898411,Predictive models of Alzheimer's disease dementia risk in older adults with mild cognitive impairment: a systematic review and critical appraisal,"Wang X, Zhou S, Ye N, Li Y, Zhou P, Chen G, Hu H.",BMC Geriatr. 2024 Jun 19;24(1):531. doi: 10.1186/s12877-024-05044-8.,Wang X,BMC Geriatr,2024,19-06-2024,PMC11188292,,10.1186/s12877-024-05044-8
38893490,Zeolite and Neurodegenerative Diseases,"Panaiotov S, Tancheva L, Kalfin R, Petkova-Kirova P.",Molecules. 2024 Jun 2;29(11):2614. doi: 10.3390/molecules29112614.,Panaiotov S,Molecules,2024,19-06-2024,PMC11173861,,10.3390/molecules29112614
38892488,"Therapeutic Effects of Plant Anthocyanin against Alzheimer's Disease and Modulate Gut Health, Short-Chain Fatty Acids","Bayazid AB, Lim BO.",Nutrients. 2024 May 21;16(11):1554. doi: 10.3390/nu16111554.,Bayazid AB,Nutrients,2024,19-06-2024,PMC11173718,,10.3390/nu16111554
38892094,A Comprehensive Analytical Review of Polyphenols: Evaluating Neuroprotection in Alzheimer's Disease,"Vicente-Zurdo D, Gómez-Mejía E, Rosales-Conrado N, León-González ME.",Int J Mol Sci. 2024 May 28;25(11):5906. doi: 10.3390/ijms25115906.,Vicente-Zurdo D,Int J Mol Sci,2024,19-06-2024,PMC11173253,,10.3390/ijms25115906
38878554,Modulation of gut microbiome in the treatment of neurodegenerative diseases: A systematic review,"Mincic AM, Antal M, Filip L, Miere D.",Clin Nutr. 2024 Jul;43(7):1832-1849. doi: 10.1016/j.clnu.2024.05.036. Epub 2024 May 31.,Mincic AM,Clin Nutr,2024,15-06-2024,,,10.1016/j.clnu.2024.05.036
38875437,Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial,"Lee W, Kim M.",Medicine (Baltimore). 2024 Jun 14;103(24):e38067. doi: 10.1097/MD.0000000000038067.,Lee W,Medicine (Baltimore),2024,14-06-2024,PMC11175912,,10.1097/MD.0000000000038067
38875036,"Healthcare Needs Patterns and Pattern-Predicting Factors in Dementia: Results of the Comprehensive, Computerized Unmet Needs Assessment from the Randomized, Controlled Interventional Trial InDePendent","Michalowsky B, Rädke A, Scharf A, Mühlichen F, Buchholz M, Platen M, Kleinke F, Penndorf P, Pfitzner S, van den Berg N, Hoffmann W.",J Alzheimers Dis. 2024;100(1):345-356. doi: 10.3233/JAD-240025.,Michalowsky B,J Alzheimers Dis,2024,14-06-2024,PMC11307004,,10.3233/JAD-240025
38872204,A multidomain lifestyle intervention to maintain optimal cognitive functioning in Dutch older adults-study design and baseline characteristics of the FINGER-NL randomized controlled trial,"Deckers K, Zwan MD, Soons LM, Waterink L, Beers S, van Houdt S, Stiensma B, Kwant JZ, Wimmers SCPM, Heutz RAM, Claassen JAHR, Oosterman JM, de Heus RAA, van de Rest O, Vermeiren Y, Voshaar RCO, Smidt N, Broersen LM, Sikkes SAM, Aarts E; MOCIA consortium; FINGER-NL consortium; Köhler S, van der Flier WM.",Alzheimers Res Ther. 2024 Jun 13;16(1):126. doi: 10.1186/s13195-024-01495-8.,Deckers K,Alzheimers Res Ther,2024,13-06-2024,PMC11170777,,10.1186/s13195-024-01495-8
38871111,Selenium-containing compounds: a new hope for innovative treatments in Alzheimer's disease and Parkinson's disease,"Pyka P, Garbo S, Fioravanti R, Jacob C, Hittinger M, Handzlik J, Zwergel C, Battistelli C.",Drug Discov Today. 2024 Aug;29(8):104062. doi: 10.1016/j.drudis.2024.104062. Epub 2024 Jun 11.,Pyka P,Drug Discov Today,2024,13-06-2024,,,10.1016/j.drudis.2024.104062
38869035,CSF and plasma biomarkers in cerebral amyloid angiopathy: A single-center study and a systematic review/meta-analysis,"Theodorou A, Tsantzali I, Stefanou MI, Sacco S, Katsanos AH, Shoamanesh A, Karapanayiotides T, Koutroulou I, Stamati P, Werring DJ, Cordonnier C, Palaiodimou L, Zompola C, Boviatsis E, Stavrinou L, Frantzeskaki F, Steiner T, Alexandrov AV, Paraskevas GP, Tsivgoulis G.",Eur Stroke J. 2025 Mar;10(1):278-288. doi: 10.1177/23969873241260538. Epub 2024 Jun 13.,Theodorou A,Eur Stroke J,2025,13-06-2024,PMC11569450,,10.1177/23969873241260538
38868666,"Alzheimer's disease and its treatment-yesterday, today, and tomorrow","Kim AY, Al Jerdi S, MacDonald R, Triggle CR.",Front Pharmacol. 2024 May 24;15:1399121. doi: 10.3389/fphar.2024.1399121. eCollection 2024.,Kim AY,Front Pharmacol,2024,13-06-2024,PMC11167451,,10.3389/fphar.2024.1399121
38867460,Use of lecanemab for the treatment of Alzheimer's disease: A systematic review,"Hossain MF, Husna AU, Kharel M.",Brain Behav. 2024 Jun;14(6):e3592. doi: 10.1002/brb3.3592.,Hossain MF,Brain Behav,2024,13-06-2024,PMC11169267,,10.1002/brb3.3592
38860393,Research progress on phosphodiesterase 4 inhibitors in central nervous system diseases,"Adili A, Dilihumaer A, Zhu H, Tang H.",Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Jun 6;53(3):390-398. doi: 10.3724/zdxbyxb-2024-0023.,Adili A,Zhejiang Da Xue Xue Bao Yi Xue Ban,2024,11-06-2024,PMC11348698,,10.3724/zdxbyxb-2024-0023
38858522,Adverse effects of methylphenidate for apathy in patients with Alzheimer's disease (ADMET2 trial),"Zeng L, Perin J, Gross AL, Shade D, Lanctôt KL, Lerner AJ, Mintzer JE, Brawman-Mintzer O, Padala PR, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Herrmann N, Rosenberg PB.",Int J Geriatr Psychiatry. 2024 Jun;39(6):e6108. doi: 10.1002/gps.6108.,Zeng L,Int J Geriatr Psychiatry,2024,10-06-2024,PMC11265565,NIHMS2001589,10.1002/gps.6108
38857590,A Systematic Review and Meta-Analysis on the Prevalence of Mild Cognitive Impairment and Dementia in Mexico,"Magallón-Zertuche V, Garrido-Dzib AG, Salazar-Gonzalez E, González-Castro DG, Chávez-Loría G, Avila-Nava A, Gutiérrez-Solis AL.",Dement Geriatr Cogn Disord. 2024;53(5):274-288. doi: 10.1159/000539560. Epub 2024 Jun 10.,Magallón-Zertuche V,Dement Geriatr Cogn Disord,2024,10-06-2024,,,10.1159/000539560
38849944,"Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer's disease: a randomized, controlled clinical trial","Ornish D, Madison C, Kivipelto M, Kemp C, McCulloch CE, Galasko D, Artz J, Rentz D, Lin J, Norman K, Ornish A, Tranter S, DeLamarter N, Wingers N, Richling C, Kaddurah-Daouk R, Knight R, McDonald D, Patel L, Verdin E, E Tanzi R, Arnold SE.",Alzheimers Res Ther. 2024 Jun 7;16(1):122. doi: 10.1186/s13195-024-01482-z.,Ornish D,Alzheimers Res Ther,2024,07-06-2024,PMC11157928,,10.1186/s13195-024-01482-z
38848180,Plasma pTau181 Predicts Clinical Progression in a Phase 2 Randomized Controlled Trial of the 11β-HSD1 Inhibitor Xanamem® for Mild Alzheimer's Disease,"Taylor J, Jaros M, Chen C, Harrison J, Hilt D.",J Alzheimers Dis. 2024;100(1):139-150. doi: 10.3233/JAD-231456.,Taylor J,J Alzheimers Dis,2024,07-06-2024,PMC11307031,,10.3233/JAD-231456
38848174,Effects of 6-Month Combined Physical Exercise and Cognitive Training on Neuropsychological and Neurophysiological Function in Older Adults with Subjective Cognitive Decline: A Randomized Controlled Trial,"Cheng CH, Hsieh YW, Chang CC, Hsiao FJ, Chen LF, Wang PN.",J Alzheimers Dis. 2024;100(1):175-192. doi: 10.3233/JAD-231257.,Cheng CH,J Alzheimers Dis,2024,07-06-2024,PMC11307082,,10.3233/JAD-231257
38844706,Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer's Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy,"Sheng L, Bhalla R.",Neurochem Res. 2024 Sep;49(9):2273-2302. doi: 10.1007/s11064-024-04178-w. Epub 2024 Jun 6.,Sheng L,Neurochem Res,2024,06-06-2024,PMC11310295,,10.1007/s11064-024-04178-w
38842037,Development of disease-modifying therapies against Alzheimer's disease,Iwatsubo T.,Psychiatry Clin Neurosci. 2024 Sep;78(9):491-494. doi: 10.1111/pcn.13681. Epub 2024 Jun 6.,Iwatsubo T,Psychiatry Clin Neurosci,2024,06-06-2024,PMC11488598,,10.1111/pcn.13681
38841103,Association of soluble TREM2 with Alzheimer's disease and mild cognitive impairment: a systematic review and meta-analysis,"Wang R, Zhan Y, Zhu W, Yang Q, Pei J.",Front Aging Neurosci. 2024 May 22;16:1407980. doi: 10.3389/fnagi.2024.1407980. eCollection 2024.,Wang R,Front Aging Neurosci,2024,06-06-2024,PMC11150578,,10.3389/fnagi.2024.1407980
38836267,Prevalence of Cerebral Amyloid Angiopathy Pathology and Strictly Lobar Microbleeds in East-Asian Versus Western Populations: A Systematic Review and Meta-Analysis,"De Kort AM, Verbeek MM, Schreuder FHBM, Klijn CJM, Jäkel L.",J Stroke. 2024 May;26(2):179-189. doi: 10.5853/jos.2023.04287. Epub 2024 May 30.,De Kort AM,J Stroke,2024,05-06-2024,PMC11164577,,10.5853/jos.2023.04287
38832504,Cerebrovascular Effects of Sildenafil in Small Vessel Disease: The OxHARP Trial,"Webb AJS, Birks JS, Feakins KA, Lawson A, Dawson J, Rothman AMK, Werring DJ, Llwyd O, Stewart CR, Thomas J.",Circ Res. 2024 Jul 5;135(2):320-331. doi: 10.1161/CIRCRESAHA.124.324327. Epub 2024 Jun 4.,Webb AJS,Circ Res,2024,04-06-2024,PMC11227301,EMS196246,10.1161/CIRCRESAHA.124.324327
38830501,Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents,"Pereira M, Cruz MT, Fortuna A, Bicker J.",Drug Discov Today. 2024 Jul;29(7):104052. doi: 10.1016/j.drudis.2024.104052. Epub 2024 Jun 1.,Pereira M,Drug Discov Today,2024,03-06-2024,,,10.1016/j.drudis.2024.104052
38830181,Trial Participation in Neurodegenerative Diseases: Barriers and Facilitators: A Systematic Review and Meta-Analysis,"Weemering DN, Beelen A, Kliest T, van Leeuwen LAG, van den Berg LH, van Eijk RPA.",Neurology. 2024 Jul 9;103(1):e209503. doi: 10.1212/WNL.0000000000209503. Epub 2024 Jun 3.,Weemering DN,Neurology,2024,03-06-2024,PMC11244742,,10.1212/WNL.0000000000209503
38829477,The Promising Role of Selenium and Yeast in the Fight Against Protein Amyloidosis,"Kieliszek M, Sapazhenkava K.",Biol Trace Elem Res. 2025 Mar;203(3):1251-1268. doi: 10.1007/s12011-024-04245-x. Epub 2024 Jun 3.,Kieliszek M,Biol Trace Elem Res,2025,03-06-2024,PMC11872778,,10.1007/s12011-024-04245-x
38829443,Targeting Biometals in Alzheimer's Disease with Metal Chelating Agents Including Coumarin Derivatives,"Gucký A, Hamuľaková S.",CNS Drugs. 2024 Jul;38(7):507-532. doi: 10.1007/s40263-024-01093-0. Epub 2024 Jun 3.,Gucký A,CNS Drugs,2024,03-06-2024,PMC11182807,,10.1007/s40263-024-01093-0
38824833,Peptides derived from growth factors: Exploring their diverse impact from antimicrobial properties to neuroprotection,"Hai-Na Z, Jun-Jie J, Guang-Meng X.",Biomed Pharmacother. 2024 Jul;176:116830. doi: 10.1016/j.biopha.2024.116830. Epub 2024 Jun 1.,Hai-Na Z,Biomed Pharmacother,2024,02-06-2024,,,10.1016/j.biopha.2024.116830
38824515,Effective dosage and mode of exercise for enhancing cognitive function in Alzheimer's disease and dementia: a systematic review and Bayesian Model-Based Network Meta-analysis of RCTs,"Yuan Y, Yang Y, Hu X, Zhang L, Xiong Z, Bai Y, Zeng J, Xu F.",BMC Geriatr. 2024 Jun 1;24(1):480. doi: 10.1186/s12877-024-05060-8.,Yuan Y,BMC Geriatr,2024,02-06-2024,PMC11143595,,10.1186/s12877-024-05060-8
38814196,A randomized controlled trial on the effects of traditional Thai mind-body exercise (Ruesi Dadton) on biomarkers in mild cognitive impairment,"Khanthong P, Sriyakul K, Dechakhamphu A, Krajarng A, Kamalashiran C, Jayathavaj V, Tungsukruthai P.",Eur J Phys Rehabil Med. 2024 Aug;60(4):604-610. doi: 10.23736/S1973-9087.24.08015-8. Epub 2024 May 30.,Khanthong P,Eur J Phys Rehabil Med,2024,30-05-2024,PMC11403630,,10.23736/S1973-9087.24.08015-8
38812709,Alcohol Use Disorder and Dementia: A Review,Zahr NM.,Alcohol Res. 2024 May 23;44(1):03. doi: 10.35946/arcr.v44.1.03. eCollection 2024.,Zahr NM,Alcohol Res,2024,30-05-2024,PMC11135165,,10.35946/arcr.v44.1.03
38812396,The Effects of Chiropractic Spinal Adjustment on EEG in Adults with Alzheimer's and Parkinson's Disease: A Pilot Randomised Cross-over Trial,"Navid MS, Niazi IK, Holt K, Nedergaard RB, Amjad I, Ghani U, Kumari N, Shafique M, Duehr J, Trager RJ, Haavik H.",J Integr Neurosci. 2024 May 11;23(5):98. doi: 10.31083/j.jin2305098.,Navid MS,J Integr Neurosci,2024,30-05-2024,,,10.31083/j.jin2305098
38812047,Integrating a multimodal lifestyle intervention with medical food in prodromal Alzheimer's disease: the MIND-AD(mini) randomized controlled trial,"Thunborg C, Wang R, Rosenberg A, Sindi S, Andersen P, Andrieu S, Broersen LM, Coley N, Couderc C, Duval CZ, Faxen-Irving G, Hagman G, Hallikainen M, Håkansson K, Kekkonen E, Lehtisalo J, Levak N, Mangialasche F, Pantel J, Rydström A, Stigsdotter-Neely A, Wimo A, Ngandu T, Soininen H, Hartmann T, Solomon A, Kivipelto M.",Alzheimers Res Ther. 2024 May 30;16(1):118. doi: 10.1186/s13195-024-01468-x.,Thunborg C,Alzheimers Res Ther,2024,29-05-2024,PMC11138035,,10.1186/s13195-024-01468-x
38804321,Treating Depression in Dementia Patients: A Risk or Remedy-A Narrative Review,Sultan S.,Geriatrics (Basel). 2024 May 15;9(3):64. doi: 10.3390/geriatrics9030064.,Sultan S,Geriatrics (Basel),2024,28-05-2024,PMC11130822,,10.3390/geriatrics9030064
38804315,Cerebral Blood Flow in Alzheimer's Disease: A Meta-Analysis on Transcranial Doppler Investigations,"Zuin M, De Vito A, Romagnoli T, Polastri M, Capatti E, Azzini C, Brombo G, Zuliani G.",Geriatrics (Basel). 2024 May 4;9(3):58. doi: 10.3390/geriatrics9030058.,Zuin M,Geriatrics (Basel),2024,28-05-2024,PMC11130854,,10.3390/geriatrics9030058
38795641,Plant-derived bioactive compounds and their novel role in central nervous system disorder treatment via ATF4 targeting: A systematic literature review,"Zhang N, Zhang S, Dong X.",Biomed Pharmacother. 2024 Jul;176:116811. doi: 10.1016/j.biopha.2024.116811. Epub 2024 May 24.,Zhang N,Biomed Pharmacother,2024,25-05-2024,,,10.1016/j.biopha.2024.116811
38795271,Phosphodiesterase-5 inhibitors use and the risk of alzheimer's disease: a systematic review and meta-analysis,"Abouelmagd ME, Abdelmeseh M, Elrosasy A, Saad YH, Alnajjar AZ, Eid M, Hassan A, Abbas A.",Neurol Sci. 2024 Nov;45(11):5261-5270. doi: 10.1007/s10072-024-07583-9. Epub 2024 May 25.,Abouelmagd ME,Neurol Sci,2024,25-05-2024,PMC11470851,,10.1007/s10072-024-07583-9
38792618,The Role of Physical Activity in Adjunctive Nursing Management of Neuro-Degenerative Diseases among Older Adults: A Systematic Review of Interventional Studies,Alanazi MA.,Life (Basel). 2024 May 7;14(5):597. doi: 10.3390/life14050597.,Alanazi MA,Life (Basel),2024,25-05-2024,PMC11122640,,10.3390/life14050597
38791416,Cannabinoid and Orexigenic Systems Interplay as a New Focus of Research in Alzheimer's Disease,"Rebassa JB, Capó T, Lillo J, Raïch I, Reyes-Resina I, Navarro G.",Int J Mol Sci. 2024 May 15;25(10):5378. doi: 10.3390/ijms25105378.,Rebassa JB,Int J Mol Sci,2024,25-05-2024,PMC11121409,,10.3390/ijms25105378
38791206,Advances in Therapeutics to Alleviate Cognitive Decline and Neuropsychiatric Symptoms of Alzheimer's Disease,"Li J, Haj Ebrahimi A, Ali AB.",Int J Mol Sci. 2024 May 9;25(10):5169. doi: 10.3390/ijms25105169.,Li J,Int J Mol Sci,2024,25-05-2024,PMC11121252,,10.3390/ijms25105169
38791160,The Vital Role of Melatonin and Its Metabolites in the Neuroprotection and Retardation of Brain Aging,"Bocheva G, Bakalov D, Iliev P, Tafradjiiska-Hadjiolova R.",Int J Mol Sci. 2024 May 8;25(10):5122. doi: 10.3390/ijms25105122.,Bocheva G,Int J Mol Sci,2024,25-05-2024,PMC11121732,,10.3390/ijms25105122
38790495,Dual-Task vs. Single-Task Gait Training to Improve Spatiotemporal Gait Parameters in People with Parkinson's Disease: A Systematic Review and Meta-Analysis,"Sarasso E, Parente MP, Agosta F, Filippi M, Corbetta D.",Brain Sci. 2024 May 20;14(5):517. doi: 10.3390/brainsci14050517.,Sarasso E,Brain Sci,2024,25-05-2024,PMC11119953,,10.3390/brainsci14050517
38789832,Facilitation of working memory capacity by transcranial direct current stimulation: a secondary analysis from the augmenting cognitive training in older adults (ACT) study,"Aksu S, Indahlastari A, O'Shea A, Marsiske M, Cohen R, Alexander GE, DeKosky ST, Hishaw GA, Dai Y, Wu SS, Woods AJ.",Geroscience. 2024 Oct;46(5):4075-4110. doi: 10.1007/s11357-024-01205-0. Epub 2024 May 25.,Aksu S,Geroscience,2024,24-05-2024,PMC11336148,,10.1007/s11357-024-01205-0
38788800,Adult-onset hearing loss and incident cognitive impairment and dementia - A systematic review and meta-analysis of cohort studies,"Yu RC, Proctor D, Soni J, Pikett L, Livingston G, Lewis G, Schilder A, Bamiou D, Mandavia R, Omar R, Pavlou M, Lin F, Goman AM, Gonzalez SC.",Ageing Res Rev. 2024 Jul;98:102346. doi: 10.1016/j.arr.2024.102346. Epub 2024 May 23.,Yu RC,Ageing Res Rev,2024,24-05-2024,,,10.1016/j.arr.2024.102346
38786027,Exposure to Environmental Toxins: Potential Implications for Stroke Risk via the Gut- and Lung-Brain Axis,"Ruggles A, Benakis C.",Cells. 2024 May 8;13(10):803. doi: 10.3390/cells13100803.,Ruggles A,Cells,2024,24-05-2024,PMC11119296,,10.3390/cells13100803
38773569,Considerations for biomarker strategies in clinical trials investigating tau-targeting therapeutics for Alzheimer's disease,"Penny LK, Lofthouse R, Arastoo M, Porter A, Palliyil S, Harrington CR, Wischik CM.",Transl Neurodegener. 2024 May 21;13(1):25. doi: 10.1186/s40035-024-00417-w.,Penny LK,Transl Neurodegener,2024,22-05-2024,PMC11107038,,10.1186/s40035-024-00417-w
38764122,Clinical observation on treatment of Alzheimer's disease with Sun's scalp-abdominal acupuncture combined with donepezil hydrochloride,"Zhang SQ, Ma S, Yang TS, Zhang M.",Zhen Ci Yan Jiu. 2024 May 25;49(5):506-511. doi: 10.13702/j.1000-0607.20230220.,Zhang SQ,Zhen Ci Yan Jiu,2024,19-05-2024,,,10.13702/j.1000-0607.20230220
38763517,Interventions to prevent obesity in children aged 5 to 11 years old,"Spiga F, Davies AL, Tomlinson E, Moore TH, Dawson S, Breheny K, Savović J, Gao Y, Phillips SM, Hillier-Brown F, Hodder RK, Wolfenden L, Higgins JP, Summerbell CD.",Cochrane Database Syst Rev. 2024 May 20;5(5):CD015328. doi: 10.1002/14651858.CD015328.pub2.,Spiga F,Cochrane Database Syst Rev,2024,19-05-2024,PMC11102828,,10.1002/14651858.CD015328.pub2
38762101,Type 2 diabetes mellitus/obesity drugs: A neurodegenerative disorders savior or a bridge too far?,"Kopp KO, Glotfelty EJ, Li Y, Lahiri DK, Greig NH.",Ageing Res Rev. 2024 Jul;98:102343. doi: 10.1016/j.arr.2024.102343. Epub 2024 May 16.,Kopp KO,Ageing Res Rev,2024,18-05-2024,PMC11378160,NIHMS1999289,10.1016/j.arr.2024.102343
38760589,"p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial","Shanks HRC, Chen K, Reiman EM, Blennow K, Cummings JL, Massa SM, Longo FM, Börjesson-Hanson A, Windisch M, Schmitz TW.",Nat Med. 2024 Jun;30(6):1761-1770. doi: 10.1038/s41591-024-02977-w. Epub 2024 May 17.,Shanks HRC,Nat Med,2024,17-05-2024,PMC11186782,,10.1038/s41591-024-02977-w
38759015,Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials,"Zeng B, Tang C, Wang J, Yang Q, Ren Q, Liu X.",J Alzheimers Dis. 2024;99(4):1173-1186. doi: 10.3233/JAD-240161.,Zeng B,J Alzheimers Dis,2024,17-05-2024,PMC11191524,,10.3233/JAD-240161
38756533,Cerebrospinal fluid/serum albumin ratio in patients with Lewy body disease: a systematic review and meta-analysis,"Li M, Gan J, Yang X, Liu S, Ji Y.",Front Aging Neurosci. 2024 May 2;16:1390036. doi: 10.3389/fnagi.2024.1390036. eCollection 2024.,Li M,Front Aging Neurosci,2024,17-05-2024,PMC11096505,,10.3389/fnagi.2024.1390036
38751782,A review of SaiLuoTong (MLC-SLT) development in vascular cognitive impairment and dementia,"Ampil ER, Ong PA, Krespi Y, Yang YH.",Front Pharmacol. 2024 May 1;15:1343820. doi: 10.3389/fphar.2024.1343820. eCollection 2024.,Ampil ER,Front Pharmacol,2024,16-05-2024,PMC11094335,,10.3389/fphar.2024.1343820
38749442,Reverse repurposing: Potential utility of cancer drugs in nonmalignant illnesses,"Nikanjam M, Wells K, Kato S, Adashek JJ, Block S, Kurzrock R.",Med. 2024 Jul 12;5(7):689-717. doi: 10.1016/j.medj.2024.04.008. Epub 2024 May 14.,Nikanjam M,Med,2024,15-05-2024,PMC11246816,NIHMS1990233,10.1016/j.medj.2024.04.008
38746639,Clinical Evidence for GLP-1 Receptor Agonists in Alzheimer's Disease: A Systematic Review,"Liang Y, Doré V, Rowe CC, Krishnadas N.",J Alzheimers Dis Rep. 2024 May 7;8(1):777-789. doi: 10.3233/ADR-230181. eCollection 2024.,Liang Y,J Alzheimers Dis Rep,2024,15-05-2024,PMC11091751,,10.3233/ADR-230181
38745011,Progranulin AAV gene therapy for frontotemporal dementia: translational studies and phase 1/2 trial interim results,"Sevigny J, Uspenskaya O, Heckman LD, Wong LC, Hatch DA, Tewari A, Vandenberghe R, Irwin DJ, Saracino D, Le Ber I, Ahmed R, Rohrer JD, Boxer AL, Boland S, Sheehan P, Brandes A, Burstein SR, Shykind BM, Kamalakaran S, Daniels CW, David Litwack E, Mahoney E, Velaga J, McNamara I, Sondergaard P, Sajjad SA, Kobayashi YM, Abeliovich A, Hefti F.",Nat Med. 2024 May;30(5):1406-1415. doi: 10.1038/s41591-024-02973-0. Epub 2024 May 14.,Sevigny J,Nat Med,2024,14-05-2024,PMC11108785,,10.1038/s41591-024-02973-0
38744143,"The impact of chelating compounds on Cu(2+), Fe(2+)/(3+), and Zn(2+) ions in Alzheimer's disease treatment","Mazur T, Malik M, Bieńko DC.",J Inorg Biochem. 2024 Aug;257:112601. doi: 10.1016/j.jinorgbio.2024.112601. Epub 2024 May 9.,Mazur T,J Inorg Biochem,2024,14-05-2024,,,10.1016/j.jinorgbio.2024.112601
38741193,"Tau- and α-synuclein-targeted gold nanoparticles: applications, opportunities, and future outlooks in the diagnosis and therapy of neurodegenerative diseases","Tapia-Arellano A, Cabrera P, Cortés-Adasme E, Riveros A, Hassan N, Kogan MJ.",J Nanobiotechnology. 2024 May 13;22(1):248. doi: 10.1186/s12951-024-02526-0.,Tapia-Arellano A,J Nanobiotechnology,2024,14-05-2024,PMC11092257,,10.1186/s12951-024-02526-0
38736218,A Review of the Current Status of Disease-Modifying Therapies and Prevention of Alzheimer's Disease,Parums DV.,Med Sci Monit. 2024 May 13;30:e945091. doi: 10.12659/MSM.945091.,Parums DV,Med Sci Monit,2024,13-05-2024,PMC11097689,,10.12659/MSM.945091
38732545,Exploiting Natural Niches with Neuroprotective Properties: A Comprehensive Review,"Moukham H, Lambiase A, Barone GD, Tripodi F, Coccetti P.",Nutrients. 2024 Apr 26;16(9):1298. doi: 10.3390/nu16091298.,Moukham H,Nutrients,2024,11-05-2024,PMC11085272,,10.3390/nu16091298
38732259,Exploring the Role of Apigenin in Neuroinflammation: Insights and Implications,"Charrière K, Schneider V, Perrignon-Sommet M, Lizard G, Benani A, Jacquin-Piques A, Vejux A.",Int J Mol Sci. 2024 May 6;25(9):5041. doi: 10.3390/ijms25095041.,Charrière K,Int J Mol Sci,2024,11-05-2024,PMC11084463,,10.3390/ijms25095041
38730496,Updated safety results from phase 3 lecanemab study in early Alzheimer's disease,"Honig LS, Sabbagh MN, van Dyck CH, Sperling RA, Hersch S, Matta A, Giorgi L, Gee M, Kanekiyo M, Li D, Purcell D, Dhadda S, Irizarry M, Kramer L.",Alzheimers Res Ther. 2024 May 10;16(1):105. doi: 10.1186/s13195-024-01441-8.,Honig LS,Alzheimers Res Ther,2024,10-05-2024,PMC11084061,,10.1186/s13195-024-01441-8
38728564,Design and Methods of the Early Age-Related Hearing Loss Investigation Randomized Controlled Trial,"Denham MW, Arnold ML, Sanchez VA, Lin FR, Tucker LH, Gomez MC, Fernandez K, Arpi P, Neil H, Boyle S, Selevan S, Sussman TJ, Gmelin T, Fine I, Glynn NW, Teresi J, Noble JM, Goldberg T, Luchsinger JA, Golub JS.",Otol Neurotol. 2024 Jun 1;45(5):594-601. doi: 10.1097/MAO.0000000000004093.,Denham MW,Otol Neurotol,2024,10-05-2024,PMC11093050,NIHMS1945220,10.1097/MAO.0000000000004093
38725696,Relationship between Alzheimer dementia and QT interval: A meta-analysis,Rabkin SW.,Aging Med (Milton). 2024 Apr 1;7(2):214-223. doi: 10.1002/agm2.12291. eCollection 2024 Apr.,Rabkin SW,Aging Med (Milton),2024,10-05-2024,PMC11077339,,10.1002/agm2.12291
38720896,The two-directional prospective association between inflammatory bowel disease and neurodegenerative disorders: a systematic review and meta-analysis based on longitudinal studies,"Zong J, Yang Y, Wang H, Zhang H, Yang X, Yang X.",Front Immunol. 2024 Apr 24;15:1325908. doi: 10.3389/fimmu.2024.1325908. eCollection 2024.,Zong J,Front Immunol,2024,09-05-2024,PMC11076839,,10.3389/fimmu.2024.1325908
38719432,A phase I trial of accelerated intermittent theta burst rTMS for amnestic MCI,"Aghamoosa S, Lopez J, Rbeiz K, Fleischmann HH, Horn O, Madden K, Caulfield KA, Antonucci MU, Revuelta G, McTeague LM, Benitez A.",J Neurol Neurosurg Psychiatry. 2024 Oct 16;95(11):1036-1045. doi: 10.1136/jnnp-2023-332680.,Aghamoosa S,J Neurol Neurosurg Psychiatry,2024,08-05-2024,PMC11483208,NIHMS1982999,10.1136/jnnp-2023-332680
38715252,"Meta-analysis on the interrelationship between sarcopenia and mild cognitive impairment, Alzheimer's disease and other forms of dementia","Amini N, Ibn Hach M, Lapauw L, Dupont J, Vercauteren L, Verschueren S, Tournoy J, Gielen E.",J Cachexia Sarcopenia Muscle. 2024 Aug;15(4):1240-1253. doi: 10.1002/jcsm.13485. Epub 2024 May 7.,Amini N,J Cachexia Sarcopenia Muscle,2024,08-05-2024,PMC11294028,,10.1002/jcsm.13485
38715140,"Safety and efficacy of autologous adipose tissue-derived stem cell transplantation in aging-related low-grade inflammation patients: a single-group, open-label, phase I clinical trial","Nguyen NT, Phan HT, Le PM, Nguyen LT, Do TT, Phan TT, Van Le T, Dang TM, Phan CL, Dang TT, Truong NH.",Trials. 2024 May 8;25(1):309. doi: 10.1186/s13063-024-08128-3.,Nguyen NT,Trials,2024,07-05-2024,PMC11077870,,10.1186/s13063-024-08128-3
38715084,Passive immunotherapy for Alzheimer's disease: challenges & future directions,"Yi LX, Tan EK, Zhou ZD.",J Transl Med. 2024 May 7;22(1):430. doi: 10.1186/s12967-024-05248-x.,Yi LX,J Transl Med,2024,07-05-2024,PMC11075320,,10.1186/s12967-024-05248-x
38713941,Advanced nanoparticle strategies for optimizing RNA therapeutic delivery in neurodegenerative disorders,"Naimi N, Seyedmirzaei H, Hassannejad Z, Soltani Khaboushan A.",Biomed Pharmacother. 2024 Jun;175:116691. doi: 10.1016/j.biopha.2024.116691. Epub 2024 May 6.,Naimi N,Biomed Pharmacother,2024,07-05-2024,,,10.1016/j.biopha.2024.116691
38711368,Interpretation of 10 years of Alzheimer's disease genetic findings in the perspective of statistical heterogeneity,"Gao S, Wang T, Han Z, Hu Y, Zhu P, Xue Y, Huang C, Chen Y, Liu G.",Brief Bioinform. 2024 Mar 27;25(3):bbae140. doi: 10.1093/bib/bbae140.,Gao S,Brief Bioinform,2024,07-05-2024,PMC11074593,,10.1093/bib/bbae140
38709534,Effectiveness of Personalized Hippocampal Network-Targeted Stimulation in Alzheimer Disease: A Randomized Clinical Trial,"Jung YH, Jang H, Park S, Kim HJ, Seo SW, Kim GB, Shon YM, Kim S, Na DL.",JAMA Netw Open. 2024 May 1;7(5):e249220. doi: 10.1001/jamanetworkopen.2024.9220.,Jung YH,JAMA Netw Open,2024,06-05-2024,PMC11074813,,10.1001/jamanetworkopen.2024.9220
38708587,A systematic review/meta-analysis of prevalence and incidence rates illustrates systemic underrepresentation of individuals racialized as Asian and/or Asian-American in ADRD research,"Zhu Y, Park S, Kolady R, Zha W, Ma Y, Dias A, McGuire K, Hardi A, Lin S, Ismail Z, Adkins-Jackson PB, Trani JF, Babulal GM.",Alzheimers Dement. 2024 Jun;20(6):4315-4330. doi: 10.1002/alz.13820. Epub 2024 May 6.,Zhu Y,Alzheimers Dement,2024,06-05-2024,PMC11180860,,10.1002/alz.13820
38708467,In health and illness: does taste remain consistent? Exploring the influence of inflammation on taste perception through a systematic review and meta-analysis,"López-Salido SC, Espinoza-Gutiérrez HA, Housni FE, Flores-Soto ME, Viveros-Paredes JM.",Eur Rev Med Pharmacol Sci. 2024 Apr;28(8):3085-3098. doi: 10.26355/eurrev_202404_36024.,López-Salido SC,Eur Rev Med Pharmacol Sci,2024,06-05-2024,,,10.26355/eurrev_202404_36024
38706280,Who Benefited Most from the Internet-Based Conversational Engagement RCT (I-CONECT)? Application of the Personalized Medicine Approach to a Behavioral Intervention Study,"Wu CY, Yu K, Arnold SE, Das S, Dodge HH.",J Prev Alzheimers Dis. 2024;11(3):639-648. doi: 10.14283/jpad.2024.41.,Wu CY,J Prev Alzheimers Dis,2024,06-05-2024,PMC11061034,,10.14283/jpad.2024.41
38706271,"Phase 2A Learnings Incorporated into RewinD-LB, a Phase 2B Clinical Trial of Neflamapimod in Dementia with Lewy Bodies","Prins ND, de Haan W, Gardner A, Blackburn K, Chu HM, Galvin JE, Alam JJ.",J Prev Alzheimers Dis. 2024;11(3):549-557. doi: 10.14283/jpad.2024.36.,Prins ND,J Prev Alzheimers Dis,2024,06-05-2024,PMC11061005,,10.14283/jpad.2024.36
38706269,"""Time Saved"" Calculations to Improve Decision-Making in Progressive Disease Studies","Dickson SP, Haaland B, Mallinckrodt CH, Dubois B, O'Keefe P, Morgan M, Peters O, Fernández Santana Iii A, Harrison J, Schneeberger A, Hendrix S.",J Prev Alzheimers Dis. 2024;11(3):529-536. doi: 10.14283/jpad.2024.64.,Dickson SP,J Prev Alzheimers Dis,2024,06-05-2024,PMC11060991,,10.14283/jpad.2024.64
38686327,Effects of movement training based on rhythmic auditory stimulation in cognitive impairment: a meta-analysis of randomized controlled clinical trial,"Wang YN, Wen XN, Chen Y, Xu N, Zhang JH, Hou X, Liu JP, Li P, Chen JY, Wang JH, Sun XY.",Front Neurosci. 2024 Apr 15;18:1360935. doi: 10.3389/fnins.2024.1360935. eCollection 2024.,Wang YN,Front Neurosci,2024,30-04-2024,PMC11057238,,10.3389/fnins.2024.1360935
38685540,Developing theragnostics for Alzheimer's disease: Insights from cancer treatment,"Lee HJ, Choi HJ, Jeong YJ, Na YH, Hong JT, Han JM, Hoe HS, Lim KH.",Int J Biol Macromol. 2024 Jun;269(Pt 2):131925. doi: 10.1016/j.ijbiomac.2024.131925. Epub 2024 Apr 27.,Lee HJ,Int J Biol Macromol,2024,30-04-2024,,,10.1016/j.ijbiomac.2024.131925
38683602,Downstream Biomarker Effects of Gantenerumab or Solanezumab in Dominantly Inherited Alzheimer Disease: The DIAN-TU-001 Randomized Clinical Trial,"Wagemann O, Liu H, Wang G, Shi X, Bittner T, Scelsi MA, Farlow MR, Clifford DB, Supnet-Bell C, Santacruz AM, Aschenbrenner AJ, Hassenstab JJ, Benzinger TLS, Gordon BA, Coalier KA, Cruchaga C, Ibanez L, Perrin RJ, Xiong C, Li Y, Morris JC, Lah JJ, Berman SB, Roberson ED, van Dyck CH, Galasko D, Gauthier S, Hsiung GR, Brooks WS, Pariente J, Mummery CJ, Day GS, Ringman JM, Mendez PC, St George-Hyslop P, Fox NC, Suzuki K, Okhravi HR, Chhatwal J, Levin J, Jucker M, Sims JR, Holdridge KC, Proctor NK, Yaari R, Andersen SW, Mancini M, Llibre-Guerra J, Bateman RJ, McDade E; Dominantly Inherited Alzheimer Network–Trials Unit.",JAMA Neurol. 2024 Jun 1;81(6):582-593. doi: 10.1001/jamaneurol.2024.0991.,Wagemann O,JAMA Neurol,2024,29-04-2024,PMC11059071,,10.1001/jamaneurol.2024.0991
38678292,Utilization of fluid-based biomarkers as endpoints in disease-modifying clinical trials for Alzheimer's disease: a systematic review,"Oosthoek M, Vermunt L, de Wilde A, Bongers B, Antwi-Berko D, Scheltens P, van Bokhoven P, Vijverberg EGB, Teunissen CE.",Alzheimers Res Ther. 2024 Apr 27;16(1):93. doi: 10.1186/s13195-024-01456-1.,Oosthoek M,Alzheimers Res Ther,2024,27-04-2024,PMC11055304,,10.1186/s13195-024-01456-1
38677445,Glucagon-like peptide-1 class drugs show clear protective effects in Parkinson's and Alzheimer's disease clinical trials: A revolution in the making?,Hölscher C.,Neuropharmacology. 2024 Aug 1;253:109952. doi: 10.1016/j.neuropharm.2024.109952. Epub 2024 Apr 25.,Hölscher C,Neuropharmacology,2024,27-04-2024,,,10.1016/j.neuropharm.2024.109952
38674921,L-Carnitine in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review,"Wang W, Pan D, Liu Q, Chen X, Wang S.",Nutrients. 2024 Apr 20;16(8):1232. doi: 10.3390/nu16081232.,Wang W,Nutrients,2024,27-04-2024,PMC11055039,,10.3390/nu16081232
38674150,Dual Drug Repurposing: The Example of Saracatinib,"Ramos R, Vale N.",Int J Mol Sci. 2024 Apr 22;25(8):4565. doi: 10.3390/ijms25084565.,Ramos R,Int J Mol Sci,2024,27-04-2024,PMC11050334,,10.3390/ijms25084565
38673751,Another Use for a Proven Drug: Experimental Evidence for the Potential of Artemisinin and Its Derivatives to Treat Alzheimer's Disease,"Kiss E, Kins S, Gorgas K, Venczel Szakács KH, Kirsch J, Kuhse J.",Int J Mol Sci. 2024 Apr 9;25(8):4165. doi: 10.3390/ijms25084165.,Kiss E,Int J Mol Sci,2024,27-04-2024,PMC11049906,,10.3390/ijms25084165
38669533,Sociodemographic and Clinical Characteristics of People Living with Dementia and Their Associations with Unmet Healthcare Needs: Insights from the Baseline Assessment of the InDePendent Study,"Scharf A, Kleinke F, Michalowsky B, Rädke A, Pfitzner S, Mühlichen F, Buchholz M, van den Berg N, Hoffmann W.",J Alzheimers Dis. 2024;99(2):559-575. doi: 10.3233/JAD-231173.,Scharf A,J Alzheimers Dis,2024,26-04-2024,PMC11191535,,10.3233/JAD-231173
38664651,Uncovering the extent of dementia prevalence in Iran: a comprehensive systematic review and meta-analysis,"Oshnouei S, Safaralizade M, Eslamlou NF, Heidari M.",BMC Public Health. 2024 Apr 25;24(1):1168. doi: 10.1186/s12889-024-18415-y.,Oshnouei S,BMC Public Health,2024,25-04-2024,PMC11046958,,10.1186/s12889-024-18415-y
38664425,Effects of microbiome-based interventions on neurodegenerative diseases: a systematic review and meta-analysis,"Chui ZSW, Chan LML, Zhang EWH, Liang S, Choi EPH, Lok KYW, Tun HM, Kwok JYY.",Sci Rep. 2024 Apr 26;14(1):9558. doi: 10.1038/s41598-024-59250-w.,Chui ZSW,Sci Rep,2024,25-04-2024,PMC11045862,,10.1038/s41598-024-59250-w
38653089,Advances in glioblastoma multiforme: Integrating therapy and pathology perspectives,"Shahcheraghi SH, Alimardani M, Lotfi M, Lotfi M, Uversky VN, Guetchueng ST, Palakurthi SS, Charbe NB, Hromić-Jahjefendić A, Aljabali AAA, Gadewar MM, Malik S, Goyal R, El-Tanani M, Mishra V, Mishra Y, Tambuwala MM.",Pathol Res Pract. 2024 May;257:155285. doi: 10.1016/j.prp.2024.155285. Epub 2024 Apr 5.,Shahcheraghi SH,Pathol Res Pract,2024,23-04-2024,,,10.1016/j.prp.2024.155285
38647197,Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial,"Saadmaan G, Dalmasso MC, Ramirez A, Hiltunen M, Kemppainen N, Lehtisalo J, Mangialasche F, Ngandu T, Rinne J, Soininen H, Stephen R, Kivipelto M, Solomon A.",Alzheimers Dement. 2024 Jun;20(6):4345-4350. doi: 10.1002/alz.13843. Epub 2024 Apr 22.,Saadmaan G,Alzheimers Dement,2024,22-04-2024,PMC11180864,,10.1002/alz.13843
38644649,Inhaled Pollutants of the Gero-Exposome and Later-Life Health,"Finch CE, Thorwald MA.",J Gerontol A Biol Sci Med Sci. 2024 Jul 1;79(7):glae107. doi: 10.1093/gerona/glae107.,Finch CE,J Gerontol A Biol Sci Med Sci,2024,22-04-2024,PMC11170295,,10.1093/gerona/glae107
38642588,Impact of Short-Term Computerized Cognitive Training on Cognition in Older Adults With and Without Genetic Risk of Alzheimer's Disease: Outcomes From the START Randomized Controlled Trial,"Corbett A, Williams G, Creese B, Hampshire A, Palmer A, Brooker H, Ballard C.",J Am Med Dir Assoc. 2024 May;25(5):860-865. doi: 10.1016/j.jamda.2024.03.008. Epub 2024 Apr 17.,Corbett A,J Am Med Dir Assoc,2024,20-04-2024,,,10.1016/j.jamda.2024.03.008
38640313,Evaluating the efficacy and safety of Alzheimer's disease drugs: A meta-analysis and systematic review,"Chen Y, Lai M, Tao M.",Medicine (Baltimore). 2024 Apr 19;103(16):e37799. doi: 10.1097/MD.0000000000037799.,Chen Y,Medicine (Baltimore),2024,19-04-2024,PMC11029996,,10.1097/MD.0000000000037799
38618193,Serum Exosomal miRNA-125b and miRNA-451a are Potential Diagnostic Biomarker for Alzheimer's Diseases,"Duan X, Zheng Q, Liang L, Zhou L.",Degener Neurol Neuromuscul Dis. 2024 Apr 8;14:21-31. doi: 10.2147/DNND.S444567. eCollection 2024.,Duan X,Degener Neurol Neuromuscul Dis,2024,15-04-2024,PMC11012623,,10.2147/DNND.S444567
38613568,Amyloid antibody therapy for early-stage Alzheimer's disease: a critical review of three recent trials,"Guiloff AE, Rudge P.",J Neurol. 2024 May;271(5):2914-2916. doi: 10.1007/s00415-024-12361-w. Epub 2024 Apr 13.,Guiloff AE,J Neurol,2024,13-04-2024,PMC11055802,,10.1007/s00415-024-12361-w
38612719,"Personalized, Precision Medicine to Cure Alzheimer's Dementia: Approach #1",Fessel J.,Int J Mol Sci. 2024 Mar 31;25(7):3909. doi: 10.3390/ijms25073909.,Fessel J,Int J Mol Sci,2024,13-04-2024,PMC11012190,,10.3390/ijms25073909
38612701,Alzheimer's Amyloid Hypothesis and Antibody Therapy: Melting Glaciers?,"Høilund-Carlsen PF, Alavi A, Castellani RJ, Neve RL, Perry G, Revheim ME, Barrio JR.",Int J Mol Sci. 2024 Mar 31;25(7):3892. doi: 10.3390/ijms25073892.,Høilund-Carlsen PF,Int J Mol Sci,2024,13-04-2024,PMC11012162,,10.3390/ijms25073892
38611758,Neuroinflammation of Microglial Regulation in Alzheimer's Disease: Therapeutic Approaches,"Chen H, Zeng Y, Wang D, Li Y, Xing J, Zeng Y, Liu Z, Zhou X, Fan H.",Molecules. 2024 Mar 26;29(7):1478. doi: 10.3390/molecules29071478.,Chen H,Molecules,2024,13-04-2024,PMC11013124,,10.3390/molecules29071478
38610807,Benefits of Music Therapy in the Cognitive Impairments of Alzheimer's-Type Dementia: A Systematic Review,"Jiménez-Palomares M, Garrido-Ardila EM, Chávez-Bravo E, Torres-Piles ST, González-Sánchez B, Rodríguez-Mansilla MJ, De Toro-García Á, Rodríguez-Mansilla J.",J Clin Med. 2024 Apr 1;13(7):2042. doi: 10.3390/jcm13072042.,Jiménez-Palomares M,J Clin Med,2024,13-04-2024,PMC11012733,,10.3390/jcm13072042
38610163,Language and Communication Interventions in People with Alzheimer's Disease: A Systematic Review,"Dimitriou NK, Nousia A, Georgopoulou EN, Martzoukou M, Liampas I, Dardiotis E, Nasios G.",Healthcare (Basel). 2024 Mar 29;12(7):741. doi: 10.3390/healthcare12070741.,Dimitriou NK,Healthcare (Basel),2024,13-04-2024,PMC11011709,,10.3390/healthcare12070741
38610055,Risk of conversion to mild cognitive impairment or dementia among subjects with amyloid and tau pathology: a systematic review and meta-analysis,"Huszár Z, Engh MA, Pavlekovics M, Sato T, Steenkamp Y, Hanseeuw B, Terebessy T, Molnár Z, Hegyi P, Csukly G.",Alzheimers Res Ther. 2024 Apr 12;16(1):81. doi: 10.1186/s13195-024-01455-2.,Huszár Z,Alzheimers Res Ther,2024,12-04-2024,PMC11015617,,10.1186/s13195-024-01455-2
38600070,Predictors for survival in patients with Alzheimer's disease: a large comprehensive meta-analysis,"Zheng X, Wang S, Huang J, Li C, Shang H.",Transl Psychiatry. 2024 Apr 10;14(1):184. doi: 10.1038/s41398-024-02897-w.,Zheng X,Transl Psychiatry,2024,10-04-2024,PMC11006915,,10.1038/s41398-024-02897-w
38599469,Serotonergic dysfunction may mediate the relationship between alcohol consumption and Alzheimer's disease,"Pierson SR, Kolling LJ, James TD, Pushpavathi SG, Marcinkiewcz CA.",Pharmacol Res. 2024 May;203:107171. doi: 10.1016/j.phrs.2024.107171. Epub 2024 Apr 9.,Pierson SR,Pharmacol Res,2024,10-04-2024,PMC11088857,NIHMS1985981,10.1016/j.phrs.2024.107171
38597219,Pharmacological interventions to improve sleep in people with Alzheimer's disease: a meta-analysis of randomized controlled trials,"Bedward A, Kaur J, Seedat S, Donohue H, Kow CS, Rasheed MK, Javed A, Hasan SS.",Expert Rev Neurother. 2024 May;24(5):527-539. doi: 10.1080/14737175.2024.2341004. Epub 2024 Apr 10.,Bedward A,Expert Rev Neurother,2024,10-04-2024,,,10.1080/14737175.2024.2341004
38577975,Anorexigenic neuropeptides as anti-obesity and neuroprotective agents: exploring the neuroprotective effects of anorexigenic neuropeptides,"Strnadová V, Pačesová A, Charvát V, Šmotková Z, Železná B, Kuneš J, Maletínská L.",Biosci Rep. 2024 Apr 24;44(4):BSR20231385. doi: 10.1042/BSR20231385.,Strnadová V,Biosci Rep,2024,05-04-2024,PMC11043025,,10.1042/BSR20231385
38577491,Clinical evidence of hyperbaric oxygen therapy for Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials,"Lin G, Zhao L, Lin J, Li X, Xu L.",Front Aging Neurosci. 2024 Mar 21;16:1360148. doi: 10.3389/fnagi.2024.1360148. eCollection 2024.,Lin G,Front Aging Neurosci,2024,05-04-2024,PMC10991696,,10.3389/fnagi.2024.1360148
38573101,The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with Alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs,"Zhang Y, Sun Y, Hu X, Yao Y, Wang J.",Int J Surg. 2024 Jun 1;110(6):3937-3945. doi: 10.1097/JS9.0000000000001381.,Zhang Y,Int J Surg,2024,04-04-2024,PMC11175821,,10.1097/JS9.0000000000001381
38571463,"Virgin coconut oil - its methods of extraction, properties and clinical usage: a review","Rao YL, Pai MM, Krishnaprasad PR, Pai MV, Murlimanju BV, Mohan A, Prabhu LV, Vadgaonkar R.",Clin Ter. 2024 Mar-Apr;175(2):83-91. doi: 10.7417/CT.2024.5037.,Rao YL,Clin Ter,2024,04-04-2024,,,10.7417/CT.2024.5037
38569102,Health Trajectories of Skilled Nursing Facility Patients With Alzheimer's Disease and Related Dementias: Evidence for Practicing Nurses,"Toles M, Ulmer C, Leeman J.",J Gerontol Nurs. 2024 Apr;50(4):34-41. doi: 10.3928/00989134-20240312-03. Epub 2024 Apr 1.,Toles M,J Gerontol Nurs,2024,03-04-2024,PMC11556862,NIHMS2011626,10.3928/00989134-20240312-03
38567735,Results from the long-term extension of PRIME: A randomized Phase 1b trial of aducanumab,"Chen T, O'Gorman J, Castrillo-Viguera C, Rajagovindan R, Curiale GG, Tian Y, Patel D, von Rosenstiel P, von Hehn C, Salloway S, Hock C, Nitsch RM, Haeberlein SB, Sandrock A, Singhal P.",Alzheimers Dement. 2024 May;20(5):3406-3415. doi: 10.1002/alz.13755. Epub 2024 Apr 3.,Chen T,Alzheimers Dement,2024,03-04-2024,PMC11095417,,10.1002/alz.13755
38565814,Long-acting exenatide does not prevent cognitive decline in mild cognitive impairment: a proof-of-concept clinical trial,"Dei Cas A, Micheli MM, Aldigeri R, Gardini S, Ferrari-Pellegrini F, Perini M, Messa G, Antonini M, Spigoni V, Cinquegrani G, Vazzana A, Moretti V, Caffarra P, Bonadonna RC.",J Endocrinol Invest. 2024 Sep;47(9):2339-2349. doi: 10.1007/s40618-024-02320-7. Epub 2024 Apr 2.,Dei Cas A,J Endocrinol Invest,2024,02-04-2024,PMC11368991,,10.1007/s40618-024-02320-7
38565747,The efficacy and safety of lecanemab 10 mg/kg biweekly compared to a placebo in patients with Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials,"Abdelazim K, Allam AA, Afifi B, Abdulazeem H, Elbehiry AI.",Neurol Sci. 2024 Aug;45(8):3583-3597. doi: 10.1007/s10072-024-07477-w. Epub 2024 Apr 3.,Abdelazim K,Neurol Sci,2024,02-04-2024,PMC11254984,,10.1007/s10072-024-07477-w
38561021,Minimal clinically important difference in Alzheimer's disease: Rapid review,"Muir RT, Hill MD, Black SE, Smith EE.",Alzheimers Dement. 2024 May;20(5):3352-3363. doi: 10.1002/alz.13770. Epub 2024 Apr 1.,Muir RT,Alzheimers Dement,2024,01-04-2024,PMC11095473,,10.1002/alz.13770
38559636,Periodontitis and Neuropathic Diseases: A Literature Review,"Cabanillas J, Risco R, Munive-Degregori A, Guerrero ME, Mauricio F, Mayta-Tovalino F.",J Int Soc Prev Community Dent. 2024 Jan 4;14(1):10-15. doi: 10.4103/jispcd.jispcd_68_22. eCollection 2024 Jan-Feb.,Cabanillas J,J Int Soc Prev Community Dent,2024,01-04-2024,PMC10980301,,10.4103/jispcd.jispcd_68_22
38558015,Progress in Pharmacologic Management of Neuropsychiatric Syndromes in Neurodegenerative Disorders: A Review,"Cummings J, Lanctot K, Grossberg G, Ballard C.",JAMA Neurol. 2024 Jun 1;81(6):645-653. doi: 10.1001/jamaneurol.2024.0586.,Cummings J,JAMA Neurol,2024,01-04-2024,PMC11164642,NIHMS1990063,10.1001/jamaneurol.2024.0586
38542700,"Exploring the Influence of Gut-Brain Axis Modulation on Cognitive Health: A Comprehensive Review of Prebiotics, Probiotics, and Symbiotics","Fekete M, Lehoczki A, Major D, Fazekas-Pongor V, Csípő T, Tarantini S, Csizmadia Z, Varga JT.",Nutrients. 2024 Mar 10;16(6):789. doi: 10.3390/nu16060789.,Fekete M,Nutrients,2024,28-03-2024,PMC10975805,,10.3390/nu16060789
38538229,Self-Modulation of Gamma-Band Synchronization through EEG-Neurofeedback Training in the Elderly,"Andrade K, Houmani N, Guieysse T, Razafimahatratra S, Klarsfeld A, Dreyfus G, Dubois B, Vialatte F, Medani T.",J Integr Neurosci. 2024 Mar 21;23(3):67. doi: 10.31083/j.jin2303067.,Andrade K,J Integr Neurosci,2024,27-03-2024,,,10.31083/j.jin2303067
38537670,Muscarinic Receptor Activators as Novel Treatments for Schizophrenia,"Paul SM, Yohn SE, Brannan SK, Neugebauer NM, Breier A.",Biol Psychiatry. 2024 Oct 15;96(8):627-637. doi: 10.1016/j.biopsych.2024.03.014. Epub 2024 Mar 25.,Paul SM,Biol Psychiatry,2024,27-03-2024,,,10.1016/j.biopsych.2024.03.014
38530578,A systematic review of goal attainment scaling implementation practices by caregivers in randomized controlled trials,"Cheema K, Dunn T, Chapman C, Rockwood K, Howlett SE, Sevinc G.",J Patient Rep Outcomes. 2024 Mar 26;8(1):37. doi: 10.1186/s41687-024-00716-w.,Cheema K,J Patient Rep Outcomes,2024,26-03-2024,PMC10965877,,10.1186/s41687-024-00716-w
38518653,Dynamics and prognostic value of serum neurofilament light chain in Guillain-Barré syndrome,"van Tilburg SJ, Teunissen CE, Maas CCHM, Thomma RCM, Walgaard C, Heijst H, Huizinga R, van Doorn PA, Jacobs BC.",EBioMedicine. 2024 Apr;102:105072. doi: 10.1016/j.ebiom.2024.105072. Epub 2024 Mar 22.,van Tilburg SJ,EBioMedicine,2024,22-03-2024,PMC10980997,,10.1016/j.ebiom.2024.105072
38513821,Non-invasive sound wave brain stimulation with Transcranial Pulse Stimulation (TPS) improves neuropsychiatric symptoms in Alzheimer's disease,"Shinzato GT, Assone T, Sandler PC, Pacheco-Barrios K, Fregni F, Radanovic M, Forlenza OV, Battistella LR.",Brain Stimul. 2024 Mar-Apr;17(2):413-415. doi: 10.1016/j.brs.2024.03.007. Epub 2024 Mar 20.,Shinzato GT,Brain Stimul,2024,21-03-2024,,,10.1016/j.brs.2024.03.007
38508080,Mechanistic insights into the potential role of dietary polyphenols and their nanoformulation in the management of Alzheimer's disease,"Albadrani HM, Chauhan P, Ashique S, Babu MA, Iqbal D, Almutary AG, Abomughaid MM, Kamal M, Paiva-Santos AC, Alsaweed M, Hamed M, Sachdeva P, Dewanjee S, Jha SK, Ojha S, Slama P, Jha NK.",Biomed Pharmacother. 2024 May;174:116376. doi: 10.1016/j.biopha.2024.116376. Epub 2024 Mar 19.,Albadrani HM,Biomed Pharmacother,2024,20-03-2024,,,10.1016/j.biopha.2024.116376
38501109,Systematic review and meta-analysis of the effects of menopause hormone therapy on cognition,"Andy C, Nerattini M, Jett S, Carlton C, Zarate C, Boneu C, Fauci F, Ajila T, Battista M, Pahlajani S, Christos P, Fink ME, Williams S, Brinton RD, Mosconi L.",Front Endocrinol (Lausanne). 2024 Mar 4;15:1350318. doi: 10.3389/fendo.2024.1350318. eCollection 2024.,Andy C,Front Endocrinol (Lausanne),2024,19-03-2024,PMC10944893,,10.3389/fendo.2024.1350318
38488949,The impact of exercise on blood-based biomarkers of Alzheimer's disease in cognitively unimpaired older adults,"Sewell KR, Rainey-Smith SR, Pedrini S, Peiffer JJ, Sohrabi HR, Taddei K, Markovic SJ, Martins RN, Brown BM.",Geroscience. 2024 Dec;46(6):5911-5923. doi: 10.1007/s11357-024-01130-2. Epub 2024 Mar 15.,Sewell KR,Geroscience,2024,15-03-2024,PMC11493998,,10.1007/s11357-024-01130-2
38486359,The Effects of Exergame Telerehabilitation in Persons With Subjective Cognitive Decline,"Salisbury DL, Pituch KA, Yu F.",Gerontologist. 2024 Jun 1;64(6):gnae028. doi: 10.1093/geront/gnae028.,Salisbury DL,Gerontologist,2024,15-03-2024,PMC11138364,,10.1093/geront/gnae028
38482571,Peripheral vascular function in stroke: systematic review and meta-analysis,"Bartsch BL, Hazen EM, Montgomery RN, Trieu C, Britton-Carpenter AJ, Billinger SA.",J Appl Physiol (1985). 2024 May 1;136(5):1182-1194. doi: 10.1152/japplphysiol.00601.2023. Epub 2024 Mar 14.,Bartsch BL,J Appl Physiol (1985),2024,14-03-2024,PMC11368525,,10.1152/japplphysiol.00601.2023
38477423,Adapted problem adaptation therapy for depression in mild to moderate Alzheimer's disease dementia: A randomized controlled trial,"Howard R, Cort E, Rawlinson C, Wiegand M, Downey A, Lawrence V, Banerjee S, Bentham P, Fox C, Harwood R, Hunter R, Livingston G, Moniz-Cook E, Panca M, Raczek M, Ivenso C, Russell G, Thomas A, Wilkinson P, Freemantle N, Gould R.",Alzheimers Dement. 2024 Apr;20(4):2990-2999. doi: 10.1002/alz.13766. Epub 2024 Mar 13.,Howard R,Alzheimers Dement,2024,13-03-2024,PMC11032547,,10.1002/alz.13766
38476498,The influence of pharmacist-led collaborative care on clinical outcomes in type 2 diabetes mellitus: a multicenter randomized control trial,"Iqbal MZ, Alqahtani SS, Mubarak N, Shahid S, Mohammed R, Mustafa A, Khan AH, Iqbal MS.",Front Public Health. 2024 Feb 27;12:1323102. doi: 10.3389/fpubh.2024.1323102. eCollection 2024.,Iqbal MZ,Front Public Health,2024,13-03-2024,PMC10929610,,10.3389/fpubh.2024.1323102
38474254,Lactiplantibacillus (Lactobacillus) plantarum as a Complementary Treatment to Improve Symptomatology in Neurodegenerative Disease: A Systematic Review of Open Access Literature,"Beltrán-Velasco AI, Reiriz M, Uceda S, Echeverry-Alzate V.",Int J Mol Sci. 2024 Mar 5;25(5):3010. doi: 10.3390/ijms25053010.,Beltrán-Velasco AI,Int J Mol Sci,2024,13-03-2024,PMC10931784,,10.3390/ijms25053010
38474192,Update on Antioxidant Therapy with Edaravone: Expanding Applications in Neurodegenerative Diseases,"Yamashita T, Abe K.",Int J Mol Sci. 2024 Mar 3;25(5):2945. doi: 10.3390/ijms25052945.,Yamashita T,Int J Mol Sci,2024,13-03-2024,PMC10932469,,10.3390/ijms25052945
38471120,A span-based model for extracting overlapping PICO entities from randomized controlled trial publications,"Zhang G, Zhou Y, Hu Y, Xu H, Weng C, Peng Y.",J Am Med Inform Assoc. 2024 Apr 19;31(5):1163-1171. doi: 10.1093/jamia/ocae065.,Zhang G,J Am Med Inform Assoc,2024,12-03-2024,PMC11031223,,10.1093/jamia/ocae065
38469572,Iron quantification in basal ganglia: quantitative susceptibility mapping as a potential biomarker for Alzheimer's disease - a systematic review and meta-analysis,"Ghaderi S, Mohammadi S, Nezhad NJ, Karami S, Sayehmiri F.",Front Neurosci. 2024 Feb 26;18:1338891. doi: 10.3389/fnins.2024.1338891. eCollection 2024.,Ghaderi S,Front Neurosci,2024,12-03-2024,PMC10925682,,10.3389/fnins.2024.1338891
38468511,"Head Injury Treatment With Healthy and Advanced Dietary Supplements: A Pilot Randomized Controlled Trial of the Tolerability, Safety, and Efficacy of Branched Chain Amino Acids in the Treatment of Concussion in Adolescents and Young Adults","Corwin DJ, Myers SR, Arbogast KB, Lim MM, Elliott JE, Metzger KB, LeRoux P, Elkind J, Metheny H, Berg J, Pettijohn K, Master CL, Kirschen MP, Cohen AS.",J Neurotrauma. 2024 Jun;41(11-12):1299-1309. doi: 10.1089/neu.2023.0433. Epub 2024 Apr 11.,Corwin DJ,J Neurotrauma,2024,12-03-2024,PMC11339555,,10.1089/neu.2023.0433
38462491,The effectiveness of exercise interventions targeting sleep in older adults with cognitive impairment or Alzheimer's disease and related dementias (AD/ADRD): A systematic review and meta-analysis,"Páez A, Frimpong E, Mograss M, Dang-Vu TT.",J Sleep Res. 2024 Dec;33(6):e14189. doi: 10.1111/jsr.14189. Epub 2024 Mar 10.,Páez A,J Sleep Res,2024,10-03-2024,PMC11597006,,10.1111/jsr.14189
38461816,Motoric Cognitive Risk Syndrome and the Risk of Incident Dementia: A Systematic Review and Meta-Analysis of Cohort Studies,"Xu W, Bai A, Liang Y, Lin Z.",Gerontology. 2024;70(5):479-490. doi: 10.1159/000535082. Epub 2024 Mar 8.,Xu W,Gerontology,2024,10-03-2024,PMC11098020,,10.1159/000535082
38461634,Effects of chronic intranasal oxytocin on visual attention to faces vs. natural scenes in older adults,"Shoenfelt A, Pehlivanoglu D, Lin T, Ziaei M, Feifel D, Ebner NC.",Psychoneuroendocrinology. 2024 Jun;164:107018. doi: 10.1016/j.psyneuen.2024.107018. Epub 2024 Mar 4.,Shoenfelt A,Psychoneuroendocrinology,2024,10-03-2024,PMC11699979,NIHMS2044924,10.1016/j.psyneuen.2024.107018
38457150,Can Physical Exercise Be Considered as a Promising Enhancer of Global Cognition in People with Parkinson's Disease? Results of a Systematic Review and Meta-Analysis,"Folkerts AK, Ernst M, Gollan R, Cryns N, Monsef I, Skoetz N, Kalbe E.",J Parkinsons Dis. 2024;14(s1):S115-S133. doi: 10.3233/JPD-230343.,Folkerts AK,J Parkinsons Dis,2024,08-03-2024,PMC11380223,,10.3233/JPD-230343
38457007,Learning ratio performance on a brief visual learning and memory test moderates cognitive training gains in Double Decision task in healthy older adults,"Hardcastle C, Kraft JN, Hausman HK, O'Shea A, Albizu A, Evangelista ND, Boutzoukas EM, Van Etten EJ, Bharadwaj PK, Song H, Smith SG, Porges E, DeKosky ST, Hishaw GA, Wu SS, Marsiske M, Cohen R, Alexander GE, Woods AJ.",Geroscience. 2024 Aug;46(4):3929-3943. doi: 10.1007/s11357-024-01115-1. Epub 2024 Mar 8.,Hardcastle C,Geroscience,2024,08-03-2024,PMC11226577,,10.1007/s11357-024-01115-1
38451331,Markers for the detection of Lewy body disease versus Alzheimer's disease in mild cognitive impairment: a systematic review and meta-analysis,"Burgio MI, Veronese N, Sarà D, Saccaro C, Masnata R, Vassallo G, Catania A, Catanese G, Mueller C, Smith L, Dominguez LJ, Vernuccio L, Barbagallo M.",Aging Clin Exp Res. 2024 Mar 7;36(1):60. doi: 10.1007/s40520-024-02704-y.,Burgio MI,Aging Clin Exp Res,2024,07-03-2024,PMC10920203,,10.1007/s40520-024-02704-y
38447959,Cannabinoids for Behavioral Symptoms in Dementia: An Overview,"Broers B, Bianchi F.",Pharmacopsychiatry. 2024 May;57(3):160-168. doi: 10.1055/a-2262-7837. Epub 2024 Mar 6.,Broers B,Pharmacopsychiatry,2024,06-03-2024,,,10.1055/a-2262-7837
38442672,"Phytochemicals targeting Alzheimer's disease via the AMP-activated protein kinase pathway, effects, and mechanisms of action","Zhao Z, Yan J, Huang L, Yang X.",Biomed Pharmacother. 2024 Apr;173:116373. doi: 10.1016/j.biopha.2024.116373. Epub 2024 Mar 4.,Zhao Z,Biomed Pharmacother,2024,05-03-2024,,,10.1016/j.biopha.2024.116373
38441832,Insulin Delivery to the Brain via the Nasal Route: Unraveling the Potential for Alzheimer's Disease Therapy,"Wong CYJ, Baldelli A, Hoyos CM, Tietz O, Ong HX, Traini D.",Drug Deliv Transl Res. 2024 Jul;14(7):1776-1793. doi: 10.1007/s13346-024-01558-1. Epub 2024 Mar 5.,Wong CYJ,Drug Deliv Transl Res,2024,05-03-2024,PMC11153287,,10.1007/s13346-024-01558-1
38439609,Safety and efficacy of acetylcholinesterase inhibitors for Alzheimer's disease: A systematic review and meta-analysis,"Gao Y, Liu Y, Li Y.",Adv Clin Exp Med. 2024 Nov;33(11):1179-1187. doi: 10.17219/acem/176051.,Gao Y,Adv Clin Exp Med,2024,05-03-2024,,,10.17219/acem/176051
38438012,tDCS reduces depression and state anxiety symptoms in older adults from the augmenting cognitive training in older adults study (ACT),"Hausman HK, Alexander GE, Cohen R, Marsiske M, DeKosky ST, Hishaw GA, O'Shea A, Kraft JN, Dai Y, Wu S, Woods AJ.",Brain Stimul. 2024 Mar-Apr;17(2):283-311. doi: 10.1016/j.brs.2024.02.021. Epub 2024 Mar 2.,Hausman HK,Brain Stimul,2024,04-03-2024,PMC11110843,NIHMS1991135,10.1016/j.brs.2024.02.021
38436963,Dementia Prevention and Treatment: A Narrative Review,"Reuben DB, Kremen S, Maust DT.",JAMA Intern Med. 2024 May 1;184(5):563-572. doi: 10.1001/jamainternmed.2023.8522.,Reuben DB,JAMA Intern Med,2024,04-03-2024,,,10.1001/jamainternmed.2023.8522
38430933,Associations of environmental factors with neurodegeneration: An exposome-wide Mendelian randomization investigation,"Li D, Zhou L, Cao Z, Wang J, Yang H, Lyu M, Zhang Y, Yang R, Wang J, Bian Y, Xu W, Wang Y.",Ageing Res Rev. 2024 Mar;95:102254. doi: 10.1016/j.arr.2024.102254. Epub 2024 Feb 29.,Li D,Ageing Res Rev,2024,02-03-2024,,,10.1016/j.arr.2024.102254
38427486,Tau Immunotherapies for Alzheimer's Disease and Related Tauopathies: Status of Trials and Insights from Preclinical Studies,Sigurdsson EM.,J Alzheimers Dis. 2024;101(s1):S129-S140. doi: 10.3233/JAD-231238.,Sigurdsson EM,J Alzheimers Dis,2024,01-03-2024,PMC11587787,NIHMS2033116,10.3233/JAD-231238
38427485,Safety Profile of Pimavanserin Therapy in Elderly Patients with Neurodegenerative Disease-Related Neuropsychiatric Symptoms: A Phase 3B Study,"Alva G, Cubała WJ, Berrio A, Coate B, Abler V, Pathak S.",J Alzheimers Dis. 2024;98(1):265-274. doi: 10.3233/JAD-231167.,Alva G,J Alzheimers Dis,2024,01-03-2024,PMC10977351,,10.3233/JAD-231167
38427480,Unlocking the Potential of Repetitive Transcranial Magnetic Stimulation in Alzheimer's Disease: A Meta-Analysis of Randomized Clinical Trials to Optimize Intervention Strategies,"Li S, Lan X, Liu Y, Zhou J, Pei Z, Su X, Guo Y.",J Alzheimers Dis. 2024;98(2):481-503. doi: 10.3233/JAD-231031.,Li S,J Alzheimers Dis,2024,01-03-2024,PMC10977421,,10.3233/JAD-231031
38426329,"Hypertension, Neurodegeneration, and Cognitive Decline","Pacholko A, Iadecola C.",Hypertension. 2024 May;81(5):991-1007. doi: 10.1161/HYPERTENSIONAHA.123.21356. Epub 2024 Mar 1.,Pacholko A,Hypertension,2024,01-03-2024,PMC11023809,NIHMS1967823,10.1161/HYPERTENSIONAHA.123.21356
38424433,Proton Pump Inhibitors and Cognitive Health: Review on Unraveling the Dementia Connection and Co-morbid Risks,"Khan Z, Mehan S, Saifi MA, Gupta GD, Narula AS, Kalfin R.",Curr Alzheimer Res. 2024;20(11):739-757. doi: 10.2174/0115672050289946240223050737.,Khan Z,Curr Alzheimer Res,2024,29-02-2024,PMC11107432,,10.2174/0115672050289946240223050737
38423195,The association of glucose metabolism measures and diabetes status with Alzheimer's disease biomarkers of amyloid and tau: A systematic review and meta-analysis,"van Gils V, Rizzo M, Côté J, Viechtbauer W, Fanelli G, Salas-Salvadó J, Wimberley T, Bulló M, Fernandez-Aranda F, Dalsgaard S, Visser PJ, Jansen WJ, Vos SJB.",Neurosci Biobehav Rev. 2024 Apr;159:105604. doi: 10.1016/j.neubiorev.2024.105604. Epub 2024 Feb 27.,van Gils V,Neurosci Biobehav Rev,2024,29-02-2024,,,10.1016/j.neubiorev.2024.105604
38420112,"A review: effects of neurofeedback on patients with mild cognitive impairment (MCI), and Alzheimer's disease (AD)",Tazaki M.,Front Hum Neurosci. 2024 Feb 14;17:1331436. doi: 10.3389/fnhum.2023.1331436. eCollection 2023.,Tazaki M,Front Hum Neurosci,2024,29-02-2024,PMC10899454,,10.3389/fnhum.2023.1331436
38419903,"Sleep, mood disorders, and the ketogenic diet: potential therapeutic targets for bipolar disorder and schizophrenia","Choi J, Kang J, Kim T, Nehs CJ.",Front Psychiatry. 2024 Feb 14;15:1358578. doi: 10.3389/fpsyt.2024.1358578. eCollection 2024.,Choi J,Front Psychiatry,2024,29-02-2024,PMC10899493,,10.3389/fpsyt.2024.1358578
38414633,A case for seeking sex-specific treatments in Alzheimer's disease,Lynch MA.,Front Aging Neurosci. 2024 Feb 13;16:1346621. doi: 10.3389/fnagi.2024.1346621. eCollection 2024.,Lynch MA,Front Aging Neurosci,2024,28-02-2024,PMC10897030,,10.3389/fnagi.2024.1346621
38405664,Neuroprotective effects of dipeptidyl peptidase 4 inhibitor on Alzheimer's disease: a narrative review,"Jiang X, Li J, Yao X, Ding H, Gu A, Zhou Z.",Front Pharmacol. 2024 Feb 9;15:1361651. doi: 10.3389/fphar.2024.1361651. eCollection 2024.,Jiang X,Front Pharmacol,2024,26-02-2024,PMC10884281,,10.3389/fphar.2024.1361651
38405341,Prognostic and Predictive Factors in Early Alzheimer's Disease: A Systematic Review,"Garcia MJ, Leadley R, Ross J, Bozeat S, Redhead G, Hansson O, Iwatsubo T, Villain N, Cummings J.",J Alzheimers Dis Rep. 2024 Feb 16;8(1):203-240. doi: 10.3233/ADR-230045. eCollection 2024.,Garcia MJ,J Alzheimers Dis Rep,2024,26-02-2024,PMC10894607,,10.3233/ADR-230045
38399380,[(18)F]Fluspidine-A PET Tracer for Imaging of σ(1) Receptors in the Central Nervous System,"Ludwig FA, Laurini E, Schmidt J, Pricl S, Deuther-Conrad W, Wünsch B.",Pharmaceuticals (Basel). 2024 Jan 28;17(2):166. doi: 10.3390/ph17020166.,Ludwig FA,Pharmaceuticals (Basel),2024,24-02-2024,PMC10892410,,10.3390/ph17020166
38399373,Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics,"Cha Y, Kagalwala MN, Ross J.",Pharmaceuticals (Basel). 2024 Jan 25;17(2):158. doi: 10.3390/ph17020158.,Cha Y,Pharmaceuticals (Basel),2024,24-02-2024,PMC10891920,,10.3390/ph17020158
38397037,Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection,"Chiang MC, Yang YP, Nicol CJB, Wang CJ.",Int J Mol Sci. 2024 Feb 17;25(4):2360. doi: 10.3390/ijms25042360.,Chiang MC,Int J Mol Sci,2024,24-02-2024,PMC10888679,,10.3390/ijms25042360
38396804,The Potential Use of Vitamin D3 and Phytochemicals for Their Anti-Ageing Effects,"Santa K, Kumazawa Y, Watanabe K, Nagaoka I.",Int J Mol Sci. 2024 Feb 9;25(4):2125. doi: 10.3390/ijms25042125.,Santa K,Int J Mol Sci,2024,24-02-2024,PMC10889119,,10.3390/ijms25042125
38396302,New precision medicine avenues to the prevention of Alzheimer's disease from insights into the structure and function of γ-secretases,"De Strooper B, Karran E.",EMBO J. 2024 Mar;43(6):887-903. doi: 10.1038/s44318-024-00057-w. Epub 2024 Feb 23.,De Strooper B,EMBO J,2024,24-02-2024,PMC10943082,,10.1038/s44318-024-00057-w
38393913,Vaccines and Dementia: Part II. Efficacy of BCG and Other Vaccines Against Dementia,"Greenblatt CL, Lathe R.",J Alzheimers Dis. 2024;98(2):361-372. doi: 10.3233/JAD-231323.,Greenblatt CL,J Alzheimers Dis,2024,23-02-2024,PMC10977380,,10.3233/JAD-231323
38393051,Oleaginous Microbial Lipids' Potential in the Prevention and Treatment of Neurological Disorders,"Alhattab M, Moorthy LS, Patel D, Franco CMM, Puri M.",Mar Drugs. 2024 Feb 6;22(2):80. doi: 10.3390/md22020080.,Alhattab M,Mar Drugs,2024,23-02-2024,PMC10890163,,10.3390/md22020080
38392012,Electrochemical Acetylcholinesterase Sensors for Anti-Alzheimer's Disease Drug Determination,"Ivanov A, Shamagsumova R, Larina M, Evtugyn G.",Biosensors (Basel). 2024 Feb 9;14(2):93. doi: 10.3390/bios14020093.,Ivanov A,Biosensors (Basel),2024,23-02-2024,PMC10886970,,10.3390/bios14020093
38389785,Tinnitus-associated cognitive and psychological impairments: a comprehensive review meta-analysis,"Yang D, Zhang D, Zhang X, Li X.",Front Neurosci. 2024 Feb 8;18:1275560. doi: 10.3389/fnins.2024.1275560. eCollection 2024.,Yang D,Front Neurosci,2024,23-02-2024,PMC10881733,,10.3389/fnins.2024.1275560
38386949,"Assessment of Efficacy and Safety of Zagotenemab: Results From PERISCOPE-ALZ, a Phase 2 Study in Early Symptomatic Alzheimer Disease","Fleisher AS, Munsie LM, Perahia DGS, Andersen SW, Higgins IA, Hauck PM, Lo AC, Sims JR, Brys M, Mintun M; PERISCOPE-ALZ Site Investigators.",Neurology. 2024 Mar 12;102(5):e208061. doi: 10.1212/WNL.0000000000208061. Epub 2024 Feb 22.,Fleisher AS,Neurology,2024,22-02-2024,PMC11067698,,10.1212/WNL.0000000000208061
38386173,Multidomain interventions for sarcopenia and cognitive flexibility in older adults for promoting healthy aging: a systematic review and meta-analysis of randomized controlled trials,"García-Llorente AM, Casimiro-Andújar AJ, Linhares DG, De Souza Vale RG, Marcos-Pardo PJ.",Aging Clin Exp Res. 2024 Feb 22;36(1):47. doi: 10.1007/s40520-024-02700-2.,García-Llorente AM,Aging Clin Exp Res,2024,22-02-2024,PMC10884056,,10.1007/s40520-024-02700-2
38385077,Polyphenols Targeting NF-κB Pathway in Neurological Disorders: What We Know So Far?,"Mamun AA, Shao C, Geng P, Wang S, Xiao J.",Int J Biol Sci. 2024 Jan 27;20(4):1332-1355. doi: 10.7150/ijbs.90982. eCollection 2024.,Mamun AA,Int J Biol Sci,2024,22-02-2024,PMC10878147,,10.7150/ijbs.90982
38382942,Monoclonal antibody therapy for Alzheimer's disease focusing on intracerebral targets,"Gu X, Qi L, Qi Q, Zhou J, Chen S, Wang L.",Biosci Trends. 2024 Mar 19;18(1):49-65. doi: 10.5582/bst.2023.01288. Epub 2024 Feb 21.,Gu X,Biosci Trends,2024,21-02-2024,,,10.5582/bst.2023.01288
38379273,An analysis of omega-3 clinical trials and a call for personalized supplementation for dementia prevention,"Castellanos-Perilla N, Borda MG, Aarsland D, Barreto GE.",Expert Rev Neurother. 2024 Mar;24(3):313-324. doi: 10.1080/14737175.2024.2313547. Epub 2024 Feb 20.,Castellanos-Perilla N,Expert Rev Neurother,2024,21-02-2024,PMC11090157,,10.1080/14737175.2024.2313547
38378160,A Meta-Analysis of Fall Risk in Older Adults With Alzheimer's Disease,"Mahmoudzadeh Khalili S, Simpkins C, Yang F.",J Am Med Dir Assoc. 2024 May;25(5):781-788.e3. doi: 10.1016/j.jamda.2024.01.005. Epub 2024 Feb 17.,Mahmoudzadeh Khalili S,J Am Med Dir Assoc,2024,20-02-2024,PMC11065606,NIHMS1963353,10.1016/j.jamda.2024.01.005
38361643,Comparative efficacy of various exercise interventions on sleep in patients with cognitive impairment: a systematic review and meta-analysis,"Zhang J, Liu Y, Sun Q, Shi J, Ni J, Li T, Long Z, Wei M, Tian J.",Front Neurol. 2024 Feb 1;15:1300459. doi: 10.3389/fneur.2024.1300459. eCollection 2024.,Zhang J,Front Neurol,2024,16-02-2024,PMC10867314,,10.3389/fneur.2024.1300459
38360452,Repetitive transcranial magnetic stimulation as a treatment for Alzheimer's disease: A randomized placebo-controlled double-blind clinical trial,"Moussavi Z, Uehara M, Rutherford G, Lithgow B, Millikin C, Wang X, Saha C, Mansouri B, Omelan C, Fellows L, Fitzgerald PB, Koski L.",Neurotherapeutics. 2024 Apr;21(3):e00331. doi: 10.1016/j.neurot.2024.e00331. Epub 2024 Feb 14.,Moussavi Z,Neurotherapeutics,2024,15-02-2024,PMC10937236,,10.1016/j.neurot.2024.e00331
38355715,Cognitive and immunological effects of yoga compared to memory training in older women at risk for alzheimer's disease,"Grzenda A, Siddarth P, Milillo MM, Aguilar-Faustino Y, Khalsa DS, Lavretsky H.",Transl Psychiatry. 2024 Feb 14;14(1):96. doi: 10.1038/s41398-024-02807-0.,Grzenda A,Transl Psychiatry,2024,14-02-2024,PMC10867110,,10.1038/s41398-024-02807-0
38355013,Systemic Inflammation in Asthma: What Are the Risks and Impacts Outside the Airway?,"Tattersall MC, Jarjour NN, Busse PJ.",J Allergy Clin Immunol Pract. 2024 Apr;12(4):849-862. doi: 10.1016/j.jaip.2024.02.004. Epub 2024 Feb 12.,Tattersall MC,J Allergy Clin Immunol Pract,2024,14-02-2024,PMC11219096,NIHMS1986903,10.1016/j.jaip.2024.02.004
38353689,"ACD856, a novel positive allosteric modulator of Trk receptors, single ascending doses in healthy subjects: Safety and pharmacokinetics","Nilsson B, Bylund J, Halldin MM, Rother M, Rein-Hedin E, Önnestam K, Segerdahl M.",Eur J Clin Pharmacol. 2024 May;80(5):717-727. doi: 10.1007/s00228-024-03645-1. Epub 2024 Feb 14.,Nilsson B,Eur J Clin Pharmacol,2024,14-02-2024,PMC11001683,,10.1007/s00228-024-03645-1
38346453,Cholecystokinin (CCK): a neuromodulator with therapeutic potential in Alzheimer's and Parkinson's disease,"Reich N, Hölscher C.",Front Neuroendocrinol. 2024 Apr;73:101122. doi: 10.1016/j.yfrne.2024.101122. Epub 2024 Feb 10.,Reich N,Front Neuroendocrinol,2024,12-02-2024,,,10.1016/j.yfrne.2024.101122
38346414,Potentially Modifiable Risk Factors for Dementia and Mild Cognitive Impairment: An Umbrella Review and Meta-Analysis,"Jones A, Ali MU, Kenny M, Mayhew A, Mokashi V, He H, Lin S, Yavari E, Paik K, Subramanian D, Dydynsky R, Aryal K, Correia RH, Dash D, Manis DR, O'Connell M, Liu-Ambrose T, Taler V, McMillan JM, Hogan DB, Kirkland S, Costa AP, Wolfson C, Raina P, Griffith L.",Dement Geriatr Cogn Disord. 2024;53(2):91-106. doi: 10.1159/000536643. Epub 2024 Feb 26.,Jones A,Dement Geriatr Cogn Disord,2024,12-02-2024,,,10.1159/000536643
38342754,New horizons in the diagnosis and management of Alzheimer's Disease in older adults,"Dolphin H, Dyer AH, Morrison L, Shenkin SD, Welsh T, Kennelly SP.",Age Ageing. 2024 Feb 1;53(2):afae005. doi: 10.1093/ageing/afae005.,Dolphin H,Age Ageing,2024,11-02-2024,PMC10859247,,10.1093/ageing/afae005
38339193,"Extra-Virgin Olive Oil in Alzheimer's Disease: A Comprehensive Review of Cellular, Animal, and Clinical Studies","Alkhalifa AE, Al-Ghraiybah NF, Kaddoumi A.",Int J Mol Sci. 2024 Feb 5;25(3):1914. doi: 10.3390/ijms25031914.,Alkhalifa AE,Int J Mol Sci,2024,10-02-2024,PMC10856527,,10.3390/ijms25031914
38338219,Epidemiology of Dementia in China in 2010-2020: A Systematic Review and Meta-Analysis,"Yin Y, Tam HL, Quint J, Chen M, Ding R, Zhang X.",Healthcare (Basel). 2024 Jan 28;12(3):334. doi: 10.3390/healthcare12030334.,Yin Y,Healthcare (Basel),2024,10-02-2024,PMC10855047,,10.3390/healthcare12030334
38334629,A Systematic Review on Drugs Acting as Nicotinic Acetylcholine Receptor Agonists in the Treatment of Dementia,"Crestini A, Carbone E, Rivabene R, Ancidoni A, Rosa P, Tata AM, Fabrizi E, Locuratolo N, Vanacore N, Lacorte E, Piscopo P.",Cells. 2024 Jan 26;13(3):237. doi: 10.3390/cells13030237.,Crestini A,Cells,2024,09-02-2024,PMC10854606,,10.3390/cells13030237
38331381,Design of a pragmatic randomized implementation effectiveness trial testing a health system wide hypertension program for older adults,"Gupta A, Chouhdry H, Ellis SD, Young K, Mahnken J, Comfort B, Shanks D, McGreevy S, Rudy C, Zufer T, Mabry S, Woodward J, Wilson A, Anderson H, Loucks J, Chandaka S, Abu-El-Rub N, Mazzotti DR, Song X, Schmitz N, Conroy M, Supiano MA, Waitman LR, Burns JM.",Contemp Clin Trials. 2024 Mar;138:107466. doi: 10.1016/j.cct.2024.107466. Epub 2024 Feb 7.,Gupta A,Contemp Clin Trials,2024,08-02-2024,PMC11774317,NIHMS2047412,10.1016/j.cct.2024.107466
38329083,"Efficacy and safety of transcranial magnetic stimulation on cognition in mild cognitive impairment, Alzheimer's disease, Alzheimer's disease-related dementias, and other cognitive disorders: a systematic review and meta-analysis","Pagali SR, Kumar R, LeMahieu AM, Basso MR, Boeve BF, Croarkin PE, Geske JR, Hassett LC, Huston J 3rd, Kung S, Lundstrom BN, Petersen RC, St Louis EK, Welker KM, Worrell GA, Pascual-Leone A, Lapid MI.",Int Psychogeriatr. 2024 Oct;36(10):880-928. doi: 10.1017/S1041610224000085. Epub 2024 Feb 8.,Pagali SR,Int Psychogeriatr,2024,08-02-2024,PMC11306417,NIHMS1958750,10.1017/S1041610224000085
38323508,The Australian National University Alzheimer's Disease Risk Index (ANU-ADRI) score as a predictor for cognitive decline and potential surrogate outcome in the FINGER lifestyle randomized controlled trial,"Hall A, Barbera M, Lehtisalo J, Antikainen R, Huque H, Laatikainen T, Ngandu T, Soininen H, Stephen R, Strandberg T, Kivipelto M, Anstey KJ, Solomon A.",Eur J Neurol. 2024 May;31(5):e16238. doi: 10.1111/ene.16238. Epub 2024 Feb 7.,Hall A,Eur J Neurol,2024,07-02-2024,PMC11235774,,10.1111/ene.16238
38321321,Acetyl-cholinesterase-inhibitors reconsidered. A narrative review of post-marketing studies on Alzheimer's disease,"Zuliani G, Zuin M, Romagnoli T, Polastri M, Cervellati C, Brombo G.",Aging Clin Exp Res. 2024 Feb 7;36(1):23. doi: 10.1007/s40520-023-02675-6.,Zuliani G,Aging Clin Exp Res,2024,06-02-2024,PMC10847178,,10.1007/s40520-023-02675-6
38317762,Current trends in psychotherapies and psychosocial interventions for people with dementia: a scoping review of randomized controlled trials,"Vicente C, Fernandes S, Romão A, Fernandes JB.",Front Psychiatry. 2024 Jan 22;15:1286475. doi: 10.3389/fpsyt.2024.1286475. eCollection 2024.,Vicente C,Front Psychiatry,2024,06-02-2024,PMC10838973,,10.3389/fpsyt.2024.1286475
38310304,Anodal HD-tDCS on the dominant anterior temporal lobe and dorsolateral prefrontal cortex: clinical results in patients with mild cognitive impairment,"Rezakhani S, Amiri M, Hassani A, Esmaeilpour K, Sheibani V.",Alzheimers Res Ther. 2024 Feb 3;16(1):27. doi: 10.1186/s13195-023-01370-y.,Rezakhani S,Alzheimers Res Ther,2024,03-02-2024,PMC10837991,,10.1186/s13195-023-01370-y
38306046,The Effects of Pomegranate Seed Oil on Mild Cognitive Impairment,"Chatzikostopoulos T, Gialaouzidis M, Koutoupa A, Tsolaki M.",J Alzheimers Dis. 2024;97(4):1961-1970. doi: 10.3233/JAD-231100.,Chatzikostopoulos T,J Alzheimers Dis,2024,02-02-2024,PMC10977427,,10.3233/JAD-231100
38305989,Muscarinic control of cardiovascular function in humans: a review of current clinical evidence,Palma JA.,Clin Auton Res. 2024 Feb;34(1):31-44. doi: 10.1007/s10286-024-01016-5. Epub 2024 Feb 2.,Palma JA,Clin Auton Res,2024,02-02-2024,PMC10994193,NIHMS1979518,10.1007/s10286-024-01016-5
38304427,Brain FADE syndrome: the final common pathway of chronic inflammation in neurological disease,"Hanafy KA, Jovin TG.",Front Immunol. 2024 Jan 18;15:1332776. doi: 10.3389/fimmu.2024.1332776. eCollection 2024.,Hanafy KA,Front Immunol,2024,02-02-2024,PMC10830639,,10.3389/fimmu.2024.1332776
38302876,Case report: a unique presentation of memantine overdose causing echolalia and hypertension,"Durrani S, Ahmed S.",BMC Geriatr. 2024 Feb 1;24(1):123. doi: 10.1186/s12877-024-04658-2.,Durrani S,BMC Geriatr,2024,02-02-2024,PMC10835811,,10.1186/s12877-024-04658-2
38296163,Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease,"Guarnieri L, Bosco F, Leo A, Citraro R, Palma E, De Sarro G, Mollace V.",Ageing Res Rev. 2024 Mar;95:102210. doi: 10.1016/j.arr.2024.102210. Epub 2024 Feb 1.,Guarnieri L,Ageing Res Rev,2024,31-01-2024,,,10.1016/j.arr.2024.102210
38292722,Chitosan hydrogel nanoparticle enhance therapeutic effect of bovine umbilical mesenchymal stem cell conditioned medium on canine cognitive dysfunction or canine Alzheimer's like mediated by inhibition of neuronal apoptotic,"Wihadmadyatami H, Zulfikar MA, Herawati H, Pratama DAOA, Saragih GR, Kustiati U, Handayani AN.",Open Vet J. 2023 Dec;13(12):1504-1516. doi: 10.5455/OVJ.2023.v13.i12.1. Epub 2023 Dec 31.,Wihadmadyatami H,Open Vet J,2023,31-01-2024,PMC10824087,,10.5455/OVJ.2023.v13.i12.1
38287652,Potential of dietary polyphenols for protection from age-related decline and neurodegeneration: a role for gut microbiota?,"Ross FC, Mayer DE, Horn J, Cryan JF, Del Rio D, Randolph E, Gill CIR, Gupta A, Ross RP, Stanton C, Mayer EA.",Nutr Neurosci. 2024 Sep;27(9):1058-1076. doi: 10.1080/1028415X.2023.2298098. Epub 2024 Jan 29.,Ross FC,Nutr Neurosci,2024,30-01-2024,,,10.1080/1028415X.2023.2298098
38285515,Lessons Learned from Approval of Aducanumab for Alzheimer's Disease,"Heidebrink JL, Paulson HL.",Annu Rev Med. 2024 Jan 29;75:99-111. doi: 10.1146/annurev-med-051022-043645.,Heidebrink JL,Annu Rev Med,2024,29-01-2024,PMC10926277,NIHMS1970262,10.1146/annurev-med-051022-043645
38283842,Polygala tenuifolia and Acorus tatarinowii in the treatment of Alzheimer's disease: a systematic review and meta-analysis,"Zhang Y, Tian J, Ni J, Wei M, Li T, Shi J.",Front Pharmacol. 2024 Jan 12;14:1268000. doi: 10.3389/fphar.2023.1268000. eCollection 2023.,Zhang Y,Front Pharmacol,2024,29-01-2024,PMC10815298,,10.3389/fphar.2023.1268000
38278659,"Disentangling tau: One protein, many therapeutic approaches","Lane-Donovan C, Boxer AL.",Neurotherapeutics. 2024 Mar;21(2):e00321. doi: 10.1016/j.neurot.2024.e00321. Epub 2024 Jan 25.,Lane-Donovan C,Neurotherapeutics,2024,26-01-2024,PMC10963923,,10.1016/j.neurot.2024.e00321
38278201,Hypertensive disorders of pregnancy and the risk of maternal dementia: a systematic review and meta-analysis,"Carey C, Mulcahy E, McCarthy FP, Jennings E, Kublickiene K, Khashan A, Barrett P.",Am J Obstet Gynecol. 2024 Aug;231(2):196-210. doi: 10.1016/j.ajog.2024.01.013. Epub 2024 Jan 24.,Carey C,Am J Obstet Gynecol,2024,26-01-2024,,,10.1016/j.ajog.2024.01.013
38275752,The Potential of a Stratified Approach to Drug Repurposing in Alzheimer's Disease,"Anderson C, Bucholc M, McClean PL, Zhang SD.",Biomolecules. 2023 Dec 21;14(1):11. doi: 10.3390/biom14010011.,Anderson C,Biomolecules,2023,26-01-2024,PMC10813465,,10.3390/biom14010011
38273408,A pilot study to evaluate the effect of CT1812 treatment on synaptic density and other biomarkers in Alzheimer's disease,"van Dyck CH, Mecca AP, O'Dell RS, Bartlett HH, Diepenbrock NG, Huang Y, Hamby ME, Grundman M, Catalano SM, Caggiano AO, Carson RE.",Alzheimers Res Ther. 2024 Jan 25;16(1):20. doi: 10.1186/s13195-024-01382-2.,van Dyck CH,Alzheimers Res Ther,2024,25-01-2024,PMC10809445,,10.1186/s13195-024-01382-2
38270898,Occupational and domestic exposure associations with cerebral small vessel disease and vascular dementia: A systematic review and meta-analysis,"Clancy U, Cheng Y, Brara A, Doubal FN, Wardlaw JM.",Alzheimers Dement. 2024 Apr;20(4):3021-3033. doi: 10.1002/alz.13647. Epub 2024 Jan 25.,Clancy U,Alzheimers Dement,2024,25-01-2024,PMC11032565,,10.1002/alz.13647
38270120,Polypharmacological Potential of Phosphodiesterase 5 Inhibitors for the Treatment of Neurocognitive Disorders,"Kumar A, Kim F, Song DK, Choung JJ.",Aging Dis. 2024 Oct 1;15(5):2008-2014. doi: 10.14336/AD.2023.1129.,Kumar A,Aging Dis,2024,25-01-2024,PMC11346399,,10.14336/AD.2023.1129
38263073,"Subclinical epileptiform activity in the Alzheimer continuum: association with disease, cognition and detection method","Nous A, Seynaeve L, Feys O, Wens V, De Tiège X, Van Mierlo P, Baroumand AG, Nieboer K, Allemeersch GJ, Mangelschots S, Michiels V, van der Zee J, Van Broeckhoven C, Ribbens A, Houbrechts R, De Witte S, Wittens MMJ, Bjerke M, Vanlersberghe C, Ceyssens S, Nagels G, Smolders I, Engelborghs S.",Alzheimers Res Ther. 2024 Jan 23;16(1):19. doi: 10.1186/s13195-023-01373-9.,Nous A,Alzheimers Res Ther,2024,23-01-2024,PMC10804650,,10.1186/s13195-023-01373-9
38259497,Immunological dimensions of neuroinflammation and microglial activation: exploring innovative immunomodulatory approaches to mitigate neuroinflammatory progression,"Fornari Laurindo L, Aparecido Dias J, Cressoni Araújo A, Torres Pomini K, Machado Galhardi C, Rucco Penteado Detregiachi C, Santos de Argollo Haber L, Donizeti Roque D, Dib Bechara M, Vialogo Marques de Castro M, de Souza Bastos Mazuqueli Pereira E, José Tofano R, Jasmin Santos German Borgo I, Maria Barbalho S.",Front Immunol. 2024 Jan 8;14:1305933. doi: 10.3389/fimmu.2023.1305933. eCollection 2023.,Fornari Laurindo L,Front Immunol,2024,23-01-2024,PMC10800801,,10.3389/fimmu.2023.1305933
38259476,The immunomodulatory effects of mesenchymal stem cell-derived extracellular vesicles in Alzheimer's disease,"Ye Y, Gao M, Shi W, Gao Y, Li Y, Yang W, Zheng X, Lu X.",Front Immunol. 2024 Jan 8;14:1325530. doi: 10.3389/fimmu.2023.1325530. eCollection 2023.,Ye Y,Front Immunol,2024,23-01-2024,PMC10800421,,10.3389/fimmu.2023.1325530
38256338,Androgen Deprivation Therapy for Prostate Cancer: Focus on Cognitive Function and Mood,"Reiss AB, Gulkarov S, Pinkhasov A, Sheehan KM, Srivastava A, De Leon J, Katz AE.",Medicina (Kaunas). 2023 Dec 30;60(1):77. doi: 10.3390/medicina60010077.,Reiss AB,Medicina (Kaunas),2023,23-01-2024,PMC10819522,,10.3390/medicina60010077
38256144,The Potentiality of Natural Products and Herbal Medicine as Novel Medications for Parkinson's Disease: A Promising Therapeutic Approach,"So YJ, Lee JU, Yang GS, Yang G, Kim SW, Lee JH, Kim JU.",Int J Mol Sci. 2024 Jan 15;25(2):1071. doi: 10.3390/ijms25021071.,So YJ,Int J Mol Sci,2024,23-01-2024,PMC10816678,,10.3390/ijms25021071
38255905,Modulation of Tau Pathology in Alzheimer's Disease by Dietary Bioactive Compounds,"Shi H, Zhao Y.",Int J Mol Sci. 2024 Jan 9;25(2):831. doi: 10.3390/ijms25020831.,Shi H,Int J Mol Sci,2024,23-01-2024,PMC10815728,,10.3390/ijms25020831
38253509,Clinically Important Benefits and Harms of Monoclonal Antibodies Targeting Amyloid for the Treatment of Alzheimer Disease: A Systematic Review and Meta-Analysis,"Ebell MH, Barry HC, Baduni K, Grasso G.",Ann Fam Med. 2024 Jan-Feb;22(1):50-62. doi: 10.1370/afm.3050.,Ebell MH,Ann Fam Med,2024,22-01-2024,PMC11233076,,10.1370/afm.3050
38252656,Positive affect disrupts neurodegeneration effects on cognitive training plasticity in older adults,"Anthony M, Turnbull A, Tadin D, Lin FV.",Soc Cogn Affect Neurosci. 2024 Feb 21;19(1):nsae004. doi: 10.1093/scan/nsae004.,Anthony M,Soc Cogn Affect Neurosci,2024,22-01-2024,PMC10939393,,10.1093/scan/nsae004
38247208,A Narrative Review on the Advance of Probiotics to Metabiotics,"Jang HJ, Lee NK, Paik HD.",J Microbiol Biotechnol. 2024 Mar 28;34(3):487-494. doi: 10.4014/jmb.2311.11023. Epub 2024 Jan 29.,Jang HJ,J Microbiol Biotechnol,2024,22-01-2024,PMC11018519,,10.4014/jmb.2311.11023
38247000,The therapeutic potential of probucol and probucol analogues in neurodegenerative diseases,"Sharif A, Mamo J, Lam V, Al-Salami H, Mooranian A, Watts GF, Clarnette R, Luna G, Takechi R.",Transl Neurodegener. 2024 Jan 22;13(1):6. doi: 10.1186/s40035-024-00398-w.,Sharif A,Transl Neurodegener,2024,21-01-2024,PMC10802046,,10.1186/s40035-024-00398-w
38241161,Mitochondrial dysfunction in neurodegenerative disorders,"Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B.",Neurotherapeutics. 2024 Jan;21(1):e00292. doi: 10.1016/j.neurot.2023.10.002. Epub 2023 Dec 19.,Klemmensen MM,Neurotherapeutics,2024,19-01-2024,PMC10903104,,10.1016/j.neurot.2023.10.002
38238647,Feasibility and preliminary efficacy of different intensities of functional training in elderly type 2 diabetes patients with cognitive impairment: a pilot randomised controlled trial,"Ghahfarrokhi MM, Shirvani H, Rahimi M, Bazgir B, Shamsadini A, Sobhani V.",BMC Geriatr. 2024 Jan 18;24(1):71. doi: 10.1186/s12877-024-04698-8.,Ghahfarrokhi MM,BMC Geriatr,2024,18-01-2024,PMC10797744,,10.1186/s12877-024-04698-8
38233280,The effects of insufficient sleep and adequate sleep on cognitive function in healthy adults,"Zimmerman ME, Benasi G, Hale C, Yeung LK, Cochran J, Brickman AM, St-Onge MP.",Sleep Health. 2024 Apr;10(2):229-236. doi: 10.1016/j.sleh.2023.11.011. Epub 2024 Jan 16.,Zimmerman ME,Sleep Health,2024,17-01-2024,PMC11045317,NIHMS1959997,10.1016/j.sleh.2023.11.011
38230521,The Janus face of antipsychotics in glial cells: Focus on glioprotection,"Schmitz I, da Silva A, Bobermin LD, Gonçalves CA, Steiner J, Quincozes-Santos A.",Exp Biol Med (Maywood). 2023 Nov;248(22):2120-2130. doi: 10.1177/15353702231222027. Epub 2024 Jan 17.,Schmitz I,Exp Biol Med (Maywood),2023,17-01-2024,PMC10800129,,10.1177/15353702231222027
38224283,Systematic review and meta‑analysis of observational studies to check the protective role of non‑steroidal anti‑inflammatory drugs in Alzheimer's disease,"Asthana A, Tripathi S, Agarwal R.",Acta Neurobiol Exp (Wars). 2023 Dec 4;83(4):386-394. doi: 10.55782/ane-2023-2467.,Asthana A,Acta Neurobiol Exp (Wars),2023,15-01-2024,,,10.55782/ane-2023-2467
38219962,Passive immunotherapy for Alzheimer's disease,"Guo X, Yan L, Zhang D, Zhao Y.",Ageing Res Rev. 2024 Feb;94:102192. doi: 10.1016/j.arr.2024.102192. Epub 2024 Jan 14.,Guo X,Ageing Res Rev,2024,14-01-2024,,,10.1016/j.arr.2024.102192
38219389,"An insight review on the neuropharmacological effects, mechanisms of action, pharmacokinetics and toxicity of mitragynine","Annuar NAK, Azlan UK, Mediani A, Tong X, Han R, Al-Olayan E, Baharum SN, Bunawan H, Sarian MN, Hamezah HS, Jantan I.",Biomed Pharmacother. 2024 Feb;171:116134. doi: 10.1016/j.biopha.2024.116134. Epub 2024 Jan 13.,Annuar NAK,Biomed Pharmacother,2024,14-01-2024,,,10.1016/j.biopha.2024.116134
38217592,High-Fat Diets in Animal Models of Alzheimer's Disease: How Can Eating Too Much Fat Increase Alzheimer's Disease Risk?,"Valentin-Escalera J, Leclerc M, Calon F.",J Alzheimers Dis. 2024;97(3):977-1005. doi: 10.3233/JAD-230118.,Valentin-Escalera J,J Alzheimers Dis,2024,13-01-2024,PMC10836579,,10.3233/JAD-230118
38203753,Multi-Target-Directed Cinnamic Acid Hybrids Targeting Alzheimer's Disease,"Drakontaeidi A, Pontiki E.",Int J Mol Sci. 2024 Jan 1;25(1):582. doi: 10.3390/ijms25010582.,Drakontaeidi A,Int J Mol Sci,2024,11-01-2024,PMC10778916,,10.3390/ijms25010582
38203341,Mechanisms of 3-Hydroxyl 3-Methylglutaryl CoA Reductase in Alzheimer's Disease,"Zhou X, Wu X, Wang R, Han L, Li H, Zhao W.",Int J Mol Sci. 2023 Dec 22;25(1):170. doi: 10.3390/ijms25010170.,Zhou X,Int J Mol Sci,2023,11-01-2024,PMC10778631,,10.3390/ijms25010170
38203294,Molecular Mechanisms of Neuroprotection by Ketone Bodies and Ketogenic Diet in Cerebral Ischemia and Neurodegenerative Diseases,"Jang J, Kim SR, Lee JE, Lee S, Son HJ, Choe W, Yoon KS, Kim SS, Yeo EJ, Kang I.",Int J Mol Sci. 2023 Dec 21;25(1):124. doi: 10.3390/ijms25010124.,Jang J,Int J Mol Sci,2023,11-01-2024,PMC10779133,,10.3390/ijms25010124
38201846,"Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer's Dementia: A 12-Week Randomized, Double-Blind Active-Controlled Study","Hsu YC, Huang YY, Tsai SY, Kuo YW, Lin JH, Ho HH, Chen JF, Hsia KC, Sun Y.",Nutrients. 2023 Dec 20;16(1):16. doi: 10.3390/nu16010016.,Hsu YC,Nutrients,2023,11-01-2024,PMC10780998,,10.3390/nu16010016
38180039,Radiotherapy for non-cancer diseases: benefits and long-term risks,"Thariat J, Little MP, Zablotska LB, Samson P, O'Banion MK, Leuraud K, Bergom C, Girault G, Azimzadeh O, Bouffler S, Hamada N.",Int J Radiat Biol. 2024;100(4):505-526. doi: 10.1080/09553002.2023.2295966. Epub 2024 Jan 5.,Thariat J,Int J Radiat Biol,2024,05-01-2024,PMC11039429,NIHMS1978150,10.1080/09553002.2023.2295966
38179602,The high cost of care and limited evidence on cost-effective strategies for Lewy body dementia: systematic review of evidence,"Boland E, Fitzpatrick R, Ryan D, Kane J, Betzhold S, Leroi I, Kinchin I.",BJPsych Open. 2024 Jan 5;10(1):e20. doi: 10.1192/bjo.2023.626.,Boland E,BJPsych Open,2024,05-01-2024,PMC10790215,,10.1192/bjo.2023.626
38174446,Drug Repositioning of Pioglitazone in Management and Improving the Cognitive Function among the Patients With Mild to Moderate Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Basutkar RS, Sudarsan P, Robin SM, Bhaskar V, Viswanathan B, Sivasankaran P.",Neurol India. 2023 Nov-Dec;71(6):1132-1141. doi: 10.4103/0028-3886.391397.,Basutkar RS,Neurol India,2023,04-01-2024,,,10.4103/0028-3886.391397
38170690,Can the gut microbiome inform the effects of omega-3 fatty acid supplementation trials on cognition?,"Kerman BE, Self W, Yassine HN.",Curr Opin Clin Nutr Metab Care. 2024 Mar 1;27(2):116-124. doi: 10.1097/MCO.0000000000001007. Epub 2023 Dec 22.,Kerman BE,Curr Opin Clin Nutr Metab Care,2024,03-01-2024,PMC10872319,NIHMS1952767,10.1097/MCO.0000000000001007
38169888,Current biomarkers and treatment strategies in Alzheimer disease: An overview and future perspectives,"Bhole RP, Chikhale RV, Rathi KM.",IBRO Neurosci Rep. 2023 Nov 30;16:8-42. doi: 10.1016/j.ibneur.2023.11.003. eCollection 2024 Jun.,Bhole RP,IBRO Neurosci Rep,2023,03-01-2024,PMC10758887,,10.1016/j.ibneur.2023.11.003
38165676,Mediation of Age and Thrombectomy Outcome by Neuroimaging Markers of Frailty in Patients With Stroke,"Benali F, Singh N, Fladt J, Jaroenngarmsamer T, Bala F, Ospel JM, Buck BH, Dowlatshahi D, Field TS, Hanel RA, Peeling L, Tymianski M, Hill MD, Goyal M, Ganesh A; ESCAPE-NA1 Investigators.",JAMA Netw Open. 2024 Jan 2;7(1):e2349628. doi: 10.1001/jamanetworkopen.2023.49628.,Benali F,JAMA Netw Open,2024,02-01-2024,PMC10762575,,10.1001/jamanetworkopen.2023.49628
38163396,2D nanostructures: Potential in diagnosis and treatment of Alzheimer's disease,"Tufail S, Sherwani MA, Shamim Z, Abdullah, Goh KW, Alomary MN, Ansari MA, Almosa AA, Ming LC, Abdullah ADI, Khan FB, Menhali AA, Mirza S, Ayoub MA.",Biomed Pharmacother. 2024 Jan;170:116070. doi: 10.1016/j.biopha.2023.116070. Epub 2023 Dec 31.,Tufail S,Biomed Pharmacother,2024,01-01-2024,,,10.1016/j.biopha.2023.116070
38160357,Effect of Metformin on Plasma and Cerebrospinal Fluid Biomarkers in Non-Diabetic Older Adults with Mild Cognitive Impairment Related to Alzheimer's Disease,"Weinberg MS, He Y, Kivisäkk P, Arnold SE, Das S.",J Alzheimers Dis. 2024;99(s2):S355-S365. doi: 10.3233/JAD-230899.,Weinberg MS,J Alzheimers Dis,2024,31-12-2023,PMC11911006,NIHMS2060333,10.3233/JAD-230899
39963034,The relationship between sleep apnoea and the risk of dementia: An updated systematic review and meta-analysis,"Li YP, Zhang YY, Du XM, Ding YQ, Sun J, Lang XY, Kang ZY, Li XD.",Folia Neuropathol. 2024;62(4):406-415. doi: 10.5114/fn.2024.145596.,Li YP,Folia Neuropathol,2024,18-02-2025,,,10.5114/fn.2024.145596
38151879,Multi-Domain Interventions for Dementia Prevention - A Systematic Review,"Castro CB, Costa LM, Dias CB, Chen J, Hillebrandt H, Gardener SL, Brown BM, Loo RL, Garg ML, Rainey-Smith SR, Martins RN, Sohrabi HR.",J Nutr Health Aging. 2023;27(12):1271-1280. doi: 10.1007/s12603-023-2046-2.,Castro CB,J Nutr Health Aging,2023,28-12-2023,,,10.1007/s12603-023-2046-2
38143779,A Hierarchical Multi-Dimensional Cognitive Training Program for Preventive Cognitive Decline in Acute Ischemic Stroke Patients: Study Protocol for a Randomized Controlled Trial,"Chen Y, Lan M.",J Alzheimers Dis Rep. 2023 Nov 22;7(1):1267-1275. doi: 10.3233/ADR-230097. eCollection 2023.,Chen Y,J Alzheimers Dis Rep,2023,25-12-2023,PMC10741896,,10.3233/ADR-230097
38143774,Alpha 2-Macroglobulin Polymorphisms and Susceptibility to Alzheimer's Disease: A Comprehensive Meta-Analysis Based on 62 Studies,"Zhang H, Liu D, Duan Y, Liu Y, Liu J, Bai N, Zhou Q, Xu Z, Li L, Liu H.",J Alzheimers Dis Rep. 2023 Dec 18;7(1):1351-1370. doi: 10.3233/ADR-230131. eCollection 2023.,Zhang H,J Alzheimers Dis Rep,2023,25-12-2023,PMC10741958,,10.3233/ADR-230131
38139372,Biological Diagnosis of Alzheimer's Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?,"Souchet B, Michaïl A, Billoir B, Braudeau J.",Int J Mol Sci. 2023 Dec 16;24(24):17544. doi: 10.3390/ijms242417544.,Souchet B,Int J Mol Sci,2023,23-12-2023,PMC10744068,,10.3390/ijms242417544
38138293,Exploring the Multifaceted Potential of Sildenafil in Medicine,"Pușcașu C, Zanfirescu A, Negreș S, Șeremet OC.",Medicina (Kaunas). 2023 Dec 17;59(12):2190. doi: 10.3390/medicina59122190.,Pușcașu C,Medicina (Kaunas),2023,23-12-2023,PMC10744870,,10.3390/medicina59122190
38137096,Neuroprotective Effects of Moderate Hypoxia: A Systematic Review,"Damgaard V, Mariegaard J, Lindhardsen JM, Ehrenreich H, Miskowiak KW.",Brain Sci. 2023 Nov 27;13(12):1648. doi: 10.3390/brainsci13121648.,Damgaard V,Brain Sci,2023,23-12-2023,PMC10741927,,10.3390/brainsci13121648
38135855,"Caspases in Alzheimer's Disease: Mechanism of Activation, Role, and Potential Treatment","Wójcik P, Jastrzębski MK, Zięba A, Matosiuk D, Kaczor AA.",Mol Neurobiol. 2024 Jul;61(7):4834-4853. doi: 10.1007/s12035-023-03847-1. Epub 2023 Dec 23.,Wójcik P,Mol Neurobiol,2024,22-12-2023,PMC11236938,,10.1007/s12035-023-03847-1
38132971,The Effects of Transcranial Direct Current Stimulation in Patients with Mild Cognitive Impairment,"Palimariciuc M, Oprea DC, Cristofor AC, Florea T, Dobrin RP, Dobrin I, Gireadă B, Gavril R, Mawas I, Bejenariu AC, Knieling A, Ciobica A, Chiriță R.",Neurol Int. 2023 Nov 29;15(4):1423-1442. doi: 10.3390/neurolint15040092.,Palimariciuc M,Neurol Int,2023,22-12-2023,PMC10745513,,10.3390/neurolint15040092
38129775,Memory support training and lifestyle modifications to promote healthy aging in persons at risk for Alzheimer's disease: a digital application supported intervention (Brain Boosters),"Tomaszewski Farias S, Fox J, Dulaney H, Chan M, Namboodiri S, Harvey DJ, Weakley A, Rahman S, Luna C, Beech BF, Campbell L, Schmitter-Edgecombe M.",BMC Geriatr. 2023 Dec 21;23(1):881. doi: 10.1186/s12877-023-04574-x.,Tomaszewski Farias S,BMC Geriatr,2023,22-12-2023,PMC10740219,,10.1186/s12877-023-04574-x
38116916,"Impact of the iWHELD digital person-centered care program on quality of life, agitation and psychotropic medications in people with dementia living in nursing homes during the COVID-19 pandemic: A randomized controlled trial","McDermid J, Henley W, Corbett A, Williams G, Fossey J, Clare L, Fox C, Aarsland D, Khan Z, Soto M, Woodward-Carlton B, Cook EM, Cummings J, Sweetnam A, Chan X, Lawrence M, Ballard C; iWHELD study group.",Alzheimers Dement. 2024 Mar;20(3):1797-1806. doi: 10.1002/alz.13582. Epub 2023 Dec 20.,McDermid J,Alzheimers Dement,2024,20-12-2023,PMC10984502,,10.1002/alz.13582
38116771,Molecular Regulation of the CNS by Vitamin D,"Máčová L, Kancheva R, Bičíková M.",Physiol Res. 2023 Dec 17;72(S4):S339-S356. doi: 10.33549/physiolres.935248.,Máčová L,Physiol Res,2023,20-12-2023,,,10.33549/physiolres.935248
38113700,Pimavanserin for psychosis in Parkinson's disease dementia: Subgroup analysis of the HARMONY Trial,"Weintraub D, Espay AJ, Sharma VD, Tariot PN, Abler V, Pathak S, Stankovic S.",Parkinsonism Relat Disord. 2024 Feb;119:105951. doi: 10.1016/j.parkreldis.2023.105951. Epub 2023 Dec 12.,Weintraub D,Parkinsonism Relat Disord,2024,19-12-2023,,,10.1016/j.parkreldis.2023.105951
38111602,The Effect of Tele-Savvy on Sleep Quality and Insomnia in Caregivers of Persons Living with Dementia,"Brewster GS, Higgins M, McPhillips MV, Bonds Johnson K, Epps F, Yeager KA, Bliwise DL, Hepburn K.",Clin Interv Aging. 2023 Dec 14;18:2117-2127. doi: 10.2147/CIA.S425741. eCollection 2023.,Brewster GS,Clin Interv Aging,2023,19-12-2023,PMC10726954,,10.2147/CIA.S425741
38109077,Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers: A Secondary Analysis of a Randomized Clinical Trial,"Brum WS, Docherty KF, Ashton NJ, Zetterberg H, Hansson O, McMurray JJV, Blennow K.",JAMA Neurol. 2024 Feb 1;81(2):197-200. doi: 10.1001/jamaneurol.2023.4719.,Brum WS,JAMA Neurol,2024,18-12-2023,PMC10728797,,10.1001/jamaneurol.2023.4719
38106895,High prevalence of subjective cognitive decline in older Chinese adults: a systematic review and meta-analysis,"Xue C, Li J, Hao M, Chen L, Chen Z, Tang Z, Tang H, Fang Q.",Front Public Health. 2023 Dec 1;11:1277995. doi: 10.3389/fpubh.2023.1277995. eCollection 2023.,Xue C,Front Public Health,2023,18-12-2023,PMC10722401,,10.3389/fpubh.2023.1277995
38105307,Masitinib as a neuroprotective agent: a scoping review of preclinical and clinical evidence,"Hamad AA, Amer BE, Hawas Y, Mabrouk MA, Meshref M.",Neurol Sci. 2024 May;45(5):1861-1873. doi: 10.1007/s10072-023-07259-w. Epub 2023 Dec 18.,Hamad AA,Neurol Sci,2024,17-12-2023,PMC11021265,,10.1007/s10072-023-07259-w
38101301,"Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the ""ADAMANT"" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial","Cullen NC, Novak P, Tosun D, Kovacech B, Hanes J, Kontsekova E, Fresser M, Ropele S, Feldman HH, Schmidt R, Winblad B, Zilka N.",EBioMedicine. 2024 Jan;99:104923. doi: 10.1016/j.ebiom.2023.104923. Epub 2023 Dec 14.,Cullen NC,EBioMedicine,2024,15-12-2023,PMC10733085,,10.1016/j.ebiom.2023.104923
38100555,Cancer drugs with high repositioning potential for Alzheimer's disease,"Majeed J, Sabbagh MN, Kang MH, Lawrence JJ, Pruitt K, Bacus S, Reyna E, Brown M, Decourt B.",Expert Opin Emerg Drugs. 2023 Dec;28(4):311-332. doi: 10.1080/14728214.2023.2296079. Epub 2023 Dec 26.,Majeed J,Expert Opin Emerg Drugs,2023,15-12-2023,PMC10877737,NIHMS1953304,10.1080/14728214.2023.2296079
38093366,NeuroEPO plus (NeuralCIM(®)) in mild-to-moderate Alzheimer's clinical syndrome: the ATHENEA randomized clinical trial,"Sosa S, Bringas G, Urrutia N, Peñalver AI, López D, González E, Fernández A, Hernández ZM, Viña A, Peña Y, Batista JF, Valenzuela C, León K, Crombet T, Rodríguez T, Pérez L; ATHENEA Investigators.",Alzheimers Res Ther. 2023 Dec 13;15(1):215. doi: 10.1186/s13195-023-01356-w.,Sosa S,Alzheimers Res Ther,2023,14-12-2023,PMC10716956,,10.1186/s13195-023-01356-w
38087195,Application of machine learning in measurement of ageing and geriatric diseases: a systematic review,"Das A, Dhillon P.",BMC Geriatr. 2023 Dec 12;23(1):841. doi: 10.1186/s12877-023-04477-x.,Das A,BMC Geriatr,2023,12-12-2023,PMC10717316,,10.1186/s12877-023-04477-x
38086100,Unravelling the in vitro and in vivo potential of selenium nanoparticles in Alzheimer's disease: A bioanalytical review,"Vicente-Zurdo D, Rosales-Conrado N, León-González ME.",Talanta. 2024 Mar 1;269:125519. doi: 10.1016/j.talanta.2023.125519. Epub 2023 Dec 7.,Vicente-Zurdo D,Talanta,2024,12-12-2023,,,10.1016/j.talanta.2023.125519
38084203,A light at the end of the tunnel - from mutation identification to a potential treatment for Alzheimer's disease,Lannfelt L.,Ups J Med Sci. 2023 Nov 28;128. doi: 10.48101/ujms.v128.10316. eCollection 2023.,Lannfelt L,Ups J Med Sci,2023,12-12-2023,PMC10710852,,10.48101/ujms.v128.10316
38083976,A new perspective for evaluating the efficacy of tACS and tDCS in improving executive functions: A combined tES and fNIRS study,"Lu H, Zhang Y, Qiu H, Zhang Z, Tan X, Huang P, Zhang M, Miao D, Zhu X.",Hum Brain Mapp. 2024 Jan;45(1):e26559. doi: 10.1002/hbm.26559. Epub 2023 Dec 11.,Lu H,Hum Brain Mapp,2024,12-12-2023,PMC10789209,,10.1002/hbm.26559
38079104,Effectiveness of epigallocatechin gallate nanoparticles on the in-vivo treatment of Alzheimer's disease in a rat/mouse model: a systematic review,"Khalifa MKA, Abdel-Sattar SA, Amin OM, Kohaf NA, Zaky HS, Abd El-Fattah MA, Mohammed KHA, Badawi NM, Mansoor I, Eassa HA.",Daru. 2024 Jun;32(1):319-337. doi: 10.1007/s40199-023-00494-8. Epub 2023 Dec 11.,Khalifa MKA,Daru,2024,11-12-2023,PMC11087435,,10.1007/s40199-023-00494-8
38073390,A Meta-Analysis on Presynaptic Changes in Alzheimer's Disease,"Anschuetz A, Schwab K, Harrington CR, Wischik CM, Riedel G.",J Alzheimers Dis. 2024;97(1):145-162. doi: 10.3233/JAD-231034.,Anschuetz A,J Alzheimers Dis,2024,11-12-2023,PMC10789360,,10.3233/JAD-231034
38073386,Noninvasive Gamma Sensory Stimulation May Reduce White Matter and Myelin Loss in Alzheimer's Disease,"Da X, Hempel E, Ou Y, Rowe OE, Malchano Z, Hajós M, Kern R, Megerian JT, Cimenser A.",J Alzheimers Dis. 2024;97(1):359-372. doi: 10.3233/JAD-230506.,Da X,J Alzheimers Dis,2024,11-12-2023,PMC10789351,,10.3233/JAD-230506
38069542,The clinical efficacy of Olibanum gum chewing in patients with Mild-to-Moderate Alzheimer disease: A randomized Parallel-Design controlled trial,"Ghorat F, Sepidarkish M, Saadattalab F, Rezghi M, Shahrestani S, Gholamalizadeh M, Doaei S.",Neuropsychopharmacol Rep. 2024 Mar;44(1):109-114. doi: 10.1002/npr2.12398. Epub 2023 Dec 8.,Ghorat F,Neuropsychopharmacol Rep,2024,09-12-2023,PMC10932771,,10.1002/npr2.12398
38067664,Research Progress on Effects of Ginsenoside Rg2 and Rh1 on Nervous System and Related Mechanisms,"Liu S, Chen W, Zhao Y, Zong Y, Li J, He Z.",Molecules. 2023 Dec 4;28(23):7935. doi: 10.3390/molecules28237935.,Liu S,Molecules,2023,09-12-2023,PMC10708332,,10.3390/molecules28237935
38063254,Anticholinergic deprescribing interventions for reducing risk of cognitive decline or dementia in older adults with and without prior cognitive impairment,"Taylor-Rowan M, Alharthi AA, Noel-Storr AH, Myint PK, Stewart C, McCleery J, Quinn TJ.",Cochrane Database Syst Rev. 2023 Dec 8;12(12):CD015405. doi: 10.1002/14651858.CD015405.pub2.,Taylor-Rowan M,Cochrane Database Syst Rev,2023,08-12-2023,PMC10704558,,10.1002/14651858.CD015405.pub2
38058006,Nanocarrier-mediated curcumin delivery: An adjuvant strategy for CNS disease treatment,"Godse S, Zhou L, Sakshi S, Singla B, Singh UP, Kumar S.",Exp Biol Med (Maywood). 2023 Nov;248(22):2151-2166. doi: 10.1177/15353702231211863. Epub 2023 Dec 6.,Godse S,Exp Biol Med (Maywood),2023,07-12-2023,PMC10800127,,10.1177/15353702231211863
38056370,Transcranial direct current stimulation of the right temporoparietal junction facilitates hippocampal spatial learning in Alzheimer's disease and mild cognitive impairment,"Philippen S, Hanert A, Schönfeld R, Granert O, Yilmaz R, Jensen-Kondering U, Splittgerber M, Moliadze V, Siniatchkin M, Berg D, Bartsch T.",Clin Neurophysiol. 2024 Jan;157:48-60. doi: 10.1016/j.clinph.2023.11.003. Epub 2023 Nov 15.,Philippen S,Clin Neurophysiol,2024,06-12-2023,,,10.1016/j.clinph.2023.11.003
38052309,Hypertension & dementia: Pathophysiology & potential utility of antihypertensives in reducing disease burden,"Lyon M, Fullerton JL, Kennedy S, Work LM.",Pharmacol Ther. 2024 Jan;253:108575. doi: 10.1016/j.pharmthera.2023.108575. Epub 2023 Dec 3.,Lyon M,Pharmacol Ther,2024,05-12-2023,,,10.1016/j.pharmthera.2023.108575
38049723,Increased risk of osteoporosis in patients with cognitive impairment: a systematic review and meta-analysis,"Xie C, Wang C, Luo H.",BMC Geriatr. 2023 Dec 4;23(1):797. doi: 10.1186/s12877-023-04548-z.,Xie C,BMC Geriatr,2023,04-12-2023,PMC10694915,,10.1186/s12877-023-04548-z
38048134,Efficacy and Safety of Cilostazol in Mild Cognitive Impairment: A Randomized Clinical Trial,"Saito S, Suzuki K, Ohtani R, Maki T, Kowa H, Tachibana H, Washida K, Kawabata N, Mizuno T, Kanki R, Sudoh S, Kitaguchi H, Shindo K, Shindo A, Oka N, Yamamoto K, Yasuno F, Kakuta C, Kakuta R, Yamamoto Y, Hattori Y, Takahashi Y, Nakaoku Y, Tonomura S, Oishi N, Aso T, Taguchi A, Kagimura T, Kojima S, Taketsuna M, Tomimoto H, Takahashi R, Fukuyama H, Nagatsuka K, Yamamoto H, Fukushima M, Ihara M; COMCID Trial Investigator Group.",JAMA Netw Open. 2023 Dec 1;6(12):e2344938. doi: 10.1001/jamanetworkopen.2023.44938.,Saito S,JAMA Netw Open,2023,04-12-2023,PMC10696485,,10.1001/jamanetworkopen.2023.44938
38301064,Technologies to Increase Freedom for People Living With Dementia: CADTH Horizon Scan,"Authors; Clark M, Mierzwinski-Urban M, Mason J, Hao Q.",Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2023 Dec. Report No.: EH0113.,Authors,Technologies to Increase Freedom for People Living With Dementia: CADTH Horizon Scan,2023,01-12-2023,,,
38038339,Low-Density-Lipoprotein Cholesterol and Mortality Outcomes Among Healthy Older Adults: A Post Hoc Analysis of ASPREE Trial,"Zhou Z, Tonkin AM, Curtis AJ, Murray A, Zhu C, Reid CM, Williamson JD, Ryan J, McNeil JJ, Beilin LJ, Ernst ME, Stocks N, Lacaze P, Shah RC, Woods RL, Wolfe R, Gall S, Zoungas S, Orchard SG, Nelson MR.",J Gerontol A Biol Sci Med Sci. 2024 Apr 1;79(4):glad268. doi: 10.1093/gerona/glad268.,Zhou Z,J Gerontol A Biol Sci Med Sci,2024,01-12-2023,PMC10960624,,10.1093/gerona/glad268
38037913,Insights Into the Role of Copper in Neurodegenerative Diseases and the Therapeutic Potential of Natural Compounds,"Zhong G, Wang X, Li J, Xie Z, Wu Q, Chen J, Wang Y, Chen Z, Cao X, Li T, Liu J, Wang Q.",Curr Neuropharmacol. 2024;22(10):1650-1671. doi: 10.2174/1570159X22666231103085859.,Zhong G,Curr Neuropharmacol,2024,01-12-2023,PMC11284712,,10.2174/1570159X22666231103085859
38035058,Application of transcranial brain stimulation in dementia,"Luo Y, Yang FY, Lo RY.",Tzu Chi Med J. 2023 Jul 12;35(4):300-305. doi: 10.4103/tcmj.tcmj_91_23. eCollection 2023 Oct-Dec.,Luo Y,Tzu Chi Med J,2023,30-11-2023,PMC10683520,,10.4103/tcmj.tcmj_91_23
38034914,"Repetitive transcranial magnetic stimulation for apathy in patients with neurodegenerative conditions, cognitive impairment, stroke, and traumatic brain injury: a systematic review","Espiritu AI, Hara T, Tolledo JK, Blair M, Burhan AM.",Front Psychiatry. 2023 Nov 15;14:1259481. doi: 10.3389/fpsyt.2023.1259481. eCollection 2023.,Espiritu AI,Front Psychiatry,2023,30-11-2023,PMC10684725,,10.3389/fpsyt.2023.1259481
38033098,The association between bullous pemphigoid and cognitive outcomes in middle-aged and older adults: A systematic review and meta-analysis,"Zhou Q, Xiong Z, Yang D, Xiong C, Li X.",PLoS One. 2023 Nov 30;18(11):e0295135. doi: 10.1371/journal.pone.0295135. eCollection 2023.,Zhou Q,PLoS One,2023,30-11-2023,PMC10688758,,10.1371/journal.pone.0295135
38032638,Economic Evaluation of Exercise or Cognitive and Social Enrichment Activities for Improved Cognition After Stroke,"Adjetey C, Davis JC, Falck RS, Best JR, Dao E, Bennett K, Tai D, McGuire K, Eng JJ, Hsiung GR, Middleton LE, Hall PA, Hu M, Sakakibara BM, Liu-Ambrose T.",JAMA Netw Open. 2023 Nov 1;6(11):e2345687. doi: 10.1001/jamanetworkopen.2023.45687.,Adjetey C,JAMA Netw Open,2023,30-11-2023,PMC10690466,,10.1001/jamanetworkopen.2023.45687
38031028,"Potential use of iPSCs for disease modeling, drug screening, and cell-based therapy for Alzheimer's disease","Marei HE, Khan MUA, Hasan A.",Cell Mol Biol Lett. 2023 Nov 30;28(1):98. doi: 10.1186/s11658-023-00504-2.,Marei HE,Cell Mol Biol Lett,2023,29-11-2023,PMC10687886,,10.1186/s11658-023-00504-2
38030988,Reducing fear and avoidance of memory loss improves mood and social engagement in community-based older adults: a randomized trial,"Farina FR, Regan J, Marquez M, An H, O'Loughlin P, Pavithra P, Taddeo M, Knight RC, Bennett M, Lenaert B, Griffith JW.",BMC Geriatr. 2023 Nov 29;23(1):786. doi: 10.1186/s12877-023-04470-4.,Farina FR,BMC Geriatr,2023,29-11-2023,PMC10688470,,10.1186/s12877-023-04470-4
38029367,How reactions to a brain scan result differ for adults based on self-identified Black and White race,"Stites SD, Largent EA, Schumann R, Harkins K, Sankar P, Krieger A.",Alzheimers Dement. 2024 Mar;20(3):1527-1537. doi: 10.1002/alz.13558. Epub 2023 Nov 29.,Stites SD,Alzheimers Dement,2024,29-11-2023,PMC10984417,,10.1002/alz.13558
38024535,The Role of Traditional Chinese Medicine Natural Products in β-Amyloid Deposition and Tau Protein Hyperphosphorylation in Alzheimer's Disease,"Yan H, Feng L, Li M.",Drug Des Devel Ther. 2023 Nov 13;17:3295-3323. doi: 10.2147/DDDT.S380612. eCollection 2023.,Yan H,Drug Des Devel Ther,2023,29-11-2023,PMC10655607,,10.2147/DDDT.S380612
38022191,Exploring Methylene Blue and Its Derivatives in Alzheimer's Treatment: A Comprehensive Review of Randomized Control Trials,"Hashmi MU, Ahmed R, Mahmoud S, Ahmed K, Bushra NM, Ahmed A, Elwadie B, Madni A, Saad AB, Abdelrahman N.",Cureus. 2023 Oct 9;15(10):e46732. doi: 10.7759/cureus.46732. eCollection 2023 Oct.,Hashmi MU,Cureus,2023,29-11-2023,PMC10631450,,10.7759/cureus.46732
38018372,Validating blood tests as a possible routine diagnostic assay of Alzheimer's disease,"Kodosaki E, Zetterberg H, Heslegrave A.",Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1153-1165. doi: 10.1080/14737159.2023.2289553. Epub 2023 Dec 15.,Kodosaki E,Expert Rev Mol Diagn,2023,29-11-2023,,,10.1080/14737159.2023.2289553
38017568,The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials,"Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F, Chen Z, Wang Z.",Eur J Med Res. 2023 Nov 28;28(1):544. doi: 10.1186/s40001-023-01512-w.,Wu W,Eur J Med Res,2023,29-11-2023,PMC10683264,,10.1186/s40001-023-01512-w
38017549,How healthy participants value additional diagnostic testing with amyloid-PET in patients diagnosed with mild cognitive impairment - a bidding game experiment,"van Maurik IS, Bakker ED, van Unnik AAJM, Broulikova HM, Zwan MD, van de Giessen E, Berkhof J, Bouwman FH, Bosmans JE, van der Flier WM.",Alzheimers Res Ther. 2023 Nov 28;15(1):208. doi: 10.1186/s13195-023-01346-y.,van Maurik IS,Alzheimers Res Ther,2023,29-11-2023,PMC10683285,,10.1186/s13195-023-01346-y
38015288,"Prevalence, treatment, and neural correlates of apathy in different forms of dementia: a narrative review","Parrotta I, Cacciatore S, D'Andrea F, D'Anna M, Giancaterino G, Lazzaro G, Arcara G, Manzo N.",Neurol Sci. 2024 Apr;45(4):1343-1376. doi: 10.1007/s10072-023-07197-7. Epub 2023 Nov 28.,Parrotta I,Neurol Sci,2024,28-11-2023,PMC10942903,,10.1007/s10072-023-07197-7
38012285,TANGO: a placebo-controlled randomized phase 2 study of efficacy and safety of the anti-tau monoclonal antibody gosuranemab in early Alzheimer's disease,"Shulman M, Kong J, O'Gorman J, Ratti E, Rajagovindan R, Viollet L, Huang E, Sharma S, Racine AM, Czerkowicz J, Graham D, Li Y, Hering H, Haeberlein SB.",Nat Aging. 2023 Dec;3(12):1591-1601. doi: 10.1038/s43587-023-00523-w. Epub 2023 Nov 27.,Shulman M,Nat Aging,2023,27-11-2023,PMC10724064,,10.1038/s43587-023-00523-w
38010725,Effect of Personalized Risk-Reduction Strategies on Cognition and Dementia Risk Profile Among Older Adults: The SMARRT Randomized Clinical Trial,"Yaffe K, Vittinghoff E, Dublin S, Peltz CB, Fleckenstein LE, Rosenberg DE, Barnes DE, Balderson BH, Larson EB.",JAMA Intern Med. 2024 Jan 1;184(1):54-62. doi: 10.1001/jamainternmed.2023.6279.,Yaffe K,JAMA Intern Med,2024,27-11-2023,PMC10682943,,10.1001/jamainternmed.2023.6279
38007648,Effect of Nordic Sensi® Chair on Behavioral and Psychological Symptoms of Dementia in Nursing Homes Residents: A Randomized Controlled Trial,"García-Alberca JM, de la Rosa MD, Solo de Zaldívar P, Ledesma M, Oltra E, Gris E, Ocejo O, Torrecilla J, Zafra C, Sánchez-Fernández A, Mancilla T, López-Romero M, Jerez R, Santana N, Lara JP, Barbancho MÁ, Blanco-Reina E.",J Alzheimers Dis. 2023;96(4):1609-1622. doi: 10.3233/JAD-230391.,García-Alberca JM,J Alzheimers Dis,2023,26-11-2023,PMC10741310,,10.3233/JAD-230391
38006405,Psychoeducation versus psychoeducation integrated with yoga for family caregivers of people with Alzheimer's disease: a randomized clinical trial,"de Araujo EL, Rodrigues MR, Kozasa EH, Lacerda SS.",Eur J Ageing. 2023 Nov 25;20(1):46. doi: 10.1007/s10433-023-00792-9.,de Araujo EL,Eur J Ageing,2023,25-11-2023,PMC10676341,,10.1007/s10433-023-00792-9
38005352,Research Progress on Natural Plant Molecules in Regulating the Blood-Brain Barrier in Alzheimer's Disease,"Wu W, Huang J, Han P, Zhang J, Wang Y, Jin F, Zhou Y.",Molecules. 2023 Nov 16;28(22):7631. doi: 10.3390/molecules28227631.,Wu W,Molecules,2023,25-11-2023,PMC10674591,,10.3390/molecules28227631
38005310,Emerging Role of Plant-Based Bioactive Compounds as Therapeutics in Parkinson's Disease,"Kumari N, Anand S, Shah K, Chauhan NS, Sethiya NK, Singhal M.",Molecules. 2023 Nov 14;28(22):7588. doi: 10.3390/molecules28227588.,Kumari N,Molecules,2023,25-11-2023,PMC10673433,,10.3390/molecules28227588
38003702,Can Ashwagandha Benefit the Endocrine System?-A Review,"Wiciński M, Fajkiel-Madajczyk A, Kurant Z, Kurant D, Gryczka K, Falkowski M, Wiśniewska M, Słupski M, Ohla J, Zabrzyński J.",Int J Mol Sci. 2023 Nov 20;24(22):16513. doi: 10.3390/ijms242216513.,Wiciński M,Int J Mol Sci,2023,25-11-2023,PMC10671406,,10.3390/ijms242216513
38002991,Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms,"Vuic B, Milos T, Tudor L, Nikolac Perkovic M, Konjevod M, Nedic Erjavec G, Farkas V, Uzun S, Mimica N, Svob Strac D.",Genes (Basel). 2023 Nov 6;14(11):2048. doi: 10.3390/genes14112048.,Vuic B,Genes (Basel),2023,25-11-2023,PMC10671071,,10.3390/genes14112048
37996817,"Safety, tolerability, pharmacokinetics and effects of diet on AD16, a novel neuroinflammatory inhibitor for Alzheimer's disease: a randomized phase 1 study","Peng D, Xu S, Zou T, Wang Y, Ouyang W, Zhang Y, Dong C, Li D, Guo J, Shen Q, Hu X, Zhou W, Li X, Qin Q.",BMC Med. 2023 Nov 23;21(1):459. doi: 10.1186/s12916-023-03126-9.,Peng D,BMC Med,2023,23-11-2023,PMC10666448,,10.1186/s12916-023-03126-9
37995334,The Relevance of Arterial Blood Pressure in the Management of Glaucoma Progression: A Systematic Review,"Van Eijgen J, Melgarejo JD, Van Laeken J, Van der Pluijm C, Matheussen H, Verhaegen M, Van Keer K, Maestre GE, Al-Aswad LA, Vanassche T, Zhang ZY, Stalmans I.",Am J Hypertens. 2024 Feb 15;37(3):179-198. doi: 10.1093/ajh/hpad111.,Van Eijgen J,Am J Hypertens,2024,23-11-2023,PMC10906067,,10.1093/ajh/hpad111
37993885,Cross-cultural effects of reminiscence therapy on life satisfaction and autobiographical memory of older adults: a pilot study across Mexico and Spain,"Rueda AV, Cabaco AS, Mejía-Ramírez MA, Afonso RM, Castillo-Riedel E.",Alzheimers Res Ther. 2023 Nov 22;15(1):204. doi: 10.1186/s13195-023-01347-x.,Rueda AV,Alzheimers Res Ther,2023,23-11-2023,PMC10664501,,10.1186/s13195-023-01347-x
37983528,The role of myelin in neurodegeneration: implications for drug targets and neuroprotection strategies,"Parrilla GE, Gupta V, Wall RV, Salkar A, Basavarajappa D, Mirzaei M, Chitranshi N, Graham SL, You Y.",Rev Neurosci. 2023 Nov 22;35(3):271-292. doi: 10.1515/revneuro-2023-0081. Print 2024 Apr 25.,Parrilla GE,Rev Neurosci,2023,20-11-2023,,,10.1515/revneuro-2023-0081
37973488,"Using Structured Observations to Evaluate the Effects of a Personalized Music Intervention on Agitated Behaviors and Mood in Nursing Home Residents With Dementia: Results From an Embedded, Pragmatic Randomized Controlled Trial","Sisti A, Gutman R, Mor V, Dionne L, Rudolph JL, Baier RR, McCreedy EM.",Am J Geriatr Psychiatry. 2024 Mar;32(3):300-311. doi: 10.1016/j.jagp.2023.10.016. Epub 2023 Nov 2.,Sisti A,Am J Geriatr Psychiatry,2024,16-11-2023,PMC10922136,NIHMS1944318,10.1016/j.jagp.2023.10.016
37971292,Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review,"Gindri IM, Ferrari G, Pinto LPS, Bicca J, Dos Santos IK, Dallacosta D, Roesler CRM.",Am J Physiol Endocrinol Metab. 2024 Apr 1;326(4):E417-E427. doi: 10.1152/ajpendo.00242.2023. Epub 2023 Nov 16.,Gindri IM,Am J Physiol Endocrinol Metab,2024,16-11-2023,,,10.1152/ajpendo.00242.2023
37970326,Effect of Daily Coffee Consumption on the Risk of Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Nila IS, Villagra Moran VM, Khan ZA, Hong Y.",J Lifestyle Med. 2023 Aug 31;13(2):83-89. doi: 10.15280/jlm.2023.13.2.83.,Nila IS,J Lifestyle Med,2023,16-11-2023,PMC10630722,,10.15280/jlm.2023.13.2.83
37968954,[The role of antidiabetic drugs in the treatment of Alzheimer's disease: systematic review],"Ishmuratova AN, Abramov MA, Kuznetsov KO, Ivanyuta MV, Shakirova ZF, Kitapova AI, Usmonov MD, Chernousova LM, Valeeva LI, Kuznetsova AY, Baislamov AS, Shaihetdinova AR, Mirgaliev AA, Orozberdiev ST, Yakupova KI.",Probl Endokrinol (Mosk). 2023 Nov 11;69(5):73-83. doi: 10.14341/probl13183.,Ishmuratova AN,Probl Endokrinol (Mosk),2023,16-11-2023,PMC10680548,,10.14341/probl13183
37968718,A phase 1 open-label pilot study of low-dose interleukine-2 immunotherapy in patients with Alzheimer's disease,"Faridar A, Eid AM, Thome AD, Zhao W, Beers DR, Pascual MB, Nakawah MO, Roman GC, Davis CS, Grundman M, Masdeu JC, Appel SH.",Transl Neurodegener. 2023 Nov 16;12(1):54. doi: 10.1186/s40035-023-00387-5.,Faridar A,Transl Neurodegener,2023,16-11-2023,PMC10652426,,10.1186/s40035-023-00387-5
37966285,Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease,"Bateman RJ, Smith J, Donohue MC, Delmar P, Abbas R, Salloway S, Wojtowicz J, Blennow K, Bittner T, Black SE, Klein G, Boada M, Grimmer T, Tamaoka A, Perry RJ, Turner RS, Watson D, Woodward M, Thanasopoulou A, Lane C, Baudler M, Fox NC, Cummings JL, Fontoura P, Doody RS; GRADUATE I and II Investigators and the Gantenerumab Study Group.",N Engl J Med. 2023 Nov 16;389(20):1862-1876. doi: 10.1056/NEJMoa2304430.,Bateman RJ,N Engl J Med,2023,15-11-2023,PMC10794000,NIHMS1946860,10.1056/NEJMoa2304430
37964856,A bibliometric and thematic analysis of the trends in the research on ginkgo biloba extract from 1985 to 2022,"Ji HJ, Zhou XH, Wu HY, Liu HX, Zhang GZ.",Heliyon. 2023 Oct 24;9(11):e21214. doi: 10.1016/j.heliyon.2023.e21214. eCollection 2023 Nov.,Ji HJ,Heliyon,2023,15-11-2023,PMC10641152,,10.1016/j.heliyon.2023.e21214
37960316,The Role of Methionine-Rich Diet in Unhealthy Cerebrovascular and Brain Aging: Mechanisms and Implications for Cognitive Impairment,"Ungvari A, Gulej R, Csik B, Mukli P, Negri S, Tarantini S, Yabluchanskiy A, Benyo Z, Csiszar A, Ungvari Z.",Nutrients. 2023 Nov 3;15(21):4662. doi: 10.3390/nu15214662.,Ungvari A,Nutrients,2023,14-11-2023,PMC10650229,,10.3390/nu15214662
37958705,Common and Trace Metals in Alzheimer's and Parkinson's Diseases,"Doroszkiewicz J, Farhan JA, Mroczko J, Winkel I, Perkowski M, Mroczko B.",Int J Mol Sci. 2023 Oct 29;24(21):15721. doi: 10.3390/ijms242115721.,Doroszkiewicz J,Int J Mol Sci,2023,14-11-2023,PMC10649239,,10.3390/ijms242115721
37955923,Patient and Family Outcomes of Community Neurologist Palliative Education and Telehealth Support in Parkinson Disease,"Kluger BM, Katz M, Galifianakis NB, Pantilat SZ, Hauser JM, Khan R, Friedman C, Vaughan CL, Goto Y, Long SJ, Martin CS, Dini M, McQueen RB, Palmer L, Fairclough D, Seeberger LC, Sillau SH, Kutner JS.",JAMA Neurol. 2024 Jan 1;81(1):39-49. doi: 10.1001/jamaneurol.2023.4260.,Kluger BM,JAMA Neurol,2024,13-11-2023,PMC10644250,,10.1001/jamaneurol.2023.4260
37955845,Anti-Amyloid Monoclonal Antibodies for the Treatment of Alzheimer's Disease,"Cummings J, Osse AML, Cammann D, Powell J, Chen J.",BioDrugs. 2024 Jan;38(1):5-22. doi: 10.1007/s40259-023-00633-2. Epub 2023 Nov 13.,Cummings J,BioDrugs,2024,13-11-2023,PMC10789674,NIHMS1946854,10.1007/s40259-023-00633-2
37944706,"The effectiveness of dance movement interventions for older adults with mild cognitive impairment, Alzheimer's disease, and dementia: A systematic scoping review and meta-analysis","Tao D, Awan-Scully R, Ash GI, Pei Z, Gu Y, Gao Y, Cole A, Baker JS.",Ageing Res Rev. 2023 Dec;92:102120. doi: 10.1016/j.arr.2023.102120. Epub 2023 Nov 8.,Tao D,Ageing Res Rev,2023,09-11-2023,PMC11262040,NIHMS2009058,10.1016/j.arr.2023.102120
37943296,Pharmacological update of mirtazapine: a narrative literature review,"Hassanein EHM, Althagafy HS, Baraka MA, Abd-Alhameed EK, Ibrahim IM.",Naunyn Schmiedebergs Arch Pharmacol. 2024 May;397(5):2603-2619. doi: 10.1007/s00210-023-02818-6. Epub 2023 Nov 9.,Hassanein EHM,Naunyn Schmiedebergs Arch Pharmacol,2024,09-11-2023,PMC11074035,,10.1007/s00210-023-02818-6
37941382,Online Chair Yoga and Digital Learning for Rural Underserved Older Adults at Risk for Alzheimer's Disease and Related Dementias,"Park J, Wiese LAK, Holt J.",Clin Gerontol. 2025 Jul-Sep;48(4):699-715. doi: 10.1080/07317115.2023.2277333. Epub 2023 Nov 8.,Park J,Clin Gerontol,2025,09-11-2023,PMC11076416,NIHMS1957178,10.1080/07317115.2023.2277333
37940779,P2X7 Receptor: an Emerging Target in Alzheimer's Disease,"Huang Q, Ying J, Yu W, Dong Y, Xiong H, Zhang Y, Liu J, Wang X, Hua F.",Mol Neurobiol. 2024 May;61(5):2866-2880. doi: 10.1007/s12035-023-03699-9. Epub 2023 Nov 9.,Huang Q,Mol Neurobiol,2024,08-11-2023,PMC11043177,,10.1007/s12035-023-03699-9
37937120,Systematic review and meta-analysis of the effects of menopause hormone therapy on risk of Alzheimer's disease and dementia,"Nerattini M, Jett S, Andy C, Carlton C, Zarate C, Boneu C, Battista M, Pahlajani S, Loeb-Zeitlin S, Havryulik Y, Williams S, Christos P, Fink M, Brinton RD, Mosconi L.",Front Aging Neurosci. 2023 Oct 23;15:1260427. doi: 10.3389/fnagi.2023.1260427. eCollection 2023.,Nerattini M,Front Aging Neurosci,2023,08-11-2023,PMC10625913,,10.3389/fnagi.2023.1260427
37935416,Internet-Based Conversational Engagement Randomized Controlled Clinical Trial (I-CONECT) Among Socially Isolated Adults 75+ Years Old With Normal Cognition or Mild Cognitive Impairment: Topline Results,"Dodge HH, Yu K, Wu CY, Pruitt PJ, Asgari M, Kaye JA, Hampstead BM, Struble L, Potempa K, Lichtenberg P, Croff R, Albin RL, Silbert LC; I-CONECT Team.",Gerontologist. 2024 Apr 1;64(4):gnad147. doi: 10.1093/geront/gnad147.,Dodge HH,Gerontologist,2024,07-11-2023,PMC10943511,,10.1093/geront/gnad147
37934614,Gut microbiome-targeted therapies for Alzheimer's disease,"Zhang T, Gao G, Kwok LY, Sun Z.",Gut Microbes. 2023 Dec;15(2):2271613. doi: 10.1080/19490976.2023.2271613. Epub 2023 Nov 7.,Zhang T,Gut Microbes,2023,07-11-2023,PMC10631445,,10.1080/19490976.2023.2271613
37933726,A prospective feasibility trial exploring novel biomarkers for neurotoxicity after isolated limb perfusion,"Corderfeldt Keiller A, Axelsson M, Bragadottir G, Blennow K, Zetterberg H, Olofsson Bagge R.",Perfusion. 2024 Nov;39(8):1657-1666. doi: 10.1177/02676591231213506. Epub 2023 Nov 7.,Corderfeldt Keiller A,Perfusion,2024,07-11-2023,PMC11505376,,10.1177/02676591231213506
37929898,[Alzheimer's disease. Current evidence on the preventive role of nutrition],"Lorenzo-Mora AM, Lozano-Estevan MDC, Ghazi Y, González-Rodríguez LG.",Nutr Hosp. 2023 Nov 22;40(Spec No2):41-45. doi: 10.20960/nh.04954.,Lorenzo-Mora AM,Nutr Hosp,2023,06-11-2023,,,10.20960/nh.04954
37929672,"A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer's disease and agitated behaviours: the HTA-SYMBAD trial","Banerjee S, Farina N, Henderson C, High J, Stirling S, Shepstone L, Fountain J, Ballard C, Bentham P, Burns A, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Swart AM, Telling T, Tabet N.",Health Technol Assess. 2023 Oct;27(23):1-108. doi: 10.3310/VPDT7105.,Banerjee S,Health Technol Assess,2023,06-11-2023,PMC10641860,,10.3310/VPDT7105
37927258,Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer's Disease via Neuroinflammation and Ferroptosis,"Yang J, Shi X, Wang Y, Ma M, Liu H, Wang J, Xu Z.",J Alzheimers Dis. 2023;96(3):927-945. doi: 10.3233/JAD-230593.,Yang J,J Alzheimers Dis,2023,06-11-2023,PMC10741341,,10.3233/JAD-230593
37924845,Evaluation of clinical benefits of treatments for Alzheimer's disease,"Liu KY, Walsh S, Brayne C, Merrick R, Richard E, Howard R.",Lancet Healthy Longev. 2023 Nov;4(11):e645-e651. doi: 10.1016/S2666-7568(23)00193-9.,Liu KY,Lancet Healthy Longev,2023,04-11-2023,,,10.1016/S2666-7568(23)00193-9
37916259,Effect of Periodontal Disease on Alzheimer's Disease: A Systematic Review,"Bouziane A, Lattaf S, Abdallaoui Maan L.",Cureus. 2023 Oct 1;15(10):e46311. doi: 10.7759/cureus.46311. eCollection 2023 Oct.,Bouziane A,Cureus,2023,02-11-2023,PMC10616904,,10.7759/cureus.46311
37905388,"Long-term Tai Chi practice in older adults is associated with ""younger"" functional abilities","Ma Y, Gow BJ, Song R, Rist PM, Hausdorff JM, Lipsitz LA, Manor B, Wayne PM.",Aging Cell. 2024 Jan;23(1):e14023. doi: 10.1111/acel.14023. Epub 2023 Oct 31.,Ma Y,Aging Cell,2024,31-10-2023,PMC10776109,,10.1111/acel.14023
37904726,Neuroprotective effects of gemfibrozil in neurological disorders: Focus on inflammation and molecular mechanisms,"Ivraghi MS, Zamanian MY, Gupta R, Achmad H, Alsaab HO, Hjazi A, Romero-Parra RM, Alwaily ER, Hussien BM, Hakimizadeh E.",CNS Neurosci Ther. 2024 Mar;30(3):e14473. doi: 10.1111/cns.14473. Epub 2023 Oct 30.,Ivraghi MS,CNS Neurosci Ther,2024,31-10-2023,PMC10916451,,10.1111/cns.14473
37904465,Herpes Zoster virus infection and the risk of developing dementia: A systematic review and meta-analysis,"Elhalag RH, Motawea KR, Talat NE, Rouzan SS, Reyad SM, Elsayed SM, Chébl P, Abowafia M, Shah J.",Medicine (Baltimore). 2023 Oct 27;102(43):e34503. doi: 10.1097/MD.0000000000034503.,Elhalag RH,Medicine (Baltimore),2023,31-10-2023,PMC10615483,,10.1097/MD.0000000000034503
37904435,Network pharmacology and molecular docking approaches predict the mechanisms of Corididius chinensis in treating manganese-induced nervous system diseases: A review,"Zhang M, Lou H, Ma J, Xiong K, Hou X.",Medicine (Baltimore). 2023 Oct 27;102(43):e35669. doi: 10.1097/MD.0000000000035669.,Zhang M,Medicine (Baltimore),2023,31-10-2023,PMC10615487,,10.1097/MD.0000000000035669
37902726,Exploratory Tau Biomarker Results From a Multiple Ascending-Dose Study of BIIB080 in Alzheimer Disease: A Randomized Clinical Trial,"Edwards AL, Collins JA, Junge C, Kordasiewicz H, Mignon L, Wu S, Li Y, Lin L, DuBois J, Hutchison RM, Ziogas N, Shulman M, Martarello L, Graham D, Lane R, Budd Haeberlein S, Beaver J.",JAMA Neurol. 2023 Dec 1;80(12):1344-1352. doi: 10.1001/jamaneurol.2023.3861.,Edwards AL,JAMA Neurol,2023,30-10-2023,PMC10616768,,10.1001/jamaneurol.2023.3861
37902139,Novel anti-amyloid-beta (Aβ) monoclonal antibody lecanemab for Alzheimer's disease: A systematic review,"Chowdhury S, Chowdhury NS.",Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231209839. doi: 10.1177/03946320231209839.,Chowdhury S,Int J Immunopathol Pharmacol,2023,30-10-2023,PMC10617290,,10.1177/03946320231209839
37898443,The evolving role of cholesteryl ester transfer protein inhibition beyond cardiovascular disease,"Mehta N, Dangas K, Ditmarsch M, Rensen PCN, Dicklin MR, Kastelein JJP.",Pharmacol Res. 2023 Nov;197:106972. doi: 10.1016/j.phrs.2023.106972. Epub 2023 Oct 28.,Mehta N,Pharmacol Res,2023,28-10-2023,,,10.1016/j.phrs.2023.106972
37895161,Mechanistic Intimate Insights into the Role of Hydrogen Sulfide in Alzheimer's Disease: A Recent Systematic Review,"Munteanu C, Iordan DA, Hoteteu M, Popescu C, Postoiu R, Onu I, Onose G.",Int J Mol Sci. 2023 Oct 23;24(20):15481. doi: 10.3390/ijms242015481.,Munteanu C,Int J Mol Sci,2023,28-10-2023,PMC10607039,,10.3390/ijms242015481
37894629,Review of Phytochemical Potency as a Natural Anti-Helicobacter pylori and Neuroprotective Agent,"Tandoro Y, Chen BK, Ali A, Wang CK.",Molecules. 2023 Oct 18;28(20):7150. doi: 10.3390/molecules28207150.,Tandoro Y,Molecules,2023,28-10-2023,PMC10609179,,10.3390/molecules28207150
37894595,"Ethnic, Botanic, Phytochemistry and Pharmacology of the Acorus L. Genus: A Review","Zhao Y, Li J, Cao G, Zhao D, Li G, Zhang H, Yan M.",Molecules. 2023 Oct 16;28(20):7117. doi: 10.3390/molecules28207117.,Zhao Y,Molecules,2023,28-10-2023,PMC10609487,,10.3390/molecules28207117
37892438,Roles of Omega-3 Polyunsaturated Fatty Acids in Managing Cognitive Impairment in Chronic Obstructive Pulmonary Disease: A Review,"Zailani H, Satyanarayanan SK, Liao WC, Hsu YT, Huang SY, Gałecki P, Su KP, Chang JP.",Nutrients. 2023 Oct 13;15(20):4363. doi: 10.3390/nu15204363.,Zailani H,Nutrients,2023,28-10-2023,PMC10609799,,10.3390/nu15204363
37892128,The Main Therapeutic Applications of Cannabidiol (CBD) and Its Potential Effects on Aging with Respect to Alzheimer's Disease,"Trojan V, Landa L, Šulcová A, Slíva J, Hřib R.",Biomolecules. 2023 Sep 26;13(10):1446. doi: 10.3390/biom13101446.,Trojan V,Biomolecules,2023,28-10-2023,PMC10604144,,10.3390/biom13101446
37879942,Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort Study,"Zhou Z, Ryan J, Tonkin AM, Zoungas S, Lacaze P, Wolfe R, Orchard SG, Murray AM, McNeil JJ, Yu C, Watts GF, Hussain SM, Beilin LJ, Ernst ME, Stocks N, Woods RL, Zhu C, Reid CM, Shah RC, Chong TT, Sood A, Sheets KM, Nelson MR.",Neurology. 2023 Nov 27;101(22):e2288-e2299. doi: 10.1212/WNL.0000000000207923.,Zhou Z,Neurology,2023,25-10-2023,PMC10727221,,10.1212/WNL.0000000000207923
37875856,Tango-therapy vs physical exercise in older people with dementia; a randomized controlled trial,"Bracco L, Pinto-Carral A, Hillaert L, Mourey F.",BMC Geriatr. 2023 Oct 24;23(1):693. doi: 10.1186/s12877-023-04342-x.,Bracco L,BMC Geriatr,2023,24-10-2023,PMC10598907,,10.1186/s12877-023-04342-x
37874111,Genotypic Effects of the TOMM40'523 Variant and APOE on Longitudinal Cognitive Change over 4 Years: The TOMMORROW Study,"Zou H, Luo S, Liu H, Lutz MW, Bennett DA, Plassman BL, Welsh-Bohmer KA.",J Prev Alzheimers Dis. 2023;10(4):886-894. doi: 10.14283/jpad.2023.115.,Zou H,J Prev Alzheimers Dis,2023,24-10-2023,PMC10734664,NIHMS1949684,10.14283/jpad.2023.115
37874084,Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics,"Riessland M, Orr ME.",J Prev Alzheimers Dis. 2023;10(4):633-646. doi: 10.14283/jpad.2023.104.,Riessland M,J Prev Alzheimers Dis,2023,24-10-2023,PMC11103249,NIHMS1986263,10.14283/jpad.2023.104
37872582,Cognitive impact of multidomain intervention and omega 3 according to blood Aβ42/40 ratio: a subgroup analysis from the randomized MAPT trial,"Delrieu J, Vellas B, Guyonnet S, Cantet C, Ovod V, Li Y, Bollinger J, Bateman R, Andrieu S; MAPT/DSA group.",Alzheimers Res Ther. 2023 Oct 23;15(1):183. doi: 10.1186/s13195-023-01325-3.,Delrieu J,Alzheimers Res Ther,2023,23-10-2023,PMC10594723,,10.1186/s13195-023-01325-3
37868743,Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review,"Singh K, Bhushan B, Chanchal DK, Sharma SK, Rani K, Yadav MK, Porwal P, Kumar S, Sharma A, Virmani T, Kumar G, Noman AA.",Behav Neurol. 2023 Oct 12;2023:8825358. doi: 10.1155/2023/8825358. eCollection 2023.,Singh K,Behav Neurol,2023,23-10-2023,PMC10586905,,10.1155/2023/8825358
37868345,Review of microbiota gut brain axis and innate immunity in inflammatory and infective diseases,"Yuan C, He Y, Xie K, Feng L, Gao S, Cai L.",Front Cell Infect Microbiol. 2023 Oct 4;13:1282431. doi: 10.3389/fcimb.2023.1282431. eCollection 2023.,Yuan C,Front Cell Infect Microbiol,2023,23-10-2023,PMC10585369,,10.3389/fcimb.2023.1282431
37848035,Accelerating Alzheimer's therapeutic development: The past and future of clinical trials,"Boxer AL, Sperling R.",Cell. 2023 Oct 26;186(22):4757-4772. doi: 10.1016/j.cell.2023.09.023. Epub 2023 Oct 16.,Boxer AL,Cell,2023,17-10-2023,PMC10625460,NIHMS1937977,10.1016/j.cell.2023.09.023
37846476,The role of oestrogen therapy in reducing risk of Alzheimer's disease: systematic review,"Wong GRM, Lee EJA, Liaw QY, Rajaram H.",BJPsych Open. 2023 Oct 17;9(6):e194. doi: 10.1192/bjo.2023.579.,Wong GRM,BJPsych Open,2023,17-10-2023,PMC10594166,,10.1192/bjo.2023.579
37838279,NOX-induced oxidative stress is a primary trigger of major neurodegenerative disorders,"Zilberter Y, Tabuena DR, Zilberter M.",Prog Neurobiol. 2023 Dec;231:102539. doi: 10.1016/j.pneurobio.2023.102539. Epub 2023 Oct 12.,Zilberter Y,Prog Neurobiol,2023,14-10-2023,PMC11758986,NIHMS2046151,10.1016/j.pneurobio.2023.102539
37834834,Repetitive Transcranial Magnetic Stimulation (rTMS) in Mild Cognitive Impairment: Effects on Cognitive Functions-A Systematic Review,"Sharbafshaaer M, Gigi I, Lavorgna L, Esposito S, Bonavita S, Tedeschi G, Esposito F, Trojsi F.",J Clin Med. 2023 Sep 25;12(19):6190. doi: 10.3390/jcm12196190.,Sharbafshaaer M,J Clin Med,2023,14-10-2023,PMC10573645,,10.3390/jcm12196190
37833948,Anti-Amyloid Therapies for Alzheimer's Disease and the Amyloid Cascade Hypothesis,Fedele E.,Int J Mol Sci. 2023 Sep 24;24(19):14499. doi: 10.3390/ijms241914499.,Fedele E,Int J Mol Sci,2023,14-10-2023,PMC10578107,,10.3390/ijms241914499
37832633,Memantine: Updating a rare success story in pro-cognitive therapeutics,"Karimi Tari P, Parsons CG, Collingridge GL, Rammes G.",Neuropharmacology. 2024 Feb 15;244:109737. doi: 10.1016/j.neuropharm.2023.109737. Epub 2023 Oct 11.,Karimi Tari P,Neuropharmacology,2024,13-10-2023,,,10.1016/j.neuropharm.2023.109737
37831127,High intake of ultra-processed food is associated with dementia in adults: a systematic review and meta-analysis of observational studies,"Henney AE, Gillespie CS, Alam U, Hydes TJ, Mackay CE, Cuthbertson DJ.",J Neurol. 2024 Jan;271(1):198-210. doi: 10.1007/s00415-023-12033-1. Epub 2023 Oct 13.,Henney AE,J Neurol,2024,13-10-2023,PMC10770002,,10.1007/s00415-023-12033-1
37814198,Connecting memory and functional brain networks in older adults: a resting-state fMRI study,"Waner JL, Hausman HK, Kraft JN, Hardcastle C, Evangelista ND, O'Shea A, Albizu A, Boutzoukas EM, Van Etten EJ, Bharadwaj PK, Song H, Smith SG, DeKosky ST, Hishaw GA, Wu SS, Marsiske M, Cohen R, Alexander GE, Porges EC, Woods AJ.",Geroscience. 2023 Oct;45(5):3079-3093. doi: 10.1007/s11357-023-00967-3. Epub 2023 Oct 10.,Waner JL,Geroscience,2023,09-10-2023,PMC10643735,,10.1007/s11357-023-00967-3
37812437,Amyloid Positron Emission Tomography and Subsequent Health Care Use Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia,"Rabinovici GD, Carrillo MC, Apgar C, Gareen IF, Gutman R, Hanna L, Hillner BE, March A, Romanoff J, Siegel BA, Smith K, Song Y, Weber C, Whitmer RA, Gatsonis C.",JAMA Neurol. 2023 Nov 1;80(11):1166-1173. doi: 10.1001/jamaneurol.2023.3490.,Rabinovici GD,JAMA Neurol,2023,09-10-2023,PMC10562987,,10.1001/jamaneurol.2023.3490
37810956,Rapamycin Responds to Alzheimer's Disease: A Potential Translational Therapy,"Hou SJ, Zhang SX, Li Y, Xu SY.",Clin Interv Aging. 2023 Oct 2;18:1629-1639. doi: 10.2147/CIA.S429440. eCollection 2023.,Hou SJ,Clin Interv Aging,2023,09-10-2023,PMC10557994,,10.2147/CIA.S429440
37807782,Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications,"Bredesen DE, Toups K, Hathaway A, Gordon D, Chung H, Raji C, Boyd A, Hill BD, Hausman-Cohen S, Attarha M, Chwa WJ, Kurakin A, Jarrett M.",J Alzheimers Dis. 2023;96(2):429-437. doi: 10.3233/JAD-230467.,Bredesen DE,J Alzheimers Dis,2023,09-10-2023,PMC10741308,,10.3233/JAD-230467
37805464,Development and validation of a nomogram model for prediction of stroke-associated pneumonia associated with intracerebral hemorrhage,"Wang Y, Chen Y, Chen R, Xu Y, Zheng H, Xu J, Xia J, Cai Y, Xu H, Wang X.",BMC Geriatr. 2023 Oct 7;23(1):633. doi: 10.1186/s12877-023-04310-5.,Wang Y,BMC Geriatr,2023,07-10-2023,PMC10559607,,10.1186/s12877-023-04310-5
37800614,"Inflammatory signaling pathways in the treatment of Alzheimer's disease with inhibitors, natural products and metabolites (Review)","Zheng Y, Zhang X, Zhang R, Wang Z, Gan J, Gao Q, Yang L, Xu P, Jiang X.",Int J Mol Med. 2023 Nov;52(5):111. doi: 10.3892/ijmm.2023.5314. Epub 2023 Oct 6.,Zheng Y,Int J Mol Med,2023,06-10-2023,PMC10558228,,10.3892/ijmm.2023.5314
37792075,Behavioral Treatment for Speech and Language in Primary Progressive Aphasia and Primary Progressive Apraxia of Speech: A Systematic Review,"Wauters LD, Croot K, Dial HR, Duffy JR, Grasso SM, Kim E, Schaffer Mendez K, Ballard KJ, Clark HM, Kohley L, Murray LL, Rogalski EJ, Figeys M, Milman L, Henry ML.",Neuropsychol Rev. 2024 Sep;34(3):882-923. doi: 10.1007/s11065-023-09607-1. Epub 2023 Oct 4.,Wauters LD,Neuropsychol Rev,2024,04-10-2023,PMC11473583,,10.1007/s11065-023-09607-1
37790283,Association of age-related hearing loss with cognitive impairment and dementia: an umbrella review,"Ying G, Zhao G, Xu X, Su S, Xie X.",Front Aging Neurosci. 2023 Sep 18;15:1241224. doi: 10.3389/fnagi.2023.1241224. eCollection 2023.,Ying G,Front Aging Neurosci,2023,04-10-2023,PMC10543744,,10.3389/fnagi.2023.1241224
37788493,Antiepileptic Drugs as Potential Dementia Prophylactics Following Traumatic Brain Injury,"Locskai LF, Alyenbaawi H, Allison WT.",Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:577-598. doi: 10.1146/annurev-pharmtox-051921-013930. Epub 2023 Oct 3.,Locskai LF,Annu Rev Pharmacol Toxicol,2024,03-10-2023,,,10.1146/annurev-pharmtox-051921-013930
37788254,Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson's Disease Project,"Vollstedt EJ, Madoev H, Aasly A, Ahmad-Annuar A, Al-Mubarak B, Alcalay RN, Alvarez V, Amorin I, Annesi G, Arkadir D, Bardien S, Barker RA, Barkhuizen M, Basak AN, Bonifati V, Boon A, Brighina L, Brockmann K, Carmine Belin A, Carr J, Clarimon J, Cornejo-Olivas M, Correia Guedes L, Corvol JC, Crosiers D, Damásio J, Das P, de Carvalho Aguiar P, De Rosa A, Dorszewska J, Ertan S, Ferese R, Ferreira J, Gatto E, Genç G, Giladi N, Gómez-Garre P, Hanagasi H, Hattori N, Hentati F, Hoffman-Zacharska D, Illarioshkin SN, Jankovic J, Jesús S, Kaasinen V, Kievit A, Klivenyi P, Kostic V, Koziorowski D, Kühn AA, Lang AE, Lim SY, Lin CH, Lohmann K, Markovic V, Martikainen MH, Mellick G, Merello M, Milanowski L, Mir P, Öztop-Çakmak Ö, Pimentel MMG, Pulkes T, Puschmann A, Rogaeva E, Sammler EM, Skaalum Petersen M, Skorvanek M, Spitz M, Suchowersky O, Tan AH, Termsarasab P, Thaler A, Tumas V, Valente EM, van de Warrenburg B, Williams-Gray CH, Wu RM, Zhang B, Zimprich A, Solle J, Padmanabhan S, Klein C.",PLoS One. 2023 Oct 3;18(10):e0292180. doi: 10.1371/journal.pone.0292180. eCollection 2023.,Vollstedt EJ,PLoS One,2023,03-10-2023,PMC10547150,,10.1371/journal.pone.0292180
37784171,Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update,"Huang LK, Kuan YC, Lin HW, Hu CJ.",J Biomed Sci. 2023 Oct 2;30(1):83. doi: 10.1186/s12929-023-00976-6.,Huang LK,J Biomed Sci,2023,02-10-2023,PMC10544555,,10.1186/s12929-023-00976-6
37777345,"Air pollution, glymphatic impairment, and Alzheimer's disease","Hussain R, Graham U, Elder A, Nedergaard M.",Trends Neurosci. 2023 Nov;46(11):901-911. doi: 10.1016/j.tins.2023.08.010. Epub 2023 Sep 28.,Hussain R,Trends Neurosci,2023,30-09-2023,PMC11934145,NIHMS2046464,10.1016/j.tins.2023.08.010
37776210,Study design and methods: U.S. study to protect brain health through lifestyle intervention to reduce risk (U.S. POINTER),"Baker LD, Snyder HM, Espeland MA, Whitmer RA, Kivipelto M, Woolard N, Katula J, Papp KV, Ventrelle J, Graef S, Hill MA, Rushing S, Spell J, Lovato L, Felton D, Williams BJ, Ghadimi Nouran M, Raman R, Ngandu T, Solomon A, Wilmoth S, Cleveland ML, Williamson JD, Lambert KL, Tomaszewski Farias S, Day CE, Tangney CC, Gitelman DR, Matongo O, Reynolds T, Pavlik VN, Yu MM, Alexander AS, Elbein R, McDonald AM, Salloway S, Wing RR, Antkowiak S, Morris MC, Carrillo MC; U.S. POINTER Study Group.",Alzheimers Dement. 2024 Feb;20(2):769-782. doi: 10.1002/alz.13365. Epub 2023 Sep 30.,Baker LD,Alzheimers Dement,2024,30-09-2023,PMC10916955,,10.1002/alz.13365
37764277,Therapeutic Effects of Baicalin on Diseases Related to Gut-Brain Axis Dysfunctions,"Hu Q, Hou S, Xiong B, Wen Y, Wang J, Zeng J, Ma X, Wang F.",Molecules. 2023 Sep 7;28(18):6501. doi: 10.3390/molecules28186501.,Hu Q,Molecules,2023,28-09-2023,PMC10535911,,10.3390/molecules28186501
37762479,Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment,"Olloquequi J, Ettcheto M, Cano A, Fortuna A, Bicker J, Sánchez-Lopez E, Paz C, Ureña J, Verdaguer E, Auladell C, Camins A.",Int J Mol Sci. 2023 Sep 16;24(18):14177. doi: 10.3390/ijms241814177.,Olloquequi J,Int J Mol Sci,2023,28-09-2023,PMC10531537,,10.3390/ijms241814177
37762203,Treatment of Alzheimer's Disease: Beyond Symptomatic Therapies,"Buccellato FR, D'Anca M, Tartaglia GM, Del Fabbro M, Scarpini E, Galimberti D.",Int J Mol Sci. 2023 Sep 9;24(18):13900. doi: 10.3390/ijms241813900.,Buccellato FR,Int J Mol Sci,2023,28-09-2023,PMC10531090,,10.3390/ijms241813900
37759788,"Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy","Voicu V, Brehar FM, Toader C, Covache-Busuioc RA, Corlatescu AD, Bordeianu A, Costin HP, Bratu BG, Glavan LA, Ciurea AV.",Biomolecules. 2023 Sep 14;13(9):1388. doi: 10.3390/biom13091388.,Voicu V,Biomolecules,2023,28-09-2023,PMC10526757,,10.3390/biom13091388
37756366,"Alzheimer's Disease: A Review of Pathology, Current Treatments, and the Potential Therapeutic Effect of Decreasing Oxidative Stress by Combined Vitamin D and l-Cysteine Supplementation","Jain SK, Stevens CM, Margret JJ, Levine SN.",Antioxid Redox Signal. 2024 Apr;40(10-12):663-678. doi: 10.1089/ars.2023.0245. Epub 2023 Dec 8.,Jain SK,Antioxid Redox Signal,2024,27-09-2023,PMC11001507,,10.1089/ars.2023.0245
37750713,Oh my gut! Is the microbial origin of neurodegenerative diseases real?,"Walker A, Czyz DM.",Infect Immun. 2023 Oct 17;91(10):e0043722. doi: 10.1128/iai.00437-22. Epub 2023 Sep 26.,Walker A,Infect Immun,2023,26-09-2023,PMC10580905,,10.1128/iai.00437-22
39726673,Monoclonal Antibody Treatments for Alzheimer's Disease: Aducanumab and Lecanemab,Chowdhury S.,Discoveries (Craiova). 2023 Sep 25;11(3):e173. doi: 10.15190/d.2023.12. eCollection 2023 Jul-Sep.,Chowdhury S,Discoveries (Craiova),2023,27-12-2024,PMC11671221,,10.15190/d.2023.12
37746412,Comparative Study of Safety and Efficacy of Angiotensin-Receptor Blockers and Anti Amyloid-ß Monoclonal Antibodies for the Treatment of Alzheimer's Disease: A Systematic Review,"Shahid K, Tamene Y, Mody SP, Sadiq KO, Shivakumar YM, Burra E, Ramphall S.",Cureus. 2023 Aug 23;15(8):e43984. doi: 10.7759/cureus.43984. eCollection 2023 Aug.,Shahid K,Cureus,2023,25-09-2023,PMC10516255,,10.7759/cureus.43984
37733162,Angiotensin Receptor Blockers and Cognition: a Scoping Review,"Zhou Z, Orchard SG, Nelson MR, Fravel MA, Ernst ME.",Curr Hypertens Rep. 2024 Jan;26(1):1-19. doi: 10.1007/s11906-023-01266-0. Epub 2023 Sep 21.,Zhou Z,Curr Hypertens Rep,2024,21-09-2023,PMC10796582,,10.1007/s11906-023-01266-0
37732473,Ascertainment and Statistical Issues for Randomized Trials of Cardiovascular Interventions for Cognitive Impairment and Dementia,"Pajewski NM, Donohue MC, Raman R, Espeland MA.",Hypertension. 2024 Jan;81(1):45-53. doi: 10.1161/HYPERTENSIONAHA.123.19941. Epub 2023 Sep 21.,Pajewski NM,Hypertension,2024,21-09-2023,PMC10840823,NIHMS1919199,10.1161/HYPERTENSIONAHA.123.19941
37730689,Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer's disease,"Delgado-Peraza F, Nogueras-Ortiz C, Simonsen AH, Knight DD, Yao PJ, Goetzl EJ, Jensen CS, Høgh P, Gottrup H, Vestergaard K, Hasselbalch SG, Kapogiannis D.",Alzheimers Res Ther. 2023 Sep 20;15(1):156. doi: 10.1186/s13195-023-01303-9.,Delgado-Peraza F,Alzheimers Res Ther,2023,20-09-2023,PMC10510190,,10.1186/s13195-023-01303-9
37729908,Alzheimer's disease: From immunotherapy to immunoprevention,"Jucker M, Walker LC.",Cell. 2023 Sep 28;186(20):4260-4270. doi: 10.1016/j.cell.2023.08.021. Epub 2023 Sep 19.,Jucker M,Cell,2023,20-09-2023,PMC10578497,NIHMS1927464,10.1016/j.cell.2023.08.021
37728864,Alzheimer's Disease: Novel Targets and Investigational Drugs for Disease Modification,"Cummings JL, Osse AML, Kinney JW.",Drugs. 2023 Oct;83(15):1387-1408. doi: 10.1007/s40265-023-01938-w. Epub 2023 Sep 20.,Cummings JL,Drugs,2023,20-09-2023,PMC10582128,,10.1007/s40265-023-01938-w
37725199,Pathophysiological Aspects and Therapeutic Armamentarium of Alzheimer's Disease: Recent Trends and Future Development,"Dave BP, Shah YB, Maheshwari KG, Mansuri KA, Prajapati BS, Postwala HI, Chorawala MR.",Cell Mol Neurobiol. 2023 Nov;43(8):3847-3884. doi: 10.1007/s10571-023-01408-7. Epub 2023 Sep 19.,Dave BP,Cell Mol Neurobiol,2023,19-09-2023,PMC11407742,,10.1007/s10571-023-01408-7
37721736,Outcomes in Patients With Poststroke Seizures: A Systematic Review and Meta-Analysis,"Misra S, Kasner SE, Dawson J, Tanaka T, Zhao Y, Zaveri HP, Eldem E, Vazquez J, Silva LS, Mohidat S, Hickman LB, Khan EI, Funaro MC, Nicolo JP, Mazumder R, Yasuda CL, Sunnerhagen KS, Ihara M, Ross JS, Liebeskind DS, Kwan P, Quinn TJ, Engel J Jr, Mishra NK.",JAMA Neurol. 2023 Nov 1;80(11):1155-1165. doi: 10.1001/jamaneurol.2023.3240.,Misra S,JAMA Neurol,2023,18-09-2023,PMC10507596,,10.1001/jamaneurol.2023.3240
37721278,Role of CD36 in central nervous system diseases,"Feng M, Zhou Q, Xie H, Liu C, Zheng M, Zhang S, Zhou S, Zhao J.",Neural Regen Res. 2024 Mar;19(3):512-518. doi: 10.4103/1673-5374.380821.,Feng M,Neural Regen Res,2024,18-09-2023,PMC10581564,,10.4103/1673-5374.380821
37708433,Orexin Receptor Antagonism: Normalizing Sleep Architecture in Old Age and Disease,"Kron JOJ, Keenan RJ, Hoyer D, Jacobson LH.",Annu Rev Pharmacol Toxicol. 2024 Jan 23;64:359-386. doi: 10.1146/annurev-pharmtox-040323-031929. Epub 2023 Sep 14.,Kron JOJ,Annu Rev Pharmacol Toxicol,2024,14-09-2023,,,10.1146/annurev-pharmtox-040323-031929
37706540,Technology caregiver intervention for Alzheimer's disease (I-CARE): Feasibility and preliminary efficacy of Brain CareNotes,"Rodriguez MJ, Kercher VM, Jordan EJ, Savoy A, Hill JR, Werner N, Owora A, Castelluccio P, Boustani MA, Holden RJ.",J Am Geriatr Soc. 2023 Dec;71(12):3836-3847. doi: 10.1111/jgs.18591. Epub 2023 Sep 14.,Rodriguez MJ,J Am Geriatr Soc,2023,14-09-2023,PMC10841172,NIHMS1929174,10.1111/jgs.18591
37705077,Effectiveness of creative story therapy for dementia: a systematic review and meta-analysis,"Ma J, Wang Q, Lang Y, Lv S, Xu Y, Wei B.",Eur J Med Res. 2023 Sep 14;28(1):342. doi: 10.1186/s40001-023-01337-7.,Ma J,Eur J Med Res,2023,13-09-2023,PMC10500921,,10.1186/s40001-023-01337-7
37698858,"Use of Antihypertensives, Blood Pressure, and Estimated Risk of Dementia in Late Life: An Individual Participant Data Meta-Analysis","Lennon MJ, Lam BCP, Lipnicki DM, Crawford JD, Peters R, Schutte AE, Brodaty H, Thalamuthu A, Rydberg-Sterner T, Najar J, Skoog I, Riedel-Heller SG, Röhr S, Pabst A, Lobo A, De-la-Cámara C, Lobo E, Bello T, Gureje O, Ojagbemi A, Lipton RB, Katz MJ, Derby CA, Kim KW, Han JW, Oh DJ, Rolandi E, Davin A, Rossi M, Scarmeas N, Yannakoulia M, Dardiotis T, Hendrie HC, Gao S, Carrière I, Ritchie K, Anstey KJ, Cherbuin N, Xiao S, Yue L, Li W, Guerchet MM, Preux PM, Aboyans V, Haan MN, Aiello AE, Ng TP, Nyunt MSZ, Gao Q, Scazufca M, Sachdev PSS.",JAMA Netw Open. 2023 Sep 5;6(9):e2333353. doi: 10.1001/jamanetworkopen.2023.33353.,Lennon MJ,JAMA Netw Open,2023,12-09-2023,PMC10498335,,10.1001/jamanetworkopen.2023.33353
37698424,The Alzheimer's Disease Neuroimaging Initiative in the era of Alzheimer's disease treatment: A review of ADNI studies from 2021 to 2022,"Veitch DP, Weiner MW, Miller M, Aisen PS, Ashford MA, Beckett LA, Green RC, Harvey D, Jack CR Jr, Jagust W, Landau SM, Morris JC, Nho KT, Nosheny R, Okonkwo O, Perrin RJ, Petersen RC, Rivera Mindt M, Saykin A, Shaw LM, Toga AW, Tosun D; Alzheimer's Disease Neuroimaging Initiative.",Alzheimers Dement. 2024 Jan;20(1):652-694. doi: 10.1002/alz.13449. Epub 2023 Sep 12.,Veitch DP,Alzheimers Dement,2024,12-09-2023,PMC10841343,NIHMS1926141,10.1002/alz.13449
37697714,Anti-amyloid antibody treatments for Alzheimer's disease,"Perneczky R, Dom G, Chan A, Falkai P, Bassetti C.",Eur J Neurol. 2024 Feb;31(2):e16049. doi: 10.1111/ene.16049. Epub 2023 Sep 11.,Perneczky R,Eur J Neurol,2024,12-09-2023,PMC11235913,,10.1111/ene.16049
37695586,Video Intervention and Goals-of-Care Documentation in Hospitalized Older Adults: The VIDEO-PCE Randomized Clinical Trial,"Volandes AE, Zupanc SN, Lakin JR, Cabral HJ, Burns EA, Carney MT, Lopez S, Itty J, Emmert K, Martin NJ, Cole T, Dobie A, Cucinotta T, Joel M, Caruso LB, Henault L, Dugas JN, Astone K, Winter M, Wang N, Davis AD, Garde C, Rodriguez PM, El-Jawahri A, Moseley ET, Das S, Sciacca K, Ramirez AM, Gromova V, Lambert S, Sanghani S, Lindvall C, Paasche-Orlow MK.",JAMA Netw Open. 2023 Sep 5;6(9):e2332556. doi: 10.1001/jamanetworkopen.2023.32556.,Volandes AE,JAMA Netw Open,2023,11-09-2023,PMC10495866,,10.1001/jamanetworkopen.2023.32556
37695107,A Randomized Double-blind Study to Assess the Skin Irritation and Sensitization Potential of a Once-weekly Donepezil Transdermal Delivery System in Healthy Volunteers,"Sabbagh MN, Mathew P, Blau A.",Alzheimer Dis Assoc Disord. 2023 Oct-Dec 01;37(4):290-295. doi: 10.1097/WAD.0000000000000578. Epub 2023 Sep 11.,Sabbagh MN,Alzheimer Dis Assoc Disord,2023,11-09-2023,PMC10664792,,10.1097/WAD.0000000000000578
37688657,Exposome and unhealthy aging: environmental drivers from air pollution to occupational exposures,"Pandics T, Major D, Fazekas-Pongor V, Szarvas Z, Peterfi A, Mukli P, Gulej R, Ungvari A, Fekete M, Tompa A, Tarantini S, Yabluchanskiy A, Conley S, Csiszar A, Tabak AG, Benyo Z, Adany R, Ungvari Z.",Geroscience. 2023 Dec;45(6):3381-3408. doi: 10.1007/s11357-023-00913-3. Epub 2023 Sep 9.,Pandics T,Geroscience,2023,09-09-2023,PMC10643494,,10.1007/s11357-023-00913-3
37686737,Association of Selenium Levels with Neurodegenerative Disease: A Systemic Review and Meta-Analysis,"Zhou J, Zhang W, Cao Z, Lian S, Li J, Nie J, Huang Y, Zhao K, He J, Liu C.",Nutrients. 2023 Aug 24;15(17):3706. doi: 10.3390/nu15173706.,Zhou J,Nutrients,2023,09-09-2023,PMC10490073,,10.3390/nu15173706
37685879,Glutathione-Mediated Neuroprotective Effect of Purine Derivatives,"Matsumura N, Aoyama K.",Int J Mol Sci. 2023 Aug 22;24(17):13067. doi: 10.3390/ijms241713067.,Matsumura N,Int J Mol Sci,2023,09-09-2023,PMC10487553,,10.3390/ijms241713067
37685564,Does Music Intervention Improve Anxiety in Dementia Patients? A Systematic Review and Meta-Analysis of Randomized Controlled Trials,"Ting B, Chen DT, Hsu WT, Liang CS, Malau IA, Li WC, Lee SL, Jingling L, Su KP.",J Clin Med. 2023 Aug 24;12(17):5497. doi: 10.3390/jcm12175497.,Ting B,J Clin Med,2023,09-09-2023,PMC10488399,,10.3390/jcm12175497
37683098,A Hybrid Effectiveness/Implementation Clinical Trial of Adherence to Long-Term Oxygen Therapy for Chronic Obstructive Pulmonary Disease,"Prieto-Centurion V, Holm KE, Casaburi R, Porszasz J, Basu S, Bracken NE, Gallardo R 3rd, Gonzalez V, Illendula SD, Sandhaus RA, Sullivan JL, Walsh LJ, Gerald LB, Krishnan JA.",Ann Am Thorac Soc. 2023 Nov;20(11):1561-1570. doi: 10.1513/AnnalsATS.202302-104OC.,Prieto-Centurion V,Ann Am Thorac Soc,2023,08-09-2023,PMC10632931,,10.1513/AnnalsATS.202302-104OC
37682445,Psychiatric Adverse Events of Acetylcholinesterase Inhibitors in Alzheimer's Disease and Parkinson's Dementia: Systematic Review and Meta-Analysis,"Bittner N, Funk CSM, Schmidt A, Bermpohl F, Brandl EJ, Algharably EEA, Kreutz R, Riemer TG.",Drugs Aging. 2023 Nov;40(11):953-964. doi: 10.1007/s40266-023-01065-x. Epub 2023 Sep 8.,Bittner N,Drugs Aging,2023,08-09-2023,PMC10600312,,10.1007/s40266-023-01065-x
37679990,Guilingji capsule for Alzheimer's disease: secondary analysis of a randomized non-inferiority controlled trial,"Ming Z, Yimiao L, Huichan W, Yu C, Lina MA, Hui P, Hao LI.",J Tradit Chin Med. 2023 Oct;43(5):1019-1025. doi: 10.19852/j.cnki.jtcm.20230404.006.,Ming Z,J Tradit Chin Med,2023,08-09-2023,PMC10465832,,10.19852/j.cnki.jtcm.20230404.006
37679434,Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial,"Gonzales MM, Garbarino VR, Kautz TF, Palavicini JP, Lopez-Cruzan M, Dehkordi SK, Mathews JJ, Zare H, Xu P, Zhang B, Franklin C, Habes M, Craft S, Petersen RC, Tchkonia T, Kirkland JL, Salardini A, Seshadri S, Musi N, Orr ME.",Nat Med. 2023 Oct;29(10):2481-2488. doi: 10.1038/s41591-023-02543-w. Epub 2023 Sep 7.,Gonzales MM,Nat Med,2023,07-09-2023,PMC10875739,NIHMS1960645,10.1038/s41591-023-02543-w
37679245,Targeting the adenosine A(2A) receptor for neuroprotection and cognitive improvement in traumatic brain injury and Parkinson's disease,"Zhao Y, Zhou YG, Chen JF.",Chin J Traumatol. 2024 May;27(3):125-133. doi: 10.1016/j.cjtee.2023.08.003. Epub 2023 Aug 25.,Zhao Y,Chin J Traumatol,2024,07-09-2023,PMC11138351,,10.1016/j.cjtee.2023.08.003
37667521,Gout/hyperuricemia reduces the risk of Alzheimer's disease: A meta-analysis based on latest evidence,"Wang L, Tan Z, Wang FY, Wu WP, Wu JC.",Brain Behav. 2023 Oct;13(10):e3207. doi: 10.1002/brb3.3207. Epub 2023 Sep 4.,Wang L,Brain Behav,2023,05-09-2023,PMC10570495,,10.1002/brb3.3207
37666228,Lithium: An Old Drug for New Therapeutic Strategy for Alzheimer's Disease and Related Dementia,"Shim SS, Berglund K, Yu SP.",Neurodegener Dis. 2023;23(1-2):1-12. doi: 10.1159/000533797. Epub 2023 Sep 4.,Shim SS,Neurodegener Dis,2023,04-09-2023,,,10.1159/000533797
37663597,Risk of neurodegenerative disease or dementia in adults with attention-deficit/hyperactivity disorder: a systematic review,"Becker S, Chowdhury M, Tavilsup P, Seitz D, Callahan BL.",Front Psychiatry. 2023 Aug 17;14:1158546. doi: 10.3389/fpsyt.2023.1158546. eCollection 2023.,Becker S,Front Psychiatry,2023,04-09-2023,PMC10469775,,10.3389/fpsyt.2023.1158546
37662616,"Antibody-Mediated Clearance of Brain Amyloid-β: Mechanisms of Action, Effects of Natural and Monoclonal Anti-Aβ Antibodies, and Downstream Effects",Loeffler DA.,J Alzheimers Dis Rep. 2023 Aug 14;7(1):873-899. doi: 10.3233/ADR-230025. eCollection 2023.,Loeffler DA,J Alzheimers Dis Rep,2023,04-09-2023,PMC10473157,,10.3233/ADR-230025
37659206,Exploring the therapeutic potential of natural compounds for Alzheimer's disease: Mechanisms of action and pharmacological properties,"Liu J, Li T, Zhong G, Pan Y, Gao M, Su S, Liang Y, Ma C, Liu Y, Wang Q, Shi Q.",Biomed Pharmacother. 2023 Oct;166:115406. doi: 10.1016/j.biopha.2023.115406. Epub 2023 Sep 4.,Liu J,Biomed Pharmacother,2023,02-09-2023,,,10.1016/j.biopha.2023.115406
37657939,Association of Plasma Phosphorylated Tau With the Response to Neflamapimod Treatment in Patients With Dementia With Lewy Bodies,"Alam JJ, Maruff P, Doctrow SR, Chu HM, Conway J, Gomperts SN, Teunissen C.",Neurology. 2023 Oct 24;101(17):e1708-e1717. doi: 10.1212/WNL.0000000000207755. Epub 2023 Sep 1.,Alam JJ,Neurology,2023,01-09-2023,PMC10624490,,10.1212/WNL.0000000000207755
37646225,Recombinant Antibody Fragments for Neurological Disorders: An Update,"Manoutcharian K, Gevorkian G.",Curr Neuropharmacol. 2024;22(13):2157-2167. doi: 10.2174/1570159X21666230830142554.,Manoutcharian K,Curr Neuropharmacol,2024,30-08-2023,PMC11337690,,10.2174/1570159X21666230830142554
37643887,Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants With Mild-to-Moderate Alzheimer Disease: Lauriet,"Monteiro C, Toth B, Brunstein F, Bobbala A, Datta S, Ceniceros R, Sanabria Bohorquez SM, Anania VG, Wildsmith KR, Schauer SP, Lee J, Dolton MJ, Ramakrishnan V, Abramzon D, Teng E; Lauriet investigators.",Neurology. 2023 Oct 3;101(14):e1391-e1401. doi: 10.1212/WNL.0000000000207663. Epub 2023 Aug 29.,Monteiro C,Neurology,2023,29-08-2023,PMC10573141,,10.1212/WNL.0000000000207663
37641484,Sex differences in the association between tau PET and cognitive performance in a non-Hispanic White cohort with preclinical AD,"Wang X, Sundermann EE, Buckley RF, Banks SJ; A4 Study Team.",Alzheimers Dement. 2024 Jan;20(1):25-33. doi: 10.1002/alz.13432. Epub 2023 Aug 28.,Wang X,Alzheimers Dement,2024,29-08-2023,PMC10916995,,10.1002/alz.13432
37639488,Management of neuropsychiatric symptoms in dementia,Devanand DP.,Curr Opin Neurol. 2023 Oct 1;36(5):498-503. doi: 10.1097/WCO.0000000000001199. Epub 2023 Aug 7.,Devanand DP,Curr Opin Neurol,2023,28-08-2023,PMC10529332,NIHMS1921134,10.1097/WCO.0000000000001199
37628821,Antiseizure Medications in Alzheimer's Disease from Preclinical to Clinical Evidence,"Bosco F, Guarnieri L, Rania V, Palma E, Citraro R, Corasaniti MT, Leo A, De Sarro G.",Int J Mol Sci. 2023 Aug 10;24(16):12639. doi: 10.3390/ijms241612639.,Bosco F,Int J Mol Sci,2023,26-08-2023,PMC10454935,,10.3390/ijms241612639
37625524,Sensory gamma entrainment: Impact on amyloid protein and therapeutic mechanism,"Hu J, Zheng L, Guan Z, Zhong K, Huang F, Huang Q, Yang J, Li W, Li S.",Brain Res Bull. 2023 Oct 1;202:110750. doi: 10.1016/j.brainresbull.2023.110750. Epub 2023 Aug 23.,Hu J,Brain Res Bull,2023,25-08-2023,,,10.1016/j.brainresbull.2023.110750
37624998,Feasibility of Telehealth Occupational Therapy for Behavioral Symptoms of Adults With Dementia: Randomized Controlled Trial,"Rhodus EK, Baum C, Kryscio R, Liu C, George R, Thompson M, Lowry K, Coy B, Barber J, Nichols H, Curtis A, Holloman A, Jicha GA.",Am J Occup Ther. 2023 Jul 1;77(4):7704205010. doi: 10.5014/ajot.2023.050124.,Rhodus EK,Am J Occup Ther,2023,25-08-2023,PMC10494967,,10.5014/ajot.2023.050124
37624129,Effects of Exercise on Quality of Life in Subjects with Alzheimer's Disease: Systematic Review with Meta-Analysis of Randomized Clinical Trials,"Mendes M, Correia É, Vitorino A, Rodrigues J, Cid L, Bento T, Antunes R, Monteiro D, Couto N.",Sports (Basel). 2023 Aug 9;11(8):149. doi: 10.3390/sports11080149.,Mendes M,Sports (Basel),2023,25-08-2023,PMC10457886,,10.3390/sports11080149
37606550,Updates on pharmacological treatment for Alzheimer's disease,Tipton PW.,Neurol Neurochir Pol. 2024;58(2):150-160. doi: 10.5603/pjnns.96286. Epub 2023 Aug 22.,Tipton PW,Neurol Neurochir Pol,2024,22-08-2023,,,10.5603/pjnns.96286
37593850,Acoustic stimulation as a promising technique to enhance slow-wave sleep in Alzheimer's disease: results of a pilot study,"Van den Bulcke L, Peeters AM, Heremans E, Davidoff H, Borzée P, De Vos M, Emsell L, Van den Stock J, De Roo M, Tournoy J, Buyse B, Vandenbulcke M, Van Audenhove C, Testelmans D, Van Den Bossche M.",J Clin Sleep Med. 2023 Dec 1;19(12):2107-2112. doi: 10.5664/jcsm.10778.,Van den Bulcke L,J Clin Sleep Med,2023,18-08-2023,PMC10692948,,10.5664/jcsm.10778
37592310,Relationship between brain iron dynamics and blood-brain barrier function during childhood: a quantitative magnetic resonance imaging study,"Uchida Y, Kan H, Furukawa G, Onda K, Sakurai K, Takada K, Matsukawa N, Oishi K.",Fluids Barriers CNS. 2023 Aug 17;20(1):60. doi: 10.1186/s12987-023-00464-x.,Uchida Y,Fluids Barriers CNS,2023,17-08-2023,PMC10433620,,10.1186/s12987-023-00464-x
37592293,A systematic review of the safety and efficacy on cognitive function of herbal and nutritional medicines in older adults with and without subjective cognitive impairment,"Cave AE, Chang DH, Münch GW, Steiner-Lim GZ.",Syst Rev. 2023 Aug 17;12(1):143. doi: 10.1186/s13643-023-02301-6.,Cave AE,Syst Rev,2023,17-08-2023,PMC10433666,,10.1186/s13643-023-02301-6
37587767,Artificial intelligence for dementia drug discovery and trials optimization,"Doherty T, Yao Z, Khleifat AAL, Tantiangco H, Tamburin S, Albertyn C, Thakur L, Llewellyn DJ, Oxtoby NP, Lourida I; Deep Dementia Phenotyping (DEMON) Network; Ranson JM, Duce JA.",Alzheimers Dement. 2023 Dec;19(12):5922-5933. doi: 10.1002/alz.13428. Epub 2023 Aug 16.,Doherty T,Alzheimers Dement,2023,17-08-2023,,,10.1002/alz.13428
37586651,Glutamine metabolism in diseases associated with mitochondrial dysfunction,"Bornstein R, Mulholland MT, Sedensky M, Morgan P, Johnson SC.",Mol Cell Neurosci. 2023 Sep;126:103887. doi: 10.1016/j.mcn.2023.103887. Epub 2023 Aug 15.,Bornstein R,Mol Cell Neurosci,2023,16-08-2023,PMC10773532,NIHMS1956329,10.1016/j.mcn.2023.103887
37575992,Uric acid and glaucoma: a systematic review and meta-analysis,"Mohammadi M, Yarmohammadi A, Salehi-Abargouei A, Ghasemirad H, Shirvani M, Ghoshouni H.",Front Med (Lausanne). 2023 Jul 28;10:1159316. doi: 10.3389/fmed.2023.1159316. eCollection 2023.,Mohammadi M,Front Med (Lausanne),2023,14-08-2023,PMC10422028,,10.3389/fmed.2023.1159316
37571391,Polyphenols and Their Impact on the Prevention of Neurodegenerative Diseases and Development,"Grabska-Kobyłecka I, Szpakowski P, Król A, Książek-Winiarek D, Kobyłecki A, Głąbiński A, Nowak D.",Nutrients. 2023 Aug 4;15(15):3454. doi: 10.3390/nu15153454.,Grabska-Kobyłecka I,Nutrients,2023,12-08-2023,PMC10420887,,10.3390/nu15153454
37571363,The Effects of Andrographis paniculata (Burm.F.) Wall. Ex Nees and Andrographolide on Neuroinflammation in the Treatment of Neurodegenerative Diseases,"Bosco F, Ruga S, Citraro R, Leo A, Guarnieri L, Maiuolo J, Oppedisano F, Macrì R, Scarano F, Nucera S, Bava I, Palma E, Muscoli C, Hancke J, De Sarro G, Mollace V.",Nutrients. 2023 Aug 2;15(15):3428. doi: 10.3390/nu15153428.,Bosco F,Nutrients,2023,12-08-2023,PMC10421033,,10.3390/nu15153428
37570794,Neurological Applications of Celery (Apium graveolens): A Scoping Review,"Tan TYC, Lim XY, Norahmad NA, Chanthira Kumar H, Teh BP, Lai NM, Syed Mohamed AF.",Molecules. 2023 Aug 2;28(15):5824. doi: 10.3390/molecules28155824.,Tan TYC,Molecules,2023,12-08-2023,PMC10420906,,10.3390/molecules28155824
37570686,American Ginseng for the Treatment of Alzheimer's Disease: A Review,"Shan M, Bai Y, Fang X, Lan X, Zhang Y, Cao Y, Zhu D, Luo H.",Molecules. 2023 Jul 28;28(15):5716. doi: 10.3390/molecules28155716.,Shan M,Molecules,2023,12-08-2023,PMC10420665,,10.3390/molecules28155716
37570596,Apitherapy in Post-Ischemic Brain Neurodegeneration of Alzheimer's Disease Proteinopathy: Focus on Honey and Its Flavonoids and Phenolic Acids,"Pluta R, Miziak B, Czuczwar SJ.",Molecules. 2023 Jul 25;28(15):5624. doi: 10.3390/molecules28155624.,Pluta R,Molecules,2023,12-08-2023,PMC10420307,,10.3390/molecules28155624
37569888,A Brief Review on the Potential of Psychedelics for Treating Alzheimer's Disease and Related Depression,"Pilozzi A, Foster S, Mischoulon D, Fava M, Huang X.",Int J Mol Sci. 2023 Aug 7;24(15):12513. doi: 10.3390/ijms241512513.,Pilozzi A,Int J Mol Sci,2023,12-08-2023,PMC10419627,,10.3390/ijms241512513
37569871,Roles of Non-Coding RNA in Alzheimer's Disease Pathophysiology,"Olufunmilayo EO, Holsinger RMD.",Int J Mol Sci. 2023 Aug 6;24(15):12498. doi: 10.3390/ijms241512498.,Olufunmilayo EO,Int J Mol Sci,2023,12-08-2023,PMC10420049,,10.3390/ijms241512498
37569861,Exploring Molecular Targets for Mitochondrial Therapies in Neurodegenerative Diseases,"Plascencia-Villa G, Perry G.",Int J Mol Sci. 2023 Aug 6;24(15):12486. doi: 10.3390/ijms241512486.,Plascencia-Villa G,Int J Mol Sci,2023,12-08-2023,PMC10419704,,10.3390/ijms241512486
37569669,Phenolic Compounds of Rhodiola rosea L. as the Potential Alternative Therapy in the Treatment of Chronic Diseases,"Bernatoniene J, Jakstas V, Kopustinskiene DM.",Int J Mol Sci. 2023 Jul 31;24(15):12293. doi: 10.3390/ijms241512293.,Bernatoniene J,Int J Mol Sci,2023,12-08-2023,PMC10418374,,10.3390/ijms241512293
37561556,Oxidative Stress Occurs Prior to Amyloid Aβ Plaque Formation and Tau Phosphorylation in Alzheimer's Disease: Role of Glutathione and Metal Ions,"Roy RG, Mandal PK, Maroon JC.",ACS Chem Neurosci. 2023 Sep 6;14(17):2944-2954. doi: 10.1021/acschemneuro.3c00486. Epub 2023 Aug 10.,Roy RG,ACS Chem Neurosci,2023,10-08-2023,PMC10485904,,10.1021/acschemneuro.3c00486
37558161,Physical activity and amyloid beta in middle-aged and older adults: A systematic review and meta-analysis,"Rodriguez-Ayllon M, Solis-Urra P, Arroyo-Ávila C, Álvarez-Ortega M, Molina-García P, Molina-Hidalgo C, Gómez-Río M, Brown B, Erickson KI, Esteban-Cornejo I.",J Sport Health Sci. 2024 Mar;13(2):133-144. doi: 10.1016/j.jshs.2023.08.001. Epub 2023 Aug 7.,Rodriguez-Ayllon M,J Sport Health Sci,2024,09-08-2023,PMC10980893,,10.1016/j.jshs.2023.08.001
37549216,Dance movement therapy for dementia,"Karkou V, Aithal S, Richards M, Hiley E, Meekums B.",Cochrane Database Syst Rev. 2023 Aug 7;8(8):CD011022. doi: 10.1002/14651858.CD011022.pub3.,Karkou V,Cochrane Database Syst Rev,2023,07-08-2023,PMC10405778,,10.1002/14651858.CD011022.pub3
37545728,Increased risk of dementia among people with a history of fractures: a systematic review and meta-analysis of population-based studies,"Su L, Liao Y, Liu X, Xie X, Li Y.",Front Neurol. 2023 Jul 20;14:1185721. doi: 10.3389/fneur.2023.1185721. eCollection 2023.,Su L,Front Neurol,2023,07-08-2023,PMC10400716,,10.3389/fneur.2023.1185721
37528850,Transcranial magnetic stimulation effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease: a systematic review and meta-analysis,"Yan Y, Tian M, Wang T, Wang X, Wang Y, Shi J.",Front Neurol. 2023 Jul 17;14:1209205. doi: 10.3389/fneur.2023.1209205. eCollection 2023.,Yan Y,Front Neurol,2023,02-08-2023,PMC10389278,,10.3389/fneur.2023.1209205
37526325,Does repetitive transcranial magnetic stimulation improve cognitive function in age-related neurodegenerative diseases? A systematic review and meta-analysis,"Miller A, Allen RJ, Juma AA, Chowdhury R, Burke MR.",Int J Geriatr Psychiatry. 2023 Aug;38(8):e5974. doi: 10.1002/gps.5974.,Miller A,Int J Geriatr Psychiatry,2023,01-08-2023,,,10.1002/gps.5974
37516827,The impact of neck pain on gait health: a systematic review and meta-analysis,"Burton W, Ma Y, Manor B, Hausdorff JM, Kowalski MH, Bain PA, Wayne PM.",BMC Musculoskelet Disord. 2023 Jul 29;24(1):618. doi: 10.1186/s12891-023-06721-2.,Burton W,BMC Musculoskelet Disord,2023,29-07-2023,PMC10385921,,10.1186/s12891-023-06721-2
37511539,Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges,"Kong AH, Wu AJ, Ho OK, Leung MM, Huang AS, Yu Y, Zhang G, Lyu A, Li M, Cheung KH.",Int J Mol Sci. 2023 Jul 22;24(14):11780. doi: 10.3390/ijms241411780.,Kong AH,Int J Mol Sci,2023,29-07-2023,PMC10380291,,10.3390/ijms241411780
37511207,Repositioning of Anti-Diabetic Drugs against Dementia: Insight from Molecular Perspectives to Clinical Trials,"Mantik KEK, Kim S, Gu B, Moon S, Kwak HB, Park DH, Kang JH.",Int J Mol Sci. 2023 Jul 14;24(14):11450. doi: 10.3390/ijms241411450.,Mantik KEK,Int J Mol Sci,2023,29-07-2023,PMC10380685,,10.3390/ijms241411450
37511061,Potential Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Cognitive Decline and Dementia in Diabetes Mellitus,"Pelle MC, Zaffina I, Giofrè F, Pujia R, Arturi F.",Int J Mol Sci. 2023 Jul 11;24(14):11301. doi: 10.3390/ijms241411301.,Pelle MC,Int J Mol Sci,2023,29-07-2023,PMC10379573,,10.3390/ijms241411301
37511056,Synthetic Thioesters of Thiamine: Promising Tools for Slowing Progression of Neurodegenerative Diseases,Bettendorff L.,Int J Mol Sci. 2023 Jul 10;24(14):11296. doi: 10.3390/ijms241411296.,Bettendorff L,Int J Mol Sci,2023,29-07-2023,PMC10379298,,10.3390/ijms241411296
37511037,Targeting Protein Aggregates with Natural Products: An Optional Strategy for Neurodegenerative Diseases,"Xiang L, Wang Y, Liu S, Liu B, Jin X, Cao X.",Int J Mol Sci. 2023 Jul 10;24(14):11275. doi: 10.3390/ijms241411275.,Xiang L,Int J Mol Sci,2023,29-07-2023,PMC10379780,,10.3390/ijms241411275
37508993,A Systematic Review of Pharmacological Interventions for Apathy in Aging Neurocognitive Disorders,"Theleritis C, Siarkos K, Politis A, Smyrnis N, Papageorgiou C, Politis AM.",Brain Sci. 2023 Jul 12;13(7):1061. doi: 10.3390/brainsci13071061.,Theleritis C,Brain Sci,2023,29-07-2023,PMC10377475,,10.3390/brainsci13071061
37508913,The Impact of Dance Movement Interventions on Psychological Health in Older Adults without Dementia: A Systematic Review and Meta-Analysis,"Podolski OS, Whitfield T, Schaaf L, Cornaro C, Köbe T, Koch S, Wirth M.",Brain Sci. 2023 Jun 22;13(7):981. doi: 10.3390/brainsci13070981.,Podolski OS,Brain Sci,2023,29-07-2023,PMC10377702,,10.3390/brainsci13070981
37495380,Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology,"Ramanan VK, Armstrong MJ, Choudhury P, Coerver KA, Hamilton RH, Klein BC, Wolk DA, Wessels SR, Jones LK Jr; AAN Quality Committee.",Neurology. 2023 Nov 7;101(19):842-852. doi: 10.1212/WNL.0000000000207757. Epub 2023 Jul 26.,Ramanan VK,Neurology,2023,26-07-2023,PMC10663011,,10.1212/WNL.0000000000207757
37494786,"Kaempferol, a potential neuroprotective agent in neurodegenerative diseases: From chemistry to medicine","Jin S, Zhang L, Wang L.",Biomed Pharmacother. 2023 Sep;165:115215. doi: 10.1016/j.biopha.2023.115215. Epub 2023 Jul 24.,Jin S,Biomed Pharmacother,2023,26-07-2023,,,10.1016/j.biopha.2023.115215
37494038,Low-Dose Aspirin and the Risk of Stroke and Intracerebral Bleeding in Healthy Older People: Secondary Analysis of a Randomized Clinical Trial,"Cloud GC, Williamson JD, Thao LTP, Tran C, Eaton CB, Wolfe R, Nelson MR, Reid CM, Newman AB, Lockery J, Fitzgerald SM, Murray AM, Shah RC, Woods RL, Donnan GA, McNeil JJ.",JAMA Netw Open. 2023 Jul 3;6(7):e2325803. doi: 10.1001/jamanetworkopen.2023.25803.,Cloud GC,JAMA Netw Open,2023,26-07-2023,PMC10372701,,10.1001/jamanetworkopen.2023.25803
37490246,Intersectionality in Alzheimer's Disease: The Role of Female Sex and Black American Race in the Development and Prevalence of Alzheimer's Disease,"Misiura MB, Butts B, Hammerschlag B, Munkombwe C, Bird A, Fyffe M, Hemphill A, Dotson VM, Wharton W.",Neurotherapeutics. 2023 Jul;20(4):1019-1036. doi: 10.1007/s13311-023-01408-x. Epub 2023 Jul 25.,Misiura MB,Neurotherapeutics,2023,25-07-2023,PMC10457280,,10.1007/s13311-023-01408-x
37490245,Anti-Amyloid Immunotherapies for Alzheimer's Disease: A 2023 Clinical Update,"Yadollahikhales G, Rojas JC.",Neurotherapeutics. 2023 Jul;20(4):914-931. doi: 10.1007/s13311-023-01405-0. Epub 2023 Jul 25.,Yadollahikhales G,Neurotherapeutics,2023,25-07-2023,PMC10457266,,10.1007/s13311-023-01405-0
37489323,An Update on Apathy in Alzheimer's Disease,"Dolphin H, Dyer AH, McHale C, O'Dowd S, Kennelly SP.",Geriatrics (Basel). 2023 Jul 14;8(4):75. doi: 10.3390/geriatrics8040075.,Dolphin H,Geriatrics (Basel),2023,25-07-2023,PMC10366907,,10.3390/geriatrics8040075
37483927,"Effect of internet-based vs. in-person multimodal interventions on patients with mild to moderate Alzheimer's disease: a randomized, cross-over, open-label trial","Jung YH, Park SC, Lee JH, Kim MJ, Lee S, Chung SJ, Moon JY, Choi YH, Ju J, Han HJ, Lee SY.",Front Public Health. 2023 Jul 7;11:1203201. doi: 10.3389/fpubh.2023.1203201. eCollection 2023.,Jung YH,Front Public Health,2023,24-07-2023,PMC10361252,,10.3389/fpubh.2023.1203201
37483326,Confirmed Synergy Between the ɛ4 Allele of Apolipoprotein E and the Variant K of Butyrylcholinesterase as a Risk Factor for Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Ratis RC, Dacoregio MI, Simão-Silva DP, Mateus RP, Machado LPB, Bonini JS, da Silva WCFN.",J Alzheimers Dis Rep. 2023 Jun 19;7(1):613-625. doi: 10.3233/ADR-220084. eCollection 2023.,Ratis RC,J Alzheimers Dis Rep,2023,24-07-2023,PMC10357125,,10.3233/ADR-220084
37483001,"Efficacy of Adjunctive Therapy with Zonisamide Versus Increased Dose of Levodopa for Motor Symptoms in Patients with Dementia with Lewy Bodies: The Randomized, Controlled, Non-Inferiority DUEL Study","Ikeda M, Mori E, Orimo S, Yamada T, Konishi O.",J Alzheimers Dis. 2023;95(1):251-264. doi: 10.3233/JAD-230335.,Ikeda M,J Alzheimers Dis,2023,24-07-2023,PMC10578290,,10.3233/JAD-230335
37482992,Impact of Yoga Versus Memory Enhancement Training on Hippocampal Connectivity in Older Women at Risk for Alzheimer's Disease,"Kilpatrick LA, Siddarth P, Krause-Sorio B, Milillo MM, Aguilar-Faustino Y, Ercoli L, Narr KL, Khalsa DS, Lavretsky H.",J Alzheimers Dis. 2023;95(1):149-159. doi: 10.3233/JAD-221159.,Kilpatrick LA,J Alzheimers Dis,2023,24-07-2023,PMC10578221,,10.3233/JAD-221159
37482773,The fructose survival hypothesis for obesity,"Johnson RJ, Lanaspa MA, Sanchez-Lozada LG, Tolan D, Nakagawa T, Ishimoto T, Andres-Hernando A, Rodriguez-Iturbe B, Stenvinkel P.",Philos Trans R Soc Lond B Biol Sci. 2023 Sep 11;378(1885):20220230. doi: 10.1098/rstb.2022.0230. Epub 2023 Jul 24.,Johnson RJ,Philos Trans R Soc Lond B Biol Sci,2023,24-07-2023,PMC10363705,,10.1098/rstb.2022.0230
37481573,Quantification of identifying cognitive impairment using olfactory-stimulated functional near-infrared spectroscopy with machine learning: a post hoc analysis of a diagnostic trial and validation of an external additional trial,"Kim J, Lee H, Lee J, Rhee SY, Shin JI, Lee SW, Cho W, Min C, Kwon R, Kim JG, Yon DK.",Alzheimers Res Ther. 2023 Jul 22;15(1):127. doi: 10.1186/s13195-023-01268-9.,Kim J,Alzheimers Res Ther,2023,22-07-2023,PMC10362671,,10.1186/s13195-023-01268-9
37478886,"Hearing intervention versus health education control to reduce cognitive decline in older adults with hearing loss in the USA (ACHIEVE): a multicentre, randomised controlled trial","Lin FR, Pike JR, Albert MS, Arnold M, Burgard S, Chisolm T, Couper D, Deal JA, Goman AM, Glynn NW, Gmelin T, Gravens-Mueller L, Hayden KM, Huang AR, Knopman D, Mitchell CM, Mosley T, Pankow JS, Reed NS, Sanchez V, Schrack JA, Windham BG, Coresh J; ACHIEVE Collaborative Research Group.",Lancet. 2023 Sep 2;402(10404):786-797. doi: 10.1016/S0140-6736(23)01406-X. Epub 2023 Jul 18.,Lin FR,Lancet,2023,21-07-2023,PMC10529382,NIHMS1920276,10.1016/S0140-6736(23)01406-X
37470978,Amyloid-Lowering Monoclonal Antibodies for the Treatment of Early Alzheimer's Disease,"Leisher S, Bohorquez A, Gay M, Garcia V, Jones R, Baldaranov D, Rafii MS.",CNS Drugs. 2023 Aug;37(8):671-677. doi: 10.1007/s40263-023-01021-8. Epub 2023 Jul 20.,Leisher S,CNS Drugs,2023,20-07-2023,PMC10439019,,10.1007/s40263-023-01021-8
37470678,Tailored Music Listening in Persons With Dementia: A Feasibility Randomized Clinical Trial,"Petrovsky DV, Bradt J, McPhillips MV, Sefcik JS, Gitlin LN, Hodgson NA.",Am J Alzheimers Dis Other Demen. 2023 Jan-Dec;38:15333175231186728. doi: 10.1177/15333175231186728.,Petrovsky DV,Am J Alzheimers Dis Other Demen,2023,20-07-2023,PMC10489003,NIHMS1923968,10.1177/15333175231186728
37469978,Expression and function of estrogen receptors and estrogen-related receptors in the brain and their association with Alzheimer's disease,"Sato K, Takayama KI, Inoue S.",Front Endocrinol (Lausanne). 2023 Jul 4;14:1220150. doi: 10.3389/fendo.2023.1220150. eCollection 2023.,Sato K,Front Endocrinol (Lausanne),2023,20-07-2023,PMC10352578,,10.3389/fendo.2023.1220150
37466280,Trial of the MIND Diet for Prevention of Cognitive Decline in Older Persons,"Barnes LL, Dhana K, Liu X, Carey VJ, Ventrelle J, Johnson K, Hollings CS, Bishop L, Laranjo N, Stubbs BJ, Reilly X, Agarwal P, Zhang S, Grodstein F, Tangney CC, Holland TM, Aggarwal NT, Arfanakis K, Morris MC, Sacks FM.",N Engl J Med. 2023 Aug 17;389(7):602-611. doi: 10.1056/NEJMoa2302368. Epub 2023 Jul 18.,Barnes LL,N Engl J Med,2023,19-07-2023,PMC10513737,NIHMS1925840,10.1056/NEJMoa2302368
37465125,Natural antioxidants that act against Alzheimer's disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action,"Sidiropoulou GA, Metaxas A, Kourti M.",Front Endocrinol (Lausanne). 2023 Jul 3;14:1217730. doi: 10.3389/fendo.2023.1217730. eCollection 2023.,Sidiropoulou GA,Front Endocrinol (Lausanne),2023,19-07-2023,PMC10351420,,10.3389/fendo.2023.1217730
37463839,"Cognitive prescriptions for reducing dementia risk factors among Black/African Americans: feasibility, acceptability, and preliminary efficacy","Fazeli PL, Hopkins C, Vance DE, Wadley V, Li P, Turan B, Wang DH, Bowen PG, Clay OJ.",Ethn Health. 2024 Jan;29(1):1-24. doi: 10.1080/13557858.2023.2231669. Epub 2023 Jul 18.,Fazeli PL,Ethn Health,2024,18-07-2023,PMC11232533,NIHMS1920926,10.1080/13557858.2023.2231669
37458272,Trial of Solanezumab in Preclinical Alzheimer's Disease,"Sperling RA, Donohue MC, Raman R, Rafii MS, Johnson K, Masters CL, van Dyck CH, Iwatsubo T, Marshall GA, Yaari R, Mancini M, Holdridge KC, Case M, Sims JR, Aisen PS; A4 Study Team.",N Engl J Med. 2023 Sep 21;389(12):1096-1107. doi: 10.1056/NEJMoa2305032. Epub 2023 Jul 17.,Sperling RA,N Engl J Med,2023,17-07-2023,PMC10559996,NIHMS1933000,10.1056/NEJMoa2305032
37451163,The potential of psychedelics for the treatment of Alzheimer's disease and related dementias,"Winkelman MJ, Szabo A, Frecska E.",Eur Neuropsychopharmacol. 2023 Nov;76:3-16. doi: 10.1016/j.euroneuro.2023.07.003. Epub 2023 Jul 12.,Winkelman MJ,Eur Neuropsychopharmacol,2023,14-07-2023,,,10.1016/j.euroneuro.2023.07.003
37450931,Alzheimer's Disease Puzzle: Delving into Pathogenesis Hypotheses,"Nasb M, Tao W, Chen N.",Aging Dis. 2024 Feb 1;15(1):43-73. doi: 10.14336/AD.2023.0608.,Nasb M,Aging Dis,2024,14-07-2023,PMC10796101,,10.14336/AD.2023.0608
37450489,Biomarker disclosure protocols in prodromal Alzheimer's disease clinical trials,"Rahman-Filipiak A, Bolton C, Grill JD, Rostamzadeh A, Chin N, Heidebrink J, Getz S, Fowler NR, Rosen A, Lingler J, Wijsman E, Clark L; Advisory Group on Risk Evidence Education in Dementia (AGREED).",Alzheimers Dement. 2023 Sep;19(9):4270-4275. doi: 10.1002/alz.13380. Epub 2023 Jul 14.,Rahman-Filipiak A,Alzheimers Dement,2023,14-07-2023,PMC10530125,NIHMS1917790,10.1002/alz.13380
37450303,Effects of Meditation Training and Non-Native Language Training on Cognition in Older Adults: A Secondary Analysis of a Randomized Clinical Trial,"Demnitz-King H, Requier F, Whitfield T, Schlosser M, Gonneaud J, Ware C, Barnhofer T, Coll-Padros N, Dautricourt S, Delarue M, Klimecki OM, Paly L, Salmon E, Schild AK, Wirth M, Frison E, Lutz A, Chételat G, Collette F, Marchant NL; Medit-Ageing Research Group.",JAMA Netw Open. 2023 Jul 3;6(7):e2317848. doi: 10.1001/jamanetworkopen.2023.17848.,Demnitz-King H,JAMA Netw Open,2023,14-07-2023,PMC10349342,,10.1001/jamanetworkopen.2023.17848
37449130,An update on stem cell and stem cell-derived extracellular vesicle-based therapy in the management of Alzheimer's disease,"Jeyaraman M, Rajendran RL, Muthu S, Jeyaraman N, Sharma S, Jha SK, Muthukanagaraj P, Hong CM, Furtado da Fonseca L, Santos Duarte Lana JF, Ahn BC, Gangadaran P.",Heliyon. 2023 Jun 29;9(7):e17808. doi: 10.1016/j.heliyon.2023.e17808. eCollection 2023 Jul.,Jeyaraman M,Heliyon,2023,14-07-2023,PMC10336689,,10.1016/j.heliyon.2023.e17808
37447385,A Triterpenoid Lupeol as an Antioxidant and Anti-Neuroinflammatory Agent: Impacts on Oxidative Stress in Alzheimer's Disease,"Park JS, Rehman IU, Choe K, Ahmad R, Lee HJ, Kim MO.",Nutrients. 2023 Jul 7;15(13):3059. doi: 10.3390/nu15133059.,Park JS,Nutrients,2023,14-07-2023,PMC10347110,,10.3390/nu15133059
37446369,Vitamin E and Its Molecular Effects in Experimental Models of Neurodegenerative Diseases,"da Cunha Germano BC, de Morais LCC, Idalina Neta F, Fernandes ACL, Pinheiro FI, do Rego ACM, Araújo Filho I, de Azevedo EP, de Paiva Cavalcanti JRL, Guzen FP, Cobucci RN.",Int J Mol Sci. 2023 Jul 7;24(13):11191. doi: 10.3390/ijms241311191.,da Cunha Germano BC,Int J Mol Sci,2023,14-07-2023,PMC10342514,,10.3390/ijms241311191
37446262,From the Bush to the Brain: Preclinical Stages of Ethnobotanical Anti-Inflammatory and Neuroprotective Drug Discovery-An Australian Example,"Kumar P, Mathew S, Gamage R, Bodkin F, Doyle K, Rossetti I, Wagnon I, Zhou X, Raju R, Gyengesi E, Münch G.",Int J Mol Sci. 2023 Jul 4;24(13):11086. doi: 10.3390/ijms241311086.,Kumar P,Int J Mol Sci,2023,14-07-2023,PMC10342267,,10.3390/ijms241311086
37445890,DHA/EPA (Omega-3) and LA/GLA (Omega-6) as Bioactive Molecules in Neurodegenerative Diseases,"Kousparou C, Fyrilla M, Stephanou A, Patrikios I.",Int J Mol Sci. 2023 Jun 27;24(13):10717. doi: 10.3390/ijms241310717.,Kousparou C,Int J Mol Sci,2023,14-07-2023,PMC10341783,,10.3390/ijms241310717
37445682,Therapeutic Candidates for Alzheimer's Disease: Saponins,"Zhang R, Zeng M, Zhang X, Zheng Y, Lv N, Wang L, Gan J, Li Y, Jiang X, Yang L.",Int J Mol Sci. 2023 Jun 22;24(13):10505. doi: 10.3390/ijms241310505.,Zhang R,Int J Mol Sci,2023,14-07-2023,PMC10341681,,10.3390/ijms241310505
37433768,Role of neuroinflammation in neurodegeneration development,"Zhang W, Xiao D, Mao Q, Xia H.",Signal Transduct Target Ther. 2023 Jul 12;8(1):267. doi: 10.1038/s41392-023-01486-5.,Zhang W,Signal Transduct Target Ther,2023,11-07-2023,PMC10336149,,10.1038/s41392-023-01486-5
37431284,Clinical characteristics of early-onset versus late-onset Alzheimer's disease: a systematic review and meta-analysis,"Seath P, Macedo-Orrego LE, Velayudhan L.",Int Psychogeriatr. 2024 Dec;36(12):1093-1109. doi: 10.1017/S1041610223000509. Epub 2023 Jul 11.,Seath P,Int Psychogeriatr,2024,11-07-2023,,,10.1017/S1041610223000509
37425610,Attempts to Develop Vaccines Against Alzheimer's Disease: A Systematic Review of Ongoing and Completed Vaccination Trials in Humans,"Thakur A, Bogati S, Pandey S.",Cureus. 2023 Jun 8;15(6):e40138. doi: 10.7759/cureus.40138. eCollection 2023 Jun.,Thakur A,Cureus,2023,10-07-2023,PMC10329479,,10.7759/cureus.40138
37423452,Affinity maturation of antibody fragments: A review encompassing the development from random approaches to computational rational optimization,"Li J, Kang G, Wang J, Yuan H, Wu Y, Meng S, Wang P, Zhang M, Wang Y, Feng Y, Huang H, de Marco A.",Int J Biol Macromol. 2023 Aug 30;247:125733. doi: 10.1016/j.ijbiomac.2023.125733. Epub 2023 Jul 7.,Li J,Int J Biol Macromol,2023,09-07-2023,,,10.1016/j.ijbiomac.2023.125733
37414155,Under the umbrella of depression and Alzheimer's disease physiopathology: Can cannabinoids be a dual-pleiotropic therapy?,"Fonseca C, Ettcheto M, Bicker J, Fernandes MJ, Falcão A, Camins A, Fortuna A.",Ageing Res Rev. 2023 Sep;90:101998. doi: 10.1016/j.arr.2023.101998. Epub 2023 Jul 5.,Fonseca C,Ageing Res Rev,2023,06-07-2023,,,10.1016/j.arr.2023.101998
37408664,Barriers and solutions to Alzheimer's disease clinical trial participation for Black Americans,"Savold J, Cole M, Thorpe RJ Jr.",Alzheimers Dement (N Y). 2023 Jul 4;9(3):e12402. doi: 10.1002/trc2.12402. eCollection 2023 Jul-Sep.,Savold J,Alzheimers Dement (N Y),2023,06-07-2023,PMC10318422,,10.1002/trc2.12402
37407386,"The association of increased body mass index on cardiorespiratory fitness, physical activity, and cognition in adults with down syndrome","Dodd D, Helsel B, Bodde AE, Danon JC, Sherman JR, Donnelly JE, Washburn RA, Ptomey LT.",Disabil Health J. 2023 Oct;16(4):101497. doi: 10.1016/j.dhjo.2023.101497. Epub 2023 Jun 16.,Dodd D,Disabil Health J,2023,05-07-2023,PMC10680094,NIHMS1942755,10.1016/j.dhjo.2023.101497
37400870,Extrasynaptic NMDA receptors in acute and chronic excitotoxicity: implications for preventive treatments of ischemic stroke and late-onset Alzheimer's disease,"Yu SP, Jiang MQ, Shim SS, Pourkhodadad S, Wei L.",Mol Neurodegener. 2023 Jul 3;18(1):43. doi: 10.1186/s13024-023-00636-1.,Yu SP,Mol Neurodegener,2023,03-07-2023,PMC10318843,,10.1186/s13024-023-00636-1
37397787,Metformin: A Review of Potential Mechanism and Therapeutic Utility Beyond Diabetes,"Dutta S, Shah RB, Singhal S, Dutta SB, Bansal S, Sinha S, Haque M.",Drug Des Devel Ther. 2023 Jun 26;17:1907-1932. doi: 10.2147/DDDT.S409373. eCollection 2023.,Dutta S,Drug Des Devel Ther,2023,03-07-2023,PMC10312383,,10.2147/DDDT.S409373
37392597,"Safety, tolerability, immunogenicity, and efficacy of UB-311 in participants with mild Alzheimer's disease: a randomised, double-blind, placebo-controlled, phase 2a study","Yu HJ, Dickson SP, Wang PN, Chiu MJ, Huang CC, Chang CC, Liu H, Hendrix SB, Dodart JC, Verma A, Wang CY, Cummings J.",EBioMedicine. 2023 Aug;94:104665. doi: 10.1016/j.ebiom.2023.104665. Epub 2023 Jun 29.,Yu HJ,EBioMedicine,2023,01-07-2023,PMC10338203,,10.1016/j.ebiom.2023.104665
37389428,Cognitive rehabilitation for people with mild to moderate dementia,"Kudlicka A, Martyr A, Bahar-Fuchs A, Sabates J, Woods B, Clare L.",Cochrane Database Syst Rev. 2023 Jun 29;6(6):CD013388. doi: 10.1002/14651858.CD013388.pub2.,Kudlicka A,Cochrane Database Syst Rev,2023,30-06-2023,PMC10310315,,10.1002/14651858.CD013388.pub2
37389302,Key questions for the evaluation of anti-amyloid immunotherapies for Alzheimer's disease,"Liu KY, Villain N, Ayton S, Ackley SF, Planche V, Howard R, Thambisetty M.",Brain Commun. 2023 Jun 2;5(3):fcad175. doi: 10.1093/braincomms/fcad175. eCollection 2023.,Liu KY,Brain Commun,2023,30-06-2023,PMC10306158,,10.1093/braincomms/fcad175
37387459,"Clinical trials in dementia with Lewy bodies: the evolving concept of co-pathologies, patient selection and biomarkers","Gibson LL, Abdelnour C, Chong J, Ballard C, Aarsland D.",Curr Opin Neurol. 2023 Aug 1;36(4):264-275. doi: 10.1097/WCO.0000000000001173. Epub 2023 Jun 9.,Gibson LL,Curr Opin Neurol,2023,30-06-2023,PMC10328538,,10.1097/WCO.0000000000001173
37385457,Sex representation in neurodegenerative and psychiatric disorders' preclinical and clinical studies,"DuMont M, Agostinis A, Singh K, Swan E, Buttle Y, Tropea D.",Neurobiol Dis. 2023 Aug;184:106214. doi: 10.1016/j.nbd.2023.106214. Epub 2023 Jun 28.,DuMont M,Neurobiol Dis,2023,29-06-2023,,,10.1016/j.nbd.2023.106214
37380020,A non-pharmacological multi-modal therapy to improve sleep and cognition and reduce mild cognitive impairment risk: Design and methodology of a randomized clinical trial,"Emert SE, Taylor DJ, Gartenberg D, Schade MM, Roberts DM, Nagy SM, Russell M, Huskey A, Mueller M, Gamaldo A, Buxton OM.",Contemp Clin Trials. 2023 Sep;132:107275. doi: 10.1016/j.cct.2023.107275. Epub 2023 Jun 26.,Emert SE,Contemp Clin Trials,2023,28-06-2023,PMC11972623,NIHMS2061745,10.1016/j.cct.2023.107275
37379733,Protective effects of sleep duration and physical activity on cognitive performance are influenced by β-amyloid and brain volume but not tau burden among cognitively unimpaired older adults,"Aslanyan V, Ortega N, Fenton L, Harrison TM, Raman R, Mack WJ, Pa J.",Neuroimage Clin. 2023;39:103460. doi: 10.1016/j.nicl.2023.103460. Epub 2023 Jun 24.,Aslanyan V,Neuroimage Clin,2023,28-06-2023,PMC10316126,,10.1016/j.nicl.2023.103460
37379265,Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis,"Wu S, Stogios N, Hahn M, Navagnanavel J, Emami Z, Chintoh A, Gerretsen P, Graff-Guerrero A, Rajji TK, Remington G, Agarwal SM.",PLoS One. 2023 Jun 28;18(6):e0286887. doi: 10.1371/journal.pone.0286887. eCollection 2023.,Wu S,PLoS One,2023,28-06-2023,PMC10306194,,10.1371/journal.pone.0286887
37375352,Research Progress on Neuroprotective Effects of Isoquinoline Alkaloids,"Li J, Wu Y, Dong S, Yu Y, Wu Y, Xiang B, Li Q.",Molecules. 2023 Jun 16;28(12):4797. doi: 10.3390/molecules28124797.,Li J,Molecules,2023,28-06-2023,PMC10302352,,10.3390/molecules28124797
37373321,A Systematic Review of the Effects of Capsaicin on Alzheimer's Disease,"Inyang D, Saumtally T, Nnadi CN, Devi S, So PW.",Int J Mol Sci. 2023 Jun 15;24(12):10176. doi: 10.3390/ijms241210176.,Inyang D,Int J Mol Sci,2023,28-06-2023,PMC10299122,,10.3390/ijms241210176
37372995,Dementia in Diabetes: The Role of Hypoglycemia,"Husain KH, Sarhan SF, AlKhalifa HKAA, Buhasan A, Moin ASM, Butler AE.",Int J Mol Sci. 2023 Jun 7;24(12):9846. doi: 10.3390/ijms24129846.,Husain KH,Int J Mol Sci,2023,28-06-2023,PMC10298520,,10.3390/ijms24129846
37372013,Therapeutic Potential of Heterocyclic Compounds Targeting Mitochondrial Calcium Homeostasis and Signaling in Alzheimer's Disease and Parkinson's Disease,"Tapias V, González-Andrés P, Peña LF, Barbero A, Núñez L, Villalobos C.",Antioxidants (Basel). 2023 Jun 15;12(6):1282. doi: 10.3390/antiox12061282.,Tapias V,Antioxidants (Basel),2023,28-06-2023,PMC10294814,,10.3390/antiox12061282
37371547,Caffeine for Prevention of Alzheimer's Disease: Is the A(2A) Adenosine Receptor Its Target?,"Merighi S, Travagli A, Nigro M, Pasquini S, Cappello M, Contri C, Varani K, Vincenzi F, Borea PA, Gessi S.",Biomolecules. 2023 Jun 8;13(6):967. doi: 10.3390/biom13060967.,Merighi S,Biomolecules,2023,28-06-2023,PMC10296091,,10.3390/biom13060967
37371506,APOE Peripheral and Brain Impact: APOE4 Carriers Accelerate Their Alzheimer Continuum and Have a High Risk of Suicide in PM(2.5) Polluted Cities,"Calderón-Garcidueñas L, Hernández-Luna J, Aiello-Mora M, Brito-Aguilar R, Evelson PA, Villarreal-Ríos R, Torres-Jardón R, Ayala A, Mukherjee PS.",Biomolecules. 2023 May 31;13(6):927. doi: 10.3390/biom13060927.,Calderón-Garcidueñas L,Biomolecules,2023,28-06-2023,PMC10296707,,10.3390/biom13060927
37357520,"Naturally Occurring Cholinesterase Inhibitors from Plants, Fungi, Algae, and Animals: A Review of the Most Effective Inhibitors Reported in 2012-2022","Murray AP, Biscussi B, Cavallaro V, Donozo M, Rodriguez SA.",Curr Neuropharmacol. 2024;22(10):1621-1649. doi: 10.2174/1570159X21666230623105929.,Murray AP,Curr Neuropharmacol,2024,26-06-2023,PMC11284722,,10.2174/1570159X21666230623105929
37357285,"Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer's Prevention Trial: A global Perspective from the API Generation Program","Walsh T, Duff L, Riviere ME, Tariot PN, Doak K, Smith M, Borowsky B, Lopez Lopez C, Arratia PC, Liu F, Scholten I, Gordon D, Arbuckle J, Graf A, Quinn M, Ricart J, Langbaum JB.",J Prev Alzheimers Dis. 2023;10(3):453-463. doi: 10.14283/jpad.2023.27.,Walsh T,J Prev Alzheimers Dis,2023,25-06-2023,PMC10426731,NIHMS1918902,10.14283/jpad.2023.27
37355902,Race and Ethnicity in Lewy Body Dementia: A Narrative Review,"Bayram E, Holden SK, Fullard M, Armstrong MJ; Lewy Body Dementia Association Community Engagement Working Group.",J Alzheimers Dis. 2023;94(3):861-878. doi: 10.3233/JAD-230207.,Bayram E,J Alzheimers Dis,2023,25-06-2023,PMC10448838,NIHMS1913035,10.3233/JAD-230207
37355891,Observed Improvement in Cognition During a Personalized Lifestyle Intervention in People with Cognitive Decline,"Sandison H, Callan NGL, Rao RV, Phipps J, Bradley R.",J Alzheimers Dis. 2023;94(3):993-1004. doi: 10.3233/JAD-230004.,Sandison H,J Alzheimers Dis,2023,25-06-2023,PMC10473097,,10.3233/JAD-230004
37353809,Differential response to donepezil in MRI subtypes of mild cognitive impairment,"Diaz-Galvan P, Lorenzon G, Mohanty R, Mårtensson G, Cavedo E, Lista S, Vergallo A, Kantarci K, Hampel H, Dubois B, Grothe MJ, Ferreira D, Westman E.",Alzheimers Res Ther. 2023 Jun 23;15(1):117. doi: 10.1186/s13195-023-01253-2.,Diaz-Galvan P,Alzheimers Res Ther,2023,23-06-2023,PMC10288762,,10.1186/s13195-023-01253-2
37349974,The effects of noninvasive brain stimulation on cognitive function in patients with mild cognitive impairment and Alzheimer's disease using resting-state functional magnetic resonance imaging: A systematic review and meta-analysis,"Wang T, Yan S, Lu J.",CNS Neurosci Ther. 2023 Nov;29(11):3160-3172. doi: 10.1111/cns.14314. Epub 2023 Jun 22.,Wang T,CNS Neurosci Ther,2023,23-06-2023,PMC10580344,,10.1111/cns.14314
37343515,Clinical trials in vascular cognitive impairment following SPRINT-MIND: An international perspective,"Elahi FM, Alladi S, Black SE, Claassen JAHR, DeCarli C, Hughes TM, Moonen J, Pajewski NM, Price BR, Satizabal C, Shaaban CE, Silva NCBS, Snyder HM, Sveikata L, Williamson JD, Wolters FJ, Hainsworth AH.",Cell Rep Med. 2023 Jun 20;4(6):101089. doi: 10.1016/j.xcrm.2023.101089.,Elahi FM,Cell Rep Med,2023,21-06-2023,PMC10314118,,10.1016/j.xcrm.2023.101089
37341896,Turning the Spotlight to Cholinergic Pharmacotherapy of the Human Language System,"Dávila G, Torres-Prioris MJ, López-Barroso D, Berthier ML.",CNS Drugs. 2023 Jul;37(7):599-637. doi: 10.1007/s40263-023-01017-4. Epub 2023 Jun 21.,Dávila G,CNS Drugs,2023,21-06-2023,PMC10374790,,10.1007/s40263-023-01017-4
37339345,Metformin for Treatment of Acute COVID-19: Systematic Review of Clinical Trial Data Against SARS-CoV-2,"Erickson SM, Fenno SL, Barzilai N, Kuchel G, Bartley JM, Justice JN, Buse JB, Bramante CT.",Diabetes Care. 2023 Jul 1;46(7):1432-1442. doi: 10.2337/dc22-2539.,Erickson SM,Diabetes Care,2023,20-06-2023,PMC10300519,,10.2337/dc22-2539
37334618,Physical Exercise as a Potential Treatment for Fatigue in Parkinson's Disease? A Systematic Review and Meta-Analysis of Pharmacological and Non-Pharmacological Interventions,"Folkerts AK, Nielsen J, Gollan R, Lansu A, Solfronk D, Monsef I, Ernst M, Skoetz N, Zeuner KE, Kalbe E.",J Parkinsons Dis. 2023;13(5):659-679. doi: 10.3233/JPD-225116.,Folkerts AK,J Parkinsons Dis,2023,19-06-2023,PMC10473113,,10.3233/JPD-225116
37334374,Biologic drugs in the treatment of chronic inflammatory pulmonary diseases: recent developments and future perspectives,"Plichta J, Kuna P, Panek M.",Front Immunol. 2023 Jun 2;14:1207641. doi: 10.3389/fimmu.2023.1207641. eCollection 2023.,Plichta J,Front Immunol,2023,19-06-2023,PMC10272527,,10.3389/fimmu.2023.1207641
37332343,Mapping new pharmacological interventions for cognitive function in Alzheimer's disease: a systematic review of randomized clinical trials,"Xu Lou I, Chen J, Ali K, Shaikh AL, Chen Q.",Front Pharmacol. 2023 Jun 1;14:1190604. doi: 10.3389/fphar.2023.1190604. eCollection 2023.,Xu Lou I,Front Pharmacol,2023,19-06-2023,PMC10270324,,10.3389/fphar.2023.1190604
37328855,Ultrasound-mediated blood-brain barrier opening uncovers an intracerebral perivenous fluid network in persons with Alzheimer's disease,"Mehta RI, Carpenter JS, Mehta RI, Haut MW, Wang P, Ranjan M, Najib U, D'Haese PF, Rezai AR.",Fluids Barriers CNS. 2023 Jun 16;20(1):46. doi: 10.1186/s12987-023-00447-y.,Mehta RI,Fluids Barriers CNS,2023,16-06-2023,PMC10276371,,10.1186/s12987-023-00447-y
37328112,Antidiabetic agents as a novel treatment for Alzheimer's and Parkinson's disease,"Nowell J, Blunt E, Gupta D, Edison P.",Ageing Res Rev. 2023 Aug;89:101979. doi: 10.1016/j.arr.2023.101979. Epub 2023 Jun 14.,Nowell J,Ageing Res Rev,2023,16-06-2023,,,10.1016/j.arr.2023.101979
39081997,Hearing loss and its link to cognitive impairment and dementia,"Azeem A, Julleekeea A, Knight B, Sohail I, Bruyns-Haylett M, Sastre M.",Front Dement. 2023 Jun 15;2:1199319. doi: 10.3389/frdem.2023.1199319. eCollection 2023.,Azeem A,Front Dement,2023,31-07-2024,PMC11285555,,10.3389/frdem.2023.1199319
37313493,Effectiveness of Caregiver-Provided Individual Cognitive Interventions in Older Adults with Dementia,"Silva R, Bobrowicz-Campos E, Santos-Costa P, Cardoso R, Bernardo J, Santana E, Almeida I, Loureiro R, Cardoso D, Apóstolo J.",J Alzheimers Dis Rep. 2023 May 23;7(1):433-459. doi: 10.3233/ADR-220115. eCollection 2023.,Silva R,J Alzheimers Dis Rep,2023,14-06-2023,PMC10259075,,10.3233/ADR-220115
37313236,"Emerging Evidence for the Use of Antidiabetic Drugs, Glucagon-like Peptide 1 Receptor Agonists, for the Treatment of Alzheimer's Disease","Colin IM, Szczepanski LW, Gérard AC, Elosegi JA.",touchREV Endocrinol. 2023 May;19(1):16-24. doi: 10.17925/EE.2023.19.1.16. Epub 2023 May 23.,Colin IM,touchREV Endocrinol,2023,14-06-2023,PMC10258618,,10.17925/EE.2023.19.1.16
37308535,Disparity in the use of Alzheimer's disease treatment in Southern Brazil,"De Marco M, Brandi AL, Bieger A, Krug B, Camozzato A, Picon PD, Chaves MLF, Castilhos RM.",Sci Rep. 2023 Jun 12;13(1):9555. doi: 10.1038/s41598-023-36604-4.,De Marco M,Sci Rep,2023,12-06-2023,PMC10261112,,10.1038/s41598-023-36604-4
37302035,Micro- and Macronutrient Intake and Food Group Frequency Consumed by Subjects with Cognitive Impairment and Dementia in Latin America: A Systematic Review,"Garrido-Dzib AG, Chávez-Loría G, Magallón-Zertuche V, Avila-Nava A, Palacios-González B, Gutiérrez-Solis AL.",J Alzheimers Dis. 2023;94(2):425-439. doi: 10.3233/JAD-230231.,Garrido-Dzib AG,J Alzheimers Dis,2023,11-06-2023,PMC10357157,,10.3233/JAD-230231
37302021,Providing genetic testing and genetic counseling for Parkinson's disease to the community,"Cook L, Verbrugge J, Schwantes-An TH, Schulze J, Beck JC, Naito A, Hall A, Chan AK, Casaceli CJ, Marder K, Nance M, Schwarzschild MA, Simuni T, Wills AM, Alcalay RN; Parkinson’s Foundation and Parkinson's Study Group (PSG).",Genet Med. 2023 Oct;25(10):100907. doi: 10.1016/j.gim.2023.100907. Epub 2023 Jun 8.,Cook L,Genet Med,2023,11-06-2023,,,10.1016/j.gim.2023.100907
37299001,"Acorus tatarinowii Schott: A Review of Its Botany, Traditional Uses, Phytochemistry, and Pharmacology","Wang M, Tang HP, Wang S, Hu WJ, Li JY, Yu AQ, Bai QX, Yang BY, Kuang HX.",Molecules. 2023 Jun 2;28(11):4525. doi: 10.3390/molecules28114525.,Wang M,Molecules,2023,10-06-2023,PMC10254448,,10.3390/molecules28114525
37296934,Drug Repurposing in Oncology: A Systematic Review of Randomized Controlled Clinical Trials,"Ioakeim-Skoufa I, Tobajas-Ramos N, Menditto E, Aza-Pascual-Salcedo M, Gimeno-Miguel A, Orlando V, González-Rubio F, Fanlo-Villacampa A, Lasala-Aza C, Ostasz E, Vicente-Romero J.",Cancers (Basel). 2023 May 30;15(11):2972. doi: 10.3390/cancers15112972.,Ioakeim-Skoufa I,Cancers (Basel),2023,10-06-2023,PMC10251882,,10.3390/cancers15112972
37296599,Deep Brain Stimulation beyond the Clinic: Navigating the Future of Parkinson's and Alzheimer's Disease Therapy,"Senevirathne DKL, Mahboob A, Zhai K, Paul P, Kammen A, Lee DJ, Yousef MS, Chaari A.",Cells. 2023 May 25;12(11):1478. doi: 10.3390/cells12111478.,Senevirathne DKL,Cells,2023,10-06-2023,PMC10252401,,10.3390/cells12111478
37295957,Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift?,"Knopman DS, Hershey L.",Neurology. 2023 Oct 3;101(14):610-620. doi: 10.1212/WNL.0000000000207438. Epub 2023 Jun 9.,Knopman DS,Neurology,2023,09-06-2023,PMC10573150,,10.1212/WNL.0000000000207438
37293601,Exposure to Ionizing Radiation and Risk of Dementia: A Systematic Review and Meta-Analysis,"Srivastava T, Chirikova E, Birk S, Xiong F, Benzouak T, Liu JY, Villeneuve PJ, Zablotska LB.",Radiat Res. 2023 May;199(5):490-505. doi: 10.1667/rade-22-00153.1. Epub 2023 Mar 22.,Srivastava T,Radiat Res,2023,09-06-2023,PMC10249679,NIHMS1904357,10.1667/rade-22-00153.1
37284987,"Repurposing Niclosamide as a plausible neurotherapeutic in autism spectrum disorders, targeting mitochondrial dysfunction: a strong hypothesis","Varma M, Bhandari R, Kuhad A.",Metab Brain Dis. 2024 Mar;39(3):387-401. doi: 10.1007/s11011-023-01247-x. Epub 2023 Jun 7.,Varma M,Metab Brain Dis,2024,07-06-2023,PMC10957696,,10.1007/s11011-023-01247-x
37280110,"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","Hampel H, Elhage A, Cho M, Apostolova LG, Nicoll JAR, Atri A.",Brain. 2023 Nov 2;146(11):4414-4424. doi: 10.1093/brain/awad188.,Hampel H,Brain,2023,06-06-2023,PMC10629981,,10.1093/brain/awad188
37271721,Perioperative changes in neurocognitive and Alzheimer's disease-related cerebrospinal fluid biomarkers in older patients randomised to isoflurane or propofol for anaesthetic maintenance,"Villalobos D, Reese M, Wright MC, Wong M, Syed A, Park J, Hall A, Browndyke JN, Martucci KT, Devinney MJ, Acker L, Moretti EW, Talbot L, Colin B, Ohlendorf B, Waligorska T, Shaw LM, Whitson HE, Cohen HJ, Mathew JP, Berger M.",Br J Anaesth. 2023 Aug;131(2):328-337. doi: 10.1016/j.bja.2023.04.019. Epub 2023 Jun 2.,Villalobos D,Br J Anaesth,2023,04-06-2023,PMC10375507,,10.1016/j.bja.2023.04.019
37267668,Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): A systematic review with individual patients' data analysis,"Corniello C, Dono F, Evangelista G, Consoli S, De Angelis S, Cipollone S, Liviello D, Polito G, Melchiorre S, Russo M, Granzotto A, Anzellotti F, Onofrj M, Thomas A, Sensi SL.",Seizure. 2023 Jul;109:62-67. doi: 10.1016/j.seizure.2023.05.017. Epub 2023 May 21.,Corniello C,Seizure,2023,02-06-2023,,,10.1016/j.seizure.2023.05.017
37263875,[The controversy over early diagnosis of Alzheimer's disease: A literature review of the advantages and disadvantages],"Gräßel E, Lauer N.",Z Evid Fortbild Qual Gesundhwes. 2023 Jun;179:95-105. doi: 10.1016/j.zefq.2023.04.004. Epub 2023 May 30.,Gräßel E,Z Evid Fortbild Qual Gesundhwes,2023,01-06-2023,,,10.1016/j.zefq.2023.04.004
37261829,Patterns of Regional Brain Atrophy and Brain Aging in Middle- and Older-Aged Adults With Type 1 Diabetes,"Habes M, Jacobson AM, Braffett BH, Rashid T, Ryan CM, Shou H, Cui Y, Davatzikos C, Luchsinger JA, Biessels GJ, Bebu I, Gubitosi-Klug RA, Bryan RN, Nasrallah IM; DCCT/EDIC Research Group.",JAMA Netw Open. 2023 Jun 1;6(6):e2316182. doi: 10.1001/jamanetworkopen.2023.16182.,Habes M,JAMA Netw Open,2023,01-06-2023,PMC10236234,,10.1001/jamanetworkopen.2023.16182
37260849,Brain function effects of exercise interventions for cognitive decline: a systematic review and meta-analysis,"Karamacoska D, Butt A, Leung IHK, Childs RL, Metri NJ, Uruthiran V, Tan T, Sabag A, Steiner-Lim GZ.",Front Neurosci. 2023 May 16;17:1127065. doi: 10.3389/fnins.2023.1127065. eCollection 2023.,Karamacoska D,Front Neurosci,2023,01-06-2023,PMC10228832,,10.3389/fnins.2023.1127065
37259037,A systematic review and meta-analysis on the efficacy outcomes of selective serotonin reuptake inhibitors in depression in Alzheimer's disease,"Zhang J, Zheng X, Zhao Z.",BMC Neurol. 2023 May 31;23(1):210. doi: 10.1186/s12883-023-03191-w.,Zhang J,BMC Neurol,2023,31-05-2023,PMC10230772,,10.1186/s12883-023-03191-w
37252983,Dietary flavanols restore hippocampal-dependent memory in older adults with lower diet quality and lower habitual flavanol consumption,"Brickman AM, Yeung LK, Alschuler DM, Ottaviani JI, Kuhnle GGC, Sloan RP, Luttmann-Gibson H, Copeland T, Schroeter H, Sesso HD, Manson JE, Wall M, Small SA.",Proc Natl Acad Sci U S A. 2023 Jun 6;120(23):e2216932120. doi: 10.1073/pnas.2216932120. Epub 2023 May 30.,Brickman AM,Proc Natl Acad Sci U S A,2023,30-05-2023,PMC10265949,,10.1073/pnas.2216932120
37250908,Retinal imaging biomarkers of Alzheimer's disease: A systematic review and meta-analysis of studies using brain amyloid beta status for case definition,"Ashraf G, McGuinness M, Khan MA, Obtinalla C, Hadoux X, van Wijngaarden P.",Alzheimers Dement (Amst). 2023 May 25;15(2):e12421. doi: 10.1002/dad2.12421. eCollection 2023 Apr-Jun.,Ashraf G,Alzheimers Dement (Amst),2023,30-05-2023,PMC10210353,,10.1002/dad2.12421
37250469,Therapeutic Potential of Nanomedicine in Management of Alzheimer's Disease and Glioma,"Anwar F, Al-Abbasi FA, Naqvi S, Sheikh RA, Alhayyani S, Asseri AH, Asar TO, Kumar V.",Int J Nanomedicine. 2023 May 22;18:2737-2756. doi: 10.2147/IJN.S405454. eCollection 2023.,Anwar F,Int J Nanomedicine,2023,30-05-2023,PMC10211371,,10.2147/IJN.S405454
37248908,The Effects of Medium Chain Triglyceride for Alzheimer's Disease Related Cognitive Impairment: A Systematic Review and Meta-Analysis,"Sun L, Ye KX, Wong HLK, Wang L, Lim SL, Chao YX, Zhang C, Yap KZ, Feng L.",J Alzheimers Dis. 2023;94(2):441-456. doi: 10.3233/JAD-230406.,Sun L,J Alzheimers Dis,2023,30-05-2023,PMC10357178,,10.3233/JAD-230406
37248634,Does resveratrol improve cognition in humans? A scientometric study to an in-depth review,"Tu W, Song M, Fan X.",CNS Neurosci Ther. 2023 Sep;29(9):2413-2429. doi: 10.1111/cns.14276. Epub 2023 May 29.,Tu W,CNS Neurosci Ther,2023,30-05-2023,PMC10401104,,10.1111/cns.14276
37245842,Primary outcome from the augmenting cognitive training in older adults study (ACT): A tDCS and cognitive training randomized clinical trial,"Hausman HK, Alexander GE, Cohen R, Marsiske M, DeKosky ST, Hishaw GA, O'Shea A, Kraft JN, Dai Y, Wu S, Woods AJ.",Brain Stimul. 2023 May-Jun;16(3):904-917. doi: 10.1016/j.brs.2023.05.021. Epub 2023 May 26.,Hausman HK,Brain Stimul,2023,28-05-2023,PMC10436327,NIHMS1920671,10.1016/j.brs.2023.05.021
37245533,A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk - Study rationale and design,"Davidy T, Yore I, Cukierman-Yaffe T, Ravona-Springer R, Livny A, Lesman-Segev OH, Azuri Y, Carmichael O, Kapogiannis D, Zetterberg H, Lin H, Sano M, Beeri MS.",Mech Ageing Dev. 2023 Jul;213:111825. doi: 10.1016/j.mad.2023.111825. Epub 2023 May 26.,Davidy T,Mech Ageing Dev,2023,28-05-2023,PMC12120971,NIHMS1911951,10.1016/j.mad.2023.111825
37244993,Biometals in Alzheimer disease: emerging therapeutic and diagnostic potential of molybdenum and iodine,"Botchway BOA, Liu X, Zhou Y, Fang M.",J Transl Med. 2023 May 27;21(1):351. doi: 10.1186/s12967-023-04220-5.,Botchway BOA,J Transl Med,2023,27-05-2023,PMC10224607,,10.1186/s12967-023-04220-5
37244291,Multivitamin Supplementation Improves Memory in Older Adults: A Randomized Clinical Trial,"Yeung LK, Alschuler DM, Wall M, Luttmann-Gibson H, Copeland T, Hale C, Sloan RP, Sesso HD, Manson JE, Brickman AM.",Am J Clin Nutr. 2023 Jul;118(1):273-282. doi: 10.1016/j.ajcnut.2023.05.011. Epub 2023 May 24.,Yeung LK,Am J Clin Nutr,2023,27-05-2023,PMC10375458,,10.1016/j.ajcnut.2023.05.011
37242153,The Relationship of Ketogenic Diet with Neurodegenerative and Psychiatric Diseases: A Scoping Review from Basic Research to Clinical Practice,"Mentzelou M, Dakanalis A, Vasios GK, Gialeli M, Papadopoulou SK, Giaginis C.",Nutrients. 2023 May 11;15(10):2270. doi: 10.3390/nu15102270.,Mentzelou M,Nutrients,2023,27-05-2023,PMC10220548,,10.3390/nu15102270
37240173,Natural Products as the Potential to Improve Alzheimer's and Parkinson's Disease,"Kim SW, Lee JH, Kim B, Yang G, Kim JU.",Int J Mol Sci. 2023 May 16;24(10):8827. doi: 10.3390/ijms24108827.,Kim SW,Int J Mol Sci,2023,27-05-2023,PMC10218422,,10.3390/ijms24108827
37239057,Dimethyl Fumarate as Potential Treatment for Alzheimer's Disease: Rationale and Clinical Trial Design,"Sharkus R, Thakkar R, Kolson DL, Constantinescu CS.",Biomedicines. 2023 May 8;11(5):1387. doi: 10.3390/biomedicines11051387.,Sharkus R,Biomedicines,2023,27-05-2023,PMC10216730,,10.3390/biomedicines11051387
37238617,A New Generation of IMiDs as Treatments for Neuroinflammatory and Neurodegenerative Disorders,"Kopp KO, Greer ME, Glotfelty EJ, Hsueh SC, Tweedie D, Kim DS, Reale M, Vargesson N, Greig NH.",Biomolecules. 2023 Apr 26;13(5):747. doi: 10.3390/biom13050747.,Kopp KO,Biomolecules,2023,27-05-2023,PMC10216254,,10.3390/biom13050747
37231200,Effects of GLP-1 receptor agonists on neurological complications of diabetes,"García-Casares N, González-González G, de la Cruz-Cosme C, Garzón-Maldonado FJ, de Rojas-Leal C, Ariza MJ, Narváez M, Barbancho MÁ, García-Arnés JA, Tinahones FJ.",Rev Endocr Metab Disord. 2023 Aug;24(4):655-672. doi: 10.1007/s11154-023-09807-3. Epub 2023 May 26.,García-Casares N,Rev Endocr Metab Disord,2023,25-05-2023,PMC10404567,,10.1007/s11154-023-09807-3
37226162,Avoiding future controversies in the Alzheimer's disease space through understanding the aducanumab data and FDA review,"Dickson SP, Hennessey S, Nicodemus Johnson J, Knowlton N, Hendrix SB.",Alzheimers Res Ther. 2023 May 24;15(1):98. doi: 10.1186/s13195-023-01238-1.,Dickson SP,Alzheimers Res Ther,2023,24-05-2023,PMC10207692,,10.1186/s13195-023-01238-1
37224131,Gut microbiome dysbiosis in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis,"Jemimah S, Chabib CMM, Hadjileontiadis L, AlShehhi A.",PLoS One. 2023 May 24;18(5):e0285346. doi: 10.1371/journal.pone.0285346. eCollection 2023.,Jemimah S,PLoS One,2023,24-05-2023,PMC10208513,,10.1371/journal.pone.0285346
37222252,Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease: The Lacunar Intervention Trial-2 (LACI-2) Randomized Clinical Trial,"Wardlaw JM, Woodhouse LJ, Mhlanga II, Oatey K, Heye AK, Bamford J, Cvoro V, Doubal FN, England T, Hassan A, Montgomery A, O'Brien JT, Roffe C, Sprigg N, Werring DJ, Bath PM; Lacunar Intervention Trial-2 (LACI-2) Investigator Group.",JAMA Neurol. 2023 Jul 1;80(7):682-692. doi: 10.1001/jamaneurol.2023.1526.,Wardlaw JM,JAMA Neurol,2023,24-05-2023,PMC10209826,,10.1001/jamaneurol.2023.1526
37220880,Music Therapy Increases Social and Emotional Well-Being in Persons With Dementia: A Randomized Clinical Crossover Trial Comparing Singing to Verbal Discussion,"Reschke-Hernández AE, Gfeller K, Oleson J, Tranel D.",J Music Ther. 2023 Oct 7;60(3):314-342. doi: 10.1093/jmt/thad015.,Reschke-Hernández AE,J Music Ther,2023,23-05-2023,PMC10560009,,10.1093/jmt/thad015
37217854,Frameworks for estimating causal effects in observational settings: comparing confounder adjustment and instrumental variables,"Zawadzki RS, Grill JD, Gillen DL; Alzheimer’s Disease Neuroimaging Initiative.",BMC Med Res Methodol. 2023 May 22;23(1):122. doi: 10.1186/s12874-023-01936-2.,Zawadzki RS,BMC Med Res Methodol,2023,22-05-2023,PMC10201752,,10.1186/s12874-023-01936-2
37214392,Effect of nutrition in Alzheimer's disease: A systematic review,"Xu Lou I, Ali K, Chen Q.",Front Neurosci. 2023 May 4;17:1147177. doi: 10.3389/fnins.2023.1147177. eCollection 2023.,Xu Lou I,Front Neurosci,2023,22-05-2023,PMC10194838,,10.3389/fnins.2023.1147177
37213538,Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials,"Qiao Y, Chi Y, Zhang Q, Ma Y.",Front Aging Neurosci. 2023 May 5;15:1169499. doi: 10.3389/fnagi.2023.1169499. eCollection 2023.,Qiao Y,Front Aging Neurosci,2023,22-05-2023,PMC10196238,,10.3389/fnagi.2023.1169499
37212116,Pilot Study of Second-Generation DNA Methylation Epigenetic Markers in Relation to Cognitive and Neuropsychiatric Symptoms in Older Adults,"Vyas CM, Sadreyev RI, Gatchel JR, Kang JH, Reynolds CF, Mischoulon D, Chang G, Hazra A, Manson JE, Blacker D, De Vivo I, Okereke OI.",J Alzheimers Dis. 2023;93(4):1563-1575. doi: 10.3233/JAD-230093.,Vyas CM,J Alzheimers Dis,2023,22-05-2023,PMC10336852,NIHMS1913741,10.3233/JAD-230093
37212108,Efficacy of a Mobile-Based Multidomain Intervention to Improve Cognitive Function and Health-Related Outcomes Among Older Korean Adults with Subjective Cognitive Decline,"Lee J, Kim J, Park A, Hong RK, Ko M, Heo M, Kim H, Chung JY.",J Alzheimers Dis. 2023;93(4):1551-1562. doi: 10.3233/JAD-221299.,Lee J,J Alzheimers Dis,2023,22-05-2023,PMC10357136,,10.3233/JAD-221299
37212107,miRNAs and Stem Cells as Promising Diagnostic and Therapeutic Targets for Alzheimer's Disease,"Elzayat EM, Shahien SA, El-Sherif AA, Hosney M.",J Alzheimers Dis. 2023;94(s1):S203-S225. doi: 10.3233/JAD-221298.,Elzayat EM,J Alzheimers Dis,2023,22-05-2023,PMC10473110,,10.3233/JAD-221298
37210894,Mechanisms of ferroptosis in Alzheimer's disease and therapeutic effects of natural plant products: A review,"Zhao D, Yang K, Guo H, Zeng J, Wang S, Xu H, Ge A, Zeng L, Chen S, Ge J.",Biomed Pharmacother. 2023 Aug;164:114312. doi: 10.1016/j.biopha.2023.114312. Epub 2023 May 19.,Zhao D,Biomed Pharmacother,2023,21-05-2023,,,10.1016/j.biopha.2023.114312
37204054,Latin American Initiative for Lifestyle Intervention to Prevent Cognitive Decline (LatAm-FINGERS): Study design and harmonization,"Crivelli L, Calandri IL, Suemoto CK, Salinas RM, Velilla LM, Yassuda MS, Caramelli P, Lopera F, Nitrini R, Sevlever GE, Sosa AL, Acosta D, Baietti AMC, Cusicanqui MI, Custodio N, De Simone SD, Derio CD, Duque-Peñailillo L, Duran JC, Jiménez-Velázquez IZ, Leon-Salas JM, Bergamo Y, Clarens MF, Damian A, Demey I, Helou MB, Márquez C, Martin ME, Martin MDGM, Querze D, Surace EI, Acosta-Egea S, Aguirre-Salvador E, de Souza LC, Cançado GHDCP, Brucki SMD, Friedlaender CV, Gomes KB, Gutierrez M, Ríos CL, Galindo JGM, Montesinos R, Nuñez-Herrera A, Ospina-Henao S, Rodríguez G, Masson VR, Sánchez M, Schenk CE, Soto L, Barbosa MT, Tosatti JAG, Vicuña Y, Espeland M, Hakansson K, Kivipelto M, Baker L, Snyder H, Carrillo M, Allegri RF.",Alzheimers Dement. 2023 Sep;19(9):4046-4060. doi: 10.1002/alz.13101. Epub 2023 May 19.,Crivelli L,Alzheimers Dement,2023,19-05-2023,PMC11021182,NIHMS1984097,10.1002/alz.13101
37190102,The Therapeutic Potential of Non-Invasive and Invasive Cerebellar Stimulation Techniques in Hereditary Ataxias,"Benussi A, Batsikadze G, França C, Cury RG, Maas RPPWM.",Cells. 2023 Apr 20;12(8):1193. doi: 10.3390/cells12081193.,Benussi A,Cells,2023,16-05-2023,PMC10137097,,10.3390/cells12081193
37189779,Metals in Alzheimer's Disease,"Babić Leko M, Langer Horvat L, Španić Popovački E, Zubčić K, Hof PR, Šimić G.",Biomedicines. 2023 Apr 12;11(4):1161. doi: 10.3390/biomedicines11041161.,Babić Leko M,Biomedicines,2023,16-05-2023,PMC10136077,,10.3390/biomedicines11041161
37189612,Evidence That Increasing Serum 25(OH)D Concentrations to 30 ng/mL in the Kingdom of Saudi Arabia and the United Arab Emirates Could Greatly Improve Health Outcomes,"Grant WB, Al Anouti F, Boucher BJ, Fakhoury HMA, Moukayed M, Pilz S, Al-Daghri NM.",Biomedicines. 2023 Mar 23;11(4):994. doi: 10.3390/biomedicines11040994.,Grant WB,Biomedicines,2023,16-05-2023,PMC10136066,,10.3390/biomedicines11040994
37189413,Molecular Mind Games: The Medicinal Action of Cyclodextrins in Neurodegenerative Diseases,Braga SS.,Biomolecules. 2023 Apr 12;13(4):666. doi: 10.3390/biom13040666.,Braga SS,Biomolecules,2023,16-05-2023,PMC10136110,,10.3390/biom13040666
37182884,Multifocal Transcranial Direct Current Stimulation in Primary Progressive Aphasia Does Not Provide a Clinical Benefit Over Speech Therapy,"Borrego-Écija S, Montagut N, Martín-Trias P, Vaqué-Alcázar L, Illán-Gala I, Balasa M, Lladó A, Casanova-Mollà J, Bargalló N, Valls-Solé J, Lleó A, Bartrés-Faz D, Sánchez-Valle R.",J Alzheimers Dis. 2023;93(3):1169-1180. doi: 10.3233/JAD-230069.,Borrego-Écija S,J Alzheimers Dis,2023,14-05-2023,,,10.3233/JAD-230069
37182871,Effect of Acetylcholinesterase Inhibitors on Cerebral Perfusion and Cognition: A Systematic Review,"Moyaert P, Beun S, Achten E, Clement P.",J Alzheimers Dis. 2023;93(4):1211-1221. doi: 10.3233/JAD-221125.,Moyaert P,J Alzheimers Dis,2023,14-05-2023,PMC10357189,,10.3233/JAD-221125
37181628,"Gout and risk of dementia, Alzheimer's disease or vascular dementia: a meta-epidemiology study","Li X, Huang L, Tang Y, Hu X, Wen C.",Front Aging Neurosci. 2023 Apr 26;15:1051809. doi: 10.3389/fnagi.2023.1051809. eCollection 2023.,Li X,Front Aging Neurosci,2023,14-05-2023,PMC10169719,,10.3389/fnagi.2023.1051809
37181568,Tau-PET imaging in Parkinson's disease: a systematic review and meta-analysis,"Zhang J, Jin J, Su D, Feng T, Zhao H.",Front Neurol. 2023 Apr 27;14:1145939. doi: 10.3389/fneur.2023.1145939. eCollection 2023.,Zhang J,Front Neurol,2023,14-05-2023,PMC10174250,,10.3389/fneur.2023.1145939
37175665,Autoimmune Neuroinflammatory Diseases: Role of Interleukins,"Khan AW, Farooq M, Hwang MJ, Haseeb M, Choi S.",Int J Mol Sci. 2023 Apr 27;24(9):7960. doi: 10.3390/ijms24097960.,Khan AW,Int J Mol Sci,2023,13-05-2023,PMC10178921,,10.3390/ijms24097960
37173791,A phase 1b randomized clinical trial of CT1812 to measure Aβ oligomer displacement in Alzheimer's disease using an indwelling CSF catheter,"LaBarbera KM, Sheline YI, Izzo NJ, Yuede CM, Waybright L, Yurko R, Edwards HM, Gardiner WD, Blennow K, Zetterberg H, Börjesson-Hanson A, Morgan R, Davis CS, Guttendorf RJ, Schneider LS, DeKosky S, LeVine H 3rd, Grundman M, Caggiano AO, Cirrito JR, Catalano SM, Hamby ME.",Transl Neurodegener. 2023 May 12;12(1):24. doi: 10.1186/s40035-023-00358-w.,LaBarbera KM,Transl Neurodegener,2023,12-05-2023,PMC10176668,,10.1186/s40035-023-00358-w
37167559,Differential Effects of an Emergency Department-to-Home Care Transitions Intervention in an Older Adult Population: A Latent Class Analysis,"Green RK, Nieser KJ, Jacobsohn GC, Cochran AL, Caprio TV, Cushman JT, Kind AJH, Lohmeier M, Shah MN.",Med Care. 2023 Jun 1;61(6):400-408. doi: 10.1097/MLR.0000000000001848. Epub 2023 May 11.,Green RK,Med Care,2023,11-05-2023,PMC10176501,NIHMS1883705,10.1097/MLR.0000000000001848
37166702,Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders,"Malar DS, Thitilertdecha P, Ruckvongacheep KS, Brimson S, Tencomnao T, Brimson JM.",CNS Drugs. 2023 May;37(5):399-440. doi: 10.1007/s40263-023-01007-6. Epub 2023 May 11.,Malar DS,CNS Drugs,2023,11-05-2023,PMC10173947,,10.1007/s40263-023-01007-6
37166012,Efficacy and safety of negative allosteric modulators of 5-hydroxytryptamine 2A receptors in the treatment of Alzheimer's disease psychosis: A systematic review and meta-analysis,"Chen Y, Sun J, Yang Z, Bi H.",Adv Clin Exp Med. 2023 Oct;32(10):1089-1098. doi: 10.17219/acem/161159.,Chen Y,Adv Clin Exp Med,2023,11-05-2023,,,10.17219/acem/161159
37161397,Sleep Profiles of Caregivers for Persons Living with Dementia: A Qualitative Study,"Brewster GS, Pierpaoli Parker C, Epps F, Bonds Johnson K, Yeager KA.",West J Nurs Res. 2023 Aug;45(8):688-695. doi: 10.1177/01939459231175242. Epub 2023 May 10.,Brewster GS,West J Nurs Res,2023,10-05-2023,PMC10976108,NIHMS1979101,10.1177/01939459231175242
37160649,"Dementia, infections and vaccines: 30 years of controversy","Ecarnot F, Boccardi V, Calcagno A, Franceschi C, Fülop T, Itzhaki RF, Michel JP, Panza F, Rainero I, Solfrizzi V, Ticinesi A, Veronese N, Maggi S.",Aging Clin Exp Res. 2023 Jun;35(6):1145-1160. doi: 10.1007/s40520-023-02409-8. Epub 2023 May 9.,Ecarnot F,Aging Clin Exp Res,2023,09-05-2023,PMC10169152,,10.1007/s40520-023-02409-8
37155177,Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial,"Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, Molinuevo JL, Grau-Rivera O, Gispert JD, Drzezga A, Jessen F, Zeyen P, Nordberg A, Savitcheva I, Jelic V, Walker Z, Edison P, Demonet JF, Gismondi R, Farrar G, Stephens AW, Frisoni GB; Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) Consortium.",JAMA Neurol. 2023 Jun 1;80(6):548-557. doi: 10.1001/jamaneurol.2023.0997.,Altomare D,JAMA Neurol,2023,08-05-2023,PMC10167601,,10.1001/jamaneurol.2023.0997
37151227,Cerebrospinal fluid and positron-emission tomography biomarkers for noradrenergic dysfunction in neurodegenerative diseases: a systematic review and meta-analysis,"Lancini E, Haag L, Bartl F, Rühling M, Ashton NJ, Zetterberg H, Düzel E, Hämmerer D, Betts MJ.",Brain Commun. 2023 Mar 29;5(3):fcad085. doi: 10.1093/braincomms/fcad085. eCollection 2023.,Lancini E,Brain Commun,2023,08-05-2023,PMC10154713,,10.1093/braincomms/fcad085
37139053,Tooth loss and the risk of cognitive decline and dementia: A meta-analysis of cohort studies,"Li L, Zhang Q, Yang D, Yang S, Zhao Y, Jiang M, Wang X, Zhao L, Liu Q, Lu Z, Zhou X, Gan Y, Wu C.",Front Neurol. 2023 Apr 17;14:1103052. doi: 10.3389/fneur.2023.1103052. eCollection 2023.,Li L,Front Neurol,2023,04-05-2023,PMC10150074,,10.3389/fneur.2023.1103052
37138160,Fluid and Biopsy Based Biomarkers in Parkinson's Disease,"Coughlin DG, Irwin DJ.",Neurotherapeutics. 2023 Jul;20(4):932-954. doi: 10.1007/s13311-023-01379-z. Epub 2023 May 3.,Coughlin DG,Neurotherapeutics,2023,03-05-2023,PMC10457253,,10.1007/s13311-023-01379-z
37125549,Technology-Based Counselling for People with Dementia and Their Informal Carers: A Systematic Review and Meta-Analysis,"Bauernschmidt D, Hirt J, Langer G, Meyer G, Unverzagt S, Wilde F, Wittmann J, Bieber A.",J Alzheimers Dis. 2023;93(3):891-906. doi: 10.3233/JAD-221194.,Bauernschmidt D,J Alzheimers Dis,2023,01-05-2023,PMC10258880,,10.3233/JAD-221194
37125534,Cognitive Impairment After Ischemic and Hemorrhagic Stroke: A Scientific Statement From the American Heart Association/American Stroke Association,"El Husseini N, Katzan IL, Rost NS, Blake ML, Byun E, Pendlebury ST, Aparicio HJ, Marquine MJ, Gottesman RF, Smith EE; American Heart Association Stroke Council; Council on Cardiovascular and Stroke Nursing; Council on Cardiovascular Radiology and Intervention; Council on Hypertension; and Council on Lifestyle and Cardiometabolic Health.",Stroke. 2023 Jun;54(6):e272-e291. doi: 10.1161/STR.0000000000000430. Epub 2023 May 1.,El Husseini N,Stroke,2023,01-05-2023,,,10.1161/STR.0000000000000430
37123370,Deep brain stimulation for the treatment of Alzheimer's disease: A systematic review and meta-analysis,"Majdi A, Deng Z, Sadigh-Eteghad S, De Vloo P, Nuttin B, Mc Laughlin M.",Front Neurosci. 2023 Apr 13;17:1154180. doi: 10.3389/fnins.2023.1154180. eCollection 2023.,Majdi A,Front Neurosci,2023,01-05-2023,PMC10133458,,10.3389/fnins.2023.1154180
37122144,Therapeutic potential of aromatic plant extracts in Alzheimer's disease: Comprehensive review of their underlying mechanisms,"Ma Y, Li Y, Yin R, Guo P, Lei N, Li G, Xiong L, Xie Y.",CNS Neurosci Ther. 2023 Aug;29(8):2045-2059. doi: 10.1111/cns.14234. Epub 2023 Apr 30.,Ma Y,CNS Neurosci Ther,2023,01-05-2023,PMC10352876,,10.1111/cns.14234
37114956,Current study on diagnosis and treatment of Alzheimer's disease by targeting amyloid b-protein,"Hua KY, Zhao WJ.",Folia Neuropathol. 2023;61(1):8-15. doi: 10.5114/fn.2022.119778.,Hua KY,Folia Neuropathol,2023,28-04-2023,,,10.5114/fn.2022.119778
37113132,Preliminary evidence for developing safe and efficient fecal microbiota transplantation as potential treatment for aged related cognitive impairments,"Chen X, Zhang W, Lin Z, Zheng C, Chen S, Zhou H, Liu Z.",Front Cell Infect Microbiol. 2023 Apr 11;13:1103189. doi: 10.3389/fcimb.2023.1103189. eCollection 2023.,Chen X,Front Cell Infect Microbiol,2023,28-04-2023,PMC10127103,,10.3389/fcimb.2023.1103189
37111131,Antioxidant Compounds from Edible Mushrooms as Potential Candidates for Treating Age-Related Neurodegenerative Diseases,"Liuzzi GM, Petraglia T, Latronico T, Crescenzi A, Rossano R.",Nutrients. 2023 Apr 15;15(8):1913. doi: 10.3390/nu15081913.,Liuzzi GM,Nutrients,2023,28-04-2023,PMC10145943,,10.3390/nu15081913
37108814,Improving the Treatment Effect of Carotenoids on Alzheimer's Disease through Various Nano-Delivery Systems,"Su W, Xu W, Liu E, Su W, Polyakov NE.",Int J Mol Sci. 2023 Apr 21;24(8):7652. doi: 10.3390/ijms24087652.,Su W,Int J Mol Sci,2023,28-04-2023,PMC10142927,,10.3390/ijms24087652
37095250,"Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial","Mummery CJ, Börjesson-Hanson A, Blackburn DJ, Vijverberg EGB, De Deyn PP, Ducharme S, Jonsson M, Schneider A, Rinne JO, Ludolph AC, Bodenschatz R, Kordasiewicz H, Swayze EE, Fitzsimmons B, Mignon L, Moore KM, Yun C, Baumann T, Li D, Norris DA, Crean R, Graham DL, Huang E, Ratti E, Bennett CF, Junge C, Lane RM.",Nat Med. 2023 Jun;29(6):1437-1447. doi: 10.1038/s41591-023-02326-3. Epub 2023 Apr 24.,Mummery CJ,Nat Med,2023,24-04-2023,PMC10287562,,10.1038/s41591-023-02326-3
37088953,Repetitive transcranial magnetic stimulation may be superior to drug therapy in the treatment of Alzheimer's disease: A systematic review and Bayesian network meta-analysis,"Wei N, Liu H, Ye W, Xu S, Lu C, Dai A, Hou T, Zeng X, Wu J, Chen J.",CNS Neurosci Ther. 2023 Oct;29(10):2912-2924. doi: 10.1111/cns.14228. Epub 2023 Apr 23.,Wei N,CNS Neurosci Ther,2023,24-04-2023,PMC10493651,,10.1111/cns.14228
37087882,Repurposing of FDA-approved drugs as dual-acting MAO-B and AChE inhibitors against Alzheimer's disease: An in silico and in vitro study,"Mateev E, Kondeva-Burdina M, Georgieva M, Zlatkov A.",J Mol Graph Model. 2023 Jul;122:108471. doi: 10.1016/j.jmgm.2023.108471. Epub 2023 Apr 14.,Mateev E,J Mol Graph Model,2023,23-04-2023,,,10.1016/j.jmgm.2023.108471
37086918,Magnetic iron oxide nanoparticles for brain imaging and drug delivery,"Qiao R, Fu C, Forgham H, Javed I, Huang X, Zhu J, Whittaker AK, Davis TP.",Adv Drug Deliv Rev. 2023 Jun;197:114822. doi: 10.1016/j.addr.2023.114822. Epub 2023 Apr 21.,Qiao R,Adv Drug Deliv Rev,2023,22-04-2023,,,10.1016/j.addr.2023.114822
37085328,Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum,"Kuhn E, Perrotin A, La Joie R, Touron E, Dautricourt S, Vanhoutte M, Vivien D, de La Sayette V, Chételat G; Alzheimer's Disease Neuroimaging Initiative.",Neurology. 2023 Jun 13;100(24):e2454-e2465. doi: 10.1212/WNL.0000000000207338. Epub 2023 Apr 21.,Kuhn E,Neurology,2023,21-04-2023,PMC10264050,,10.1212/WNL.0000000000207338
37084148,The Promise of Niacin in Neurology,"Wuerch E, Urgoiti GR, Yong VW.",Neurotherapeutics. 2023 Jul;20(4):1037-1054. doi: 10.1007/s13311-023-01376-2. Epub 2023 Apr 21.,Wuerch E,Neurotherapeutics,2023,21-04-2023,PMC10457276,,10.1007/s13311-023-01376-2
37082807,Pragmatic evaluation of events and benefits of lipid lowering in older adults (PREVENTABLE): Trial design and rationale,"Joseph J, Pajewski NM, Dolor RJ, Sellers MA, Perdue LH, Peeples SR, Henrie AM, Woolard N, Jones WS, Benziger CP, Orkaby AR, Mixon AS, VanWormer JJ, Shapiro MD, Kistler CE, Polonsky TS, Chatterjee R, Chamberlain AM, Forman DE, Knowlton KU, Gill TM, Newby LK, Hammill BG, Cicek MS, Williams NA, Decker JE, Ou J, Rubinstein J, Choudhary G, Gazmuri RJ, Schmader KE, Roumie CL, Vaughan CP, Effron MB, Cooper-DeHoff RM, Supiano MA, Shah RC, Whittle JC, Hernandez AF, Ambrosius WT, Williamson JD, Alexander KP; PREVENTABLE Trial Research Group.",J Am Geriatr Soc. 2023 Jun;71(6):1701-1713. doi: 10.1111/jgs.18312. Epub 2023 Apr 20.,Joseph J,J Am Geriatr Soc,2023,21-04-2023,PMC10258159,NIHMS1880216,10.1111/jgs.18312
37077141,Evaluating the effects of glucagon-like peptide-1 receptor agonists on cognitive function in Alzheimer's disease: A systematic review and meta-analysis,"Bi Z, Wang L, Wang W.",Adv Clin Exp Med. 2023 Nov;32(11):1223-1231. doi: 10.17219/acem/161734.,Bi Z,Adv Clin Exp Med,2023,20-04-2023,,,10.17219/acem/161734
37067896,Tele-Savvy Outcomes of Non-Hispanic Black American and White Caregivers,"Bonds Johnson K, Higgins M, Epps F, Brewster GS, Alexander K, Hepburn K.",Gerontologist. 2024 Jan 1;64(1):gnad044. doi: 10.1093/geront/gnad044.,Bonds Johnson K,Gerontologist,2024,17-04-2023,PMC10733122,,10.1093/geront/gnad044
37066690,Cost consequence analysis of Apathy in Dementia Methylphenidate Trial 2 (ADMET 2),"Lanctôt KL, Chen C, Mah E, Kiss A, Li A, Shade D, Scherer RW, Vieira D, Coulibaly H, Rosenberg PB, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer J, Herrmann N.",Int Psychogeriatr. 2023 Nov;35(11):664-672. doi: 10.1017/S1041610223000327. Epub 2023 Apr 17.,Lanctôt KL,Int Psychogeriatr,2023,17-04-2023,PMC10579450,NIHMS1892907,10.1017/S1041610223000327
37058492,Case management interventions in chronic disease reduce anxiety and depressive symptoms: A systematic review and meta-analysis,"Geerlings AD, Janssen Daalen JM, Ypinga JHL, Bloem BR, Meinders MJ, Munneke M, Darweesh SKL.",PLoS One. 2023 Apr 14;18(4):e0282590. doi: 10.1371/journal.pone.0282590. eCollection 2023.,Geerlings AD,PLoS One,2023,14-04-2023,PMC10104285,,10.1371/journal.pone.0282590
37055865,Redox dysregulation as a driver for DNA damage and its relationship to neurodegenerative diseases,"Shadfar S, Parakh S, Jamali MS, Atkin JD.",Transl Neurodegener. 2023 Apr 14;12(1):18. doi: 10.1186/s40035-023-00350-4.,Shadfar S,Transl Neurodegener,2023,13-04-2023,PMC10103468,,10.1186/s40035-023-00350-4
37049399,The Potential Use of Honey as a Neuroprotective Agent for the Management of Neurodegenerative Diseases,"Fadzil MAM, Mustar S, Rashed AA.",Nutrients. 2023 Mar 23;15(7):1558. doi: 10.3390/nu15071558.,Fadzil MAM,Nutrients,2023,13-04-2023,PMC10096917,,10.3390/nu15071558
37047994,The Senior Companion Program Plus (SCP Plus): Examining the Preliminary Effectiveness of a Lay Provider Program to Support African American Alzheimer's Disease and Related Dementias (ADRD) Caregivers,"Xu L, Fields NL, Williams IC, Gaugler JE, Kunz-Lomelin A, Cipher DJ, Feinhals G.",Int J Environ Res Public Health. 2023 Apr 3;20(7):5380. doi: 10.3390/ijerph20075380.,Xu L,Int J Environ Res Public Health,2023,13-04-2023,PMC10094539,,10.3390/ijerph20075380
37047549,Cognitive Decline in Early and Premature Menopause,"Sochocka M, Karska J, Pszczołowska M, Ochnik M, Fułek M, Fułek K, Kurpas D, Chojdak-Łukasiewicz J, Rosner-Tenerowicz A, Leszek J.",Int J Mol Sci. 2023 Mar 31;24(7):6566. doi: 10.3390/ijms24076566.,Sochocka M,Int J Mol Sci,2023,13-04-2023,PMC10095144,,10.3390/ijms24076566
37047250,Mouse Models with SGLT2 Mutations: Toward Understanding the Role of SGLT2 beyond Glucose Reabsorption,"Unno K, Taguchi K, Takagi Y, Hase T, Meguro S, Nakamura Y.",Int J Mol Sci. 2023 Mar 27;24(7):6278. doi: 10.3390/ijms24076278.,Unno K,Int J Mol Sci,2023,13-04-2023,PMC10094282,,10.3390/ijms24076278
37046209,"The impact of the COVID-19 pandemic on neuropsychiatric and sleep disorders, and quality of life in individuals with neurodegenerative and demyelinating diseases: a systematic review and meta-analysis of observational studies","de Oliveira MPB, de Castro AEF, Miri AL, Lima CR, Truax BD, Probst VS, Smaili SM.",BMC Neurol. 2023 Apr 12;23(1):150. doi: 10.1186/s12883-023-03176-9.,de Oliveira MPB,BMC Neurol,2023,12-04-2023,PMC10091330,,10.1186/s12883-023-03176-9
37043277,Serious Games for Learning Among Older Adults With Cognitive Impairment: Systematic Review and Meta-analysis,"Abd-Alrazaq A, Abuelezz I, AlSaad R, Al-Jafar E, Ahmed A, Aziz S, Nashwan A, Sheikh J.",J Med Internet Res. 2023 Apr 12;25:e43607. doi: 10.2196/43607.,Abd-Alrazaq A,J Med Internet Res,2023,12-04-2023,PMC10134019,,10.2196/43607
37040116,Lecanemab for Patients With Early Alzheimer Disease: Bayesian Analysis of a Phase 2b Dose-Finding Randomized Clinical Trial,"Berry DA, Dhadda S, Kanekiyo M, Li D, Swanson CJ, Irizarry M, Kramer LD, Berry SM.",JAMA Netw Open. 2023 Apr 3;6(4):e237230. doi: 10.1001/jamanetworkopen.2023.7230.,Berry DA,JAMA Netw Open,2023,11-04-2023,PMC10091161,,10.1001/jamanetworkopen.2023.7230
37036495,Evidence of trospium's ability to mitigate cholinergic adverse events related to xanomeline: phase 1 study results,"Breier A, Brannan SK, Paul SM, Miller AC.",Psychopharmacology (Berl). 2023 May;240(5):1191-1198. doi: 10.1007/s00213-023-06362-2. Epub 2023 Apr 10.,Breier A,Psychopharmacology (Berl),2023,10-04-2023,PMC10102054,,10.1007/s00213-023-06362-2
37027074,The Use of Stem Cells as a Potential Treatment Method for Selected Neurodegenerative Diseases: Review,"Cecerska-Heryć E, Pękała M, Serwin N, Gliźniewicz M, Grygorcewicz B, Michalczyk A, Heryć R, Budkowska M, Dołęgowska B.",Cell Mol Neurobiol. 2023 Aug;43(6):2643-2673. doi: 10.1007/s10571-023-01344-6. Epub 2023 Apr 7.,Cecerska-Heryć E,Cell Mol Neurobiol,2023,07-04-2023,PMC10333383,,10.1007/s10571-023-01344-6
37023625,"Levetiracetam, from broad-spectrum use to precision prescription: A narrative review and expert opinion","Celdran de Castro A, Nascimento FA, Beltran-Corbellini Á, Toledano R, Garcia-Morales I, Gil-Nagel A, Aledo-Serrano Á.",Seizure. 2023 Apr;107:121-131. doi: 10.1016/j.seizure.2023.03.017. Epub 2023 Mar 24.,Celdran de Castro A,Seizure,2023,06-04-2023,,,10.1016/j.seizure.2023.03.017
37022634,Geroprotective interventions in the 3xTg mouse model of Alzheimer's disease,"Sonsalla MM, Lamming DW.",Geroscience. 2023 Jun;45(3):1343-1381. doi: 10.1007/s11357-023-00782-w. Epub 2023 Apr 6.,Sonsalla MM,Geroscience,2023,06-04-2023,PMC10400530,,10.1007/s11357-023-00782-w
37022140,The effect of weight loss following 18 months of lifestyle intervention on brain age assessed with resting-state functional connectivity,"Levakov G, Kaplan A, Yaskolka Meir A, Rinott E, Tsaban G, Zelicha H, Blüher M, Ceglarek U, Stumvoll M, Shelef I, Avidan G, Shai I.",Elife. 2023 Apr 6;12:e83604. doi: 10.7554/eLife.83604.,Levakov G,Elife,2023,06-04-2023,PMC10174688,,10.7554/eLife.83604
37017910,Dementia with Lewy Bodies Drug Therapies in Clinical Trials: Systematic Review up to 2022,"Abdelnour C, Gonzalez MC, Gibson LL, Poston KL, Ballard CG, Cummings JL, Aarsland D.",Neurol Ther. 2023 Jun;12(3):727-749. doi: 10.1007/s40120-023-00467-8. Epub 2023 Apr 5.,Abdelnour C,Neurol Ther,2023,05-04-2023,PMC10195935,,10.1007/s40120-023-00467-8
37017737,Longitudinal head-to-head comparison of (11)C-PiB and (18)F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease,"Chen CD, McCullough A, Gordon B, Joseph-Mathurin N, Flores S, McKay NS, Hobbs DA, Hornbeck R, Fagan AM, Cruchaga C, Goate AM, Perrin RJ, Wang G, Li Y, Shi X, Xiong C, Pontecorvo MJ, Klein G, Su Y, Klunk WE, Jack C, Koeppe R, Snider BJ, Berman SB, Roberson ED, Brosch J, Surti G, Jiménez-Velázquez IZ, Galasko D, Honig LS, Brooks WS, Clarnette R, Wallon D, Dubois B, Pariente J, Pasquier F, Sanchez-Valle R, Shcherbinin S, Higgins I, Tunali I, Masters CL, van Dyck CH, Masellis M, Hsiung R, Gauthier S, Salloway S, Clifford DB, Mills S, Supnet-Bell C, McDade E, Bateman RJ, Benzinger TLS; DIAN-TU Study Team.",Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5.,Chen CD,Eur J Nucl Med Mol Imaging,2023,05-04-2023,PMC10330155,NIHMS1894746,10.1007/s00259-023-06209-0
37015192,Genomic Investigation of Remission and Relapse of Psychotic Depression Treated with Sertraline plus Olanzapine: The STOP-PD II Study,"Men X, Marshe V, Elsheikh SS, Alexopoulos GS, Marino P, Meyers BS, Mulsant BH, Rothschild AJ, Voineskos AN, Whyte EM, Kennedy JL, Flint AJ, Müller DJ.",Neuropsychobiology. 2023;82(3):168-178. doi: 10.1159/000529637. Epub 2023 Apr 4.,Men X,Neuropsychobiology,2023,04-04-2023,PMC10871684,,10.1159/000529637
37014414,Repurposing drugs against Alzheimer's disease: can the anti-multiple sclerosis drug fingolimod (FTY720) effectively tackle inflammation processes in AD?,"Leßmann V, Kartalou GI, Endres T, Pawlitzki M, Gottmann K.",J Neural Transm (Vienna). 2023 Aug;130(8):1003-1012. doi: 10.1007/s00702-023-02618-5. Epub 2023 Apr 4.,Leßmann V,J Neural Transm (Vienna),2023,04-04-2023,PMC10374694,,10.1007/s00702-023-02618-5
37013586,"Aerobic exercise improves executive functions in females, but not males, without the BDNF Val66Met polymorphism","Barha CK, Starkey SY, Hsiung GYR, Tam R, Liu-Ambrose T.",Biol Sex Differ. 2023 Apr 3;14(1):16. doi: 10.1186/s13293-023-00499-7.,Barha CK,Biol Sex Differ,2023,04-04-2023,PMC10069071,,10.1186/s13293-023-00499-7
37012306,"A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress","Morató X, Marquié M, Tartari JP, Lafuente A, Abdelnour C, Alegret M, Jofresa S, Buendía M, Pancho A, Aguilera N, Ibarria M, Diego S, Cuevas R, Cañada L, Calvet A, Antonio EE, Pérez-Cordón A, Sanabria Á, de Rojas I, Nuñez-Llaves R, Cano A, Orellana A, Montrreal L, Cañabate P, Rosende-Roca M, Vargas L, Bojaryn U, Ricciardi M, Ariton DM, Espinosa A, Ortega G, Muñoz N, Lleonart N, Alarcón-Martín E, Moreno M, Preckler S, Tantinya N, Ramis M, Nogales AB, Seguer S, Martín E, Pytel V, Valero S, Gurruchaga M, Tárraga L, Ruiz A, Boada M.",Sci Rep. 2023 Apr 3;13(1):5406. doi: 10.1038/s41598-023-32515-6.,Morató X,Sci Rep,2023,03-04-2023,PMC10070452,,10.1038/s41598-023-32515-6
37005885,Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease,"Rahmani F, Ghezzi L, Tosti V, Liu J, Song SK, Wu AT, Rajamanickam J, Obert KA, Benzinger TLS, Mittendorfer B, Piccio L, Raji CA.",J Alzheimers Dis. 2023;93(1):263-273. doi: 10.3233/JAD-221007.,Rahmani F,J Alzheimers Dis,2023,03-04-2023,PMC10460547,NIHMS1924105,10.3233/JAD-221007
37005070,Traditional Chinese medicine Jia Wei Gui Pi Tang improves behavioural and psychological symptoms of dementia and favourable positive emotions in patients,"Nogami T, Iwasaki K, Kimura H, Higashi T, Arai M, Butler JP, Fujii M, Sasaki H.",Psychogeriatrics. 2023 May;23(3):503-511. doi: 10.1111/psyg.12962. Epub 2023 Apr 2.,Nogami T,Psychogeriatrics,2023,02-04-2023,PMC11577992,,10.1111/psyg.12962
37003513,Small-molecule modulators of tumor necrosis factor signaling,"Chédotal H, Narayanan D, Povlsen K, Gotfredsen CH, Brambilla R, Gajhede M, Bach A, Clausen MH.",Drug Discov Today. 2023 Jun;28(6):103575. doi: 10.1016/j.drudis.2023.103575. Epub 2023 Mar 30.,Chédotal H,Drug Discov Today,2023,01-04-2023,,,10.1016/j.drudis.2023.103575
36994422,Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review,"Hort J, Duning T, Hoerr R.",Neuropsychiatr Dis Treat. 2023 Mar 23;19:647-660. doi: 10.2147/NDT.S401231. eCollection 2023.,Hort J,Neuropsychiatr Dis Treat,2023,30-03-2023,PMC10041984,,10.2147/NDT.S401231
36990042,Probiotic intervention benefits multiple neural behaviors in older adults with mild cognitive impairment,"Fei Y, Wang R, Lu J, Peng S, Yang S, Wang Y, Zheng K, Li R, Lin L, Li M.",Geriatr Nurs. 2023 May-Jun;51:167-175. doi: 10.1016/j.gerinurse.2023.03.006. Epub 2023 Mar 28.,Fei Y,Geriatr Nurs,2023,29-03-2023,,,10.1016/j.gerinurse.2023.03.006
36986229,Supplementation with Flaxseed Oil Rich in Alpha-Linolenic Acid Improves Verbal Fluency in Healthy Older Adults,"Ogawa T, Sawane K, Ookoshi K, Kawashima R.",Nutrients. 2023 Mar 21;15(6):1499. doi: 10.3390/nu15061499.,Ogawa T,Nutrients,2023,29-03-2023,PMC10056498,,10.3390/nu15061499
36985608,Nature-Inspired Bioactive Compounds: A Promising Approach for Ferroptosis-Linked Human Diseases?,"El Hajj S, Canabady-Rochelle L, Gaucher C.",Molecules. 2023 Mar 14;28(6):2636. doi: 10.3390/molecules28062636.,El Hajj S,Molecules,2023,29-03-2023,PMC10059971,,10.3390/molecules28062636
36984879,The Role of Dietary Antioxidants and Their Potential Mechanisms in Alzheimer's Disease Treatment,"Knight E, Geetha T, Broderick TL, Babu JR.",Metabolites. 2023 Mar 17;13(3):438. doi: 10.3390/metabo13030438.,Knight E,Metabolites,2023,29-03-2023,PMC10054164,,10.3390/metabo13030438
36982324,Minocycline as Treatment for Psychiatric and Neurological Conditions: A Systematic Review and Meta-Analysis,"Panizzutti B, Skvarc D, Lin S, Croce S, Meehan A, Bortolasci CC, Marx W, Walker AJ, Hasebe K, Kavanagh BE, Morris MJ, Mohebbi M, Turner A, Gray L, Berk L, Walder K, Berk M, Dean OM.",Int J Mol Sci. 2023 Mar 9;24(6):5250. doi: 10.3390/ijms24065250.,Panizzutti B,Int J Mol Sci,2023,29-03-2023,PMC10049047,,10.3390/ijms24065250
36979483,The Role of the Transcription Factor Nrf2 in Alzheimer's Disease: Therapeutic Opportunities,"De Plano LM, Calabrese G, Rizzo MG, Oddo S, Caccamo A.",Biomolecules. 2023 Mar 17;13(3):549. doi: 10.3390/biom13030549.,De Plano LM,Biomolecules,2023,29-03-2023,PMC10046499,,10.3390/biom13030549
36976193,Potential Active Marine Peptides as Anti-Aging Drugs or Drug Candidates,"Yang H, Zhang Q, Zhang B, Zhao Y, Wang N.",Mar Drugs. 2023 Feb 23;21(3):144. doi: 10.3390/md21030144.,Yang H,Mar Drugs,2023,28-03-2023,PMC10053682,,10.3390/md21030144
36973733,The effect of music therapy on cognitive functions in patients with Alzheimer's disease: a systematic review of randomized controlled trials,"Bleibel M, El Cheikh A, Sadier NS, Abou-Abbas L.",Alzheimers Res Ther. 2023 Mar 27;15(1):65. doi: 10.1186/s13195-023-01214-9.,Bleibel M,Alzheimers Res Ther,2023,27-03-2023,PMC10041788,,10.1186/s13195-023-01214-9
36973044,Accelerated Brain Volume Loss Caused by Anti-β-Amyloid Drugs: A Systematic Review and Meta-analysis,"Alves F, Kalinowski P, Ayton S.",Neurology. 2023 May 16;100(20):e2114-e2124. doi: 10.1212/WNL.0000000000207156. Epub 2023 Mar 27.,Alves F,Neurology,2023,27-03-2023,PMC10186239,,10.1212/WNL.0000000000207156
36972279,Semantic-based memory-encoding strategy and cognitive stimulation in enhancing cognitive function and daily task performance for older adults with mild cognitive impairment: A pilot non-randomised cluster controlled trial,"Mraz H, Tong CY, Liu KPY.",PLoS One. 2023 Mar 27;18(3):e0283449. doi: 10.1371/journal.pone.0283449. eCollection 2023.,Mraz H,PLoS One,2023,27-03-2023,PMC10042350,,10.1371/journal.pone.0283449
36971436,A systematic review of specialty dementia care units in long-term care settings,"Orth J, Flowers D, Betz G, Cagle JG.",Int J Geriatr Psychiatry. 2023 Apr;38(4):e5907. doi: 10.1002/gps.5907.,Orth J,Int J Geriatr Psychiatry,2023,27-03-2023,PMC10369478,NIHMS1907552,10.1002/gps.5907
36968685,Efficacy of Electroconvulsive Therapy for the Treatment of Movement Disorders: A Literature Review,"Muhammad N, Brooks Iii N, Chatham L, Chatham A, Muthukanagaraj P.",Cureus. 2023 Mar 24;15(3):e36634. doi: 10.7759/cureus.36634. eCollection 2023 Mar.,Muhammad N,Cureus,2023,27-03-2023,PMC10038173,,10.7759/cureus.36634
36966972,Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases,Chen C.,Pharmacol Ther. 2023 Apr;244:108394. doi: 10.1016/j.pharmthera.2023.108394. Epub 2023 Mar 24.,Chen C,Pharmacol Ther,2023,26-03-2023,PMC10123871,NIHMS1887859,10.1016/j.pharmthera.2023.108394
36966665,Puerarin: a potential natural neuroprotective agent for neurological disorders,"Liu X, Huang R, Wan J.",Biomed Pharmacother. 2023 Jun;162:114581. doi: 10.1016/j.biopha.2023.114581. Epub 2023 Mar 24.,Liu X,Biomed Pharmacother,2023,26-03-2023,,,10.1016/j.biopha.2023.114581
36966524,Suitability of Goal Attainment Scaling in Older Adult Populations with Neurodegenerative Disease Experiencing Cognitive Impairment: A Systematic Review and Meta-Analysis,"Fegter O, Santos H, Rademaker AW, Roberts AC, Rogalski E.",Gerontology. 2023;69(8):1002-1013. doi: 10.1159/000529984. Epub 2023 Mar 24.,Fegter O,Gerontology,2023,26-03-2023,PMC11214152,NIHMS1999118,10.1159/000529984
36960422,Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer's disease: A systematic review and meta-analysis,"Li D, Ma J, Wei B, Gao S, Lang Y, Wan X.",Front Aging Neurosci. 2023 Mar 7;15:1124710. doi: 10.3389/fnagi.2023.1124710. eCollection 2023.,Li D,Front Aging Neurosci,2023,24-03-2023,PMC10028084,,10.3389/fnagi.2023.1124710
36959856,Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer's disease: A systematic review and meta-analysis of animal studies,"Kamaruzzaman MA, Romli MH, Abas R, Vidyadaran S, Hidayat Baharuldin MT, Nasaruddin ML, Thirupathirao V, Sura S, Warsito K, Mohd Nor NH, Azwaruddin MA, Alshawsh MA, Mohd Moklas MA.",Front Pharmacol. 2023 Mar 3;14:1053680. doi: 10.3389/fphar.2023.1053680. eCollection 2023.,Kamaruzzaman MA,Front Pharmacol,2023,24-03-2023,PMC10028478,,10.3389/fphar.2023.1053680
36958392,"Person with Heart Failure and Care Partner Dyads: Current Knowledge, Challenges, and Future Directions: State-of-the-Art Review","Bidwell JT, Conway C, Babicheva V, Lee CS.",J Card Fail. 2023 Aug;29(8):1187-1206. doi: 10.1016/j.cardfail.2023.02.017. Epub 2023 Mar 22.,Bidwell JT,J Card Fail,2023,23-03-2023,PMC10514243,NIHMS1905707,10.1016/j.cardfail.2023.02.017
36949020,Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review,"Jalili C, Kiani A, Gholami M, Bahrehmand F, Fakhri S, Kakehbaraei S, Kakebaraei S.",IET Nanobiotechnol. 2023 May;17(3):154-170. doi: 10.1049/nbt2.12127. Epub 2023 Mar 22.,Jalili C,IET Nanobiotechnol,2023,22-03-2023,PMC10190566,,10.1049/nbt2.12127
36947499,Circulating long non-coding RNAs as novel diagnostic biomarkers for Alzheimer's disease (AD): A systematic review and meta-analysis,"Shobeiri P, Alilou S, Jaberinezhad M, Zare F, Karimi N, Maleki S, Teixeira AL, Perry G, Rezaei N.",PLoS One. 2023 Mar 22;18(3):e0281784. doi: 10.1371/journal.pone.0281784. eCollection 2023.,Shobeiri P,PLoS One,2023,22-03-2023,PMC10032479,,10.1371/journal.pone.0281784
36946597,"Beyond ""Psychotropic"": Repurposing Psychiatric Drugs for COVID-19, Alzheimer's Disease, and Cancer","Lenze EJ, Reiersen AM, Zorumski CF, Santosh PJ.",J Clin Psychiatry. 2023 Mar 20;84(3):22r14494. doi: 10.4088/JCP.22r14494.,Lenze EJ,J Clin Psychiatry,2023,22-03-2023,PMC12315912,NIHMS2095687,10.4088/JCP.22r14494
36946420,Long-term Impact of a 10-Year Intensive Lifestyle Intervention on a Deficit Accumulation Frailty Index: Action for Health in Diabetes Trial,"Evans JK, Usoh CO, Simpson FR, Espinoza S, Hazuda H, Pandey A, Beckner T, Espeland MA.",J Gerontol A Biol Sci Med Sci. 2023 Oct 28;78(11):2119-2126. doi: 10.1093/gerona/glad088.,Evans JK,J Gerontol A Biol Sci Med Sci,2023,22-03-2023,PMC10613011,,10.1093/gerona/glad088
36942495,Multi-networks connectivity at baseline predicts the clinical efficacy of left angular gyrus-navigated rTMS in the spectrum of Alzheimer's disease: A sham-controlled study,"Chen HF, Sheng XN, Yang ZY, Shao PF, Xu HH, Qin RM, Zhao H, Bai F.",CNS Neurosci Ther. 2023 Aug;29(8):2267-2280. doi: 10.1111/cns.14177. Epub 2023 Mar 21.,Chen HF,CNS Neurosci Ther,2023,21-03-2023,PMC10352882,,10.1111/cns.14177
36941403,Optical coherence tomography angiography measurements in Parkinson's disease: A systematic review and meta-analysis,"Salehi MA, Rezagholi F, Mohammadi S, Zakavi SS, Jahanshahi A, Gouravani M, Yazdanpanah G, Seddon I, Jabbehdari S, Singh RP.",Eye (Lond). 2023 Oct;37(15):3145-3156. doi: 10.1038/s41433-023-02483-2. Epub 2023 Mar 20.,Salehi MA,Eye (Lond),2023,21-03-2023,PMC10564940,,10.1038/s41433-023-02483-2
36936504,Importance of high-quality evidence regarding the use of Bacopa monnieri in dementia,"Agarwal A, Mishra B, Gupta A, Srivastava MVP, Basheer A, Sharma J, Vishnu VY.",Front Aging Neurosci. 2023 Mar 1;15:1134775. doi: 10.3389/fnagi.2023.1134775. eCollection 2023.,Agarwal A,Front Aging Neurosci,2023,20-03-2023,PMC10014812,,10.3389/fnagi.2023.1134775
36936502,Comparative efficacy and safety of antidepressant therapy for the agitation of dementia: A systematic review and network meta-analysis,"Chen K, Li H, Yang L, Jiang Y, Wang Q, Zhang J, He J.",Front Aging Neurosci. 2023 Mar 3;15:1103039. doi: 10.3389/fnagi.2023.1103039. eCollection 2023.,Chen K,Front Aging Neurosci,2023,20-03-2023,PMC10020338,,10.3389/fnagi.2023.1103039
36935901,Role of MSC-derived small extracellular vesicles in tissue repair and regeneration,"Aguiar Koga BA, Fernandes LA, Fratini P, Sogayar MC, Carreira ACO.",Front Cell Dev Biol. 2023 Mar 1;10:1047094. doi: 10.3389/fcell.2022.1047094. eCollection 2022.,Aguiar Koga BA,Front Cell Dev Biol,2023,20-03-2023,PMC10014555,,10.3389/fcell.2022.1047094
36929703,A digital health home intervention for people within the Alzheimer's disease continuum: results from the Ability-TelerehABILITation pilot randomized controlled trial,"Rossetto F, Isernia S, Realdon O, Borgnis F, Blasi V, Pagliari C, Cabinio M, Alberoni M, Mantovani F, Clerici M, Baglio F.",Ann Med. 2023 Dec;55(1):1080-1091. doi: 10.1080/07853890.2023.2185672.,Rossetto F,Ann Med,2023,17-03-2023,PMC10030155,,10.1080/07853890.2023.2185672
36929474,Comparison of Cognitive Intervention Strategies for Individuals With Alzheimer's Disease: A Systematic Review and Network Meta-analysis,"Xiang C, Zhang Y.",Neuropsychol Rev. 2024 Jun;34(2):402-416. doi: 10.1007/s11065-023-09584-5. Epub 2023 Mar 16.,Xiang C,Neuropsychol Rev,2024,17-03-2023,PMC11166762,,10.1007/s11065-023-09584-5
36927491,Plasma phospho-tau in Alzheimer's disease: towards diagnostic and therapeutic trial applications,"Gonzalez-Ortiz F, Kac PR, Brum WS, Zetterberg H, Blennow K, Karikari TK.",Mol Neurodegener. 2023 Mar 16;18(1):18. doi: 10.1186/s13024-023-00605-8.,Gonzalez-Ortiz F,Mol Neurodegener,2023,17-03-2023,PMC10022272,,10.1186/s13024-023-00605-8
36927428,Emerging Promise of Therapeutic Approaches Targeting Mitochondria in Neurodegenerative Disorders,"Rahman MM, Tumpa MAA, Rahaman MS, Islam F, Sutradhar PR, Ahmed M, Alghamdi BS, Hafeez A, Alexiou A, Perveen A, Ashraf GM.",Curr Neuropharmacol. 2023;21(5):1081-1099. doi: 10.2174/1570159X21666230316150559.,Rahman MM,Curr Neuropharmacol,2023,17-03-2023,PMC10286587,,10.2174/1570159X21666230316150559
36925964,Polyphenols: Natural food grade biomolecules for treating neurodegenerative diseases from a multi-target perspective,"Li Z, Zhao T, Shi M, Wei Y, Huang X, Shen J, Zhang X, Xie Z, Huang P, Yuan K, Li Z, Li N, Qin D.",Front Nutr. 2023 Feb 28;10:1139558. doi: 10.3389/fnut.2023.1139558. eCollection 2023.,Li Z,Front Nutr,2023,17-03-2023,PMC10011110,,10.3389/fnut.2023.1139558
36921191,Potential of marine compounds in the treatment of neurodegenerative diseases: a review,"Guimarães PL, Tavares DQ, Carrião GS, Oliveira MEH, Oliveira CR.",Braz J Biol. 2023 Mar 13;83:e266795. doi: 10.1590/1519-6984.266795. eCollection 2023.,Guimarães PL,Braz J Biol,2023,15-03-2023,,,10.1590/1519-6984.266795
36918783,"Melatonin as a Harmonizing Factor of Circadian Rhythms, Neuronal Cell Cycle and Neurogenesis: Additional Arguments for Its Therapeutic Use in Alzheimer's Disease","Shukla M, Vincent B.",Curr Neuropharmacol. 2023;21(5):1273-1298. doi: 10.2174/1570159X21666230314142505.,Shukla M,Curr Neuropharmacol,2023,15-03-2023,PMC10286584,,10.2174/1570159X21666230314142505
36905719,Wrist-worn sensor-based measurements for drug effect detection with small samples in people with Lewy Body Dementia,"Chen C, Kowahl NR, Rainaldi E, Burq M, Munsie LM, Battioui C, Wang J, Biglan K, Marks WJ Jr, Kapur R.",Parkinsonism Relat Disord. 2023 Apr;109:105355. doi: 10.1016/j.parkreldis.2023.105355. Epub 2023 Mar 4.,Chen C,Parkinsonism Relat Disord,2023,11-03-2023,,,10.1016/j.parkreldis.2023.105355
36905632,Driving practice effects for older drivers with mild cognitive impairment: A preliminary study,"Cheng YH, Pai MC, Shih BH, Jan SS, Lin CY, Chang LH.",Scand J Occup Ther. 2023 May;30(4):550-558. doi: 10.1080/11038128.2023.2184420. Epub 2023 Mar 11.,Cheng YH,Scand J Occup Ther,2023,11-03-2023,,,10.1080/11038128.2023.2184420
36903581,Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer's Disease,"Zhong X, Na Y, Yin S, Yan C, Gu J, Zhang N, Geng F.",Molecules. 2023 Mar 3;28(5):2336. doi: 10.3390/molecules28052336.,Zhong X,Molecules,2023,11-03-2023,PMC10005336,,10.3390/molecules28052336
36902074,The Effects of Momordica charantia on Type 2 Diabetes Mellitus and Alzheimer's Disease,"Richter E, Geetha T, Burnett D, Broderick TL, Babu JR.",Int J Mol Sci. 2023 Feb 28;24(5):4643. doi: 10.3390/ijms24054643.,Richter E,Int J Mol Sci,2023,11-03-2023,PMC10002567,,10.3390/ijms24054643
36901826,Natural Alkaloids as Multi-Target Compounds towards Factors Implicated in Alzheimer's Disease,"Vrabec R, Blunden G, Cahlíková L.",Int J Mol Sci. 2023 Feb 23;24(5):4399. doi: 10.3390/ijms24054399.,Vrabec R,Int J Mol Sci,2023,11-03-2023,PMC10003045,,10.3390/ijms24054399
36901731,Anti-Inflammatory Effects of Flavonoids in Common Neurological Disorders Associated with Aging,"Martínez-Coria H, Arrieta-Cruz I, Gutiérrez-Juárez R, López-Valdés HE.",Int J Mol Sci. 2023 Feb 21;24(5):4297. doi: 10.3390/ijms24054297.,Martínez-Coria H,Int J Mol Sci,2023,11-03-2023,PMC10001833,,10.3390/ijms24054297
36899898,"The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer's Disease, Amyotrophic Lateral Sclerosis and Aging","Kupershmidt L, Youdim MBH.",Cells. 2023 Feb 27;12(5):763. doi: 10.3390/cells12050763.,Kupershmidt L,Cells,2023,11-03-2023,PMC10001413,,10.3390/cells12050763
36897120,Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS,"Lucey BP, Liu H, Toedebusch CD, Freund D, Redrick T, Chahin SL, Mawuenyega KG, Bollinger JG, Ovod V, Barthélemy NR, Bateman RJ.",Ann Neurol. 2023 Jul;94(1):27-40. doi: 10.1002/ana.26641. Epub 2023 Apr 20.,Lucey BP,Ann Neurol,2023,10-03-2023,PMC10330114,NIHMS1886080,10.1002/ana.26641
36894900,"Acceptability of patient-centered, multi-disciplinary medication therapy management recommendations: results from the INCREASE randomized study","Smith NI, Martinez AI, Huffmyer M, Eckmann L, George R, Abner EL, Jicha GA, Moga DC.",BMC Geriatr. 2023 Mar 10;23(1):137. doi: 10.1186/s12877-023-03876-4.,Smith NI,BMC Geriatr,2023,09-03-2023,PMC9999619,,10.1186/s12877-023-03876-4
36893987,Design and development of the first randomized controlled trial of an intervention (IDEA) for sexual and gender minority older adults living with dementia and care partners,"Fredriksen-Goldsen K, Teri L, Kim HJ, La Fazia D, McKenzie G, Petros R, Jung HH, Jones BR, Brown C, Emlet CA.",Contemp Clin Trials. 2023 May;128:107143. doi: 10.1016/j.cct.2023.107143. Epub 2023 Mar 7.,Fredriksen-Goldsen K,Contemp Clin Trials,2023,09-03-2023,PMC10639124,NIHMS1930001,10.1016/j.cct.2023.107143
36891463,Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings,"Wessels AM, Dennehy EB, Dowsett SA, Dickson SP, Hendrix SB.",Neurol Clin Pract. 2023 Apr;13(2):e200127. doi: 10.1212/CPJ.0000000000200127. Epub 2023 Feb 16.,Wessels AM,Neurol Clin Pract,2023,09-03-2023,PMC9987204,,10.1212/CPJ.0000000000200127
36890259,Esmethadone-HCl (REL-1017): a promising rapid antidepressant,"Fava M, Stahl SM, De Martin S, Mattarei A, Bettini E, Comai S, Alimonti A, Bifari F, Pani L, Folli F, Guidetti C, Furlan A, Sgrignani J, Locatelli P, Cavalli A, O'Gorman C, Traversa S, Inturrisi CE, Pappagallo M, Manfredi PL.",Eur Arch Psychiatry Clin Neurosci. 2023 Oct;273(7):1463-1476. doi: 10.1007/s00406-023-01571-4. Epub 2023 Mar 8.,Fava M,Eur Arch Psychiatry Clin Neurosci,2023,08-03-2023,PMC10465385,,10.1007/s00406-023-01571-4
36879199,Psychometric properties of the Alzheimer's Disease Cooperative Study - Activities of Daily Living for Mild Cognitive Impairment (ADCS-MCI-ADL) scale: a post hoc analysis of the ADCS ADC-008 trial,"Potashman M, Pang M, Tahir M, Shahraz S, Dichter S, Perneczky R, Nolte S.",BMC Geriatr. 2023 Mar 6;23(1):124. doi: 10.1186/s12877-022-03527-0.,Potashman M,BMC Geriatr,2023,06-03-2023,PMC9990271,,10.1186/s12877-022-03527-0
36878051,Therapeutic potential of natural molecules against Alzheimer's disease via SIRT1 modulation,"Zhang M, Tang Z.",Biomed Pharmacother. 2023 May;161:114474. doi: 10.1016/j.biopha.2023.114474. Epub 2023 Mar 4.,Zhang M,Biomed Pharmacother,2023,06-03-2023,,,10.1016/j.biopha.2023.114474
36877496,Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest,"Ashton NJ, Moseby-Knappe M, Benedet AL, Grötschel L, Lantero-Rodriguez J, Karikari TK, Hassager C, Wise MP, Stammet P, Kjaergaard J, Friberg H, Nielsen N, Cronberg T, Zetterberg H, Blennow K.",JAMA Neurol. 2023 Apr 1;80(4):388-396. doi: 10.1001/jamaneurol.2023.0050.,Ashton NJ,JAMA Neurol,2023,06-03-2023,PMC9989959,,10.1001/jamaneurol.2023.0050
36866576,Overview of late-onset psychoses,"Devanand DP, Jeste DV, Stroup TS, Goldberg TE.",Int Psychogeriatr. 2024 Jan;36(1):28-42. doi: 10.1017/S1041610223000157. Epub 2023 Mar 3.,Devanand DP,Int Psychogeriatr,2024,03-03-2023,,,10.1017/S1041610223000157
36857053,Association of Intensive vs Standard Blood Pressure Control With Regional Changes in Cerebral Small Vessel Disease Biomarkers: Post Hoc Secondary Analysis of the SPRINT MIND Randomized Clinical Trial,"Rashid T, Li K, Toledo JB, Nasrallah I, Pajewski NM, Dolui S, Detre J, Wolk DA, Liu H, Heckbert SR, Bryan RN, Williamson J, Davatzikos C, Seshadri S, Launer LJ, Habes M.",JAMA Netw Open. 2023 Mar 1;6(3):e231055. doi: 10.1001/jamanetworkopen.2023.1055.,Rashid T,JAMA Netw Open,2023,01-03-2023,PMC9978954,,10.1001/jamanetworkopen.2023.1055
36850743,Machine Learning and Eye Movements Give Insights into Neurodegenerative Disease Mechanisms,"Przybyszewski AW, Śledzianowski A, Chudzik A, Szlufik S, Koziorowski D.",Sensors (Basel). 2023 Feb 14;23(4):2145. doi: 10.3390/s23042145.,Przybyszewski AW,Sensors (Basel),2023,28-02-2023,PMC9968124,,10.3390/s23042145
36849969,"Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trial","Dubois B, López-Arrieta J, Lipschitz S, Doskas T, Spiru L, Moroz S, Venger O, Vermersch P, Moussy A, Mansfield CD, Hermine O, Tsolaki M; AB09004 Study Group Investigators.",Alzheimers Res Ther. 2023 Feb 28;15(1):39. doi: 10.1186/s13195-023-01169-x.,Dubois B,Alzheimers Res Ther,2023,28-02-2023,PMC9972756,,10.1186/s13195-023-01169-x
36849448,Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older,"Brumm MC, Pierz KA, Lafontant DE, Caspell-Garcia C, Coffey CS, Siderowf A, Marek K.",Neurology. 2023 Apr 18;100(16):e1691-e1701. doi: 10.1212/WNL.0000000000207077. Epub 2023 Feb 27.,Brumm MC,Neurology,2023,27-02-2023,PMC10115503,,10.1212/WNL.0000000000207077
36839359,Impact of Nut Consumption on Cognition across the Lifespan,"Nishi SK, Sala-Vila A, Julvez J, Sabaté J, Ros E.",Nutrients. 2023 Feb 16;15(4):1000. doi: 10.3390/nu15041000.,Nishi SK,Nutrients,2023,25-02-2023,PMC9965316,,10.3390/nu15041000
36834617,Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?,"Mills ZB, Faull RLM, Kwakowsky A.",Int J Mol Sci. 2023 Feb 6;24(4):3205. doi: 10.3390/ijms24043205.,Mills ZB,Int J Mol Sci,2023,25-02-2023,PMC9964432,,10.3390/ijms24043205
36830678,Progress in Investigational Agents Targeting Serotonin-6 Receptors for the Treatment of Brain Disorders,"Nirogi R, Jayarajan P, Shinde A, Mohammed AR, Grandhi VR, Benade V, Goyal VK, Abraham R, Jasti V, Cummings J.",Biomolecules. 2023 Feb 7;13(2):309. doi: 10.3390/biom13020309.,Nirogi R,Biomolecules,2023,25-02-2023,PMC9953539,,10.3390/biom13020309
36825704,Natural Products-based Drugs: Potential Drug Targets Against Neurological Degeneration,"Mittal P, Goyal R, Kapoor R, Wan C, Gautam RK.",Curr Neuropharmacol. 2023;21(4):777-786. doi: 10.2174/1570159X21666230220102605.,Mittal P,Curr Neuropharmacol,2023,24-02-2023,PMC10227921,,10.2174/1570159X21666230220102605
36824566,A Systematic Review of Dietary Supplements in Alzheimer's Disease,"Chimakurthy AK, Lingam S, Pasya SKR, Copeland BJ.",Cureus. 2023 Jan 19;15(1):e33982. doi: 10.7759/cureus.33982. eCollection 2023 Jan.,Chimakurthy AK,Cureus,2023,24-02-2023,PMC9941033,,10.7759/cureus.33982
36821780,Newer glucose-lowering drugs and risk of dementia: A systematic review and meta-analysis of observational studies,"Tang H, Shao H, Shaaban CE, Yang K, Brown J, Anton S, Wu Y, Bress A, Donahoo WT, DeKosky ST, Bian J, Guo J.",J Am Geriatr Soc. 2023 Jul;71(7):2096-2106. doi: 10.1111/jgs.18306. Epub 2023 Feb 23.,Tang H,J Am Geriatr Soc,2023,23-02-2023,PMC10363181,NIHMS1874796,10.1111/jgs.18306
36814932,Conventional machine learning and deep learning in Alzheimer's disease diagnosis using neuroimaging: A review,"Zhao Z, Chuah JH, Lai KW, Chow CO, Gochoo M, Dhanalakshmi S, Wang N, Bao W, Wu X.",Front Comput Neurosci. 2023 Feb 6;17:1038636. doi: 10.3389/fncom.2023.1038636. eCollection 2023.,Zhao Z,Front Comput Neurosci,2023,23-02-2023,PMC9939698,,10.3389/fncom.2023.1038636
36805256,"Evaluating depressive symptoms, BDNF Val66Met, and APOE-ε4 as moderators of response to computerized cognitive training in heart failure","Pressler SJ, Jung M, Giordani B, Titler MG, Gradus-Pizlo I, Lake KR, Wierenga KL, Clark DG, Perkins SM, Smith DG, Mocci E, Dorsey SG.",Heart Lung. 2023 May-Jun;59:146-156. doi: 10.1016/j.hrtlng.2023.02.002. Epub 2023 Feb 18.,Pressler SJ,Heart Lung,2023,22-02-2023,PMC10065971,NIHMS1877969,10.1016/j.hrtlng.2023.02.002
36801471,An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines,"Bayani F, Hashkavaei NS, Arjmand S, Rezaei S, Uskoković V, Alijanianzadeh M, Uversky VN, Ranaei Siadat SO, Mozaffari-Jovin S, Sefidbakht Y.",Prog Biophys Mol Biol. 2023 Mar;178:32-49. doi: 10.1016/j.pbiomolbio.2023.02.004. Epub 2023 Feb 18.,Bayani F,Prog Biophys Mol Biol,2023,21-02-2023,PMC9938630,,10.1016/j.pbiomolbio.2023.02.004
36798012,"Safety, tolerability, and pharmacokinetics of fluoropezil (DC20), a novel acetylcholinesterase inhibitor: A phase I study in healthy young and elderly Chinese subjects","Qian H, Yu C, Zhu H, Ding Q, Cai Y, Jing J, Xu X, Guo R, Zhang H, Liu H, Chen X, Liu Y.",Clin Transl Sci. 2023 May;16(5):810-822. doi: 10.1111/cts.13490. Epub 2023 Feb 26.,Qian H,Clin Transl Sci,2023,17-02-2023,PMC10175976,,10.1111/cts.13490
36791792,Guiding safer risperidone prescribing in Alzheimer's disease with therapeutic drug monitoring,"Roughley M, Mena C, Howard R, Reeves S, Bertrand J.",Br J Clin Pharmacol. 2023 Jul;89(7):2316-2321. doi: 10.1111/bcp.15692. Epub 2023 Feb 28.,Roughley M,Br J Clin Pharmacol,2023,15-02-2023,,,10.1111/bcp.15692
36790601,Blood and cerebrospinal fluid biomarker changes in patients with HIV-associated neurocognitive impairment treated with lithium: analysis from a randomised placebo-controlled trial,"Thela L, Decloedt E, Zetterberg H, Gisslén M, Lesosky M, Gleich M, Koutsilieri E, Scheller C, Hye A, Joska J.",J Neurovirol. 2023 Apr;29(2):156-166. doi: 10.1007/s13365-023-01116-4. Epub 2023 Feb 15.,Thela L,J Neurovirol,2023,15-02-2023,PMC10185609,,10.1007/s13365-023-01116-4
36782122,Implementing a home-based personalised cognitive rehabilitation intervention for people with mild-to-moderate dementia: GREAT into Practice,"Clare L, Kudlicka A, Collins R, Evans S, Pool J, Henderson C, Knapp M, Litherland R, Oyebode J, Woods R.",BMC Geriatr. 2023 Feb 13;23(1):93. doi: 10.1186/s12877-022-03705-0.,Clare L,BMC Geriatr,2023,14-02-2023,PMC9925212,,10.1186/s12877-022-03705-0
36777777,"Testing the knowledge of Alzheimer's disease via an intervention study among community health service center staff in Jiaxing, China","Ma W, Zhu L, Tang J, Diao W, Qian L, Feng X, Zhang X.",Front Public Health. 2023 Jan 27;10:969653. doi: 10.3389/fpubh.2022.969653. eCollection 2022.,Ma W,Front Public Health,2023,13-02-2023,PMC9911520,,10.3389/fpubh.2022.969653
36776068,The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review,"Hui BSM, Zhi LR, Retinasamy T, Arulsamy A, Law CSW, Shaikh MF, Yeong KY.",J Alzheimers Dis. 2023;94(s1):S45-S66. doi: 10.3233/JAD-221081.,Hui BSM,J Alzheimers Dis,2023,13-02-2023,PMC10473139,,10.3233/JAD-221081
36775284,Aducanumab for the treatment of Alzheimer's disease: a systematic review,"Rahman A, Hossen MA, Chowdhury MFI, Bari S, Tamanna N, Sultana SS, Haque SN, Al Masud A, Saif-Ur-Rahman KM.",Psychogeriatrics. 2023 May;23(3):512-522. doi: 10.1111/psyg.12944. Epub 2023 Feb 12.,Rahman A,Psychogeriatrics,2023,12-02-2023,PMC11578022,,10.1111/psyg.12944
36771152,Anti-Neuroinflammatory Potential of Natural Products in the Treatment of Alzheimer's Disease,"Deng M, Yan W, Gu Z, Li Y, Chen L, He B.",Molecules. 2023 Feb 3;28(3):1486. doi: 10.3390/molecules28031486.,Deng M,Molecules,2023,11-02-2023,PMC9920976,,10.3390/molecules28031486
36770950,Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders,"Guo ZH, Khattak S, Rauf MA, Ansari MA, Alomary MN, Razak S, Yang CY, Wu DD, Ji XY.",Molecules. 2023 Jan 28;28(3):1283. doi: 10.3390/molecules28031283.,Guo ZH,Molecules,2023,11-02-2023,PMC9921752,,10.3390/molecules28031283
36770750,A Review on Recent Approaches on Molecular Docking Studies of Novel Compounds Targeting Acetylcholinesterase in Alzheimer Disease,"Peitzika SC, Pontiki E.",Molecules. 2023 Jan 21;28(3):1084. doi: 10.3390/molecules28031084.,Peitzika SC,Molecules,2023,11-02-2023,PMC9921523,,10.3390/molecules28031084
36769340,Oxidative Stress and Aging as Risk Factors for Alzheimer's Disease and Parkinson's Disease: The Role of the Antioxidant Melatonin,"Tchekalarova J, Tzoneva R.",Int J Mol Sci. 2023 Feb 3;24(3):3022. doi: 10.3390/ijms24033022.,Tchekalarova J,Int J Mol Sci,2023,11-02-2023,PMC9917989,,10.3390/ijms24033022
36768703,Melatonin Can Modulate Neurodegenerative Diseases by Regulating Endoplasmic Reticulum Stress,"Yoo YM, Joo SS.",Int J Mol Sci. 2023 Jan 25;24(3):2381. doi: 10.3390/ijms24032381.,Yoo YM,Int J Mol Sci,2023,11-02-2023,PMC9916953,,10.3390/ijms24032381
36761917,The amyloid imaging for the prevention of Alzheimer's disease consortium: A European collaboration with global impact,"Collij LE, Farrar G, Valléz García D, Bader I, Shekari M, Lorenzini L, Pemberton H, Altomare D, Pla S, Loor M, Markiewicz P, Yaqub M, Buckley C, Frisoni GB, Nordberg A, Payoux P, Stephens A, Gismondi R, Visser PJ, Ford L, Schmidt M, Birck C, Georges J, Mett A, Walker Z, Boada M, Drzezga A, Vandenberghe R, Hanseeuw B, Jessen F, Schöll M, Ritchie C, Lopes Alves I, Gispert JD, Barkhof F.",Front Neurol. 2023 Jan 20;13:1063598. doi: 10.3389/fneur.2022.1063598. eCollection 2022.,Collij LE,Front Neurol,2023,10-02-2023,PMC9907029,,10.3389/fneur.2022.1063598
36754068,The kynurenine pathway in Alzheimer's disease: a meta-analysis of central and peripheral levels,"Fernandes BS, Inam ME, Enduru N, Quevedo J, Zhao Z.",Braz J Psychiatry. 2023 May-Jun;45(3):286-297. doi: 10.47626/1516-4446-2022-2962. Epub 2022 Feb 8.,Fernandes BS,Braz J Psychiatry,2023,08-02-2023,PMC10288481,,10.47626/1516-4446-2022-2962
36752115,The Role of Ketogenic Diet in the Treatment of Neuroblastoma,"Makuku R, Sinaei Far Z, Khalili N, Moyo A, Razi S, Keshavarz-Fathi M, Mahmoudi M, Rezaei N.",Integr Cancer Ther. 2023 Jan-Dec;22:15347354221150787. doi: 10.1177/15347354221150787.,Makuku R,Integr Cancer Ther,2023,08-02-2023,PMC9909060,,10.1177/15347354221150787
36751940,Baseline characteristics of the North American prodromal Synucleinopathy cohort,"Elliott JE, Lim MM, Keil AT, Postuma RB, Pelletier A, Gagnon JF, St Louis EK, Forsberg LK, Fields JA, Huddleston DE, Bliwise DL, Avidan AY, Howell MJ, Schenck CH, McLeland J, Criswell SR, Videnovic A, During EH, Miglis MG, Shprecher DR, Lee-Iannotti JK, Boeve BF, Ju YS; North American Prodromal Synucleinopathy (NAPS) Consortium.",Ann Clin Transl Neurol. 2023 Apr;10(4):520-535. doi: 10.1002/acn3.51738. Epub 2023 Feb 8.,Elliott JE,Ann Clin Transl Neurol,2023,08-02-2023,PMC10109527,,10.1002/acn3.51738
36751779,Investigational treatments for neurodegenerative diseases caused by inheritance of gene mutations: lessons from recent clinical trials,"Imbimbo BP, Triaca V, Imbimbo C, Nisticò R.",Neural Regen Res. 2023 Aug;18(8):1679-1683. doi: 10.4103/1673-5374.363185.,Imbimbo BP,Neural Regen Res,2023,08-02-2023,PMC10154469,,10.4103/1673-5374.363185
36749830,Lecanemab (BAN2401): an anti-beta-amyloid monoclonal antibody for the treatment of Alzheimer disease,"Vitek GE, Decourt B, Sabbagh MN.",Expert Opin Investig Drugs. 2023 Feb;32(2):89-94. doi: 10.1080/13543784.2023.2178414. Epub 2023 Feb 28.,Vitek GE,Expert Opin Investig Drugs,2023,07-02-2023,PMC10275297,NIHMS1873229,10.1080/13543784.2023.2178414
36740800,New Perspectives of Taxifolin in Neurodegenerative Diseases,"Yang R, Yang X, Zhang F.",Curr Neuropharmacol. 2023;21(10):2097-2109. doi: 10.2174/1570159X21666230203101107.,Yang R,Curr Neuropharmacol,2023,06-02-2023,PMC10556370,,10.2174/1570159X21666230203101107
36736039,Cognitive rehabilitation and mindfulness reduce cognitive complaints in multiple sclerosis (REMIND-MS): A randomized controlled trial,"Nauta IM, Bertens D, Fasotti L, Fieldhouse J, Uitdehaag BMJ, Kessels RPC, Speckens AEM, de Jong BA.",Mult Scler Relat Disord. 2023 Mar;71:104529. doi: 10.1016/j.msard.2023.104529. Epub 2023 Jan 20.,Nauta IM,Mult Scler Relat Disord,2023,03-02-2023,,,10.1016/j.msard.2023.104529
36731808,Clinical efficacy and safety of compound Congrong Yizhi Capsules on Alzheimer's disease in mainland China: A systematic review with trial sequential analysis and GRADE assessment,"Wang Y, Wang N, Xu Z, Liu S, Liang X, Zhang Y, Jin X.",J Ethnopharmacol. 2023 Jun 12;309:116208. doi: 10.1016/j.jep.2023.116208. Epub 2023 Jan 31.,Wang Y,J Ethnopharmacol,2023,02-02-2023,,,10.1016/j.jep.2023.116208
36730056,"Tilavonemab in early Alzheimer's disease: results from a phase 2, randomized, double-blind study","Florian H, Wang D, Arnold SE, Boada M, Guo Q, Jin Z, Zheng H, Fisseha N, Kalluri HV, Rendenbach-Mueller B, Budur K, Gold M.",Brain. 2023 Jun 1;146(6):2275-2284. doi: 10.1093/brain/awad024.,Florian H,Brain,2023,02-02-2023,PMC10232284,,10.1093/brain/awad024
36725099,"Systematic, comprehensive, evidence-based approach to identify neuroprotective interventions for motor neuron disease: using systematic reviews to inform expert consensus","Wong C, Gregory JM, Liao J, Egan K, Vesterinen HM, Ahmad Khan A, Anwar M, Beagan C, Brown FS, Cafferkey J, Cardinali A, Chiam JY, Chiang C, Collins V, Dormido J, Elliott E, Foley P, Foo YC, Fulton-Humble L, Gane AB, Glasmacher SA, Heffernan Á, Jayaprakash K, Jayasuriya N, Kaddouri A, Kiernan J, Langlands G, Leighton D, Liu J, Lyon J, Mehta AR, Meng A, Nguyen V, Park NH, Quigley S, Rashid Y, Salzinger A, Shiell B, Singh A, Soane T, Thompson A, Tomala O, Waldron FM, Selvaraj BT, Chataway J, Swingler R, Connick P, Pal S, Chandran S, Macleod M.",BMJ Open. 2023 Feb 1;13(2):e064169. doi: 10.1136/bmjopen-2022-064169.,Wong C,BMJ Open,2023,01-02-2023,PMC9896226,,10.1136/bmjopen-2022-064169
36722274,Effect of L-Carnosine in Patients with Age-Related Diseases: A Systematic Review and Meta-Analysis,"Sureshkumar K, Durairaj M, Srinivasan K, Goh KW, Undela K, Mahalingam VT, Ardianto C, Ming LC, Ganesan RM.",Front Biosci (Landmark Ed). 2023 Jan 18;28(1):18. doi: 10.31083/j.fbl2801018.,Sureshkumar K,Front Biosci (Landmark Ed),2023,01-02-2023,,,10.31083/j.fbl2801018
36720351,The pollutome-connectome axis: a putative mechanism to explain pollution effects on neurodegeneration,"Pini L, Salvalaggio A, Wennberg AM, Dimakou A, Matteoli M, Corbetta M.",Ageing Res Rev. 2023 Apr;86:101867. doi: 10.1016/j.arr.2023.101867. Epub 2023 Jan 28.,Pini L,Ageing Res Rev,2023,31-01-2023,,,10.1016/j.arr.2023.101867
36709611,Association between anxiety symptoms and Alzheimer's disease biomarkers in cognitively healthy adults: A systematic review and meta-analysis,"Demnitz-King H, Saba L, Lau Y, Munns L, Zabihi S, Schlosser M, Del-Pino-Casado R, Orgeta V, Marchant NL.",J Psychosom Res. 2023 Mar;166:111159. doi: 10.1016/j.jpsychores.2023.111159. Epub 2023 Jan 20.,Demnitz-King H,J Psychosom Res,2023,29-01-2023,,,10.1016/j.jpsychores.2023.111159
36709275,Efficacy and safety of the novel GlyT1 inhibitor BI 425809 in Alzheimer's dementia: a randomized controlled trial,"Wunderlich G, Blahova Z, Garcia M, Jessen F.",Alzheimers Res Ther. 2023 Jan 28;15(1):24. doi: 10.1186/s13195-023-01163-3.,Wunderlich G,Alzheimers Res Ther,2023,28-01-2023,PMC9883916,,10.1186/s13195-023-01163-3
36704501,Effect of exercise on cognitive function and synaptic plasticity in Alzheimer's disease models: A systematic review and meta-analysis,"Guo L, Yang X, Zhang Y, Xu X, Li Y.",Front Aging Neurosci. 2023 Jan 10;14:1077732. doi: 10.3389/fnagi.2022.1077732. eCollection 2022.,Guo L,Front Aging Neurosci,2023,27-01-2023,PMC9872519,,10.3389/fnagi.2022.1077732
36703196,"Combined metabolic activators improve cognitive functions in Alzheimer's disease patients: a randomised, double-blinded, placebo-controlled phase-II trial","Yulug B, Altay O, Li X, Hanoglu L, Cankaya S, Lam S, Velioglu HA, Yang H, Coskun E, Idil E, Nogaylar R, Ozsimsek A, Bayram C, Bolat I, Oner S, Tozlu OO, Arslan ME, Hacimuftuoglu A, Yildirim S, Arif M, Shoaie S, Zhang C, Nielsen J, Turkez H, Borén J, Uhlén M, Mardinoglu A.",Transl Neurodegener. 2023 Jan 26;12(1):4. doi: 10.1186/s40035-023-00336-2.,Yulug B,Transl Neurodegener,2023,26-01-2023,PMC9879258,,10.1186/s40035-023-00336-2
36700520,Antithrombotic treatment after stroke due to intracerebral haemorrhage,"Cochrane A, Chen C, Stephen J, Rønning OM, Anderson CS, Hankey GJ, Al-Shahi Salman R.",Cochrane Database Syst Rev. 2023 Jan 26;1(1):CD012144. doi: 10.1002/14651858.CD012144.pub3.,Cochrane A,Cochrane Database Syst Rev,2023,26-01-2023,PMC9878977,,10.1002/14651858.CD012144.pub3
36689720,[Androgens and Parkinson's disease: the role in humans and in experiment],"Hamadyanova AU, Kuznetsov KO, Gaifullina EI, Kalandin DA, Khamidullina RR, Khalitova IF, Faizov RM, Kamaletdinova NO, Aslanova BF, Nakieva AG, Burangulova LE, Gaisina GO.",Probl Endokrinol (Mosk). 2022 Sep 4;68(6):146-156. doi: 10.14341/probl13148.,Hamadyanova AU,Probl Endokrinol (Mosk),2022,23-01-2023,PMC9939975,,10.14341/probl13148
36684083,Alzheimer's and Parkinson's disease therapies in the clinic,"Chopade P, Chopade N, Zhao Z, Mitragotri S, Liao R, Chandran Suja V.",Bioeng Transl Med. 2022 Aug 3;8(1):e10367. doi: 10.1002/btm2.10367. eCollection 2023 Jan.,Chopade P,Bioeng Transl Med,2022,23-01-2023,PMC9842041,,10.1002/btm2.10367
36683513,Activity of Choline Alphoscerate on Adult-Onset Cognitive Dysfunctions: A Systematic Review and Meta-Analysis,"Sagaro GG, Traini E, Amenta F.",J Alzheimers Dis. 2023;92(1):59-70. doi: 10.3233/JAD-221189.,Sagaro GG,J Alzheimers Dis,2023,23-01-2023,PMC10041421,,10.3233/JAD-221189
36683507,The Case for a Novel Therapeutic Approach to Dementia: Small Molecule Hepatocyte Growth Factor (HGF/MET) Positive Modulators,"Moebius HJ, Church KJ.",J Alzheimers Dis. 2023;92(1):1-12. doi: 10.3233/JAD-220871.,Moebius HJ,J Alzheimers Dis,2023,23-01-2023,PMC10041442,,10.3233/JAD-220871
36682465,Repurposing digoxin for geroprotection in patients with frailty and multimorbidity,"Lee H, Wilson D, Bunting KV, Kotecha D, Jackson T.",Ageing Res Rev. 2023 Apr;86:101860. doi: 10.1016/j.arr.2023.101860. Epub 2023 Jan 20.,Lee H,Ageing Res Rev,2023,22-01-2023,,,10.1016/j.arr.2023.101860
36678257,Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis,"Bonvicini M, Travaglini S, Lelli D, Antonelli Incalzi R, Pedone C.",Nutrients. 2023 Jan 12;15(2):386. doi: 10.3390/nu15020386.,Bonvicini M,Nutrients,2023,21-01-2023,PMC9866349,,10.3390/nu15020386
36676122,"Mediterranean Diet, Ketogenic Diet or MIND Diet for Aging Populations with Cognitive Decline: A Systematic Review","Devranis P, Vassilopoulou Ε, Tsironis V, Sotiriadis PM, Chourdakis M, Aivaliotis M, Tsolaki M.",Life (Basel). 2023 Jan 6;13(1):173. doi: 10.3390/life13010173.,Devranis P,Life (Basel),2023,21-01-2023,PMC9866105,,10.3390/life13010173
36675233,"Tacrine-Based Hybrids: Past, Present, and Future","Bubley A, Erofeev A, Gorelkin P, Beloglazkina E, Majouga A, Krasnovskaya O.",Int J Mol Sci. 2023 Jan 15;24(2):1717. doi: 10.3390/ijms24021717.,Bubley A,Int J Mol Sci,2023,21-01-2023,PMC9863713,,10.3390/ijms24021717
36672187,Zebrafish: A Model Deciphering the Impact of Flavonoids on Neurodegenerative Disorders,"Mhalhel K, Sicari M, Pansera L, Chen J, Levanti M, Diotel N, Rastegar S, Germanà A, Montalbano G.",Cells. 2023 Jan 7;12(2):252. doi: 10.3390/cells12020252.,Mhalhel K,Cells,2023,21-01-2023,PMC9856690,,10.3390/cells12020252
36672134,Sex Differences in the Level of Homocysteine in Alzheimer's Disease and Parkinson's Disease Patients: A Meta-Analysis,"Nguyen VP, Collins AE, Hickey JP, Pfeifer JA, Kalisch BE.",Brain Sci. 2023 Jan 15;13(1):153. doi: 10.3390/brainsci13010153.,Nguyen VP,Brain Sci,2023,21-01-2023,PMC9856546,,10.3390/brainsci13010153
36662216,"Application of Marine Natural Products against Alzheimer's Disease: Past, Present and Future","Hu D, Jin Y, Hou X, Zhu Y, Chen D, Tai J, Chen Q, Shi C, Ye J, Wu M, Zhang H, Lu Y.",Mar Drugs. 2023 Jan 5;21(1):43. doi: 10.3390/md21010043.,Hu D,Mar Drugs,2023,20-01-2023,PMC9867307,,10.3390/md21010043
36648966,Cognitive Rehabilitation in Schizophrenia-Associated Cognitive Impairment: A Review,"Zoupa E, Bogiatzidou O, Siokas V, Liampas I, Tzeferakos G, Mavreas V, Stylianidis S, Dardiotis E.",Neurol Int. 2022 Dec 29;15(1):12-23. doi: 10.3390/neurolint15010002.,Zoupa E,Neurol Int,2022,17-01-2023,PMC9844333,,10.3390/neurolint15010002
36639676,Theta tACS impairs episodic memory more than tDCS,"Murray NWG, Graham PL, Sowman PF, Savage G.",Sci Rep. 2023 Jan 13;13(1):716. doi: 10.1038/s41598-022-27190-y.,Murray NWG,Sci Rep,2023,13-01-2023,PMC9839727,,10.1038/s41598-022-27190-y
36637075,Omega-3 fatty acids and cognitive function,Welty FK.,Curr Opin Lipidol. 2023 Feb 1;34(1):12-21. doi: 10.1097/MOL.0000000000000862. Epub 2022 Nov 25.,Welty FK,Curr Opin Lipidol,2023,13-01-2023,PMC11878108,NIHMS1850531,10.1097/MOL.0000000000000862
36633908,Oral anticoagulants: A plausible new treatment for Alzheimer's disease?,"Toribio-Fernandez R, Ceron C, Tristão-Pereira C, Fernandez-Nueda I, Perez-Castillo A, Fernandez-Ferro J, Moro MA, Ibañez B, Fuster V, Cortes-Canteli M.",Br J Pharmacol. 2024 Mar;181(6):760-776. doi: 10.1111/bph.16032. Epub 2023 Jan 31.,Toribio-Fernandez R,Br J Pharmacol,2024,12-01-2023,,,10.1111/bph.16032
36633696,Photobiomodulation for Alzheimer's disease: photoelectric coupling effect on attenuating Aβ neurotoxicity,"Tian Z, Wang P, Huang K, Yu J, Zhang M, Liu Y, Zhao H, Zhu B, Huang X, Tong Z.",Lasers Med Sci. 2023 Jan 12;38(1):39. doi: 10.1007/s10103-022-03692-z.,Tian Z,Lasers Med Sci,2023,12-01-2023,PMC9837011,,10.1007/s10103-022-03692-z
36630846,The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer's disease,"Valis M, Dlabkova A, Hort J, Angelucci F, Pejchal J, Kuca K, Pavelek Z, Karasova JZ, Novotny M.",Biomed Pharmacother. 2023 Mar;159:114223. doi: 10.1016/j.biopha.2023.114223. Epub 2023 Jan 9.,Valis M,Biomed Pharmacother,2023,11-01-2023,,,10.1016/j.biopha.2023.114223
36629544,"Biomedical role of L-carnitine in several organ systems, cellular tissues, and COVID-19",Al-Dhuayan IS.,Braz J Biol. 2023 Jan 9;82:e267633. doi: 10.1590/1519-6984.267633. eCollection 2023.,Al-Dhuayan IS,Braz J Biol,2023,11-01-2023,,,10.1590/1519-6984.267633
36621964,Antidepressant medications in dementia: evidence and potential mechanisms of treatment-resistance,"Costello H, Roiser JP, Howard R.",Psychol Med. 2023 Feb;53(3):654-667. doi: 10.1017/S003329172200397X. Epub 2023 Jan 9.,Costello H,Psychol Med,2023,09-01-2023,PMC9976038,,10.1017/S003329172200397X
36617781,Loneliness and Cognitive Function in Older Adults Without Dementia: A Systematic Review and Meta-Analysis,"Harrington KD, Vasan S, Kang JE, Sliwinski MJ, Lim MH.",J Alzheimers Dis. 2023;91(4):1243-1259. doi: 10.3233/JAD-220832.,Harrington KD,J Alzheimers Dis,2023,09-01-2023,PMC9983432,NIHMS1868826,10.3233/JAD-220832
36615708,"Probiotic Bifidobacterium longum BB68S Improves Cognitive Functions in Healthy Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial","Shi S, Zhang Q, Sang Y, Ge S, Wang Q, Wang R, He J.",Nutrients. 2022 Dec 22;15(1):51. doi: 10.3390/nu15010051.,Shi S,Nutrients,2022,08-01-2023,PMC9824790,,10.3390/nu15010051
36615279,Potential Benefits of Anthocyanins in Chronic Disorders of the Central Nervous System,"Panchal SK, Brown L.",Molecules. 2022 Dec 22;28(1):80. doi: 10.3390/molecules28010080.,Panchal SK,Molecules,2022,08-01-2023,PMC9822395,,10.3390/molecules28010080
36615197,Anti-Inflammatory Effects of Marine Bioactive Compounds and Their Potential as Functional Food Ingredients in the Prevention and Treatment of Neuroinflammatory Disorders,Elbandy M.,Molecules. 2022 Dec 20;28(1):2. doi: 10.3390/molecules28010002.,Elbandy M,Molecules,2022,08-01-2023,PMC9822486,,10.3390/molecules28010002
36614266,Chaperone-Dependent Mechanisms as a Pharmacological Target for Neuroprotection,"Voronin MV, Abramova EV, Verbovaya ER, Vakhitova YV, Seredenin SB.",Int J Mol Sci. 2023 Jan 3;24(1):823. doi: 10.3390/ijms24010823.,Voronin MV,Int J Mol Sci,2023,08-01-2023,PMC9820882,,10.3390/ijms24010823
36613586,Updates on the Role of Probiotics against Different Health Issues: Focus on Lactobacillus,"Un-Nisa A, Khan A, Zakria M, Siraj S, Ullah S, Tipu MK, Ikram M, Kim MO.",Int J Mol Sci. 2022 Dec 21;24(1):142. doi: 10.3390/ijms24010142.,Un-Nisa A,Int J Mol Sci,2022,08-01-2023,PMC9820606,,10.3390/ijms24010142
36613531,Vitamin D in Neurological Diseases,"Plantone D, Primiano G, Manco C, Locci S, Servidei S, De Stefano N.",Int J Mol Sci. 2022 Dec 21;24(1):87. doi: 10.3390/ijms24010087.,Plantone D,Int J Mol Sci,2022,08-01-2023,PMC9820561,,10.3390/ijms24010087
36611925,Pharmacotherapy Evolution in Alzheimer's Disease: Current Framework and Relevant Directions,"Miculas DC, Negru PA, Bungau SG, Behl T, Hassan SSU, Tit DM.",Cells. 2022 Dec 28;12(1):131. doi: 10.3390/cells12010131.,Miculas DC,Cells,2022,08-01-2023,PMC9818415,,10.3390/cells12010131
36603135,"Symptoms of Anxiety, Depression, and Stress among Families of Critically Ill Patients with COVID-19: A Longitudinal Clinical Trial","Sarigiannis KA, Tringali JJ, Vu J, Eaton England A, Lietzau S, Hebert C, Banayan D, Basapur S, Glover CM, Shah RC, Gerhart J, Greenberg JA.",Ann Am Thorac Soc. 2023 May;20(5):705-712. doi: 10.1513/AnnalsATS.202209-797OC.,Sarigiannis KA,Ann Am Thorac Soc,2023,05-01-2023,PMC10174131,,10.1513/AnnalsATS.202209-797OC
36591860,Ginkgolides and bilobalide for treatment of Alzheimer's disease and COVID-19: potential mechanisms of action,"Niu TT, Yuan BY, Liu GZ.",Eur Rev Med Pharmacol Sci. 2022 Dec;26(24):9502-9510. doi: 10.26355/eurrev_202212_30702.,Niu TT,Eur Rev Med Pharmacol Sci,2022,02-01-2023,,,10.26355/eurrev_202212_30702
36589809,"PPARα: An emerging target of metabolic syndrome, neurodegenerative and cardiovascular diseases","Lin Y, Wang Y, Li PF.",Front Endocrinol (Lausanne). 2022 Dec 16;13:1074911. doi: 10.3389/fendo.2022.1074911. eCollection 2022.,Lin Y,Front Endocrinol (Lausanne),2022,02-01-2023,PMC9800994,,10.3389/fendo.2022.1074911
36588502,Apathy in patients with Alzheimer's disease is a cost-driving factor,"Kruse C, Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-Schmidinger T, Schneider A, Shah-Hosseini K, Teipel S, von Arnim CAF, Wiltfang J, van der Wurp H, Dodel R, Jessen F.",Alzheimers Dement. 2023 Jul;19(7):2853-2864. doi: 10.1002/alz.12915. Epub 2023 Jan 2.,Kruse C,Alzheimers Dement,2023,02-01-2023,,,10.1002/alz.12915
36586644,Role of monomeric amyloid-β in cognitive performance in Alzheimer's disease: Insights from clinical trials with secretase inhibitors and monoclonal antibodies,"Imbimbo BP, Ippati S, Watling M, Imbimbo C.",Pharmacol Res. 2023 Jan;187:106631. doi: 10.1016/j.phrs.2022.106631. Epub 2022 Dec 28.,Imbimbo BP,Pharmacol Res,2023,31-12-2022,,,10.1016/j.phrs.2022.106631
36585999,Revisiting the therapeutic potential of gingerols against different pharmacological activities,"Sharma S, Shukla MK, Sharma KC, Tirath, Kumar L, Anal JMH, Upadhyay SK, Bhattacharyya S, Kumar D.",Naunyn Schmiedebergs Arch Pharmacol. 2023 Apr;396(4):633-647. doi: 10.1007/s00210-022-02372-7. Epub 2022 Dec 31.,Sharma S,Naunyn Schmiedebergs Arch Pharmacol,2023,31-12-2022,PMC9803890,,10.1007/s00210-022-02372-7
36583148,A Feasibility Study of Individuals Living at Home with Alzheimer's Disease and Related Dementias: Utilization of Visual Mapping Assistive Technology to Enhance Quality of Life and Reduce Caregiver Burden,"Han SS, White K, Cisek E.",Clin Interv Aging. 2022 Dec 23;17:1885-1892. doi: 10.2147/CIA.S387255. eCollection 2022.,Han SS,Clin Interv Aging,2022,30-12-2022,PMC9793743,,10.2147/CIA.S387255
36581878,CYP46A1 activation by low-dose efavirenz enhances brain cholesterol metabolism in subjects with early Alzheimer's disease,"Lerner AJ, Arnold SE, Maxfield E, Koenig A, Toth ME, Fortin B, Mast N, Trombetta BA, Denker J, Pieper AA, Tatsuoka C, Raghupathy S, Pikuleva IA.",Alzheimers Res Ther. 2022 Dec 29;14(1):198. doi: 10.1186/s13195-022-01151-z.,Lerner AJ,Alzheimers Res Ther,2022,29-12-2022,PMC9797897,,10.1186/s13195-022-01151-z
36575843,Natural and Semi-Synthetic Flavonoid Anti-SARS-CoV-2 Agents for the Treatment of Long COVID-19 Disease and Neurodegenerative Disorders of Cognitive Decline,"Melrose J, Smith MM.",Front Biosci (Elite Ed). 2022 Oct 9;14(4):27. doi: 10.31083/j.fbe1404027.,Melrose J,Front Biosci (Elite Ed),2022,28-12-2022,,,10.31083/j.fbe1404027
36574616,"Does Multicomponent Physical Exercise Training Work for Dementia? Exploring the Effects on Cognition, Neuropsychiatric Symptoms, and Quality of Life","Borges-Machado F, Teixeira L, Carvalho J, Ribeiro O.",J Geriatr Psychiatry Neurol. 2023 Sep;36(5):376-385. doi: 10.1177/08919887221149152. Epub 2022 Dec 27.,Borges-Machado F,J Geriatr Psychiatry Neurol,2023,27-12-2022,PMC10394955,,10.1177/08919887221149152
36573329,Amyloid-β PET in Alzheimer's disease: A systematic review and Bayesian meta-analysis,"Ruan D, Sun L.",Brain Behav. 2023 Jan;13(1):e2850. doi: 10.1002/brb3.2850. Epub 2022 Dec 27.,Ruan D,Brain Behav,2023,27-12-2022,PMC9847612,,10.1002/brb3.2850
36569670,The Efficacy of Vitamin D Supplementation in Patients With Alzheimer's Disease in Preventing Cognitive Decline: A Systematic Review,"Chakkera M, Ravi N, Ramaraju R, Vats A, Nair AR, Bandhu AK, Koirala D, Pallapothu MR, Quintana Mariñez MG, Khan S.",Cureus. 2022 Nov 20;14(11):e31710. doi: 10.7759/cureus.31710. eCollection 2022 Nov.,Chakkera M,Cureus,2022,26-12-2022,PMC9771092,,10.7759/cureus.31710
36567278,Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer's and Parkinson's Diseases,"Javed H, Mohamed Fizur NM, Jha NK, Ashraf GM, Ojha S.",Curr Neuropharmacol. 2023;21(6):1421-1432. doi: 10.2174/1570159X21666221223120251.,Javed H,Curr Neuropharmacol,2023,25-12-2022,PMC10324337,,10.2174/1570159X21666221223120251
36565114,Could Country-Level Factors Explain Sex Differences in Dementia Incidence and Prevalence? A Systematic Review and Meta-Analysis,"Huque H, Eramudugolla R, Chidiac B, Ee N, Ehrenfeld L, Matthews FE, Peters R, Anstey KJ.",J Alzheimers Dis. 2023;91(4):1231-1241. doi: 10.3233/JAD-220724.,Huque H,J Alzheimers Dis,2023,24-12-2022,PMC9986694,,10.3233/JAD-220724
36558176,Phytochemical Compounds and Nanoparticles as Phytochemical Delivery Systems for Alzheimer's Disease Management,"Bakrim S, Aboulaghras S, El Menyiy N, El Omari N, Assaggaf H, Lee LH, Montesano D, Gallo M, Zengin G, AlDhaheri Y, Bouyahya A.",Molecules. 2022 Dec 19;27(24):9043. doi: 10.3390/molecules27249043.,Bakrim S,Molecules,2022,23-12-2022,PMC9781052,,10.3390/molecules27249043
36557851,Acylhydrazones and Their Biological Activity: A Review,"Socea LI, Barbuceanu SF, Pahontu EM, Dumitru AC, Nitulescu GM, Sfetea RC, Apostol TV.",Molecules. 2022 Dec 9;27(24):8719. doi: 10.3390/molecules27248719.,Socea LI,Molecules,2022,23-12-2022,PMC9783609,,10.3390/molecules27248719
36555450,Current Insights on the Use of Insulin and the Potential Use of Insulin Mimetics in Targeting Insulin Signalling in Alzheimer's Disease,"Woodfield A, Gonzales T, Helmerhorst E, Laws S, Newsholme P, Porter T, Verdile G.",Int J Mol Sci. 2022 Dec 13;23(24):15811. doi: 10.3390/ijms232415811.,Woodfield A,Int J Mol Sci,2022,23-12-2022,PMC9779379,,10.3390/ijms232415811
36551289,Development of a Gastrointestinal-Myoelectrical-Activity-Based Nomogram Model for Predicting the Risk of Mild Cognitive Impairment,"Li B, Ji S, Peng A, Yang N, Zhao X, Feng P, Zhang Y, Chen L.",Biomolecules. 2022 Dec 12;12(12):1861. doi: 10.3390/biom12121861.,Li B,Biomolecules,2022,23-12-2022,PMC9775682,,10.3390/biom12121861
36549548,Cross-sectional and prospective associations between homocysteine and a frailty index: A post-hoc analysis of the multidomain Alzheimer's prevention trial (MAPT),"St-Martin P, Dionne IJ, Maltais M, Rolland Y; MAPT/DSA Study Group.",Exp Gerontol. 2023 Feb;172:112066. doi: 10.1016/j.exger.2022.112066. Epub 2022 Dec 20.,St-Martin P,Exp Gerontol,2023,22-12-2022,,,10.1016/j.exger.2022.112066
36544184,"Lecanemab in patients with early Alzheimer's disease: detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study","McDade E, Cummings JL, Dhadda S, Swanson CJ, Reyderman L, Kanekiyo M, Koyama A, Irizarry M, Kramer LD, Bateman RJ.",Alzheimers Res Ther. 2022 Dec 21;14(1):191. doi: 10.1186/s13195-022-01124-2.,McDade E,Alzheimers Res Ther,2022,21-12-2022,PMC9768996,,10.1186/s13195-022-01124-2
36541080,Utilizing type 2 diabetes medications outside glycemic parameters - where are we headed?,"Malkani NP, Aroda VR.",Curr Opin Endocrinol Diabetes Obes. 2023 Feb 1;30(1):1-6. doi: 10.1097/MED.0000000000000787. Epub 2022 Dec 6.,Malkani NP,Curr Opin Endocrinol Diabetes Obes,2023,21-12-2022,PMC9870453,NIHMS1851193,10.1097/MED.0000000000000787
36530613,Efficacy and safety of hypoglycemic drugs in improving cognitive function in patients with Alzheimer's disease and mild cognitive impairment: A systematic review and network meta-analysis,"Wang XC, Chu CL, Li HC, Lu K, Liu CJ, Cai YF, Quan SJ, Zhang SJ.",Front Neurol. 2022 Nov 30;13:1018027. doi: 10.3389/fneur.2022.1018027. eCollection 2022.,Wang XC,Front Neurol,2022,19-12-2022,PMC9747761,,10.3389/fneur.2022.1018027
36530204,Association between loneliness and dementia risk: A systematic review and meta-analysis of cohort studies,"Qiao L, Wang G, Tang Z, Zhou S, Min J, Yin M, Li M.",Front Hum Neurosci. 2022 Dec 1;16:899814. doi: 10.3389/fnhum.2022.899814. eCollection 2022.,Qiao L,Front Hum Neurosci,2022,19-12-2022,PMC9751343,,10.3389/fnhum.2022.899814
36530084,Rationale and Design of the PARTNER Trial: Partnered Rhythmic Rehabilitation for Enhanced Motor-Cognition in Prodromal Alzheimer's Disease,"Cao K, Bay AA, Hajjar I, Wharton W, Goldstein F, Qiu D, Prusin T, McKay JL, Perkins MM, Hackney ME.",J Alzheimers Dis. 2023;91(3):1019-1033. doi: 10.3233/JAD-220783.,Cao K,J Alzheimers Dis,2023,19-12-2022,PMC10105523,NIHMS1890166,10.3233/JAD-220783
36529331,Association of air pollution with dementia: a systematic review with meta-analysis including new cohort data from China,"Tang J, Chen A, He F, Shipley M, Nevill A, Coe H, Hu Z, Zhang T, Kan H, Brunner E, Tao X, Chen R.",Environ Res. 2023 Apr 15;223:115048. doi: 10.1016/j.envres.2022.115048. Epub 2022 Dec 16.,Tang J,Environ Res,2023,18-12-2022,,,10.1016/j.envres.2022.115048
36513918,Implications of Adverse Outcomes Associated with Antipsychotics in Older Patients with Dementia: A 2011-2022 Update,"Rogowska M, Thornton M, Creese B, Velayudhan L, Aarsland D, Ballard C, Tsamakis K, Stewart R, Mueller C.",Drugs Aging. 2023 Jan;40(1):21-32. doi: 10.1007/s40266-022-00992-5. Epub 2022 Dec 14.,Rogowska M,Drugs Aging,2023,13-12-2022,PMC9747539,,10.1007/s40266-022-00992-5
36501161,Quercetin Is An Active Agent in Berries against Neurodegenerative Diseases Progression through Modulation of Nrf2/HO1,"Bayazid AB, Lim BO.",Nutrients. 2022 Dec 2;14(23):5132. doi: 10.3390/nu14235132.,Bayazid AB,Nutrients,2022,11-12-2022,PMC9737775,,10.3390/nu14235132
36501136,Extra-Virgin Olive Oil Enhances the Blood-Brain Barrier Function in Mild Cognitive Impairment: A Randomized Controlled Trial,"Kaddoumi A, Denney TS Jr, Deshpande G, Robinson JL, Beyers RJ, Redden DT, Praticò D, Kyriakides TC, Lu B, Kirby AN, Beck DT, Merner ND.",Nutrients. 2022 Dec 1;14(23):5102. doi: 10.3390/nu14235102.,Kaddoumi A,Nutrients,2022,11-12-2022,PMC9736478,,10.3390/nu14235102
36501033,The Role of Ketogenic Diet in the Treatment of Neurological Diseases,"Dyńka D, Kowalcze K, Paziewska A.",Nutrients. 2022 Nov 24;14(23):5003. doi: 10.3390/nu14235003.,Dyńka D,Nutrients,2022,11-12-2022,PMC9739023,,10.3390/nu14235003
36499656,"Is Periodontitis Associated with Age-Related Cognitive Impairment? The Systematic Review, Confounders Assessment and Meta-Analysis of Clinical Studies",Dziedzic A.,Int J Mol Sci. 2022 Dec 5;23(23):15320. doi: 10.3390/ijms232315320.,Dziedzic A,Int J Mol Sci,2022,11-12-2022,PMC9739281,,10.3390/ijms232315320
36499562,Disease-Modifying Activity of Huperzine A on Alzheimer's Disease: Evidence from Preclinical Studies on Rodent Models,"Yan YP, Chen JY, Lu JH.",Int J Mol Sci. 2022 Dec 3;23(23):15238. doi: 10.3390/ijms232315238.,Yan YP,Int J Mol Sci,2022,11-12-2022,PMC9738397,,10.3390/ijms232315238
36499159,The Neuroprotective Potentiality of Flavonoids on Alzheimer's Disease,"Calderaro A, Patanè GT, Tellone E, Barreca D, Ficarra S, Misiti F, Laganà G.",Int J Mol Sci. 2022 Nov 27;23(23):14835. doi: 10.3390/ijms232314835.,Calderaro A,Int J Mol Sci,2022,11-12-2022,PMC9736131,,10.3390/ijms232314835
36498223,Open Questions on the Electromagnetic Field Contribution to the Risk of Neurodegenerative Diseases,"Wyszkowska J, Pritchard C.",Int J Environ Res Public Health. 2022 Dec 2;19(23):16150. doi: 10.3390/ijerph192316150.,Wyszkowska J,Int J Environ Res Public Health,2022,11-12-2022,PMC9738318,,10.3390/ijerph192316150
36497772,The Effect of Aerobic Exercise on Cognitive Function in People with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,"Zhang S, Zhen K, Su Q, Chen Y, Lv Y, Yu L.",Int J Environ Res Public Health. 2022 Nov 25;19(23):15700. doi: 10.3390/ijerph192315700.,Zhang S,Int J Environ Res Public Health,2022,11-12-2022,PMC9736612,,10.3390/ijerph192315700
36497196,Mushroom Natural Products in Neurodegenerative Disease Drug Discovery,"Abitbol A, Mallard B, Tiralongo E, Tiralongo J.",Cells. 2022 Dec 6;11(23):3938. doi: 10.3390/cells11233938.,Abitbol A,Cells,2022,11-12-2022,PMC9740391,,10.3390/cells11233938
36482412,Consistency of efficacy results across various clinical measures and statistical methods in the lecanemab phase 2 trial of early Alzheimer's disease,"Dhadda S, Kanekiyo M, Li D, Swanson CJ, Irizarry M, Berry S, Kramer LD, Berry DA.",Alzheimers Res Ther. 2022 Dec 9;14(1):182. doi: 10.1186/s13195-022-01129-x.,Dhadda S,Alzheimers Res Ther,2022,09-12-2022,PMC9733166,,10.1186/s13195-022-01129-x
36472107,Research Progress of Targeting Neuro-Immune Inflammation in the Treatment of Alzheimer's Disease,"Chen H, Deng C, Meng Z, Meng S.",Front Biosci (Landmark Ed). 2022 Nov 25;27(11):312. doi: 10.31083/j.fbl2711312.,Chen H,Front Biosci (Landmark Ed),2022,06-12-2022,,,10.31083/j.fbl2711312
36470231,The Potential of Transcranial Alternating Current Stimulation to Alleviate Dual-Task Gait Costs in Older Adults: Insights from a Double-Blinded Pilot Study,"Sayig-Keren RM, Dagan M, Cornejo Thumm P, Brozgol M, Gazit E, Manor B, Hausdorff JM.",Gerontology. 2023;69(4):513-518. doi: 10.1159/000527171. Epub 2022 Dec 5.,Sayig-Keren RM,Gerontology,2023,05-12-2022,PMC10073237,NIHMS1848161,10.1159/000527171
36467555,Acupuncture May Be a Potential Complementary Therapy for Alzheimer's Disease: A Network Meta-Analysis,"Yin W, Chen Y, Xu A, Tang Y, Zeng Q, Wang X, Li Z.",Evid Based Complement Alternat Med. 2022 Nov 23;2022:6970751. doi: 10.1155/2022/6970751. eCollection 2022.,Yin W,Evid Based Complement Alternat Med,2022,05-12-2022,PMC9711957,,10.1155/2022/6970751
36460293,"Efficacy and safety of simultaneous rTMS-tDCS over bilateral angular gyrus on neuropsychiatric symptoms in patients with moderate Alzheimer's disease: A prospective, randomized, sham-controlled pilot study","Hu Y, Jia Y, Sun Y, Ding Y, Huang Z, Liu C, Wang Y.",Brain Stimul. 2022 Nov-Dec;15(6):1530-1537. doi: 10.1016/j.brs.2022.11.009. Epub 2022 Nov 30.,Hu Y,Brain Stimul,2022,02-12-2022,,,10.1016/j.brs.2022.11.009
36455806,Emulate randomized clinical trials using heterogeneous treatment effect estimation for personalized treatments: Methodology review and benchmark,"Ling Y, Upadhyaya P, Chen L, Jiang X, Kim Y.",J Biomed Inform. 2023 Jan;137:104256. doi: 10.1016/j.jbi.2022.104256. Epub 2022 Nov 28.,Ling Y,J Biomed Inform,2023,01-12-2022,PMC9845190,NIHMS1855891,10.1016/j.jbi.2022.104256
36455762,Optimizing quantification of MK6240 tau PET in unimpaired older adults,"Harrison TM, Ward TJ, Murphy A, Baker SL, Dominguez PA, Koeppe R, Vemuri P, Lockhart SN, Jung Y, Harvey DJ, Lovato L, Toga AW, Masdeu J, Oh H, Gitelman DR, Aggarwal N, Snyder HM, Baker LD, DeCarli C, Jagust WJ, Landau SM; U.S. POINTER Study Group.",Neuroimage. 2023 Jan;265:119761. doi: 10.1016/j.neuroimage.2022.119761. Epub 2022 Nov 28.,Harrison TM,Neuroimage,2023,01-12-2022,PMC9957642,NIHMS1872566,10.1016/j.neuroimage.2022.119761
36455638,Chronic pain in Alzheimer's disease: Endocannabinoid system,"Blanton H, Reddy PH, Benamar K.",Exp Neurol. 2023 Feb;360:114287. doi: 10.1016/j.expneurol.2022.114287. Epub 2022 Nov 29.,Blanton H,Exp Neurol,2023,01-12-2022,PMC9789196,NIHMS1855012,10.1016/j.expneurol.2022.114287
36454969,Gamma frequency sensory stimulation in mild probable Alzheimer's dementia patients: Results of feasibility and pilot studies,"Chan D, Suk HJ, Jackson BL, Milman NP, Stark D, Klerman EB, Kitchener E, Fernandez Avalos VS, de Weck G, Banerjee A, Beach SD, Blanchard J, Stearns C, Boes AD, Uitermarkt B, Gander P, Howard M 3rd, Sternberg EJ, Nieto-Castanon A, Anteraper S, Whitfield-Gabrieli S, Brown EN, Boyden ES, Dickerson BC, Tsai LH.",PLoS One. 2022 Dec 1;17(12):e0278412. doi: 10.1371/journal.pone.0278412. eCollection 2022.,Chan D,PLoS One,2022,01-12-2022,PMC9714926,,10.1371/journal.pone.0278412
36452439,Effect of hearing aids on cognitive functions in middle-aged and older adults with hearing loss: A systematic review and meta-analysis,"Yang Z, Ni J, Teng Y, Su M, Wei M, Li T, Fan D, Lu T, Xie H, Zhang W, Shi J, Tian J.",Front Aging Neurosci. 2022 Nov 14;14:1017882. doi: 10.3389/fnagi.2022.1017882. eCollection 2022.,Yang Z,Front Aging Neurosci,2022,01-12-2022,PMC9704725,,10.3389/fnagi.2022.1017882
36447737,Translation of Collaborative Dementia Care Management into Different Healthcare Settings: Study Protocol for a Multicenter Implementation Trial (DCM:IMPact),"Platen M, Hoffmann W, Rädke A, Scharf A, Mohr W, Mühlichen F, Michalowsky B.",J Alzheimers Dis Rep. 2022 Oct 13;6(1):617-626. doi: 10.3233/ADR-220045. eCollection 2022.,Platen M,J Alzheimers Dis Rep,2022,30-11-2022,PMC9661350,,10.3233/ADR-220045
36447240,Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease,"Bateman RJ, Cummings J, Schobel S, Salloway S, Vellas B, Boada M, Black SE, Blennow K, Fontoura P, Klein G, Assunção SS, Smith J, Doody RS.",Alzheimers Res Ther. 2022 Nov 29;14(1):178. doi: 10.1186/s13195-022-01110-8.,Bateman RJ,Alzheimers Res Ther,2022,29-11-2022,PMC9707418,,10.1186/s13195-022-01110-8
36443888,Efficacy and safety of blood derivatives therapy in Alzheimer's disease: a systematic review and meta-analysis,"Fei Z, Pan B, Pei R, Chen Z, Du X, Cao H, Li C.",Syst Rev. 2022 Nov 29;11(1):256. doi: 10.1186/s13643-022-02115-y.,Fei Z,Syst Rev,2022,29-11-2022,PMC9706869,,10.1186/s13643-022-02115-y
36442202,Impact of Computerized Cognitive Training on Default Mode Network Connectivity in Subjects at Risk for Alzheimer's Disease: A 78-week Randomized Controlled Trial,"Petrella JR, Michael AM, Qian M, Nwosu A, Sneed J, Goldberg TE, Devanand DP, Doraiswamy PM.",J Alzheimers Dis. 2023;91(1):483-494. doi: 10.3233/JAD-220946.,Petrella JR,J Alzheimers Dis,2023,28-11-2022,PMC9881022,,10.3233/JAD-220946
36442199,Mindfulness Prevents Depression and Psychopathology in Elderly People with Mild to Moderate Alzheimer's Disease: A Randomized Clinical Trial,"Quintana-Hernández DJ, Rojas-Hernández J, Santana-Del Pino A, Céspedes Suárez C, Pellejero Silva M, Miró-Barrachina MT, Ibáñez Fernández I, Estupiñán López JA, Borkel LF.",J Alzheimers Dis. 2023;91(1):471-481. doi: 10.3233/JAD-220889.,Quintana-Hernández DJ,J Alzheimers Dis,2023,28-11-2022,PMC9881020,,10.3233/JAD-220889
36440413,Effect of virtual reality exercise on interventions for patients with Alzheimer's disease: A systematic review,"Yi Y, Hu Y, Cui M, Wang C, Wang J.",Front Psychiatry. 2022 Nov 9;13:1062162. doi: 10.3389/fpsyt.2022.1062162. eCollection 2022.,Yi Y,Front Psychiatry,2022,28-11-2022,PMC9681900,,10.3389/fpsyt.2022.1062162
36435362,Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights,"Oliyaei N, Moosavi-Nasab M, Tanideh N, Iraji A.",Brain Res Bull. 2023 Feb;193:11-21. doi: 10.1016/j.brainresbull.2022.11.018. Epub 2022 Nov 23.,Oliyaei N,Brain Res Bull,2023,26-11-2022,,,10.1016/j.brainresbull.2022.11.018
36430894,The Role of Insulin Signaling in Hippocampal-Related Diseases: A Focus on Alzheimer's Disease,"Liu Q, Wang Z, Cao J, Dong Y, Chen Y.",Int J Mol Sci. 2022 Nov 20;23(22):14417. doi: 10.3390/ijms232214417.,Liu Q,Int J Mol Sci,2022,26-11-2022,PMC9699017,,10.3390/ijms232214417
36430432,Alzheimer's Disease: Treatment Strategies and Their Limitations,"Passeri E, Elkhoury K, Morsink M, Broersen K, Linder M, Tamayol A, Malaplate C, Yen FT, Arab-Tehrany E.",Int J Mol Sci. 2022 Nov 12;23(22):13954. doi: 10.3390/ijms232213954.,Passeri E,Int J Mol Sci,2022,26-11-2022,PMC9697769,,10.3390/ijms232213954
36430365,Recent Progress in Research on Mechanisms of Action of Natural Products against Alzheimer's Disease: Dietary Plant Polyphenols,"Wang Y, Wang K, Yan J, Zhou Q, Wang X.",Int J Mol Sci. 2022 Nov 11;23(22):13886. doi: 10.3390/ijms232213886.,Wang Y,Int J Mol Sci,2022,26-11-2022,PMC9695301,,10.3390/ijms232213886
36429962,Cost-Effectiveness of the Comprehensive Interdisciplinary Program-Care in Informal Caregivers of People with Alzheimer's Disease,"Muñoz-Bermejo L, González-Becerra MJ, Barrios-Fernández S, Postigo-Mota S, Jerez-Barroso MDR, Martínez JAF, Suárez-Lantarón B, Marín DM, Martín-Bermúdez N, Ortés-Gómez R, Gómez-Ullate-García de León M, Martínez-Acevedo M, Rocha-Gómez L, Espejo-Antúnez S, Fraile-Bravo M, Galán MGS, Chato-Gonzalo I, Muñoz FJD, Hernández-Mocholí MÁ, Madruga-Vicente M, Prado-Solano A, Mendoza-Muñoz M, Carlos-Vivas J, Pérez-Gómez J, Pastor-Cisneros R, Fuentes-Flores P, Pereira-Payo D, De Los Ríos-Calonge J, Urbano-Mairena J, Guerra-Bustamante J, Adsuar JC.",Int J Environ Res Public Health. 2022 Nov 18;19(22):15243. doi: 10.3390/ijerph192215243.,Muñoz-Bermejo L,Int J Environ Res Public Health,2022,26-11-2022,PMC9691117,,10.3390/ijerph192215243
36424608,Health effects of milk consumption: phenome-wide Mendelian randomization study,"Yuan S, Sun J, Lu Y, Xu F, Li D, Jiang F, Wan Z, Li X, Qin LQ, Larsson SC.",BMC Med. 2022 Nov 23;20(1):455. doi: 10.1186/s12916-022-02658-w.,Yuan S,BMC Med,2022,24-11-2022,PMC9694907,,10.1186/s12916-022-02658-w
36420620,Role of estrogen in women's Alzheimer's disease risk as modified by APOE,"Valencia-Olvera AC, Maldonado Weng J, Christensen A, LaDu MJ, Pike CJ.",J Neuroendocrinol. 2023 Feb;35(2):e13209. doi: 10.1111/jne.13209. Epub 2022 Nov 24.,Valencia-Olvera AC,J Neuroendocrinol,2023,24-11-2022,PMC10049970,NIHMS1843988,10.1111/jne.13209
36419628,Natural product-based pharmacological studies for neurological disorders,"Puri V, Kanojia N, Sharma A, Huanbutta K, Dheer D, Sangnim T.",Front Pharmacol. 2022 Nov 7;13:1011740. doi: 10.3389/fphar.2022.1011740. eCollection 2022.,Puri V,Front Pharmacol,2022,24-11-2022,PMC9676372,,10.3389/fphar.2022.1011740
36414626,"Effectiveness of KarXT (xanomeline-trospium) for cognitive impairment in schizophrenia: post hoc analyses from a randomised, double-blind, placebo-controlled phase 2 study","Sauder C, Allen LA, Baker E, Miller AC, Paul SM, Brannan SK.",Transl Psychiatry. 2022 Nov 21;12(1):491. doi: 10.1038/s41398-022-02254-9.,Sauder C,Transl Psychiatry,2022,22-11-2022,PMC9681874,,10.1038/s41398-022-02254-9
36410013,A natural history study to track brain and spinal cord changes in individuals with Friedreich's ataxia: TRACK-FA study protocol,"Georgiou-Karistianis N, Corben LA, Reetz K, Adanyeguh IM, Corti M, Deelchand DK, Delatycki MB, Dogan I, Evans R, Farmer J, França MC, Gaetz W, Harding IH, Harris KS, Hersch S, Joules R, Joers JJ, Krishnan ML, Lax M, Lock EF, Lynch D, Mareci T, Muthuhetti Gamage S, Pandolfo M, Papoutsi M, Rezende TJR, Roberts TPL, Rosenberg JT, Romanzetti S, Schulz JB, Schilling T, Schwarz AJ, Subramony S, Yao B, Zicha S, Lenglet C, Henry PG.",PLoS One. 2022 Nov 21;17(11):e0269649. doi: 10.1371/journal.pone.0269649. eCollection 2022.,Georgiou-Karistianis N,PLoS One,2022,21-11-2022,PMC9678384,,10.1371/journal.pone.0269649
36404542,Real-World Use of Symptomatic Treatments in Early Alzheimer's Disease,"Garcia MJ, Leadley R, Lang S, Ross J, Vinand E, Ballard C, Gsteiger S.",J Alzheimers Dis. 2023;91(1):151-167. doi: 10.3233/JAD-220471.,Garcia MJ,J Alzheimers Dis,2023,21-11-2022,PMC9881030,,10.3233/JAD-220471
36403899,"The effects of time-restricted eating on sleep, cognitive decline, and Alzheimer's disease","Ezzati A, Pak VM.",Exp Gerontol. 2023 Jan;171:112033. doi: 10.1016/j.exger.2022.112033. Epub 2022 Nov 17.,Ezzati A,Exp Gerontol,2023,20-11-2022,,,10.1016/j.exger.2022.112033
36399826,Applications and research progress of Traditional Chinese medicine delivered via nasal administration,"Hou H, Li Y, Xu Z, Yu Z, Peng B, Wang C, Liu W, Li W, Ye Z, Zhang G.",Biomed Pharmacother. 2023 Jan;157:113933. doi: 10.1016/j.biopha.2022.113933. Epub 2022 Nov 15.,Hou H,Biomed Pharmacother,2023,18-11-2022,,,10.1016/j.biopha.2022.113933
36398135,Predictive Power of Cognitive Biomarkers in Neurodegenerative Disease Drug Development: Utility of the P300 Event-Related Potential,"Olichney J, Xia J, Church KJ, Moebius HJ.",Neural Plast. 2022 Nov 8;2022:2104880. doi: 10.1155/2022/2104880. eCollection 2022.,Olichney J,Neural Plast,2022,18-11-2022,PMC9666049,,10.1155/2022/2104880
36395695,Associations between pituitary-ovarian hormones and cognition in recently menopausal women independent of type of hormone therapy,"Kling JM, Dowling NM, Bimonte-Nelson H, Gleason CE, Kantarci K, Stonnington CM, Harman SM, Naftolin F, Pal L, Cedars M, Manson JE, James TT, Brinton EA, Miller VM.",Maturitas. 2023 Jan;167:113-122. doi: 10.1016/j.maturitas.2022.10.002. Epub 2022 Oct 27.,Kling JM,Maturitas,2023,17-11-2022,PMC10077876,NIHMS1883649,10.1016/j.maturitas.2022.10.002
36395147,Infectious origin of Alzheimer's disease: Amyloid beta as a component of brain antimicrobial immunity,"Vojtechova I, Machacek T, Kristofikova Z, Stuchlik A, Petrasek T.",PLoS Pathog. 2022 Nov 17;18(11):e1010929. doi: 10.1371/journal.ppat.1010929. eCollection 2022 Nov.,Vojtechova I,PLoS Pathog,2022,17-11-2022,PMC9671327,,10.1371/journal.ppat.1010929
36394721,"Classification of Alzheimer's disease stage using machine learning for left and right oxygenation difference signals in the prefrontal cortex: a patient-level, single-group, diagnostic interventional trial","Kim J, Kim SC, Kang D, Yon DK, Kim JG.",Eur Rev Med Pharmacol Sci. 2022 Nov;26(21):7734-7741. doi: 10.26355/eurrev_202211_30122.,Kim J,Eur Rev Med Pharmacol Sci,2022,17-11-2022,,,10.26355/eurrev_202211_30122
36389228,The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders,"Bashir Y, Khan AU.",Front Neurosci. 2022 Oct 28;16:1030694. doi: 10.3389/fnins.2022.1030694. eCollection 2022.,Bashir Y,Front Neurosci,2022,17-11-2022,PMC9650127,,10.3389/fnins.2022.1030694
36381829,Fecal Microbiota Transplantation Role in the Treatment of Alzheimer's Disease: A Systematic Review,"Nassar ST, Tasha T, Desai A, Bajgain A, Ali A, Dutta C, Pasha K, Paul S, Abbas MS, Venugopal S.",Cureus. 2022 Oct 6;14(10):e29968. doi: 10.7759/cureus.29968. eCollection 2022 Oct.,Nassar ST,Cureus,2022,16-11-2022,PMC9637434,,10.7759/cureus.29968
36380226,Ginsenoside Rg1 in neurological diseases: From bench to bedside,"Yang SJ, Wang JJ, Cheng P, Chen LX, Hu JM, Zhu GQ.",Acta Pharmacol Sin. 2023 May;44(5):913-930. doi: 10.1038/s41401-022-01022-1. Epub 2022 Nov 15.,Yang SJ,Acta Pharmacol Sin,2023,15-11-2022,PMC10104881,,10.1038/s41401-022-01022-1
36376775,The Costs of Dementia in Europe: An Updated Review and Meta-analysis,"Jönsson L, Tate A, Frisell O, Wimo A.",Pharmacoeconomics. 2023 Jan;41(1):59-75. doi: 10.1007/s40273-022-01212-z. Epub 2022 Nov 15.,Jönsson L,Pharmacoeconomics,2023,15-11-2022,PMC9813179,,10.1007/s40273-022-01212-z
36376734,Non-drug Therapies for Alzheimer's Disease: A Review,"Li X, Ji M, Zhang H, Liu Z, Chai Y, Cheng Q, Yang Y, Cordato D, Gao J.",Neurol Ther. 2023 Feb;12(1):39-72. doi: 10.1007/s40120-022-00416-x. Epub 2022 Nov 14.,Li X,Neurol Ther,2023,15-11-2022,PMC9837368,,10.1007/s40120-022-00416-x
36374833,Association of kidney function and brain health: A systematic review and meta-analysis of cohort studies,"Tang X, Han YP, Chai YH, Gong HJ, Xu H, Patel I, Qiao YS, Zhang JY, Cardoso MA, Zhou JB.",Ageing Res Rev. 2022 Dec;82:101762. doi: 10.1016/j.arr.2022.101762. Epub 2022 Oct 29.,Tang X,Ageing Res Rev,2022,14-11-2022,,,10.1016/j.arr.2022.101762
36372278,Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment,"Kopp KO, Glotfelty EJ, Li Y, Greig NH.",Pharmacol Res. 2022 Dec;186:106550. doi: 10.1016/j.phrs.2022.106550. Epub 2022 Nov 11.,Kopp KO,Pharmacol Res,2022,13-11-2022,PMC9712272,NIHMS1850778,10.1016/j.phrs.2022.106550
36371016,Can dementia risk be reduced by following the American Heart Association's Life's Simple 7? A systematic review and dose-response meta-analysis,"Wu J, Xiong Y, Xia X, Orsini N, Qiu C, Kivipelto M, Rizzuto D, Wang R.",Ageing Res Rev. 2023 Jan;83:101788. doi: 10.1016/j.arr.2022.101788. Epub 2022 Nov 9.,Wu J,Ageing Res Rev,2023,12-11-2022,,,10.1016/j.arr.2022.101788
36364850,Research Advances on the Damage Mechanism of Skin Glycation and Related Inhibitors,"Zheng W, Li H, Go Y, Chan XHF, Huang Q, Wu J.",Nutrients. 2022 Nov 1;14(21):4588. doi: 10.3390/nu14214588.,Zheng W,Nutrients,2022,11-11-2022,PMC9655929,,10.3390/nu14214588
36364000,Repurposing SGLT2 Inhibitors for Neurological Disorders: A Focus on the Autism Spectrum Disorder,"Nakhal MM, Aburuz S, Sadek B, Akour A.",Molecules. 2022 Oct 23;27(21):7174. doi: 10.3390/molecules27217174.,Nakhal MM,Molecules,2022,11-11-2022,PMC9653623,,10.3390/molecules27217174
36362351,Antiviral Potential of Plants against COVID-19 during Outbreaks-An Update,Jamal QMS.,Int J Mol Sci. 2022 Nov 5;23(21):13564. doi: 10.3390/ijms232113564.,Jamal QMS,Int J Mol Sci,2022,11-11-2022,PMC9655040,,10.3390/ijms232113564
36362220,The Interplay between Ghrelin and Microglia in Neuroinflammation: Implications for Obesity and Neurodegenerative Diseases,"Russo C, Valle MS, Russo A, Malaguarnera L.",Int J Mol Sci. 2022 Nov 3;23(21):13432. doi: 10.3390/ijms232113432.,Russo C,Int J Mol Sci,2022,11-11-2022,PMC9654207,,10.3390/ijms232113432
36359767,"Empagliflozin Induced Ketosis, Upregulated IGF-1/Insulin Receptors and the Canonical Insulin Signaling Pathway in Neurons, and Decreased the Excitatory Neurotransmitter Glutamate in the Brain of Non-Diabetics","Avgerinos KI, Mullins RJ, Vreones M, Mustapic M, Chen Q, Melvin D, Kapogiannis D, Egan JM.",Cells. 2022 Oct 25;11(21):3372. doi: 10.3390/cells11213372.,Avgerinos KI,Cells,2022,11-11-2022,PMC9657243,,10.3390/cells11213372
36357586,Treadmill training with virtual reality to enhance gait and cognitive function among people with multiple sclerosis: a randomized controlled trial,"Galperin I, Mirelman A, Schmitz-Hübsch T, Hsieh KL, Regev K, Karni A, Brozgol M, Cornejo Thumm P, Lynch SG, Paul F, Devos H, Sosnoff J, Hausdorff JM.",J Neurol. 2023 Mar;270(3):1388-1401. doi: 10.1007/s00415-022-11469-1. Epub 2022 Nov 11.,Galperin I,J Neurol,2023,10-11-2022,PMC9649393,,10.1007/s00415-022-11469-1
36357257,Plasma Exchange in Alzheimer's Disease,"Rohrer L, Yunce M, Montine TJ, Shan H.",Transfus Med Rev. 2023 Jan;37(1):10-15. doi: 10.1016/j.tmrv.2022.09.005. Epub 2022 Oct 3.,Rohrer L,Transfus Med Rev,2023,10-11-2022,,,10.1016/j.tmrv.2022.09.005
36356629,"Science disconnected: the translational gap between basic science, clinical trials, and patient care in Alzheimer's disease","Gregory S, Saunders S, Ritchie CW.",Lancet Healthy Longev. 2022 Nov;3(11):e797-e803. doi: 10.1016/S2666-7568(22)00219-7.,Gregory S,Lancet Healthy Longev,2022,10-11-2022,,,10.1016/S2666-7568(22)00219-7
36354985,Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect,"Ferreira I, Rauter AP, Bandarra NM.",Mar Drugs. 2022 Oct 25;20(11):662. doi: 10.3390/md20110662.,Ferreira I,Mar Drugs,2022,10-11-2022,PMC9695993,,10.3390/md20110662
36353622,Beneficial effects of natural flavonoids on neuroinflammation,"Chen Y, Peng F, Xing Z, Chen J, Peng C, Li D.",Front Immunol. 2022 Oct 24;13:1006434. doi: 10.3389/fimmu.2022.1006434. eCollection 2022.,Chen Y,Front Immunol,2022,10-11-2022,PMC9638012,,10.3389/fimmu.2022.1006434
36352320,Tubulin Cytoskeleton in Neurodegenerative Diseases-not Only Primary Tubulinopathies,"Cyske Z, Gaffke L, Pierzynowska K, Węgrzyn G.",Cell Mol Neurobiol. 2023 Jul;43(5):1867-1884. doi: 10.1007/s10571-022-01304-6. Epub 2022 Nov 9.,Cyske Z,Cell Mol Neurobiol,2023,09-11-2022,PMC10287795,,10.1007/s10571-022-01304-6
36347158,Sense of meaning and purpose in life and risk of incident dementia: New data and meta-analysis,"Sutin DAR, Luchetti M, Aschwanden D, Stephan Y, Sesker AA, Terracciano A.",Arch Gerontol Geriatr. 2023 Feb;105:104847. doi: 10.1016/j.archger.2022.104847. Epub 2022 Oct 23.,Sutin DAR,Arch Gerontol Geriatr,2023,08-11-2022,PMC10015423,NIHMS1869770,10.1016/j.archger.2022.104847
36342703,Daily Low-Dose Aspirin and Risk of Serious Falls and Fractures in Healthy Older People: A Substudy of the ASPREE Randomized Clinical Trial,"Barker AL, Morello R, Thao LTP, Seeman E, Ward SA, Sanders KM, Cumming RG, Pasco JA, Ebeling PR, Woods RL, Wolfe R, Khosla S, Hussain SM, Ronaldson K, Newman AB, Williamson JD, McNeil JJ.",JAMA Intern Med. 2022 Dec 1;182(12):1289-1297. doi: 10.1001/jamainternmed.2022.5028.,Barker AL,JAMA Intern Med,2022,07-11-2022,PMC9641595,,10.1001/jamainternmed.2022.5028
36341847,A randomized controlled trial to test the efficacy of a diabetes behavioral intervention to prevent memory decline in older blacks/African Americans with diabetes and mild cognitive impairment,"Casten R, Leiby BE, Kelley M, Rovner BW.",Contemp Clin Trials. 2022 Dec;123:106977. doi: 10.1016/j.cct.2022.106977. Epub 2022 Oct 28.,Casten R,Contemp Clin Trials,2022,07-11-2022,PMC9787831,NIHMS1859388,10.1016/j.cct.2022.106977
36341846,The Preventing Alzheimer's with Cognitive Training (PACT) randomized clinical trial,"Nicholson JS, Hudak EM, Phillips CB, Chanti-Ketterl M, O'Brien JL, Ross LA, Lister JJ, Burke JR, Potter G, Plassman BL, Woods AJ, Krischer J, Edwards JD.",Contemp Clin Trials. 2022 Dec;123:106978. doi: 10.1016/j.cct.2022.106978. Epub 2022 Oct 28.,Nicholson JS,Contemp Clin Trials,2022,07-11-2022,PMC10312210,NIHMS1851540,10.1016/j.cct.2022.106978
36337711,The NLR family pyrin domain containing 3 inflammasome in the mechanism of electroacupuncture: Current status and future perspectives,"Yuan M, Wang D, Yang J, Lan H.",Front Aging Neurosci. 2022 Oct 19;14:913881. doi: 10.3389/fnagi.2022.913881. eCollection 2022.,Yuan M,Front Aging Neurosci,2022,07-11-2022,PMC9626972,,10.3389/fnagi.2022.913881
36336934,"Neural Stem Cells in the Treatment of Alzheimer's Disease: Current Status, Challenges, and Future Prospects","Chen X, Jiang S, Wang R, Bao X, Li Y.",J Alzheimers Dis. 2023;94(s1):S173-S186. doi: 10.3233/JAD-220721.,Chen X,J Alzheimers Dis,2023,07-11-2022,PMC10473082,,10.3233/JAD-220721
36336488,"High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 2: putative scenarios and timeline in case of approval, recommendations for use, implementation, and ethical considerations in France","Villain N, Planche V, Levy R.",Rev Neurol (Paris). 2022 Dec;178(10):999-1010. doi: 10.1016/j.neurol.2022.08.002. Epub 2022 Nov 3.,Villain N,Rev Neurol (Paris),2022,06-11-2022,,,10.1016/j.neurol.2022.08.002
36336171,Randomised controlled trials for the prevention of cognitive decline or dementia: A systematic review,"Coley N, Giulioli C, Aisen PS, Vellas B, Andrieu S.",Ageing Res Rev. 2022 Dec;82:101777. doi: 10.1016/j.arr.2022.101777. Epub 2022 Nov 4.,Coley N,Ageing Res Rev,2022,06-11-2022,,,10.1016/j.arr.2022.101777
36335573,"Endogenous antioxidants predicted outcome and increased after treatment: A benzoate dose-finding, randomized, double-blind, placebo-controlled trial for Alzheimer's disease","Lane HY, Wang SH, Lin CH.",Psychiatry Clin Neurosci. 2023 Feb;77(2):102-109. doi: 10.1111/pcn.13504. Epub 2022 Nov 24.,Lane HY,Psychiatry Clin Neurosci,2023,06-11-2022,PMC10099492,,10.1111/pcn.13504
36331350,"Do proton pump inhibitors increase the risk of dementia? A systematic review, meta-analysis and bias analysis","Ahn N, Nolde M, Krause E, Güntner F, Günter A, Tauscher M, Gerlach R, Meisinger C, Linseisen J, Baumeister SE, Rückert-Eheberg IM.",Br J Clin Pharmacol. 2023 Feb;89(2):602-616. doi: 10.1111/bcp.15583. Epub 2022 Nov 23.,Ahn N,Br J Clin Pharmacol,2023,04-11-2022,,,10.1111/bcp.15583
36329553,Genistein effect on cognition in prodromal Alzheimer's disease patients. The GENIAL clinical trial,"Viña J, Escudero J, Baquero M, Cebrián M, Carbonell-Asíns JA, Muñoz JE, Satorres E, Meléndez JC, Ferrer-Rebolleda J, Cózar-Santiago MDP, Santabárbara-Gómez JM, Jové M, Pamplona R, Tarazona-Santabalbina FJ, Borrás C.",Alzheimers Res Ther. 2022 Nov 4;14(1):164. doi: 10.1186/s13195-022-01097-2.,Viña J,Alzheimers Res Ther,2022,04-11-2022,PMC9635167,,10.1186/s13195-022-01097-2
36327127,Dietary fish oil increases catalase activity in patients with probable Alzheimer's disease,"Torres-Mendoza BMG, Ortiz GG, Sánchez-Romero L, Delgado-Lara DLC, García Martínez MT, Mireles-Ramírez MA, Cruz Serrano JA, Pacheco Moisés FP.",Nutr Hosp. 2022 Dec 20;39(6):1364-1368. doi: 10.20960/nh.04153.,Torres-Mendoza BMG,Nutr Hosp,2022,03-11-2022,,,10.20960/nh.04153
36321333,Functional consequences of brain exposure to saturated fatty acids: From energy metabolism and insulin resistance to neuronal damage,"Sánchez-Alegría K, Arias C.",Endocrinol Diabetes Metab. 2023 Jan;6(1):e386. doi: 10.1002/edm2.386. Epub 2022 Nov 2.,Sánchez-Alegría K,Endocrinol Diabetes Metab,2023,02-11-2022,PMC9836261,,10.1002/edm2.386
36319674,Morphometric imaging biomarker identifies Alzheimer's disease even among mixed dementia patients,"Chirila FV, Xu G, Fontaine D, Kern G, Khan TK, Brandt J, Konishi Y, Nebe-von-Caron G, White CL 3rd, Alkon DL.",Sci Rep. 2022 Nov 1;12(1):17675. doi: 10.1038/s41598-022-21796-y.,Chirila FV,Sci Rep,2022,02-11-2022,PMC9626495,,10.1038/s41598-022-21796-y
36319045,Geriatric update 2022: Preventing Alzheimer disease and more,"Morgan-Gouveia M, Drago K, Harris P, Sheffrin M.",Cleve Clin J Med. 2022 Nov 1;89(11):617-624. doi: 10.3949/ccjm.89a.21094.,Morgan-Gouveia M,Cleve Clin J Med,2022,01-11-2022,,,10.3949/ccjm.89a.21094
36317033,Acupuncture and Related Therapies for the Cognitive Function of Alzheimer's Disease: A Network Meta-Analysis,"Wang XS, Li JJ, Wang YS, Yu CC, He C, Huang ZS, Jiang T, Hao Q, Kong LH.",Iran J Public Health. 2021 Dec;50(12):2411-2426. doi: 10.18502/ijph.v50i12.7924.,Wang XS,Iran J Public Health,2021,01-11-2022,PMC9577142,,10.18502/ijph.v50i12.7924
36316487,Observational studies in Alzheimer disease: bridging preclinical studies and clinical trials,"Brenowitz WD, Yaffe K.",Nat Rev Neurol. 2022 Dec;18(12):747-757. doi: 10.1038/s41582-022-00733-7. Epub 2022 Oct 31.,Brenowitz WD,Nat Rev Neurol,2022,01-11-2022,PMC9894623,NIHMS1864321,10.1038/s41582-022-00733-7
36296397,Alzheimer's Disease as a Major Public Health Concern: Role of Dietary Saponins in Mitigating Neurodegenerative Disorders and Their Underlying Mechanisms,"Abduljawad AA, Elawad MA, Elkhalifa MEM, Ahmed A, Hamdoon AAE, Salim LHM, Ashraf M, Ayaz M, Hassan SSU, Bungau S.",Molecules. 2022 Oct 11;27(20):6804. doi: 10.3390/molecules27206804.,Abduljawad AA,Molecules,2022,27-10-2022,PMC9608803,,10.3390/molecules27206804
36295605,Polypharmacy in Older Adults with Alzheimer's Disease,"Esumi S, Ushio S, Zamami Y.",Medicina (Kaunas). 2022 Oct 13;58(10):1445. doi: 10.3390/medicina58101445.,Esumi S,Medicina (Kaunas),2022,27-10-2022,PMC9608980,,10.3390/medicina58101445
36293457,Mitochondrial Dysfunction and Neurodegenerative Disorders: Role of Nutritional Supplementation,"Mantle D, Hargreaves IP.",Int J Mol Sci. 2022 Oct 20;23(20):12603. doi: 10.3390/ijms232012603.,Mantle D,Int J Mol Sci,2022,27-10-2022,PMC9604531,,10.3390/ijms232012603
36282451,Relieving care burden and promoting health-related quality of life for family caregivers of elderly people with Alzheimer's disease via an empowerment program,"Yazdanmanesh M, Esmaeili R, Nasiri M, Vasli P.",Aging Clin Exp Res. 2023 Jan;35(1):73-83. doi: 10.1007/s40520-022-02277-8. Epub 2022 Oct 25.,Yazdanmanesh M,Aging Clin Exp Res,2023,25-10-2022,PMC9593982,,10.1007/s40520-022-02277-8
36282189,The global burden of cerebral small vessel disease in low- and middle-income countries: A systematic review and meta-analysis,"Lam BYK, Cai Y, Akinyemi R, Biessels GJ, van den Brink H, Chen C, Cheung CW, Chow KN, Chung HKH, Duering M, Fu ST, Gustafson D, Hilal S, Hui VMH, Kalaria R, Kim S, Lam MLM, de Leeuw FE, Li ASM, Markus HS, Marseglia A, Zheng H, O'Brien J, Pantoni L, Sachdev PS, Smith EE, Wardlaw J, Mok VCT.",Int J Stroke. 2023 Jan;18(1):15-27. doi: 10.1177/17474930221137019. Epub 2022 Nov 25.,Lam BYK,Int J Stroke,2023,25-10-2022,,,10.1177/17474930221137019
36281767,"Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial","Koch G, Casula EP, Bonnì S, Borghi I, Assogna M, Minei M, Pellicciari MC, Motta C, D'Acunto A, Porrazzini F, Maiella M, Ferrari C, Caltagirone C, Santarnecchi E, Bozzali M, Martorana A.",Brain. 2022 Nov 21;145(11):3776-3786. doi: 10.1093/brain/awac285.,Koch G,Brain,2022,25-10-2022,PMC9679166,,10.1093/brain/awac285
36281683,"Oral Tau Aggregation Inhibitor for Alzheimer's Disease: Design, Progress and Basis for Selection of the 16 mg/day Dose in a Phase 3, Randomized, Placebo-Controlled Trial of Hydromethylthionine Mesylate","Wischik CM, Bentham P, Gauthier S, Miller S, Kook K, Schelter BO.",J Prev Alzheimers Dis. 2022;9(4):780-790. doi: 10.14283/jpad.2022.63.,Wischik CM,J Prev Alzheimers Dis,2022,25-10-2022,PMC9226274,,10.14283/jpad.2022.63
36281668,Intervention for Cognitive Reserve Enhancement in Delaying the Onset of Alzheimer's Symptomatic Expression (INCREASE) Study: Results from a Randomized Controlled Study of Medication Therapy Management Targeting a Delay in Prodromal Dementia Symptom Progression,"Moga DC, Abner EL, Schmitt FA, Eckmann L, Huffmyer M, Martinez AI, Beech BF, George R, El Khouli RH, Ali D, Jicha GA.",J Prev Alzheimers Dis. 2022;9(4):646-654. doi: 10.14283/jpad.2022.55.,Moga DC,J Prev Alzheimers Dis,2022,25-10-2022,PMC9145115,,10.14283/jpad.2022.55
36281667,"Safety, Tolerability and Pharmacokinetics of Icapamespib, a Selective Epichaperome Inhibitor, in Healthy Adults","Silverman MH, Duggan S, Bardelli G, Sadler B, Key C, Medlock M, Reynolds L, Wallner B.",J Prev Alzheimers Dis. 2022;9(4):635-645. doi: 10.14283/jpad.2022.71.,Silverman MH,J Prev Alzheimers Dis,2022,25-10-2022,PMC9419134,,10.14283/jpad.2022.71
36281665,Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid,"Yaari R, Holdridge KC, Choi J, Donohue MC, Kantarci K, Jack CR Jr, Zuk SM, Sims JR, Johnson KA, Aisen PS, Sperling RA.",J Prev Alzheimers Dis. 2022;9(4):617-624. doi: 10.14283/jpad.2022.56.,Yaari R,J Prev Alzheimers Dis,2022,25-10-2022,PMC10966506,NIHMS1967327,10.14283/jpad.2022.56
36276430,Blood and CSF Homocysteine Levels in Alzheimer's Disease: A Meta-Analysis and Meta-Regression of Case-Control Studies,"Zhang L, Xie X, Sun Y, Zhou F.",Neuropsychiatr Dis Treat. 2022 Oct 17;18:2391-2403. doi: 10.2147/NDT.S383654. eCollection 2022.,Zhang L,Neuropsychiatr Dis Treat,2022,24-10-2022,PMC9586177,,10.2147/NDT.S383654
36276187,Internet-facilitated interventions for informal caregivers of patients with neurodegenerative disorders: Systematic review and meta-analysis,"Boyt N, Ho AK, Morris-Bankole H, Sin J.",Digit Health. 2022 Oct 20;8:20552076221129069. doi: 10.1177/20552076221129069. eCollection 2022 Jan-Dec.,Boyt N,Digit Health,2022,24-10-2022,PMC9585576,,10.1177/20552076221129069
36275009,Inflammatory bowel disease and risk of dementia: An updated meta-analysis,"Liu N, Wang Y, He L, Sun J, Wang X, Li H.",Front Aging Neurosci. 2022 Oct 5;14:962681. doi: 10.3389/fnagi.2022.962681. eCollection 2022.,Liu N,Front Aging Neurosci,2022,24-10-2022,PMC9581261,,10.3389/fnagi.2022.962681
36273943,Muscarinic acetylcholine receptors for psychotic disorders: bench-side to clinic,"Yohn SE, Weiden PJ, Felder CC, Stahl SM.",Trends Pharmacol Sci. 2022 Dec;43(12):1098-1112. doi: 10.1016/j.tips.2022.09.006. Epub 2022 Oct 20.,Yohn SE,Trends Pharmacol Sci,2022,23-10-2022,,,10.1016/j.tips.2022.09.006
36272055,Remember NIBS? tACS improves memory performance in elders with subjective memory complaints,"Varastegan S, Kazemi R, Rostami R, Khomami S, Zandbagleh A, Hadipour AL.",Geroscience. 2023 Apr;45(2):851-869. doi: 10.1007/s11357-022-00677-2. Epub 2022 Oct 22.,Varastegan S,Geroscience,2023,22-10-2022,PMC9886712,,10.1007/s11357-022-00677-2
36269510,Clinical Effectiveness of Muscarinic Receptor-Targeted Interventions in Neuropsychiatric Disorders: A Systematic Review,"Vaidya S, Guerin AA, Walker LC, Lawrence AJ.",CNS Drugs. 2022 Nov;36(11):1171-1206. doi: 10.1007/s40263-022-00964-8. Epub 2022 Oct 21.,Vaidya S,CNS Drugs,2022,21-10-2022,PMC9653329,,10.1007/s40263-022-00964-8
36267273,Advances in stromal cell therapy for management of Alzheimer's disease,"Srivastava R, Li A, Datta T, Jha NK, Talukder S, Jha SK, Chen ZS.",Front Pharmacol. 2022 Oct 4;13:955401. doi: 10.3389/fphar.2022.955401. eCollection 2022.,Srivastava R,Front Pharmacol,2022,21-10-2022,PMC9576849,,10.3389/fphar.2022.955401
36266559,Pre-frail older adults show improved cognition with StayFitLonger computerized home-based training: a randomized controlled trial,"Belleville S, Cuesta M, Bieler-Aeschlimann M, Giacomino K, Widmer A, Mittaz Hager AG, Perez-Marcos D, Cardin S, Boller B, Bier N, Aubertin-Leheudre M, Bherer L, Berryman N, Agrigoroaei S, Demonet JF.",Geroscience. 2023 Apr;45(2):811-822. doi: 10.1007/s11357-022-00674-5. Epub 2022 Oct 21.,Belleville S,Geroscience,2023,20-10-2022,PMC9589849,,10.1007/s11357-022-00674-5
36258018,Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease,"Nowell J, Blunt E, Edison P.",Mol Psychiatry. 2023 Jan;28(1):217-229. doi: 10.1038/s41380-022-01792-4. Epub 2022 Oct 18.,Nowell J,Mol Psychiatry,2023,18-10-2022,PMC9812772,,10.1038/s41380-022-01792-4
36251300,Association of Donanemab Treatment With Exploratory Plasma Biomarkers in Early Symptomatic Alzheimer Disease: A Secondary Analysis of the TRAILBLAZER-ALZ Randomized Clinical Trial,"Pontecorvo MJ, Lu M, Burnham SC, Schade AE, Dage JL, Shcherbinin S, Collins EC, Sims JR, Mintun MA.",JAMA Neurol. 2022 Dec 1;79(12):1250-1259. doi: 10.1001/jamaneurol.2022.3392.,Pontecorvo MJ,JAMA Neurol,2022,17-10-2022,PMC9577883,,10.1001/jamaneurol.2022.3392
36239924,Dementia with Lewy bodies: Impact of co-pathologies and implications for clinical trial design,"Toledo JB, Abdelnour C, Weil RS, Ferreira D, Rodriguez-Porcel F, Pilotto A, Wyman-Chick KA, Grothe MJ, Kane JPM, Taylor A, Rongve A, Scholz S, Leverenz JB, Boeve BF, Aarsland D, McKeith IG, Lewis S, Leroi I, Taylor JP; ISTAART Lewy body dementias Trial Methods Working Group.",Alzheimers Dement. 2023 Jan;19(1):318-332. doi: 10.1002/alz.12814. Epub 2022 Oct 14.,Toledo JB,Alzheimers Dement,2023,14-10-2022,PMC9881193,NIHMS1865904,10.1002/alz.12814
36239360,Is Alzheimer's disease a type 3 diabetes? A review,"Janoutová J, Machaczka O, Zatloukalová A, Janout V.",Cent Eur J Public Health. 2022 Sep;30(3):139-143. doi: 10.21101/cejph.a7238.,Janoutová J,Cent Eur J Public Health,2022,14-10-2022,,,10.21101/cejph.a7238
36235622,Does the Gut Microbial Metabolome Really Matter? The Connection between GUT Metabolome and Neurological Disorders,"Marć MA, Jastrząb R, Mytych J.",Nutrients. 2022 Sep 24;14(19):3967. doi: 10.3390/nu14193967.,Marć MA,Nutrients,2022,14-10-2022,PMC9571089,,10.3390/nu14193967
36235587,"Is Melatonin the ""Next Vitamin D""?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements","Minich DM, Henning M, Darley C, Fahoum M, Schuler CB, Frame J.",Nutrients. 2022 Sep 22;14(19):3934. doi: 10.3390/nu14193934.,Minich DM,Nutrients,2022,14-10-2022,PMC9571539,,10.3390/nu14193934
36233620,"Effects of Reminiscence Therapy on Cognition, Depression and Quality of Life in Elderly People with Alzheimer's Disease: A Systematic Review of Randomized Controlled Trials","Cammisuli DM, Cipriani G, Giusti EM, Castelnuovo G.",J Clin Med. 2022 Sep 28;11(19):5752. doi: 10.3390/jcm11195752.,Cammisuli DM,J Clin Med,2022,14-10-2022,PMC9570531,,10.3390/jcm11195752
36233223,"Potential Protective Mechanisms of S-equol, a Metabolite of Soy Isoflavone by the Gut Microbiome, on Cognitive Decline and Dementia","Sekikawa A, Wharton W, Butts B, Veliky CV, Garfein J, Li J, Goon S, Fort A, Li M, Hughes TM.",Int J Mol Sci. 2022 Oct 7;23(19):11921. doi: 10.3390/ijms231911921.,Sekikawa A,Int J Mol Sci,2022,14-10-2022,PMC9570153,,10.3390/ijms231911921
36232612,Medicinal Herbs and Their Derived Ingredients Protect against Cognitive Decline in In Vivo Models of Alzheimer's Disease,"Tsai YT, Kao ST, Cheng CY.",Int J Mol Sci. 2022 Sep 25;23(19):11311. doi: 10.3390/ijms231911311.,Tsai YT,Int J Mol Sci,2022,14-10-2022,PMC9569503,,10.3390/ijms231911311
36232368,Clinical Trials of New Drugs for Vascular Cognitive Impairment and Vascular Dementia,"Linh TTD, Hsieh YC, Huang LK, Hu CJ.",Int J Mol Sci. 2022 Sep 21;23(19):11067. doi: 10.3390/ijms231911067.,Linh TTD,Int J Mol Sci,2022,14-10-2022,PMC9569827,,10.3390/ijms231911067
36231055,Biochemical Pathways of Cellular Mechanosensing/Mechanotransduction and Their Role in Neurodegenerative Diseases Pathogenesis,"Tortorella I, Argentati C, Emiliani C, Morena F, Martino S.",Cells. 2022 Oct 1;11(19):3093. doi: 10.3390/cells11193093.,Tortorella I,Cells,2022,14-10-2022,PMC9563116,,10.3390/cells11193093
36227593,Effect of Exercise Training or Complex Mental and Social Activities on Cognitive Function in Adults With Chronic Stroke: A Randomized Clinical Trial,"Liu-Ambrose T, Falck RS, Dao E, Best JR, Davis JC, Bennett K, Hall PA, Hsiung GR, Middleton LE, Goldsmith CH, Graf P, Eng JJ.",JAMA Netw Open. 2022 Oct 3;5(10):e2236510. doi: 10.1001/jamanetworkopen.2022.36510.,Liu-Ambrose T,JAMA Netw Open,2022,13-10-2022,PMC9561961,,10.1001/jamanetworkopen.2022.36510
36226080,Bibliometric review of 1992-2022 publications on acupuncture for cognitive impairment,"Zhou R, Xiao L, Xiao W, Yi Y, Wen H, Wang H.",Front Neurol. 2022 Sep 26;13:1006830. doi: 10.3389/fneur.2022.1006830. eCollection 2022.,Zhou R,Front Neurol,2022,13-10-2022,PMC9549373,,10.3389/fneur.2022.1006830
36221865,Unveiling the Potential of Polyphenols as Anti-Amyloid Molecules in Alzheimer's Disease,"Kabir ER, Chowdhury NM, Yasmin H, Kabir MT, Akter R, Perveen A, Ashraf GM, Akter S, Rahman MH, Sweilam SH.",Curr Neuropharmacol. 2023;21(4):787-807. doi: 10.2174/1570159X20666221010113812.,Kabir ER,Curr Neuropharmacol,2023,12-10-2022,PMC10227919,,10.2174/1570159X20666221010113812
36215904,Is non-invasive brain stimulation effective for cognitive enhancement in Alzheimer's disease? An updated meta-analysis,"Šimko P, Kent JA, Rektorova I.",Clin Neurophysiol. 2022 Dec;144:23-40. doi: 10.1016/j.clinph.2022.09.010. Epub 2022 Sep 28.,Šimko P,Clin Neurophysiol,2022,10-10-2022,,,10.1016/j.clinph.2022.09.010
36206989,Beyond Erectile Dysfunction: cGMP-Specific Phosphodiesterase 5 Inhibitors for Other Clinical Disorders,"Samidurai A, Xi L, Das A, Kukreja RC.",Annu Rev Pharmacol Toxicol. 2023 Jan 20;63:585-615. doi: 10.1146/annurev-pharmtox-040122-034745. Epub 2022 Oct 7.,Samidurai A,Annu Rev Pharmacol Toxicol,2023,07-10-2022,,,10.1146/annurev-pharmtox-040122-034745
36193081,Potential Role of Phytochemical Extract from Saffron in Development of Functional Foods and Protection of Brain-Related Disorders,"Maqbool Z, Arshad MS, Ali A, Aziz A, Khalid W, Afzal MF, Bangar SP, Addi M, Hano C, Lorenzo JM.",Oxid Med Cell Longev. 2022 Sep 22;2022:6480590. doi: 10.1155/2022/6480590. eCollection 2022.,Maqbool Z,Oxid Med Cell Longev,2022,04-10-2022,PMC9526642,,10.1155/2022/6480590
36189701,Periodontal disease and systemic health: An update for medical practitioners,"Kalhan AC, Wong ML, Allen F, Gao X.",Ann Acad Med Singap. 2022 Sep;51(9):567-574. doi: 10.47102/annals-acadmedsg.2021503.,Kalhan AC,Ann Acad Med Singap,2022,03-10-2022,,,10.47102/annals-acadmedsg.2021503
36187099,Targeting the non-classical estrogen pathway in neurodegenerative diseases and brain injury disorders,"Koszegi Z, Cheong RY.",Front Endocrinol (Lausanne). 2022 Sep 15;13:999236. doi: 10.3389/fendo.2022.999236. eCollection 2022.,Koszegi Z,Front Endocrinol (Lausanne),2022,03-10-2022,PMC9521328,,10.3389/fendo.2022.999236
36184326,"High-clearance anti-amyloid immunotherapies in Alzheimer's disease. Part 1: Meta-analysis and review of efficacy and safety data, and medico-economical aspects","Villain N, Planche V, Levy R.",Rev Neurol (Paris). 2022 Dec;178(10):1011-1030. doi: 10.1016/j.neurol.2022.06.012. Epub 2022 Sep 29.,Villain N,Rev Neurol (Paris),2022,02-10-2022,,,10.1016/j.neurol.2022.06.012
36182766,Global cognitive effects of second-generation antidepressants in patients with Alzheimer's disease: A systematic review and meta-analysis of randomized controlled trials,"Qin M, Wu J, Zhou Q, Liang Z, Su Y.",J Psychiatr Res. 2022 Nov;155:371-379. doi: 10.1016/j.jpsychires.2022.09.039. Epub 2022 Sep 25.,Qin M,J Psychiatr Res,2022,01-10-2022,,,10.1016/j.jpsychires.2022.09.039
36173068,Current Naturopathy to Combat Alzheimer's Disease,"Chakrovorty A, Bhattacharjee B, Saxena A, Samadder A, Nandi S.",Curr Neuropharmacol. 2023;21(4):808-841. doi: 10.2174/1570159X20666220927121022.,Chakrovorty A,Curr Neuropharmacol,2023,29-09-2022,PMC10227918,,10.2174/1570159X20666220927121022
36172480,Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis,"Long C, Han X, Yang Y, Li T, Zhou Q, Chen Q.",Front Aging Neurosci. 2022 Sep 12;14:963933. doi: 10.3389/fnagi.2022.963933. eCollection 2022.,Long C,Front Aging Neurosci,2022,29-09-2022,PMC9512636,,10.3389/fnagi.2022.963933
36169276,Phytonutrients of bilberry fruit and saskatoon berry in the prevention and treatment of dyslipidemia,"Kopčeková J, Mrázová J.",Rocz Panstw Zakl Hig. 2022;73(3):265-274. doi: 10.32394/rpzh.2022.0216.,Kopčeková J,Rocz Panstw Zakl Hig,2022,28-09-2022,,,10.32394/rpzh.2022.0216
36158564,Effects of rTMS treatment on global cognitive function in Alzheimer's disease: A systematic review and meta-analysis,"Zhang T, Sui Y, Lu Q, Xu X, Zhu Y, Dai W, Shen Y, Wang T.",Front Aging Neurosci. 2022 Sep 8;14:984708. doi: 10.3389/fnagi.2022.984708. eCollection 2022.,Zhang T,Front Aging Neurosci,2022,26-09-2022,PMC9492846,,10.3389/fnagi.2022.984708
36158537,A quantitative meta-analysis of vitamin C in the pathophysiology of Alzheimer's disease,"Hamid M, Mansoor S, Amber S, Zahid S.",Front Aging Neurosci. 2022 Sep 7;14:970263. doi: 10.3389/fnagi.2022.970263. eCollection 2022.,Hamid M,Front Aging Neurosci,2022,26-09-2022,PMC9490219,,10.3389/fnagi.2022.970263
36157386,The Effects of Standardised versus Individualised Aerobic Exercise Prescription on Fitness-Fatness Index in Sedentary Adults: A Randomised Controlled Trial,"Kirton MJ, Burnley MT, Ramos JS, Weatherwax R, Dalleck LC.",J Sports Sci Med. 2022 Sep 1;21(3):347-355. doi: 10.52082/jssm.2022.347. eCollection 2022 Sep.,Kirton MJ,J Sports Sci Med,2022,26-09-2022,PMC9459763,,10.52082/jssm.2022.347
36155516,Modulation of Amyloid-β and Tau in Alzheimer's Disease Plasma Neuronal-Derived Extracellular Vesicles by Cerebrolysin® and Donepezil,"Alvarez XA, Winston CN, Barlow JW, Sarsoza FM, Alvarez I, Aleixandre M, Linares C, García-Fantini M, Kastberger B, Winter S, Rissman RA.",J Alzheimers Dis. 2022;90(2):705-717. doi: 10.3233/JAD-220575.,Alvarez XA,J Alzheimers Dis,2022,26-09-2022,PMC9697063,,10.3233/JAD-220575
36155513,Dementia Research on Facebook and Twitter: Current Practice and Challenges,"Hrincu V, An Z, Joseph K, Jiang YF, Robillard JM.",J Alzheimers Dis. 2022;90(2):447-459. doi: 10.3233/JAD-220525.,Hrincu V,J Alzheimers Dis,2022,26-09-2022,PMC9697056,,10.3233/JAD-220525
36152409,Molecular understanding of the translational models and the therapeutic potential natural products of Parkinson's disease,"Pang M, Peng R, Wang Y, Zhu Y, Wang P, Moussian B, Su Y, Liu X, Ming D.",Biomed Pharmacother. 2022 Nov;155:113718. doi: 10.1016/j.biopha.2022.113718. Epub 2022 Sep 21.,Pang M,Biomed Pharmacother,2022,24-09-2022,,,10.1016/j.biopha.2022.113718
36148821,"Effect of RNS60 in amyotrophic lateral sclerosis: a phase II multicentre, randomized, double-blind, placebo-controlled trial","Beghi E, Pupillo E, Bianchi E, Bonetto V, Luotti S, Pasetto L, Bendotti C, Tortarolo M, Sironi F, Camporeale L, Sherman AV, Paganoni S, Scognamiglio A, De Marchi F, Bongioanni P, Del Carratore R, Caponnetto C, Diamanti L, Martinelli D, Calvo A, Filosto M, Padovani A, Piccinelli SC, Ricci C, Dalla Giacoma S, De Angelis N, Inghilleri M, Spataro R, La Bella V, Logroscino G, Lunetta C, Tarlarini C, Mandrioli J, Martinelli I, Simonini C, Zucchi E, Monsurrò MR, Ricciardi D, Trojsi F, Riva N, Filippi M, Simone IL, Sorarù G, Spera C, Florio L, Messina S, Russo M, Siciliano G, Conte A, Saddi MV, Carboni N, Mazzini L; RNS60-ALS Study Group.",Eur J Neurol. 2023 Jan;30(1):69-86. doi: 10.1111/ene.15573. Epub 2022 Oct 7.,Beghi E,Eur J Neurol,2023,23-09-2022,PMC10092300,,10.1111/ene.15573
36147701,The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer's disease: A systemic review and meta-analysis,"Wei Z, Fu J, Liang H, Liu M, Ye X, Zhong P.",Front Aging Neurosci. 2022 Sep 6;14:980998. doi: 10.3389/fnagi.2022.980998. eCollection 2022.,Wei Z,Front Aging Neurosci,2022,23-09-2022,PMC9485622,,10.3389/fnagi.2022.980998
36145186,Comparing the Evidence from Observational Studies and Randomized Controlled Trials for Nonskeletal Health Effects of Vitamin D,"Grant WB, Boucher BJ, Al Anouti F, Pilz S.",Nutrients. 2022 Sep 15;14(18):3811. doi: 10.3390/nu14183811.,Grant WB,Nutrients,2022,23-09-2022,PMC9501276,,10.3390/nu14183811
36145090,"The Effects of Spirulina maxima Extract on Memory Improvement in Those with Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial","Choi WY, Lee WK, Kim TH, Ryu YK, Park A, Lee YJ, Heo SJ, Oh C, Chung YC, Kang DH.",Nutrients. 2022 Sep 9;14(18):3714. doi: 10.3390/nu14183714.,Choi WY,Nutrients,2022,23-09-2022,PMC9505028,,10.3390/nu14183714
36145084,Recent Advances in the Neuroprotective Properties of Ferulic Acid in Alzheimer's Disease: A Narrative Review,"Di Giacomo S, Percaccio E, Gullì M, Romano A, Vitalone A, Mazzanti G, Gaetani S, Di Sotto A.",Nutrients. 2022 Sep 8;14(18):3709. doi: 10.3390/nu14183709.,Di Giacomo S,Nutrients,2022,23-09-2022,PMC9503091,,10.3390/nu14183709
36143270,iPSCs in Neurodegenerative Disorders: A Unique Platform for Clinical Research and Personalized Medicine,"Pandey S, Jirásko M, Lochman J, Chvátal A, Chottova Dvorakova M, Kučera R.",J Pers Med. 2022 Sep 10;12(9):1485. doi: 10.3390/jpm12091485.,Pandey S,J Pers Med,2022,23-09-2022,PMC9500601,,10.3390/jpm12091485
36143150,Pathogenesis and Personalized Interventions for Pharmacological Treatment-Resistant Neuropsychiatric Symptoms in Alzheimer's Disease,"Nagata T, Shinagawa S, Inamura K, Shigeta M.",J Pers Med. 2022 Aug 24;12(9):1365. doi: 10.3390/jpm12091365.,Nagata T,J Pers Med,2022,23-09-2022,PMC9501542,,10.3390/jpm12091365
36142849,Ellagic Acid and Its Anti-Aging Effects on Central Nervous System,"Zhu H, Yan Y, Jiang Y, Meng X.",Int J Mol Sci. 2022 Sep 19;23(18):10937. doi: 10.3390/ijms231810937.,Zhu H,Int J Mol Sci,2022,23-09-2022,PMC9502104,,10.3390/ijms231810937
36140138,The Feasibility of Early Alzheimer's Disease Diagnosis Using a Neural Network Hybrid Platform,"Yu X, Srivastava S, Huang S, Hayden EY, Teplow DB, Xie YH.",Biosensors (Basel). 2022 Sep 13;12(9):753. doi: 10.3390/bios12090753.,Yu X,Biosensors (Basel),2022,23-09-2022,PMC9496690,,10.3390/bios12090753
36139030,Palmitoylethanolamide and White Matter Lesions: Evidence for Therapeutic Implications,"Valenza M, Facchinetti R, Steardo L, Scuderi C.",Biomolecules. 2022 Aug 27;12(9):1191. doi: 10.3390/biom12091191.,Valenza M,Biomolecules,2022,23-09-2022,PMC9496237,,10.3390/biom12091191
36137949,Repetitive Transcranial Magnetic Stimulation Decreases Serum Amyloid-β and Increases Ectodomain of p75 Neurotrophin Receptor in Patients with Alzheimer's Disease,"Tao Y, Lei B, Zhu Y, Fang X, Liao L, Chen D, Gao C.",J Integr Neurosci. 2022 Jul 29;21(5):140. doi: 10.31083/j.jin2105140.,Tao Y,J Integr Neurosci,2022,22-09-2022,,,10.31083/j.jin2105140
36130946,Preclinical and randomized clinical evaluation of the p38α kinase inhibitor neflamapimod for basal forebrain cholinergic degeneration,"Jiang Y, Alam JJ, Gomperts SN, Maruff P, Lemstra AW, Germann UA, Stavrides PH, Darji S, Malampati S, Peddy J, Bleiwas C, Pawlik M, Pensalfini A, Yang DS, Subbanna S, Basavarajappa BS, Smiley JF, Gardner A, Blackburn K, Chu HM, Prins ND, Teunissen CE, Harrison JE, Scheltens P, Nixon RA.",Nat Commun. 2022 Sep 21;13(1):5308. doi: 10.1038/s41467-022-32944-3.,Jiang Y,Nat Commun,2022,21-09-2022,PMC9492778,,10.1038/s41467-022-32944-3
36130664,Mitigating the impact of air pollution on dementia and brain health: Setting the policy agenda,"Castellani B, Bartington S, Wistow J, Heckels N, Ellison A, Van Tongeren M, Arnold SR, Barbrook-Johnson P, Bicket M, Pope FD, Russ TC, Clarke CL, Pirani M, Schwannauer M, Vieno M, Turnbull R, Gilbert N, Reis S.",Environ Res. 2022 Dec;215(Pt 2):114362. doi: 10.1016/j.envres.2022.114362. Epub 2022 Sep 18.,Castellani B,Environ Res,2022,21-09-2022,,,10.1016/j.envres.2022.114362
36126456,Protein tyrosine phosphatase 1B (PTP1B) as a potential therapeutic target for neurological disorders,"Olloquequi J, Cano A, Sanchez-López E, Carrasco M, Verdaguer E, Fortuna A, Folch J, Bulló M, Auladell C, Camins A, Ettcheto M.",Biomed Pharmacother. 2022 Nov;155:113709. doi: 10.1016/j.biopha.2022.113709. Epub 2022 Sep 19.,Olloquequi J,Biomed Pharmacother,2022,20-09-2022,,,10.1016/j.biopha.2022.113709
36121669,Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease: Two Phase 3 Randomized Placebo-Controlled Trials,"Ostrowitzki S, Bittner T, Sink KM, Mackey H, Rabe C, Honig LS, Cassetta E, Woodward M, Boada M, van Dyck CH, Grimmer T, Selkoe DJ, Schneider A, Blondeau K, Hu N, Quartino A, Clayton D, Dolton M, Dang Y, Ostaszewski B, Sanabria-Bohórquez SM, Rabbia M, Toth B, Eichenlaub U, Smith J, Honigberg LA, Doody RS.",JAMA Neurol. 2022 Nov 1;79(11):1113-1121. doi: 10.1001/jamaneurol.2022.2909.,Ostrowitzki S,JAMA Neurol,2022,19-09-2022,PMC9486635,,10.1001/jamaneurol.2022.2909
36120781,Comparison of Steady-State Pharmacokinetics of Donepezil Transdermal Delivery System with Oral Donepezil,"Tariot PN, Braeckman R, Oh C.",J Alzheimers Dis. 2022;90(1):161-172. doi: 10.3233/JAD-220530.,Tariot PN,J Alzheimers Dis,2022,19-09-2022,PMC9661317,,10.3233/JAD-220530
36111342,The kingdom of the prolyl-isomerase Pin1: The structural and functional convergence and divergence of Pin1,"Lee YM, Teoh DE, Yeung K, Liou YC.",Front Cell Dev Biol. 2022 Aug 30;10:956071. doi: 10.3389/fcell.2022.956071. eCollection 2022.,Lee YM,Front Cell Dev Biol,2022,16-09-2022,PMC9468764,,10.3389/fcell.2022.956071
36104179,"A Pilot Study of Whole-Brain Low-Intensity Pulsed Ultrasound Therapy for Early Stage of Alzheimer's Disease (LIPUS-AD): A Randomized, Double-Blind, Placebo-Controlled Trial","Shimokawa H, Shindo T, Ishiki A, Tomita N, Ichijyo S, Watanabe T, Nakata T, Eguchi K, Kikuchi Y, Shiroto T, Takahashi J, Yasuda S, Arai H.",Tohoku J Exp Med. 2022 Oct 25;258(3):167-175. doi: 10.1620/tjem.2022.J078. Epub 2022 Sep 15.,Shimokawa H,Tohoku J Exp Med,2022,14-09-2022,,,10.1620/tjem.2022.J078
36103934,"Understanding treatment-resistant depression using ""omics"" techniques: A systematic review","Amasi-Hartoonian N, Pariante CM, Cattaneo A, Sforzini L.",J Affect Disord. 2022 Dec 1;318:423-455. doi: 10.1016/j.jad.2022.09.011. Epub 2022 Sep 11.,Amasi-Hartoonian N,J Affect Disord,2022,14-09-2022,,,10.1016/j.jad.2022.09.011
36097997,Mortality rates in Alzheimer's disease and non-Alzheimer's dementias: a systematic review and meta-analysis,"Liang CS, Li DJ, Yang FC, Tseng PT, Carvalho AF, Stubbs B, Thompson T, Mueller C, Shin JI, Radua J, Stewart R, Rajji TK, Tu YK, Chen TY, Yeh TC, Tsai CK, Yu CL, Pan CC, Chu CS.",Lancet Healthy Longev. 2021 Aug;2(8):e479-e488. doi: 10.1016/S2666-7568(21)00140-9. Epub 2021 Jul 21.,Liang CS,Lancet Healthy Longev,2021,13-09-2022,,,10.1016/S2666-7568(21)00140-9
36097005,Association between urate-lowering therapies and cognitive decline in community-dwelling older adults,"Molet-Benhamou L, Giudici KV, de Souto Barreto P, Cantet C, Rolland Y; MAPT/DSA group.",Sci Rep. 2022 Sep 12;12(1):15299. doi: 10.1038/s41598-022-17808-6.,Molet-Benhamou L,Sci Rep,2022,12-09-2022,PMC9467991,,10.1038/s41598-022-17808-6
36096160,BChE inhibitors from marine organisms - A review,"Lins Alves LK, Cechinel Filho V, de Souza RLR, Furtado-Alle L.",Chem Biol Interact. 2022 Nov 1;367:110136. doi: 10.1016/j.cbi.2022.110136. Epub 2022 Sep 9.,Lins Alves LK,Chem Biol Interact,2022,12-09-2022,,,10.1016/j.cbi.2022.110136
36094645,Association of Amyloid Reduction After Donanemab Treatment With Tau Pathology and Clinical Outcomes: The TRAILBLAZER-ALZ Randomized Clinical Trial,"Shcherbinin S, Evans CD, Lu M, Andersen SW, Pontecorvo MJ, Willis BA, Gueorguieva I, Hauck PM, Brooks DA, Mintun MA, Sims JR.",JAMA Neurol. 2022 Oct 1;79(10):1015-1024. doi: 10.1001/jamaneurol.2022.2793.,Shcherbinin S,JAMA Neurol,2022,12-09-2022,PMC9468959,,10.1001/jamaneurol.2022.2793
36090264,Metformin use is associated with a reduced risk of cognitive impairment in adults with diabetes mellitus: A systematic review and meta-analysis,"Zhang JH, Zhang XY, Sun YQ, Lv RH, Chen M, Li M.",Front Neurosci. 2022 Aug 25;16:984559. doi: 10.3389/fnins.2022.984559. eCollection 2022.,Zhang JH,Front Neurosci,2022,12-09-2022,PMC9453211,,10.3389/fnins.2022.984559
36083623,The Effectiveness of Serious Games on Cognitive Processing Speed Among Older Adults With Cognitive Impairment: Systematic Review and Meta-analysis,"Abd-Alrazaq A, Ahmed A, Alali H, Aldardour AM, Househ M.",JMIR Serious Games. 2022 Sep 9;10(3):e36754. doi: 10.2196/36754.,Abd-Alrazaq A,JMIR Serious Games,2022,09-09-2022,PMC9508673,,10.2196/36754
36080253,"Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use","Skrzypczak-Wiercioch A, Sałat K.",Molecules. 2022 Aug 26;27(17):5481. doi: 10.3390/molecules27175481.,Skrzypczak-Wiercioch A,Molecules,2022,09-09-2022,PMC9457753,,10.3390/molecules27175481
36077418,"Protective Effects of Flavonoids against Alzheimer's Disease: Pathological Hypothesis, Potential Targets, and Structure-Activity Relationship","Li J, Sun M, Cui X, Li C.",Int J Mol Sci. 2022 Sep 2;23(17):10020. doi: 10.3390/ijms231710020.,Li J,Int J Mol Sci,2022,09-09-2022,PMC9456554,,10.3390/ijms231710020
36071869,Flavonoids as Promising Neuroprotectants and Their Therapeutic Potential against Alzheimer's Disease,"Minocha T, Birla H, Obaid AA, Rai V, Sushma P, Shivamallu C, Moustafa M, Al-Shehri M, Al-Emam A, Tikhonova MA, Yadav SK, Poeggeler B, Singh D, Singh SK.",Oxid Med Cell Longev. 2022 Aug 28;2022:6038996. doi: 10.1155/2022/6038996. eCollection 2022.,Minocha T,Oxid Med Cell Longev,2022,08-09-2022,PMC9441372,,10.1155/2022/6038996
36068789,Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature,"Alhowail A, Alsikhan R, Alsaud M, Aldubayan M, Rabbani SI.",Drug Des Devel Ther. 2022 Aug 31;16:2919-2931. doi: 10.2147/DDDT.S367229. eCollection 2022.,Alhowail A,Drug Des Devel Ther,2022,07-09-2022,PMC9441149,,10.2147/DDDT.S367229
36068621,Effects of a mindfulness-based versus a health self-management intervention on objective cognitive performance in older adults with subjective cognitive decline (SCD): a secondary analysis of the SCD-Well randomized controlled trial,"Whitfield T, Demnitz-King H, Schlosser M, Barnhofer T, Frison E, Coll-Padros N, Dautricourt S, Requier F, Delarue M, Gonneaud J, Klimecki OM, Lutz A, Paly L, Salmon E, Schild AK, Walker Z, Jessen F, Chételat G, Collette F, Wirth M, Marchant NL; Medit-Ageing Research Group.",Alzheimers Res Ther. 2022 Sep 6;14(1):125. doi: 10.1186/s13195-022-01057-w.,Whitfield T,Alzheimers Res Ther,2022,06-09-2022,PMC9446839,,10.1186/s13195-022-01057-w
36067369,Effect of Vitamin D Supplementation on Overactive Bladder and Urinary Incontinence Symptoms in Older Men: Ancillary Findings From a Randomized Trial,"Markland AD, Vaughan CP, Huang AJ, Kim E, Bubes VY, Tangpricha V, Buring JR, Lee IM, Cook NR, Manson JE, Grodstein F.",J Urol. 2023 Jan;209(1):243-252. doi: 10.1097/JU.0000000000002942. Epub 2022 Sep 6.,Markland AD,J Urol,2023,06-09-2022,PMC9742141,NIHMS1829992,10.1097/JU.0000000000002942
36056417,Hypnosis for pain and anxiety management in cognitively impaired older adults undergoing scheduled lumbar punctures: a randomized controlled pilot study,"Courtois-Amiot P, Cloppet-Fontaine A, Poissonnet A, Benit E, Dauzet M, Raynaud-Simon A, Paquet C, Lilamand M.",Alzheimers Res Ther. 2022 Sep 2;14(1):120. doi: 10.1186/s13195-022-01065-w.,Courtois-Amiot P,Alzheimers Res Ther,2022,02-09-2022,PMC9438329,,10.1186/s13195-022-01065-w
36049127,Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment,"Damiano RF, Loureiro JC, Pais MV, Pereira RF, Corradi MM, Di Santi T, Bezerra GAM, Radanovic M, Talib LL, Forlenza OV.",Braz J Psychiatry. 2023 Mar 11;45(1):46-49. doi: 10.47626/1516-4446-2022-2767.,Damiano RF,Braz J Psychiatry,2023,01-09-2022,PMC9976922,,10.47626/1516-4446-2022-2767
36047338,Efficacy and safety of 3-n-butylphthalide for the treatment of cognitive impairment: A systematic review and meta-analysis,"Zhou Q, Han C, Xia Y, Wan F, Yin S, Li Y, Kou L, Chi X, Hu J, Sun Y, Wu J, Zou W, Huang J, Wang T.",CNS Neurosci Ther. 2022 Nov;28(11):1706-1717. doi: 10.1111/cns.13952. Epub 2022 Sep 1.,Zhou Q,CNS Neurosci Ther,2022,01-09-2022,PMC9532910,,10.1111/cns.13952
36043795,Mitochondrial Medicine: A Promising Therapeutic Option Against Various Neurodegenerative Disorders,"Almikhlafi MA, Karami MM, Jana A, Alqurashi TM, Majrashi M, Alghamdi BS, Ashraf GM.",Curr Neuropharmacol. 2023;21(5):1165-1183. doi: 10.2174/1570159X20666220830112408.,Almikhlafi MA,Curr Neuropharmacol,2023,31-08-2022,PMC10286591,,10.2174/1570159X20666220830112408
36041414,Intranasal Insulin Attenuates the Long-Term Adverse Effects of Neonatal Hyperglycemia on the Hippocampus in Rats,"McClure Yauch L, Ennis-Czerniak K, Frey Ii WH, Tkac I, Rao RB.",Dev Neurosci. 2022;44(6):590-602. doi: 10.1159/000526627. Epub 2022 Aug 30.,McClure Yauch L,Dev Neurosci,2022,30-08-2022,PMC9928603,NIHMS1835423,10.1159/000526627
36041185,Unsaturated Fatty Acids in Mental Disorders: An Umbrella Review of Meta-Analyses,"Gao X, Su X, Han X, Wen H, Cheng C, Zhang S, Li W, Cai J, Zheng L, Ma J, Liao M, Ni W, Liu T, Liu D, Ma W, Han S, Zhu S, Ye Y, Zeng FF.",Adv Nutr. 2022 Dec 22;13(6):2217-2236. doi: 10.1093/advances/nmac084.,Gao X,Adv Nutr,2022,30-08-2022,PMC9776730,,10.1093/advances/nmac084
36038112,Influence of genetic and cardiometabolic risk factors in Alzheimer's disease,"Pasqualetti G, Thayanandan T, Edison P.",Ageing Res Rev. 2022 Nov;81:101723. doi: 10.1016/j.arr.2022.101723. Epub 2022 Aug 28.,Pasqualetti G,Ageing Res Rev,2022,29-08-2022,,,10.1016/j.arr.2022.101723
36034312,Neuroprotection in neurodegenerations of the brain and eye: Lessons from the past and directions for the future,"Levin LA, Patrick C, Choudry NB, Sharif NA, Goldberg JL.",Front Neurol. 2022 Aug 12;13:964197. doi: 10.3389/fneur.2022.964197. eCollection 2022.,Levin LA,Front Neurol,2022,29-08-2022,PMC9412944,,10.3389/fneur.2022.964197
36017827,Comparative Bioavailability Study of a Novel Multi-Day Patch Formulation of Rivastigmine (Twice Weekly) with Exelon® Transdermal Patch (Daily)- A Randomized Clinical Trial,"Schurad B, Koch C, Schug B, Morte A, Vaqué A, De la Torre R, Iniesta M.",Curr Alzheimer Res. 2022;19(7):541-553. doi: 10.2174/1567205019666220823105059.,Schurad B,Curr Alzheimer Res,2022,26-08-2022,PMC10186381,,10.2174/1567205019666220823105059
36017397,Intestinal Flora Balance Therapy Based on Probiotic Support Improves Cognitive Function and Symptoms in Patients with Alzheimer's Disease: A Systematic Review and Meta-analysis,"Liu C, Guo X, Chang X.",Biomed Res Int. 2022 Aug 16;2022:4806163. doi: 10.1155/2022/4806163. eCollection 2022.,Liu C,Biomed Res Int,2022,26-08-2022,PMC9398783,,10.1155/2022/4806163
36014310,"Aβ and Tau Interact with Metal Ions, Lipid Membranes and Peptide-Based Amyloid Inhibitors: Are These Common Features Relevant in Alzheimer's Disease?","Di Natale G, Sabatino G, Sciacca MFM, Tosto R, Milardi D, Pappalardo G.",Molecules. 2022 Aug 9;27(16):5066. doi: 10.3390/molecules27165066.,Di Natale G,Molecules,2022,26-08-2022,PMC9414153,,10.3390/molecules27165066
36013492,"Plants, Plants, and More Plants: Plant-Derived Nutrients and Their Protective Roles in Cognitive Function, Alzheimer's Disease, and Other Dementias","Ding H, Reiss AB, Pinkhasov A, Kasselman LJ.",Medicina (Kaunas). 2022 Jul 30;58(8):1025. doi: 10.3390/medicina58081025.,Ding H,Medicina (Kaunas),2022,26-08-2022,PMC9414574,,10.3390/medicina58081025
36012599,Antioxidant Therapeutic Strategies in Neurodegenerative Diseases,"Morén C, deSouza RM, Giraldo DM, Uff C.",Int J Mol Sci. 2022 Aug 19;23(16):9328. doi: 10.3390/ijms23169328.,Morén C,Int J Mol Sci,2022,26-08-2022,PMC9409201,,10.3390/ijms23169328
36012569,Symptomatic and Disease-Modifying Therapy Pipeline for Alzheimer's Disease: Towards a Personalized Polypharmacology Patient-Centered Approach,"Morató X, Pytel V, Jofresa S, Ruiz A, Boada M.",Int J Mol Sci. 2022 Aug 18;23(16):9305. doi: 10.3390/ijms23169305.,Morató X,Int J Mol Sci,2022,26-08-2022,PMC9409252,,10.3390/ijms23169305
36012552,"Microwave Radiation and the Brain: Mechanisms, Current Status, and Future Prospects","Mumtaz S, Rana JN, Choi EH, Han I.",Int J Mol Sci. 2022 Aug 18;23(16):9288. doi: 10.3390/ijms23169288.,Mumtaz S,Int J Mol Sci,2022,26-08-2022,PMC9409438,,10.3390/ijms23169288
36011984,Exercise to Improve Postural Stability in Older Adults with Alzheimer's Disease: A Systematic Review of Randomized Control Trials,"Adzhar MA, Manlapaz D, Singh DKA, Mesbah N.",Int J Environ Res Public Health. 2022 Aug 19;19(16):10350. doi: 10.3390/ijerph191610350.,Adzhar MA,Int J Environ Res Public Health,2022,26-08-2022,PMC9408145,,10.3390/ijerph191610350
36010610,New Therapeutic Approaches to and Mechanisms of Ginsenoside Rg1 against Neurological Diseases,"Sun Y, Yang Y, Liu S, Yang S, Chen C, Lin M, Zeng Q, Long J, Yao J, Yi F, Meng L, Ai Q, Chen N.",Cells. 2022 Aug 16;11(16):2529. doi: 10.3390/cells11162529.,Sun Y,Cells,2022,26-08-2022,PMC9406801,,10.3390/cells11162529
36009055,Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders,"Assogna M, Di Lorenzo F, Martorana A, Koch G.",Biomolecules. 2022 Aug 22;12(8):1161. doi: 10.3390/biom12081161.,Assogna M,Biomolecules,2022,26-08-2022,PMC9405819,,10.3390/biom12081161
36008956,Association between Galectin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis,"Ramos-Martínez E, Ramos-Martínez I, Sánchez-Betancourt I, Ramos-Martínez JC, Peña-Corona SI, Valencia J, Saucedo R, Almeida-Aguirre EKP, Cerbón M.",Biomolecules. 2022 Jul 31;12(8):1062. doi: 10.3390/biom12081062.,Ramos-Martínez E,Biomolecules,2022,26-08-2022,PMC9406080,,10.3390/biom12081062
36007279,Anti-Alzheimer's disease potential of traditional chinese medicinal herbs as inhibitors of BACE1 and AChE enzymes,"Dai R, Sun Y, Su R, Gao H.",Biomed Pharmacother. 2022 Oct;154:113576. doi: 10.1016/j.biopha.2022.113576. Epub 2022 Aug 22.,Dai R,Biomed Pharmacother,2022,25-08-2022,,,10.1016/j.biopha.2022.113576
36004000,Dance movement therapy for neurodegenerative diseases: A systematic review,"Wu CC, Xiong HY, Zheng JJ, Wang XQ.",Front Aging Neurosci. 2022 Aug 8;14:975711. doi: 10.3389/fnagi.2022.975711. eCollection 2022.,Wu CC,Front Aging Neurosci,2022,25-08-2022,PMC9394857,,10.3389/fnagi.2022.975711
35994031,Implementing a home-based virtual hypertension programme-a pilot feasibility study,"Gupta A, Ellis SD, Burkhardt C, Young K, Mazzotti DR, Mahnken J, Abu-El-Rub N, Chandaka S, Comfort B, Shanks D, Woodward J, Unrein A, Anderson H, Loucks J, Song X, Waitman LR, Burns JM.",Fam Pract. 2023 Mar 28;40(2):414-422. doi: 10.1093/fampra/cmac084.,Gupta A,Fam Pract,2023,22-08-2022,PMC10047620,,10.1093/fampra/cmac084
35991882,Crocins for Ischemic Stroke: A Review of Current Evidence,"Shahbaz K, Chang D, Zhou X, Low M, Seto SW, Li CG.",Front Pharmacol. 2022 Aug 5;13:825842. doi: 10.3389/fphar.2022.825842. eCollection 2022.,Shahbaz K,Front Pharmacol,2022,22-08-2022,PMC9388830,,10.3389/fphar.2022.825842
35985445,Deciphering the enigmatic crosstalk between prostate cancer and Alzheimer's disease: A current update on molecular mechanisms and combination therapy,"Poddar NK, Agarwal D, Agrawal Y, Wijayasinghe YS, Mukherjee A, Khan S.",Biochim Biophys Acta Mol Basis Dis. 2022 Nov 1;1868(11):166524. doi: 10.1016/j.bbadis.2022.166524. Epub 2022 Aug 17.,Poddar NK,Biochim Biophys Acta Mol Basis Dis,2022,19-08-2022,,,10.1016/j.bbadis.2022.166524
35982354,The potential link between obstructive sleep apnea and postoperative neurocognitive disorders: current knowledge and possible mechanisms,"Devinney MJ, VanDusen KW, Kfouri JM, Avasarala P, Spector AR, Mathew JP, Berger M.",Can J Anaesth. 2022 Oct;69(10):1272-1287. doi: 10.1007/s12630-022-02302-4. Epub 2022 Aug 18.,Devinney MJ,Can J Anaesth,2022,18-08-2022,PMC9924301,NIHMS1869081,10.1007/s12630-022-02302-4
35978949,Association of vitamin E intake in diet and supplements with risk of dementia: A meta-analysis,"Zhao R, Han X, Zhang H, Liu J, Zhang M, Zhao W, Jiang S, Li R, Cai H, You H.",Front Aging Neurosci. 2022 Aug 1;14:955878. doi: 10.3389/fnagi.2022.955878. eCollection 2022.,Zhao R,Front Aging Neurosci,2022,18-08-2022,PMC9376618,,10.3389/fnagi.2022.955878
35969390,Framework for Clinical Trials in Cerebral Small Vessel Disease (FINESSE): A Review,"Markus HS, van Der Flier WM, Smith EE, Bath P, Biessels GJ, Briceno E, Brodtman A, Chabriat H, Chen C, de Leeuw FE, Egle M, Ganesh A, Georgakis MK, Gottesman RF, Kwon S, Launer L, Mok V, O'Brien J, Ottenhoff L, Pendlebury S, Richard E, Sachdev P, Schmidt R, Springer M, Tiedt S, Wardlaw JM, Verdelho A, Webb A, Werring D, Duering M, Levine D, Dichgans M.",JAMA Neurol. 2022 Nov 1;79(11):1187-1198. doi: 10.1001/jamaneurol.2022.2262.,Markus HS,JAMA Neurol,2022,15-08-2022,PMC11036410,NIHMS1982836,10.1001/jamaneurol.2022.2262
35967772,Association between the mediterranean diet and cognitive health among healthy adults: A systematic review and meta-analysis,"Fu J, Tan LJ, Lee JE, Shin S.",Front Nutr. 2022 Jul 28;9:946361. doi: 10.3389/fnut.2022.946361. eCollection 2022.,Fu J,Front Nutr,2022,15-08-2022,PMC9372716,,10.3389/fnut.2022.946361
35959298,Effect of Wearable Sensor-Based Exercise on Musculoskeletal Disorders in Individuals With Neurodegenerative Diseases: A Systematic Review and Meta-Analysis,"Li X, Chen Z, Yue Y, Zhou X, Gu S, Tao J, Guo H, Zhu M, Du Q.",Front Aging Neurosci. 2022 Jul 26;14:934844. doi: 10.3389/fnagi.2022.934844. eCollection 2022.,Li X,Front Aging Neurosci,2022,12-08-2022,PMC9360755,,10.3389/fnagi.2022.934844
35956911,"Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders","Yousaf M, Chang D, Liu Y, Liu T, Zhou X.",Molecules. 2022 Aug 4;27(15):4961. doi: 10.3390/molecules27154961.,Yousaf M,Molecules,2022,12-08-2022,PMC9370304,,10.3390/molecules27154961
35956796,Advances on Therapeutic Strategies for Alzheimer's Disease: From Medicinal Plant to Nanotechnology,"Hassan NA, Alshamari AK, Hassan AA, Elharrif MG, Alhajri AM, Sattam M, Khattab RR.",Molecules. 2022 Jul 28;27(15):4839. doi: 10.3390/molecules27154839.,Hassan NA,Molecules,2022,12-08-2022,PMC9369981,,10.3390/molecules27154839
35956381,Effects of Selenium Supplementation in Patients with Mild Cognitive Impairment or Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Pereira ME, Souza JV, Galiciolli MEA, Sare F, Vieira GS, Kruk IL, Oliveira CS.",Nutrients. 2022 Aug 5;14(15):3205. doi: 10.3390/nu14153205.,Pereira ME,Nutrients,2022,12-08-2022,PMC9370215,,10.3390/nu14153205
35955963,Forest Biomass as a Promising Source of Bioactive Essential Oil and Phenolic Compounds for Alzheimer's Disease Therapy,"Moreira P, Matos P, Figueirinha A, Salgueiro L, Batista MT, Branco PC, Cruz MT, Pereira CF.",Int J Mol Sci. 2022 Aug 8;23(15):8812. doi: 10.3390/ijms23158812.,Moreira P,Int J Mol Sci,2022,12-08-2022,PMC9369093,,10.3390/ijms23158812
35955631,Clickable Biomaterials for Modulating Neuroinflammation,"Cornelison C, Fadel S.",Int J Mol Sci. 2022 Jul 31;23(15):8496. doi: 10.3390/ijms23158496.,Cornelison C,Int J Mol Sci,2022,12-08-2022,PMC9369181,,10.3390/ijms23158496
35955427,Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders,"Li N, Zhou T, Fei E.",Int J Mol Sci. 2022 Jul 27;23(15):8281. doi: 10.3390/ijms23158281.,Li N,Int J Mol Sci,2022,12-08-2022,PMC9368983,,10.3390/ijms23158281
35950246,mtDNA Maintenance and Alterations in the Pathogenesis of Neurodegenerative Diseases,"Shang D, Huang M, Wang B, Yan X, Wu Z, Zhang X.",Curr Neuropharmacol. 2023;21(3):578-598. doi: 10.2174/1570159X20666220810114644.,Shang D,Curr Neuropharmacol,2023,11-08-2022,PMC10207910,,10.2174/1570159X20666220810114644
35950245,Expanding Arsenal against Neurodegenerative Diseases Using Quercetin Based Nanoformulations: Breakthroughs and Bottlenecks,"Vishwas S, Kumar R, Khursheed R, Ramanunny AK, Kumar R, Awasthi A, Corrie L, Porwal O, Arshad MF, Alshammari MK, Alghitran AA, Qumayri AN, Alkhaldi SM, Alshammari AK, Chellappan DK, Gupta G, Collet T, Adams J, Dua K, Gulati M, Singh SK.",Curr Neuropharmacol. 2023;21(7):1558-1574. doi: 10.2174/1570159X20666220810105421.,Vishwas S,Curr Neuropharmacol,2023,11-08-2022,PMC10472810,,10.2174/1570159X20666220810105421
35948447,Leisure Activities and the Risk of Dementia: A Systematic Review and Meta-analysis,"Su S, Shi L, Zheng Y, Sun Y, Huang X, Zhang A, Que J, Sun X, Shi J, Bao Y, Deng J, Lu L.",Neurology. 2022 Oct 10;99(15):e1651-e1663. doi: 10.1212/WNL.0000000000200929.,Su S,Neurology,2022,10-08-2022,PMC9559944,,10.1212/WNL.0000000000200929
35946590,Recommendations to address key recruitment challenges of Alzheimer's disease clinical trials,"Langbaum JB, Zissimopoulos J, Au R, Bose N, Edgar CJ, Ehrenberg E, Fillit H, Hill CV, Hughes L, Irizarry M, Kremen S, Lakdawalla D, Lynn N, Malzbender K, Maruyama T, Massett HA, Patel D, Peneva D, Reiman EM, Romero K, Routledge C, Weiner MW, Weninger S, Aisen PS.",Alzheimers Dement. 2023 Feb;19(2):696-707. doi: 10.1002/alz.12737. Epub 2022 Aug 10.,Langbaum JB,Alzheimers Dement,2023,10-08-2022,PMC9911558,NIHMS1818572,10.1002/alz.12737
35946443,Biological and neurological activities of astaxanthin (Review),"Si P, Zhu C.",Mol Med Rep. 2022 Oct;26(4):300. doi: 10.3892/mmr.2022.12816. Epub 2022 Aug 10.,Si P,Mol Med Rep,2022,10-08-2022,PMC9435021,,10.3892/mmr.2022.12816
35946107,Serum neurofilament light and MRI predictors of cognitive decline in patients with secondary progressive multiple sclerosis: Analysis from the MS-STAT randomised controlled trial,"Williams T, Tur C, Eshaghi A, Doshi A, Chan D, Binks S, Wellington H, Heslegrave A, Zetterberg H, Chataway J.",Mult Scler. 2022 Oct;28(12):1913-1926. doi: 10.1177/13524585221114441. Epub 2022 Aug 9.,Williams T,Mult Scler,2022,10-08-2022,PMC9493411,,10.1177/13524585221114441
35945786,Effects of magnesium valproate adjuvant therapy on patients with dementia: A systematic review and meta-analysis,"Zhang C, Sun L, Sun H.",Medicine (Baltimore). 2022 Aug 5;101(31):e29642. doi: 10.1097/MD.0000000000029642.,Zhang C,Medicine (Baltimore),2022,10-08-2022,PMC9351853,,10.1097/MD.0000000000029642
35945739,A systematic review of the efficacy of donepezil hydrochloride combined with nimodipine on treating vascular dementia,"Yang Q, Liu J, Huang KL, Wang GY, Wang MY, Tan AH, Ran SM.",Medicine (Baltimore). 2022 Aug 5;101(31):e29307. doi: 10.1097/MD.0000000000029307.,Yang Q,Medicine (Baltimore),2022,10-08-2022,PMC9351939,,10.1097/MD.0000000000029307
35945508,Promoting independence in Lewy body dementia through exercise: the PRIDE study,"Inskip MJ, Mavros Y, Sachdev PS, Hausdorff JM, Hillel I, Singh MAF.",BMC Geriatr. 2022 Aug 9;22(1):650. doi: 10.1186/s12877-022-03347-2.,Inskip MJ,BMC Geriatr,2022,09-08-2022,PMC9361699,,10.1186/s12877-022-03347-2
35943792,The Effectiveness of Serious Games in Improving Memory Among Older Adults With Cognitive Impairment: Systematic Review and Meta-analysis,"Abd-Alrazaq A, Alhuwail D, Al-Jafar E, Ahmed A, Shuweihdi F, Reagu SM, Househ M.",JMIR Serious Games. 2022 Aug 9;10(3):e35202. doi: 10.2196/35202.,Abd-Alrazaq A,JMIR Serious Games,2022,09-08-2022,PMC9399845,,10.2196/35202
35939055,Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer's disease: A systematic review and meta-analysis,"Hiu SKW, Bigirumurame T, Kunonga P, Bryant A, Pillai M.",Brain Behav. 2022 Sep;12(9):e2734. doi: 10.1002/brb3.2734. Epub 2022 Aug 8.,Hiu SKW,Brain Behav,2022,08-08-2022,PMC9480932,,10.1002/brb3.2734
35936764,Blood levels of circulating methionine components in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis,"Zhao Y, Dong X, Chen B, Zhang Y, Meng S, Guo F, Guo X, Zhu J, Wang H, Cui H, Li S.",Front Aging Neurosci. 2022 Jul 22;14:934070. doi: 10.3389/fnagi.2022.934070. eCollection 2022.,Zhao Y,Front Aging Neurosci,2022,08-08-2022,PMC9354989,,10.3389/fnagi.2022.934070
35935939,Therapeutic application of quercetin in aging-related diseases: SIRT1 as a potential mechanism,"Cui Z, Zhao X, Amevor FK, Du X, Wang Y, Li D, Shu G, Tian Y, Zhao X.",Front Immunol. 2022 Jul 22;13:943321. doi: 10.3389/fimmu.2022.943321. eCollection 2022.,Cui Z,Front Immunol,2022,08-08-2022,PMC9355713,,10.3389/fimmu.2022.943321
35932158,"Effects of an essential amino acid mixture on behavioral and psychological symptoms of dementia and executive function in patients with Alzheimer's disease: A double-blind, randomized, placebo-controlled exploratory clinical trial","Takada M, Tanaka S, Tanaka K, Tsukie T, Tsukamoto-Yasui M, Suzuki K, Noguchi Y, Imaizumi A, Ishii M, Ikeuchi T.",Int J Geriatr Psychiatry. 2022 Sep;37(9):10.1002/gps.5782. doi: 10.1002/gps.5782.,Takada M,Int J Geriatr Psychiatry,2022,06-08-2022,PMC9544995,,10.1002/gps.5782
35922871,Inflammatory plasma biomarkers in subjects with preclinical Alzheimer's disease,"Prins S, de Kam ML, Teunissen CE, Groeneveld GJ.",Alzheimers Res Ther. 2022 Aug 3;14(1):106. doi: 10.1186/s13195-022-01051-2.,Prins S,Alzheimers Res Ther,2022,03-08-2022,PMC9347121,,10.1186/s13195-022-01051-2
35920161,Association of cognition with leptin and vascular endothelial growth factor in individuals with type 2 diabetes mellitus,"Espeland MA, Evans JK, Carmichael O, Luchsinger JA, Marcovina SM, Neiberg R, Johnson KC, Kahn SE, Hayden KM; Action for Health in Diabetes (Look AHEAD) MIND Ancillary Study Group.",Obesity (Silver Spring). 2022 Sep;30(9):1863-1874. doi: 10.1002/oby.23495. Epub 2022 Aug 3.,Espeland MA,Obesity (Silver Spring),2022,03-08-2022,PMC9420754,NIHMS1808919,10.1002/oby.23495
35910833,Therapeutic Potential of Different Natural Products for the Treatment of Alzheimer's Disease,"Chakraborty B, Mukerjee N, Maitra S, Zehravi M, Mukherjee D, Ghosh A, Massoud EES, Rahman MH.",Oxid Med Cell Longev. 2022 Jul 22;2022:6873874. doi: 10.1155/2022/6873874. eCollection 2022.,Chakraborty B,Oxid Med Cell Longev,2022,01-08-2022,PMC9337964,,10.1155/2022/6873874
35897078,Evaluation of tau deposition using (18)F-PI-2620 PET in MCI and early AD subjects-a MissionAD tau sub-study,"Bullich S, Mueller A, De Santi S, Koglin N, Krause S, Kaplow J, Kanekiyo M, Roé-Vellvé N, Perrotin A, Jovalekic A, Scott D, Gee M, Stephens A, Irizarry M.",Alzheimers Res Ther. 2022 Jul 27;14(1):105. doi: 10.1186/s13195-022-01048-x.,Bullich S,Alzheimers Res Ther,2022,27-07-2022,PMC9327167,,10.1186/s13195-022-01048-x
35892581,The Monkey Head Mushroom and Memory Enhancement in Alzheimer's Disease,"Yanshree, Yu WS, Fung ML, Lee CW, Lim LW, Wong KH.",Cells. 2022 Jul 24;11(15):2284. doi: 10.3390/cells11152284.,Yanshree,Cells,2022,27-07-2022,PMC9331832,,10.3390/cells11152284
35889517,Inosine in Neurodegenerative Diseases: From the Bench to the Bedside,"Basile MS, Bramanti P, Mazzon E.",Molecules. 2022 Jul 21;27(14):4644. doi: 10.3390/molecules27144644.,Basile MS,Molecules,2022,27-07-2022,PMC9316764,,10.3390/molecules27144644
35889273,A Comprehensive Review on the Benefits and Problems of Curcumin with Respect to Human Health,"Liu S, Liu J, He L, Liu L, Cheng B, Zhou F, Cao D, He Y.",Molecules. 2022 Jul 8;27(14):4400. doi: 10.3390/molecules27144400.,Liu S,Molecules,2022,27-07-2022,PMC9319031,,10.3390/molecules27144400
35887166,The Role of Psychobiotics in Supporting the Treatment of Disturbances in the Functioning of the Nervous System-A Systematic Review,"Skowron K, Budzyńska A, Wiktorczyk-Kapischke N, Chomacka K, Grudlewska-Buda K, Wilk M, Wałecka-Zacharska E, Andrzejewska M, Gospodarek-Komkowska E.",Int J Mol Sci. 2022 Jul 15;23(14):7820. doi: 10.3390/ijms23147820.,Skowron K,Int J Mol Sci,2022,27-07-2022,PMC9319704,,10.3390/ijms23147820
35887134,The Potential Role of miRNA-Regulated Autophagy in Alzheimer's Disease,"Zhang H, Liang J, Chen N.",Int J Mol Sci. 2022 Jul 14;23(14):7789. doi: 10.3390/ijms23147789.,Zhang H,Int J Mol Sci,2022,27-07-2022,PMC9317523,,10.3390/ijms23147789
35886867,Bioavailability Improvement Strategies for Icariin and Its Derivates: A Review,"Szabó R, Rácz CP, Dulf FV.",Int J Mol Sci. 2022 Jul 7;23(14):7519. doi: 10.3390/ijms23147519.,Szabó R,Int J Mol Sci,2022,27-07-2022,PMC9318307,,10.3390/ijms23147519
35885018,A Systematic Review and Meta-Analysis of Cerebrospinal Fluid Amyloid and Tau Levels Identifies Mild Cognitive Impairment Patients Progressing to Alzheimer's Disease,"Ma Y, Brettschneider J, Collingwood JF.",Biomedicines. 2022 Jul 15;10(7):1713. doi: 10.3390/biomedicines10071713.,Ma Y,Biomedicines,2022,27-07-2022,PMC9313367,,10.3390/biomedicines10071713
35878744,Current understanding of the interactions between metal ions and Apolipoprotein E in Alzheimer's disease,"Zhang Y, Gao H, Zheng W, Xu H.",Neurobiol Dis. 2022 Oct 1;172:105824. doi: 10.1016/j.nbd.2022.105824. Epub 2022 Jul 22.,Zhang Y,Neurobiol Dis,2022,25-07-2022,,,10.1016/j.nbd.2022.105824
35877166,Effectiveness of Serious Games for Improving Executive Functions Among Older Adults With Cognitive Impairment: Systematic Review and Meta-analysis,"Abd-Alrazaq A, Alhuwail D, Ahmed A, Househ M.",JMIR Serious Games. 2022 Jul 25;10(3):e36123. doi: 10.2196/36123.,Abd-Alrazaq A,JMIR Serious Games,2022,25-07-2022,PMC9361143,,10.2196/36123
35870288,Towards development of disease-modifying therapy for Alzheimer's disease using redox chemical biology pathways,Lipton SA.,Curr Opin Pharmacol. 2022 Oct;66:102267. doi: 10.1016/j.coph.2022.102267. Epub 2022 Jul 20.,Lipton SA,Curr Opin Pharmacol,2022,23-07-2022,PMC9509422,NIHMS1822918,10.1016/j.coph.2022.102267
35869065,The effect of dietary fat consumption on Alzheimer's disease pathogenesis in mouse models,"Amelianchik A, Sweetland-Martin L, Norris EH.",Transl Psychiatry. 2022 Jul 22;12(1):293. doi: 10.1038/s41398-022-02067-w.,Amelianchik A,Transl Psychiatry,2022,22-07-2022,PMC9307654,,10.1038/s41398-022-02067-w
35867135,"Neuroimaging analyses from a randomized, controlled study to evaluate plasma exchange with albumin replacement in mild-to-moderate Alzheimer's disease: additional results from the AMBAR study","Cuberas-Borrós G, Roca I, Castell-Conesa J, Núñez L, Boada M, López OL, Grifols C, Barceló M, Pareto D, Páez A.",Eur J Nucl Med Mol Imaging. 2022 Nov;49(13):4589-4600. doi: 10.1007/s00259-022-05915-5. Epub 2022 Jul 22.,Cuberas-Borrós G,Eur J Nucl Med Mol Imaging,2022,22-07-2022,PMC9606044,,10.1007/s00259-022-05915-5
35861789,Cannabinoids to Improve Health-Related Quality of Life in Patients with Neurological or Oncological Disease: A Meta-Analysis,"Belgers V, Röttgering JG, Douw L, Klein M, Ket JCF, van de Ven PM, Würdinger T, van Linde ME, Niers JM, Weber M, Olde Rikkert MG, Lopez-Sendon J, Arrieta O, Svendsen KB, Chagas MHN, de Almeida CMO, Kouwenhoven MCM, de Witt Hamer PC.",Cannabis Cannabinoid Res. 2023 Feb;8(1):41-55. doi: 10.1089/can.2021.0187. Epub 2022 Jul 21.,Belgers V,Cannabis Cannabinoid Res,2023,21-07-2022,PMC9940814,,10.1089/can.2021.0187
35853750,Association of Self-reflection With Cognition and Brain Health in Cognitively Unimpaired Older Adults,"Demnitz-King H, Gonneaud J, Klimecki OM, Chocat A, Collette F, Dautricourt S, Jessen F, Krolak-Salmon P, Lutz A, Morse RM, Molinuevo JL, Poisnel G, Touron E, Wirth M, Walker Z, Chételat G, Marchant NL; Medit-Ageing Research Group.",Neurology. 2022 Sep 27;99(13):e1422-e1431. doi: 10.1212/WNL.0000000000200951. Epub 2022 Jul 19.,Demnitz-King H,Neurology,2022,19-07-2022,,,10.1212/WNL.0000000000200951
35852256,Cost-effectiveness of mirtazapine for agitated behaviors in dementia: findings from a randomized controlled trial,"Henderson C, Knapp M, Stirling S, Shepstone L, High J, Ballard C, Bentham P, Burns A, Farina N, Fox C, Fountain J, Francis P, Howard R, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien JT, Price A, Swart AM, Tabet N, Telling T, Thomas AJ, Banerjee S.",Int Psychogeriatr. 2022 Oct;34(10):905-917. doi: 10.1017/S1041610222000436. Epub 2022 Jul 19.,Henderson C,Int Psychogeriatr,2022,19-07-2022,,,10.1017/S1041610222000436
35850165,Scoping Review of Randomized Trials With Discontinuation of Medicines in Older Adults,"Kornholt J, Bülow C, Sørensen AMS, Pressel E, Petersen TS, Christensen MB.",J Am Med Dir Assoc. 2022 Dec;23(12):1926.e11-1926.e35. doi: 10.1016/j.jamda.2022.06.010. Epub 2022 Jul 16.,Kornholt J,J Am Med Dir Assoc,2022,19-07-2022,,,10.1016/j.jamda.2022.06.010
35841252,Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer's Disease,"Cohen S, Cummings J, Knox S, Potashman M, Harrison J.",J Prev Alzheimers Dis. 2022;9(3):507-522. doi: 10.14283/jpad.2022.41.,Cohen S,J Prev Alzheimers Dis,2022,16-07-2022,PMC9843702,NIHMS1861287,10.14283/jpad.2022.41
35833913,Antithrombotic therapy to prevent cognitive decline in people with small vessel disease on neuroimaging but without dementia,"Kwan J, Hafdi M, Chiang LLW, Myint PK, Wong LS, Quinn TJ.",Cochrane Database Syst Rev. 2022 Jul 14;7(7):CD012269. doi: 10.1002/14651858.CD012269.pub2.,Kwan J,Cochrane Database Syst Rev,2022,14-07-2022,PMC9281623,,10.1002/14651858.CD012269.pub2
35817542,Targeting Angiogenesis via Resolution of Inflammation,"Kelly AG, Panigrahy D.",Cold Spring Harb Perspect Med. 2023 Mar 1;13(3):a041172. doi: 10.1101/cshperspect.a041172.,Kelly AG,Cold Spring Harb Perspect Med,2023,11-07-2022,PMC9979849,,10.1101/cshperspect.a041172
35815777,The design and conduct of a pragmatic cluster randomized trial of an advance care planning program for nursing home residents with dementia,"Hickman SE, Mitchell SL, Hanson LC, Tu W, Stump TE, Unroe KT.",Clin Trials. 2022 Dec;19(6):623-635. doi: 10.1177/17407745221108992. Epub 2022 Jul 10.,Hickman SE,Clin Trials,2022,11-07-2022,PMC9691516,NIHMS1815034,10.1177/17407745221108992
35811518,Precision Medicine Approach to Alzheimer's Disease: Successful Pilot Project,"Toups K, Hathaway A, Gordon D, Chung H, Raji C, Boyd A, Hill BD, Hausman-Cohen S, Attarha M, Chwa WJ, Jarrett M, Bredesen DE.",J Alzheimers Dis. 2022;88(4):1411-1421. doi: 10.3233/JAD-215707.,Toups K,J Alzheimers Dis,2022,11-07-2022,PMC9484109,,10.3233/JAD-215707
35807418,Role of Natural Compounds and Target Enzymes in the Treatment of Alzheimer's Disease,"Wang S, Kong X, Chen Z, Wang G, Zhang J, Wang J.",Molecules. 2022 Jun 29;27(13):4175. doi: 10.3390/molecules27134175.,Wang S,Molecules,2022,09-07-2022,PMC9268689,,10.3390/molecules27134175
35805955,Therapeutic Potential of Allicin and Aged Garlic Extract in Alzheimer's Disease,"Tedeschi P, Nigro M, Travagli A, Catani M, Cavazzini A, Merighi S, Gessi S.",Int J Mol Sci. 2022 Jun 22;23(13):6950. doi: 10.3390/ijms23136950.,Tedeschi P,Int J Mol Sci,2022,09-07-2022,PMC9266652,,10.3390/ijms23136950
35805109,GLP-1 Receptor Agonists in Neurodegeneration: Neurovascular Unit in the Spotlight,"Monti G, Gomes Moreira D, Richner M, Mutsaers HAM, Ferreira N, Jan A.",Cells. 2022 Jun 25;11(13):2023. doi: 10.3390/cells11132023.,Monti G,Cells,2022,09-07-2022,PMC9265397,,10.3390/cells11132023
35802628,Dementia risk and dynamic response to exercise: A non-randomized clinical trial,"Vidoni ED, Morris JK, Palmer JA, Li Y, White D, Kueck PJ, John CS, Honea RA, Lepping RJ, Lee P, Mahnken JD, Martin LE, Billinger SA.",PLoS One. 2022 Jul 8;17(7):e0265860. doi: 10.1371/journal.pone.0265860. eCollection 2022.,Vidoni ED,PLoS One,2022,08-07-2022,PMC9269742,,10.1371/journal.pone.0265860
35801957,Demographic and clinical profile of residents living with dementia and depressive symptoms in Australian private residential aged care: Data from the Music Interventions for Dementia and Depression in ELderly care (MIDDEL) cluster-randomised controlled trial,"Lee YC, Sousa TV, Stretton-Smith PA, Gold C, Geretsegger M, Baker FA.",Australas J Ageing. 2022 Dec;41(4):e387-e396. doi: 10.1111/ajag.13104. Epub 2022 Jul 8.,Lee YC,Australas J Ageing,2022,08-07-2022,PMC10084363,,10.1111/ajag.13104
35797268,The effect of framing on attitudes towards Alzheimer's disease. A comparative study between younger and older adults,"Cuadrado F, Antolí A, Fernández-Calvo B.",PLoS One. 2022 Jul 7;17(7):e0270959. doi: 10.1371/journal.pone.0270959. eCollection 2022.,Cuadrado F,PLoS One,2022,07-07-2022,PMC9262181,,10.1371/journal.pone.0270959
35796264,Potential of Transcranial Direct Current Stimulation in Alzheimer's Disease: Optimizing Trials Toward Clinical Use,"Pilloni G, Charvet LE, Bikson M, Palekar N, Kim MJ.",J Clin Neurol. 2022 Jul;18(4):391-400. doi: 10.3988/jcn.2022.18.4.391.,Pilloni G,J Clin Neurol,2022,07-07-2022,PMC9262447,,10.3988/jcn.2022.18.4.391
35795585,Fruit and Vegetable Consumption and Cognitive Disorders in Older Adults: A Meta-Analysis of Observational Studies,"Zhou Y, Wang J, Cao L, Shi M, Liu H, Zhao Y, Xia Y.",Front Nutr. 2022 Jun 20;9:871061. doi: 10.3389/fnut.2022.871061. eCollection 2022.,Zhou Y,Front Nutr,2022,07-07-2022,PMC9251442,,10.3389/fnut.2022.871061
35794767,"Bipolar Disorder and Manic-Like Symptoms in Alzheimer's, Vascular and Frontotemporal Dementia: A Systematic Review","Elefante C, Brancati GE, Torrigiani S, Amadori S, Ricciardulli S, Pistolesi G, Lattanzi L, Perugi G.",Curr Neuropharmacol. 2023;21(12):2516-2542. doi: 10.2174/1570159X20666220706110157.,Elefante C,Curr Neuropharmacol,2023,07-07-2022,PMC10616925,,10.2174/1570159X20666220706110157
35791724,Toward rational use of cognitive training in those with mild cognitive impairment,"Hampstead BM, Stringer AY, Iordan AD, Ploutz-Snyder R, Sathian K.",Alzheimers Dement. 2023 Mar;19(3):933-945. doi: 10.1002/alz.12718. Epub 2022 Jul 6.,Hampstead BM,Alzheimers Dement,2023,06-07-2022,PMC9816345,NIHMS1850612,10.1002/alz.12718
35782450,Effect of Physical Exercise on Cognitive Function of Alzheimer's Disease Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trial,"Liu W, Zhang J, Wang Y, Li J, Chang J, Jia Q.",Front Psychiatry. 2022 Jun 16;13:927128. doi: 10.3389/fpsyt.2022.927128. eCollection 2022.,Liu W,Front Psychiatry,2022,05-07-2022,PMC9243422,,10.3389/fpsyt.2022.927128
35779628,(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression,"Wang X, Yang J, Hashimoto K.",Neurosci Biobehav Rev. 2022 Aug;139:104762. doi: 10.1016/j.neubiorev.2022.104762. Epub 2022 Jun 30.,Wang X,Neurosci Biobehav Rev,2022,02-07-2022,,,10.1016/j.neubiorev.2022.104762
35774605,Molecular Pathways and Roles for Vitamin K2-7 as a Health-Beneficial Nutraceutical: Challenges and Opportunities,"Jadhav N, Ajgaonkar S, Saha P, Gurav P, Pandey A, Basudkar V, Gada Y, Panda S, Jadhav S, Mehta D, Nair S.",Front Pharmacol. 2022 Jun 14;13:896920. doi: 10.3389/fphar.2022.896920. eCollection 2022.,Jadhav N,Front Pharmacol,2022,01-07-2022,PMC9237441,,10.3389/fphar.2022.896920
35771887,Actovegin in the management of patients after ischemic stroke: A systematic review,"la Fleur P, Baizhaxynova A, Reynen E, Kaunelis D, Galiyeva D.",PLoS One. 2022 Jun 30;17(6):e0270497. doi: 10.1371/journal.pone.0270497. eCollection 2022.,la Fleur P,PLoS One,2022,30-06-2022,PMC9246213,,10.1371/journal.pone.0270497
35760047,Progestogen-Mediated Neuroprotection in Central Nervous System Disorders,"Bassani TB, Bartolomeo CS, Oliveira RB, Ureshino RP.",Neuroendocrinology. 2023;113(1):14-35. doi: 10.1159/000525677. Epub 2022 Jun 27.,Bassani TB,Neuroendocrinology,2023,27-06-2022,,,10.1159/000525677
35758526,Hypertension and Alzheimer's disease pathology at autopsy: A systematic review,"Abdulrahman H, van Dalen JW, den Brok M, Latimer CS, Larson EB, Richard E.",Alzheimers Dement. 2022 Nov;18(11):2308-2326. doi: 10.1002/alz.12707. Epub 2022 Jun 27.,Abdulrahman H,Alzheimers Dement,2022,27-06-2022,PMC9796086,,10.1002/alz.12707
35750991,Can the administration of platelet lysates to the brain help treat neurological disorders?,"Nebie O, Buée L, Blum D, Burnouf T.",Cell Mol Life Sci. 2022 Jun 24;79(7):379. doi: 10.1007/s00018-022-04397-w.,Nebie O,Cell Mol Life Sci,2022,24-06-2022,PMC9243829,,10.1007/s00018-022-04397-w
35746960,"Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer's Disease","Li Q, Rubin L, Silva M, Li S, Yang C, Lazarovici P, Zheng W.",Oxid Med Cell Longev. 2022 Jun 14;2022:3777021. doi: 10.1155/2022/3777021. eCollection 2022.,Li Q,Oxid Med Cell Longev,2022,24-06-2022,PMC9213169,,10.1155/2022/3777021
35745002,Curcumin Scaffold as a Multifunctional Tool for Alzheimer's Disease Research,"Yang H, Zeng F, Luo Y, Zheng C, Ran C, Yang J.",Molecules. 2022 Jun 17;27(12):3879. doi: 10.3390/molecules27123879.,Yang H,Molecules,2022,24-06-2022,PMC9227459,,10.3390/molecules27123879
35744865,Neuroprotective Effect of Caffeine in Alzheimer's Disease,"M Yelanchezian YM, Waldvogel HJ, Faull RLM, Kwakowsky A.",Molecules. 2022 Jun 10;27(12):3737. doi: 10.3390/molecules27123737.,M Yelanchezian YM,Molecules,2022,24-06-2022,PMC9227174,,10.3390/molecules27123737
35744831,Expatiating the Pharmacological and Nanotechnological Aspects of the Alkaloidal Drug Berberine: Current and Future Trends,"Behl T, Singh S, Sharma N, Zahoor I, Albarrati A, Albratty M, Meraya AM, Najmi A, Bungau S.",Molecules. 2022 Jun 9;27(12):3705. doi: 10.3390/molecules27123705.,Behl T,Molecules,2022,24-06-2022,PMC9229453,,10.3390/molecules27123705
35743035,Molecular Hydrogen Neuroprotection in Post-Ischemic Neurodegeneration in the Form of Alzheimer's Disease Proteinopathy: Underlying Mechanisms and Potential for Clinical Implementation-Fantasy or Reality?,"Pluta R, Januszewski S, Czuczwar SJ.",Int J Mol Sci. 2022 Jun 13;23(12):6591. doi: 10.3390/ijms23126591.,Pluta R,Int J Mol Sci,2022,24-06-2022,PMC9224395,,10.3390/ijms23126591
35742220,The Effectiveness of Multi-Component Interventions on the Positive and Negative Aspects of Well-Being among Informal Caregivers of People with Dementia: A Systematic Review and Meta-Analysis,"He J, Wang J, Zhong H, Guan C.",Int J Environ Res Public Health. 2022 Jun 7;19(12):6973. doi: 10.3390/ijerph19126973.,He J,Int J Environ Res Public Health,2022,24-06-2022,PMC9222573,,10.3390/ijerph19126973
35736165,"Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive Review","Martins B, Vieira M, Delerue-Matos C, Grosso C, Soares C.",Mar Drugs. 2022 May 28;20(6):362. doi: 10.3390/md20060362.,Martins B,Mar Drugs,2022,23-06-2022,PMC9227170,,10.3390/md20060362
35734582,Non-invasive brain stimulation and neuroenhancement,"Antal A, Luber B, Brem AK, Bikson M, Brunoni AR, Cohen Kadosh R, Dubljević V, Fecteau S, Ferreri F, Flöel A, Hallett M, Hamilton RH, Herrmann CS, Lavidor M, Loo C, Lustenberger C, Machado S, Miniussi C, Moliadze V, Nitsche MA, Rossi S, Rossini PM, Santarnecchi E, Seeck M, Thut G, Turi Z, Ugawa Y, Venkatasubramanian G, Wenderoth N, Wexler A, Ziemann U, Paulus W.",Clin Neurophysiol Pract. 2022 May 25;7:146-165. doi: 10.1016/j.cnp.2022.05.002. eCollection 2022.,Antal A,Clin Neurophysiol Pract,2022,23-06-2022,PMC9207555,,10.1016/j.cnp.2022.05.002
35730441,An Updated Review on The Properties of Melissa officinalis L.: Not Exclusively Anti-anxiety,"Zam W, Quispe C, Sharifi-Rad J, López MD, Schoebitz M, Martorell M, Sharopov F, Fokou PVT, Mishra AP, Chandran D, Kumar M, Chen JT, Pezzani R.",Front Biosci (Schol Ed). 2022 Jun 7;14(2):16. doi: 10.31083/j.fbs1402016.,Zam W,Front Biosci (Schol Ed),2022,22-06-2022,,,10.31083/j.fbs1402016
35718870,The Ketogenic Diet and Alzheimer's Disease,"Hersant H, Grossberg G.",J Nutr Health Aging. 2022;26(6):606-614. doi: 10.1007/s12603-022-1807-7.,Hersant H,J Nutr Health Aging,2022,19-06-2022,,,10.1007/s12603-022-1807-7
35716694,Potential disease-modifying therapies for Huntington's disease: lessons learned and future opportunities,"Tabrizi SJ, Estevez-Fraga C, van Roon-Mom WMC, Flower MD, Scahill RI, Wild EJ, Muñoz-Sanjuan I, Sampaio C, Rosser AE, Leavitt BR.",Lancet Neurol. 2022 Jul;21(7):645-658. doi: 10.1016/S1474-4422(22)00121-1.,Tabrizi SJ,Lancet Neurol,2022,18-06-2022,PMC7613206,EMS146360,10.1016/S1474-4422(22)00121-1
35713714,"Promising application of polyoxometalates in the treatment of cancer, infectious diseases and Alzheimer's disease","Wang X, Wei S, Zhao C, Li X, Jin J, Shi X, Su Z, Li J, Wang J.",J Biol Inorg Chem. 2022 Aug;27(4-5):405-419. doi: 10.1007/s00775-022-01942-7. Epub 2022 Jun 17.,Wang X,J Biol Inorg Chem,2022,17-06-2022,PMC9203773,,10.1007/s00775-022-01942-7
35701227,Combined physical exercise-working memory training on slowing down cognitive decline in elders with mild clinical Alzheimer disease: a randomised controlled study (abridged secondary publication),"Lam LCW, Chan WC, Kwok TCY, Lee JSW, Yu BML, Lee S, Lee ATC, Ma SL, Cheng ST.",Hong Kong Med J. 2022 Jun;28 Suppl 3(3):28-30.,Lam LCW,Hong Kong Med J,2022,14-06-2022,,,
35700915,Effect of cerebellum stimulation on cognitive recovery in patients with Alzheimer disease: A randomized clinical trial,"Yao Q, Tang F, Wang Y, Yan Y, Dong L, Wang T, Zhu D, Tian M, Lin X, Shi J.",Brain Stimul. 2022 Jul-Aug;15(4):910-920. doi: 10.1016/j.brs.2022.06.004. Epub 2022 Jun 11.,Yao Q,Brain Stimul,2022,14-06-2022,,,10.1016/j.brs.2022.06.004
35698099,Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia,"Roberts AC, Rademaker AW, Salley EA, Mooney A, Morhardt D, Fried-Oken M, Weintraub S, Mesulam M, Rogalski E.",Trials. 2022 Jun 13;23(1):487. doi: 10.1186/s13063-022-06162-7.,Roberts AC,Trials,2022,13-06-2022,PMC9190461,,10.1186/s13063-022-06162-7
35696185,Safety and Efficacy of Semorinemab in Individuals With Prodromal to Mild Alzheimer Disease: A Randomized Clinical Trial,"Teng E, Manser PT, Pickthorn K, Brunstein F, Blendstrup M, Sanabria Bohorquez S, Wildsmith KR, Toth B, Dolton M, Ramakrishnan V, Bobbala A, Sikkes SAM, Ward M, Fuji RN, Kerchner GA; Tauriel Investigators.",JAMA Neurol. 2022 Aug 1;79(8):758-767. doi: 10.1001/jamaneurol.2022.1375.,Teng E,JAMA Neurol,2022,13-06-2022,PMC9194753,,10.1001/jamaneurol.2022.1375
35694839,The influence of the macular carotenoids on women's eye and brain health,"Hammond BR, Renzi-Hammond L.",Nutr Neurosci. 2023 Aug;26(8):720-726. doi: 10.1080/1028415X.2022.2084125. Epub 2022 Jun 11.,Hammond BR,Nutr Neurosci,2023,13-06-2022,,,10.1080/1028415X.2022.2084125
35684573,The Fight against Infection and Pain: Devil's Claw (Harpagophytum procumbens) a Rich Source of Anti-Inflammatory Activity: 2011-2022,"Gxaba N, Manganyi MC.",Molecules. 2022 Jun 6;27(11):3637. doi: 10.3390/molecules27113637.,Gxaba N,Molecules,2022,10-06-2022,PMC9182060,,10.3390/molecules27113637
35684340,The Role of Microbiome in Brain Development and Neurodegenerative Diseases,"Nandwana V, Nandwana NK, Das Y, Saito M, Panda T, Das S, Almaguel F, Hosmane NS, Das BC.",Molecules. 2022 May 25;27(11):3402. doi: 10.3390/molecules27113402.,Nandwana V,Molecules,2022,10-06-2022,PMC9182002,,10.3390/molecules27113402
35682615,"An Overview of Oxidative Stress, Neuroinflammation, and Neurodegenerative Diseases","Teleanu DM, Niculescu AG, Lungu II, Radu CI, Vladâcenco O, Roza E, Costăchescu B, Grumezescu AM, Teleanu RI.",Int J Mol Sci. 2022 May 25;23(11):5938. doi: 10.3390/ijms23115938.,Teleanu DM,Int J Mol Sci,2022,10-06-2022,PMC9180653,,10.3390/ijms23115938
35681426,Alpha-Synuclein Aggregation Pathway in Parkinson's Disease: Current Status and Novel Therapeutic Approaches,"Vidović M, Rikalovic MG.",Cells. 2022 May 24;11(11):1732. doi: 10.3390/cells11111732.,Vidović M,Cells,2022,10-06-2022,PMC9179656,,10.3390/cells11111732
35678747,Dissemination of a successful dementia care program: Lessons to facilitate spread of innovations,"Reuben DB, Evertson LC, Jackson-Stoeckle R, Epstein-Lubow G, Spragens LH, Haggerty KL, Serrano KS, Jennings LA.",J Am Geriatr Soc. 2022 Sep;70(9):2686-2694. doi: 10.1111/jgs.17900. Epub 2022 Jun 9.,Reuben DB,J Am Geriatr Soc,2022,09-06-2022,PMC9489616,NIHMS1808987,10.1111/jgs.17900
35672765,Nanomaterials alleviating redox stress in neurological diseases: mechanisms and applications,"Jiang Y, Kang Y, Liu J, Yin S, Huang Z, Shao L.",J Nanobiotechnology. 2022 Jun 7;20(1):265. doi: 10.1186/s12951-022-01434-5.,Jiang Y,J Nanobiotechnology,2022,07-06-2022,PMC9171999,,10.1186/s12951-022-01434-5
35671869,Effects of interventions on cerebral perfusion in the Alzheimer's disease spectrum: A systematic review,"Marcolini S, Frentz I, Sanchez-Catasus CA, Mondragon JD, Feltes PK, van der Hoorn A, Borra RJH, Ikram MA, Dierckx RAJO, De Deyn PP.",Ageing Res Rev. 2022 Aug;79:101661. doi: 10.1016/j.arr.2022.101661. Epub 2022 Jun 4.,Marcolini S,Ageing Res Rev,2022,07-06-2022,,,10.1016/j.arr.2022.101661
35667236,New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer's disease,"Wu JJ, Yang Y, Wan Y, Xia J, Xu JF, Zhang L, Liu D, Chen L, Tang F, Ao H, Peng C.",Biomed Pharmacother. 2022 Aug;152:113207. doi: 10.1016/j.biopha.2022.113207. Epub 2022 Jun 3.,Wu JJ,Biomed Pharmacother,2022,06-06-2022,,,10.1016/j.biopha.2022.113207
35660246,Signal pathways in the treatment of Alzheimer's disease with traditional Chinese medicine,"Ding MR, Qu YJ, Hu B, An HM.",Biomed Pharmacother. 2022 Aug;152:113208. doi: 10.1016/j.biopha.2022.113208. Epub 2022 May 31.,Ding MR,Biomed Pharmacother,2022,06-06-2022,,,10.1016/j.biopha.2022.113208
35659112,Tauroursodeoxycholic acid: a potential therapeutic tool in neurodegenerative diseases,"Khalaf K, Tornese P, Cocco A, Albanese A.",Transl Neurodegener. 2022 Jun 4;11(1):33. doi: 10.1186/s40035-022-00307-z.,Khalaf K,Transl Neurodegener,2022,06-06-2022,PMC9166453,,10.1186/s40035-022-00307-z
35650449,"Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review","Mahapatra MK, Karuppasamy M, Sahoo BM.",Pharm Res. 2022 Jun;39(6):1233-1248. doi: 10.1007/s11095-022-03302-1. Epub 2022 Jun 1.,Mahapatra MK,Pharm Res,2022,01-06-2022,PMC9159769,,10.1007/s11095-022-03302-1
35649245,"Safety, pharmacokinetics and target engagement of novel RIPK1 inhibitor SAR443060 (DNL747) for neurodegenerative disorders: Randomized, placebo-controlled, double-blind phase I/Ib studies in healthy subjects and patients","Vissers MFJM, Heuberger JAAC, Groeneveld GJ, Oude Nijhuis J, De Deyn PP, Hadi S, Harris J, Tsai RM, Cruz-Herranz A, Huang F, Tong V, Erickson R, Zhu Y, Scearce-Levie K, Hsiao-Nakamoto J, Tang X, Chang M, Fox BM, Estrada AA, Pomponio RJ, Alonso-Alonso M, Zilberstein M, Atassi N, Troyer MD, Ho C.",Clin Transl Sci. 2022 Aug;15(8):2010-2023. doi: 10.1111/cts.13317. Epub 2022 Jun 1.,Vissers MFJM,Clin Transl Sci,2022,01-06-2022,PMC9372423,,10.1111/cts.13317
35645771,Multi-Concept Frailty Predicts the Late-Life Occurrence of Cognitive Decline or Dementia: An Updated Systematic Review and Meta-Analysis of Longitudinal Studies,"Guo CY, Sun Z, Tan CC, Tan L, Xu W.",Front Aging Neurosci. 2022 May 11;14:855553. doi: 10.3389/fnagi.2022.855553. eCollection 2022.,Guo CY,Front Aging Neurosci,2022,01-06-2022,PMC9131093,,10.3389/fnagi.2022.855553
35639376,Association of Dual Decline in Cognition and Gait Speed With Risk of Dementia in Older Adults,"Collyer TA, Murray AM, Woods RL, Storey E, Chong TT, Ryan J, Orchard SG, Brodtmann A, Srikanth VK, Shah RC, Callisaya ML.",JAMA Netw Open. 2022 May 2;5(5):e2214647. doi: 10.1001/jamanetworkopen.2022.14647.,Collyer TA,JAMA Netw Open,2022,31-05-2022,PMC9157262,,10.1001/jamanetworkopen.2022.14647
35633431,"Testosterone, cognitive decline and dementia in ageing men","Yeap BB, Flicker L.",Rev Endocr Metab Disord. 2022 Dec;23(6):1243-1257. doi: 10.1007/s11154-022-09728-7. Epub 2022 May 28.,Yeap BB,Rev Endocr Metab Disord,2022,28-05-2022,PMC9789006,,10.1007/s11154-022-09728-7
35631180,Catechins as a Potential Dietary Supplementation in Prevention of Comorbidities Linked with Down Syndrome,"Noll C, Kandiah J, Moroy G, Gu Y, Dairou J, Janel N.",Nutrients. 2022 May 12;14(10):2039. doi: 10.3390/nu14102039.,Noll C,Nutrients,2022,28-05-2022,PMC9147372,,10.3390/nu14102039
35630774,Potential Therapeutic Benefits of Honey in Neurological Disorders: The Role of Polyphenols,"Iftikhar A, Nausheen R, Muzaffar H, Naeem MA, Farooq M, Khurshid M, Almatroudi A, Alrumaihi F, Allemailem KS, Anwar H.",Molecules. 2022 May 20;27(10):3297. doi: 10.3390/molecules27103297.,Iftikhar A,Molecules,2022,28-05-2022,PMC9143627,,10.3390/molecules27103297
35630721,Pharmacological Approaches to the Treatment of Dementia in Down Syndrome: A Systematic Review of Randomized Clinical Studies,"de Oliveira LC, de Paula Faria D.",Molecules. 2022 May 19;27(10):3244. doi: 10.3390/molecules27103244.,de Oliveira LC,Molecules,2022,28-05-2022,PMC9147973,,10.3390/molecules27103244
35630702,Determination of Anti-Alzheimer's Disease Activity of Selected Plant Ingredients,"Tuzimski T, Petruczynik A.",Molecules. 2022 May 18;27(10):3222. doi: 10.3390/molecules27103222.,Tuzimski T,Molecules,2022,28-05-2022,PMC9147832,,10.3390/molecules27103222
35628263,The Role of miRNAs in Dexmedetomidine's Neuroprotective Effects against Brain Disorders,"Burlacu CC, Neag MA, Mitre AO, Sirbu AC, Badulescu AV, Buzoianu AD.",Int J Mol Sci. 2022 May 13;23(10):5452. doi: 10.3390/ijms23105452.,Burlacu CC,Int J Mol Sci,2022,28-05-2022,PMC9141783,,10.3390/ijms23105452
35625622,Natural Products from Plants and Algae for Treatment of Alzheimer's Disease: A Review,"Klose J, Griehl C, Roßner S, Schilling S.",Biomolecules. 2022 May 12;12(5):694. doi: 10.3390/biom12050694.,Klose J,Biomolecules,2022,28-05-2022,PMC9139049,,10.3390/biom12050694
35625595,Effects of Palmitoylethanolamide on Neurodegenerative Diseases: A Review from Rodents to Humans,"Landolfo E, Cutuli D, Petrosini L, Caltagirone C.",Biomolecules. 2022 May 5;12(5):667. doi: 10.3390/biom12050667.,Landolfo E,Biomolecules,2022,28-05-2022,PMC9138306,,10.3390/biom12050667
35620408,The Comparative Efficacy of Multiple Acupuncture for Alzheimer's Disease: A Bayesian Network Meta-Analysis,"Yin Z, Li X, Wang L, Sun M, Zhao L, Liang F.",Evid Based Complement Alternat Med. 2022 May 17;2022:3288948. doi: 10.1155/2022/3288948. eCollection 2022.,Yin Z,Evid Based Complement Alternat Med,2022,27-05-2022,PMC9129975,,10.1155/2022/3288948
35614479,The role of basket trials in drug development for neurodegenerative disorders,"Cummings J, Montes A, Kamboj S, Cacho JF.",Alzheimers Res Ther. 2022 May 25;14(1):73. doi: 10.1186/s13195-022-01015-6.,Cummings J,Alzheimers Res Ther,2022,25-05-2022,PMC9131689,,10.1186/s13195-022-01015-6
35612544,Use of Bacopa monnieri in the Treatment of Dementia Due to Alzheimer Disease: Systematic Review of Randomized Controlled Trials,"Basheer A, Agarwal A, Mishra B, Gupta A, Padma Srivastava MV, Kirubakaran R, Vishnu V.",Interact J Med Res. 2022 Aug 1;11(2):e38542. doi: 10.2196/38542.,Basheer A,Interact J Med Res,2022,25-05-2022,PMC9379783,,10.2196/38542
35611326,Role of Aducanumab in the Treatment of Alzheimer's Disease: Challenges and Opportunities,"Vaz M, Silva V, Monteiro C, Silvestre S.",Clin Interv Aging. 2022 May 18;17:797-810. doi: 10.2147/CIA.S325026. eCollection 2022.,Vaz M,Clin Interv Aging,2022,25-05-2022,PMC9124475,,10.2147/CIA.S325026
35607946,Increasing Brain Gamma Activity Improves Episodic Memory and Restores Cholinergic Dysfunction in Alzheimer's Disease,"Benussi A, Cantoni V, Grassi M, Brechet L, Michel CM, Datta A, Thomas C, Gazzina S, Cotelli MS, Bianchi M, Premi E, Gadola Y, Cotelli M, Pengo M, Perrone F, Scolaro M, Archetti S, Solje E, Padovani A, Pascual-Leone A, Borroni B.",Ann Neurol. 2022 Aug;92(2):322-334. doi: 10.1002/ana.26411. Epub 2022 Jun 6.,Benussi A,Ann Neurol,2022,24-05-2022,PMC9546168,,10.1002/ana.26411
35605299,Zinc carnosine: Frontiers advances of supplement for cancer therapy,"Tang W, Liu H, Ooi TC, Rajab NF, Cao H, Sharif R.",Biomed Pharmacother. 2022 Jul;151:113157. doi: 10.1016/j.biopha.2022.113157. Epub 2022 May 20.,Tang W,Biomed Pharmacother,2022,23-05-2022,,,10.1016/j.biopha.2022.113157
35602310,Effect of Ambient Bright Light on Behavioral and Psychological Symptoms in People With Dementia: A Systematic Review,"Jao YL, Wang J, Liao YJ, Parajuli J, Berish D, Boltz M, Van Haitsma K, Wang N, McNally L, Calkins M.",Innov Aging. 2022 Mar 24;6(3):igac018. doi: 10.1093/geroni/igac018. eCollection 2022.,Jao YL,Innov Aging,2022,23-05-2022,PMC9116897,,10.1093/geroni/igac018
35599499,Which Test Is the Best to Assess Visuo-Cognitive Impairment in Patients with Parkinson's Disease with Mild Cognitive Impairment and Dementia? A Systematic Review and Meta-Analysis,"Liebermann-Jordanidis H, Roheger M, Boosfeld L, Franklin J, Kalbe E.",J Parkinsons Dis. 2022;12(6):1749-1782. doi: 10.3233/JPD-223238.,Liebermann-Jordanidis H,J Parkinsons Dis,2022,23-05-2022,,,10.3233/JPD-223238
35595404,Pharmacogenetic studies in Alzheimer disease,"Zúñiga Santamaría T, Yescas Gómez P, Fricke Galindo I, González González M, Ortega Vázquez A, López López M.",Neurologia (Engl Ed). 2022 May;37(4):287-303. doi: 10.1016/j.nrleng.2018.03.022. Epub 2020 Jun 1.,Zúñiga Santamaría T,Neurologia (Engl Ed),2022,20-05-2022,,,10.1016/j.nrleng.2018.03.022
35572351,Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease,"Fang J, Zhang P, Zhou Y, Chiang CW, Tan J, Hou Y, Stauffer S, Li L, Pieper AA, Cummings J, Cheng F.",Nat Aging. 2021 Dec;1(12):1175-1188. doi: 10.1038/s43587-021-00138-z. Epub 2021 Dec 6.,Fang J,Nat Aging,2021,16-05-2022,PMC9097949,NIHMS1792748,10.1038/s43587-021-00138-z
35572135,"Retinal Microvascular Changes in Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review, Meta-Analysis, and Meta-Regression","Yeh TC, Kuo CT, Chou YB.",Front Aging Neurosci. 2022 Apr 28;14:860759. doi: 10.3389/fnagi.2022.860759. eCollection 2022.,Yeh TC,Front Aging Neurosci,2022,16-05-2022,PMC9096234,,10.3389/fnagi.2022.860759
35571129,What Do We Know About Medical Cannabis in Neurological Disorders and What Are the Next Steps?,"Lacroix C, Alleman-Brimault I, Zalta A, Rouby F, Cassé-Perrot C, Jouve E, Attolini L, Guilhaumou R, Micallef J, Blin O.",Front Pharmacol. 2022 Apr 27;13:883987. doi: 10.3389/fphar.2022.883987. eCollection 2022.,Lacroix C,Front Pharmacol,2022,16-05-2022,PMC9091192,,10.3389/fphar.2022.883987
35570493,"Effect of Probiotic Bifidobacterium breve in Improving Cognitive Function and Preventing Brain Atrophy in Older Patients with Suspected Mild Cognitive Impairment: Results of a 24-Week Randomized, Double-Blind, Placebo-Controlled Trial","Asaoka D, Xiao J, Takeda T, Yanagisawa N, Yamazaki T, Matsubara Y, Sugiyama H, Endo N, Higa M, Kasanuki K, Ichimiya Y, Koido S, Ohno K, Bernier F, Katsumata N, Nagahara A, Arai H, Ohkusa T, Sato N.",J Alzheimers Dis. 2022;88(1):75-95. doi: 10.3233/JAD-220148.,Asaoka D,J Alzheimers Dis,2022,16-05-2022,PMC9277669,,10.3233/JAD-220148
35569547,Dimethyl fumarate: A review of preclinical efficacy in models of neurodegenerative diseases,Majkutewicz I.,Eur J Pharmacol. 2022 Jul 5;926:175025. doi: 10.1016/j.ejphar.2022.175025. Epub 2022 May 13.,Majkutewicz I,Eur J Pharmacol,2022,15-05-2022,,,10.1016/j.ejphar.2022.175025
35566283,Procyanidins and Their Therapeutic Potential against Oral Diseases,"Chen H, Wang W, Yu S, Wang H, Tian Z, Zhu S.",Molecules. 2022 May 4;27(9):2932. doi: 10.3390/molecules27092932.,Chen H,Molecules,2022,14-05-2022,PMC9104295,,10.3390/molecules27092932
35566252,Flavonoids as Potential Anti-Inflammatory Molecules: A Review,"Al-Khayri JM, Sahana GR, Nagella P, Joseph BV, Alessa FM, Al-Mssallem MQ.",Molecules. 2022 May 2;27(9):2901. doi: 10.3390/molecules27092901.,Al-Khayri JM,Molecules,2022,14-05-2022,PMC9100260,,10.3390/molecules27092901
35565814,A Narrative Review of the Effects of Citrus Peels and Extracts on Human Brain Health and Metabolism,"Matsuzaki K, Nakajima A, Guo Y, Ohizumi Y.",Nutrients. 2022 Apr 28;14(9):1847. doi: 10.3390/nu14091847.,Matsuzaki K,Nutrients,2022,14-05-2022,PMC9103913,,10.3390/nu14091847
35563884,Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation,"Kasindi A, Fuchs DT, Koronyo Y, Rentsendorj A, Black KL, Koronyo-Hamaoui M.",Cells. 2022 May 7;11(9):1578. doi: 10.3390/cells11091578.,Kasindi A,Cells,2022,14-05-2022,PMC9099707,,10.3390/cells11091578
35563447,A(2A) Adenosine Receptor: A Possible Therapeutic Target for Alzheimer's Disease by Regulating NLRP3 Inflammasome Activity?,"Merighi S, Nigro M, Travagli A, Pasquini S, Borea PA, Varani K, Vincenzi F, Gessi S.",Int J Mol Sci. 2022 May 2;23(9):5056. doi: 10.3390/ijms23095056.,Merighi S,Int J Mol Sci,2022,14-05-2022,PMC9101264,,10.3390/ijms23095056
35563253,The Role of the Microbiota-Gut-Brain Axis in the Development of Alzheimer's Disease,"Wiatrak B, Balon K, Jawień P, Bednarz D, Jęśkowiak I, Szeląg A.",Int J Mol Sci. 2022 Apr 27;23(9):4862. doi: 10.3390/ijms23094862.,Wiatrak B,Int J Mol Sci,2022,14-05-2022,PMC9104401,,10.3390/ijms23094862
35563031,Antidiabetic Drugs in the Treatment of Alzheimer's Disease,"Michailidis M, Tata DA, Moraitou D, Kavvadas D, Karachrysafi S, Papamitsou T, Vareltzis P, Papaliagkas V.",Int J Mol Sci. 2022 Apr 22;23(9):4641. doi: 10.3390/ijms23094641.,Michailidis M,Int J Mol Sci,2022,14-05-2022,PMC9102472,,10.3390/ijms23094641
35557606,ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer's Disease,"Krafft GA, Jerecic J, Siemers E, Cline EN.",Front Neurosci. 2022 Apr 26;16:848215. doi: 10.3389/fnins.2022.848215. eCollection 2022.,Krafft GA,Front Neurosci,2022,13-05-2022,PMC9088393,,10.3389/fnins.2022.848215
35553407,Targeting Genetic Modifiers of HBG Gene Expression in Sickle Cell Disease: The miRNA Option,"Starlard-Davenport A, Gu Q, Pace BS.",Mol Diagn Ther. 2022 Sep;26(5):497-509. doi: 10.1007/s40291-022-00589-z. Epub 2022 May 12.,Starlard-Davenport A,Mol Diagn Ther,2022,13-05-2022,PMC9098152,,10.1007/s40291-022-00589-z
35550158,Association between lower body temperature and increased tau pathology in cognitively normal older adults,"Blessing EM, Parekh A, Betensky RA, Babb J, Saba N, Debure L, Varga AW, Ayappa I, Rapoport DM, Butler TA, de Leon MJ, Wisniewski T, Lopresti BJ, Osorio RS.",Neurobiol Dis. 2022 Sep;171:105748. doi: 10.1016/j.nbd.2022.105748. Epub 2022 May 10.,Blessing EM,Neurobiol Dis,2022,13-05-2022,PMC9751849,NIHMS1856912,10.1016/j.nbd.2022.105748
35547737,Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients,"Bartolomé F, Rosa L, Valenti P, Lopera F, Hernández-Gallego J, Cantero JL, Orive G, Carro E.",Front Immunol. 2022 Apr 25;13:878201. doi: 10.3389/fimmu.2022.878201. eCollection 2022.,Bartolomé F,Front Immunol,2022,13-05-2022,PMC9083828,,10.3389/fimmu.2022.878201
35546606,Diagnostic accuracy of keystroke dynamics as digital biomarkers for fine motor decline in neuropsychiatric disorders: a systematic review and meta-analysis,"Alfalahi H, Khandoker AH, Chowdhury N, Iakovakis D, Dias SB, Chaudhuri KR, Hadjileontiadis LJ.",Sci Rep. 2022 May 11;12(1):7690. doi: 10.1038/s41598-022-11865-7.,Alfalahi H,Sci Rep,2022,13-05-2022,PMC9095860,,10.1038/s41598-022-11865-7
35532913,"Safety, Tolerability, and Immunogenicity of the ACI-24 Vaccine in Adults With Down Syndrome: A Phase 1b Randomized Clinical Trial","Rafii MS, Sol O, Mobley WC, Delpretti S, Skotko BG, Burke AD, Sabbagh MN, Yuan SH, Rissman RA, Pulsifer M, Evans C, Evans AC, Beth G, Fournier N, Gray JA, Dos Santos AM, Hliva V, Vukicevic M, Kosco-Vilbois M, Streffer J, Pfeifer A, Feldman HH.",JAMA Neurol. 2022 Jun 1;79(6):565-574. doi: 10.1001/jamaneurol.2022.0983.,Rafii MS,JAMA Neurol,2022,09-05-2022,PMC9086937,,10.1001/jamaneurol.2022.0983
35527734,Diagnostic Performance of Generative Adversarial Network-Based Deep Learning Methods for Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Qu C, Zou Y, Ma Y, Chen Q, Luo J, Fan H, Jia Z, Gong Q, Chen T.",Front Aging Neurosci. 2022 Apr 21;14:841696. doi: 10.3389/fnagi.2022.841696. eCollection 2022.,Qu C,Front Aging Neurosci,2022,09-05-2022,PMC9068970,,10.3389/fnagi.2022.841696
35520949,Neuroinflammation as a Potential Therapeutic Target in Alzheimer's Disease,"Liu P, Wang Y, Sun Y, Peng G.",Clin Interv Aging. 2022 Apr 29;17:665-674. doi: 10.2147/CIA.S357558. eCollection 2022.,Liu P,Clin Interv Aging,2022,06-05-2022,PMC9064449,,10.2147/CIA.S357558
35516416,Alzheimer's disease drug development pipeline: 2022,"Cummings J, Lee G, Nahed P, Kambar MEZN, Zhong K, Fonseca J, Taghva K.",Alzheimers Dement (N Y). 2022 May 4;8(1):e12295. doi: 10.1002/trc2.12295. eCollection 2022.,Cummings J,Alzheimers Dement (N Y),2022,06-05-2022,PMC9066743,,10.1002/trc2.12295
35504802,Diagnostic performance of brief cognitive tests in cognitive impairment screening,"Carnero-Pardo C, Rego-García I, Mené Llorente M, Alonso Ródenas M, Vílchez Carrillo R.",Neurologia (Engl Ed). 2022 Jul-Aug;37(6):441-449. doi: 10.1016/j.nrleng.2019.05.011. Epub 2022 Apr 30.,Carnero-Pardo C,Neurologia (Engl Ed),2022,03-05-2022,,,10.1016/j.nrleng.2019.05.011
35493943,Impact of Anti-amyloid-β Monoclonal Antibodies on the Pathology and Clinical Profile of Alzheimer's Disease: A Focus on Aducanumab and Lecanemab,"Shi M, Chu F, Zhu F, Zhu J.",Front Aging Neurosci. 2022 Apr 12;14:870517. doi: 10.3389/fnagi.2022.870517. eCollection 2022.,Shi M,Front Aging Neurosci,2022,02-05-2022,PMC9039457,,10.3389/fnagi.2022.870517
35491418,Clinical outcome measures in dementia with Lewy bodies trials: critique and recommendations,"Rodriguez-Porcel F, Wyman-Chick KA, Abdelnour Ruiz C, Toledo JB, Ferreira D, Urwyler P, Weil RS, Kane J, Pilotto A, Rongve A, Boeve B, Taylor JP, McKeith I, Aarsland D, Lewis SJG; Lewy Body Dementias Clinical Trials Workgroup from the Lewy Body Dementias Professional Interest Area - Alzheimer’s Association International Society to Advance Alzheimer’s Research and Treatment (ISTAART)+.",Transl Neurodegener. 2022 May 2;11(1):24. doi: 10.1186/s40035-022-00299-w.,Rodriguez-Porcel F,Transl Neurodegener,2022,01-05-2022,PMC9059356,,10.1186/s40035-022-00299-w
35489824,Therapeutic news in Alzheimer's disease: Soon a disease-modifying therapy?,Villain N.,Rev Neurol (Paris). 2022 May;178(5):437-440. doi: 10.1016/j.neurol.2022.02.456. Epub 2022 Apr 28.,Villain N,Rev Neurol (Paris),2022,30-04-2022,,,10.1016/j.neurol.2022.02.456
35486412,The effects of selective serotonin reuptake inhibitors on memory functioning in older adults: A systematic literature review,"Schulkens JE, Deckers K, Jenniskens M, Blokland A, Verhey FR, Sobczak S.",J Psychopharmacol. 2022 May;36(5):578-593. doi: 10.1177/02698811221080462. Epub 2022 Apr 29.,Schulkens JE,J Psychopharmacol,2022,29-04-2022,PMC9112622,,10.1177/02698811221080462
35484991,Improvement of poststroke cognitive impairment by intermittent theta bursts: A double-blind randomized controlled trial,"Li W, Wen Q, Xie YH, Hu AL, Wu Q, Wang YX.",Brain Behav. 2022 Jun;12(6):e2569. doi: 10.1002/brb3.2569. Epub 2022 Apr 29.,Li W,Brain Behav,2022,29-04-2022,PMC9226849,,10.1002/brb3.2569
35473731,Comparative safety and efficacy of cognitive enhancers for Alzheimer's dementia: a systematic review with individual patient data network meta-analysis,"Veroniki AA, Ashoor HM, Rios P, Seitidis G, Stewart L, Clarke M, Tudur-Smith C, Mavridis D, Hemmelgarn BR, Holroyd-Leduc J, Straus SE, Tricco AC.",BMJ Open. 2022 Apr 26;12(4):e053012. doi: 10.1136/bmjopen-2021-053012.,Veroniki AA,BMJ Open,2022,27-04-2022,PMC9045061,,10.1136/bmjopen-2021-053012
35466206,The Possible Application of Ketamine in the Treatment of Depression in Alzheimer's Disease,"Mohammad Shehata I, Masood W, Nemr N, Anderson A, Bhusal K, Edinoff AN, Cornett EM, Kaye AM, Kaye AD.",Neurol Int. 2022 Mar 22;14(2):310-321. doi: 10.3390/neurolint14020025.,Mohammad Shehata I,Neurol Int,2022,25-04-2022,PMC9036213,,10.3390/neurolint14020025
35465913,Preliminary analysis of a shortened picture version of the Free and Cued Selective Reminding Test,"Rodrigo-Herrero S, Mendez-Barrio C, Bernal Sánchez-Arjona M, de Miguel-Tristancho M, Graciani-Cantisán E, Carnero-Pardo C, Franco-Macías E.",Neurologia (Engl Ed). 2022 Apr;37(3):192-198. doi: 10.1016/j.nrleng.2018.12.019. Epub 2021 Feb 26.,Rodrigo-Herrero S,Neurologia (Engl Ed),2022,25-04-2022,,,10.1016/j.nrleng.2018.12.019
35460299,Psychiatric disorders and risk of subsequent dementia: Systematic review and meta-analysis of longitudinal studies,"Stafford J, Chung WT, Sommerlad A, Kirkbride JB, Howard R.",Int J Geriatr Psychiatry. 2022 May;37(5):10.1002/gps.5711. doi: 10.1002/gps.5711.,Stafford J,Int J Geriatr Psychiatry,2022,23-04-2022,PMC9325434,,10.1002/gps.5711
35458743,Carbonic Anhydrase Activators for Neurodegeneration: An Overview,"Poggetti V, Salerno S, Baglini E, Barresi E, Da Settimo F, Taliani S.",Molecules. 2022 Apr 14;27(8):2544. doi: 10.3390/molecules27082544.,Poggetti V,Molecules,2022,23-04-2022,PMC9031706,,10.3390/molecules27082544
35458680,Beneficial Effects of Capsaicin in Disorders of the Central Nervous System,"Pasierski M, Szulczyk B.",Molecules. 2022 Apr 12;27(8):2484. doi: 10.3390/molecules27082484.,Pasierski M,Molecules,2022,23-04-2022,PMC9029810,,10.3390/molecules27082484
35456047,Blood-Based Biomarkers for Alzheimer's Disease Diagnosis and Progression: An Overview,"Varesi A, Carrara A, Pires VG, Floris V, Pierella E, Savioli G, Prasad S, Esposito C, Ricevuti G, Chirumbolo S, Pascale A.",Cells. 2022 Apr 17;11(8):1367. doi: 10.3390/cells11081367.,Varesi A,Cells,2022,23-04-2022,PMC9044750,,10.3390/cells11081367
35453600,Development of Alzheimer's Disease Biomarkers: From CSF- to Blood-Based Biomarkers,"Mankhong S, Kim S, Lee S, Kwak HB, Park DH, Joa KL, Kang JH.",Biomedicines. 2022 Apr 5;10(4):850. doi: 10.3390/biomedicines10040850.,Mankhong S,Biomedicines,2022,23-04-2022,PMC9025524,,10.3390/biomedicines10040850
35451593,Effects of vitamin B12 supplementation on pain relief in certain diseases - a literature review,"Furgała R, Stompor M.",Acta Biochim Pol. 2022 Apr 22;69(2):265-271. doi: 10.18388/abp.2020_5876.,Furgała R,Acta Biochim Pol,2022,22-04-2022,,,10.18388/abp.2020_5876
35450410,Bioactive Compounds and Their Derivatives: An Insight into Prospective Phytotherapeutic Approach against Alzheimer's Disease,"Islam F, Khadija JF, Harun-Or-Rashid M, Rahaman MS, Nafady MH, Islam MR, Akter A, Emran TB, Wilairatana P, Mubarak MS.",Oxid Med Cell Longev. 2022 Apr 11;2022:5100904. doi: 10.1155/2022/5100904. eCollection 2022.,Islam F,Oxid Med Cell Longev,2022,22-04-2022,PMC9017558,,10.1155/2022/5100904
35445687,BAILA: A Randomized Controlled Trial of Latin Dancing to Increase Physical Activity in Spanish-Speaking Older Latinos,"Marquez DX, Wilbur J, Hughes S, Wilson R, Buchner DM, Berbaum ML, McAuley E, Aguiñaga S, Balbim GM, Vásquez PM, Marques IG, Wang T, Kaushal N.",Ann Behav Med. 2022 Nov 18;56(12):1231-1243. doi: 10.1093/abm/kaac009.,Marquez DX,Ann Behav Med,2022,21-04-2022,PMC9672351,,10.1093/abm/kaac009
35443684,Cost-effectiveness of pharmacological therapies for people with Alzheimer's disease and other dementias: a systematic review and meta-analysis,"Huo Z, Lin J, Bat BKK, Chan TK, Yip BHK, Tsoi KKF.",Cost Eff Resour Alloc. 2022 Apr 20;20(1):19. doi: 10.1186/s12962-022-00354-3.,Huo Z,Cost Eff Resour Alloc,2022,21-04-2022,PMC9022294,,10.1186/s12962-022-00354-3
35440022,Meaningful benefits: a framework to assess disease-modifying therapies in preclinical and early Alzheimer's disease,"Assunção SS, Sperling RA, Ritchie C, Kerwin DR, Aisen PS, Lansdall C, Atri A, Cummings J.",Alzheimers Res Ther. 2022 Apr 19;14(1):54. doi: 10.1186/s13195-022-00984-y.,Assunção SS,Alzheimers Res Ther,2022,20-04-2022,PMC9017027,,10.1186/s13195-022-00984-y
35430328,Effect of Aspirin on CKD Progression in Older Adults: Secondary Analysis From the ASPREE Randomized Clinical Trial,"Polkinghorne KR, Wetmore JB, Thao LTP, Wolfe R, Woods RL, Ernst ME, Nelson MR, Reid CM, Shah RC, McNeil JJ, Murray AM.",Am J Kidney Dis. 2022 Dec;80(6):810-813. doi: 10.1053/j.ajkd.2022.02.019. Epub 2022 Apr 14.,Polkinghorne KR,Am J Kidney Dis,2022,17-04-2022,PMC9562592,NIHMS1816152,10.1053/j.ajkd.2022.02.019
35420334,Prediction of disability-free survival in healthy older people,"Neumann JT, Thao LTP, Murray AM, Callander E, Carr PR, Nelson MR, Wolfe R, Woods RL, Reid CM, Shah RC, Newman AB, Williamson JD, Tonkin AM, McNeil JJ; ASPREE investigators.",Geroscience. 2022 Jun;44(3):1641-1655. doi: 10.1007/s11357-022-00547-x. Epub 2022 Apr 14.,Neumann JT,Geroscience,2022,14-04-2022,PMC9213595,,10.1007/s11357-022-00547-x
35410603,What is the Role of Lithium in Epilepsy?,"Bojja SL, Singh N, Kolathur KK, Rao CM.",Curr Neuropharmacol. 2022;20(10):1850-1864. doi: 10.2174/1570159X20666220411081728.,Bojja SL,Curr Neuropharmacol,2022,12-04-2022,PMC9886805,,10.2174/1570159X20666220411081728
35410602,Strategies for Treatment of Disease-Associated Dementia Beyond Alzheimer's Disease: An Update,"Khan SS, Khatik GL, Datusalia AK.",Curr Neuropharmacol. 2023;21(2):309-339. doi: 10.2174/1570159X20666220411083922.,Khan SS,Curr Neuropharmacol,2023,12-04-2022,PMC10190146,,10.2174/1570159X20666220411083922
35408972,The Therapeutic Role of Exercise and Probiotics in Stressful Brain Conditions,"Martínez-Guardado I, Arboleya S, Grijota FJ, Kaliszewska A, Gueimonde M, Arias N.",Int J Mol Sci. 2022 Mar 25;23(7):3610. doi: 10.3390/ijms23073610.,Martínez-Guardado I,Int J Mol Sci,2022,12-04-2022,PMC8998860,,10.3390/ijms23073610
35404972,No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab,"Korthauer LE, Giugliano RP, Guo J, Sabatine MS, Sever P, Keech A, Atar D, Kurtz C, Ruff CT, Mach F, Ott BR.",PLoS One. 2022 Apr 11;17(4):e0266615. doi: 10.1371/journal.pone.0266615. eCollection 2022.,Korthauer LE,PLoS One,2022,11-04-2022,PMC9000128,,10.1371/journal.pone.0266615
35401820,Metformin in aging and aging-related diseases: clinical applications and relevant mechanisms,"Chen S, Gan D, Lin S, Zhong Y, Chen M, Zou X, Shao Z, Xiao G.",Theranostics. 2022 Mar 6;12(6):2722-2740. doi: 10.7150/thno.71360. eCollection 2022.,Chen S,Theranostics,2022,11-04-2022,PMC8965502,,10.7150/thno.71360
35396575,γ-Secretase in Alzheimer's disease,Hur JY.,Exp Mol Med. 2022 Apr;54(4):433-446. doi: 10.1038/s12276-022-00754-8. Epub 2022 Apr 8.,Hur JY,Exp Mol Med,2022,09-04-2022,PMC9076685,,10.1038/s12276-022-00754-8
35384262,Ginkgolides and Huperzine A for complementary treatment of Alzheimer's disease,"Villegas C, Perez R, Petiz LL, Glaser T, Ulrich H, Paz C.",IUBMB Life. 2022 Aug;74(8):763-779. doi: 10.1002/iub.2613. Epub 2022 Apr 5.,Villegas C,IUBMB Life,2022,06-04-2022,,,10.1002/iub.2613
35379951,Early-stage Alzheimer disease: getting trial-ready,"Aisen PS, Jimenez-Maggiora GA, Rafii MS, Walter S, Raman R.",Nat Rev Neurol. 2022 Jul;18(7):389-399. doi: 10.1038/s41582-022-00645-6. Epub 2022 Apr 4.,Aisen PS,Nat Rev Neurol,2022,05-04-2022,PMC8978175,,10.1038/s41582-022-00645-6
35379344,Sex differences in neuropsychiatric symptoms in Alzheimer's disease dementia: a meta-analysis,"Eikelboom WS, Pan M, Ossenkoppele R, Coesmans M, Gatchel JR, Ismail Z, Lanctôt KL, Fischer CE, Mortby ME, van den Berg E, Papma JM.",Alzheimers Res Ther. 2022 Apr 4;14(1):48. doi: 10.1186/s13195-022-00991-z.,Eikelboom WS,Alzheimers Res Ther,2022,05-04-2022,PMC8978393,,10.1186/s13195-022-00991-z
35368930,Effect of Resveratrol Combined with Donepezil Hydrochloride on Inflammatory Factor Level and Cognitive Function Level of Patients with Alzheimer's Disease,"Fang X, Zhang J, Zhao J, Wang L.",J Healthc Eng. 2022 Mar 25;2022:9148650. doi: 10.1155/2022/9148650. eCollection 2022.,Fang X,J Healthc Eng,2022,04-04-2022,PMC8975642,,10.1155/2022/9148650
35367766,Exploring the journey of emodin as a potential neuroprotective agent: Novel therapeutic insights with molecular mechanism of action,"Mitra S, Anjum J, Muni M, Das R, Rauf A, Islam F, Bin Emran T, Semwal P, Hemeg HA, Alhumaydhi FA, Wilairatana P.",Biomed Pharmacother. 2022 May;149:112877. doi: 10.1016/j.biopha.2022.112877. Epub 2022 Mar 31.,Mitra S,Biomed Pharmacother,2022,03-04-2022,,,10.1016/j.biopha.2022.112877
35366505,Effects of physical exercise on cognitive function of breast cancer survivors receiving chemotherapy: A systematic review of randomized controlled trials,"Ren X, Wang X, Sun J, Hui Z, Lei S, Wang C, Wang M.",Breast. 2022 Jun;63:113-122. doi: 10.1016/j.breast.2022.03.014. Epub 2022 Mar 28.,Ren X,Breast,2022,02-04-2022,PMC8976138,,10.1016/j.breast.2022.03.014
35366105,Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges,"Han J, Chitu V, Stanley ER, Wszolek ZK, Karrenbauer VD, Harris RA.",Cell Mol Life Sci. 2022 Apr 2;79(4):219. doi: 10.1007/s00018-022-04225-1.,Han J,Cell Mol Life Sci,2022,02-04-2022,PMC8976111,,10.1007/s00018-022-04225-1
35366050,Identifying best practices for disclosure of amyloid imaging results: A randomized controlled trial,"Fruijtier AD, van der Schaar J, van Maurik IS, Zwan MD, Scheltens P, Bouwman F, Pijnenburg YAL, van Berckel BNM, Ebenau J, van der Flier WM, Smets EMA, Visser LNC.",Alzheimers Dement. 2023 Jan;19(1):285-295. doi: 10.1002/alz.12630. Epub 2022 Apr 2.,Fruijtier AD,Alzheimers Dement,2023,02-04-2022,PMC10084251,,10.1002/alz.12630
35364656,"Antiviral, immunomodulatory, and neuroprotective effect of lithium",Rybakowski JK.,J Integr Neurosci. 2022 Mar 23;21(2):68. doi: 10.31083/j.jin2102068.,Rybakowski JK,J Integr Neurosci,2022,01-04-2022,,,10.31083/j.jin2102068
35363371,Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19,"Wei HF, Anchipolovsky S, Vera R, Liang G, Chuang DM.",Eur Rev Med Pharmacol Sci. 2022 Mar;26(6):2201-2214. doi: 10.26355/eurrev_202203_28369.,Wei HF,Eur Rev Med Pharmacol Sci,2022,01-04-2022,PMC9173589,NIHMS1813101,10.26355/eurrev_202203_28369
35357079,Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease,"Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, Ramdas K, Wishard T, McInerney KF, Vellas B, Sierra F, Jiang Z, Mcclain-Moss L, Perez C, Fuquay A, Rodriguez S, Hare JM, Oliva AA Jr, Baumel B.",Alzheimers Dement. 2023 Jan;19(1):261-273. doi: 10.1002/alz.12651. Epub 2022 Mar 31.,Brody M,Alzheimers Dement,2023,31-03-2022,PMC10084163,,10.1002/alz.12651
35351181,Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer's dementia in mild cognitive impairment patients,"Pichet Binette A, Palmqvist S, Bali D, Farrar G, Buckley CJ, Wolk DA, Zetterberg H, Blennow K, Janelidze S, Hansson O.",Alzheimers Res Ther. 2022 Mar 29;14(1):46. doi: 10.1186/s13195-022-00990-0.,Pichet Binette A,Alzheimers Res Ther,2022,30-03-2022,PMC8966264,,10.1186/s13195-022-00990-0
35349875,"The association between polypharmacy, frailty and disability-free survival in community-dwelling healthy older individuals","Ekram ARMS, Woods RL, Ryan J, Espinoza SE, Gilmartin-Thomas JFM, Shah RC, Mehta R, Kochar B, Lowthian JA, Lockery J, Orchard S, Nelson M, Fravel MA, Liew D, Ernst ME.",Arch Gerontol Geriatr. 2022 Jul-Aug;101:104694. doi: 10.1016/j.archger.2022.104694. Epub 2022 Mar 23.,Ekram ARMS,Arch Gerontol Geriatr,2022,29-03-2022,PMC9437977,NIHMS1831767,10.1016/j.archger.2022.104694
35346852,"Targeting brain Renin-Angiotensin System for the prevention and treatment of Alzheimer's disease: Past, present and future","Gouveia F, Camins A, Ettcheto M, Bicker J, Falcão A, Cruz MT, Fortuna A.",Ageing Res Rev. 2022 May;77:101612. doi: 10.1016/j.arr.2022.101612. Epub 2022 Mar 26.,Gouveia F,Ageing Res Rev,2022,29-03-2022,,,10.1016/j.arr.2022.101612
35346775,The multimodal action of genistein in Alzheimer's and other age-related diseases,"Mas-Bargues C, Borrás C, Viña J.",Free Radic Biol Med. 2022 Apr;183:127-137. doi: 10.1016/j.freeradbiomed.2022.03.021. Epub 2022 Mar 26.,Mas-Bargues C,Free Radic Biol Med,2022,29-03-2022,,,10.1016/j.freeradbiomed.2022.03.021
35342092,Alzheimer's Disease: Key Insights from Two Decades of Clinical Trial Failures,"Kim CK, Lee YR, Ong L, Gold M, Kalali A, Sarkar J.",J Alzheimers Dis. 2022;87(1):83-100. doi: 10.3233/JAD-215699.,Kim CK,J Alzheimers Dis,2022,28-03-2022,PMC9198803,,10.3233/JAD-215699
35340338,The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases,"Cheng D, Yang S, Zhao X, Wang G.",Drug Des Devel Ther. 2022 Mar 14;16:665-684. doi: 10.2147/DDDT.S348055. eCollection 2022.,Cheng D,Drug Des Devel Ther,2022,28-03-2022,PMC8943601,,10.2147/DDDT.S348055
35335180,Role of Cholinergic Signaling in Alzheimer's Disease,"Chen ZR, Huang JB, Yang SL, Hong FF.",Molecules. 2022 Mar 10;27(6):1816. doi: 10.3390/molecules27061816.,Chen ZR,Molecules,2022,26-03-2022,PMC8949236,,10.3390/molecules27061816
35327563,"Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age","Payne A, Nahashon S, Taka E, Adinew GM, Soliman KFA.",Biomolecules. 2022 Feb 25;12(3):371. doi: 10.3390/biom12030371.,Payne A,Biomolecules,2022,25-03-2022,PMC8945730,,10.3390/biom12030371
35327555,Novel Therapeutic Target for Prevention of Neurodegenerative Diseases: Modulation of Neuroinflammation with Sig-1R Ligands,"Bogár F, Fülöp L, Penke B.",Biomolecules. 2022 Feb 25;12(3):363. doi: 10.3390/biom12030363.,Bogár F,Biomolecules,2022,25-03-2022,PMC8945408,,10.3390/biom12030363
35309887,"Effectiveness of Physical Activity Interventions on Cognition, Neuropsychiatric Symptoms, and Quality of Life of Alzheimer's Disease: An Update of a Systematic Review and Meta-Analysis","Liang YJ, Su QW, Sheng ZR, Weng QY, Niu YF, Zhou HD, Liu CB.",Front Aging Neurosci. 2022 Mar 2;14:830824. doi: 10.3389/fnagi.2022.830824. eCollection 2022.,Liang YJ,Front Aging Neurosci,2022,21-03-2022,PMC8926300,,10.3389/fnagi.2022.830824
35308835,Aducanumab Therapy to Treat Alzheimer's Disease: A Narrative Review,"Beshir SA, Aadithsoorya AM, Parveen A, Goh SSL, Hussain N, Menon VB.",Int J Alzheimers Dis. 2022 Mar 9;2022:9343514. doi: 10.1155/2022/9343514. eCollection 2022.,Beshir SA,Int J Alzheimers Dis,2022,21-03-2022,PMC8926483,,10.1155/2022/9343514
35307412,"Genistein, a tool for geroscience","Mas-Bargues C, Borrás C, Viña J.",Mech Ageing Dev. 2022 Jun;204:111665. doi: 10.1016/j.mad.2022.111665. Epub 2022 Mar 17.,Mas-Bargues C,Mech Ageing Dev,2022,21-03-2022,,,10.1016/j.mad.2022.111665
35304765,Environmental exposure of the general population to cadmium as a risk factor of the damage to the nervous system: A critical review of current data,"Ruczaj A, Brzóska MM.",J Appl Toxicol. 2023 Jan;43(1):66-88. doi: 10.1002/jat.4322. Epub 2022 Apr 1.,Ruczaj A,J Appl Toxicol,2023,19-03-2022,PMC10084305,,10.1002/jat.4322
35304646,Lactate infusion as therapeutical intervention: a scoping review,"van Gemert LA, de Galan BE, Wevers RA, Ter Heine R, Willemsen MA.",Eur J Pediatr. 2022 Jun;181(6):2227-2235. doi: 10.1007/s00431-022-04446-3. Epub 2022 Mar 18.,van Gemert LA,Eur J Pediatr,2022,19-03-2022,PMC9110504,,10.1007/s00431-022-04446-3
35293158,New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease,"David M, Malhotra PA.",Ann Clin Transl Neurol. 2022 Apr;9(4):582-596. doi: 10.1002/acn3.51539. Epub 2022 Mar 15.,David M,Ann Clin Transl Neurol,2022,16-03-2022,PMC8994981,,10.1002/acn3.51539
35286146,Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial,"Nelson MR, Polekhina G, Woods RL, Reid CM, Tonkin AM, Wolfe R, Murray AM, Kirpach B, Ernst ME, Lockery JE, Shah RC, Stocks N, Orchard SG, Zhou Z.",Ann Intern Med. 2022 May;175(5):761-764. doi: 10.7326/M21-3823. Epub 2022 Mar 15.,Nelson MR,Ann Intern Med,2022,14-03-2022,PMC9434500,NIHMS1831758,10.7326/M21-3823
35280344,Advances in stem cell therapy in Alzheimer's disease: a comprehensive clinical trial review,"Karvelas N, Bennett S, Politis G, Kouris NI, Kole C.",Stem Cell Investig. 2022 Feb 21;9:2. doi: 10.21037/sci-2021-063. eCollection 2022.,Karvelas N,Stem Cell Investig,2022,14-03-2022,PMC8898169,,10.21037/sci-2021-063
35278154,Higher white matter hyperintensity load adversely affects pre-post proximal cognitive training performance in healthy older adults,"Boutzoukas EM, O'Shea A, Kraft JN, Hardcastle C, Evangelista ND, Hausman HK, Albizu A, Van Etten EJ, Bharadwaj PK, Smith SG, Song H, Porges EC, Hishaw A, DeKosky ST, Wu SS, Marsiske M, Alexander GE, Cohen R, Woods AJ.",Geroscience. 2022 Jun;44(3):1441-1455. doi: 10.1007/s11357-022-00538-y. Epub 2022 Mar 12.,Boutzoukas EM,Geroscience,2022,12-03-2022,PMC9213634,,10.1007/s11357-022-00538-y
35277035,Beneficial Effects of Spirulina Consumption on Brain Health,"Trotta T, Porro C, Cianciulli A, Panaro MA.",Nutrients. 2022 Feb 5;14(3):676. doi: 10.3390/nu14030676.,Trotta T,Nutrients,2022,12-03-2022,PMC8839264,,10.3390/nu14030676
35276999,A Narrative Review of the Evidence for Variations in Serum 25-Hydroxyvitamin D Concentration Thresholds for Optimal Health,"Grant WB, Al Anouti F, Boucher BJ, Dursun E, Gezen-Ak D, Jude EB, Karonova T, Pludowski P.",Nutrients. 2022 Feb 2;14(3):639. doi: 10.3390/nu14030639.,Grant WB,Nutrients,2022,12-03-2022,PMC8838864,,10.3390/nu14030639
35276927,One Giant Leap from Mouse to Man: The Microbiota-Gut-Brain Axis in Mood Disorders and Translational Challenges Moving towards Human Clinical Trials,"Forssten SD, Ouwehand AC, Griffin SM, Patterson E.",Nutrients. 2022 Jan 27;14(3):568. doi: 10.3390/nu14030568.,Forssten SD,Nutrients,2022,12-03-2022,PMC8840472,,10.3390/nu14030568
35275549,Safety and Efficacy of Monoclonal Antibodies for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Published and Unpublished Clinical Trials,"Lacorte E, Ancidoni A, Zaccaria V, Remoli G, Tariciotti L, Bellomo G, Sciancalepore F, Corbo M, Lombardo FL, Bacigalupo I, Canevelli M, Piscopo P, Vanacore N.",J Alzheimers Dis. 2022;87(1):101-129. doi: 10.3233/JAD-220046.,Lacorte E,J Alzheimers Dis,2022,11-03-2022,PMC9198746,,10.3233/JAD-220046
35275541,Yoga Prevents Gray Matter Atrophy in Women at Risk for Alzheimer's Disease: A Randomized Controlled Trial,"Krause-Sorio B, Siddarth P, Kilpatrick L, Milillo MM, Aguilar-Faustino Y, Ercoli L, Narr KL, Khalsa DS, Lavretsky H.",J Alzheimers Dis. 2022;87(2):569-581. doi: 10.3233/JAD-215563.,Krause-Sorio B,J Alzheimers Dis,2022,11-03-2022,PMC9198760,,10.3233/JAD-215563
35270811,"Technological Solutions for Diagnosis, Management and Treatment of Alzheimer's Disease-Related Symptoms: A Structured Review of the Recent Scientific Literature","Cammisuli DM, Cipriani G, Castelnuovo G.",Int J Environ Res Public Health. 2022 Mar 7;19(5):3122. doi: 10.3390/ijerph19053122.,Cammisuli DM,Int J Environ Res Public Health,2022,10-03-2022,PMC8910738,,10.3390/ijerph19053122
35266877,The Effectiveness and Safety of Serious Games for Improving Cognitive Abilities Among Elderly People With Cognitive Impairment: Systematic Review and Meta-Analysis,"Abd-Alrazaq A, Alajlani M, Alhuwail D, Toro CT, Giannicchi A, Ahmed A, Makhlouf A, Househ M.",JMIR Serious Games. 2022 Mar 10;10(1):e34592. doi: 10.2196/34592.,Abd-Alrazaq A,JMIR Serious Games,2022,10-03-2022,PMC8949701,,10.2196/34592
35265201,Advances in aptamers against Aβ and applications in Aβ detection and regulation for Alzheimer's disease,"Zheng Y, Zhang L, Zhao J, Li L, Wang M, Gao P, Wang Q, Zhang X, Wang W.",Theranostics. 2022 Jan 31;12(5):2095-2114. doi: 10.7150/thno.69465. eCollection 2022.,Zheng Y,Theranostics,2022,10-03-2022,PMC8899576,,10.7150/thno.69465
35260178,Pilot study of repeated blood-brain barrier disruption in patients with mild Alzheimer's disease with an implantable ultrasound device,"Epelbaum S, Burgos N, Canney M, Matthews D, Houot M, Santin MD, Desseaux C, Bouchoux G, Stroer S, Martin C, Habert MO, Levy M, Bah A, Martin K, Delatour B, Riche M, Dubois B, Belin L, Carpentier A.",Alzheimers Res Ther. 2022 Mar 8;14(1):40. doi: 10.1186/s13195-022-00981-1.,Epelbaum S,Alzheimers Res Ther,2022,09-03-2022,PMC8905724,,10.1186/s13195-022-00981-1
35258771,Proximal improvement and higher-order resting state network change after multidomain cognitive training intervention in healthy older adults,"Hardcastle C, Hausman HK, Kraft JN, Albizu A, O'Shea A, Boutzoukas EM, Evangelista ND, Langer K, Van Etten EJ, Bharadwaj PK, Song H, Smith SG, Porges E, DeKosky ST, Hishaw GA, Wu SS, Marsiske M, Cohen R, Alexander GE, Woods AJ.",Geroscience. 2022 Apr;44(2):1011-1027. doi: 10.1007/s11357-022-00535-1. Epub 2022 Mar 8.,Hardcastle C,Geroscience,2022,08-03-2022,PMC9135928,,10.1007/s11357-022-00535-1
35254390,Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow: Secondary Analysis of the SPRINT MIND Randomized Clinical Trial,"Dolui S, Detre JA, Gaussoin SA, Herrick JS, Wang DJJ, Tamura MK, Cho ME, Haley WE, Launer LJ, Punzi HA, Rastogi A, Still CH, Weiner DE, Wright JT Jr, Williamson JD, Wright CB, Bryan RN, Bress AP, Pajewski NM, Nasrallah IM.",JAMA Neurol. 2022 Apr 1;79(4):380-389. doi: 10.1001/jamaneurol.2022.0074.,Dolui S,JAMA Neurol,2022,07-03-2022,PMC8902686,,10.1001/jamaneurol.2022.0074
35250746,Non-pharmacological Approaches to Apathy and Depression: A Scoping Review of Mild Cognitive Impairment and Dementia,"Oba H, Kobayashi R, Kawakatsu S, Suzuki K, Otani K, Ihara K.",Front Psychol. 2022 Feb 16;13:815913. doi: 10.3389/fpsyg.2022.815913. eCollection 2022.,Oba H,Front Psychol,2022,07-03-2022,PMC8888661,,10.3389/fpsyg.2022.815913
35241627,Plasma Aβ as a biomarker for predicting Aβ-PET status in Alzheimer's disease：a systematic review with meta-analysis,"Cheng L, Li W, Chen Y, Lin Y, Wang B, Guo Q, Miao Y.",J Neurol Neurosurg Psychiatry. 2022 May;93(5):513-520. doi: 10.1136/jnnp-2021-327864. Epub 2022 Mar 3.,Cheng L,J Neurol Neurosurg Psychiatry,2022,04-03-2022,PMC9016262,,10.1136/jnnp-2021-327864
35239819,Medication reconciliation role and value in Alzheimer's disease treatment,"Shen X, Zhang Q, Shao W, Shi J, Liu B.",Arq Neuropsiquiatr. 2022 Mar;80(3):233-239. doi: 10.1590/0004-282X-ANP-2021-0147.,Shen X,Arq Neuropsiquiatr,2022,03-03-2022,PMC9648934,,10.1590/0004-282X-ANP-2021-0147
35237381,"Dietary Plant Polyphenols as the Potential Drugs in Neurodegenerative Diseases: Current Evidence, Advances, and Opportunities","Yan L, Guo MS, Zhang Y, Yu L, Wu JM, Tang Y, Ai W, Zhu FD, Law BY, Chen Q, Yu CL, Wong VK, Li H, Li M, Zhou XG, Qin DL, Wu AG.",Oxid Med Cell Longev. 2022 Feb 21;2022:5288698. doi: 10.1155/2022/5288698. eCollection 2022.,Yan L,Oxid Med Cell Longev,2022,03-03-2022,PMC8885204,,10.1155/2022/5288698
35236261,Beyond its Psychiatric Use: The Benefits of Low-dose Lithium Supplementation,"Hamstra SI, Roy BD, Tiidus P, MacNeil AJ, Klentrou P, MacPherson REK, Fajardo VA.",Curr Neuropharmacol. 2023;21(4):891-910. doi: 10.2174/1570159X20666220302151224.,Hamstra SI,Curr Neuropharmacol,2023,03-03-2022,PMC10227915,,10.2174/1570159X20666220302151224
35231697,"""Aducanumab"" making a comeback in Alzheimer's disease: An old wine in a new bottle","Behl T, Kaur I, Sehgal A, Singh S, Sharma N, Makeen HA, Albratty M, Alhazmi HA, Felemban SG, Alsubayiel AM, Bhatia S, Bungau S.",Biomed Pharmacother. 2022 Apr;148:112746. doi: 10.1016/j.biopha.2022.112746. Epub 2022 Feb 26.,Behl T,Biomed Pharmacother,2022,01-03-2022,,,10.1016/j.biopha.2022.112746
35228379,[Synthetic Studies on Small Molecule Natural Products with Neurotrophic Activity],Fukuyama Y.,Yakugaku Zasshi. 2022;142(3):241-277. doi: 10.1248/yakushi.21-00201.,Fukuyama Y,Yakugaku Zasshi,2022,01-03-2022,,,10.1248/yakushi.21-00201
35224525,A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data,"Neumann JT, Thao LTP, Callander E, Carr PR, Qaderi V, Nelson MR, Reid CM, Woods RL, Orchard SG, Wolfe R, Polekhina G, Williamson JD, Trauer JM, Newman AB, Murray AM, Ernst ME, Tonkin AM, McNeil JJ.",Lancet Healthy Longev. 2022 Feb;3(2):e89-e97. doi: 10.1016/s2666-7568(21)00308-1. Epub 2022 Feb 7.,Neumann JT,Lancet Healthy Longev,2022,28-02-2022,PMC8880962,NIHMS1778473,10.1016/s2666-7568(21)00308-1
35221992,Association of Headache Disorders and the Risk of Dementia: Meta-Analysis of Cohort Studies,"Qu H, Yang S, Yao Z, Sun X, Chen H.",Front Aging Neurosci. 2022 Feb 11;14:804341. doi: 10.3389/fnagi.2022.804341. eCollection 2022.,Qu H,Front Aging Neurosci,2022,28-02-2022,PMC8873983,,10.3389/fnagi.2022.804341
35220356,Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials,"McManus KR, Lapid MI, Forester BP, Mueller M, Hermida AP, Nykamp L, Harper DG, Seiner SJ, Sanghani S, Patrick R, Gentry MT, Kung S, Leal JC, Johnson EK, Petrides G.",J ECT. 2022 Sep 1;38(3):165-170. doi: 10.1097/YCT.0000000000000832. Epub 2022 Mar 1.,McManus KR,J ECT,2022,27-02-2022,PMC9420159,NIHMS1767680,10.1097/YCT.0000000000000832
35219701,Therapeutic strategies for tauopathies and drug repurposing as a potential approach,"Islam M, Shen F, Regmi D, Du D.",Biochem Pharmacol. 2022 Apr;198:114979. doi: 10.1016/j.bcp.2022.114979. Epub 2022 Feb 24.,Islam M,Biochem Pharmacol,2022,27-02-2022,PMC9159505,NIHMS1787790,10.1016/j.bcp.2022.114979
35217901,Advancement of nanomedicines in chronic inflammatory disorders,"Jogpal V, Sanduja M, Dutt R, Garg V, Tinku.",Inflammopharmacology. 2022 Apr;30(2):355-368. doi: 10.1007/s10787-022-00927-x. Epub 2022 Feb 25.,Jogpal V,Inflammopharmacology,2022,26-02-2022,PMC8879181,,10.1007/s10787-022-00927-x
35216107,Comprehensive Review Regarding Mercury Poisoning and Its Complex Involvement in Alzheimer's Disease,"Paduraru E, Iacob D, Rarinca V, Rusu A, Jijie R, Ilie OD, Ciobica A, Nicoara M, Doroftei B.",Int J Mol Sci. 2022 Feb 11;23(4):1992. doi: 10.3390/ijms23041992.,Paduraru E,Int J Mol Sci,2022,26-02-2022,PMC8879904,,10.3390/ijms23041992
35215469,Phenolic Acids and Prevention of Cognitive Decline: Polyphenols with a Neuroprotective Role in Cognitive Disorders and Alzheimer's Disease,"Caruso G, Godos J, Privitera A, Lanza G, Castellano S, Chillemi A, Bruni O, Ferri R, Caraci F, Grosso G.",Nutrients. 2022 Feb 15;14(4):819. doi: 10.3390/nu14040819.,Caruso G,Nutrients,2022,26-02-2022,PMC8875888,,10.3390/nu14040819
35215287,Traditional East Asian Herbal Medicine Treatment for Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Lee J, Kwon S, Jin C, Cho SY, Park SU, Jung WS, Moon SK, Park JM, Ko CN, Cho KH.",Pharmaceuticals (Basel). 2022 Jan 31;15(2):174. doi: 10.3390/ph15020174.,Lee J,Pharmaceuticals (Basel),2022,26-02-2022,PMC8874541,,10.3390/ph15020174
35212023,Estradiol treatment in young postmenopausal women with self-reported cognitive complaints: Effects on cholinergic-mediated cognitive performance,"Conley AC, Albert KM, McDonald BC, Saykin AJ, Dumas JA, Newhouse PA.",Hum Psychopharmacol. 2022 Sep;37(5):e2838. doi: 10.1002/hup.2838. Epub 2022 Feb 24.,Conley AC,Hum Psychopharmacol,2022,25-02-2022,PMC9399322,NIHMS1807338,10.1002/hup.2838
35207764,Combined Motor and Cognitive Rehabilitation: The Impact on Motor Performance in Patients with Mild Cognitive Impairment. Systematic Review and Meta-Analysis,"Kiper P, Richard M, Stefanutti F, Pierson-Poinsignon R, Cacciante L, Perin C, Mazzucchelli M, Viganò B, Meroni R.",J Pers Med. 2022 Feb 14;12(2):276. doi: 10.3390/jpm12020276.,Kiper P,J Pers Med,2022,25-02-2022,PMC8874573,,10.3390/jpm12020276
35207561,Potential Applications of Artificial Intelligence in Clinical Trials for Alzheimer's Disease,"Seo Y, Jang H, Lee H.",Life (Basel). 2022 Feb 12;12(2):275. doi: 10.3390/life12020275.,Seo Y,Life (Basel),2022,25-02-2022,PMC8879055,,10.3390/life12020275
35204840,Are Cell-Based Therapies Safe and Effective in the Treatment of Neurodegenerative Diseases? A Systematic Review with Meta-Analysis,"Van den Bos J, Ouaamari YE, Wouters K, Cools N, Wens I.",Biomolecules. 2022 Feb 21;12(2):340. doi: 10.3390/biom12020340.,Van den Bos J,Biomolecules,2022,25-02-2022,PMC8869169,,10.3390/biom12020340
35202456,The Microbiota-Gut-Brain Axis in Alzheimer's Disease: A Review of Taxonomic Alterations and Potential Avenues for Interventions,"Murray ER, Kemp M, Nguyen TT.",Arch Clin Neuropsychol. 2022 Feb 22;37(3):595-607. doi: 10.1093/arclin/acac008.,Murray ER,Arch Clin Neuropsychol,2022,24-02-2022,PMC9035085,,10.1093/arclin/acac008
35189101,Does protracted radon exposure play a role in the development of dementia?,"Zhang Y, Lu L, Chen C, Field RW, D'Alton M, Kahe K.",Environ Res. 2022 Jul;210:112980. doi: 10.1016/j.envres.2022.112980. Epub 2022 Feb 19.,Zhang Y,Environ Res,2022,21-02-2022,PMC9081166,NIHMS1783328,10.1016/j.envres.2022.112980
35185754,Transcranial Direct Current Stimulation (tDCS) as a Useful Rehabilitation Strategy to Improve Cognition in Patients With Alzheimer's Disease and Parkinson's Disease: An Updated Systematic Review of Randomized Controlled Trials,"Cammisuli DM, Cignoni F, Ceravolo R, Bonuccelli U, Castelnuovo G.",Front Neurol. 2022 Feb 2;12:798191. doi: 10.3389/fneur.2021.798191. eCollection 2021.,Cammisuli DM,Front Neurol,2022,21-02-2022,PMC8847129,,10.3389/fneur.2021.798191
35185522,"Efficacy and Safety of Probiotics for the Treatment of Alzheimer's Disease, Mild Cognitive Impairment, and Parkinson's Disease: A Systematic Review and Meta-Analysis","Xiang S, Ji JL, Li S, Cao XP, Xu W, Tan L, Tan CC.",Front Aging Neurosci. 2022 Feb 3;14:730036. doi: 10.3389/fnagi.2022.730036. eCollection 2022.,Xiang S,Front Aging Neurosci,2022,21-02-2022,PMC8851038,,10.3389/fnagi.2022.730036
35184428,(18)F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment,"Chun MY, Lee J, Jeong JH, Roh JH, Oh SJ, Oh M, Oh JS, Kim JS, Moon SH, Woo SY, Kim YJ, Choe YS, Kim HJ, Na DL, Jang H, Seo SW.",Yonsei Med J. 2022 Mar;63(3):259-264. doi: 10.3349/ymj.2022.63.3.259.,Chun MY,Yonsei Med J,2022,20-02-2022,PMC8860937,,10.3349/ymj.2022.63.3.259
35183180,Costs associated with treatment of insomnia in Alzheimer's disease caregivers: a comparison of mindfulness meditation and cognitive behavioral therapy for insomnia,"Bentley TGK, Castillo D, Sadeghi N, Piber D, Carroll J, Olmstead R, Irwin MR.",BMC Health Serv Res. 2022 Feb 19;22(1):231. doi: 10.1186/s12913-022-07619-w.,Bentley TGK,BMC Health Serv Res,2022,20-02-2022,PMC8858547,,10.1186/s12913-022-07619-w
35180125,"Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Positive Modulator of HGF/MET, Fosgonimeton, in Healthy Volunteers and Subjects with Alzheimer's Disease: Randomized, Placebo-Controlled, Double-Blind, Phase I Clinical Trial","Hua X, Church K, Walker W, L'Hostis P, Viardot G, Danjou P, Hendrix S, Moebius HJ.",J Alzheimers Dis. 2022;86(3):1399-1413. doi: 10.3233/JAD-215511.,Hua X,J Alzheimers Dis,2022,18-02-2022,PMC9108585,,10.3233/JAD-215511
35173531,The role of melatonin in the treatment of type 2 diabetes mellitus and Alzheimer's disease,"Shen S, Liao Q, Wong YK, Chen X, Yang C, Xu C, Sun J, Wang J.",Int J Biol Sci. 2022 Jan 1;18(3):983-994. doi: 10.7150/ijbs.66871. eCollection 2022.,Shen S,Int J Biol Sci,2022,17-02-2022,PMC8771831,,10.7150/ijbs.66871
35164167,"Medicine-Food Herbs against Alzheimer's Disease: A Review of Their Traditional Functional Features, Substance Basis, Clinical Practices and Mechanisms of Action","Guo P, Zhang B, Zhao J, Wang C, Wang Z, Liu A, Du G.",Molecules. 2022 Jan 28;27(3):901. doi: 10.3390/molecules27030901.,Guo P,Molecules,2022,15-02-2022,PMC8839204,,10.3390/molecules27030901
35163773,A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics,"Lamptey RNL, Chaulagain B, Trivedi R, Gothwal A, Layek B, Singh J.",Int J Mol Sci. 2022 Feb 6;23(3):1851. doi: 10.3390/ijms23031851.,Lamptey RNL,Int J Mol Sci,2022,15-02-2022,PMC8837071,,10.3390/ijms23031851
35163136,Selected Natural Products in Neuroprotective Strategies for Alzheimer's Disease-A Non-Systematic Review,"Wojtunik-Kulesza K, Oniszczuk T, Mołdoch J, Kowalska I, Szponar J, Oniszczuk A.",Int J Mol Sci. 2022 Jan 21;23(3):1212. doi: 10.3390/ijms23031212.,Wojtunik-Kulesza K,Int J Mol Sci,2022,15-02-2022,PMC8835836,,10.3390/ijms23031212
35162238,Physical Activity Improves Cognition and Activities of Daily Living in Adults with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,"Zhou S, Chen S, Liu X, Zhang Y, Zhao M, Li W.",Int J Environ Res Public Health. 2022 Jan 22;19(3):1216. doi: 10.3390/ijerph19031216.,Zhou S,Int J Environ Res Public Health,2022,15-02-2022,PMC8834999,,10.3390/ijerph19031216
35159288,Can We Use Ginkgo biloba Extract to Treat Alzheimer's Disease? Lessons from Preclinical and Clinical Studies,"Xie L, Zhu Q, Lu J.",Cells. 2022 Jan 29;11(3):479. doi: 10.3390/cells11030479.,Xie L,Cells,2022,15-02-2022,PMC8833923,,10.3390/cells11030479
35154564,Neurobiological Promises of the Bitter Diterpene Lactone Andrographolide,"Hossain R, Quispe C, Herrera-Bravo J, Beltrán JF, Islam MT, Shaheen S, Cruz-Martins N, Martorell M, Kumar M, Sharifi-Rad J, Ozdemir FA, Setzer WN, Alshehri MM, Calina D, Cho WC.",Oxid Med Cell Longev. 2022 Feb 1;2022:3079577. doi: 10.1155/2022/3079577. eCollection 2022.,Hossain R,Oxid Med Cell Longev,2022,14-02-2022,PMC8825670,,10.1155/2022/3079577
35147964,The Alteration of Neurogenesis and Pathological Markers in Alzheimer's Disease After Deep Brain Stimulation,"Nassehi B, Kocabicak E, Temel Y, Hescham S.",Turk Neurosurg. 2022;32(4):535-548. doi: 10.5137/1019-5149.JTN.35598-21.2.,Nassehi B,Turk Neurosurg,2022,11-02-2022,,,10.5137/1019-5149.JTN.35598-21.2
35142667,Repurposed anti-cancer epidermal growth factor receptor inhibitors: mechanisms of neuroprotective effects in Alzheimer's disease,"Mansour HM, Fawzy HM, El-Khatib AS, Khattab MM.",Neural Regen Res. 2022 Sep;17(9):1913-1918. doi: 10.4103/1673-5374.332132.,Mansour HM,Neural Regen Res,2022,10-02-2022,PMC8848623,,10.4103/1673-5374.332132
35142666,Neuroprotective effects of naturally sourced bioactive polysaccharides: an update,"Xu XL, Li S, Zhang R, Le WD.",Neural Regen Res. 2022 Sep;17(9):1907-1912. doi: 10.4103/1673-5374.335142.,Xu XL,Neural Regen Res,2022,10-02-2022,PMC8848587,,10.4103/1673-5374.335142
35139803,A systematic review and meta-analysis of studies on screening for mild cognitive impairment in primary healthcare,"Karimi L, Mahboub-Ahari A, Jahangiry L, Sadeghi-Bazargani H, Farahbakhsh M.",BMC Psychiatry. 2022 Feb 9;22(1):97. doi: 10.1186/s12888-022-03730-8.,Karimi L,BMC Psychiatry,2022,10-02-2022,PMC8827177,,10.1186/s12888-022-03730-8
35135524,The effects of involvement in training and volunteering with families of people with dementia on the knowledge and attitudes of volunteers towards dementia,"Cheung DSK, Ho LYW, Kwok RKH, Lai DLL, Lai CKY.",BMC Public Health. 2022 Feb 8;22(1):258. doi: 10.1186/s12889-022-12687-y.,Cheung DSK,BMC Public Health,2022,09-02-2022,PMC8822773,,10.1186/s12889-022-12687-y
35131314,Repositioning and development of new treatments for neurodegenerative diseases: Focus on neuroinflammation,"Arbo BD, Schimith LE, Goulart Dos Santos M, Hort MA.",Eur J Pharmacol. 2022 Mar 15;919:174800. doi: 10.1016/j.ejphar.2022.174800. Epub 2022 Feb 5.,Arbo BD,Eur J Pharmacol,2022,08-02-2022,,,10.1016/j.ejphar.2022.174800
35129210,Public opinion regarding U.S. Food and Drug Administration approval of aducanumab and potential policy responses: A nationally representative survey,"DiStefano MJ, Alexander GC, Polsky D, Anderson GF.",J Am Geriatr Soc. 2022 Jun;70(6):1685-1694. doi: 10.1111/jgs.17692. Epub 2022 Feb 7.,DiStefano MJ,J Am Geriatr Soc,2022,07-02-2022,PMC9177789,NIHMS1800203,10.1111/jgs.17692
35120284,Methylphenidate and Other Pharmacologic Treatments for Apathy in Alzheimer's Disease,Andrade C.,J Clin Psychiatry. 2022 Feb 1;83(1):22f14398. doi: 10.4088/JCP.22f14398.,Andrade C,J Clin Psychiatry,2022,04-02-2022,,,10.4088/JCP.22f14398
35119081,Effects of transcranial magnetic stimulation on neurobiological changes in Alzheimer's disease (Review),"Bashir S, Uzair M, Abualait T, Arshad M, Khallaf RA, Niaz A, Thani Z, Yoo WK, Túnez I, Demirtas-Tatlidede A, Meo SA.",Mol Med Rep. 2022 Apr;25(4):109. doi: 10.3892/mmr.2022.12625. Epub 2022 Feb 4.,Bashir S,Mol Med Rep,2022,04-02-2022,PMC8845030,,10.3892/mmr.2022.12625
35118644,Serum biomarkers of brain injury after uncomplicated cardiac surgery: Secondary analysis from a randomized trial,"Barbu M, Jónsson K, Zetterberg H, Blennow K, Kolsrud O, Ricksten SE, Dellgren G, Björk K, Jeppsson A.",Acta Anaesthesiol Scand. 2022 Apr;66(4):447-453. doi: 10.1111/aas.14033. Epub 2022 Feb 19.,Barbu M,Acta Anaesthesiol Scand,2022,04-02-2022,PMC9302991,,10.1111/aas.14033
35109786,"The roles of Eph receptors, neuropilin-1, P2X7, and CD147 in COVID-19-associated neurodegenerative diseases: inflammasome and JaK inhibitors as potential promising therapies","Zalpoor H, Akbari A, Samei A, Forghaniesfidvajani R, Kamali M, Afzalnia A, Manshouri S, Heidari F, Pornour M, Khoshmirsafa M, Aazami H, Seif F.",Cell Mol Biol Lett. 2022 Feb 2;27(1):10. doi: 10.1186/s11658-022-00311-1.,Zalpoor H,Cell Mol Biol Lett,2022,03-02-2022,PMC8809072,,10.1186/s11658-022-00311-1
35109724,Systematic review of pharmacological interventions for people with Lewy body dementia,"Watts KE, Storr NJ, Barr PG, Rajkumar AP.",Aging Ment Health. 2023 Feb;27(2):203-216. doi: 10.1080/13607863.2022.2032601. Epub 2022 Feb 2.,Watts KE,Aging Ment Health,2023,03-02-2022,,,10.1080/13607863.2022.2032601
35105293,Impact of the Cannabinoid System in Alzheimer's Disease,"Li S, Huang Y, Yu L, Ji X, Wu J.",Curr Neuropharmacol. 2023;21(3):715-726. doi: 10.2174/1570159X20666220201091006.,Li S,Curr Neuropharmacol,2023,02-02-2022,PMC10207907,,10.2174/1570159X20666220201091006
35104057,Postoperative changes in cognition and cerebrospinal fluid neurodegenerative disease biomarkers,"Berger M, Browndyke JN, Cooter Wright M, Nobuhara C, Reese M, Acker L, Bullock WM, Colin BJ, Devinney MJ, Moretti EW, Moul JW, Ohlendorf B, Laskowitz DT, Waligorska T, Shaw LM, Whitson HE, Cohen HJ, Mathew JP; MADCO-PC Investigators.",Ann Clin Transl Neurol. 2022 Feb;9(2):155-170. doi: 10.1002/acn3.51499. Epub 2022 Feb 1.,Berger M,Ann Clin Transl Neurol,2022,01-02-2022,PMC8862419,,10.1002/acn3.51499
35103388,Sex differences in cognitive resilience in preclinical autosomal-dominant Alzheimer's disease carriers and non-carriers: Baseline findings from the API ADAD Colombia Trial,"Vila-Castelar C, Tariot PN, Sink KM, Clayton D, Langbaum JB, Thomas RG, Chen Y, Su Y, Chen K, Hu N, Giraldo-Chica M, Tobón C, Acosta-Baena N, Luna E, Londoño M, Ospina P, Tirado V, Muñoz C, Henao E, Bocanegra Y, Alvarez S, Rios-Romenets S, Ghisays V, Goradia D, Lee W, Luo J, Malek-Ahmadi MH, Protas HD, Lopera F, Reiman EM, Quiroz YT; API ADAD Colombia Trial Group.",Alzheimers Dement. 2022 Nov;18(11):2272-2282. doi: 10.1002/alz.12552. Epub 2022 Feb 1.,Vila-Castelar C,Alzheimers Dement,2022,01-02-2022,PMC9339586,NIHMS1783831,10.1002/alz.12552
35101105,Psychotherapeutic interventions in individuals at risk for Alzheimer's dementia: a systematic review,"Rostamzadeh A, Kahlert A, Kalthegener F, Jessen F.",Alzheimers Res Ther. 2022 Jan 31;14(1):18. doi: 10.1186/s13195-021-00956-8.,Rostamzadeh A,Alzheimers Res Ther,2022,01-02-2022,PMC8802419,,10.1186/s13195-021-00956-8
35098981,Representation of Racial and Ethnic Minority Populations in Dementia Prevention Trials: A Systematic Review,"Shaw AR, Perales-Puchalt J, Johnson E, Espinoza-Kissell P, Acosta-Rullan M, Frederick S, Lewis A, Chang H, Mahnken J, Vidoni ED.",J Prev Alzheimers Dis. 2022;9(1):113-118. doi: 10.14283/jpad.2021.49.,Shaw AR,J Prev Alzheimers Dis,2022,31-01-2022,PMC8804327,NIHMS1741314,10.14283/jpad.2021.49
35098971,Multimodal Preventive Trial for Alzheimer's Disease: MIND-ADmini Pilot Trial Study Design and Progress,"Sindi S, Thunborg C, Rosenberg A, Andersen P, Andrieu S, Broersen LM, Coley N, Couderc C, Duval CZ, Faxen-Irving G, Hagman G, Hallikainen M, Håkansson K, Lehtisalo J, Levak N, Mangialasche F, Pantel J, Kekkonen E, Rydström A, Stigsdotter-Neely A, Wimo A, Ngandu T, Soininen H, Hartmann T, Solomon A, Kivipelto M.",J Prev Alzheimers Dis. 2022;9(1):30-39. doi: 10.14283/jpad.2022.4.,Sindi S,J Prev Alzheimers Dis,2022,31-01-2022,PMC8783958,,10.14283/jpad.2022.4
35098970,Senolytic Therapy to Modulate the Progression of Alzheimer's Disease (SToMP-AD): A Pilot Clinical Trial,"Gonzales MM, Garbarino VR, Marques Zilli E, Petersen RC, Kirkland JL, Tchkonia T, Musi N, Seshadri S, Craft S, Orr ME.",J Prev Alzheimers Dis. 2022;9(1):22-29. doi: 10.14283/jpad.2021.62.,Gonzales MM,J Prev Alzheimers Dis,2022,31-01-2022,PMC8612719,,10.14283/jpad.2021.62
35096208,Kynurenine Pathway Metabolites as Biomarkers in Alzheimer's Disease,"Liang Y, Xie S, He Y, Xu M, Qiao X, Zhu Y, Wu W.",Dis Markers. 2022 Jan 19;2022:9484217. doi: 10.1155/2022/9484217. eCollection 2022.,Liang Y,Dis Markers,2022,31-01-2022,PMC8791723,,10.1155/2022/9484217
35084721,Heterogeneity in Alzheimer's Disease Diagnosis and Progression Rates: Implications for Therapeutic Trials,"Duara R, Barker W.",Neurotherapeutics. 2022 Jan;19(1):8-25. doi: 10.1007/s13311-022-01185-z. Epub 2022 Jan 27.,Duara R,Neurotherapeutics,2022,27-01-2022,PMC9130395,,10.1007/s13311-022-01185-z
35080735,Primary Palliative Care in Dementia,Weisbrod N.,Neurotherapeutics. 2022 Jan;19(1):143-151. doi: 10.1007/s13311-021-01171-x. Epub 2022 Jan 26.,Weisbrod N,Neurotherapeutics,2022,26-01-2022,PMC8791082,,10.1007/s13311-021-01171-x
35079029,Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial,"Kellar D, Register T, Lockhart SN, Aisen P, Raman R, Rissman RA, Brewer J, Craft S.",Sci Rep. 2022 Jan 25;12(1):1346. doi: 10.1038/s41598-022-05165-3.,Kellar D,Sci Rep,2022,26-01-2022,PMC8789895,,10.1038/s41598-022-05165-3
35069976,A New Perspective on the Treatment of Alzheimer's Disease and Sleep Deprivation-Related Consequences: Can Curcumin Help?,"Küpeli Akkol E, Bardakcı H, Yücel Ç, Şeker Karatoprak G, Karpuz B, Khan H.",Oxid Med Cell Longev. 2022 Jan 12;2022:6168199. doi: 10.1155/2022/6168199. eCollection 2022.,Küpeli Akkol E,Oxid Med Cell Longev,2022,24-01-2022,PMC8769857,,10.1155/2022/6168199
35067193,RNA-based therapeutics for neurological diseases,Anthony K.,RNA Biol. 2022;19(1):176-190. doi: 10.1080/15476286.2021.2021650. Epub 2021 Dec 31.,Anthony K,RNA Biol,2022,24-01-2022,PMC8786337,,10.1080/15476286.2021.2021650
35062074,Therapeutic promise of carotenoids as antioxidants and anti-inflammatory agents in neurodegenerative disorders,"Kabir MT, Rahman MH, Shah M, Jamiruddin MR, Basak D, Al-Harrasi A, Bhatia S, Ashraf GM, Najda A, El-Kott AF, Mohamed HRH, Al-Malky HS, Germoush MO, Altyar AE, Alwafai EB, Ghaboura N, Abdel-Daim MM.",Biomed Pharmacother. 2022 Feb;146:112610. doi: 10.1016/j.biopha.2021.112610. Epub 2022 Jan 4.,Kabir MT,Biomed Pharmacother,2022,22-01-2022,,,10.1016/j.biopha.2021.112610
35054924,GLP-1a: Going beyond Traditional Use,"Laurindo LF, Barbalho SM, Guiguer EL, da Silva Soares de Souza M, de Souza GA, Fidalgo TM, Araújo AC, de Souza Gonzaga HF, de Bortoli Teixeira D, de Oliveira Silva Ullmann T, Sloan KP, Sloan LA.",Int J Mol Sci. 2022 Jan 10;23(2):739. doi: 10.3390/ijms23020739.,Laurindo LF,Int J Mol Sci,2022,21-01-2022,PMC8775408,,10.3390/ijms23020739
35054296,"Serum Vitamin D as a Biomarker in Autoimmune, Psychiatric and Neurodegenerative Diseases","Bivona G, Gambino CM, Lo Sasso B, Scazzone C, Giglio RV, Agnello L, Ciaccio M.",Diagnostics (Basel). 2022 Jan 6;12(1):130. doi: 10.3390/diagnostics12010130.,Bivona G,Diagnostics (Basel),2022,21-01-2022,PMC8774449,,10.3390/diagnostics12010130
35049930,Marine Organisms as Alkaloid Biosynthesizers of Potential Anti-Alzheimer Agents,"Lima E, Medeiros J.",Mar Drugs. 2022 Jan 15;20(1):75. doi: 10.3390/md20010075.,Lima E,Mar Drugs,2022,20-01-2022,PMC8780771,,10.3390/md20010075
35049127,Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementia,"Belleville S, Cloutier S, Mellah S, Willis S, Vellas B, Andrieu S, Coley N, Ngandu T; MAPT/DSA group.",Alzheimers Dement. 2022 Nov;18(11):2140-2150. doi: 10.1002/alz.12544. Epub 2022 Jan 20.,Belleville S,Alzheimers Dement,2022,20-01-2022,PMC9786573,,10.1002/alz.12544
35043999,Air Pollution and the Risk of Parkinson's Disease: A Review,"Murata H, Barnhill LM, Bronstein JM.",Mov Disord. 2022 May;37(5):894-904. doi: 10.1002/mds.28922. Epub 2022 Jan 19.,Murata H,Mov Disord,2022,19-01-2022,PMC9119911,NIHMS1767664,10.1002/mds.28922
35041261,Effects of eszopiclone on sleep quality and cognitive function in elderly patients with Alzheimer's disease and sleep disorder: A randomized controlled trial,"Huo S, Cheng L, Li S, Xu F.",Brain Behav. 2022 Feb;12(2):e2488. doi: 10.1002/brb3.2488. Epub 2022 Jan 18.,Huo S,Brain Behav,2022,18-01-2022,PMC8865158,,10.1002/brb3.2488
35027502,Gut microbiota in patients with Alzheimer's disease spectrum: a systematic review and meta-analysis,"Hung CC, Chang CC, Huang CW, Nouchi R, Cheng CH.",Aging (Albany NY). 2022 Jan 14;14(1):477-496. doi: 10.18632/aging.203826. Epub 2022 Jan 14.,Hung CC,Aging (Albany NY),2022,14-01-2022,PMC8791218,,10.18632/aging.203826
35027110,Management of Atrial Fibrillation in Patients 75 Years and Older: JACC State-of-the-Art Review,"Volgman AS, Nair G, Lyubarova R, Merchant FM, Mason P, Curtis AB, Wenger NK, Aggarwal NT, Kirkpatrick JN, Benjamin EJ.",J Am Coll Cardiol. 2022 Jan 18;79(2):166-179. doi: 10.1016/j.jacc.2021.10.037.,Volgman AS,J Am Coll Cardiol,2022,14-01-2022,,,10.1016/j.jacc.2021.10.037
35021306,Impact of Testosterone on Alzheimer's Disease,Bianchi VE.,World J Mens Health. 2022 Apr;40(2):243-256. doi: 10.5534/wjmh.210175. Epub 2022 Jan 2.,Bianchi VE,World J Mens Health,2022,12-01-2022,PMC8987133,,10.5534/wjmh.210175
35013934,Emotional and Neuropsychiatric Disorders Associated with Alzheimer's Disease,"Heilman KM, Nadeau SE.",Neurotherapeutics. 2022 Jan;19(1):99-116. doi: 10.1007/s13311-021-01172-w. Epub 2022 Jan 10.,Heilman KM,Neurotherapeutics,2022,11-01-2022,PMC9130428,,10.1007/s13311-021-01172-w
35011505,The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors,"Hughes TD, Güner OF, Iradukunda EC, Phillips RS, Bowen JP.",Molecules. 2022 Jan 2;27(1):273. doi: 10.3390/molecules27010273.,Hughes TD,Molecules,2022,11-01-2022,PMC8747024,,10.3390/molecules27010273
35011468,New Promising Therapeutic Avenues of Curcumin in Brain Diseases,"Benameur T, Giacomucci G, Panaro MA, Ruggiero M, Trotta T, Monda V, Pizzolorusso I, Lofrumento DD, Porro C, Messina G.",Molecules. 2021 Dec 31;27(1):236. doi: 10.3390/molecules27010236.,Benameur T,Molecules,2021,11-01-2022,PMC8746812,,10.3390/molecules27010236
35011465,Role of Phenolic Compounds in Human Disease: Current Knowledge and Future Prospects,"Rahman MM, Rahaman MS, Islam MR, Rahman F, Mithi FM, Alqahtani T, Almikhlafi MA, Alghamdi SQ, Alruwaili AS, Hossain MS, Ahmed M, Das R, Emran TB, Uddin MS.",Molecules. 2021 Dec 30;27(1):233. doi: 10.3390/molecules27010233.,Rahman MM,Molecules,2021,11-01-2022,PMC8746501,,10.3390/molecules27010233
35010895,Probiotics for Alzheimer's Disease: A Systematic Review,"Naomi R, Embong H, Othman F, Ghazi HF, Maruthey N, Bahari H.",Nutrients. 2021 Dec 22;14(1):20. doi: 10.3390/nu14010020.,Naomi R,Nutrients,2021,11-01-2022,PMC8746506,,10.3390/nu14010020
35010526,The Role of Executive Function in the Effectiveness of Multi-Component Interventions Targeting Physical Activity Behavior in Office Workers,"Wang R, Blom V, Nooijen CFJ, Kallings LV, Ekblom Ö, Ekblom MM.",Int J Environ Res Public Health. 2021 Dec 27;19(1):266. doi: 10.3390/ijerph19010266.,Wang R,Int J Environ Res Public Health,2021,11-01-2022,PMC8751160,,10.3390/ijerph19010266
35008933,"A Growing Link between Circadian Rhythms, Type 2 Diabetes Mellitus and Alzheimer's Disease","Peng X, Fan R, Xie L, Shi X, Dong K, Zhang S, Tao J, Xu W, Ma D, Chen J, Yang Y.",Int J Mol Sci. 2022 Jan 3;23(1):504. doi: 10.3390/ijms23010504.,Peng X,Int J Mol Sci,2022,11-01-2022,PMC8745289,,10.3390/ijms23010504
35008771,Roles and Mechanisms of the Protein Quality Control System in Alzheimer's Disease,"Liu Y, Ding R, Xu Z, Xue Y, Zhang D, Zhang Y, Li W, Li X.",Int J Mol Sci. 2021 Dec 29;23(1):345. doi: 10.3390/ijms23010345.,Liu Y,Int J Mol Sci,2021,11-01-2022,PMC8745298,,10.3390/ijms23010345
35002241,"Fluoxetine May Enhance VEGF, BDNF and Cognition in Patients with Vascular Cognitive Impairment No Dementia: An Open-Label Randomized Clinical Study","Zhang L, Liu X, Li T, Xu B, Fu B.",Neuropsychiatr Dis Treat. 2021 Dec 29;17:3819-3825. doi: 10.2147/NDT.S334647. eCollection 2021.,Zhang L,Neuropsychiatr Dis Treat,2021,10-01-2022,PMC8721155,,10.2147/NDT.S334647
34999745,"Vitamin D and Multiple Health Outcomes: An Umbrella Review of Observational Studies, Randomized Controlled Trials, and Mendelian Randomization Studies","Liu D, Meng X, Tian Q, Cao W, Fan X, Wu L, Song M, Meng Q, Wang W, Wang Y.",Adv Nutr. 2022 Aug 1;13(4):1044-1062. doi: 10.1093/advances/nmab142.,Liu D,Adv Nutr,2022,09-01-2022,PMC9340982,,10.1093/advances/nmab142
34999335,"Omega-3 fatty acid, carotenoid and vitamin E supplementation improves working memory in older adults: A randomised clinical trial","Power R, Nolan JM, Prado-Cabrero A, Roche W, Coen R, Power T, Mulcahy R.",Clin Nutr. 2022 Feb;41(2):405-414. doi: 10.1016/j.clnu.2021.12.004. Epub 2021 Dec 7.,Power R,Clin Nutr,2022,09-01-2022,,,10.1016/j.clnu.2021.12.004
34996522,Plasma MCP-1 and changes on cognitive function in community-dwelling older adults,"Sanchez-Sanchez JL, Giudici KV, Guyonnet S, Delrieu J, Li Y, Bateman RJ, Parini A, Vellas B, de Souto Barreto P; MAPT/DSA Group.",Alzheimers Res Ther. 2022 Jan 7;14(1):5. doi: 10.1186/s13195-021-00940-2.,Sanchez-Sanchez JL,Alzheimers Res Ther,2022,08-01-2022,PMC8742409,,10.1186/s13195-021-00940-2
34995992,Serum amyloid P component level is associated with clinical response to escitalopram treatment in patients with major depressive disorder,"Yang J, Zhou J, Zhou J, Wang H, Sun Z, Zhu X, He Y, Wong AHC, Liu F, Wang G.",J Psychiatr Res. 2022 Feb;146:172-178. doi: 10.1016/j.jpsychires.2021.12.051. Epub 2021 Dec 30.,Yang J,J Psychiatr Res,2022,07-01-2022,,,10.1016/j.jpsychires.2021.12.051
34994734,Treatment of insomnia - effect of trazodone and hypnotics on sleep,"Wichniak A, Wierzbicka AE, Jarema M.",Psychiatr Pol. 2021 Aug 31;55(4):743-755. doi: 10.12740/PP/125650. Epub 2021 Aug 31.,Wichniak A,Psychiatr Pol,2021,07-01-2022,,,10.12740/PP/125650
34991675,Biomarkers for sepsis: more than just fever and leukocytosis-a narrative review,"Barichello T, Generoso JS, Singer M, Dal-Pizzol F.",Crit Care. 2022 Jan 6;26(1):14. doi: 10.1186/s13054-021-03862-5.,Barichello T,Crit Care,2022,07-01-2022,PMC8740483,,10.1186/s13054-021-03862-5
34990844,The role of serotonin within the microbiota-gut-brain axis in the development of Alzheimer's disease: A narrative review,"Aaldijk E, Vermeiren Y.",Ageing Res Rev. 2022 Mar;75:101556. doi: 10.1016/j.arr.2021.101556. Epub 2022 Jan 3.,Aaldijk E,Ageing Res Rev,2022,06-01-2022,,,10.1016/j.arr.2021.101556
34990108,Potential Role of Heterocyclic Aromatic Amines in Neurodegeneration,"Syeda T, Cannon JR.",Chem Res Toxicol. 2022 Jan 17;35(1):59-72. doi: 10.1021/acs.chemrestox.1c00274. Epub 2022 Jan 6.,Syeda T,Chem Res Toxicol,2022,06-01-2022,PMC10443083,NIHMS1923191,10.1021/acs.chemrestox.1c00274
34985325,A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders,"Sorboni SG, Moghaddam HS, Jafarzadeh-Esfehani R, Soleimanpour S.",Clin Microbiol Rev. 2022 Jan 19;35(1):e0033820. doi: 10.1128/CMR.00338-20. Epub 2022 Jan 5.,Sorboni SG,Clin Microbiol Rev,2022,05-01-2022,PMC8729913,,10.1128/CMR.00338-20
34983696,Therapy development for spinal muscular atrophy: perspectives for muscular dystrophies and neurodegenerative disorders,"Jablonka S, Hennlein L, Sendtner M.",Neurol Res Pract. 2022 Jan 4;4(1):2. doi: 10.1186/s42466-021-00162-9.,Jablonka S,Neurol Res Pract,2022,05-01-2022,PMC8725368,,10.1186/s42466-021-00162-9
34970956,Stem Cell-based Therapeutic and Diagnostic Approaches in Alzheimer's Disease,"Abdi S, Javanmehr N, Ghasemi-Kasman M, Bali HY, Pirzadeh M.",Curr Neuropharmacol. 2022;20(6):1093-1115. doi: 10.2174/1570159X20666211231090659.,Abdi S,Curr Neuropharmacol,2022,31-12-2021,PMC9886816,,10.2174/1570159X20666211231090659
34970718,Neuronavigated Magnetic Stimulation combined with cognitive training for Alzheimer's patients: an EEG graph study,"Vecchio F, Quaranta D, Miraglia F, Pappalettera C, Di Iorio R, L'Abbate F, Cotelli M, Marra C, Rossini PM.",Geroscience. 2022 Feb;44(1):159-172. doi: 10.1007/s11357-021-00508-w. Epub 2021 Dec 31.,Vecchio F,Geroscience,2022,31-12-2021,PMC8811083,,10.1007/s11357-021-00508-w
34969940,Circulating Interleukin-6 Levels and Incident Ischemic Stroke: A Systematic Review and Meta-analysis of Prospective Studies,"Papadopoulos A, Palaiopanos K, Björkbacka H, Peters A, de Lemos JA, Seshadri S, Dichgans M, Georgakis MK.",Neurology. 2022 Mar 8;98(10):e1002-e1012. doi: 10.1212/WNL.0000000000013274. Epub 2021 Dec 30.,Papadopoulos A,Neurology,2022,31-12-2021,PMC8967391,,10.1212/WNL.0000000000013274
34966890,Computational Approaches for Supporting Combination Therapy in the Post-Aducanumab Era in Alzheimer's Disease,"Geerts H, van der Graaf P.",J Alzheimers Dis Rep. 2021 Nov 23;5(1):815-826. doi: 10.3233/ADR-210039. eCollection 2021.,Geerts H,J Alzheimers Dis Rep,2021,30-12-2021,PMC8673549,,10.3233/ADR-210039
34964149,Acute response to cholinergic challenge predicts long-term response to galantamine treatment in patients with Alzheimer's disease,"Baakman AC, Gavan C, van Doeselaar L, de Kam M, Broekhuizen K, Bajenaru O, Camps L, Swart EL, Kalisvaart K, Schoonenboom N, Lemstra E, Scheltens P, Cohen A, van Gerven J, Groeneveld GJ.",Br J Clin Pharmacol. 2022 Jun;88(6):2814-2829. doi: 10.1111/bcp.15206. Epub 2022 Jan 26.,Baakman AC,Br J Clin Pharmacol,2022,29-12-2021,PMC9306507,,10.1111/bcp.15206
34960015,Effect of Ketogenic Diet on Quality of Life in Adults with Chronic Disease: A Systematic Review of Randomized Controlled Trials,"Abboud M, AlAnouti F, Georgaki E, Papandreou D.",Nutrients. 2021 Dec 14;13(12):4463. doi: 10.3390/nu13124463.,Abboud M,Nutrients,2021,28-12-2021,PMC8708168,,10.3390/nu13124463
34957783,"Hypertension and cognitive dysfunction: a review of mechanisms, life-course observational studies and clinical trial results","Mahinrad S, Sorond FA, Gorelick PB.",Rev Cardiovasc Med. 2021 Dec 22;22(4):1429-1449. doi: 10.31083/j.rcm2204148.,Mahinrad S,Rev Cardiovasc Med,2021,27-12-2021,,,10.31083/j.rcm2204148
34957393,Accelerating Hyperparameter Tuning in Machine Learning for Alzheimer's Disease With High Performance Computing,"Zhang F, Petersen M, Johnson L, Hall J, O'Bryant SE.",Front Artif Intell. 2021 Dec 8;4:798962. doi: 10.3389/frai.2021.798962. eCollection 2021.,Zhang F,Front Artif Intell,2021,27-12-2021,PMC8692864,,10.3389/frai.2021.798962
34957177,Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Mild Cognitive Impairment and Alzheimer's Disease: A Meta-Analysis,"Li X, Lv C, Song J, Li J.",Front Nutr. 2021 Dec 8;8:757673. doi: 10.3389/fnut.2021.757673. eCollection 2021.,Li X,Front Nutr,2021,27-12-2021,PMC8692377,,10.3389/fnut.2021.757673
34953393,The biological activities of butyrylcholinesterase inhibitors,"Zhou S, Huang G.",Biomed Pharmacother. 2022 Feb;146:112556. doi: 10.1016/j.biopha.2021.112556. Epub 2021 Dec 22.,Zhou S,Biomed Pharmacother,2022,25-12-2021,,,10.1016/j.biopha.2021.112556
34951390,Potential Roles of α-amylase in Alzheimer's Disease: Biomarker and Drug Target,"Chen WN, Tang KS, Yeong KY.",Curr Neuropharmacol. 2022;20(8):1554-1563. doi: 10.2174/1570159X20666211223124715.,Chen WN,Curr Neuropharmacol,2022,24-12-2021,PMC9881084,,10.2174/1570159X20666211223124715
34948222,Role of the Cholinergic Anti-Inflammatory Reflex in Central Nervous System Diseases,"Ramos-Martínez IE, Rodríguez MC, Cerbón M, Ramos-Martínez JC, Ramos-Martínez EG.",Int J Mol Sci. 2021 Dec 14;22(24):13427. doi: 10.3390/ijms222413427.,Ramos-Martínez IE,Int J Mol Sci,2021,24-12-2021,PMC8705572,,10.3390/ijms222413427
34948180,Mitochondrial Oxidative Stress-A Causative Factor and Therapeutic Target in Many Diseases,"Kowalczyk P, Sulejczak D, Kleczkowska P, Bukowska-Ośko I, Kucia M, Popiel M, Wietrak E, Kramkowski K, Wrzosek K, Kaczyńska K.",Int J Mol Sci. 2021 Dec 13;22(24):13384. doi: 10.3390/ijms222413384.,Kowalczyk P,Int J Mol Sci,2021,24-12-2021,PMC8707347,,10.3390/ijms222413384
34944768,The Effect of a Multimodal Occupational Therapy Program with Cognition-Oriented Approach on Cognitive Function and Activities of Daily Living in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials,"Ham MJ, Kim S, Jo YJ, Park C, Nam Y, Yoo DH, Moon M.",Biomedicines. 2021 Dec 20;9(12):1951. doi: 10.3390/biomedicines9121951.,Ham MJ,Biomedicines,2021,24-12-2021,PMC8698550,,10.3390/biomedicines9121951
34937781,Association of CSF Aβ(38) Levels With Risk of Alzheimer Disease-Related Decline,"Cullen N, Janelidze S, Palmqvist S, Stomrud E, Mattsson-Carlgren N, Hansson O; Alzheimer’s Disease Neuroimaging Initiative.",Neurology. 2022 Mar 1;98(9):e958-e967. doi: 10.1212/WNL.0000000000013228. Epub 2021 Dec 22.,Cullen N,Neurology,2022,23-12-2021,PMC8901176,,10.1212/WNL.0000000000013228
34934803,Dementia risk reduction: why haven't the pharmacological risk reduction trials worked? An in-depth exploration of seven established risk factors,"Peters R, Breitner J, James S, Jicha GA, Meyer PF, Richards M, Smith AD, Yassine HN, Abner E, Hainsworth AH, Kehoe PG, Beckett N, Weber C, Anderson C, Anstey KJ, Dodge HH.",Alzheimers Dement (N Y). 2021 Dec 8;7(1):e12202. doi: 10.1002/trc2.12202. eCollection 2021.,Peters R,Alzheimers Dement (N Y),2021,22-12-2021,PMC8655351,,10.1002/trc2.12202
34930421,Impact of multisession 40Hz tACS on hippocampal perfusion in patients with Alzheimer's disease,"Sprugnoli G, Munsch F, Cappon D, Paciorek R, Macone J, Connor A, El Fakhri G, Salvador R, Ruffini G, Donohoe K, Shafi MM, Press D, Alsop DC, Pascual Leone A, Santarnecchi E.",Alzheimers Res Ther. 2021 Dec 20;13(1):203. doi: 10.1186/s13195-021-00922-4.,Sprugnoli G,Alzheimers Res Ther,2021,21-12-2021,PMC8690894,,10.1186/s13195-021-00922-4
34922475,"Remote activity monitoring for family caregivers of persons living with dementia: a mixed methods, randomized controlled evaluation","Gaugler JE, Zmora R, Mitchell LL, Finlay J, Rosebush CE, Nkimbeng M, Baker ZG, Albers EA, Peterson CM.",BMC Geriatr. 2021 Dec 18;21(1):715. doi: 10.1186/s12877-021-02634-8.,Gaugler JE,BMC Geriatr,2021,19-12-2021,PMC8684277,,10.1186/s12877-021-02634-8
34919634,A phase II study repurposing atomoxetine for neuroprotection in mild cognitive impairment,"Levey AI, Qiu D, Zhao L, Hu WT, Duong DM, Higginbotham L, Dammer EB, Seyfried NT, Wingo TS, Hales CM, Gámez Tansey M, Goldstein DS, Abrol A, Calhoun VD, Goldstein FC, Hajjar I, Fagan AM, Galasko D, Edland SD, Hanfelt J, Lah JJ, Weinshenker D.",Brain. 2022 Jun 30;145(6):1924-1938. doi: 10.1093/brain/awab452.,Levey AI,Brain,2022,17-12-2021,PMC9630662,,10.1093/brain/awab452
34918337,Antipsychotics for agitation and psychosis in people with Alzheimer's disease and vascular dementia,"Mühlbauer V, Möhler R, Dichter MN, Zuidema SU, Köpke S, Luijendijk HJ.",Cochrane Database Syst Rev. 2021 Dec 17;12(12):CD013304. doi: 10.1002/14651858.CD013304.pub2.,Mühlbauer V,Cochrane Database Syst Rev,2021,17-12-2021,PMC8678509,,10.1002/14651858.CD013304.pub2
34911424,Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Nexus of Cholinergic and Nerve Growth Factor Dysfunction,"Moss DE, Perez RG.",Curr Alzheimer Res. 2021;18(13):1010-1022. doi: 10.2174/1567205018666211215150547.,Moss DE,Curr Alzheimer Res,2021,16-12-2021,PMC8855657,NIHMS1773269,10.2174/1567205018666211215150547
34910821,Psychological and pharmacological interventions for depression in patients with coronary artery disease,"Tully PJ, Ang SY, Lee EJ, Bendig E, Bauereiß N, Bengel J, Baumeister H.",Cochrane Database Syst Rev. 2021 Dec 15;12(12):CD008012. doi: 10.1002/14651858.CD008012.pub4.,Tully PJ,Cochrane Database Syst Rev,2021,15-12-2021,PMC8673695,,10.1002/14651858.CD008012.pub4
34909647,Perspective insights of repurposing the pleiotropic efficacy of statins in neurodegenerative disorders: An expository appraisal,"Bhat A, Dalvi H, Jain H, Rangaraj N, Singh SB, Srivastava S.",Curr Res Pharmacol Drug Discov. 2020 Dec 31;2:100012. doi: 10.1016/j.crphar.2020.100012. eCollection 2021.,Bhat A,Curr Res Pharmacol Drug Discov,2020,15-12-2021,PMC8663947,,10.1016/j.crphar.2020.100012
34906131,Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies,"Larsson SC, Burgess S.",BMC Med. 2021 Dec 15;19(1):320. doi: 10.1186/s12916-021-02188-x.,Larsson SC,BMC Med,2021,15-12-2021,PMC8672504,,10.1186/s12916-021-02188-x
34900527,Gains from no real PAINS: Where 'Fair Trial Strategy' stands in the development of multi-target ligands,"Sun J, Zhong H, Wang K, Li N, Chen L.",Acta Pharm Sin B. 2021 Nov;11(11):3417-3432. doi: 10.1016/j.apsb.2021.02.023. Epub 2021 Mar 4.,Sun J,Acta Pharm Sin B,2021,13-12-2021,PMC8642439,,10.1016/j.apsb.2021.02.023
34899316,An Overview of Systematic Reviews of Chinese Herbal Medicine for Alzheimer's Disease,"Liu N, Zhang T, Sun J, Yao J, Ma L, Fu J, Li H.",Front Pharmacol. 2021 Nov 26;12:761661. doi: 10.3389/fphar.2021.761661. eCollection 2021.,Liu N,Front Pharmacol,2021,13-12-2021,PMC8664324,,10.3389/fphar.2021.761661
34896392,Aptamers targeting amyloidogenic proteins and their emerging role in neurodegenerative diseases,"Murakami K, Izuo N, Bitan G.",J Biol Chem. 2022 Jan;298(1):101478. doi: 10.1016/j.jbc.2021.101478. Epub 2021 Dec 9.,Murakami K,J Biol Chem,2022,13-12-2021,PMC8728582,,10.1016/j.jbc.2021.101478
34896021,Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly,"Congdon EE, Jiang Y, Sigurdsson EM.",Semin Cell Dev Biol. 2022 Jun;126:125-137. doi: 10.1016/j.semcdb.2021.12.002. Epub 2021 Dec 9.,Congdon EE,Semin Cell Dev Biol,2022,13-12-2021,PMC9680670,NIHMS1763473,10.1016/j.semcdb.2021.12.002
34884818,miRNAs as Therapeutic Tools in Alzheimer's Disease,"Lee CY, Ryu IS, Ryu JH, Cho HJ.",Int J Mol Sci. 2021 Dec 1;22(23):13012. doi: 10.3390/ijms222313012.,Lee CY,Int J Mol Sci,2021,10-12-2021,PMC8657443,,10.3390/ijms222313012
34884693,"Recent Advances in Biological Activity, New Formulations and Prodrugs of Ferulic Acid","Stompor-Gorący M, Machaczka M.",Int J Mol Sci. 2021 Nov 28;22(23):12889. doi: 10.3390/ijms222312889.,Stompor-Gorący M,Int J Mol Sci,2021,10-12-2021,PMC8657461,,10.3390/ijms222312889
34883313,"The relative contributions of biomarkers, disease modifying treatment, and dementia severity to Alzheimer's stigma: A vignette-based experiment","Stites SD, Gill J, Largent EA, Harkins K, Sankar P, Krieger A, Karlawish J.",Soc Sci Med. 2022 Jan;292:114620. doi: 10.1016/j.socscimed.2021.114620. Epub 2021 Dec 1.,Stites SD,Soc Sci Med,2022,09-12-2021,PMC8748419,NIHMS1762559,10.1016/j.socscimed.2021.114620
34880449,Pyroglutamate Aβ cascade as drug target in Alzheimer's disease,Bayer TA.,Mol Psychiatry. 2022 Apr;27(4):1880-1885. doi: 10.1038/s41380-021-01409-2. Epub 2021 Dec 8.,Bayer TA,Mol Psychiatry,2022,09-12-2021,PMC9126800,,10.1038/s41380-021-01409-2
34879470,A short review on the influence of magnetic fields on neurological diseases,"Funk RHW, Fähnle M.",Front Biosci (Schol Ed). 2021 Dec 3;13(2):181-189. doi: 10.52586/S561.,Funk RHW,Front Biosci (Schol Ed),2021,08-12-2021,,,10.52586/S561
34871380,Statin use and risk of dementia or Alzheimer's disease: a systematic review and meta-analysis of observational studies,"Olmastroni E, Molari G, De Beni N, Colpani O, Galimberti F, Gazzotti M, Zambon A, Catapano AL, Casula M.",Eur J Prev Cardiol. 2022 May 5;29(5):804-814. doi: 10.1093/eurjpc/zwab208.,Olmastroni E,Eur J Prev Cardiol,2022,06-12-2021,,,10.1093/eurjpc/zwab208
34870696,Research Criteria for the Behavioral Variant of Alzheimer Disease: A Systematic Review and Meta-analysis,"Ossenkoppele R, Singleton EH, Groot C, Dijkstra AA, Eikelboom WS, Seeley WW, Miller B, Laforce RJ, Scheltens P, Papma JM, Rabinovici GD, Pijnenburg YAL.",JAMA Neurol. 2022 Jan 1;79(1):48-60. doi: 10.1001/jamaneurol.2021.4417.,Ossenkoppele R,JAMA Neurol,2022,06-12-2021,PMC8649917,,10.1001/jamaneurol.2021.4417
34866146,Effect of Polyphenols on Cognitive Function: Evidence from Population-Based Studies and Clinical Trials,"Yang W, Cui K, Li X, Zhao J, Zeng Z, Song R, Qi X, Xu W.",J Nutr Health Aging. 2021;25(10):1190-1204. doi: 10.1007/s12603-021-1685-4.,Yang W,J Nutr Health Aging,2021,06-12-2021,PMC12275588,,10.1007/s12603-021-1685-4
34864675,Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease,"Crestini A, Santilli F, Martellucci S, Carbone E, Sorice M, Piscopo P, Mattei V.",J Alzheimers Dis. 2022;85(2):503-518. doi: 10.3233/JAD-215171.,Crestini A,J Alzheimers Dis,2022,05-12-2021,,,10.3233/JAD-215171
34862851,Biodegradable nanoparticles for the treatment of epilepsy: From current advances to future challenges,"Bonilla L, Esteruelas G, Ettcheto M, Espina M, García ML, Camins A, Souto EB, Cano A, Sánchez-López E.",Epilepsia Open. 2022 Aug;7 Suppl 1(Suppl 1):S121-S132. doi: 10.1002/epi4.12567. Epub 2021 Dec 13.,Bonilla L,Epilepsia Open,2022,04-12-2021,PMC9340299,,10.1002/epi4.12567
34862742,Kynurenic acid in neurodegenerative disorders-unique neuroprotection or double-edged sword?,"Ostapiuk A, Urbanska EM.",CNS Neurosci Ther. 2022 Jan;28(1):19-35. doi: 10.1111/cns.13768. Epub 2021 Dec 3.,Ostapiuk A,CNS Neurosci Ther,2022,04-12-2021,PMC8673711,,10.1111/cns.13768
34859493,"Safety and Efficacy of Mevidalen in Lewy Body Dementia: A Phase 2, Randomized, Placebo-Controlled Trial","Biglan K, Munsie L, Svensson KA, Ardayfio P, Pugh M, Sims J, Brys M.",Mov Disord. 2022 Mar;37(3):513-524. doi: 10.1002/mds.28879. Epub 2021 Dec 2.,Biglan K,Mov Disord,2022,03-12-2021,PMC9300146,,10.1002/mds.28879
34859379,Lewy Body Dementias: Controversies and Drug Development,"Chiu SY, Bowers D, Armstrong MJ.",Neurotherapeutics. 2022 Jan;19(1):55-67. doi: 10.1007/s13311-021-01161-z. Epub 2021 Dec 2.,Chiu SY,Neurotherapeutics,2022,03-12-2021,PMC9130410,,10.1007/s13311-021-01161-z
34856171,Alzheimer's Disease THErapy With NEuroaid (ATHENE): A Randomized Double-Blind Delayed-Start Trial,"Chen CLH, Lu Q, Moorakonda RB, Kandiah N, Tan BY, Villaraza SG, Cano J, Venketasubramanian N.",J Am Med Dir Assoc. 2022 Mar;23(3):379-386.e3. doi: 10.1016/j.jamda.2021.10.018. Epub 2021 Nov 29.,Chen CLH,J Am Med Dir Assoc,2022,02-12-2021,,,10.1016/j.jamda.2021.10.018
34856086,Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias,"Balázs N, Bereczki D, Kovács T.",Ideggyogy Sz. 2021 Nov 30;74(11-12):379-387. doi: 10.18071/isz.74.0379.,Balázs N,Ideggyogy Sz,2021,02-12-2021,,,10.18071/isz.74.0379
34853363,Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial,"Kang JH, Vyas CM, Okereke OI, Ogata S, Albert M, Lee IM, D'Agostino D, Buring JE, Cook NR, Grodstein F, Manson JE.",Sci Rep. 2021 Dec 1;11(1):23253. doi: 10.1038/s41598-021-02485-8.,Kang JH,Sci Rep,2021,02-12-2021,PMC8636504,,10.1038/s41598-021-02485-8
34852746,BACE1: A Key Regulator in Alzheimer's Disease Progression and Current Development of its Inhibitors,"Patel S, Bansoad AV, Singh R, Khatik GL.",Curr Neuropharmacol. 2022;20(6):1174-1193. doi: 10.2174/1570159X19666211201094031.,Patel S,Curr Neuropharmacol,2022,02-12-2021,PMC9886827,,10.2174/1570159X19666211201094031
34852745,Amylin Pharmacology in Alzheimer's Disease Pathogenesis and Treatment,"Corrigan RR, Piontkivska H, Casadesus G.",Curr Neuropharmacol. 2022;20(10):1894-1907. doi: 10.2174/1570159X19666211201093147.,Corrigan RR,Curr Neuropharmacol,2022,02-12-2021,PMC9886804,,10.2174/1570159X19666211201093147
34848116,Nonpharmacologic Interventions for Family Caregivers of People Living With Dementia in Latin-America: A Scoping Review,"Aravena JM, Gajardo J, Saguez R, Hinton L, Gitlin LN.",Am J Geriatr Psychiatry. 2022 Aug;30(8):859-877. doi: 10.1016/j.jagp.2021.10.013. Epub 2021 Nov 2.,Aravena JM,Am J Geriatr Psychiatry,2022,01-12-2021,PMC11731639,NIHMS1753434,10.1016/j.jagp.2021.10.013
34847709,Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled Trial,"Blair GW, Janssen E, Stringer MS, Thrippleton MJ, Chappell F, Shi Y, Hamilton I, Flaherty K, Appleton JP, Doubal FN, Bath PM, Wardlaw JM.",Stroke. 2022 Jan;53(1):29-33. doi: 10.1161/STROKEAHA.121.034866. Epub 2021 Dec 1.,Blair GW,Stroke,2022,01-12-2021,PMC8700302,EMS138069,10.1161/STROKEAHA.121.034866
34847159,Bacterial variation in the oral microbiota in multiple sclerosis patients,"Zangeneh Z, Abdi-Ali A, Khamooshian K, Alvandi A, Abiri R.",PLoS One. 2021 Nov 30;16(11):e0260384. doi: 10.1371/journal.pone.0260384. eCollection 2021.,Zangeneh Z,PLoS One,2021,30-11-2021,PMC8631616,,10.1371/journal.pone.0260384
34844537,A(2A) Adenosine Receptor Antagonists in Neurodegenerative Diseases,"Merighi S, Borea PA, Varani K, Vincenzi F, Jacobson KA, Gessi S.",Curr Med Chem. 2022;29(24):4138-4151. doi: 10.2174/0929867328666211129122550.,Merighi S,Curr Med Chem,2022,30-11-2021,PMC9148371,NIHMS1776846,10.2174/0929867328666211129122550
34836972,Effect of N-methyl-D-aspartate receptor enhancing agents on cognition in dementia: an exploratory systematic review and meta-analysis of randomized controlled trials,"Chang CH, Liu CY, Chen SJ, Tsai HC.",Sci Rep. 2021 Nov 26;11(1):22996. doi: 10.1038/s41598-021-02040-5.,Chang CH,Sci Rep,2021,27-11-2021,PMC8626464,,10.1038/s41598-021-02040-5
34836179,APOE ɛ4 Is Associated with Postprandial Inflammation in Older Adults with Metabolic Syndrome Traits,"Schönknecht YB, Crommen S, Stoffel-Wagner B, Coenen M, Fimmers R, Stehle P, Ramirez A, Egert S.",Nutrients. 2021 Nov 2;13(11):3924. doi: 10.3390/nu13113924.,Schönknecht YB,Nutrients,2021,27-11-2021,PMC8624753,,10.3390/nu13113924
34836000,"Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease","Jayatunga DPW, Hone E, Khaira H, Lunelli T, Singh H, Guillemin GJ, Fernando B, Garg ML, Verdile G, Martins RN.",Nutrients. 2021 Oct 23;13(11):3744. doi: 10.3390/nu13113744.,Jayatunga DPW,Nutrients,2021,27-11-2021,PMC8617978,,10.3390/nu13113744
34835984,Effects of Nutrition on Cognitive Function in Adults with or without Cognitive Impairment: A Systematic Review of Randomized Controlled Clinical Trials,"Gutierrez L, Folch A, Rojas M, Cantero JL, Atienza M, Folch J, Camins A, Ruiz A, Papandreou C, Bulló M.",Nutrients. 2021 Oct 22;13(11):3728. doi: 10.3390/nu13113728.,Gutierrez L,Nutrients,2021,27-11-2021,PMC8621754,,10.3390/nu13113728
34831595,Environmental Substances Associated with Alzheimer's Disease-A Scoping Review,"Elonheimo HM, Andersen HR, Katsonouri A, Tolonen H.",Int J Environ Res Public Health. 2021 Nov 11;18(22):11839. doi: 10.3390/ijerph182211839.,Elonheimo HM,Int J Environ Res Public Health,2021,27-11-2021,PMC8622417,,10.3390/ijerph182211839
34830352,Digging Deeper: Advancements in Visualization of Inhibitory Synapses in Neurodegenerative Disorders,"Radulović S, Sunkara S, Maurer C, Leitinger G.",Int J Mol Sci. 2021 Nov 18;22(22):12470. doi: 10.3390/ijms222212470.,Radulović S,Int J Mol Sci,2021,27-11-2021,PMC8623765,,10.3390/ijms222212470
34830337,Significance of GABA(A) Receptor for Cognitive Function and Hippocampal Pathology,"Sakimoto Y, Oo PM, Goshima M, Kanehisa I, Tsukada Y, Mitsushima D.",Int J Mol Sci. 2021 Nov 18;22(22):12456. doi: 10.3390/ijms222212456.,Sakimoto Y,Int J Mol Sci,2021,27-11-2021,PMC8623595,,10.3390/ijms222212456
34830192,Alzheimer's Disease and Type 2 Diabetes Mellitus: The Use of MCT Oil and a Ketogenic Diet,"Takeishi J, Tatewaki Y, Nakase T, Takano Y, Tomita N, Yamamoto S, Mutoh T, Taki Y.",Int J Mol Sci. 2021 Nov 15;22(22):12310. doi: 10.3390/ijms222212310.,Takeishi J,Int J Mol Sci,2021,27-11-2021,PMC8624628,,10.3390/ijms222212310
34830148,Phytosterols: Potential Metabolic Modulators in Neurodegenerative Diseases,"Sharma N, Tan MA, An SSA.",Int J Mol Sci. 2021 Nov 12;22(22):12255. doi: 10.3390/ijms222212255.,Sharma N,Int J Mol Sci,2021,27-11-2021,PMC8618769,,10.3390/ijms222212255
34830074,Metals in ALS TDP-43 Pathology,"Koski L, Ronnevi C, Berntsson E, Wärmländer SKTS, Roos PM.",Int J Mol Sci. 2021 Nov 11;22(22):12193. doi: 10.3390/ijms222212193.,Koski L,Int J Mol Sci,2021,27-11-2021,PMC8622279,,10.3390/ijms222212193
34828439,Dyrk1a from Gene Function in Development and Physiology to Dosage Correction across Life Span in Down Syndrome,"Atas-Ozcan H, Brault V, Duchon A, Herault Y.",Genes (Basel). 2021 Nov 20;12(11):1833. doi: 10.3390/genes12111833.,Atas-Ozcan H,Genes (Basel),2021,27-11-2021,PMC8624927,,10.3390/genes12111833
34827714,D-Amino Acids and D-Amino Acid-Containing Peptides: Potential Disease Biomarkers and Therapeutic Targets?,"Abdulbagi M, Wang L, Siddig O, Di B, Li B.",Biomolecules. 2021 Nov 18;11(11):1716. doi: 10.3390/biom11111716.,Abdulbagi M,Biomolecules,2021,27-11-2021,PMC8615943,,10.3390/biom11111716
34825873,"Curcumin, Resveratrol and Cannabidiol as Natural Key Prototypes in Drug Design for Neuroprotective Agents","Viegas FPD, Gontijo VS, de Freitas Silva M, Ortiz CJC, Dos Reis Rosa Franco G, Ernesto JT, Damasio CM, Silva IMF, Campos TG, Viegas C.",Curr Neuropharmacol. 2022;20(7):1297-1328. doi: 10.2174/1570159X19666210712152532.,Viegas FPD,Curr Neuropharmacol,2022,26-11-2021,PMC9881080,,10.2174/1570159X19666210712152532
34822784,From structure to clinic: Design of a muscarinic M1 receptor agonist with potential to treatment of Alzheimer's disease,"Brown AJH, Bradley SJ, Marshall FH, Brown GA, Bennett KA, Brown J, Cansfield JE, Cross DM, de Graaf C, Hudson BD, Dwomoh L, Dias JM, Errey JC, Hurrell E, Liptrot J, Mattedi G, Molloy C, Nathan PJ, Okrasa K, Osborne G, Patel JC, Pickworth M, Robertson N, Shahabi S, Bundgaard C, Phillips K, Broad LM, Goonawardena AV, Morairty SR, Browning M, Perini F, Dawson GR, Deakin JFW, Smith RT, Sexton PM, Warneck J, Vinson M, Tasker T, Tehan BG, Teobald B, Christopoulos A, Langmead CJ, Jazayeri A, Cooke RM, Rucktooa P, Congreve MS, Weir M, Tobin AB.",Cell. 2021 Nov 24;184(24):5886-5901.e22. doi: 10.1016/j.cell.2021.11.001.,Brown AJH,Cell,2021,25-11-2021,PMC7616177,EMS197030,10.1016/j.cell.2021.11.001
34818648,Traumatic Brain Injury and Risk of Dementia and Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Gu D, Ou S, Liu G.",Neuroepidemiology. 2022;56(1):4-16. doi: 10.1159/000520966. Epub 2021 Nov 24.,Gu D,Neuroepidemiology,2022,24-11-2021,,,10.1159/000520966
34816433,Psychedelic-inspired approaches for treating neurodegenerative disorders,"Saeger HN, Olson DE.",J Neurochem. 2022 Jul;162(1):109-127. doi: 10.1111/jnc.15544. Epub 2021 Dec 5.,Saeger HN,J Neurochem,2022,24-11-2021,PMC9126991,NIHMS1759083,10.1111/jnc.15544
34807243,Amyloid-Related Imaging Abnormalities in 2 Phase 3 Studies Evaluating Aducanumab in Patients With Early Alzheimer Disease,"Salloway S, Chalkias S, Barkhof F, Burkett P, Barakos J, Purcell D, Suhy J, Forrestal F, Tian Y, Umans K, Wang G, Singhal P, Budd Haeberlein S, Smirnakis K.",JAMA Neurol. 2022 Jan 1;79(1):13-21. doi: 10.1001/jamaneurol.2021.4161.,Salloway S,JAMA Neurol,2022,22-11-2021,PMC8609465,,10.1001/jamaneurol.2021.4161
34798299,Formaldehyde toxicity in age-related neurological dementia,"Kou Y, Zhao H, Cui D, Han H, Tong Z.",Ageing Res Rev. 2022 Jan;73:101512. doi: 10.1016/j.arr.2021.101512. Epub 2021 Nov 17.,Kou Y,Ageing Res Rev,2022,19-11-2021,,,10.1016/j.arr.2021.101512
34797294,"Acupuncture for amnestic mild cognitive impairment: A pilot multicenter, randomized, parallel controlled trial","Zhang J, Kuang X, Tang C, Xu N, Xiao S, Xiao L, Wang S, Dong Y, Lu L, Zhang L.",Medicine (Baltimore). 2021 Nov 19;100(46):e27686. doi: 10.1097/MD.0000000000027686.,Zhang J,Medicine (Baltimore),2021,19-11-2021,PMC8601273,,10.1097/MD.0000000000027686
34791571,Plasma exchange with albumin replacement and disease progression in amyotrophic lateral sclerosis: a pilot study,"Povedano M, Paipa A, Barceló M, Woodward MK, Ortega S, Domínguez R, Aragonés ME, Horrillo R, Costa M, Páez A.",Neurol Sci. 2022 May;43(5):3211-3221. doi: 10.1007/s10072-021-05723-z. Epub 2021 Nov 18.,Povedano M,Neurol Sci,2022,18-11-2021,PMC9018657,,10.1007/s10072-021-05723-z
34786815,"Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)","Pajewski NM, Elahi FM, Tamura MK, Hinman JD, Nasrallah IM, Ix JH, Miller LM, Launer LJ, Wright CB, Supiano MA, Lerner AJ, Sudduth TL, Killeen AA, Cheung AK, Reboussin DM, Wilcock DM, Williamson JD.",Alzheimers Dement. 2022 Aug;18(8):1472-1483. doi: 10.1002/alz.12496. Epub 2021 Nov 17.,Pajewski NM,Alzheimers Dement,2022,17-11-2021,PMC9110563,NIHMS1743025,10.1002/alz.12496
34786698,Using smartphone technology to improve prospective memory functioning: A randomized controlled trial,"Scullin MK, Jones WE, Phenis R, Beevers S, Rosen S, Dinh K, Kiselica A, Keefe FJ, Benge JF.",J Am Geriatr Soc. 2022 Feb;70(2):459-469. doi: 10.1111/jgs.17551. Epub 2021 Nov 17.,Scullin MK,J Am Geriatr Soc,2022,17-11-2021,PMC8821124,NIHMS1752065,10.1111/jgs.17551
34780067,Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery,"Legg LA, Rudberg AS, Hua X, Wu S, Hackett ML, Tilney R, Lindgren L, Kutlubaev MA, Hsieh CF, Barugh AJ, Hankey GJ, Lundström E, Dennis M, Mead GE.",Cochrane Database Syst Rev. 2021 Nov 15;11(11):CD009286. doi: 10.1002/14651858.CD009286.pub4.,Legg LA,Cochrane Database Syst Rev,2021,15-11-2021,PMC8592088,,10.1002/14651858.CD009286.pub4
34776442,Partnering a Compensatory Application with Activity-Aware Prompting to Improve Use in Individuals with Amnestic Mild Cognitive Impairment: A Randomized Controlled Pilot Clinical Trial,"Schmitter-Edgecombe M, Brown K, Luna C, Chilton R, Sumida CA, Holder L, Cook D.",J Alzheimers Dis. 2022;85(1):73-90. doi: 10.3233/JAD-215022.,Schmitter-Edgecombe M,J Alzheimers Dis,2022,15-11-2021,PMC9922794,NIHMS1868610,10.3233/JAD-215022
34770864,Neuroprotective Potential of Chrysin: Mechanistic Insights and Therapeutic Potential for Neurological Disorders,"Mishra A, Mishra PS, Bandopadhyay R, Khurana N, Angelopoulou E, Paudel YN, Piperi C.",Molecules. 2021 Oct 26;26(21):6456. doi: 10.3390/molecules26216456.,Mishra A,Molecules,2021,13-11-2021,PMC8588021,,10.3390/molecules26216456
34770789,Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives,"Ciccone L, Cerri C, Nencetti S, Orlandini E.",Molecules. 2021 Oct 22;26(21):6380. doi: 10.3390/molecules26216380.,Ciccone L,Molecules,2021,13-11-2021,PMC8588504,,10.3390/molecules26216380
34769364,Alzheimer's Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound,"He Z, You G, Liu Q, Li N.",Int J Mol Sci. 2021 Nov 3;22(21):11931. doi: 10.3390/ijms222111931.,He Z,Int J Mol Sci,2021,13-11-2021,PMC8584792,,10.3390/ijms222111931
34769257,Why Have the Benefits of DHA Not Been Borne Out in the Treatment and Prevention of Alzheimer's Disease? A Narrative Review Focused on DHA Metabolism and Adipose Tissue,"Heath RJ, Wood TR.",Int J Mol Sci. 2021 Oct 31;22(21):11826. doi: 10.3390/ijms222111826.,Heath RJ,Int J Mol Sci,2021,13-11-2021,PMC8584218,,10.3390/ijms222111826
34769082,Nanoparticles for Targeted Brain Drug Delivery: What Do We Know?,"Pinheiro RGR, Coutinho AJ, Pinheiro M, Neves AR.",Int J Mol Sci. 2021 Oct 28;22(21):11654. doi: 10.3390/ijms222111654.,Pinheiro RGR,Int J Mol Sci,2021,13-11-2021,PMC8584083,,10.3390/ijms222111654
34765631,An Interactive Review on the Role of Tocotrienols in the Neurodegenerative Disorders,"Naomi R, Shafie NH, Kaniappan P, Bahari H.",Front Nutr. 2021 Oct 26;8:754086. doi: 10.3389/fnut.2021.754086. eCollection 2021.,Naomi R,Front Nutr,2021,12-11-2021,PMC8576197,,10.3389/fnut.2021.754086
34764859,Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Mild Cognitive Impairment: A Meta-Analysis of Randomized Controlled Trials,"Zhang X, Lan X, Chen C, Ren H, Guo Y.",Front Hum Neurosci. 2021 Oct 26;15:723715. doi: 10.3389/fnhum.2021.723715. eCollection 2021.,Zhang X,Front Hum Neurosci,2021,12-11-2021,PMC8576192,,10.3389/fnhum.2021.723715
34763080,Randomized Controlled Trial of a Cognitive Intervention to Improve Memory in Heart Failure,"Pressler SJ, Jung M, Gradus-Pizlo I, Titler MG, Smith DG, Gao S, Lake KR, Burney H, Clark DG, Wierenga KL, Dorsey SG, Giordani B.",J Card Fail. 2022 Apr;28(4):519-530. doi: 10.1016/j.cardfail.2021.10.008. Epub 2021 Nov 8.,Pressler SJ,J Card Fail,2022,11-11-2021,PMC9018491,NIHMS1764230,10.1016/j.cardfail.2021.10.008
34758073,The Effect of Low-Dose Aspirin on Frailty Phenotype and Frailty Index in Community-Dwelling Older Adults in the ASPirin in Reducing Events in the Elderly Study,"Espinoza SE, Woods RL, Ekram ARMS, Ernst ME, Polekhina G, Wolfe R, Shah RC, Ward SA, Storey E, Nelson MR, Reid CM, Lockery JE, Orchard SG, Trevaks R, Fitzgerald SM, Stocks NP, Chan A, McNeil JJ, Murray AM, Newman AB, Ryan J.",J Gerontol A Biol Sci Med Sci. 2022 Oct 6;77(10):2007-2014. doi: 10.1093/gerona/glab340.,Espinoza SE,J Gerontol A Biol Sci Med Sci,2022,10-11-2021,PMC9536436,,10.1093/gerona/glab340
34756133,Non-coding RNAs and their bioengineering applications for neurological diseases,"Das T, Das TK, Khodarkovskaya A, Dash S.",Bioengineered. 2021 Dec;12(2):11675-11698. doi: 10.1080/21655979.2021.2003667.,Das T,Bioengineered,2021,10-11-2021,PMC8810045,,10.1080/21655979.2021.2003667
34752934,Accelerated intermittent theta-burst stimulation broadly ameliorates symptoms and cognition in Alzheimer's disease: A randomized controlled trial,"Wu X, Ji GJ, Geng Z, Wang L, Yan Y, Wu Y, Xiao G, Gao L, Wei Q, Zhou S, Wei L, Tian Y, Wang K.",Brain Stimul. 2022 Jan-Feb;15(1):35-45. doi: 10.1016/j.brs.2021.11.007. Epub 2021 Nov 6.,Wu X,Brain Stimul,2022,09-11-2021,,,10.1016/j.brs.2021.11.007
34751120,Advances in PPARs Molecular Dynamics and Glitazones as a Repurposing Therapeutic Strategy through Mitochondrial Redox Dynamics against Neurodegeneration,"Durai P, Beeraka NM, Ramachandrappa HVP, Krishnan P, Gudur P, Raghavendra NM, Ravanappa PKB.",Curr Neuropharmacol. 2022;20(5):893-915. doi: 10.2174/1570159X19666211109141330.,Durai P,Curr Neuropharmacol,2022,09-11-2021,PMC9881103,,10.2174/1570159X19666211109141330
34748789,Mitochondrial iron metabolism and neurodegenerative diseases,"Cheng R, Dhorajia VV, Kim J, Kim Y.",Neurotoxicology. 2022 Jan;88:88-101. doi: 10.1016/j.neuro.2021.11.003. Epub 2021 Nov 5.,Cheng R,Neurotoxicology,2022,08-11-2021,PMC8748425,NIHMS1757134,10.1016/j.neuro.2021.11.003
34732465,Early lowering of blood pressure after acute intracerebral haemorrhage: a systematic review and meta-analysis of individual patient data,"Moullaali TJ, Wang X, Sandset EC, Woodhouse LJ, Law ZK, Arima H, Butcher KS, Chalmers J, Delcourt C, Edwards L, Gupta S, Jiang W, Koch S, Potter J, Qureshi AI, Robinson TG, Al-Shahi Salman R, Saver JL, Sprigg N, Wardlaw JM, Anderson CS, Bath PM; Blood Pressure in Acute Stroke (BASC) Investigators.",J Neurol Neurosurg Psychiatry. 2022 Jan;93(1):6-13. doi: 10.1136/jnnp-2021-327195. Epub 2021 Nov 3.,Moullaali TJ,J Neurol Neurosurg Psychiatry,2022,04-11-2021,PMC8685661,,10.1136/jnnp-2021-327195
34726348,"Neuropsychological, neuropsychiatric, and quality-of-life assessments in Alzheimer's disease patients treated with plasma exchange with albumin replacement from the randomized AMBAR study","Boada M, López OL, Olazarán J, Núñez L, Pfeffer M, Puente O, Piñol-Ripoll G, Gámez JE, Anaya F, Kiprov D, Alegret M, Grifols C, Barceló M, Bozzo J, Szczepiorkowski ZM, Páez A; AMBAR Trial Group.",Alzheimers Dement. 2022 Jul;18(7):1314-1324. doi: 10.1002/alz.12477. Epub 2021 Nov 2.,Boada M,Alzheimers Dement,2022,02-11-2021,PMC9540900,,10.1002/alz.12477
34724257,Diffusion Magnetic Resonance Imaging Detects Progression in Parkinson's Disease: A Placebo-Controlled Trial of Rasagiline,"Arpin DJ, Mitchell T, Archer DB, Burciu RG, Chu WT, Gao H, Guttuso T, Hess CW, Lai S, Malaty IA, McFarland NR, Pasternak O, Price CC, Shukla AW, Wu SS, Okun MS, Vaillancourt DE.",Mov Disord. 2022 Feb;37(2):325-333. doi: 10.1002/mds.28838. Epub 2021 Nov 1.,Arpin DJ,Mov Disord,2022,01-11-2021,PMC9019575,NIHMS1795149,10.1002/mds.28838
34748298,Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT,"Kehoe PG, Turner N, Howden B, Jarutyt L, Clegg SL, Malone IB, Barnes J, Nielsen C, Sudre CH, Wilson A, Thai NJ, Blair PS, Coulthard EJ, Lane JA, Passmore P, Taylor J, Mutsaerts HJ, Thomas DL, Fox NC, Wilkinson I, Ben-Shlomo Y.",Southampton (UK): NIHR Journals Library; 2021 Nov.,Kehoe PG,Losartan to slow the progression of mild-to-moderate Alzheimer’s disease through angiotensin targeting: the RADAR RCT,2021,01-11-2021,,,10.3310/eme08190
34716744,Mortality risk in chronic Chagas cardiomyopathy: a systematic review and meta-analysis,"Chadalawada S, Rassi A Jr, Samara O, Monzon A, Gudapati D, Vargas Barahona L, Hyson P, Sillau S, Mestroni L, Taylor M, da Consolação Vieira Moreira M, DeSanto K, Agudelo Higuita NI, Franco-Paredes C, Henao-Martínez AF.",ESC Heart Fail. 2021 Dec;8(6):5466-5481. doi: 10.1002/ehf2.13648. Epub 2021 Oct 30.,Chadalawada S,ESC Heart Fail,2021,30-10-2021,PMC8712892,,10.1002/ehf2.13648
34709529,Cognitive Functioning and Health in Hispanic/Latina Breast Cancer Survivors,"Marín-Chollom AM, Hale C, Koch P, Gaffney AO, Contento I, Shen H, Hershman DL, Brickman AM, Greenlee H.",J Immigr Minor Health. 2022 Jun;24(3):597-604. doi: 10.1007/s10903-021-01300-w. Epub 2021 Oct 28.,Marín-Chollom AM,J Immigr Minor Health,2022,28-10-2021,PMC9046461,NIHMS1759371,10.1007/s10903-021-01300-w
34702870,Analysis of whole exome sequencing in severe mental illness hints at selection of brain development and immune related genes,"Mahadevan J, Pathak AK, Vemula A, Nadella RK, Viswanath B, Jain S; Accelerator Program for Discovery in Brain disorders using Stem cells (ADBS) Consortium; Purushottam M, Mondal M.",Sci Rep. 2021 Oct 26;11(1):21088. doi: 10.1038/s41598-021-00123-x.,Mahadevan J,Sci Rep,2021,27-10-2021,PMC8548332,,10.1038/s41598-021-00123-x
34702069,Axonal Injury Partially Mediates Associations Between Increased Left Ventricular Mass Index and White Matter Damage,"Moore EE, Khan OA, Shashikumar N, Pechman KR, Liu D, Bell SP, Nair S, Terry JG, Gifford KA, Anderson AW, Landman BA, Blennow K, Zetterberg H, Hohman TJ, Carr JJ, Jefferson AL.",Stroke. 2022 Mar;53(3):808-816. doi: 10.1161/STROKEAHA.121.034349. Epub 2021 Oct 27.,Moore EE,Stroke,2022,27-10-2021,PMC8885768,NIHMS1745390,10.1161/STROKEAHA.121.034349
34697913,"Population pharmacokinetics and standard uptake value ratio of aducanumab, an amyloid plaque-removing agent, in patients with Alzheimer's disease","Kandadi Muralidharan K, Tong X, Kowalski KG, Rajagovindan R, Lin L, Budd Haberlain S, Nestorov I.",CPT Pharmacometrics Syst Pharmacol. 2022 Jan;11(1):7-19. doi: 10.1002/psp4.12728. Epub 2021 Oct 26.,Kandadi Muralidharan K,CPT Pharmacometrics Syst Pharmacol,2022,26-10-2021,PMC8752104,,10.1002/psp4.12728
34694325,FDA Drug Approval and the Ethics of Desperation,"Largent EA, Peterson A, Lynch HF.",JAMA Intern Med. 2021 Dec 1;181(12):1555-1556. doi: 10.1001/jamainternmed.2021.6045.,Largent EA,JAMA Intern Med,2021,25-10-2021,PMC8649053,NIHMS1751070,10.1001/jamainternmed.2021.6045
34688369,"Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial","Banerjee S, High J, Stirling S, Shepstone L, Swart AM, Telling T, Henderson C, Ballard C, Bentham P, Burns A, Farina N, Fox C, Francis P, Howard R, Knapp M, Leroi I, Livingston G, Nilforooshan R, Nurock S, O'Brien J, Price A, Thomas AJ, Tabet N.",Lancet. 2021 Oct 23;398(10310):1487-1497. doi: 10.1016/S0140-6736(21)01210-1.,Banerjee S,Lancet,2021,24-10-2021,PMC8546216,,10.1016/S0140-6736(21)01210-1
34687726,A geroscience motivated approach to treat Alzheimer's disease: Senolytics move to clinical trials,"Gonzales MM, Krishnamurthy S, Garbarino V, Daeihagh AS, Gillispie GJ, Deep G, Craft S, Orr ME.",Mech Ageing Dev. 2021 Dec;200:111589. doi: 10.1016/j.mad.2021.111589. Epub 2021 Oct 21.,Gonzales MM,Mech Ageing Dev,2021,23-10-2021,PMC9059898,NIHMS1797561,10.1016/j.mad.2021.111589
34687634,"Safety and efficacy of losartan for the reduction of brain atrophy in clinically diagnosed Alzheimer's disease (the RADAR trial): a double-blind, randomised, placebo-controlled, phase 2 trial","Kehoe PG, Turner N, Howden B, Jarutyte L, Clegg SL, Malone IB, Barnes J, Nielsen C, Sudre CH, Wilson A, Thai NJ, Blair PS, Coulthard E, Lane JA, Passmore P, Taylor J, Mutsaerts HJ, Thomas DL, Fox NC, Wilkinson I, Ben-Shlomo Y; RADAR investigators.",Lancet Neurol. 2021 Nov;20(11):895-906. doi: 10.1016/S1474-4422(21)00263-5.,Kehoe PG,Lancet Neurol,2021,23-10-2021,PMC8528717,,10.1016/S1474-4422(21)00263-5
34685633,Ferulic Acid in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies,"Wang EJ, Wu MY, Lu JH.",Cells. 2021 Oct 5;10(10):2653. doi: 10.3390/cells10102653.,Wang EJ,Cells,2021,23-10-2021,PMC8534433,,10.3390/cells10102653
34684833,"Phytochemistry, Ethnopharmacological Uses, Biological Activities, and Therapeutic Applications of Cassia obtusifolia L.: A Comprehensive Review","Ali MY, Park S, Chang M.",Molecules. 2021 Oct 15;26(20):6252. doi: 10.3390/molecules26206252.,Ali MY,Molecules,2021,23-10-2021,PMC8538231,,10.3390/molecules26206252
34680155,Hyperbaric Oxygen Treatment-From Mechanisms to Cognitive Improvement,"Gottfried I, Schottlender N, Ashery U.",Biomolecules. 2021 Oct 15;11(10):1520. doi: 10.3390/biom11101520.,Gottfried I,Biomolecules,2021,23-10-2021,PMC8533945,,10.3390/biom11101520
34680044,A Proteomic View of Cellular and Molecular Effects of Cannabis,"Abyadeh M, Gupta V, Paulo JA, Gupta V, Chitranshi N, Godinez A, Saks D, Hasan M, Amirkhani A, McKay M, Salekdeh GH, Haynes PA, Graham SL, Mirzaei M.",Biomolecules. 2021 Sep 27;11(10):1411. doi: 10.3390/biom11101411.,Abyadeh M,Biomolecules,2021,23-10-2021,PMC8533448,,10.3390/biom11101411
34680041,Inhibition of Astrocytic Histamine N-Methyltransferase as a Possible Target for the Treatment of Alzheimer's Disease,"Flores-Clemente C, Nicolás-Vázquez MI, Mera Jiménez E, Hernández-Rodríguez M.",Biomolecules. 2021 Sep 26;11(10):1408. doi: 10.3390/biom11101408.,Flores-Clemente C,Biomolecules,2021,23-10-2021,PMC8533269,,10.3390/biom11101408
34673821,Mortality in association with antipsychotic medication use and clinical outcomes among geriatric psychiatry outpatients with COVID-19,"Austria B, Haque R, Mittal S, Scott J, Vengassery A, Maltz D, Li W, Greenwald B, Freudenberg-Hua Y.",PLoS One. 2021 Oct 21;16(10):e0258916. doi: 10.1371/journal.pone.0258916. eCollection 2021.,Austria B,PLoS One,2021,21-10-2021,PMC8530340,,10.1371/journal.pone.0258916
34670217,Association between Serum Prolactin Levels and Neurodegenerative Diseases: Systematic Review and Meta-Analysis,"Duc Nguyen H, Hoang NMH, Ko M, Seo D, Kim S, Jo WH, Bae JW, Kim MS.",Neuroimmunomodulation. 2022;29(2):85-96. doi: 10.1159/000519552. Epub 2021 Oct 20.,Duc Nguyen H,Neuroimmunomodulation,2022,20-10-2021,,,10.1159/000519552
34664858,"Investigation of combined treatment of acupuncture and neurofeedback for improving cognitive function in mild neurocognitive disorder: A randomized, assessor-blind, pilot study","Jeong JH, Jung C, Kim J, Kim JY, Kim HS, Park YC, Lee JH, Jung IC.",Medicine (Baltimore). 2021 Sep 17;100(37):e27218. doi: 10.1097/MD.0000000000027218.,Jeong JH,Medicine (Baltimore),2021,19-10-2021,PMC8448021,,10.1097/MD.0000000000027218
34659987,Melatonin in Traumatic Brain Injury and Cognition,"Blum B, Kaushal S, Khan S, Kim JH, Alvarez Villalba CL.",Cureus. 2021 Sep 6;13(9):e17776. doi: 10.7759/cureus.17776. eCollection 2021 Sep.,Blum B,Cureus,2021,18-10-2021,PMC8494149,,10.7759/cureus.17776
34657288,The penalty of stress - Epichaperomes negatively reshaping the brain in neurodegenerative disorders,"Ginsberg SD, Joshi S, Sharma S, Guzman G, Wang T, Arancio O, Chiosis G.",J Neurochem. 2021 Dec;159(6):958-979. doi: 10.1111/jnc.15525. Epub 2021 Oct 31.,Ginsberg SD,J Neurochem,2021,17-10-2021,PMC8688321,NIHMS1752268,10.1111/jnc.15525
34647685,Brain energy failure in dementia syndromes: Opportunities and challenges for glucagon-like peptide-1 receptor agonists,"Yassine HN, Solomon V, Thakral A, Sheikh-Bahaei N, Chui HC, Braskie MN, Schneider LS, Talbot K.",Alzheimers Dement. 2022 Mar;18(3):478-497. doi: 10.1002/alz.12474. Epub 2021 Oct 14.,Yassine HN,Alzheimers Dement,2022,14-10-2021,PMC8940606,NIHMS1734469,10.1002/alz.12474
34647482,Implications of the COVID-19 Pandemic on Adult Day Services and the Families They Serve,"Parker LJ, Marx K, Gaugler JE, Gitlin LN.",Am J Alzheimers Dis Other Demen. 2021 Jan-Dec;36:15333175211050152. doi: 10.1177/15333175211050152.,Parker LJ,Am J Alzheimers Dis Other Demen,2021,14-10-2021,PMC8745481,NIHMS1761314,10.1177/15333175211050152
34645914,Cerebrospinal fluid markers for synaptic function and Alzheimer type changes in late life depression,"Siafarikas N, Kirsebom BE, Srivastava DP, Eriksson CM, Auning E, Hessen E, Selbaek G, Blennow K, Aarsland D, Fladby T.",Sci Rep. 2021 Oct 13;11(1):20375. doi: 10.1038/s41598-021-99794-9.,Siafarikas N,Sci Rep,2021,14-10-2021,PMC8514484,,10.1038/s41598-021-99794-9
34641529,"The Neuroprotective Role of Polydatin: Neuropharmacological Mechanisms, Molecular Targets, Therapeutic Potentials, and Clinical Perspective","Fakhri S, Gravandi MM, Abdian S, Akkol EK, Farzaei MH, Sobarzo-Sánchez E.",Molecules. 2021 Oct 2;26(19):5985. doi: 10.3390/molecules26195985.,Fakhri S,Molecules,2021,13-10-2021,PMC8513080,,10.3390/molecules26195985
34639140,An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure,"Boopathi S, Poma AB, Garduño-Juárez R.",Int J Mol Sci. 2021 Oct 6;22(19):10798. doi: 10.3390/ijms221910798.,Boopathi S,Int J Mol Sci,2021,13-10-2021,PMC8509255,,10.3390/ijms221910798
34639120,Neuroendocrine Effects of Carnitines on Reproductive Impairments,"Petrillo T, Battipaglia C, Virmani MA, Genazzani AR, Genazzani AD.",Int J Mol Sci. 2021 Oct 5;22(19):10781. doi: 10.3390/ijms221910781.,Petrillo T,Int J Mol Sci,2021,13-10-2021,PMC8509461,,10.3390/ijms221910781
34636299,Computer Aided Drug Design Methodologies with Natural Products in the Drug Research Against Alzheimer's Disease,"de Sousa NF, Scotti L, de Moura ÉP, Dos Santos Maia M, Rodrigues GCS, de Medeiros HIR, Lopes SM, Scotti MT.",Curr Neuropharmacol. 2022;20(5):857-885. doi: 10.2174/1570159X19666211005145952.,de Sousa NF,Curr Neuropharmacol,2022,12-10-2021,PMC9881095,,10.2174/1570159X19666211005145952
34635802,"The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer's disease: a randomized, triple-blind, placebo-controlled trial","Louzada LL, Machado FV, Quintas JL, Ribeiro GA, Silva MV, Mendonça-Silva DL, Gonçalves BSB, Nóbrega OT, Camargos EF.",Neuropsychopharmacology. 2022 Jan;47(2):570-579. doi: 10.1038/s41386-021-01191-3. Epub 2021 Oct 11.,Louzada LL,Neuropsychopharmacology,2022,12-10-2021,PMC8674235,,10.1038/s41386-021-01191-3
34635167,Multidomain interventions: state-of-the-art and future directions for protocols to implement precision dementia risk reduction. A user manual for Brain Health Services-part 4 of 6,"Solomon A, Stephen R, Altomare D, Carrera E, Frisoni GB, Kulmala J, Molinuevo JL, Nilsson P, Ngandu T, Ribaldi F, Vellas B, Scheltens P, Kivipelto M; European Task Force for Brain Health Services.",Alzheimers Res Ther. 2021 Oct 11;13(1):171. doi: 10.1186/s13195-021-00875-8.,Solomon A,Alzheimers Res Ther,2021,12-10-2021,PMC8507202,,10.1186/s13195-021-00875-8
34634603,New trends in pharmacological control of neuropsychiatric symptoms of dementia,"Scuteri D, Corasaniti MT, Tonin P, Nicotera P, Bagetta G.",Curr Opin Pharmacol. 2021 Dec;61:69-76. doi: 10.1016/j.coph.2021.09.002. Epub 2021 Oct 9.,Scuteri D,Curr Opin Pharmacol,2021,11-10-2021,,,10.1016/j.coph.2021.09.002
34633054,"Mental depression: Relation to different disease status, newer treatments and its association with COVID-19 pandemic (Review)","Abdel-Bakky MS, Amin E, Faris TM, Abdellatif AAH.",Mol Med Rep. 2021 Dec;24(6):839. doi: 10.3892/mmr.2021.12479. Epub 2021 Oct 11.,Abdel-Bakky MS,Mol Med Rep,2021,11-10-2021,PMC8524409,,10.3892/mmr.2021.12479
34623437,Membrane lipid raft homeostasis is directly linked to neurodegeneration,"Moll T, Marshall JNG, Soni N, Zhang S, Cooper-Knock J, Shaw PJ.",Essays Biochem. 2021 Dec 22;65(7):999-1011. doi: 10.1042/EBC20210026.,Moll T,Essays Biochem,2021,08-10-2021,PMC8709890,,10.1042/EBC20210026
34622228,Levels of circulating semaglutide determine reductions in HbA1c and body weight in people with type 2 diabetes,"Overgaard RV, Hertz CL, Ingwersen SH, Navarria A, Drucker DJ.",Cell Rep Med. 2021 Sep 3;2(9):100387. doi: 10.1016/j.xcrm.2021.100387. eCollection 2021 Sep 21.,Overgaard RV,Cell Rep Med,2021,08-10-2021,PMC8484505,,10.1016/j.xcrm.2021.100387
34620151,"Efficacy and safety of Kami-guibi-tang for mild cognitive impairment: a pilot, randomized, double-blind, placebo-controlled trial","Shin HY, Kim HR, Jahng GH, Jin C, Kwon S, Cho SY, Park SU, Jung WS, Moon SK, Ko CN, Park JM.",BMC Complement Med Ther. 2021 Oct 7;21(1):251. doi: 10.1186/s12906-021-03428-6.,Shin HY,BMC Complement Med Ther,2021,08-10-2021,PMC8495912,,10.1186/s12906-021-03428-6
34618817,Biomarkers of neurodegeneration and glial activation validated in Alzheimer's disease assessed in longitudinal cerebrospinal fluid samples of Parkinson's disease,"Bartl M, Dakna M, Galasko D, Hutten SJ, Foroud T, Quan M, Marek K, Siderowf A, Franz J, Trenkwalder C, Mollenhauer B; Parkinson’s Progression Markers Initiative.",PLoS One. 2021 Oct 7;16(10):e0257372. doi: 10.1371/journal.pone.0257372. eCollection 2021.,Bartl M,PLoS One,2021,07-10-2021,PMC8496858,,10.1371/journal.pone.0257372
34612190,Properties of the Cognitive Function Battery for the MIND Diet Intervention to Prevent Alzheimer's Disease,"Krueger KR, Dhana K, Aggarwal NT, Arfanakis K, Carey VJ, Sacks FM, Barnes LL.",J Int Neuropsychol Soc. 2022 Sep;28(8):790-797. doi: 10.1017/S1355617721001089. Epub 2021 Oct 6.,Krueger KR,J Int Neuropsychol Soc,2022,06-10-2021,PMC8983783,NIHMS1729384,10.1017/S1355617721001089
34609083,Immunomodulation induced by central nervous system-related peptides as a therapeutic strategy for neurodegenerative disorders,"Palumbo ML, Moroni AD, Quiroga S, Castro MM, Burgueño AL, Genaro AM.",Pharmacol Res Perspect. 2021 Oct;9(5):e00795. doi: 10.1002/prp2.795.,Palumbo ML,Pharmacol Res Perspect,2021,05-10-2021,PMC8491457,,10.1002/prp2.795
34607104,Mechanistic role of boswellic acids in Alzheimer's disease: Emphasis on anti-inflammatory properties,"Siddiqui A, Shah Z, Jahan RN, Othman I, Kumari Y.",Biomed Pharmacother. 2021 Dec;144:112250. doi: 10.1016/j.biopha.2021.112250. Epub 2021 Oct 1.,Siddiqui A,Biomed Pharmacother,2021,04-10-2021,,,10.1016/j.biopha.2021.112250
34603320,The Impact of Ageing on the CNS Immune Response in Alzheimer's Disease,"Chee SEJ, Solito E.",Front Immunol. 2021 Sep 17;12:738511. doi: 10.3389/fimmu.2021.738511. eCollection 2021.,Chee SEJ,Front Immunol,2021,04-10-2021,PMC8484764,,10.3389/fimmu.2021.738511
34603007,Innate Immune System Activation and Neuroinflammation in Down Syndrome and Neurodegeneration: Therapeutic Targets or Partners?,"Ahmed MM, Johnson NR, Boyd TD, Coughlan C, Chial HJ, Potter H.",Front Aging Neurosci. 2021 Sep 16;13:718426. doi: 10.3389/fnagi.2021.718426. eCollection 2021.,Ahmed MM,Front Aging Neurosci,2021,04-10-2021,PMC8481947,,10.3389/fnagi.2021.718426
34602470,Diet Effects on Cerebrospinal Fluid Amino Acids Levels in Adults with Normal Cognition and Mild Cognitive Impairment,"Russin KJ, Nair KS, Montine TJ, Baker LD, Craft S.",J Alzheimers Dis. 2021;84(2):843-853. doi: 10.3233/JAD-210471.,Russin KJ,J Alzheimers Dis,2021,04-10-2021,PMC8673538,,10.3233/JAD-210471
34595510,"Effectiveness of music therapy for autism spectrum disorder, dementia, depression, insomnia and schizophrenia: update of systematic reviews","Gassner L, Geretsegger M, Mayer-Ferbas J.",Eur J Public Health. 2022 Feb 1;32(1):27-34. doi: 10.1093/eurpub/ckab042.,Gassner L,Eur J Public Health,2022,01-10-2021,PMC8846327,,10.1093/eurpub/ckab042
34590409,Diversity in Alzheimer's disease drug trials: The importance of eligibility criteria,"Franzen S, Smith JE, van den Berg E, Rivera Mindt M, van Bruchem-Visser RL, Abner EL, Schneider LS, Prins ND, Babulal GM, Papma JM.",Alzheimers Dement. 2022 Apr;18(4):810-823. doi: 10.1002/alz.12433. Epub 2021 Sep 30.,Franzen S,Alzheimers Dement,2022,30-09-2021,PMC8964823,NIHMS1775420,10.1002/alz.12433
34589083,Safety and Preliminary Efficacy of a Novel Host-Modulatory Therapy for Reducing Gingival Inflammation,"Hasturk H, Schulte F, Martins M, Sherzai H, Floros C, Cugini M, Chiu CJ, Hardt M, Van Dyke T.",Front Immunol. 2021 Sep 13;12:704163. doi: 10.3389/fimmu.2021.704163. eCollection 2021.,Hasturk H,Front Immunol,2021,30-09-2021,PMC8475270,,10.3389/fimmu.2021.704163
34585229,Immunotherapy for Alzheimer's Disease: Current Scenario and Future Perspectives,"Usman MB, Bhardwaj S, Roychoudhury S, Kumar D, Alexiou A, Kumar P, Ambasta RK, Prasher P, Shukla S, Upadhye V, Khan FA, Awasthi R, Shastri MD, Singh SK, Gupta G, Chellappan DK, Dua K, Jha SK, Ruokolainen J, Kesari KK, Ojha S, Jha NK.",J Prev Alzheimers Dis. 2021;8(4):534-551. doi: 10.14283/jpad.2021.52.,Usman MB,J Prev Alzheimers Dis,2021,29-09-2021,PMC12280796,,10.14283/jpad.2021.52
34585216,The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT),"Costa N, Mounié M, Pagès A, Derumeaux H, Rapp T, Guyonnet S, Coley N, Cantet C, Carrié I, Andrieu S, Molinier L.",J Prev Alzheimers Dis. 2021;8(4):425-435. doi: 10.14283/jpad.2021.47.,Costa N,J Prev Alzheimers Dis,2021,29-09-2021,PMC12280784,,10.14283/jpad.2021.47
34585215,Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging,"Lowe SL, Duggan Evans C, Shcherbinin S, Cheng YJ, Willis BA, Gueorguieva I, Lo AC, Fleisher AS, Dage JL, Ardayfio P, Aguiar G, Ishibai M, Takaichi G, Chua L, Mullins G, Sims JR.",J Prev Alzheimers Dis. 2021;8(4):414-424. doi: 10.14283/jpad.2021.56.,Lowe SL,J Prev Alzheimers Dis,2021,29-09-2021,PMC12280776,,10.14283/jpad.2021.56
34584616,Nano-Derived Therapeutic Formulations with Curcumin in Inflammation-Related Diseases,"Quispe C, Cruz-Martins N, Manca ML, Manconi M, Sytar O, Hudz N, Shanaida M, Kumar M, Taheri Y, Martorell M, Sharifi-Rad J, Pintus G, Cho WC.",Oxid Med Cell Longev. 2021 Sep 15;2021:3149223. doi: 10.1155/2021/3149223. eCollection 2021.,Quispe C,Oxid Med Cell Longev,2021,29-09-2021,PMC8470924,,10.1155/2021/3149223
34580600,Association of Methylenetetrahydrofolate Reductase C677T Gene Polymorphisms with Mild Cognitive Impairment Susceptibility: A Systematic Review and Meta-Analysis,"Sun J, Jiang X, Zhao M, Ma L, Pei H, Liu N, Li H.",Behav Neurol. 2021 Sep 18;2021:2962792. doi: 10.1155/2021/2962792. eCollection 2021.,Sun J,Behav Neurol,2021,28-09-2021,PMC8464412,,10.1155/2021/2962792
34579042,The Effects of Intermittent Fasting on Brain and Cognitive Function,"Gudden J, Arias Vasquez A, Bloemendaal M.",Nutrients. 2021 Sep 10;13(9):3166. doi: 10.3390/nu13093166.,Gudden J,Nutrients,2021,28-09-2021,PMC8470960,,10.3390/nu13093166
34578844,Effects of Supplementation with Folic Acid and Its Combinations with Other Nutrients on Cognitive Impairment and Alzheimer's Disease: A Narrative Review,"Puga AM, Ruperto M, Samaniego-Vaesken ML, Montero-Bravo A, Partearroyo T, Varela-Moreiras G.",Nutrients. 2021 Aug 26;13(9):2966. doi: 10.3390/nu13092966.,Puga AM,Nutrients,2021,28-09-2021,PMC8470370,,10.3390/nu13092966
34577053,Non-Alkaloid Cholinesterase Inhibitory Compounds from Natural Sources,"Tamfu AN, Kucukaydin S, Yeskaliyeva B, Ozturk M, Dinica RM.",Molecules. 2021 Sep 14;26(18):5582. doi: 10.3390/molecules26185582.,Tamfu AN,Molecules,2021,28-09-2021,PMC8472022,,10.3390/molecules26185582
34576912,Cashew Nut Shell Liquid (CNSL) as a Source of Drugs for Alzheimer's Disease,"Uliassi E, de Oliveira AS, de Camargo Nascente L, Romeiro LAS, Bolognesi ML.",Molecules. 2021 Sep 7;26(18):5441. doi: 10.3390/molecules26185441.,Uliassi E,Molecules,2021,28-09-2021,PMC8466601,,10.3390/molecules26185441
34576302,Brain Renin-Angiotensin System as Novel and Potential Therapeutic Target for Alzheimer's Disease,"Loera-Valencia R, Eroli F, Garcia-Ptacek S, Maioli S.",Int J Mol Sci. 2021 Sep 20;22(18):10139. doi: 10.3390/ijms221810139.,Loera-Valencia R,Int J Mol Sci,2021,28-09-2021,PMC8468637,,10.3390/ijms221810139
34576251,Enjoy Carefully: The Multifaceted Role of Vitamin E in Neuro-Nutrition,"Regner-Nelke L, Nelke C, Schroeter CB, Dziewas R, Warnecke T, Ruck T, Meuth SG.",Int J Mol Sci. 2021 Sep 18;22(18):10087. doi: 10.3390/ijms221810087.,Regner-Nelke L,Int J Mol Sci,2021,28-09-2021,PMC8466828,,10.3390/ijms221810087
34575610,Are Parkinson's Disease Patients the Ideal Preclinical Population for Alzheimer's Disease Therapeutics?,"Tropea TF, Chen-Plotkin A.",J Pers Med. 2021 Aug 25;11(9):834. doi: 10.3390/jpm11090834.,Tropea TF,J Pers Med,2021,28-09-2021,PMC8472048,,10.3390/jpm11090834
34572558,The Histaminergic System in Neuropsychiatric Disorders,"Cheng L, Liu J, Chen Z.",Biomolecules. 2021 Sep 11;11(9):1345. doi: 10.3390/biom11091345.,Cheng L,Biomolecules,2021,28-09-2021,PMC8467868,,10.3390/biom11091345
34570180,Effect of Methylphenidate on Apathy in Patients With Alzheimer Disease: The ADMET 2 Randomized Clinical Trial,"Mintzer J, Lanctôt KL, Scherer RW, Rosenberg PB, Herrmann N, van Dyck CH, Padala PR, Brawman-Mintzer O, Porsteinsson AP, Lerner AJ, Craft S, Levey AI, Burke W, Perin J, Shade D; ADMET 2 Research Group.",JAMA Neurol. 2021 Nov 1;78(11):1324-1332. doi: 10.1001/jamaneurol.2021.3356.,Mintzer J,JAMA Neurol,2021,27-09-2021,PMC8477302,,10.1001/jamaneurol.2021.3356
34570177,Effect of Levetiracetam on Cognition in Patients With Alzheimer Disease With and Without Epileptiform Activity: A Randomized Clinical Trial,"Vossel K, Ranasinghe KG, Beagle AJ, La A, Ah Pook K, Castro M, Mizuiri D, Honma SM, Venkateswaran N, Koestler M, Zhang W, Mucke L, Howell MJ, Possin KL, Kramer JH, Boxer AL, Miller BL, Nagarajan SS, Kirsch HE.",JAMA Neurol. 2021 Nov 1;78(11):1345-1354. doi: 10.1001/jamaneurol.2021.3310.,Vossel K,JAMA Neurol,2021,27-09-2021,PMC8477304,,10.1001/jamaneurol.2021.3310
34569950,Investigating Auditory Electrophysiological Measures of Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis of Event-Related Potential Studies,"Tarawneh HY, Mulders WHAM, Sohrabi HR, Martins RN, Jayakody DMP.",J Alzheimers Dis. 2021;84(1):419-448. doi: 10.3233/JAD-210556.,Tarawneh HY,J Alzheimers Dis,2021,27-09-2021,PMC8609695,,10.3233/JAD-210556
34569029,Impact of Pharmacotherapy on Insomnia in Patients with Alzheimer's Disease,"Roland JP, Bliwise DL.",Drugs Aging. 2021 Nov;38(11):951-966. doi: 10.1007/s40266-021-00891-1. Epub 2021 Sep 27.,Roland JP,Drugs Aging,2021,27-09-2021,PMC8593056,,10.1007/s40266-021-00891-1
34568342,Cognitive Enhancement of Repetitive Transcranial Magnetic Stimulation in Patients With Mild Cognitive Impairment and Early Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Xie Y, Li Y, Nie L, Zhang W, Ke Z, Ku Y.",Front Cell Dev Biol. 2021 Sep 10;9:734046. doi: 10.3389/fcell.2021.734046. eCollection 2021.,Xie Y,Front Cell Dev Biol,2021,27-09-2021,PMC8461243,,10.3389/fcell.2021.734046
34562355,Cholesterol-induced toxicity: An integrated view of the role of cholesterol in multiple diseases,"Song Y, Liu J, Zhao K, Gao L, Zhao J.",Cell Metab. 2021 Oct 5;33(10):1911-1925. doi: 10.1016/j.cmet.2021.09.001. Epub 2021 Sep 24.,Song Y,Cell Metab,2021,25-09-2021,,,10.1016/j.cmet.2021.09.001
34561430,Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease,"Schmidt AF, Hunt NB, Gordillo-Marañón M, Charoen P, Drenos F, Kivimaki M, Lawlor DA, Giambartolomei C, Papacosta O, Chaturvedi N, Bis JC, O'Donnell CJ, Wannamethee G, Wong A, Price JF, Hughes AD, Gaunt TR, Franceschini N, Mook-Kanamori DO, Zwierzyna M, Sofat R, Hingorani AD, Finan C.",Nat Commun. 2021 Sep 24;12(1):5640. doi: 10.1038/s41467-021-25703-3.,Schmidt AF,Nat Commun,2021,25-09-2021,PMC8463530,,10.1038/s41467-021-25703-3
34560903,Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial,"Coley N, Coniasse-Brioude D, Igier V, Fournier T, Poulain JP, Andrieu S; ACCEPT study group.",Alzheimers Res Ther. 2021 Sep 24;13(1):157. doi: 10.1186/s13195-021-00904-6.,Coley N,Alzheimers Res Ther,2021,25-09-2021,PMC8464095,,10.1186/s13195-021-00904-6
34559097,Chinese herbal medicine for mild cognitive impairment using mini-mental state examination: A systematic review and meta-analysis,"Wang W, Diwu Y, Liu Q, Zhou Y, Sayed TI, Wang D, Gou Y.",Medicine (Baltimore). 2021 Sep 24;100(38):e27034. doi: 10.1097/MD.0000000000027034.,Wang W,Medicine (Baltimore),2021,24-09-2021,PMC8462642,,10.1097/MD.0000000000027034
34543687,"Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure","Kurella Tamura M, Gaussoin S, Pajewski NM, Zaharchuk G, Freedman BI, Rapp SR, Auchus AP, Haley WE, Oparil S, Kendrick J, Roumie CL, Beddhu S, Cheung AK, Williamson JD, Detre JA, Dolui S, Bryan RN, Nasrallah IM; SPRINT Research Group.",Am J Kidney Dis. 2022 May;79(5):677-687.e1. doi: 10.1053/j.ajkd.2021.07.024. Epub 2021 Sep 17.,Kurella Tamura M,Am J Kidney Dis,2022,20-09-2021,PMC8926938,NIHMS1766773,10.1053/j.ajkd.2021.07.024
34542418,The Effect of Reminiscence Therapy Using Virtual Reality on Apathy in Residential Aged Care: Multisite Nonrandomized Controlled Trial,"Saredakis D, Keage HA, Corlis M, Ghezzi ES, Loffler H, Loetscher T.",J Med Internet Res. 2021 Sep 20;23(9):e29210. doi: 10.2196/29210.,Saredakis D,J Med Internet Res,2021,20-09-2021,PMC8491119,,10.2196/29210
34539551,Needs Assessment of Safe Medicines Management for Older People With Cognitive Disorders in Home Care: An Integrative Systematic Review,"Vaismoradi M, Behboudi-Gandevani S, Lorenzl S, Weck C, Paal P.",Front Neurol. 2021 Sep 3;12:694572. doi: 10.3389/fneur.2021.694572. eCollection 2021.,Vaismoradi M,Front Neurol,2021,20-09-2021,PMC8446192,,10.3389/fneur.2021.694572
34539340,Amyloid-β and α-Synuclein Immunotherapy: From Experimental Studies to Clinical Trials,"Nimmo JT, Kelly L, Verma A, Carare RO, Nicoll JAR, Dodart JC.",Front Neurosci. 2021 Sep 1;15:733857. doi: 10.3389/fnins.2021.733857. eCollection 2021.,Nimmo JT,Front Neurosci,2021,20-09-2021,PMC8441015,,10.3389/fnins.2021.733857
34538724,Cognitive health after menopause: Does menopausal hormone therapy affect it?,"Stute P, Wienges J, Koller AS, Giese C, Wesemüller W, Janka H, Baumgartner S.",Best Pract Res Clin Endocrinol Metab. 2021 Dec;35(6):101565. doi: 10.1016/j.beem.2021.101565. Epub 2021 Aug 17.,Stute P,Best Pract Res Clin Endocrinol Metab,2021,20-09-2021,,,10.1016/j.beem.2021.101565
34532852,Cannabinoids for the treatment of dementia,"Bosnjak Kuharic D, Markovic D, Brkovic T, Jeric Kegalj M, Rubic Z, Vuica Vukasovic A, Jeroncic A, Puljak L.",Cochrane Database Syst Rev. 2021 Sep 17;9(9):CD012820. doi: 10.1002/14651858.CD012820.pub2.,Bosnjak Kuharic D,Cochrane Database Syst Rev,2021,17-09-2021,PMC8446835,,10.1002/14651858.CD012820.pub2
34532845,The Development of Pharmacological Therapies for Alzheimer's Disease,"Lin P, Sun J, Cheng Q, Yang Y, Cordato D, Gao J.",Neurol Ther. 2021 Dec;10(2):609-626. doi: 10.1007/s40120-021-00282-z. Epub 2021 Sep 16.,Lin P,Neurol Ther,2021,17-09-2021,PMC8571471,,10.1007/s40120-021-00282-z
34531939,Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms,"Sharifi-Rad J, Cruz-Martins N, López-Jornet P, Lopez EP, Harun N, Yeskaliyeva B, Beyatli A, Sytar O, Shaheen S, Sharopov F, Taheri Y, Docea AO, Calina D, Cho WC.",Oxid Med Cell Longev. 2021 Aug 23;2021:6492346. doi: 10.1155/2021/6492346. eCollection 2021.,Sharifi-Rad J,Oxid Med Cell Longev,2021,17-09-2021,PMC8440074,,10.1155/2021/6492346
34528692,Communication Partner Engagement: A Relevant Factor for Functional Outcomes in Speech-Language Therapy for Aphasic Dementia,"Rogalski E, Roberts A, Salley E, Saxon M, Fought A, Esparza M, Blaze E, Coventry C, Mesulam MM, Weintraub S, Mooney A, Khayum B, Rademaker A.",J Gerontol B Psychol Sci Soc Sci. 2022 Jun 1;77(6):1017-1025. doi: 10.1093/geronb/gbab165.,Rogalski E,J Gerontol B Psychol Sci Soc Sci,2022,16-09-2021,PMC9159055,,10.1093/geronb/gbab165
34527222,Higher circulating α-carotene was associated with better cognitive function: an evaluation among the MIND trial participants,"Liu X, Dhana K, Furtado JD, Agarwal P, Aggarwal NT, Tangney C, Laranjo N, Carey V, Barnes LL, Sacks FM.",J Nutr Sci. 2021 Aug 16;10:e64. doi: 10.1017/jns.2021.56. eCollection 2021.,Liu X,J Nutr Sci,2021,16-09-2021,PMC8411267,,10.1017/jns.2021.56
34527172,The Beneficial Role of Natural Endocrine Disruptors: Phytoestrogens in Alzheimer's Disease,"Domańska A, Orzechowski A, Litwiniuk A, Kalisz M, Bik W, Baranowska-Bik A.",Oxid Med Cell Longev. 2021 Sep 3;2021:3961445. doi: 10.1155/2021/3961445. eCollection 2021.,Domańska A,Oxid Med Cell Longev,2021,16-09-2021,PMC8437597,,10.1155/2021/3961445
34525922,"7,8-Dihydroxyflavone and Neuropsychiatric Disorders: A Translational Perspective from the Mechanism to Drug Development","Yang S, Zhu G.",Curr Neuropharmacol. 2022;20(8):1479-1497. doi: 10.2174/1570159X19666210915122820.,Yang S,Curr Neuropharmacol,2022,16-09-2021,PMC9881092,,10.2174/1570159X19666210915122820
34525328,Effects of COVID-19 on preclinical and clinical research in neurology: Examples from research on neurodegeneration and Alzheimer's disease,"Snider BJ, Holtzman DM.",Neuron. 2021 Oct 20;109(20):3199-3202. doi: 10.1016/j.neuron.2021.08.026. Epub 2021 Aug 24.,Snider BJ,Neuron,2021,15-09-2021,,,10.1016/j.neuron.2021.08.026
34521461,Intracerebroventricular injection of human umbilical cord blood mesenchymal stem cells in patients with Alzheimer's disease dementia: a phase I clinical trial,"Kim HJ, Cho KR, Jang H, Lee NK, Jung YH, Kim JP, Lee JI, Chang JW, Park S, Kim ST, Moon SW, Seo SW, Choi SJ, Na DL.",Alzheimers Res Ther. 2021 Sep 14;13(1):154. doi: 10.1186/s13195-021-00897-2.,Kim HJ,Alzheimers Res Ther,2021,15-09-2021,PMC8439008,,10.1186/s13195-021-00897-2
34519802,Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial,"Parkinson Study Group SURE-PD3 Investigators; Schwarzschild MA, Ascherio A, Casaceli C, Curhan GC, Fitzgerald R, Kamp C, Lungu C, Macklin EA, Marek K, Mozaffarian D, Oakes D, Rudolph A, Shoulson I, Videnovic A, Scott B, Gauger L, Aldred J, Bixby M, Ciccarello J, Gunzler SA, Henchcliffe C, Brodsky M, Keith K, Hauser RA, Goetz C, LeDoux MS, Hinson V, Kumar R, Espay AJ, Jimenez-Shahed J, Hunter C, Christine C, Daley A, Leehey M, de Marcaida JA, Friedman JH, Hung A, Bwala G, Litvan I, Simon DK, Simuni T, Poon C, Schiess MC, Chou K, Park A, Bhatti D, Peterson C, Criswell SR, Rosenthal L, Durphy J, Shill HA, Mehta SH, Ahmed A, Deik AF, Fang JY, Stover N, Zhang L, Dewey RB Jr, Gerald A, Boyd JT, Houston E, Suski V, Mosovsky S, Cloud L, Shah BB, Saint-Hilaire M, James R, Zauber SE, Reich S, Shprecher D, Pahwa R, Langhammer A, LaFaver K, LeWitt PA, Kaminski P, Goudreau J, Russell D, Houghton DJ, Laroche A, Thomas K, McGraw M, Mari Z, Serrano C, Blindauer K, Rabin M, Kurlan R, Morgan JC, Soileau M, Ainslie M, Bodis-Wollner I, Schneider RB, Waters C, Ratel AS, Beck CA, Bolger P, Callahan KF, Crotty GF, Klements D, Kostrzebski M, et al.",JAMA. 2021 Sep 14;326(10):926-939. doi: 10.1001/jama.2021.10207.,Parkinson Study Group SURE-PD3 Investigators,JAMA,2021,14-09-2021,PMC8441591,,10.1001/jama.2021.10207
34518975,Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer's Disease,"Wan T, Fu M, Jiang Y, Jiang W, Li P, Zhou S.",Neurochem Res. 2022 Feb;47(2):205-217. doi: 10.1007/s11064-021-03448-1. Epub 2021 Sep 13.,Wan T,Neurochem Res,2022,14-09-2021,PMC8436866,,10.1007/s11064-021-03448-1
34517373,Nonocular Influencing Factors for Primary Glaucoma: An Umbrella Review of Meta-Analysis,"Li W, Pan J, Wei M, Lv Z, Chen S, Qin Y, Li N.",Ophthalmic Res. 2021;64(6):938-950. doi: 10.1159/000519247. Epub 2021 Sep 13.,Li W,Ophthalmic Res,2021,13-09-2021,,,10.1159/000519247
34516308,World regional differences in outcomes for patients with peripheral artery disease: Insights from the EUCLID trial,"Norgren L, North R, Baumgartner I, Berger JS, Blomster JI, Hiatt WR, Jones WS, Katona BG, Mahaffey KW, Mulder H, Patel MR, Rockhold FW, Fowkes FGR.",Vasc Med. 2022 Feb;27(1):21-29. doi: 10.1177/1358863X211038620. Epub 2021 Sep 13.,Norgren L,Vasc Med,2022,13-09-2021,PMC8808360,NIHMS1733385,10.1177/1358863X211038620
34515784,Proportion of Women and Reporting of Outcomes by Sex in Clinical Trials for Alzheimer Disease: A Systematic Review and Meta-analysis,"Martinkova J, Quevenco FC, Karcher H, Ferrari A, Sandset EC, Szoeke C, Hort J, Schmidt R, Chadha AS, Ferretti MT.",JAMA Netw Open. 2021 Sep 1;4(9):e2124124. doi: 10.1001/jamanetworkopen.2021.24124.,Martinkova J,JAMA Netw Open,2021,13-09-2021,PMC12243614,,10.1001/jamanetworkopen.2021.24124
34511121,Impact of an educational programme on Alzheimer's disease patients' quality of life: results of the randomized controlled trial THERAD,"Villars H, Cantet C, de Peretti E, Perrin A, Soto-Martin M, Gardette V.",Alzheimers Res Ther. 2021 Sep 12;13(1):152. doi: 10.1186/s13195-021-00896-3.,Villars H,Alzheimers Res Ther,2021,13-09-2021,PMC8436545,,10.1186/s13195-021-00896-3
34507866,Challenges faced by families of critically ill patients during the first wave of the COVID-19 pandemic,"Greenberg JA, Basapur S, Quinn TV, Bulger JL, Schwartz NH, Oh SK, Shah RC, Glover CM.",Patient Educ Couns. 2022 Feb;105(2):297-303. doi: 10.1016/j.pec.2021.08.029. Epub 2021 Aug 27.,Greenberg JA,Patient Educ Couns,2022,11-09-2021,PMC8393512,,10.1016/j.pec.2021.08.029
34504851,Glaucoma Is Not Associated With Alzheimer's Disease or Dementia: A Meta-Analysis of Cohort Studies,"Zhao W, Lv X, Wu G, Zhou X, Tian H, Qu X, Sun H, He Y, Zhang Y, Wang C, Tian J.",Front Med (Lausanne). 2021 Aug 24;8:688551. doi: 10.3389/fmed.2021.688551. eCollection 2021.,Zhao W,Front Med (Lausanne),2021,10-09-2021,PMC8423132,,10.3389/fmed.2021.688551
34500759,Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges,"Rahman MH, Bajgai J, Fadriquela A, Sharma S, Trinh TT, Akter R, Jeong YJ, Goh SH, Kim CS, Lee KJ.",Molecules. 2021 Sep 2;26(17):5327. doi: 10.3390/molecules26175327.,Rahman MH,Molecules,2021,10-09-2021,PMC8433718,,10.3390/molecules26175327
34496365,The Functional Roles of Curcumin on Astrocytes in Neurodegenerative Diseases,"Mohammadi A, Hosseinzadeh Colagar A, Khorshidian A, Amini SM.",Neuroimmunomodulation. 2022;29(1):4-14. doi: 10.1159/000517901. Epub 2021 Sep 8.,Mohammadi A,Neuroimmunomodulation,2022,08-09-2021,,,10.1159/000517901
34490422,Disease Modelling of Cognitive Outcomes and Biomarkers in the European Prevention of Alzheimer's Dementia Longitudinal Cohort,"Howlett J, Hill SM, Ritchie CW, Tom BDM.",Front Big Data. 2021 Aug 20;4:676168. doi: 10.3389/fdata.2021.676168. eCollection 2021.,Howlett J,Front Big Data,2021,07-09-2021,PMC8417903,,10.3389/fdata.2021.676168
34489759,Effectiveness of Resilience Interventions on Psychosocial Outcomes for Persons With Neurocognitive Disorders: A Systematic Review and Meta-Analysis,"Wang Y, Chi I, Zhan Y, Chen W, Li T.",Front Psychiatry. 2021 Aug 19;12:709860. doi: 10.3389/fpsyt.2021.709860. eCollection 2021.,Wang Y,Front Psychiatry,2021,07-09-2021,PMC8416755,,10.3389/fpsyt.2021.709860
34488599,Neuroprotective Effects of Neuropeptide Y against Neurodegenerative Disease,"Pain S, Brot S, Gaillard A.",Curr Neuropharmacol. 2022 Aug 3;20(9):1717-1725. doi: 10.2174/1570159X19666210906120302.,Pain S,Curr Neuropharmacol,2022,07-09-2021,PMC9881060,,10.2174/1570159X19666210906120302
34479020,Nanotechnology-based drug delivery for central nervous system disorders,"Nguyen TT, Dung Nguyen TT, Vo TK, Tran NM, Nguyen MK, Van Vo T, Van Vo G.",Biomed Pharmacother. 2021 Nov;143:112117. doi: 10.1016/j.biopha.2021.112117. Epub 2021 Aug 31.,Nguyen TT,Biomed Pharmacother,2021,03-09-2021,,,10.1016/j.biopha.2021.112117
34477823,Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial,"Al-Shahi Salman R, Dennis MS, Sandercock PAG, Sudlow CLM, Wardlaw JM, Whiteley WN, Murray GD, Stephen J, Rodriguez A, Lewis S, Werring DJ, White PM; RESTART Collaboration.",JAMA Neurol. 2021 Oct 1;78(10):1179-1186. doi: 10.1001/jamaneurol.2021.2956.,Al-Shahi Salman R,JAMA Neurol,2021,03-09-2021,PMC8417806,,10.1001/jamaneurol.2021.2956
34476990,Alzheimer's Disease: Efficacy of Mono- and Combination Therapy. A Systematic Review,"Knorz AL, Quante A.",J Geriatr Psychiatry Neurol. 2022 Jul;35(4):475-486. doi: 10.1177/08919887211044746. Epub 2021 Sep 3.,Knorz AL,J Geriatr Psychiatry Neurol,2022,03-09-2021,PMC9210120,,10.1177/08919887211044746
34470561,Neuroprotective effect and potential of cellular prion protein and its cleavage products for treatment of neurodegenerative disorders part I. a literature review,"Dexter E, Kong Q.",Expert Rev Neurother. 2021 Sep;21(9):969-982. doi: 10.1080/14737175.2021.1965881. Epub 2021 Sep 2.,Dexter E,Expert Rev Neurother,2021,02-09-2021,PMC8453080,NIHMS1733904,10.1080/14737175.2021.1965881
34468878,The association between cognitive impairment/dementia and albuminuria: a systematic review and meta-analysis,"Li H, Zhao S, Wang R, Gao B.",Clin Exp Nephrol. 2022 Jan;26(1):45-53. doi: 10.1007/s10157-021-02127-3. Epub 2021 Aug 28.,Li H,Clin Exp Nephrol,2022,01-09-2021,PMC8738457,,10.1007/s10157-021-02127-3
34461326,Neuromodulatory treatments for psychiatric disease: A comprehensive survey of the clinical trial landscape,"Elias GJB, Boutet A, Parmar R, Wong EHY, Germann J, Loh A, Paff M, Pancholi A, Gwun D, Chow CT, Gouveia FV, Harmsen IE, Beyn ME, Santarnecchi E, Fasano A, Blumberger DM, Kennedy SH, Lozano AM, Bhat V.",Brain Stimul. 2021 Sep-Oct;14(5):1393-1403. doi: 10.1016/j.brs.2021.08.021. Epub 2021 Aug 27.,Elias GJB,Brain Stimul,2021,30-08-2021,,,10.1016/j.brs.2021.08.021
34459400,Cognitive Effects of the BET Protein Inhibitor Apabetalone: A Prespecified Montreal Cognitive Assessment Analysis Nested in the BETonMACE Randomized Controlled Trial,"Cummings J, Schwartz GG, Nicholls SJ, Khan A, Halliday C, Toth PP, Sweeney M, Johansson JO, Wong NCW, Kulikowski E, Kalantar-Zadeh K, Lebioda K, Ginsberg HN, Winblad B, Zetterberg H, Ray KK.",J Alzheimers Dis. 2021;83(4):1703-1715. doi: 10.3233/JAD-210570.,Cummings J,J Alzheimers Dis,2021,30-08-2021,PMC8609701,,10.3233/JAD-210570
34459396,Prevalence of Low-Value Care and Its Associations with Patient-Centered Outcomes in Dementia,"Platen M, Fleßa S, Rädke A, Wucherer D, Thyrian JR, Mohr W, Scharf A, Mühlichen F, Hoffmann W, Michalowsky B.",J Alzheimers Dis. 2021;83(4):1775-1787. doi: 10.3233/JAD-210439.,Platen M,J Alzheimers Dis,2021,30-08-2021,PMC8609693,,10.3233/JAD-210439
34447487,The Neuroprotective Effects of Moderate and Regular Caffeine Consumption in Alzheimer's Disease,"Zhou X, Zhang L.",Oxid Med Cell Longev. 2021 Aug 17;2021:5568011. doi: 10.1155/2021/5568011. eCollection 2021.,Zhou X,Oxid Med Cell Longev,2021,27-08-2021,PMC8384510,,10.1155/2021/5568011
34445753,Combination of Drugs and Cell Transplantation: More Beneficial Stem Cell-Based Regenerative Therapies Targeting Neurological Disorders,"Nishimura K, Takata K.",Int J Mol Sci. 2021 Aug 22;22(16):9047. doi: 10.3390/ijms22169047.,Nishimura K,Int J Mol Sci,2021,27-08-2021,PMC8396512,,10.3390/ijms22169047
34445613,Neuropharmacology of Cevimeline and Muscarinic Drugs-Focus on Cognition and Neurodegeneration,"Oleksak P, Novotny M, Patocka J, Nepovimova E, Hort J, Pavlik J, Klimova B, Valis M, Kuca K.",Int J Mol Sci. 2021 Aug 18;22(16):8908. doi: 10.3390/ijms22168908.,Oleksak P,Int J Mol Sci,2021,27-08-2021,PMC8396258,,10.3390/ijms22168908
34444766,"Efficacy and Safety of Sesame Oil Cake Extract on Memory Function Improvement: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Pilot Study","Jung SJ, Jung ES, Ha KC, Baek HI, Park YK, Han SK, Chae SW, Lee SO, Chung YC.",Nutrients. 2021 Jul 28;13(8):2606. doi: 10.3390/nu13082606.,Jung SJ,Nutrients,2021,27-08-2021,PMC8399671,,10.3390/nu13082606
34442086,Repetitive Transcranial Magnetic Stimulation in the Treatment of Alzheimer's Disease and Other Dementias,"Aloizou AM, Pateraki G, Anargyros K, Siokas V, Bakirtzis C, Sgantzos M, Messinis L, Nasios G, Peristeri E, Bogdanos DP, Doskas TK, Tzeferakos G, Dardiotis E.",Healthcare (Basel). 2021 Jul 28;9(8):949. doi: 10.3390/healthcare9080949.,Aloizou AM,Healthcare (Basel),2021,27-08-2021,PMC8391181,,10.3390/healthcare9080949
34440761,Stem Cells: Innovative Therapeutic Options for Neurodegenerative Diseases?,"Bonaventura G, Munafò A, Bellanca CM, La Cognata V, Iemmolo R, Attaguile GA, Di Mauro R, Di Benedetto G, Cantarella G, Barcellona ML, Cavallaro S, Bernardini R.",Cells. 2021 Aug 5;10(8):1992. doi: 10.3390/cells10081992.,Bonaventura G,Cells,2021,27-08-2021,PMC8391848,,10.3390/cells10081992
34440720,cAMP Compartmentalization in Cerebrovascular Endothelial Cells: New Therapeutic Opportunities in Alzheimer's Disease,"Viña D, Seoane N, Vasquez EC, Campos-Toimil M.",Cells. 2021 Jul 31;10(8):1951. doi: 10.3390/cells10081951.,Viña D,Cells,2021,27-08-2021,PMC8392343,,10.3390/cells10081951
34436484,Acyl-Coenzyme A: Cholesterol Acyltransferase (ACAT) in Cholesterol Metabolism: From Its Discovery to Clinical Trials and the Genomics Era,"Hai Q, Smith JD.",Metabolites. 2021 Aug 14;11(8):543. doi: 10.3390/metabo11080543.,Hai Q,Metabolites,2021,26-08-2021,PMC8398989,,10.3390/metabo11080543
34429054,PLGA-Based Curcumin Delivery System: An Interesting Therapeutic Approach in the Treatment of Alzheimer's Disease,"Shahbaz SK, Koushki K, Sathyapalan T, Majeed M, Sahebkar A.",Curr Neuropharmacol. 2022;20(2):309-323. doi: 10.2174/1570159X19666210823103020.,Shahbaz SK,Curr Neuropharmacol,2022,25-08-2021,PMC9413791,,10.2174/1570159X19666210823103020
34425883,"Rationale and study design of a randomized, placebo-controlled, double-blind phase 2b trial to evaluate efficacy, safety, and tolerability of an oral glutaminyl cyclase inhibitor varoglutamstat (PQ912) in study participants with MCI and mild AD-VIVIAD","Vijverberg EGB, Axelsen TM, Bihlet AR, Henriksen K, Weber F, Fuchs K, Harrison JE, Kühn-Wache K, Alexandersen P, Prins ND, Scheltens P.",Alzheimers Res Ther. 2021 Aug 23;13(1):142. doi: 10.1186/s13195-021-00882-9.,Vijverberg EGB,Alzheimers Res Ther,2021,24-08-2021,PMC8381483,,10.1186/s13195-021-00882-9
34425832,Combination of cell-penetrating peptides with nanomaterials for the potential therapeutics of central nervous system disorders: a review,"Zhang Y, Guo P, Ma Z, Lu P, Kebebe D, Liu Z.",J Nanobiotechnology. 2021 Aug 23;19(1):255. doi: 10.1186/s12951-021-01002-3.,Zhang Y,J Nanobiotechnology,2021,24-08-2021,PMC8381574,,10.1186/s12951-021-01002-3
34421917,"Warm, Sweetened Milk at the Twilight of Immunity - Alzheimer's Disease - Inflammaging, Insulin Resistance, M. paratuberculosis and Immunosenescence",Dow CT.,Front Immunol. 2021 Aug 5;12:714179. doi: 10.3389/fimmu.2021.714179. eCollection 2021.,Dow CT,Front Immunol,2021,23-08-2021,PMC8375433,,10.3389/fimmu.2021.714179
34421799,Methodological Issues in Randomized Clinical Trials for Prodromal Alzheimer's and Parkinson's Disease,de Aquino CH.,Front Neurol. 2021 Aug 6;12:694329. doi: 10.3389/fneur.2021.694329. eCollection 2021.,de Aquino CH,Front Neurol,2021,23-08-2021,PMC8377160,,10.3389/fneur.2021.694329
34421571,Effectiveness and Safety of Acupuncture for Vascular Cognitive Impairment: A Systematic Review and Meta-Analysis,"Su XT, Sun N, Zhang N, Wang LQ, Zou X, Li JL, Yang JW, Shi GX, Liu CZ.",Front Aging Neurosci. 2021 Aug 6;13:692508. doi: 10.3389/fnagi.2021.692508. eCollection 2021.,Su XT,Front Aging Neurosci,2021,23-08-2021,PMC8377366,,10.3389/fnagi.2021.692508
34420957,Functional Neurophysiological Biomarkers of Early-Stage Alzheimer's Disease: A Perspective of Network Hyperexcitability in Disease Progression,"Tok S, Ahnaou A, Drinkenburg W.",J Alzheimers Dis. 2022;88(3):809-836. doi: 10.3233/JAD-210397.,Tok S,J Alzheimers Dis,2022,23-08-2021,PMC9484128,,10.3233/JAD-210397
34416493,Emerging roles of oxidative stress in brain aging and Alzheimer's disease,"Ionescu-Tucker A, Cotman CW.",Neurobiol Aging. 2021 Nov;107:86-95. doi: 10.1016/j.neurobiolaging.2021.07.014. Epub 2021 Jul 25.,Ionescu-Tucker A,Neurobiol Aging,2021,20-08-2021,,,10.1016/j.neurobiolaging.2021.07.014
34405076,Statins' Effect on Cognitive Outcome After Traumatic Brain Injury: A Systematic Review,"Sultan W, Sapkota A, Khurshid H, Qureshi IA, Jahan N, Went TR, Dominic JL, Win M, Kannan A, Tara A, Ruo SW, Alfonso M.",Cureus. 2021 Aug 6;13(8):e16953. doi: 10.7759/cureus.16953. eCollection 2021 Aug.,Sultan W,Cureus,2021,18-08-2021,PMC8352842,,10.7759/cureus.16953
34404290,Evaluating pimavanserin as a treatment for psychiatric disorders: A pharmacological property in search of an indication,"Davis J, Zamora D, Horowitz M, Leucht S.",Expert Opin Pharmacother. 2021 Sep;22(13):1651-1660. doi: 10.1080/14656566.2021.1942455. Epub 2021 Aug 18.,Davis J,Expert Opin Pharmacother,2021,18-08-2021,,,10.1080/14656566.2021.1942455
34394839,Redox Homeostasis and Prospects for Therapeutic Targeting in Neurodegenerative Disorders,"Akanji MA, Rotimi DE, Elebiyo TC, Awakan OJ, Adeyemi OS.",Oxid Med Cell Longev. 2021 Aug 3;2021:9971885. doi: 10.1155/2021/9971885. eCollection 2021.,Akanji MA,Oxid Med Cell Longev,2021,16-08-2021,PMC8355971,,10.1155/2021/9971885
34393189,Outcome Measures for Dementia With Lewy Body Clinical Trials: A Review,"Patel B, Irwin DJ, Kaufer D, Boeve BF, Taylor A, Armstrong MJ.",Alzheimer Dis Assoc Disord. 2022 Jan-Mar 01;36(1):64-72. doi: 10.1097/WAD.0000000000000473.,Patel B,Alzheimer Dis Assoc Disord,2022,16-08-2021,PMC8847491,NIHMS1723643,10.1097/WAD.0000000000000473
34392394,Dietary and supplemental long-chain omega-3 fatty acids as moderators of cognitive impairment and Alzheimer's disease,"Wood AHR, Chappell HF, Zulyniak MA.",Eur J Nutr. 2022 Mar;61(2):589-604. doi: 10.1007/s00394-021-02655-4. Epub 2021 Aug 15.,Wood AHR,Eur J Nutr,2022,15-08-2021,PMC8854294,,10.1007/s00394-021-02655-4
34392373,Dietary patterns in middle age: effects on concurrent neurocognition and risk of age-related cognitive decline,"Gauci S, Young LM, Arnoldy L, Lassemillante AC, Scholey A, Pipingas A.",Nutr Rev. 2022 Apr 8;80(5):1129-1159. doi: 10.1093/nutrit/nuab047.,Gauci S,Nutr Rev,2022,15-08-2021,PMC8990759,,10.1093/nutrit/nuab047
34386944,The PI3K/Akt signaling axis in Alzheimer's disease: a valuable target to stimulate or suppress?,"Razani E, Pourbagheri-Sigaroodi A, Safaroghli-Azar A, Zoghi A, Shanaki-Bavarsad M, Bashash D.",Cell Stress Chaperones. 2021 Nov;26(6):871-887. doi: 10.1007/s12192-021-01231-3. Epub 2021 Aug 13.,Razani E,Cell Stress Chaperones,2021,13-08-2021,PMC8578535,,10.1007/s12192-021-01231-3
34385925,Herbal Medicine for Behavioral and Psychological Symptoms of Dementia: A Systematic Review and Meta-Analysis,"Kwon CY, Lee B.",Front Pharmacol. 2021 Jul 27;12:713287. doi: 10.3389/fphar.2021.713287. eCollection 2021.,Kwon CY,Front Pharmacol,2021,13-08-2021,PMC8353144,,10.3389/fphar.2021.713287
34385535,Incident stroke in patients with Alzheimer's disease: systematic review and meta-analysis,"Pinho J, Quintas-Neves M, Dogan I, Reetz K, Reich A, Costa AS.",Sci Rep. 2021 Aug 12;11(1):16385. doi: 10.1038/s41598-021-95821-x.,Pinho J,Sci Rep,2021,13-08-2021,PMC8361108,,10.1038/s41598-021-95821-x
34384369,Factors associated with brain ageing - a systematic review,"Wrigglesworth J, Ward P, Harding IH, Nilaweera D, Wu Z, Woods RL, Ryan J.",BMC Neurol. 2021 Aug 12;21(1):312. doi: 10.1186/s12883-021-02331-4.,Wrigglesworth J,BMC Neurol,2021,13-08-2021,PMC8359541,,10.1186/s12883-021-02331-4
34381308,Inflammation and Alzheimer's Disease: Mechanisms and Therapeutic Implications by Natural Products,"Rather MA, Khan A, Alshahrani S, Rashid H, Qadri M, Rashid S, Alsaffar RM, Kamal MA, Rehman MU.",Mediators Inflamm. 2021 Jul 31;2021:9982954. doi: 10.1155/2021/9982954. eCollection 2021.,Rather MA,Mediators Inflamm,2021,12-08-2021,PMC8352708,,10.1155/2021/9982954
34370636,"Phytochemicals Targeting Oxidative Stress, Interconnected Neuroinflammatory, and Neuroapoptotic Pathways Following Radiation","Fakhri S, Piri S, Moradi SZ, Khan H.",Curr Neuropharmacol. 2022;20(5):836-856. doi: 10.2174/1570159X19666210809103346.,Fakhri S,Curr Neuropharmacol,2022,09-08-2021,PMC9881105,,10.2174/1570159X19666210809103346
34366826,Can Control Infections Slow Down the Progression of Alzheimer's Disease? Talking About the Role of Infections in Alzheimer's Disease,"Shi M, Li C, Tian X, Chu F, Zhu J.",Front Aging Neurosci. 2021 Jul 22;13:685863. doi: 10.3389/fnagi.2021.685863. eCollection 2021.,Shi M,Front Aging Neurosci,2021,09-08-2021,PMC8339924,,10.3389/fnagi.2021.685863
34366337,"Pilot Evaluation of the Unsupervised, At-Home Cogstate Brief Battery in ADNI-2","Edgar CJ, Siemers E, Maruff P, Petersen RC, Aisen PS, Weiner MW, Albala B; Alzheimer’s Disease Neuroimaging Initiative.",J Alzheimers Dis. 2021;83(2):915-925. doi: 10.3233/JAD-210201.,Edgar CJ,J Alzheimers Dis,2021,09-08-2021,PMC8543269,,10.3233/JAD-210201
34365016,"¡Mi Vida Saludable! A randomized, controlled, 2 × 2 factorial trial of a diet and physical activity intervention among Latina breast cancer survivors: Study design and methods","Santiago-Torres M, Contento I, Koch P, Tsai WY, Brickman AM, Gaffney AO, Thomson CA, Crane TE, Dominguez N, Sepulveda J, Marín-Chollom AM, Paul R, Shi Z, Ulanday KT, Hale C, Hershman D, Greenlee H.",Contemp Clin Trials. 2021 Nov;110:106524. doi: 10.1016/j.cct.2021.106524. Epub 2021 Aug 6.,Santiago-Torres M,Contemp Clin Trials,2021,08-08-2021,PMC8595705,NIHMS1740661,10.1016/j.cct.2021.106524
34364094,Cerebrospinal fluid orexin in Alzheimer's disease: a systematic review and meta-analysis,"Treu SP, Plante DT.",Sleep Med. 2021 Sep;85:230-238. doi: 10.1016/j.sleep.2021.07.007. Epub 2021 Jul 13.,Treu SP,Sleep Med,2021,07-08-2021,PMC8429218,NIHMS1730727,10.1016/j.sleep.2021.07.007
34362303,Five-year outcomes after IVIG for mild cognitive impairment due to alzheimer disease,"Kile S, Au W, Parise C, Rose K, Donnel T, Hankins A, Au Y, Chan M, Ghassemi A.",BMC Neurosci. 2021 Aug 6;22(1):49. doi: 10.1186/s12868-021-00651-2.,Kile S,BMC Neurosci,2021,07-08-2021,PMC8349062,,10.1186/s12868-021-00651-2
34361850,The Therapeutic Potential of Celastrol in Central Nervous System Disorders: Highlights from In Vitro and In Vivo Approaches,"Schiavone S, Morgese MG, Tucci P, Trabace L.",Molecules. 2021 Aug 3;26(15):4700. doi: 10.3390/molecules26154700.,Schiavone S,Molecules,2021,07-08-2021,PMC8347599,,10.3390/molecules26154700
34361762,The Ultrastructure of Tissue Damage by Amyloid Fibrils,"Koike H, Katsuno M.",Molecules. 2021 Jul 29;26(15):4611. doi: 10.3390/molecules26154611.,Koike H,Molecules,2021,07-08-2021,PMC8347239,,10.3390/molecules26154611
34361686,Neuroprotective Potential of Limonene and Limonene Containing Natural Products,"Eddin LB, Jha NK, Meeran MFN, Kesari KK, Beiram R, Ojha S.",Molecules. 2021 Jul 27;26(15):4535. doi: 10.3390/molecules26154535.,Eddin LB,Molecules,2021,07-08-2021,PMC8348102,,10.3390/molecules26154535
34360973,Novel Therapeutic Approaches for Alzheimer's Disease: An Updated Review,"Yu TW, Lane HY, Lin CH.",Int J Mol Sci. 2021 Jul 30;22(15):8208. doi: 10.3390/ijms22158208.,Yu TW,Int J Mol Sci,2021,07-08-2021,PMC8348485,,10.3390/ijms22158208
34360966,Emerging hiPSC Models for Drug Discovery in Neurodegenerative Diseases,"Trudler D, Ghatak S, Lipton SA.",Int J Mol Sci. 2021 Jul 30;22(15):8196. doi: 10.3390/ijms22158196.,Trudler D,Int J Mol Sci,2021,07-08-2021,PMC8347370,,10.3390/ijms22158196
34360906,Brain Glucose Transporters: Role in Pathogenesis and Potential Targets for the Treatment of Alzheimer's Disease,Szablewski L.,Int J Mol Sci. 2021 Jul 29;22(15):8142. doi: 10.3390/ijms22158142.,Szablewski L,Int J Mol Sci,2021,07-08-2021,PMC8348194,,10.3390/ijms22158142
34360799,Novel Insight in Idiopathic Normal Pressure Hydrocephalus (iNPH) Biomarker Discovery in CSF,"Torretta E, Arosio B, Barbacini P, Capitanio D, Rossi PD, Moriggi M, Clerici M, Mari D, Cesari M, Gelfi C.",Int J Mol Sci. 2021 Jul 27;22(15):8034. doi: 10.3390/ijms22158034.,Torretta E,Int J Mol Sci,2021,07-08-2021,PMC8347603,,10.3390/ijms22158034
34360360,Comparative Efficacy of Active Group Music Intervention versus Group Music Listening in Alzheimer's Disease,"Gómez-Gallego M, Gómez-Gallego JC, Gallego-Mellado M, García-García J.",Int J Environ Res Public Health. 2021 Jul 30;18(15):8067. doi: 10.3390/ijerph18158067.,Gómez-Gallego M,Int J Environ Res Public Health,2021,07-08-2021,PMC8345612,,10.3390/ijerph18158067
34360049,The Present State of Lithium for the Prevention of Dementia Related to Alzheimer's Dementia in Clinical and Epidemiological Studies: A Critical Review,"Ishii N, Terao T, Hirakawa H.",Int J Environ Res Public Health. 2021 Jul 22;18(15):7756. doi: 10.3390/ijerph18157756.,Ishii N,Int J Environ Res Public Health,2021,07-08-2021,PMC8345730,,10.3390/ijerph18157756
34359543,Probiotics for Mild Cognitive Impairment and Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Zhu G, Zhao J, Zhang H, Chen W, Wang G.",Foods. 2021 Jul 20;10(7):1672. doi: 10.3390/foods10071672.,Zhu G,Foods,2021,07-08-2021,PMC8303183,,10.3390/foods10071672
34356644,COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?,"Lundstrom K, Barh D, Uhal BD, Takayama K, Aljabali AAA, Abd El-Aziz TM, Lal A, Redwan EM, Adadi P, Chauhan G, Sherchan SP, Azad GK, Rezaei N, Serrano-Aroca Á, Bazan NG, Hassan SS, Panda PK, Pal Choudhury P, Pizzol D, Kandimalla R, Baetas-da-Cruz W, Mishra YK, Palu G, Brufsky AM, Tambuwala MM, Uversky VN.",Biomolecules. 2021 Jul 13;11(7):1020. doi: 10.3390/biom11071020.,Lundstrom K,Biomolecules,2021,06-08-2021,PMC8301964,,10.3390/biom11071020
34356112,"Hydroxyurea-The Good, the Bad and the Ugly","Musiałek MW, Rybaczek D.",Genes (Basel). 2021 Jul 19;12(7):1096. doi: 10.3390/genes12071096.,Musiałek MW,Genes (Basel),2021,06-08-2021,PMC8304116,,10.3390/genes12071096
34354136,Lower regional gray matter volume in the absence of higher cortical amyloid burden in late-life depression,"Takamiya A, Vande Casteele T, Koole M, De Winter FL, Bouckaert F, Van den Stock J, Sunaert S, Dupont P, Vandenberghe R, Van Laere K, Vandenbulcke M, Emsell L.",Sci Rep. 2021 Aug 5;11(1):15981. doi: 10.1038/s41598-021-95206-0.,Takamiya A,Sci Rep,2021,06-08-2021,PMC8342521,,10.1038/s41598-021-95206-0
34342879,Utility of the iPad NIH Toolbox Cognition Battery in a clinical trial of older adults,"Parsey CM, Bagger JE, Trittschuh EH, Hanson AJ.",J Am Geriatr Soc. 2021 Dec;69(12):3519-3528. doi: 10.1111/jgs.17382. Epub 2021 Aug 3.,Parsey CM,J Am Geriatr Soc,2021,03-08-2021,PMC8648969,NIHMS1725722,10.1111/jgs.17382
34339416,Menopausal hormone therapy and women's health: An umbrella review,"Zhang GQ, Chen JL, Luo Y, Mathur MB, Anagnostis P, Nurmatov U, Talibov M, Zhang J, Hawrylowicz CM, Lumsden MA, Critchley H, Sheikh A, Lundbäck B, Lässer C, Kankaanranta H, Lee SH, Nwaru BI.",PLoS Med. 2021 Aug 2;18(8):e1003731. doi: 10.1371/journal.pmed.1003731. eCollection 2021 Aug.,Zhang GQ,PLoS Med,2021,02-08-2021,PMC8366967,,10.1371/journal.pmed.1003731
34338761,Validation of a Deficit-Accumulation Frailty Index in the ASPirin in Reducing Events in the Elderly Study and Its Predictive Capacity for Disability-Free Survival,"Ryan J, Espinoza S, Ernst ME, Ekram ARMS, Wolfe R, Murray AM, Shah RC, Orchard SG, Fitzgerald S, Beilin LJ, Ward SA, Williamson JD, Newman AB, McNeil JJ, Woods RL.",J Gerontol A Biol Sci Med Sci. 2022 Jan 7;77(1):19-26. doi: 10.1093/gerona/glab225.,Ryan J,J Gerontol A Biol Sci Med Sci,2022,02-08-2021,PMC8751791,,10.1093/gerona/glab225
34332638,"An Investigation of Levetiracetam in Alzheimer's Disease (ILiAD): a double-blind, placebo-controlled, randomised crossover proof of concept study","Sen A, Akinola M, Tai XY, Symmonds M, Davis Jones G, Mura S, Galloway J, Hallam A, Chan JYC, Koychev I, Butler C, Geddes J, Van Der Putt R, Thompson S, Manohar SG, Frangou E, Love S, McShane R, Husain M.",Trials. 2021 Jul 31;22(1):508. doi: 10.1186/s13063-021-05404-4.,Sen A,Trials,2021,01-08-2021,PMC8325256,,10.1186/s13063-021-05404-4
34329735,Mitophagy in Huntington's disease,"Šonský I, Vodička P, Vodičková Kepková K, Hansíková H.",Neurochem Int. 2021 Oct;149:105147. doi: 10.1016/j.neuint.2021.105147. Epub 2021 Jul 28.,Šonský I,Neurochem Int,2021,30-07-2021,,,10.1016/j.neuint.2021.105147
34329196,Chocolate consumption and all-cause and cause-specific mortality in a US population: a post hoc analysis of the PLCO cancer screening trial,"Zhong GC, Hu TY, Yang PF, Peng Y, Wu JJ, Sun WP, Cheng L, Wang CR.",Aging (Albany NY). 2021 Jul 29;13(14):18564-18585. doi: 10.18632/aging.203302. Epub 2021 Jul 29.,Zhong GC,Aging (Albany NY),2021,30-07-2021,PMC8351724,,10.18632/aging.203302
34328092,"An updated review on the versatile role of chrysin in neurological diseases: Chemistry, pharmacology, and drug delivery approaches","Talebi M, Talebi M, Farkhondeh T, Kopustinskiene DM, Simal-Gandara J, Bernatoniene J, Samarghandian S.",Biomed Pharmacother. 2021 Sep;141:111906. doi: 10.1016/j.biopha.2021.111906. Epub 2021 Jul 16.,Talebi M,Biomed Pharmacother,2021,30-07-2021,,,10.1016/j.biopha.2021.111906
34315645,Apathy as a Treatment Target in Alzheimer's Disease: Implications for Clinical Trials,"Mortby ME, Adler L, Agüera-Ortiz L, Bateman DR, Brodaty H, Cantillon M, Geda YE, Ismail Z, Lanctôt KL, Marshall GA, Padala PR, Politis A, Rosenberg PB, Siarkos K, Sultzer DL, Theleritis C; ISTAART NPS PIA.",Am J Geriatr Psychiatry. 2022 Feb;30(2):119-147. doi: 10.1016/j.jagp.2021.06.016. Epub 2021 Jul 1.,Mortby ME,Am J Geriatr Psychiatry,2022,28-07-2021,,,10.1016/j.jagp.2021.06.016
34315519,Cognitively unimpaired individuals with a low burden of Aβ pathology have a distinct CSF biomarker profile,"Milà-Alomà M, Shekari M, Salvadó G, Gispert JD, Arenaza-Urquijo EM, Operto G, Falcon C, Vilor-Tejedor N, Grau-Rivera O, Sala-Vila A, Sánchez-Benavides G, González-de-Echávarri JM, Minguillon C, Fauria K, Niñerola-Baizán A, Perissinotti A, Simon M, Kollmorgen G, Zetterberg H, Blennow K, Suárez-Calvet M, Molinuevo JL; ALFA study.",Alzheimers Res Ther. 2021 Jul 27;13(1):134. doi: 10.1186/s13195-021-00863-y.,Milà-Alomà M,Alzheimers Res Ther,2021,28-07-2021,PMC8314554,,10.1186/s13195-021-00863-y
34311086,Chemical update on the potential for serotonin 5-HT(6) and 5-HT(7) receptor agents in the treatment of Alzheimer's disease,"Kucwaj-Brysz K, Baltrukevich H, Czarnota K, Handzlik J.",Bioorg Med Chem Lett. 2021 Oct 1;49:128275. doi: 10.1016/j.bmcl.2021.128275. Epub 2021 Jul 23.,Kucwaj-Brysz K,Bioorg Med Chem Lett,2021,26-07-2021,,,10.1016/j.bmcl.2021.128275
34310044,"Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial","Hoscheidt S, Sanderlin AH, Baker LD, Jung Y, Lockhart S, Kellar D, Whitlow CT, Hanson AJ, Friedman S, Register T, Leverenz JB, Craft S.",Alzheimers Dement. 2022 Mar;18(3):457-468. doi: 10.1002/alz.12421. Epub 2021 Jul 26.,Hoscheidt S,Alzheimers Dement,2022,26-07-2021,PMC9207984,NIHMS1716856,10.1002/alz.12421
34305572,Hearing Loss and Dementia: A Meta-Analysis of Prospective Cohort Studies,"Liang Z, Li A, Xu Y, Qian X, Gao X.",Front Aging Neurosci. 2021 Jul 8;13:695117. doi: 10.3389/fnagi.2021.695117. eCollection 2021.,Liang Z,Front Aging Neurosci,2021,26-07-2021,PMC8295986,,10.3389/fnagi.2021.695117
34300254,Acupuncture for Behavioral and Psychological Symptoms of Dementia: A Systematic Review and Meta-Analysis,"Kwon CY, Lee B.",J Clin Med. 2021 Jul 13;10(14):3087. doi: 10.3390/jcm10143087.,Kwon CY,J Clin Med,2021,24-07-2021,PMC8303524,,10.3390/jcm10143087
34299756,The Long-Term Public Health Impact of Social Distancing on Brain Health: Topical Review,"Kumar A, Salinas J.",Int J Environ Res Public Health. 2021 Jul 8;18(14):7307. doi: 10.3390/ijerph18147307.,Kumar A,Int J Environ Res Public Health,2021,24-07-2021,PMC8305633,,10.3390/ijerph18147307
34299575,Nanomaterials for Modulating the Aggregation of β-Amyloid Peptides,"Huang Y, Chang Y, Liu L, Wang J.",Molecules. 2021 Jul 15;26(14):4301. doi: 10.3390/molecules26144301.,Huang Y,Molecules,2021,24-07-2021,PMC8305396,,10.3390/molecules26144301
34299029,Applications of Radiolabelled Curcumin and Its Derivatives in Medicinal Chemistry,"Mari M, Carrozza D, Ferrari E, Asti M.",Int J Mol Sci. 2021 Jul 10;22(14):7410. doi: 10.3390/ijms22147410.,Mari M,Int J Mol Sci,2021,24-07-2021,PMC8306375,,10.3390/ijms22147410
34298986,Activity of Selected Group of Monoterpenes in Alzheimer's Disease Symptoms in Experimental Model Studies-A Non-Systematic Review,"Wojtunik-Kulesza K, Rudkowska M, Kasprzak-Drozd K, Oniszczuk A, Borowicz-Reutt K.",Int J Mol Sci. 2021 Jul 8;22(14):7366. doi: 10.3390/ijms22147366.,Wojtunik-Kulesza K,Int J Mol Sci,2021,24-07-2021,PMC8306454,,10.3390/ijms22147366
34297895,Recruitment of a multi-site randomized controlled trial of aerobic exercise for older adults with amnestic mild cognitive impairment: The EXERT trial,"Shadyab AH, LaCroix AZ, Feldman HH, van Dyck CH, Okonkwo OC, Tam SP, Fairchild JK, Welsh-Bohmer KA, Matthews G, Bennett D, Shadyab AA, Schafer KA, Morrison RH, Kipperman SA, Mason J, Tan D, Thomas RG, Cotman CW, Baker LD; ADCS EXERT Study Group.",Alzheimers Dement. 2021 Nov;17(11):1808-1817. doi: 10.1002/alz.12401. Epub 2021 Jul 23.,Shadyab AH,Alzheimers Dement,2021,23-07-2021,PMC9292825,,10.1002/alz.12401
34296549,Effects of Electrical Automatic Massage on Cognition and Sleep Quality in Alzheimer's Disease Spectrum Patients: A Randomized Controlled Trial,"Kim YJ, Kim HR, Jung YH, Park YH, Seo SW.",Yonsei Med J. 2021 Aug;62(8):717-725. doi: 10.3349/ymj.2021.62.8.717.,Kim YJ,Yonsei Med J,2021,23-07-2021,PMC8298867,,10.3349/ymj.2021.62.8.717
34292973,"Regional brain volumes relate to Alzheimer's disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study","Libowitz MR, Wei K, Tran T, Chu K, Moncrieffe K, Harrington MG, King K.",PLoS One. 2021 Jul 22;16(7):e0254332. doi: 10.1371/journal.pone.0254332. eCollection 2021.,Libowitz MR,PLoS One,2021,22-07-2021,PMC8297871,,10.1371/journal.pone.0254332
34287475,"Dengzhan shengmai capsule combined with donepezil hydrochloride in the treatment of Alzheimer's disease: preliminary findings, randomized and controlled clinical trial","Huang P, He XY, Xu M.",Rev Assoc Med Bras (1992). 2021 Feb;67(2):190-194. doi: 10.1590/1806-9282.67.02.20200378.,Huang P,Rev Assoc Med Bras (1992),2021,21-07-2021,,,10.1590/1806-9282.67.02.20200378
34285915,The Potential Benefits of Nanotechnology in Treating Alzheimer's Disease,"Ling TS, Chandrasegaran S, Xuan LZ, Suan TL, Elaine E, Nathan DV, Chai YH, Gunasekaran B, Salvamani S.",Biomed Res Int. 2021 Jul 4;2021:5550938. doi: 10.1155/2021/5550938. eCollection 2021.,Ling TS,Biomed Res Int,2021,21-07-2021,PMC8275379,,10.1155/2021/5550938
34275209,Effects of simvastatin on white matter integrity in healthy middle-aged adults,"Vogt NM, Hunt JFV, Ma Y, Van Hulle CA, Adluru N, Chappell RJ, Lazar KK, Jacobson LE, Austin BP, Asthana S, Johnson SC, Bendlin BB, Carlsson CM.",Ann Clin Transl Neurol. 2021 Aug;8(8):1656-1667. doi: 10.1002/acn3.51421. Epub 2021 Jul 18.,Vogt NM,Ann Clin Transl Neurol,2021,18-07-2021,PMC8351379,,10.1002/acn3.51421
34274565,Recent advances in drug repurposing using machine learning,"Urbina F, Puhl AC, Ekins S.",Curr Opin Chem Biol. 2021 Dec;65:74-84. doi: 10.1016/j.cbpa.2021.06.001. Epub 2021 Jul 16.,Urbina F,Curr Opin Chem Biol,2021,18-07-2021,PMC8671152,NIHMS1716900,10.1016/j.cbpa.2021.06.001
34274158,Impact of hemoglobin biophysical studies on molecular pathogenesis and drug therapy for sickle cell disease,Eaton WA.,Mol Aspects Med. 2022 Apr;84:100971. doi: 10.1016/j.mam.2021.100971. Epub 2021 Jul 14.,Eaton WA,Mol Aspects Med,2022,18-07-2021,PMC8758802,NIHMS1713719,10.1016/j.mam.2021.100971
34271969,Efficacy and safety of pharmacotherapy for Alzheimer's disease and for behavioural and psychological symptoms of dementia in older patients with moderate and severe functional impairments: a systematic review of controlled trials,"Seibert M, Mühlbauer V, Holbrook J, Voigt-Radloff S, Brefka S, Dallmeier D, Denkinger M, Schönfeldt-Lecuona C, Klöppel S, von Arnim CAF.",Alzheimers Res Ther. 2021 Jul 16;13(1):131. doi: 10.1186/s13195-021-00867-8.,Seibert M,Alzheimers Res Ther,2021,17-07-2021,PMC8285815,,10.1186/s13195-021-00867-8
34271944,Adapting to the COVID-19 pandemic on Building Research in Diet and Cognition (BRIDGE) trial,"Fitzgibbon M, Blumstein L, Schiffer L, Antonic MA, McLeod A, Dakers R, Restrepo L, Boots EA, Sanchez-Flack JC, Tussing-Humphreys L, Lamar M.",Trials. 2021 Jul 16;22(1):459. doi: 10.1186/s13063-021-05383-6.,Fitzgibbon M,Trials,2021,17-07-2021,PMC8284687,,10.1186/s13063-021-05383-6
34268448,A systematic review and network meta-analysis of interventions for subjective cognitive decline,"Roheger M, Hennersdorf XS, Riemann S, Flöel A, Meinzer M.",Alzheimers Dement (N Y). 2021 Jul 12;7(1):e12180. doi: 10.1002/trc2.12180. eCollection 2021.,Roheger M,Alzheimers Dement (N Y),2021,16-07-2021,PMC8274308,,10.1002/trc2.12180
34261627,"Associations between statins and adverse events in primary prevention of cardiovascular disease: systematic review with pairwise, network, and dose-response meta-analyses","Cai T, Abel L, Langford O, Monaghan G, Aronson JK, Stevens RJ, Lay-Flurrie S, Koshiaris C, McManus RJ, Hobbs FDR, Sheppard JP.",BMJ. 2021 Jul 14;374:n1537. doi: 10.1136/bmj.n1537.,Cai T,BMJ,2021,15-07-2021,PMC8279037,,10.1136/bmj.n1537
34259071,Evaluation of [(18)F]-JNJ-64326067-AAA tau PET tracer in humans,"Baker SL, Provost K, Thomas W, Whitman AJ, Janabi M, Schmidt ME, Timmers M, Kolb HC, Rabinovici GD, Jagust WJ.",J Cereb Blood Flow Metab. 2021 Dec;41(12):3302-3313. doi: 10.1177/0271678X211031035. Epub 2021 Jul 14.,Baker SL,J Cereb Blood Flow Metab,2021,14-07-2021,PMC8669274,,10.1177/0271678X211031035
34251396,The Trial to Reduce Antimicrobial Use in Nursing Home Residents With Alzheimer Disease and Other Dementias (TRAIN-AD): A Cluster Randomized Clinical Trial,"Mitchell SL, D'Agata EMC, Hanson LC, Loizeau AJ, Habtemariam DA, Tsai T, Anderson RA, Shaffer ML.",JAMA Intern Med. 2021 Sep 1;181(9):1174-1182. doi: 10.1001/jamainternmed.2021.3098.,Mitchell SL,JAMA Intern Med,2021,12-07-2021,PMC8276127,,10.1001/jamainternmed.2021.3098
34245589,"Resources, methods, and data infrastructure to promote research in dementia care, caregiving, and services","Pike KJ, Fazio S, Bynum JPW, Travison TG, Wendler D, Mor V.",J Am Geriatr Soc. 2021 Jul;69(7):1793-1800. doi: 10.1111/jgs.17339.,Pike KJ,J Am Geriatr Soc,2021,10-07-2021,PMC8351358,NIHMS1716087,10.1111/jgs.17339
34245409,Neuroregulatory role of ginkgolides,"Gachowska M, Szlasa W, Saczko J, Kulbacka J.",Mol Biol Rep. 2021 Jul;48(7):5689-5697. doi: 10.1007/s11033-021-06535-2. Epub 2021 Jul 10.,Gachowska M,Mol Biol Rep,2021,10-07-2021,PMC8338821,,10.1007/s11033-021-06535-2
34244959,"Atrial Fibrillation Is Associated with Cognitive Impairment, All-Cause Dementia, Vascular Dementia, and Alzheimer's Disease: a Systematic Review and Meta-Analysis","Papanastasiou CA, Theochari CA, Zareifopoulos N, Arfaras-Melainis A, Giannakoulas G, Karamitsos TD, Palaiodimos L, Ntaios G, Avgerinos KI, Kapogiannis D, Kokkinidis DG.",J Gen Intern Med. 2021 Oct;36(10):3122-3135. doi: 10.1007/s11606-021-06954-8. Epub 2021 Jul 9.,Papanastasiou CA,J Gen Intern Med,2021,10-07-2021,PMC8481403,,10.1007/s11606-021-06954-8
34240455,"Safety, pharmacokinetics and quantitative EEG modulation of TAK-071, a novel muscarinic M1 receptor positive allosteric modulator, in healthy subjects","Yin W, Mamashli F, Buhl DL, Khudyakov P, Volfson D, Martenyi F, Gevorkyan H, Rosen L, Simen AA.",Br J Clin Pharmacol. 2022 Feb;88(2):600-612. doi: 10.1111/bcp.14975. Epub 2021 Jul 31.,Yin W,Br J Clin Pharmacol,2022,09-07-2021,PMC9291057,,10.1111/bcp.14975
34233766,Reappraisal of metabolic dysfunction in neurodegeneration: Focus on mitochondrial function and calcium signaling,"Jadiya P, Garbincius JF, Elrod JW.",Acta Neuropathol Commun. 2021 Jul 7;9(1):124. doi: 10.1186/s40478-021-01224-4.,Jadiya P,Acta Neuropathol Commun,2021,08-07-2021,PMC8262011,,10.1186/s40478-021-01224-4
34233431,Alzheimer's disease: exploring nature's 'medicinal chest' for new therapeutic agents,Tsarbopoulos A.,Biomol Concepts. 2020 Dec 23;11(1):201-208. doi: 10.1515/bmc-2020-0018.,Tsarbopoulos A,Biomol Concepts,2020,08-07-2021,,,10.1515/bmc-2020-0018
34227926,Can a Micronutrient Mixture Delay the Onset and Progression of Symptoms of Single-Point Mutation Diseases?,"Prasad KN, Bondy SC.",J Am Nutr Assoc. 2022 Jul;41(5):489-498. doi: 10.1080/07315724.2021.1910592. Epub 2021 Jul 6.,Prasad KN,J Am Nutr Assoc,2022,06-07-2021,,,10.1080/07315724.2021.1910592
34227053,Mild cognitive impairment: when nutrition helps brain energy rescue-a report from the EuGMS 2020 Congress,"Cunnane SC, Sieber CC, Swerdlow RH, Cruz-Jentoft AJ.",Eur Geriatr Med. 2021 Dec;12(6):1285-1292. doi: 10.1007/s41999-021-00534-z. Epub 2021 Jul 5.,Cunnane SC,Eur Geriatr Med,2021,06-07-2021,PMC8626370,,10.1007/s41999-021-00534-z
34223154,Correlation between CSF and blood neurofilament light chain protein: a systematic review and meta-analysis,"Alagaratnam J, von Widekind S, De Francesco D, Underwood J, Edison P, Winston A, Zetterberg H, Fidler S.",BMJ Neurol Open. 2021 Jun 16;3(1):e000143. doi: 10.1136/bmjno-2021-000143. eCollection 2021.,Alagaratnam J,BMJ Neurol Open,2021,05-07-2021,PMC8211066,,10.1136/bmjno-2021-000143
34217888,"An innovative protocol for the artificial speech-directed, contactless administration of laboratory-based comprehensive cognitive assessments: PAAD-2 trial management during the COVID-19 pandemic","Park KS, Etnier JL.",Contemp Clin Trials. 2021 Aug;107:106500. doi: 10.1016/j.cct.2021.106500. Epub 2021 Jul 2.,Park KS,Contemp Clin Trials,2021,04-07-2021,PMC8249106,,10.1016/j.cct.2021.106500
34216034,Targeted tDCS Mitigates Dual-Task Costs to Gait and Balance in Older Adults,"Zhou J, Manor B, Yu W, Lo OY, Gouskova N, Salvador R, Katz R, Cornejo Thumm P, Brozgol M, Ruffini G, Pascual-Leone A, Lipsitz LA, Hausdorff JM.",Ann Neurol. 2021 Sep;90(3):428-439. doi: 10.1002/ana.26156. Epub 2021 Jul 17.,Zhou J,Ann Neurol,2021,03-07-2021,PMC8434977,NIHMS1721328,10.1002/ana.26156
34214643,Western diet as a trigger of Alzheimer's disease: From metabolic syndrome and systemic inflammation to neuroinflammation and neurodegeneration,"Więckowska-Gacek A, Mietelska-Porowska A, Wydrych M, Wojda U.",Ageing Res Rev. 2021 Sep;70:101397. doi: 10.1016/j.arr.2021.101397. Epub 2021 Jun 30.,Więckowska-Gacek A,Ageing Res Rev,2021,02-07-2021,,,10.1016/j.arr.2021.101397
34209883,Nutraceutical and Probiotic Approaches to Examine Molecular Interactions of the Amyloid Precursor Protein APP in Drosophila Models of Alzheimer's Disease,"Jalali D, Guevarra JA, Martinez L, Hung L, Vonhoff FJ.",Int J Mol Sci. 2021 Jun 29;22(13):7022. doi: 10.3390/ijms22137022.,Jalali D,Int J Mol Sci,2021,02-07-2021,PMC8269328,,10.3390/ijms22137022
34209482,MicroRNAs in Prion Diseases-From Molecular Mechanisms to Insights in Translational Medicine,"Contiliani DF, Ribeiro YA, de Moraes VN, Pereira TC.",Cells. 2021 Jun 29;10(7):1620. doi: 10.3390/cells10071620.,Contiliani DF,Cells,2021,02-07-2021,PMC8307047,,10.3390/cells10071620
34209461,Metal-Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin,"Prasad S, DuBourdieu D, Srivastava A, Kumar P, Lall R.",Int J Mol Sci. 2021 Jun 30;22(13):7094. doi: 10.3390/ijms22137094.,Prasad S,Int J Mol Sci,2021,02-07-2021,PMC8268053,,10.3390/ijms22137094
34208980,A Critical Review of the Study of Neuroprotective Diets to Reduce Cognitive Decline,"Duplantier SC, Gardner CD.",Nutrients. 2021 Jun 30;13(7):2264. doi: 10.3390/nu13072264.,Duplantier SC,Nutrients,2021,02-07-2021,PMC8308213,,10.3390/nu13072264
34208833,Metabolic Syndrome: Is It Time to Add the Central Nervous System?,"Rojas M, Chávez-Castillo M, Pirela D, Parra H, Nava M, Chacín M, Angarita L, Añez R, Salazar J, Ortiz R, Durán Agüero S, Gravini-Donado M, Bermúdez V, Díaz-Camargo E.",Nutrients. 2021 Jun 30;13(7):2254. doi: 10.3390/nu13072254.,Rojas M,Nutrients,2021,02-07-2021,PMC8308252,,10.3390/nu13072254
34208575,"Brain Disposition of Antibody-Based Therapeutics: Dogma, Approaches and Perspectives","Kouhi A, Pachipulusu V, Kapenstein T, Hu P, Epstein AL, Khawli LA.",Int J Mol Sci. 2021 Jun 16;22(12):6442. doi: 10.3390/ijms22126442.,Kouhi A,Int J Mol Sci,2021,02-07-2021,PMC8235515,,10.3390/ijms22126442
34208482,Bridging Cyanobacteria to Neurodegenerative Diseases: A New Potential Source of Bioactive Compounds against Alzheimer's Disease,"Castaneda A, Ferraz R, Vieira M, Cardoso I, Vasconcelos V, Martins R.",Mar Drugs. 2021 Jun 16;19(6):343. doi: 10.3390/md19060343.,Castaneda A,Mar Drugs,2021,02-07-2021,PMC8235772,,10.3390/md19060343
34207701,Multi-Component Intervention Program on Habitual Physical Activity Parameters and Cognitive Function in Patients with Mild Cognitive Impairment: A Randomized Controlled Trial,"Jeong MK, Park KW, Ryu JK, Kim GM, Jung HH, Park H.",Int J Environ Res Public Health. 2021 Jun 9;18(12):6240. doi: 10.3390/ijerph18126240.,Jeong MK,Int J Environ Res Public Health,2021,02-07-2021,PMC8296099,,10.3390/ijerph18126240
34207264,Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors,"Behl T, Kaur D, Sehgal A, Singh S, Sharma N, Zengin G, Andronie-Cioara FL, Toma MM, Bungau S, Bumbu AG.",Molecules. 2021 Jun 18;26(12):3724. doi: 10.3390/molecules26123724.,Behl T,Molecules,2021,02-07-2021,PMC8234097,,10.3390/molecules26123724
34206089,An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?,"Sciaccaluga M, Megaro A, Bellomo G, Ruffolo G, Romoli M, Palma E, Costa C.",Int J Mol Sci. 2021 Jun 1;22(11):5991. doi: 10.3390/ijms22115991.,Sciaccaluga M,Int J Mol Sci,2021,02-07-2021,PMC8199544,,10.3390/ijms22115991
34205123,"Dual-Specificity, Tyrosine Phosphorylation-Regulated Kinases (DYRKs) and cdc2-Like Kinases (CLKs) in Human Disease, an Overview","Lindberg MF, Meijer L.",Int J Mol Sci. 2021 Jun 3;22(11):6047. doi: 10.3390/ijms22116047.,Lindberg MF,Int J Mol Sci,2021,02-07-2021,PMC8199962,,10.3390/ijms22116047
34204308,Role of Withaferin A and Its Derivatives in the Management of Alzheimer's Disease: Recent Trends and Future Perspectives,"Das R, Rauf A, Akhter S, Islam MN, Emran TB, Mitra S, Khan IN, Mubarak MS.",Molecules. 2021 Jun 17;26(12):3696. doi: 10.3390/molecules26123696.,Das R,Molecules,2021,02-07-2021,PMC8234716,,10.3390/molecules26123696
34203244,Exploitation of Marine Molecules to Manage Alzheimer's Disease,"Silva M, Seijas P, Otero P.",Mar Drugs. 2021 Jun 28;19(7):373. doi: 10.3390/md19070373.,Silva M,Mar Drugs,2021,02-07-2021,PMC8307759,,10.3390/md19070373
34194012,Targeting oxidative stress in disease: promise and limitations of antioxidant therapy,"Forman HJ, Zhang H.",Nat Rev Drug Discov. 2021 Sep;20(9):689-709. doi: 10.1038/s41573-021-00233-1. Epub 2021 Jun 30.,Forman HJ,Nat Rev Drug Discov,2021,01-07-2021,PMC8243062,,10.1038/s41573-021-00233-1
34193983,Optical coherence tomography angiography in Alzheimer's disease: a systematic review and meta-analysis,"Katsimpris A, Karamaounas A, Sideri AM, Katsimpris J, Georgalas I, Petrou P.",Eye (Lond). 2022 Jul;36(7):1419-1426. doi: 10.1038/s41433-021-01648-1. Epub 2021 Jun 30.,Katsimpris A,Eye (Lond),2022,01-07-2021,PMC9232568,,10.1038/s41433-021-01648-1
34193504,Repurposing bromocriptine for Aβ metabolism in Alzheimer's disease (REBRAnD) study: randomised placebo-controlled double-blind comparative trial and open-label extension trial to investigate the safety and efficacy of bromocriptine in Alzheimer's disease with presenilin 1 (PSEN1) mutations,"Kondo T, Banno H, Okunomiya T, Amino Y, Endo K, Nakakura A, Uozumi R, Kinoshita A, Tada H, Morita S, Ishikawa H, Shindo A, Yasuda K, Taruno Y, Maki T, Suehiro T, Mori K, Ikeda M, Fujita K, Izumi Y, Kanemaru K, Ishii K, Shigenobu K, Kutoku Y, Sunada Y, Kawakatsu S, Shiota S, Watanabe T, Uchikawa O, Takahashi R, Tomimoto H, Inoue H.",BMJ Open. 2021 Jun 30;11(6):e051343. doi: 10.1136/bmjopen-2021-051343.,Kondo T,BMJ Open,2021,01-07-2021,PMC8246358,,10.1136/bmjopen-2021-051343
34188459,Effects of ICT-Based Multicomponent Program on Body Composition and Cognitive Function in Older Adults: A Randomized Controlled Clinical Study,"Kim DR, Song S, Kim GM, Chang JH, Tak YJ, Huh U, Cho JS, Liao Y, Han KS, Ko MH, Park JH.",Clin Interv Aging. 2021 Jun 21;16:1161-1171. doi: 10.2147/CIA.S306894. eCollection 2021.,Kim DR,Clin Interv Aging,2021,30-06-2021,PMC8232840,,10.2147/CIA.S306894
34186009,Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease,"Balendra V, Singh SK.",Open Biol. 2021 Jun;11(6):210013. doi: 10.1098/rsob.210013. Epub 2021 Jun 30.,Balendra V,Open Biol,2021,29-06-2021,PMC8241491,,10.1098/rsob.210013
34183688,Plasma neurofilament light chain is associated with cognitive decline in non-dementia older adults,"He L, Morley JE, Aggarwal G, Nguyen AD, Vellas B, de Souto Barreto P; MAPT/DSA Group.",Sci Rep. 2021 Jun 28;11(1):13394. doi: 10.1038/s41598-021-91038-0.,He L,Sci Rep,2021,29-06-2021,PMC8238930,,10.1038/s41598-021-91038-0
34183087,A tablet-based intervention for activating nursing home residents with dementia: results from a cluster-randomized controlled trial,"O'Sullivan JL, Lech S, Gellert P, Grittner U, Voigt-Antons JN, Möller S, Kuhlmey A, Nordheim J.",Int Psychogeriatr. 2022 Feb;34(2):129-141. doi: 10.1017/S1041610221000818. Epub 2021 Jun 29.,O'Sullivan JL,Int Psychogeriatr,2022,29-06-2021,,,10.1017/S1041610221000818
34181171,Recent advances on drug development and emerging therapeutic agents for Alzheimer's disease,"Athar T, Al Balushi K, Khan SA.",Mol Biol Rep. 2021 Jul;48(7):5629-5645. doi: 10.1007/s11033-021-06512-9. Epub 2021 Jun 28.,Athar T,Mol Biol Rep,2021,28-06-2021,PMC8236749,,10.1007/s11033-021-06512-9
34177558,Neurofeedback and the Aging Brain: A Systematic Review of Training Protocols for Dementia and Mild Cognitive Impairment,"Trambaiolli LR, Cassani R, Mehler DMA, Falk TH.",Front Aging Neurosci. 2021 Jun 9;13:682683. doi: 10.3389/fnagi.2021.682683. eCollection 2021.,Trambaiolli LR,Front Aging Neurosci,2021,28-06-2021,PMC8221422,,10.3389/fnagi.2021.682683
34174392,White matter plasticity in healthy older adults: The effects of aerobic exercise,"Mendez Colmenares A, Voss MW, Fanning J, Salerno EA, Gothe NP, Thomas ML, McAuley E, Kramer AF, Burzynska AZ.",Neuroimage. 2021 Oct 1;239:118305. doi: 10.1016/j.neuroimage.2021.118305. Epub 2021 Jun 24.,Mendez Colmenares A,Neuroimage,2021,26-06-2021,,,10.1016/j.neuroimage.2021.118305
34166841,"Rationale, study design and implementation of the LUCINDA Trial: Leuprolide plus Cholinesterase Inhibition to reduce Neurologic Decline in Alzheimer's","Butler T, Goldberg JD, Galvin JE, Maloney T, Ravdin L, Glodzik L, de Leon MJ, Hochman T, Bowen RL, Atwood CS.",Contemp Clin Trials. 2021 Aug;107:106488. doi: 10.1016/j.cct.2021.106488. Epub 2021 Jun 22.,Butler T,Contemp Clin Trials,2021,24-06-2021,PMC8550816,NIHMS1721038,10.1016/j.cct.2021.106488
34164794,"Safety and Pharmacokinetics of HTL0018318, a Novel M(1) Receptor Agonist, Given in Combination with Donepezil at Steady State: A Randomized Trial in Healthy Elderly Subjects","Bakker C, van der Aart J, Labots G, Liptrot J, Cross DM, Klaassen ES, Dickinson S, Tasker T, Groeneveld GJ.",Drugs R D. 2021 Sep;21(3):295-304. doi: 10.1007/s40268-021-00352-5. Epub 2021 Jun 23.,Bakker C,Drugs R D,2021,24-06-2021,PMC8363684,,10.1007/s40268-021-00352-5
34158290,Risk of dementia in gout and hyperuricaemia: a meta-analysis of cohort studies,"Pan SY, Cheng RJ, Xia ZJ, Zhang QP, Liu Y.",BMJ Open. 2021 Jun 22;11(6):e041680. doi: 10.1136/bmjopen-2020-041680.,Pan SY,BMJ Open,2021,23-06-2021,PMC8220455,,10.1136/bmjopen-2020-041680
34155411,A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease,"Salloway S, Farlow M, McDade E, Clifford DB, Wang G, Llibre-Guerra JJ, Hitchcock JM, Mills SL, Santacruz AM, Aschenbrenner AJ, Hassenstab J, Benzinger TLS, Gordon BA, Fagan AM, Coalier KA, Cruchaga C, Goate AA, Perrin RJ, Xiong C, Li Y, Morris JC, Snider BJ, Mummery C, Surti GM, Hannequin D, Wallon D, Berman SB, Lah JJ, Jimenez-Velazquez IZ, Roberson ED, van Dyck CH, Honig LS, Sánchez-Valle R, Brooks WS, Gauthier S, Galasko DR, Masters CL, Brosch JR, Hsiung GR, Jayadev S, Formaglio M, Masellis M, Clarnette R, Pariente J, Dubois B, Pasquier F, Jack CR Jr, Koeppe R, Snyder PJ, Aisen PS, Thomas RG, Berry SM, Wendelberger BA, Andersen SW, Holdridge KC, Mintun MA, Yaari R, Sims JR, Baudler M, Delmar P, Doody RS, Fontoura P, Giacobino C, Kerchner GA, Bateman RJ; Dominantly Inherited Alzheimer Network–Trials Unit.",Nat Med. 2021 Jul;27(7):1187-1196. doi: 10.1038/s41591-021-01369-8. Epub 2021 Jun 21.,Salloway S,Nat Med,2021,22-06-2021,PMC8988051,NIHMS1790300,10.1038/s41591-021-01369-8
34154581,The promising shadow of microbubble over medical sciences: from fighting wide scope of prevalence disease to cancer eradication,"Jangjou A, Meisami AH, Jamali K, Niakan MH, Abbasi M, Shafiee M, Salehi M, Hosseinzadeh A, Amani AM, Vaez A.",J Biomed Sci. 2021 Jun 21;28(1):49. doi: 10.1186/s12929-021-00744-4.,Jangjou A,J Biomed Sci,2021,22-06-2021,PMC8215828,,10.1186/s12929-021-00744-4
34151817,Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease,"Targum SD, Fosdick L, Drake KE, Rosenberg PB, Burke AD, Wolk DA, Foote KD, Asaad WF, Sabbagh M, Smith GS, Lozano AM, Lyketsos CG.",J Alzheimers Dis. 2021;82(3):1243-1257. doi: 10.3233/JAD-210530.,Targum SD,J Alzheimers Dis,2021,21-06-2021,PMC8461716,,10.3233/JAD-210530
34151595,Preliminary Validation of the Triana Test: A New Story Recall Test Based on Emotional Material,"Luque-Tirado A, Rodrigo-Herrero S, Sánchez-Arjona MB, Franco-Macías E.",Am J Alzheimers Dis Other Demen. 2021 Jan-Dec;36:15333175211025911. doi: 10.1177/15333175211025911.,Luque-Tirado A,Am J Alzheimers Dis Other Demen,2021,21-06-2021,PMC10581115,,10.1177/15333175211025911
34146517,Effectiveness of Brain Gaming in Older Adults With Cognitive Impairments: A Systematic Review and Meta-Analysis,"Kletzel SL, Sood P, Negm A, Heyn PC, Krishnan S, Machtinger J, Hu X, Devos H.",J Am Med Dir Assoc. 2021 Nov;22(11):2281-2288.e5. doi: 10.1016/j.jamda.2021.05.022. Epub 2021 Jun 16.,Kletzel SL,J Am Med Dir Assoc,2021,19-06-2021,PMC8628430,NIHMS1750305,10.1016/j.jamda.2021.05.022
34145880,"Riluzole, a glutamate modulator, slows cerebral glucose metabolism decline in patients with Alzheimer's disease","Matthews DC, Mao X, Dowd K, Tsakanikas D, Jiang CS, Meuser C, Andrews RD, Lukic AS, Lee J, Hampilos N, Shafiian N, Sano M, David Mozley P, Fillit H, McEwen BS, Shungu DC, Pereira AC.",Brain. 2021 Dec 31;144(12):3742-3755. doi: 10.1093/brain/awab222.,Matthews DC,Brain,2021,19-06-2021,PMC8719848,,10.1093/brain/awab222
34144200,Challenges in the management of chronic wound infections,"Falcone M, De Angelis B, Pea F, Scalise A, Stefani S, Tasinato R, Zanetti O, Dalla Paola L.",J Glob Antimicrob Resist. 2021 Sep;26:140-147. doi: 10.1016/j.jgar.2021.05.010. Epub 2021 Jun 16.,Falcone M,J Glob Antimicrob Resist,2021,18-06-2021,,,10.1016/j.jgar.2021.05.010
34140586,A methodology for an acute exercise clinical trial called dementia risk and dynamic response to exercise,"White D, John CS, Kucera A, Truver B, Lepping RJ, Kueck PJ, Lee P, Martin L, Billinger SA, Burns JM, Morris JK, Vidoni ED.",Sci Rep. 2021 Jun 17;11(1):12776. doi: 10.1038/s41598-021-92177-0.,White D,Sci Rep,2021,18-06-2021,PMC8211849,,10.1038/s41598-021-92177-0
34134758,Enriched gardens improve cognition and independence of nursing home residents with dementia: a pilot controlled trial,"Bourdon E, Belmin J.",Alzheimers Res Ther. 2021 Jun 16;13(1):116. doi: 10.1186/s13195-021-00849-w.,Bourdon E,Alzheimers Res Ther,2021,17-06-2021,PMC8207740,,10.1186/s13195-021-00849-w
34134667,The preventive efficacy of vitamin B supplements on the cognitive decline of elderly adults: a systematic review and meta-analysis,"Li S, Guo Y, Men J, Fu H, Xu T.",BMC Geriatr. 2021 Jun 16;21(1):367. doi: 10.1186/s12877-021-02253-3.,Li S,BMC Geriatr,2021,17-06-2021,PMC8207668,,10.1186/s12877-021-02253-3
34131267,Omega-3 polyunsaturated fatty acids protect against inflammation through production of LOX and CYP450 lipid mediators: relevance for major depression and for human hippocampal neurogenesis,"Borsini A, Nicolaou A, Camacho-Muñoz D, Kendall AC, Di Benedetto MG, Giacobbe J, Su KP, Pariante CM.",Mol Psychiatry. 2021 Nov;26(11):6773-6788. doi: 10.1038/s41380-021-01160-8. Epub 2021 Jun 16.,Borsini A,Mol Psychiatry,2021,16-06-2021,PMC8760043,,10.1038/s41380-021-01160-8
34126778,Implementation Science in Thailand: Design and Methods of a Geriatric Mental Health Cluster-Randomized Trial,"Chen H, Levkoff S, Chuengsatiansup K, Sihapark S, Hinton L, Gallagher-Thompson D, Tongsiri S, Wisetpholchai B, Fritz S, Lamont A, Domlyn A, Wandersman A, Marques AH.",Psychiatr Serv. 2022 Jan 1;73(1):83-91. doi: 10.1176/appi.ps.202000028. Epub 2021 Jun 15.,Chen H,Psychiatr Serv,2022,15-06-2021,PMC8785231,NIHMS1706552,10.1176/appi.ps.202000028
34124244,The Influence of Serum Uric Acid Level on Alzheimer's Disease: A Narrative Review,"Qiao M, Chen C, Liang Y, Luo Y, Wu W.",Biomed Res Int. 2021 Jun 2;2021:5525710. doi: 10.1155/2021/5525710. eCollection 2021.,Qiao M,Biomed Res Int,2021,14-06-2021,PMC8192189,,10.1155/2021/5525710
34122601,Efficacy and Safety of Scalp Acupuncture for Insomnia: A Systematic Review and Meta-Analysis,"Liu FG, Tan AH, Peng CQ, Tan YX, Yao MC.",Evid Based Complement Alternat Med. 2021 May 22;2021:6621993. doi: 10.1155/2021/6621993. eCollection 2021.,Liu FG,Evid Based Complement Alternat Med,2021,14-06-2021,PMC8166479,,10.1155/2021/6621993
34120175,Efficacy of exercise-based interventions in preventing falls among community-dwelling older persons with cognitive impairment: is there enough evidence? An updated systematic review and meta-analysis,"Li F, Harmer P, Eckstrom E, Ainsworth BE, Fitzgerald K, Voit J, Chou LS, Welker FL, Needham S.",Age Ageing. 2021 Sep 11;50(5):1557-1568. doi: 10.1093/ageing/afab110.,Li F,Age Ageing,2021,13-06-2021,PMC8437077,,10.1093/ageing/afab110
34118986,Role of liraglutide in Alzheimer's disease pathology,"Vargas-Soria M, Carranza-Naval MJ, Del Marco A, Garcia-Alloza M.",Alzheimers Res Ther. 2021 Jun 12;13(1):112. doi: 10.1186/s13195-021-00853-0.,Vargas-Soria M,Alzheimers Res Ther,2021,13-06-2021,PMC8199799,,10.1186/s13195-021-00853-0
34112355,Zinc,"Skalny AV, Aschner M, Tinkov AA.",Adv Food Nutr Res. 2021;96:251-310. doi: 10.1016/bs.afnr.2021.01.003. Epub 2021 May 24.,Skalny AV,Adv Food Nutr Res,2021,11-06-2021,PMC8208231,NIHMS1708141,10.1016/bs.afnr.2021.01.003
34110536,Critical Appraisal of Amyloid Lowering Agents in AD,"Decourt B, Boumelhem F, Pope ED 3rd, Shi J, Mari Z, Sabbagh MN.",Curr Neurol Neurosci Rep. 2021 Jun 10;21(8):39. doi: 10.1007/s11910-021-01125-y.,Decourt B,Curr Neurol Neurosci Rep,2021,10-06-2021,PMC8192384,,10.1007/s11910-021-01125-y
34105297,Physiological and Pathological Factors Affecting Drug Delivery to the Brain by Nanoparticles,"Islam Y, Leach AG, Smith J, Pluchino S, Coxon CR, Sivakumaran M, Downing J, Fatokun AA, Teixidò M, Ehtezazi T.",Adv Sci (Weinh). 2021 Jun;8(11):e2002085. doi: 10.1002/advs.202002085. Epub 2021 Mar 15.,Islam Y,Adv Sci (Weinh),2021,09-06-2021,PMC8188209,,10.1002/advs.202002085
34101780,"Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer's Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial","Chen H, Liu S, Ge B, Zhou D, Li M, Li W, Ma F, Liu Z, Ji Y, Huang G.",J Prev Alzheimers Dis. 2021;8(3):249-256. doi: 10.14283/jpad.2021.22.,Chen H,J Prev Alzheimers Dis,2021,08-06-2021,PMC12280771,,10.14283/jpad.2021.22
34101779,Intranasal Insulin Reduces White Matter Hyperintensity Progression in Association with Improvements in Cognition and CSF Biomarker Profiles in Mild Cognitive Impairment and Alzheimer's Disease,"Kellar D, Lockhart SN, Aisen P, Raman R, Rissman RA, Brewer J, Craft S.",J Prev Alzheimers Dis. 2021;8(3):240-248. doi: 10.14283/jpad.2021.14.,Kellar D,J Prev Alzheimers Dis,2021,08-06-2021,PMC10233712,NIHMS1892908,10.14283/jpad.2021.14
34101156,Current Status of Clinical Trials on Tau Immunotherapies,"Ji C, Sigurdsson EM.",Drugs. 2021 Jul;81(10):1135-1152. doi: 10.1007/s40265-021-01546-6. Epub 2021 Jun 8.,Ji C,Drugs,2021,08-06-2021,PMC8752054,NIHMS1762215,10.1007/s40265-021-01546-6
34099360,Noradrenaline in the aging brain: Promoting cognitive reserve or accelerating Alzheimer's disease?,Mather M.,Semin Cell Dev Biol. 2021 Aug;116:108-124. doi: 10.1016/j.semcdb.2021.05.013. Epub 2021 Jun 4.,Mather M,Semin Cell Dev Biol,2021,08-06-2021,PMC8292227,NIHMS1711940,10.1016/j.semcdb.2021.05.013
34097124,The effects of trazodone on human cognition: a systematic review,"Gonçalo AMG, Vieira-Coelho MA.",Eur J Clin Pharmacol. 2021 Nov;77(11):1623-1637. doi: 10.1007/s00228-021-03161-6. Epub 2021 Jun 7.,Gonçalo AMG,Eur J Clin Pharmacol,2021,07-06-2021,PMC8182348,,10.1007/s00228-021-03161-6
34093436,Effects of Aerobic Exercise Training on Systemic Biomarkers and Cognition in Late Middle-Aged Adults at Risk for Alzheimer's Disease,"Gaitán JM, Moon HY, Stremlau M, Dubal DB, Cook DB, Okonkwo OC, van Praag H.",Front Endocrinol (Lausanne). 2021 May 20;12:660181. doi: 10.3389/fendo.2021.660181. eCollection 2021.,Gaitán JM,Front Endocrinol (Lausanne),2021,07-06-2021,PMC8173166,,10.3389/fendo.2021.660181
34088252,Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective,"Su LD, Wang N, Han J, Shen Y.",Neuroscientist. 2022 Oct;28(5):453-468. doi: 10.1177/10738584211021018. Epub 2021 Jun 4.,Su LD,Neuroscientist,2022,05-06-2021,PMC9449437,,10.1177/10738584211021018
34087277,Effects of physical exercise on plasma brain-derived neurotrophic factor in neurodegenerative disorders: A systematic review and meta-analysis of randomized controlled trials,"Ruiz-González D, Hernández-Martínez A, Valenzuela PL, Morales JS, Soriano-Maldonado A.",Neurosci Biobehav Rev. 2021 Sep;128:394-405. doi: 10.1016/j.neubiorev.2021.05.025. Epub 2021 Jun 1.,Ruiz-González D,Neurosci Biobehav Rev,2021,04-06-2021,,,10.1016/j.neubiorev.2021.05.025
34083161,Emerging insights into the role of albumin with plasma exchange in Alzheimer's disease management,"Costa M, Páez A.",Transfus Apher Sci. 2021 Jun;60(3):103164. doi: 10.1016/j.transci.2021.103164. Epub 2021 May 21.,Costa M,Transfus Apher Sci,2021,04-06-2021,,,10.1016/j.transci.2021.103164
34083109,New insights in drug development for Alzheimer's disease based on microglia function,"Qiao O, Ji H, Zhang Y, Zhang X, Zhang X, Liu N, Huang L, Liu C, Gao W.",Biomed Pharmacother. 2021 Aug;140:111703. doi: 10.1016/j.biopha.2021.111703. Epub 2021 Jun 1.,Qiao O,Biomed Pharmacother,2021,04-06-2021,,,10.1016/j.biopha.2021.111703
34078793,[Donepezil Reduces Amyloid Precursor Protein Endocytosis by Resulting from Increase in the Expression of Sorting Nexin Protein 33],Takada-Takatori Y.,Yakugaku Zasshi. 2021;141(6):851-856. doi: 10.1248/yakushi.20-00251-6.,Takada-Takatori Y,Yakugaku Zasshi,2021,03-06-2021,,,10.1248/yakushi.20-00251-6
34078792,[Development of a Novel Alzheimer's Disease Model Based on the Theory of the Toxic-conformer of Amyloid β],"Izuo N, Shimizu T, Murakami K, Irie K.",Yakugaku Zasshi. 2021;141(6):843-849. doi: 10.1248/yakushi.20-00251-5.,Izuo N,Yakugaku Zasshi,2021,03-06-2021,,,10.1248/yakushi.20-00251-5
34078790,[Pharmacokinetics/Pharmacodynamic Analysis to Link Pharmacokinetics to Efficacy and Drug Interaction of Alzheimer's Disease Drugs],Kiriyama A.,Yakugaku Zasshi. 2021;141(6):831-833. doi: 10.1248/yakushi.20-00251-3.,Kiriyama A,Yakugaku Zasshi,2021,03-06-2021,,,10.1248/yakushi.20-00251-3
34077494,"Plasma markers predict changes in amyloid, tau, atrophy and cognition in non-demented subjects","Pereira JB, Janelidze S, Stomrud E, Palmqvist S, van Westen D, Dage JL, Mattsson-Carlgren N, Hansson O.",Brain. 2021 Oct 22;144(9):2826-2836. doi: 10.1093/brain/awab163.,Pereira JB,Brain,2021,02-06-2021,PMC8557344,,10.1093/brain/awab163
34072914,Gluten and FODMAPs Relationship with Mental Disorders: Systematic Review,"Aranburu E, Matias S, Simón E, Larretxi I, Martínez O, Bustamante MÁ, Fernández-Gil MDP, Miranda J.",Nutrients. 2021 May 31;13(6):1894. doi: 10.3390/nu13061894.,Aranburu E,Nutrients,2021,02-06-2021,PMC8228761,,10.3390/nu13061894
34071695,Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer's Disease: Systematic Review and Meta-Analysis,"Zuin M, Cervellati C, Trentini A, Passaro A, Rosta V, Zimetti F, Zuliani G.",Diagnostics (Basel). 2021 May 28;11(6):984. doi: 10.3390/diagnostics11060984.,Zuin M,Diagnostics (Basel),2021,02-06-2021,PMC8229134,,10.3390/diagnostics11060984
34071350,Targeting Adrenergic Receptors in Metabolic Therapies for Heart Failure,Perez DM.,Int J Mol Sci. 2021 May 28;22(11):5783. doi: 10.3390/ijms22115783.,Perez DM,Int J Mol Sci,2021,02-06-2021,PMC8198887,,10.3390/ijms22115783
34068096,Some Candidate Drugs for Pharmacotherapy of Alzheimer's Disease,"Miziak B, Błaszczyk B, Czuczwar SJ.",Pharmaceuticals (Basel). 2021 May 13;14(5):458. doi: 10.3390/ph14050458.,Miziak B,Pharmaceuticals (Basel),2021,02-06-2021,PMC8152728,,10.3390/ph14050458
34067632,Coenzyme Q(10): Clinical Applications beyond Cardiovascular Diseases,"Testai L, Martelli A, Flori L, Cicero AFG, Colletti A.",Nutrients. 2021 May 17;13(5):1697. doi: 10.3390/nu13051697.,Testai L,Nutrients,2021,02-06-2021,PMC8156424,,10.3390/nu13051697
34065698,Virtual Reality-Based Cognitive Stimulation on People with Mild to Moderate Dementia due to Alzheimer's Disease: A Pilot Randomized Controlled Trial,"Oliveira J, Gamito P, Souto T, Conde R, Ferreira M, Corotnean T, Fernandes A, Silva H, Neto T.",Int J Environ Res Public Health. 2021 May 16;18(10):5290. doi: 10.3390/ijerph18105290.,Oliveira J,Int J Environ Res Public Health,2021,02-06-2021,PMC8156930,,10.3390/ijerph18105290
34065606,Green Tea Epigallocatechin-3-gallate (EGCG) Targeting Protein Misfolding in Drug Discovery for Neurodegenerative Diseases,"Gonçalves PB, Sodero ACR, Cordeiro Y.",Biomolecules. 2021 May 20;11(5):767. doi: 10.3390/biom11050767.,Gonçalves PB,Biomolecules,2021,02-06-2021,PMC8160836,,10.3390/biom11050767
34065042,Glutathione in the Brain,Aoyama K.,Int J Mol Sci. 2021 May 9;22(9):5010. doi: 10.3390/ijms22095010.,Aoyama K,Int J Mol Sci,2021,02-06-2021,PMC8125908,,10.3390/ijms22095010
34064670,The Effects of Statins on Neurotransmission and Their Neuroprotective Role in Neurological and Psychiatric Disorders,"Kosowski M, Smolarczyk-Kosowska J, Hachuła M, Maligłówka M, Basiak M, Machnik G, Pudlo R, Okopień B.",Molecules. 2021 May 11;26(10):2838. doi: 10.3390/molecules26102838.,Kosowski M,Molecules,2021,02-06-2021,PMC8150718,,10.3390/molecules26102838
34059401,Low Dose Lithium Treatment of Behavioral Complications in Alzheimer's Disease: Lit-AD Randomized Clinical Trial,"Devanand DP, Crocco E, Forester BP, Husain MM, Lee S, Vahia IV, Andrews H, Simon-Pearson L, Imran N, Luca L, Huey ED, Deliyannides DA, Pelton GH.",Am J Geriatr Psychiatry. 2022 Jan;30(1):32-42. doi: 10.1016/j.jagp.2021.04.014. Epub 2021 May 12.,Devanand DP,Am J Geriatr Psychiatry,2022,01-06-2021,PMC8586042,NIHMS1703560,10.1016/j.jagp.2021.04.014
34057813,Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis,"Jäkel L, De Kort AM, Klijn CJM, Schreuder FHBM, Verbeek MM.",Alzheimers Dement. 2022 Jan;18(1):10-28. doi: 10.1002/alz.12366. Epub 2021 May 31.,Jäkel L,Alzheimers Dement,2022,31-05-2021,PMC9290643,,10.1002/alz.12366
34054944,Diagnostic and Therapeutic Potential of Exosomal MicroRNAs for Neurodegenerative Diseases,"He M, Zhang HN, Tang ZC, Gao SG.",Neural Plast. 2021 May 16;2021:8884642. doi: 10.1155/2021/8884642. eCollection 2021.,He M,Neural Plast,2021,31-05-2021,PMC8143892,,10.1155/2021/8884642
34044875,A phase 2 double-blind placebo-controlled 24-week treatment clinical study of the p38 alpha kinase inhibitor neflamapimod in mild Alzheimer's disease,"Prins ND, Harrison JE, Chu HM, Blackburn K, Alam JJ, Scheltens P; REVERSE-SD Study Investigators.",Alzheimers Res Ther. 2021 May 27;13(1):106. doi: 10.1186/s13195-021-00843-2.,Prins ND,Alzheimers Res Ther,2021,28-05-2021,PMC8157623,,10.1186/s13195-021-00843-2
34043846,Risk of dementia in patients with atrial fibrillation: Short versus long follow-up. A systematic review and meta-analysis,"Zuin M, Roncon L, Passaro A, Bosi C, Cervellati C, Zuliani G.",Int J Geriatr Psychiatry. 2021 Oct;36(10):1488-1500. doi: 10.1002/gps.5582. Epub 2021 May 27.,Zuin M,Int J Geriatr Psychiatry,2021,27-05-2021,PMC8518611,,10.1002/gps.5582
34039035,Cognitive Impairment and Dementia After Stroke: Design and Rationale for the DISCOVERY Study,"Rost NS, Meschia JF, Gottesman R, Wruck L, Helmer K, Greenberg SM; DISCOVERY Investigators.",Stroke. 2021 Aug;52(8):e499-e516. doi: 10.1161/STROKEAHA.120.031611. Epub 2021 May 27.,Rost NS,Stroke,2021,27-05-2021,PMC8316324,NIHMS1698838,10.1161/STROKEAHA.120.031611
34034029,"Metallobiology and therapeutic chelation of biometals (copper, zinc and iron) in Alzheimer's disease: Limitations, and current and future perspectives","Fasae KD, Abolaji AO, Faloye TR, Odunsi AY, Oyetayo BO, Enya JI, Rotimi JA, Akinyemi RO, Whitworth AJ, Aschner M.",J Trace Elem Med Biol. 2021 Sep;67:126779. doi: 10.1016/j.jtemb.2021.126779. Epub 2021 May 15.,Fasae KD,J Trace Elem Med Biol,2021,25-05-2021,,,10.1016/j.jtemb.2021.126779
34028812,Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia,"Cunningham EL, Todd SA, Passmore P, Bullock R, McGuinness B.",Cochrane Database Syst Rev. 2021 May 24;5(5):CD004034. doi: 10.1002/14651858.CD004034.pub4.,Cunningham EL,Cochrane Database Syst Rev,2021,24-05-2021,PMC8142793,,10.1002/14651858.CD004034.pub4
34028358,Internet-Based Cognitive Behavioral Therapy for Patients Reporting Symptoms of Anxiety and Depression After Myocardial Infarction: U-CARE Heart Randomized Controlled Trial Twelve-Month Follow-up,"Humphries SM, Wallert J, Norlund F, Wallin E, Burell G, von Essen L, Held C, Olsson EMG.",J Med Internet Res. 2021 May 24;23(5):e25465. doi: 10.2196/25465.,Humphries SM,J Med Internet Res,2021,24-05-2021,PMC8185614,,10.2196/25465
34026447,Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges,"Zhang W, Mehta A, Tong Z, Esser L, Voelcker NH.",Adv Sci (Weinh). 2021 Mar 7;8(10):2003937. doi: 10.1002/advs.202003937. eCollection 2021 May.,Zhang W,Adv Sci (Weinh),2021,24-05-2021,PMC8132167,,10.1002/advs.202003937
34019093,Karyopherin abnormalities in neurodegenerative proteinopathies,"Pasha T, Zatorska A, Sharipov D, Rogelj B, Hortobágyi T, Hirth F.",Brain. 2021 Nov 29;144(10):2915-2932. doi: 10.1093/brain/awab201.,Pasha T,Brain,2021,21-05-2021,PMC8194669,,10.1093/brain/awab201
34013755,One-year aerobic exercise altered cerebral vasomotor reactivity in mild cognitive impairment,"Tomoto T, Tarumi T, Chen JN, Hynan LS, Cullum CM, Zhang R.",J Appl Physiol (1985). 2021 Jul 1;131(1):119-130. doi: 10.1152/japplphysiol.00158.2021. Epub 2021 May 20.,Tomoto T,J Appl Physiol (1985),2021,20-05-2021,PMC8325610,,10.1152/japplphysiol.00158.2021
34012020,Visuospatial working memory dysfunction from tapping span test as a diagnostic tool for patients with mild posterior cortical atrophy,"Funayama M, Takata T, Nakagawa Y, Sunagawa K, Nakajima A, Kawashima H, Mimura M.",Sci Rep. 2021 May 19;11(1):10580. doi: 10.1038/s41598-021-90159-w.,Funayama M,Sci Rep,2021,20-05-2021,PMC8134425,,10.1038/s41598-021-90159-w
34010531,Final Report of a Trial of Intensive versus Standard Blood-Pressure Control,"SPRINT Research Group; Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, Evans GW, Johnson KC, Kitzman DW, Oparil S, Rahman M, Reboussin DM, Rocco MV, Sink KM, Snyder JK, Whelton PK, Williamson JD, Wright JT Jr, Ambrosius WT.",N Engl J Med. 2021 May 20;384(20):1921-1930. doi: 10.1056/NEJMoa1901281.,SPRINT Research Group,N Engl J Med,2021,19-05-2021,PMC9907774,NIHMS1709331,10.1056/NEJMoa1901281
34006157,Lessons from the COVID-19 pandemic for improving outpatient neuropalliative care: A qualitative study of patient and caregiver perspectives,"Macchi ZA, Ayele R, Dini M, Lamira J, Katz M, Pantilat SZ, Jones J, Kluger BM.",Palliat Med. 2021 Jul;35(7):1258-1266. doi: 10.1177/02692163211017383. Epub 2021 May 18.,Macchi ZA,Palliat Med,2021,19-05-2021,PMC9447864,NIHMS1831334,10.1177/02692163211017383
34001020,Learning to play golf for elderly people with subjective memory complaints: feasibility of a single-blinded randomized pilot trial,"Stroehlein JK, Vieluf S, Zimmer P, Schenk A, Oberste M, Goelz C, van den Bongard F, Reinsberger C.",BMC Neurol. 2021 May 17;21(1):200. doi: 10.1186/s12883-021-02186-9.,Stroehlein JK,BMC Neurol,2021,18-05-2021,PMC8127313,,10.1186/s12883-021-02186-9
34000250,Efficacy of preclinical pharmacological interventions against alterations of neuronal network oscillations in Alzheimer's disease: A systematic review,"Isla AG, Balleza-Tapia H, Fisahn A.",Exp Neurol. 2021 Sep;343:113743. doi: 10.1016/j.expneurol.2021.113743. Epub 2021 May 14.,Isla AG,Exp Neurol,2021,17-05-2021,,,10.1016/j.expneurol.2021.113743
33999936,MADRID+90 study on factors associated with longevity: Study design and preliminary data,"Fernández-Blázquez MA, Del Ser T, Frades-Payo B, Ávila-Villanueva M, Valentí-Soler M, Benítez-Robredo MT, Bermejo-Aguña A, Pedrero-Pérez EJ, Quilis-Sancho J, Pastor AB, Fernández-Garrido C, Morales-Alonso S, Diaz-Olalla JM, Santos NC, Maestú F, Gómez-Ramírez J.",PLoS One. 2021 May 17;16(5):e0251796. doi: 10.1371/journal.pone.0251796. eCollection 2021.,Fernández-Blázquez MA,PLoS One,2021,17-05-2021,PMC8128242,,10.1371/journal.pone.0251796
33990649,Combination of automated brain volumetry on MRI and quantitative tau deposition on THK-5351 PET to support diagnosis of Alzheimer's disease,"Kim M, Kim SJ, Park JE, Yun J, Shim WH, Oh JS, Oh M, Roh JH, Seo SW, Oh SJ, Kim JS.",Sci Rep. 2021 May 14;11(1):10343. doi: 10.1038/s41598-021-89797-x.,Kim M,Sci Rep,2021,15-05-2021,PMC8121780,,10.1038/s41598-021-89797-x
33988909,Effects of comprehensive intervention on life quality among the elderly with Alzheimer Disease and their caregivers based on mixed models,"Yang L, Xuan C, Yu C, Jin X, Zheng P, Yan J.",Nurs Open. 2022 Mar;9(2):1412-1422. doi: 10.1002/nop2.917. Epub 2021 May 14.,Yang L,Nurs Open,2022,14-05-2021,PMC8859043,,10.1002/nop2.917
33980288,Factors contributing to cognitive improvement effects of acupuncture in patients with mild cognitive impairment: a pilot randomized controlled trial,"Kim JH, Cho MR, Shin JC, Park GC, Lee JS.",Trials. 2021 May 12;22(1):341. doi: 10.1186/s13063-021-05296-4.,Kim JH,Trials,2021,13-05-2021,PMC8117619,,10.1186/s13063-021-05296-4
33977757,A narrative review of the impact of cerebellar dysfunction and sleep disturbances after general anesthesia in patients with Alzheimer's disease,"Song B, Zhu J.",Ann Palliat Med. 2021 Jun;10(6):6919-6925. doi: 10.21037/apm-20-2597. Epub 2021 Apr 23.,Song B,Ann Palliat Med,2021,12-05-2021,,,10.21037/apm-20-2597
33976533,The Application of Zonisamide to Patients Suffering from Dementia with Lewy Bodies: Emerging Clinical Data,"Tousi B, Leverenz JB.",Drug Des Devel Ther. 2021 May 3;15:1811-1817. doi: 10.2147/DDDT.S240865. eCollection 2021.,Tousi B,Drug Des Devel Ther,2021,12-05-2021,PMC8106402,,10.2147/DDDT.S240865
33973646,Treatment of epilepsy for people with Alzheimer's disease,"Liu J, Wang LN.",Cochrane Database Syst Rev. 2021 May 11;5(5):CD011922. doi: 10.1002/14651858.CD011922.pub4.,Liu J,Cochrane Database Syst Rev,2021,11-05-2021,PMC8111487,,10.1002/14651858.CD011922.pub4
33971764,Psychoeducational Program for the Family Member Caregivers of People with Dementia to Reduce Perceived Burden and Increase Patient's Quality of Life: A Randomized Controlled Trial,"Tawfik NM, Sabry NA, Darwish H, Mowafy M, Soliman SSA.",J Prim Care Community Health. 2021 Jan-Dec;12:21501327211014088. doi: 10.1177/21501327211014088.,Tawfik NM,J Prim Care Community Health,2021,11-05-2021,PMC8120530,,10.1177/21501327211014088
33971031,Recent developments of HDAC inhibitors: Emerging indications and novel molecules,"Bondarev AD, Attwood MM, Jonsson J, Chubarev VN, Tarasov VV, Schiöth HB.",Br J Clin Pharmacol. 2021 Dec;87(12):4577-4597. doi: 10.1111/bcp.14889. Epub 2021 May 27.,Bondarev AD,Br J Clin Pharmacol,2021,10-05-2021,,,10.1111/bcp.14889
33970268,Change in CAIDE Dementia Risk Score and Neuroimaging Biomarkers During a 2-Year Multidomain Lifestyle Randomized Controlled Trial: Results of a Post-Hoc Subgroup Analysis,"Stephen R, Ngandu T, Liu Y, Peltonen M, Antikainen R, Kemppainen N, Laatikainen T, Lötjönen J, Rinne J, Strandberg T, Tuomilehto J, Vanninen R, Soininen H, Kivipelto M, Solomon A; FINGER Study Group.",J Gerontol A Biol Sci Med Sci. 2021 Jul 13;76(8):1407-1414. doi: 10.1093/gerona/glab130.,Stephen R,J Gerontol A Biol Sci Med Sci,2021,10-05-2021,PMC8277089,,10.1093/gerona/glab130
33965726,Leveraging hallmark Alzheimer's molecular targets using phytoconstituents: Current perspective and emerging trends,"Dhage PA, Sharbidre AA, Dakua SP, Balakrishnan S.",Biomed Pharmacother. 2021 Jul;139:111634. doi: 10.1016/j.biopha.2021.111634. Epub 2021 May 6.,Dhage PA,Biomed Pharmacother,2021,09-05-2021,,,10.1016/j.biopha.2021.111634
33957167,Neurocognitive effects of melatonin treatment in healthy adults and individuals with Alzheimer's disease and insomnia: A systematic review and meta-analysis of randomized controlled trials,"Sumsuzzman DM, Choi J, Jin Y, Hong Y.",Neurosci Biobehav Rev. 2021 Aug;127:459-473. doi: 10.1016/j.neubiorev.2021.04.034. Epub 2021 May 3.,Sumsuzzman DM,Neurosci Biobehav Rev,2021,06-05-2021,,,10.1016/j.neubiorev.2021.04.034
33952306,Anticancer drugs repurposed for Alzheimer's disease: a systematic review,"Ancidoni A, Bacigalupo I, Remoli G, Lacorte E, Piscopo P, Sarti G, Corbo M, Vanacore N, Canevelli M.",Alzheimers Res Ther. 2021 May 5;13(1):96. doi: 10.1186/s13195-021-00831-6.,Ancidoni A,Alzheimers Res Ther,2021,06-05-2021,PMC8101105,,10.1186/s13195-021-00831-6
33946588,Alzheimer's Disease-Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran,Grossmann K.,Int J Mol Sci. 2021 Apr 30;22(9):4805. doi: 10.3390/ijms22094805.,Grossmann K,Int J Mol Sci,2021,05-05-2021,PMC8125318,,10.3390/ijms22094805
33946349,Nitric Oxide as a Target for Phytochemicals in Anti-Neuroinflammatory Prevention Therapy,"Subedi L, Gaire BP, Parveen A, Kim SY.",Int J Mol Sci. 2021 Apr 30;22(9):4771. doi: 10.3390/ijms22094771.,Subedi L,Int J Mol Sci,2021,05-05-2021,PMC8124914,,10.3390/ijms22094771
33935094,"Paraoxonase 1, B Vitamins Supplementation, and Mild Cognitive Impairment","Perła-Kaján J, Włoczkowska O, Zioła-Frankowska A, Frankowski M, Smith AD, de Jager CA, Refsum H, Jakubowski H.",J Alzheimers Dis. 2021;81(3):1211-1229. doi: 10.3233/JAD-210137.,Perła-Kaján J,J Alzheimers Dis,2021,03-05-2021,PMC8293656,,10.3233/JAD-210137
33930191,Promising tacrine/huperzine A-based dimeric acetylcholinesterase inhibitors for neurodegenerative disorders: From relieving symptoms to modifying diseases through multitarget,"Mak S, Li W, Fu H, Luo J, Cui W, Hu S, Pang Y, Carlier PR, Tsim KW, Pi R, Han Y.",J Neurochem. 2021 Sep;158(6):1381-1393. doi: 10.1111/jnc.15379. Epub 2021 Jul 5.,Mak S,J Neurochem,2021,30-04-2021,PMC8458250,NIHMS1738554,10.1111/jnc.15379
33929683,Alzheimer's Disease and Epilepsy: A Perspective on the Opportunities for Overlapping Therapeutic Innovation,"Lehmann L, Lo A, Knox KM, Barker-Haliski M.",Neurochem Res. 2021 Aug;46(8):1895-1912. doi: 10.1007/s11064-021-03332-y. Epub 2021 Apr 30.,Lehmann L,Neurochem Res,2021,30-04-2021,PMC8254705,NIHMS1705711,10.1007/s11064-021-03332-y
33925284,HDL Cholesterol and Non-Cardiovascular Disease: A Narrative Review,"Kjeldsen EW, Nordestgaard LT, Frikke-Schmidt R.",Int J Mol Sci. 2021 Apr 27;22(9):4547. doi: 10.3390/ijms22094547.,Kjeldsen EW,Int J Mol Sci,2021,30-04-2021,PMC8123633,,10.3390/ijms22094547
33924876,"Resveratrol, Metabolic Dysregulation, and Alzheimer's Disease: Considerations for Neurogenerative Disease","Yang AJT, Bagit A, MacPherson REK.",Int J Mol Sci. 2021 Apr 28;22(9):4628. doi: 10.3390/ijms22094628.,Yang AJT,Int J Mol Sci,2021,30-04-2021,PMC8125227,,10.3390/ijms22094628
33923999,The Effects of Bariatric Surgery on Vitamin B Status and Mental Health,"Al Mansoori A, Shakoor H, Ali HI, Feehan J, Al Dhaheri AS, Cheikh Ismail L, Bosevski M, Apostolopoulos V, Stojanovska L.",Nutrients. 2021 Apr 20;13(4):1383. doi: 10.3390/nu13041383.,Al Mansoori A,Nutrients,2021,30-04-2021,PMC8073305,,10.3390/nu13041383
33923359,The Role of Resveratrol in Human Male Fertility,"Mongioì LM, Perelli S, Condorelli RA, Barbagallo F, Crafa A, Cannarella R, La Vignera S, Calogero AE.",Molecules. 2021 Apr 24;26(9):2495. doi: 10.3390/molecules26092495.,Mongioì LM,Molecules,2021,30-04-2021,PMC8123193,,10.3390/molecules26092495
33921992,Importance of Bioactive Substances in Sheep's Milk in Human Health,"Flis Z, Molik E.",Int J Mol Sci. 2021 Apr 22;22(9):4364. doi: 10.3390/ijms22094364.,Flis Z,Int J Mol Sci,2021,30-04-2021,PMC8122369,,10.3390/ijms22094364
33921556,Alternative Targets to Fight Alzheimer's Disease: Focus on Astrocytes,"Valenza M, Facchinetti R, Menegoni G, Steardo L, Scuderi C.",Biomolecules. 2021 Apr 19;11(4):600. doi: 10.3390/biom11040600.,Valenza M,Biomolecules,2021,30-04-2021,PMC8073475,,10.3390/biom11040600
33920971,Effects of Two Randomized and Controlled Multi-Component Interventions Focusing On 24-Hour Movement Behavior among Office Workers: A Compositional Data Analysis,"Larisch LM, Bojsen-Møller E, Nooijen CFJ, Blom V, Ekblom M, Ekblom Ö, Arvidsson D, Fridolfsson J, Hallman DM, Mathiassen SE, Wang R, Kallings LV.",Int J Environ Res Public Health. 2021 Apr 15;18(8):4191. doi: 10.3390/ijerph18084191.,Larisch LM,Int J Environ Res Public Health,2021,30-04-2021,PMC8071247,,10.3390/ijerph18084191
33920726,"A Comprehensive Analysis into the Therapeutic Application of Natural Products as SIRT6 Modulators in Alzheimer's Disease, Aging, Cancer, Inflammation, and Diabetes","Akter R, Afrose A, Rahman MR, Chowdhury R, Nirzhor SSR, Khan RI, Kabir MT.",Int J Mol Sci. 2021 Apr 17;22(8):4180. doi: 10.3390/ijms22084180.,Akter R,Int J Mol Sci,2021,30-04-2021,PMC8073883,,10.3390/ijms22084180
33920326,Recent Developments in New Therapeutic Agents against Alzheimer and Parkinson Diseases: In-Silico Approaches,"Cruz-Vicente P, Passarinha LA, Silvestre S, Gallardo E.",Molecules. 2021 Apr 11;26(8):2193. doi: 10.3390/molecules26082193.,Cruz-Vicente P,Molecules,2021,30-04-2021,PMC8069930,,10.3390/molecules26082193
33919010,Cannabidiol in Neurological and Neoplastic Diseases: Latest Developments on the Molecular Mechanism of Action,"Ożarowski M, Karpiński TM, Zielińska A, Souto EB, Wielgus K.",Int J Mol Sci. 2021 Apr 21;22(9):4294. doi: 10.3390/ijms22094294.,Ożarowski M,Int J Mol Sci,2021,30-04-2021,PMC8122338,,10.3390/ijms22094294
33917843,Neuroprotective Herbs for the Management of Alzheimer's Disease,"Gregory J, Vengalasetti YV, Bredesen DE, Rao RV.",Biomolecules. 2021 Apr 8;11(4):543. doi: 10.3390/biom11040543.,Gregory J,Biomolecules,2021,30-04-2021,PMC8068256,,10.3390/biom11040543
33915701,Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761(®)),"Tomino C, Ilari S, Solfrizzi V, Malafoglia V, Zilio G, Russo P, Proietti S, Marcolongo F, Scapagnini G, Muscoli C, Rossini PM.",Pharmaceuticals (Basel). 2021 Apr 1;14(4):305. doi: 10.3390/ph14040305.,Tomino C,Pharmaceuticals (Basel),2021,30-04-2021,PMC8065464,,10.3390/ph14040305
33915501,Potential therapeutic natural products against Alzheimer's disease with Reference of Acetylcholinesterase,"Ahmed S, Khan ST, Zargaham MK, Khan AU, Khan S, Hussain A, Uddin J, Khan A, Al-Harrasi A.",Biomed Pharmacother. 2021 Jul;139:111609. doi: 10.1016/j.biopha.2021.111609. Epub 2021 May 4.,Ahmed S,Biomed Pharmacother,2021,29-04-2021,,,10.1016/j.biopha.2021.111609
33907010,Lithium beyond psychiatric indications: the reincarnation of a new old drug,"Haupt M, Bähr M, Doeppner TR.",Neural Regen Res. 2021 Dec;16(12):2383-2387. doi: 10.4103/1673-5374.313015.,Haupt M,Neural Regen Res,2021,28-04-2021,PMC8374558,,10.4103/1673-5374.313015
33905474,"Mapping autonomic, mood and cognitive effects of hypothalamic region deep brain stimulation","Neudorfer C, Elias GJB, Jakobs M, Boutet A, Germann J, Narang K, Loh A, Paff M, Horn A, Kucharczyk W, Deeb W, Salvato B, Almeida L, Foote KD, Rosenberg PB, Tang-Wai DF, Anderson WS, Mari Z, Ponce FA, Wolk DA, Burke AD, Salloway S, Sabbagh MN, Chakravarty MM, Smith GS, Lyketsos CG, Okun MS, Lozano AM.",Brain. 2021 Oct 22;144(9):2837-2851. doi: 10.1093/brain/awab170.,Neudorfer C,Brain,2021,27-04-2021,PMC8557336,,10.1093/brain/awab170
33904966,Memory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial,"Schmidt N, Tödt I, Berg D, Schlenstedt C, Folkerts AK, Ophey A, Dimenshteyn K, Elben S, Wojtecki L, Liepelt-Scarfone I, Schulte C, Sulzer P, Eggers C, Kalbe E, Witt K.",J Neurol. 2021 Dec;268(12):4655-4666. doi: 10.1007/s00415-021-10568-9. Epub 2021 Apr 27.,Schmidt N,J Neurol,2021,27-04-2021,PMC8563628,,10.1007/s00415-021-10568-9
33903610,Classification of patients with Alzheimer's disease using the arterial pulse spectrum and a multilayer-perceptron analysis,"Lin SK, Hsiu H, Chen HS, Yang CJ.",Sci Rep. 2021 Apr 26;11(1):8882. doi: 10.1038/s41598-021-87903-7.,Lin SK,Sci Rep,2021,27-04-2021,PMC8076260,,10.1038/s41598-021-87903-7
33900631,Protective properties of GLP-1 and associated peptide hormones in neurodegenerative disorders,Hölscher C.,Br J Pharmacol. 2022 Feb;179(4):695-714. doi: 10.1111/bph.15508. Epub 2021 May 29.,Hölscher C,Br J Pharmacol,2022,26-04-2021,PMC8820183,,10.1111/bph.15508
33891333,"Safety, pharmacokinetics and pharmacodynamics of HTL0009936, a selective muscarinic M(1) -acetylcholine receptor agonist: A randomized cross-over trial","Bakker C, Prins S, Liptrot J, Hart EP, Klaassen ES, Brown GA, Brown A, Congreve M, Weir M, Marshall FH, Stevens J, Cross DM, Tasker T, Nathan PJ, Groeneveld GJ.",Br J Clin Pharmacol. 2021 Nov;87(11):4439-4449. doi: 10.1111/bcp.14872. Epub 2021 May 8.,Bakker C,Br J Clin Pharmacol,2021,23-04-2021,PMC8596821,,10.1111/bcp.14872
33886503,"Growth differentiation factor 11: a ""rejuvenation factor"" involved in regulation of age-related diseases?","Ma Y, Liu Y, Han F, Qiu H, Shi J, Huang N, Hou N, Sun X.",Aging (Albany NY). 2021 Apr 22;13(8):12258-12272. doi: 10.18632/aging.202881. Epub 2021 Apr 22.,Ma Y,Aging (Albany NY),2021,22-04-2021,PMC8109099,,10.18632/aging.202881
33883008,"Safety, pharmacokinetics and exploratory pro-cognitive effects of HTL0018318, a selective M(1) receptor agonist, in healthy younger adult and elderly subjects: a multiple ascending dose study","Bakker C, Tasker T, Liptrot J, Hart EP, Klaassen ES, Doll RJ, Brown GA, Brown A, Congreve M, Weir M, Marshall FH, Cross DM, Groeneveld GJ, Nathan PJ.",Alzheimers Res Ther. 2021 Apr 21;13(1):87. doi: 10.1186/s13195-021-00816-5.,Bakker C,Alzheimers Res Ther,2021,22-04-2021,PMC8061066,,10.1186/s13195-021-00816-5
33882807,Essential Oils in Experimental Models of Neuropsychiatric Disorders: A Systematic Review,"Fernandes LCB, Costa IM, Freire MAM, Lima FOV, Neta FI, de Souza Lucena EE, Alves RD, Cavalcanti JRLP, Pinheiro FI, de Azevedo EP, Freitas CIA, Guzen FP.",Curr Neuropharmacol. 2021;19(10):1738-1759. doi: 10.2174/1570159X19666210421091734.,Fernandes LCB,Curr Neuropharmacol,2021,22-04-2021,PMC8977636,,10.2174/1570159X19666210421091734
33881530,Effect of Sodium Benzoate on Cognitive Function Among Patients With Behavioral and Psychological Symptoms of Dementia: Secondary Analysis of a Randomized Clinical Trial,"Lin CH, Chen PK, Wang SH, Lane HY.",JAMA Netw Open. 2021 Apr 1;4(4):e216156. doi: 10.1001/jamanetworkopen.2021.6156.,Lin CH,JAMA Netw Open,2021,21-04-2021,PMC8060832,,10.1001/jamanetworkopen.2021.6156
33878882,Prospects of Saffron and its Derivatives in Alzheimer's Disease,"Zandi N, Pazoki B, Momeni Roudsari N, Lashgari NA, Jamshidi V, Momtaz S, Abdolghaffari AH, Akhondzadeh S.",Arch Iran Med. 2021 Mar 1;24(3):233-252. doi: 10.34172/aim.2021.35.,Zandi N,Arch Iran Med,2021,21-04-2021,,,10.34172/aim.2021.35
33877683,Dantrolene repurposed to treat sepsis or septic shock and COVID-19 patients,"Wei H, Liang G, Vera RM.",Eur Rev Med Pharmacol Sci. 2021 Apr;25(7):3136-3144. doi: 10.26355/eurrev_202104_25569.,Wei H,Eur Rev Med Pharmacol Sci,2021,20-04-2021,PMC8612127,NIHMS1757096,10.26355/eurrev_202104_25569
33873195,Effects of a Mindfulness-Based Intervention versus Health Self-Management on Subclinical Anxiety in Older Adults with Subjective Cognitive Decline: The SCD-Well Randomized Superiority Trial,"Marchant NL, Barnhofer T, Coueron R, Wirth M, Lutz A, Arenaza-Urquijo EM, Collette F, Poisnel G, Demnitz-King H, Schild AK, Coll-Padros N, Delphin-Combe F, Whitfield T, Schlosser M, Gonneaud J, Asselineau J, Walker Z, Krolak-Salmon P, Molinuevo JL, Frison E, Chételat G, Jessen F, Klimecki OM; The Medit-Ageing Research Group.",Psychother Psychosom. 2021;90(5):341-350. doi: 10.1159/000515669. Epub 2021 Apr 19.,Marchant NL,Psychother Psychosom,2021,19-04-2021,,,10.1159/000515669
33872681,Development of grape polyphenols as multi-targeting strategies for Alzheimer's disease,"El Gaamouch F, Liu K, Lin HY, Wu C, Wang J.",Neurochem Int. 2021 Jul;147:105046. doi: 10.1016/j.neuint.2021.105046. Epub 2021 Apr 16.,El Gaamouch F,Neurochem Int,2021,19-04-2021,PMC8178246,NIHMS1694729,10.1016/j.neuint.2021.105046
33869067,Nanomaterial Complexes Enriched With Natural Compounds Used in Cancer Therapies: A Perspective for Clinical Application,"Saavedra-Leos MZ, Jordan-Alejandre E, López-Camarillo C, Pozos-Guillen A, Leyva-Porras C, Silva-Cázares MB.",Front Oncol. 2021 Apr 1;11:664380. doi: 10.3389/fonc.2021.664380. eCollection 2021.,Saavedra-Leos MZ,Front Oncol,2021,19-04-2021,PMC8047625,,10.3389/fonc.2021.664380
33865446,"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Aβ protofibril antibody","Swanson CJ, Zhang Y, Dhadda S, Wang J, Kaplow J, Lai RYK, Lannfelt L, Bradley H, Rabe M, Koyama A, Reyderman L, Berry DA, Berry S, Gordon R, Kramer LD, Cummings JL.",Alzheimers Res Ther. 2021 Apr 17;13(1):80. doi: 10.1186/s13195-021-00813-8.,Swanson CJ,Alzheimers Res Ther,2021,18-04-2021,PMC8053280,,10.1186/s13195-021-00813-8
33865016,Potential medicinal value of celastrol and its synthesized analogues for central nervous system diseases,"Bai X, Fu RJ, Zhang S, Yue SJ, Chen YY, Xu DQ, Tang YP.",Biomed Pharmacother. 2021 Jul;139:111551. doi: 10.1016/j.biopha.2021.111551. Epub 2021 Apr 14.,Bai X,Biomed Pharmacother,2021,17-04-2021,,,10.1016/j.biopha.2021.111551
33863370,Association of small intestinal bacterial overgrowth with Parkinson's disease: a systematic review and meta-analysis,"Li X, Feng X, Jiang Z, Jiang Z.",Gut Pathog. 2021 Apr 16;13(1):25. doi: 10.1186/s13099-021-00420-w.,Li X,Gut Pathog,2021,17-04-2021,PMC8051095,,10.1186/s13099-021-00420-w
33860614,Measures of resting state EEG rhythms for clinical trials in Alzheimer's disease: Recommendations of an expert panel,"Babiloni C, Arakaki X, Azami H, Bennys K, Blinowska K, Bonanni L, Bujan A, Carrillo MC, Cichocki A, de Frutos-Lucas J, Del Percio C, Dubois B, Edelmayer R, Egan G, Epelbaum S, Escudero J, Evans A, Farina F, Fargo K, Fernández A, Ferri R, Frisoni G, Hampel H, Harrington MG, Jelic V, Jeong J, Jiang Y, Kaminski M, Kavcic V, Kilborn K, Kumar S, Lam A, Lim L, Lizio R, Lopez D, Lopez S, Lucey B, Maestú F, McGeown WJ, McKeith I, Moretti DV, Nobili F, Noce G, Olichney J, Onofrj M, Osorio R, Parra-Rodriguez M, Rajji T, Ritter P, Soricelli A, Stocchi F, Tarnanas I, Taylor JP, Teipel S, Tucci F, Valdes-Sosa M, Valdes-Sosa P, Weiergräber M, Yener G, Guntekin B.",Alzheimers Dement. 2021 Sep;17(9):1528-1553. doi: 10.1002/alz.12311. Epub 2021 Apr 15.,Babiloni C,Alzheimers Dement,2021,16-04-2021,PMC8647863,NIHMS1757313,10.1002/alz.12311
33846962,"The Use, Standardization, and Interpretation of Brain Imaging Data in Clinical Trials of Neurodegenerative Disorders",Schwarz AJ.,Neurotherapeutics. 2021 Apr;18(2):686-708. doi: 10.1007/s13311-021-01027-4. Epub 2021 Apr 12.,Schwarz AJ,Neurotherapeutics,2021,13-04-2021,PMC8423963,,10.1007/s13311-021-01027-4
33845179,The brain as an insulin-sensitive metabolic organ,"Milstein JL, Ferris HA.",Mol Metab. 2021 Oct;52:101234. doi: 10.1016/j.molmet.2021.101234. Epub 2021 Apr 15.,Milstein JL,Mol Metab,2021,12-04-2021,PMC8513144,,10.1016/j.molmet.2021.101234
33843684,Repurposing Licensed Drugs for Use Against Alzheimer's Disease,Norins LC.,J Alzheimers Dis. 2021;81(3):921-932. doi: 10.3233/JAD-210080.,Norins LC,J Alzheimers Dis,2021,12-04-2021,PMC8293650,,10.3233/JAD-210080
33841302,Dominant and Modifiable Risk Factors for Dementia in Sub-Saharan Africa: A Systematic Review and Meta-Analysis,"Ojagbemi A, Okekunle AP, Babatunde O.",Front Neurol. 2021 Mar 25;12:627761. doi: 10.3389/fneur.2021.627761. eCollection 2021.,Ojagbemi A,Front Neurol,2021,12-04-2021,PMC8027065,,10.3389/fneur.2021.627761
33841079,Systemic Review on Transcranial Electrical Stimulation Parameters and EEG/fNIRS Features for Brain Diseases,"Yang D, Shin YI, Hong KS.",Front Neurosci. 2021 Mar 26;15:629323. doi: 10.3389/fnins.2021.629323. eCollection 2021.,Yang D,Front Neurosci,2021,12-04-2021,PMC8032955,,10.3389/fnins.2021.629323
33840227,Late-Life Vascular Risk Score in Association With Postmortem Cerebrovascular Disease Brain Pathologies,"Oveisgharan S, Yu L, Capuano A, Arvanitakis Z, Barnes LL, Schneider JA, Bennett DA, Buchman AS.",Stroke. 2021 Jun;52(6):2060-2067. doi: 10.1161/STROKEAHA.120.030226. Epub 2021 Apr 12.,Oveisgharan S,Stroke,2021,12-04-2021,PMC9069859,NIHMS1685903,10.1161/STROKEAHA.120.030226
33831607,Effects of monoclonal antibodies against amyloid-β on clinical and biomarker outcomes and adverse event risks: A systematic review and meta-analysis of phase III RCTs in Alzheimer's disease,"Avgerinos KI, Ferrucci L, Kapogiannis D.",Ageing Res Rev. 2021 Jul;68:101339. doi: 10.1016/j.arr.2021.101339. Epub 2021 Apr 5.,Avgerinos KI,Ageing Res Rev,2021,08-04-2021,PMC8161699,NIHMS1694211,10.1016/j.arr.2021.101339
33829706,[A Preliminary Study of Applying Geometric Deep Learning in Brain Morphometry for Diagnosis of Alzheimer's Disease],"Xie W, Sun HQ, Chen JW, Zeng Y, Xu X, Li ZL, Xia CC.",Sichuan Da Xue Xue Bao Yi Xue Ban. 2021 Mar;52(2):300-305. doi: 10.12182/20210360103.,Xie W,Sichuan Da Xue Xue Bao Yi Xue Ban,2021,08-04-2021,PMC10408926,,10.12182/20210360103
33827960,Plasma Neurofilament Light for Prediction of Disease Progression in Familial Frontotemporal Lobar Degeneration,"Rojas JC, Wang P, Staffaroni AM, Heller C, Cobigo Y, Wolf A, Goh SM, Ljubenkov PA, Heuer HW, Fong JC, Taylor JB, Veras E, Song L, Jeromin A, Hanlon D, Yu L, Khinikar A, Sivasankaran R, Kieloch A, Valentin MA, Karydas AM, Mitic LL, Pearlman R, Kornak J, Kramer JH, Miller BL, Kantarci K, Knopman DS, Graff-Radford N, Petrucelli L, Rademakers R, Irwin DJ, Grossman M, Ramos EM, Coppola G, Mendez MF, Bordelon Y, Dickerson BC, Ghoshal N, Huey ED, Mackenzie IR, Appleby BS, Domoto-Reilly K, Hsiung GR, Toga AW, Weintraub S, Kaufer DI, Kerwin D, Litvan I, Onyike CU, Pantelyat A, Roberson ED, Tartaglia MC, Foroud T, Chen W, Czerkowicz J, Graham DL, van Swieten JC, Borroni B, Sanchez-Valle R, Moreno F, Laforce R, Graff C, Synofzik M, Galimberti D, Rowe JB, Masellis M, Finger E, Vandenberghe R, de Mendonça A, Tagliavini F, Santana I, Ducharme S, Butler CR, Gerhard A, Levin J, Danek A, Otto M, Sorbi S, Cash DM, Convery RS, Bocchetta M, Foiani M, Greaves CV, Peakman G, Russell L, Swift I, Todd E, Rohrer JD, Boeve BF, Rosen HJ, Boxer AL; ALLFTD and GENFI consortia.",Neurology. 2021 May 4;96(18):e2296-e2312. doi: 10.1212/WNL.0000000000011848. Epub 2021 Apr 7.,Rojas JC,Neurology,2021,08-04-2021,PMC8166434,,10.1212/WNL.0000000000011848
33818905,Monoclonal antibody therapy efficacy can be boosted by combinations with other treatments: Predictions using an integrated Alzheimer's Disease Platform,"Karelina T, Lerner S, Stepanov A, Meerson M, Demin O.",CPT Pharmacometrics Syst Pharmacol. 2021 Jun;10(6):543-550. doi: 10.1002/psp4.12628. Epub 2021 May 2.,Karelina T,CPT Pharmacometrics Syst Pharmacol,2021,05-04-2021,PMC8213414,,10.1002/psp4.12628
33818342,The effectiveness of physical exercise interventions in the management of neuropsychiatric symptoms in dementia patients: a systematic review,"Kouloutbani K, Venetsanou F, Markati A, Karteroliotis KE, Politis A.",Int Psychogeriatr. 2022 Feb;34(2):177-190. doi: 10.1017/S1041610221000193. Epub 2021 Apr 5.,Kouloutbani K,Int Psychogeriatr,2022,05-04-2021,,,10.1017/S1041610221000193
33818039,Converging evidence in support of omega-3 polyunsaturated fatty acids as a potential therapy for Huntington's disease symptoms,"Vega OM, Cepeda C.",Rev Neurosci. 2021 Apr 5;32(8):871-886. doi: 10.1515/revneuro-2021-0013. Print 2021 Dec 20.,Vega OM,Rev Neurosci,2021,05-04-2021,PMC10017201,NIHMS1880825,10.1515/revneuro-2021-0013
33814447,A Precision Medicine Approach to Treating Alzheimer's Disease Using Rosiglitazone Therapy: A Biomarker Analysis of the REFLECT Trials,"O'Bryant SE, Zhang F, Petersen M, Johnson L, Hall J, Rissman RA.",J Alzheimers Dis. 2021;81(2):557-568. doi: 10.3233/JAD-201610.,O'Bryant SE,J Alzheimers Dis,2021,05-04-2021,PMC8203239,,10.3233/JAD-201610
33814437,"β-Lactolin Enhances Neural Activity, Indicated by Event-Related P300 Amplitude, in Healthy Adults: A Randomized Controlled Trial","Kanatome A, Ano Y, Shinagawa K, Ide Y, Shibata M, Umeda S.",J Alzheimers Dis. 2021;81(2):787-796. doi: 10.3233/JAD-201413.,Kanatome A,J Alzheimers Dis,2021,05-04-2021,PMC8203246,,10.3233/JAD-201413
33809987,Fenamates as Potential Therapeutics for Neurodegenerative Disorders,"Hill J, Zawia NH.",Cells. 2021 Mar 22;10(3):702. doi: 10.3390/cells10030702.,Hill J,Cells,2021,03-04-2021,PMC8004804,,10.3390/cells10030702
33805800,Cyclin-Dependent Kinases (CDK) and Their Role in Diseases Development-Review,"Łukasik P, Załuski M, Gutowska I.",Int J Mol Sci. 2021 Mar 13;22(6):2935. doi: 10.3390/ijms22062935.,Łukasik P,Int J Mol Sci,2021,03-04-2021,PMC7998717,,10.3390/ijms22062935
33804675,Citicoline in Ophthalmological Neurodegenerative Disease: A Comprehensive Review,"Oddone F, Rossetti L, Parravano M, Sbardella D, Coletta M, Ziccardi L, Roberti G, Carnevale C, Romano D, Manni G, Parisi V.",Pharmaceuticals (Basel). 2021 Mar 20;14(3):281. doi: 10.3390/ph14030281.,Oddone F,Pharmaceuticals (Basel),2021,03-04-2021,PMC8003774,,10.3390/ph14030281
33804658,A State of the Art of Antioxidant Properties of Curcuminoids in Neurodegenerative Diseases,"Silvestro S, Sindona C, Bramanti P, Mazzon E.",Int J Mol Sci. 2021 Mar 20;22(6):3168. doi: 10.3390/ijms22063168.,Silvestro S,Int J Mol Sci,2021,03-04-2021,PMC8003642,,10.3390/ijms22063168
33803217,Machine Learning and Novel Biomarkers for the Diagnosis of Alzheimer's Disease,"Chang CH, Lin CH, Lane HY.",Int J Mol Sci. 2021 Mar 9;22(5):2761. doi: 10.3390/ijms22052761.,Chang CH,Int J Mol Sci,2021,03-04-2021,PMC7963160,,10.3390/ijms22052761
33798735,Dichotomous role of microtubule associated protein tau as a biomarker of response to and a target for increasing efficacy of taxane treatment in cancers of epithelial origin,Barbolina MV.,Pharmacol Res. 2021 Jun;168:105585. doi: 10.1016/j.phrs.2021.105585. Epub 2021 Mar 30.,Barbolina MV,Pharmacol Res,2021,02-04-2021,PMC8165012,NIHMS1688879,10.1016/j.phrs.2021.105585
33798485,An Efficacy Trial of Long-Term Care Residents With Alzheimer's Disease Using Videos to Communicate Care Preferences,"Towsley GL, Wong B, Baier RR, Neller S.",J Am Med Dir Assoc. 2021 Jul;22(7):1559-1560. doi: 10.1016/j.jamda.2021.02.032. Epub 2021 Mar 30.,Towsley GL,J Am Med Dir Assoc,2021,02-04-2021,PMC8297558,NIHMS1724594,10.1016/j.jamda.2021.02.032
33787038,A systematic review and meta-analysis of the clinical effects of Souvenaid in patients with Alzheimer's disease,"Shim Y, Yoon B, Na S, Lim EY, Hong YJ, Yang DW.",Asia Pac J Clin Nutr. 2021;30(1):30-41. doi: 10.6133/apjcn.202103_30(1).0005.,Shim Y,Asia Pac J Clin Nutr,2021,31-03-2021,,,10.6133/apjcn.202103_30(1).0005
33781287,Precision therapeutic targets for COVID-19,"Krumm ZA, Lloyd GM, Francis CP, Nasif LH, Mitchell DA, Golde TE, Giasson BI, Xia Y.",Virol J. 2021 Mar 29;18(1):66. doi: 10.1186/s12985-021-01526-y.,Krumm ZA,Virol J,2021,30-03-2021,PMC8006140,,10.1186/s12985-021-01526-y
33780529,Recruitment and Screening Methods in Alzheimer's Disease Research: The FIT-AD Trial,"Greimel S, Wyman JF, Zhang L, Yu F.",J Gerontol A Biol Sci Med Sci. 2022 Mar 3;77(3):547-553. doi: 10.1093/gerona/glab092.,Greimel S,J Gerontol A Biol Sci Med Sci,2022,29-03-2021,PMC8893175,,10.1093/gerona/glab092
33776997,The Cholinergic Drug Galantamine Alleviates Oxidative Stress Alongside Anti-inflammatory and Cardio-Metabolic Effects in Subjects With the Metabolic Syndrome in a Randomized Trial,"Sangaleti CT, Katayama KY, De Angelis K, Lemos de Moraes T, Araújo AA, Lopes HF, Camacho C, Bortolotto LA, Michelini LC, Irigoyen MC, Olofsson PS, Barnaby DP, Tracey KJ, Pavlov VA, Consolim Colombo FM.",Front Immunol. 2021 Mar 11;12:613979. doi: 10.3389/fimmu.2021.613979. eCollection 2021.,Sangaleti CT,Front Immunol,2021,29-03-2021,PMC7991724,,10.3389/fimmu.2021.613979
33771205,"Efficacy and safety of GV1001 in patients with moderate-to-severe Alzheimer's disease already receiving donepezil: a phase 2 randomized, double-blind, placebo-controlled, multicenter clinical trial","Koh SH, Kwon HS, Choi SH, Jeong JH, Na HR, Lee CN, Yang Y, Lee AY, Lee JH, Park KW, Han HJ, Kim BC, Park JS, Lee JY, Kim S, Lee KY.",Alzheimers Res Ther. 2021 Mar 26;13(1):66. doi: 10.1186/s13195-021-00803-w.,Koh SH,Alzheimers Res Ther,2021,27-03-2021,PMC7995588,,10.1186/s13195-021-00803-w
33766132,Research diagnostic criteria for Alzheimer's disease: findings from the LipiDiDiet randomized controlled trial,"Rosenberg A, Solomon A, Soininen H, Visser PJ, Blennow K, Hartmann T, Kivipelto M; LipiDiDiet clinical study group.",Alzheimers Res Ther. 2021 Mar 25;13(1):64. doi: 10.1186/s13195-021-00799-3.,Rosenberg A,Alzheimers Res Ther,2021,26-03-2021,PMC7995792,,10.1186/s13195-021-00799-3
33763470,ABCA1-Labeled Exosomes in Serum Contain Higher MicroRNA-193b Levels in Alzheimer's Disease,"Liu CG, Zhao Y, Lu Y, Wang PC.",Biomed Res Int. 2021 Mar 8;2021:5450397. doi: 10.1155/2021/5450397. eCollection 2021.,Liu CG,Biomed Res Int,2021,25-03-2021,PMC7963893,,10.1155/2021/5450397
33762220,"Exposure to gamma tACS in Alzheimer's disease: A randomized, double-blind, sham-controlled, crossover, pilot study","Benussi A, Cantoni V, Cotelli MS, Cotelli M, Brattini C, Datta A, Thomas C, Santarnecchi E, Pascual-Leone A, Borroni B.",Brain Stimul. 2021 May-Jun;14(3):531-540. doi: 10.1016/j.brs.2021.03.007. Epub 2021 Mar 21.,Benussi A,Brain Stimul,2021,25-03-2021,,,10.1016/j.brs.2021.03.007
33755924,"First-in-Human Randomized Trial to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of the KDM1A Inhibitor Vafidemstat","Antonijoan RM, Ferrero-Cafiero JM, Coimbra J, Puntes M, Martínez-Colomer J, Arévalo MI, Mascaró C, Molinero C, Buesa C, Maes T.",CNS Drugs. 2021 Mar;35(3):331-344. doi: 10.1007/s40263-021-00797-x. Epub 2021 Mar 23.,Antonijoan RM,CNS Drugs,2021,23-03-2021,PMC7985749,,10.1007/s40263-021-00797-x
33742194,"Exercise, diet, and cognition in a 4-year randomized controlled trial: Dose-Responses to Exercise Training (DR's EXTRA)","Komulainen P, Tuomilehto J, Savonen K, Männikkö R, Hassinen M, Lakka TA, Hänninen T, Kiviniemi V, Jacobs DR, Kivipelto M, Rauramaa R.",Am J Clin Nutr. 2021 Jun 1;113(6):1428-1439. doi: 10.1093/ajcn/nqab018.,Komulainen P,Am J Clin Nutr,2021,20-03-2021,PMC8244125,,10.1093/ajcn/nqab018
33740274,Systematic review of coexistent epileptic seizures and Alzheimer's disease: Incidence and prevalence,"Xu Y, Lavrencic L, Radford K, Booth A, Yoshimura S, Anstey KJ, Anderson CS, Peters R.",J Am Geriatr Soc. 2021 Jul;69(7):2011-2020. doi: 10.1111/jgs.17101. Epub 2021 Mar 19.,Xu Y,J Am Geriatr Soc,2021,19-03-2021,,,10.1111/jgs.17101
33731209,"A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia","Xiao S, Chan P, Wang T, Hong Z, Wang S, Kuang W, He J, Pan X, Zhou Y, Ji Y, Wang L, Cheng Y, Peng Y, Ye Q, Wang X, Wu Y, Qu Q, Chen S, Li S, Chen W, Xu J, Peng D, Zhao Z, Li Y, Zhang J, Du Y, Chen W, Fan D, Yan Y, Liu X, Zhang W, Luo B, Wu W, Shen L, Liu C, Mao P, Wang Q, Zhao Q, Guo Q, Zhou Y, Li Y, Jiang L, Ren W, Ouyang Y, Wang Y, Liu S, Jia J, Zhang N, Liu Z, He R, Feng T, Lu W, Tang H, Gao P, Zhang Y, Chen L, Wang L, Yin Y, Xu Q, Xiao J, Cong L, Cheng X, Zhang H, Gao D, Xia M, Lian T, Peng G, Zhang X, Jiao B, Hu H, Chen X, Guan Y, Cui R, Huang Q, Xin X, Chen H, Ding Y, Zhang J, Feng T, Cantillon M, Chen K, Cummings JL, Ding J, Geng M, Zhang Z.",Alzheimers Res Ther. 2021 Mar 17;13(1):62. doi: 10.1186/s13195-021-00795-7.,Xiao S,Alzheimers Res Ther,2021,18-03-2021,PMC7967962,,10.1186/s13195-021-00795-7
33728019,"Pathology, Risk Factors, and Oxidative Damage Related to Type 2 Diabetes-Mediated Alzheimer's Disease and the Rescuing Effects of the Potent Antioxidant Anthocyanin","Khan MS, Ikram M, Park TJ, Kim MO.",Oxid Med Cell Longev. 2021 Feb 27;2021:4051207. doi: 10.1155/2021/4051207. eCollection 2021.,Khan MS,Oxid Med Cell Longev,2021,17-03-2021,PMC7936905,,10.1155/2021/4051207
33727798,"Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects","Sheng L, Cao W, Lin P, Chen W, Xu H, Zhong C, Yuan F, Chen H, Li H, Liu C, Yang M, Li X.",Drug Des Devel Ther. 2021 Mar 9;15:1101-1110. doi: 10.2147/DDDT.S296197. eCollection 2021.,Sheng L,Drug Des Devel Ther,2021,17-03-2021,PMC7955752,,10.2147/DDDT.S296197
33723124,Emerging role of cannabinoids and synthetic cannabinoid receptor 1/cannabinoid receptor 2 receptor agonists in cancer treatment and chemotherapy-associated cancer management,"Shah SA, Gupta AS, Kumar P.",J Cancer Res Ther. 2021 Jan-Mar;17(1):1-9. doi: 10.4103/jcrt.JCRT_488_18.,Shah SA,J Cancer Res Ther,2021,16-03-2021,,,10.4103/jcrt.JCRT_488_18
33716713,Serum Uric Acid and the Risk of Dementia: A Systematic Review and Meta-Analysis,"Zhou Z, Zhong S, Liang Y, Zhang X, Zhang R, Kang K, Qu H, Xu Y, Zhao C, Zhao M.",Front Aging Neurosci. 2021 Feb 25;13:625690. doi: 10.3389/fnagi.2021.625690. eCollection 2021.,Zhou Z,Front Aging Neurosci,2021,15-03-2021,PMC7947796,,10.3389/fnagi.2021.625690
33704934,Study on the neuroprotective effects of Genistein on Alzheimer's disease,"Duan X, Li Y, Xu F, Ding H.",Brain Behav. 2021 May;11(5):e02100. doi: 10.1002/brb3.2100. Epub 2021 Mar 11.,Duan X,Brain Behav,2021,11-03-2021,PMC8119804,,10.1002/brb3.2100
33704781,Cholinesterase inhibitors for vascular dementia and other vascular cognitive impairments: a network meta-analysis,"Battle CE, Abdul-Rahim AH, Shenkin SD, Hewitt J, Quinn TJ.",Cochrane Database Syst Rev. 2021 Feb 22;2(2):CD013306. doi: 10.1002/14651858.CD013306.pub2.,Battle CE,Cochrane Database Syst Rev,2021,11-03-2021,PMC8407366,,10.1002/14651858.CD013306.pub2
33686089,Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from (18)F-FDG PET brain persistent homology network,"Hsu TW, Fuh JL, Wang DW, Chen LF, Chang CJ, Huang WS, Wu HM, Guo WY.",Sci Rep. 2021 Mar 8;11(1):5396. doi: 10.1038/s41598-021-84722-8.,Hsu TW,Sci Rep,2021,09-03-2021,PMC7940645,,10.1038/s41598-021-84722-8
33686024,Preclinical systematic review of ginsenoside Rg1 for cognitive impairment in Alzheimer's disease,"Liang HY, Zhang PP, Zhang XL, Zheng YY, Huang YR, Zheng GQ, Lin Y.",Aging (Albany NY). 2021 Mar 3;13(5):7549-7569. doi: 10.18632/aging.202619. Epub 2021 Mar 3.,Liang HY,Aging (Albany NY),2021,09-03-2021,PMC7993717,,10.18632/aging.202619
33683313,Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial,"Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB, Launer LJ, Detre JA, Wolk DA, Davatzikos C, Williamson JD, Pajewski NM, Bryan RN; SPRINT Research Group.",JAMA Neurol. 2021 May 1;78(5):568-577. doi: 10.1001/jamaneurol.2021.0178.,Nasrallah IM,JAMA Neurol,2021,08-03-2021,PMC7941253,NIHMS1681875,10.1001/jamaneurol.2021.0178
33681801,Alzheimer's disease: from basic science to precision medicine approach,Forloni G.,BMJ Neurol Open. 2020 Nov 12;2(2):e000079. doi: 10.1136/bmjno-2020-000079. eCollection 2020.,Forloni G,BMJ Neurol Open,2020,08-03-2021,PMC7903168,,10.1136/bmjno-2020-000079
33676572,"27-Hydroxycholesterol, cognition, and brain imaging markers in the FINGER randomized controlled trial","Sandebring-Matton A, Goikolea J, Björkhem I, Paternain L, Kemppainen N, Laatikainen T, Ngandu T, Rinne J, Soininen H, Cedazo-Minguez A, Solomon A, Kivipelto M.",Alzheimers Res Ther. 2021 Mar 6;13(1):56. doi: 10.1186/s13195-021-00790-y.,Sandebring-Matton A,Alzheimers Res Ther,2021,07-03-2021,PMC7937194,,10.1186/s13195-021-00790-y
33674360,Value-Generating Exploratory Trials in Neurodegenerative Dementias,"Friedman LG, McKeehan N, Hara Y, Cummings JL, Matthews DC, Zhu J, Mohs RC, Wang D, Hendrix SB, Quintana M, Schneider LS, Grundman M, Dickson SP, Feldman HH, Jaeger J, Finger EC, Ryan JM, Niehoff D, Dickinson SL, Markowitz JT, Owen M, Travaglia A, Fillit HM.",Neurology. 2021 May 18;96(20):944-954. doi: 10.1212/WNL.0000000000011774. Epub 2021 Mar 5.,Friedman LG,Neurology,2021,06-03-2021,PMC8205472,,10.1212/WNL.0000000000011774
33673088,Unlocking the Secrets of Cancer Stem Cells with γ-Secretase Inhibitors: A Novel Anticancer Strategy,"Ghanbari-Movahed M, Ghanbari-Movahed Z, Momtaz S, Kilpatrick KL, Farzaei MH, Bishayee A.",Molecules. 2021 Feb 12;26(4):972. doi: 10.3390/molecules26040972.,Ghanbari-Movahed M,Molecules,2021,06-03-2021,PMC7917912,,10.3390/molecules26040972
33671302,Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies,"Zarantonello A, Pedersen H, Laursen NS, Andersen GR.",Biomolecules. 2021 Feb 17;11(2):298. doi: 10.3390/biom11020298.,Zarantonello A,Biomolecules,2021,06-03-2021,PMC7922070,,10.3390/biom11020298
33671099,Methylxanthines and Neurodegenerative Diseases: An Update,"Janitschke D, Lauer AA, Bachmann CM, Grimm HS, Hartmann T, Grimm MOW.",Nutrients. 2021 Feb 28;13(3):803. doi: 10.3390/nu13030803.,Janitschke D,Nutrients,2021,06-03-2021,PMC8000915,,10.3390/nu13030803
33669995,A Fundamental Role for Oxidants and Intracellular Calcium Signals in Alzheimer's Pathogenesis-And How a Comprehensive Antioxidant Strategy May Aid Prevention of This Disorder,"McCarty MF, DiNicolantonio JJ, Lerner A.",Int J Mol Sci. 2021 Feb 21;22(4):2140. doi: 10.3390/ijms22042140.,McCarty MF,Int J Mol Sci,2021,06-03-2021,PMC7926325,,10.3390/ijms22042140
33669988,Crosstalk between Gut and Brain in Alzheimer's Disease: The Role of Gut Microbiota Modulation Strategies,"Shabbir U, Arshad MS, Sameen A, Oh DH.",Nutrients. 2021 Feb 21;13(2):690. doi: 10.3390/nu13020690.,Shabbir U,Nutrients,2021,06-03-2021,PMC7924846,,10.3390/nu13020690
33669787,Essential Oils as a Potential Neuroprotective Remedy for Age-Related Neurodegenerative Diseases: A Review,"Abd Rashed A, Abd Rahman AZ, Rathi DNG.",Molecules. 2021 Feb 19;26(4):1107. doi: 10.3390/molecules26041107.,Abd Rashed A,Molecules,2021,06-03-2021,PMC7922935,,10.3390/molecules26041107
33669097,Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer's Disease Therapy,"Arya A, Chahal R, Rao R, Rahman MH, Kaushik D, Akhtar MF, Saleem A, Khalifa SMA, El-Seedi HR, Kamel M, Albadrani GM, Abdel-Daim MM, Mittal V.",Biomolecules. 2021 Feb 25;11(3):350. doi: 10.3390/biom11030350.,Arya A,Biomolecules,2021,06-03-2021,PMC7996600,,10.3390/biom11030350
33668128,"Pyrazole Scaffold Synthesis, Functionalization, and Applications in Alzheimer's Disease and Parkinson's Disease Treatment (2011-2020)","Li X, Yu Y, Tu Z.",Molecules. 2021 Feb 24;26(5):1202. doi: 10.3390/molecules26051202.,Li X,Molecules,2021,06-03-2021,PMC7956461,,10.3390/molecules26051202
33667787,The involvement of NLRP3 inflammasome in the treatment of neurodegenerative diseases,"Feng YS, Tan ZX, Wu LY, Dong F, Zhang F.",Biomed Pharmacother. 2021 Jun;138:111428. doi: 10.1016/j.biopha.2021.111428. Epub 2021 Mar 2.,Feng YS,Biomed Pharmacother,2021,05-03-2021,,,10.1016/j.biopha.2021.111428
33667281,Amyloid burden quantification depends on PET and MR image processing methodology,"Kolinger GD, Vállez García D, Willemsen ATM, Reesink FE, de Jong BM, Dierckx RAJO, De Deyn PP, Boellaard R.",PLoS One. 2021 Mar 5;16(3):e0248122. doi: 10.1371/journal.pone.0248122. eCollection 2021.,Kolinger GD,PLoS One,2021,05-03-2021,PMC7935288,,10.1371/journal.pone.0248122
33661072,Prevalence of pain in amyotrophic lateral sclerosis: a systematic review and meta-analysis,"Hurwitz N, Radakovic R, Boyce E, Peryer G.",Amyotroph Lateral Scler Frontotemporal Degener. 2021 Nov;22(7-8):449-458. doi: 10.1080/21678421.2021.1892765. Epub 2021 Mar 4.,Hurwitz N,Amyotroph Lateral Scler Frontotemporal Degener,2021,04-03-2021,,,10.1080/21678421.2021.1892765
33658371,Monocyte markers correlate with immune and neuronal brain changes in REM sleep behavior disorder,"Farmen K, Nissen SK, Stokholm MG, Iranzo A, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Borghammer P, Santamaria J, Møller A, Gaig C, Brooks DJ, Tolosa E, Pavese N, Romero-Ramos M.",Proc Natl Acad Sci U S A. 2021 Mar 9;118(10):e2020858118. doi: 10.1073/pnas.2020858118.,Farmen K,Proc Natl Acad Sci U S A,2021,04-03-2021,PMC7958435,,10.1073/pnas.2020858118
33653000,Role of Retinal Amyloid-β in Neurodegenerative Diseases: Overlapping Mechanisms and Emerging Clinical Applications,"Wang L, Mao X.",Int J Mol Sci. 2021 Feb 26;22(5):2360. doi: 10.3390/ijms22052360.,Wang L,Int J Mol Sci,2021,03-03-2021,PMC7956232,,10.3390/ijms22052360
33652858,Natural Products Targeting Amyloid Beta in Alzheimer's Disease,"Lee JH, Ahn NH, Choi SB, Kwon Y, Yang SH.",Int J Mol Sci. 2021 Feb 26;22(5):2341. doi: 10.3390/ijms22052341.,Lee JH,Int J Mol Sci,2021,03-03-2021,PMC7956407,,10.3390/ijms22052341
33646562,"Evaluating Infectious, Neoplastic, Immunological, and Degenerative Diseases of the Central Nervous System with Cerebrospinal Fluid-Based Next-Generation Sequencing","Tsamis KI, Sakkas H, Giannakis A, Ryu HS, Gartzonika C, Nikas IP.",Mol Diagn Ther. 2021 Mar;25(2):207-229. doi: 10.1007/s40291-021-00513-x. Epub 2021 Mar 1.,Tsamis KI,Mol Diagn Ther,2021,01-03-2021,PMC7917176,,10.1007/s40291-021-00513-x
33646146,Low Doses of Ionizing Radiation as a Treatment for Alzheimer's Disease: A Pilot Study,"Cuttler JM, Abdellah E, Goldberg Y, Al-Shamaa S, Symons SP, Black SE, Freedman M.",J Alzheimers Dis. 2021;80(3):1119-1128. doi: 10.3233/JAD-200620.,Cuttler JM,J Alzheimers Dis,2021,01-03-2021,PMC8150498,,10.3233/JAD-200620
33643053,Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid Angiopathy,"Saito S, Tanaka M, Satoh-Asahara N, Carare RO, Ihara M.",Front Pharmacol. 2021 Feb 12;12:643357. doi: 10.3389/fphar.2021.643357. eCollection 2021.,Saito S,Front Pharmacol,2021,01-03-2021,PMC7907591,,10.3389/fphar.2021.643357
33640979,"Results of a Randomized Trial Testing the Efficacy of Tele-Savvy, an Online Synchronous/Asynchronous Psychoeducation Program for Family Caregivers of Persons Living with Dementia","Hepburn K, Nocera J, Higgins M, Epps F, Brewster GS, Lindauer A, Morhardt D, Shah R, Bonds K, Nash R, Griffiths PC.",Gerontologist. 2022 Apr 20;62(4):616-628. doi: 10.1093/geront/gnab029.,Hepburn K,Gerontologist,2022,28-02-2021,PMC7989248,,10.1093/geront/gnab029
33638661,Diagnostic value of amyloid-PET and tau-PET: a head-to-head comparison,"Altomare D, Caprioglio C, Assal F, Allali G, Mendes A, Ribaldi F, Ceyzeriat K, Martins M, Tomczyk S, Stampacchia S, Dodich A, Boccardi M, Chicherio C, Frisoni GB, Garibotto V.",Eur J Nucl Med Mol Imaging. 2021 Jul;48(7):2200-2211. doi: 10.1007/s00259-021-05246-x. Epub 2021 Feb 27.,Altomare D,Eur J Nucl Med Mol Imaging,2021,27-02-2021,PMC8175315,,10.1007/s00259-021-05246-x
33638173,Regulators of cholinergic signaling in disorders of the central nervous system,"Winek K, Soreq H, Meisel A.",J Neurochem. 2021 Sep;158(6):1425-1438. doi: 10.1111/jnc.15332. Epub 2021 Mar 19.,Winek K,J Neurochem,2021,27-02-2021,PMC8518971,,10.1111/jnc.15332
33633739,The Role of Sphingolipids and Specialized Pro-Resolving Mediators in Alzheimer's Disease,"de Wit NM, Mol K, Rodríguez-Lorenzo S, de Vries HE, Kooij G.",Front Immunol. 2021 Jan 29;11:620348. doi: 10.3389/fimmu.2020.620348. eCollection 2020.,de Wit NM,Front Immunol,2021,26-02-2021,PMC7902029,,10.3389/fimmu.2020.620348
33629323,Empirical assessment of biases in cerebrospinal fluid biomarkers of Alzheimer's disease: an umbrella review and re-analysis of data from meta-analyses,"Jeong DY, Lee J, Kim JY, Lee KH, Li H, Lee JY, Jeong GH, Yoon S, Park EL, Hong SH, Kang JW, Song TJ, Leyhe T, Eisenhut M, Kronbichler A, Smith L, Solmi M, Stubbs B, Koyanagi A, Jacob L, Stickley A, Thompson T, Dragioti E, Oh H, Brunoni AR, Carvalho AF, Kim MS, Yon DK, Lee SW, Yang JM, Ghayda RA, Shin JI, Fusar-Poli P.",Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1536-1547. doi: 10.26355/eurrev_202102_24862.,Jeong DY,Eur Rev Med Pharmacol Sci,2021,25-02-2021,,,10.26355/eurrev_202102_24862
33624616,[Effect of physical exercise and diet based interventions on the evolution of cognitive impairment to dementia in subjects older than 45 years. A systematic review.],"Ballarín-Naya L, Malo S, Moreno-Franco B.",Rev Esp Salud Publica. 2021 Feb 24;95:e202102032.,Ballarín-Naya L,Rev Esp Salud Publica,2021,24-02-2021,,,
33622392,Randomized crossover trial of a modified ketogenic diet in Alzheimer's disease,"Phillips MCL, Deprez LM, Mortimer GMN, Murtagh DKJ, McCoy S, Mylchreest R, Gilbertson LJ, Clark KM, Simpson PV, McManus EJ, Oh JE, Yadavaraj S, King VM, Pillai A, Romero-Ferrando B, Brinkhuis M, Copeland BM, Samad S, Liao S, Schepel JAC.",Alzheimers Res Ther. 2021 Feb 23;13(1):51. doi: 10.1186/s13195-021-00783-x.,Phillips MCL,Alzheimers Res Ther,2021,24-02-2021,PMC7901512,,10.1186/s13195-021-00783-x
33621313,The Efficacy of Ketogenic Therapies in the Clinical Management of People with Neurodegenerative Disease: A Systematic Review,"Dewsbury LS, Lim CK, Steiner GZ.",Adv Nutr. 2021 Jul 30;12(4):1571-1593. doi: 10.1093/advances/nmaa180.,Dewsbury LS,Adv Nutr,2021,23-02-2021,PMC8321843,,10.1093/advances/nmaa180
33615942,Precision hormone therapy: identification of positive responders,"Kim YJ, Brinton RD.",Climacteric. 2021 Aug;24(4):350-358. doi: 10.1080/13697137.2021.1882418. Epub 2021 Feb 22.,Kim YJ,Climacteric,2021,22-02-2021,PMC8989059,NIHMS1789881,10.1080/13697137.2021.1882418
33613260,Aspirin Use on Incident Dementia and Mild Cognitive Decline: A Systematic Review and Meta-Analysis,"Li H, Li W, Zhang X, Ma XC, Zhang RW.",Front Aging Neurosci. 2021 Feb 4;12:578071. doi: 10.3389/fnagi.2020.578071. eCollection 2020.,Li H,Front Aging Neurosci,2021,22-02-2021,PMC7890199,,10.3389/fnagi.2020.578071
33612540,Modifiable Barriers for Recruitment and Retention of Older Adults Participants from Underrepresented Minorities in Alzheimer's Disease Research,"Indorewalla KK, O'Connor MK, Budson AE, Guess DiTerlizzi C, Jackson J.",J Alzheimers Dis. 2021;80(3):927-940. doi: 10.3233/JAD-201081.,Indorewalla KK,J Alzheimers Dis,2021,22-02-2021,PMC8150544,,10.3233/JAD-201081
33609776,Targeting impaired nutrient sensing with repurposed therapeutics to prevent or treat age-related cognitive decline and dementia: A systematic review,"Kioussis B, Tuttle CSL, Heard DS, Kennedy BK, Lautenschlager NT, Maier AB.",Ageing Res Rev. 2021 May;67:101302. doi: 10.1016/j.arr.2021.101302. Epub 2021 Feb 17.,Kioussis B,Ageing Res Rev,2021,20-02-2021,,,10.1016/j.arr.2021.101302
33601146,Therapeutic potential of iron chelators on osteoporosis and their cellular mechanisms,"Zhang J, Zhao H, Yao G, Qiao P, Li L, Wu S.",Biomed Pharmacother. 2021 May;137:111380. doi: 10.1016/j.biopha.2021.111380. Epub 2021 Feb 15.,Zhang J,Biomed Pharmacother,2021,18-02-2021,,,10.1016/j.biopha.2021.111380
33588732,Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review,"Ahmad SS, Khalid M, Kamal MA, Younis K.",Curr Neuropharmacol. 2021;19(11):1884-1895. doi: 10.2174/1570159X19666210215122333.,Ahmad SS,Curr Neuropharmacol,2021,16-02-2021,PMC9185787,,10.2174/1570159X19666210215122333
33587110,Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials,"Lu M, Pontecorvo MJ, Devous MD Sr, Arora AK, Galante N, McGeehan A, Devadanam C, Salloway SP, Doraiswamy PM, Curtis C, Truocchio SP, Flitter M, Locascio T, Devine M, Zimmer JA, Fleisher AS, Mintun MA; AVID Collaborators.",JAMA Neurol. 2021 Apr 1;78(4):445-453. doi: 10.1001/jamaneurol.2020.5505.,Lu M,JAMA Neurol,2021,15-02-2021,PMC7885097,,10.1001/jamaneurol.2020.5505
33583479,Quantifying the heterogeneity of cognitive functioning in Alzheimer's disease to extend the placebo-treatment dichotomy: Latent class analysis of individual-participant data from five pivotal randomized clinical trials of donepezil,"Levine SZ, Goldberg Y, Yoshida K, Samara M, Cipriani A, Iwatsubo T, Leucht S, Furawaka TA.",Eur Psychiatry. 2021 Feb 15;64(1):e16. doi: 10.1192/j.eurpsy.2021.8.,Levine SZ,Eur Psychiatry,2021,15-02-2021,PMC8057455,,10.1192/j.eurpsy.2021.8
33583459,Decisional capacity to consent to treatment and research in patients affected by Mild Cognitive Impairment. A systematic review and meta-analysis,"Parmigiani G, Del Casale A, Mandarelli G, Barchielli B, Kotzalidis GD, D'Antonio F, Di Vita A, de Lena C, Ferracuti S.",Int Psychogeriatr. 2022 Jun;34(6):529-542. doi: 10.1017/S1041610220004056. Epub 2021 Feb 15.,Parmigiani G,Int Psychogeriatr,2022,15-02-2021,,,10.1017/S1041610220004056
33582451,The application of multifunctional nanomaterials in Alzheimer's disease: A potential theranostics strategy,"Xu Y, Zhao M, Zhou D, Zheng T, Zhang H.",Biomed Pharmacother. 2021 May;137:111360. doi: 10.1016/j.biopha.2021.111360. Epub 2021 Feb 11.,Xu Y,Biomed Pharmacother,2021,14-02-2021,,,10.1016/j.biopha.2021.111360
33581283,Cortical plasticity is correlated with cognitive improvement in Alzheimer's disease patients after rTMS treatment,"Li X, Qi G, Yu C, Lian G, Zheng H, Wu S, Yuan TF, Zhou D.",Brain Stimul. 2021 May-Jun;14(3):503-510. doi: 10.1016/j.brs.2021.01.012. Epub 2021 Feb 11.,Li X,Brain Stimul,2021,13-02-2021,,,10.1016/j.brs.2021.01.012
33578876,Creatine Supplementation and Brain Health,"Roschel H, Gualano B, Ostojic SM, Rawson ES.",Nutrients. 2021 Feb 10;13(2):586. doi: 10.3390/nu13020586.,Roschel H,Nutrients,2021,13-02-2021,PMC7916590,,10.3390/nu13020586
33573996,Cannabinoids for Agitation in Alzheimer's Disease,"Outen JD, Burhanullah MH, Vandrey R, Amjad H, Harper DG, Patrick RE, May RL, Agronin ME, Forester BP, Rosenberg PB.",Am J Geriatr Psychiatry. 2021 Dec;29(12):1253-1263. doi: 10.1016/j.jagp.2021.01.015. Epub 2021 Jan 27.,Outen JD,Am J Geriatr Psychiatry,2021,12-02-2021,PMC8313629,NIHMS1671892,10.1016/j.jagp.2021.01.015
33573368,Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives,"Behl T, Kaur G, Sehgal A, Bhardwaj S, Singh S, Buhas C, Judea-Pusta C, Uivarosan D, Munteanu MA, Bungau S.",Int J Mol Sci. 2021 Jan 30;22(3):1413. doi: 10.3390/ijms22031413.,Behl T,Int J Mol Sci,2021,12-02-2021,PMC7866808,,10.3390/ijms22031413
33573300,Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases,"Kong YR, Tay KC, Su YX, Wong CK, Tan WN, Khaw KY.",Molecules. 2021 Jan 30;26(3):728. doi: 10.3390/molecules26030728.,Kong YR,Molecules,2021,12-02-2021,PMC7866829,,10.3390/molecules26030728
33571811,Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease,"Thapa P, Upadhyay SP, Suo WZ, Singh V, Gurung P, Lee ES, Sharma R, Sharma M.",Bioorg Chem. 2021 Mar;108:104681. doi: 10.1016/j.bioorg.2021.104681. Epub 2021 Jan 29.,Thapa P,Bioorg Chem,2021,11-02-2021,PMC7928223,NIHMS1668140,10.1016/j.bioorg.2021.104681
33571701,The pleiotropic neuroprotective effects of resveratrol in cognitive decline and Alzheimer's disease pathology: From antioxidant to epigenetic therapy,"Griñán-Ferré C, Bellver-Sanchis A, Izquierdo V, Corpas R, Roig-Soriano J, Chillón M, Andres-Lacueva C, Somogyvári M, Sőti C, Sanfeliu C, Pallàs M.",Ageing Res Rev. 2021 May;67:101271. doi: 10.1016/j.arr.2021.101271. Epub 2021 Feb 8.,Griñán-Ferré C,Ageing Res Rev,2021,11-02-2021,,,10.1016/j.arr.2021.101271
33569556,Nutrition-Based Approaches in Clinical Trials Targeting Cognitive Function: Highlights of the CTAD 2020,Giudici KV.,J Prev Alzheimers Dis. 2021;8(2):118-122. doi: 10.14283/jpad.2021.6.,Giudici KV,J Prev Alzheimers Dis,2021,11-02-2021,PMC7872721,,10.14283/jpad.2021.6
33568083,Rivastigmine improves dual-task gait velocity in patients with Alzheimer's disease,"Shimura H, Saiko A, Hayashi A, Hattori N, Urabe T.",BMC Neurol. 2021 Feb 10;21(1):61. doi: 10.1186/s12883-021-02098-8.,Shimura H,BMC Neurol,2021,11-02-2021,PMC7874473,,10.1186/s12883-021-02098-8
33566374,Plasma and cerebrospinal fluid ABeta42 for the differential diagnosis of Alzheimer's disease dementia in participants diagnosed with any dementia subtype in a specialist care setting,"Kokkinou M, Beishon LC, Smailagic N, Noel-Storr AH, Hyde C, Ukoumunne O, Worrall RE, Hayen A, Desai M, Ashok AH, Paul EJ, Georgopoulou A, Casoli T, Quinn TJ, Ritchie CW.",Cochrane Database Syst Rev. 2021 Feb 10;2(2):CD010945. doi: 10.1002/14651858.CD010945.pub2.,Kokkinou M,Cochrane Database Syst Rev,2021,10-02-2021,PMC8078224,,10.1002/14651858.CD010945.pub2
33559354,Preclinical and clinical biomarker studies of CT1812: A novel approach to Alzheimer's disease modification,"Izzo NJ, Yuede CM, LaBarbera KM, Limegrover CS, Rehak C, Yurko R, Waybright L, Look G, Rishton G, Safferstein H, Hamby ME, Williams C, Sadlek K, Edwards HM, Davis CS, Grundman M, Schneider LS, DeKosky ST, Chelsky D, Pike I, Henstridge C, Blennow K, Zetterberg H, LeVine H 3rd, Spires-Jones TL, Cirrito JR, Catalano SM.",Alzheimers Dement. 2021 Aug;17(8):1365-1382. doi: 10.1002/alz.12302. Epub 2021 Feb 8.,Izzo NJ,Alzheimers Dement,2021,09-02-2021,PMC8349378,NIHMS1699785,10.1002/alz.12302
33558427,Stem Cell Therapies in Alzheimer's Disease: Applications for Disease Modeling,"Si Z, Wang X.",J Pharmacol Exp Ther. 2021 May;377(2):207-217. doi: 10.1124/jpet.120.000324. Epub 2021 Feb 8.,Si Z,J Pharmacol Exp Ther,2021,09-02-2021,,,10.1124/jpet.120.000324
33557077,The Application of Seaweed Polysaccharides and Their Derived Products with Potential for the Treatment of Alzheimer's Disease,"Bauer S, Jin W, Zhang F, Linhardt RJ.",Mar Drugs. 2021 Feb 4;19(2):89. doi: 10.3390/md19020089.,Bauer S,Mar Drugs,2021,09-02-2021,PMC7913876,,10.3390/md19020089
33551785,"Past, Present, and Future of Non-invasive Brain Stimulation Approaches to Treat Cognitive Impairment in Neurodegenerative Diseases: Time for a Comprehensive Critical Review","Sanches C, Stengel C, Godard J, Mertz J, Teichmann M, Migliaccio R, Valero-Cabré A.",Front Aging Neurosci. 2021 Jan 20;12:578339. doi: 10.3389/fnagi.2020.578339. eCollection 2020.,Sanches C,Front Aging Neurosci,2021,08-02-2021,PMC7854576,,10.3389/fnagi.2020.578339
33551234,Association of White Matter Integrity With Executive Function and Antidepressant Treatment Outcome in Patients With Late-Life Depression,"He X, Pueraro E, Kim Y, Garcia CM, Maas B, Choi J, Egglefield DA, Schiff S, Sneed JR, Brown PJ, Brickman AM, Roose SP, Rutherford BR.",Am J Geriatr Psychiatry. 2021 Dec;29(12):1188-1198. doi: 10.1016/j.jagp.2021.01.004. Epub 2021 Jan 23.,He X,Am J Geriatr Psychiatry,2021,08-02-2021,PMC8298620,NIHMS1670680,10.1016/j.jagp.2021.01.004
33549028,A narrative review of relationship between gut microbiota and neuropsychiatric disorders: mechanisms and clinical application of probiotics and prebiotics,"Yang H, Liu Y, Cai R, Li Y, Gu B.",Ann Palliat Med. 2021 Feb;10(2):2304-2313. doi: 10.21037/apm-20-1365. Epub 2021 Jan 28.,Yang H,Ann Palliat Med,2021,07-02-2021,,,10.21037/apm-20-1365
33546262,Does the High Prevalence of Vitamin D Deficiency in African Americans Contribute to Health Disparities?,"Ames BN, Grant WB, Willett WC.",Nutrients. 2021 Feb 3;13(2):499. doi: 10.3390/nu13020499.,Ames BN,Nutrients,2021,06-02-2021,PMC7913332,,10.3390/nu13020499
33545661,Mechanistic new insights of flavonols on neurodegenerative diseases,"Tahir MS, Almezgagi M, Zhang Y, Bashir A, Abdullah HM, Gamah M, Wang X, Zhu Q, Shen X, Ma Q, Ali M, Solangi ZA, Malik WS, Zhang W.",Biomed Pharmacother. 2021 May;137:111253. doi: 10.1016/j.biopha.2021.111253. Epub 2021 Feb 2.,Tahir MS,Biomed Pharmacother,2021,05-02-2021,,,10.1016/j.biopha.2021.111253
33536430,Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia,"Gasca-Salas C, Fernández-Rodríguez B, Pineda-Pardo JA, Rodríguez-Rojas R, Obeso I, Hernández-Fernández F, Del Álamo M, Mata D, Guida P, Ordás-Bandera C, Montero-Roblas JI, Martínez-Fernández R, Foffani G, Rachmilevitch I, Obeso JA.",Nat Commun. 2021 Feb 3;12(1):779. doi: 10.1038/s41467-021-21022-9.,Gasca-Salas C,Nat Commun,2021,04-02-2021,PMC7859400,,10.1038/s41467-021-21022-9
35608903,"Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia","Parsons C, Lim WY, Loy C, McGuinness B, Passmore P, Ward SA, Hughes C.",Cochrane Database Syst Rev. 2021 Feb 3;2(2):CD009081. doi: 10.1002/14651858.CD009081.pub2.,Parsons C,Cochrane Database Syst Rev,2021,24-05-2022,PMC8094886,,10.1002/14651858.CD009081.pub2
33526043,Combining transcranial direct current stimulation with a motor-cognitive task: the impact on dual-task walking costs in older adults,"Schneider N, Dagan M, Katz R, Thumm PC, Brozgol M, Giladi N, Manor B, Mirelman A, Hausdorff JM.",J Neuroeng Rehabil. 2021 Feb 1;18(1):23. doi: 10.1186/s12984-021-00826-2.,Schneider N,J Neuroeng Rehabil,2021,02-02-2021,PMC7852224,,10.1186/s12984-021-00826-2
33525754,A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer's and Parkinson's Disease,"Lee JH, Kim HJ, Kim JU, Yook TH, Kim KH, Lee JY, Yang G.",Int J Mol Sci. 2021 Jan 28;22(3):1324. doi: 10.3390/ijms22031324.,Lee JH,Int J Mol Sci,2021,02-02-2021,PMC7866084,,10.3390/ijms22031324
33525407,CAPE and Neuroprotection: A Review,"Balaha M, De Filippis B, Cataldi A, di Giacomo V.",Biomolecules. 2021 Jan 28;11(2):176. doi: 10.3390/biom11020176.,Balaha M,Biomolecules,2021,02-02-2021,PMC7911454,,10.3390/biom11020176
33523004,Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial,"Yu F, Vock DM, Zhang L, Salisbury D, Nelson NW, Chow LS, Smith G, Barclay TR, Dysken M, Wyman JF.",J Alzheimers Dis. 2021;80(1):233-244. doi: 10.3233/JAD-201100.,Yu F,J Alzheimers Dis,2021,01-02-2021,PMC8075384,,10.3233/JAD-201100
33521235,Effects of physical activities on dementia-related biomarkers: A systematic review of randomized controlled trials,"Moniruzzaman M, Kadota A, Akash MS, Pruitt PJ, Miura K, Albin R, Dodge HH.",Alzheimers Dement (N Y). 2021 Jan 20;6(1):e12109. doi: 10.1002/trc2.12109. eCollection 2020.,Moniruzzaman M,Alzheimers Dement (N Y),2021,01-02-2021,PMC7816814,,10.1002/trc2.12109
33519696,The European Reference Network for Rare Neurological Diseases,"Reinhard C, Bachoud-Lévi AC, Bäumer T, Bertini E, Brunelle A, Buizer AI, Federico A, Gasser T, Groeschel S, Hermanns S, Klockgether T, Krägeloh-Mann I, Landwehrmeyer GB, Leber I, Macaya A, Mariotti C, Meissner WG, Molnar MJ, Nonnekes J, Ortigoza Escobar JD, Pérez Dueñas B, Renna Linton L, Schöls L, Schuele R, Tijssen MAJ, Vandenberghe R, Volkmer A, Wolf NI, Graessner H.",Front Neurol. 2021 Jan 14;11:616569. doi: 10.3389/fneur.2020.616569. eCollection 2020.,Reinhard C,Front Neurol,2021,01-02-2021,PMC7840612,,10.3389/fneur.2020.616569
33519198,Advances in Hollow Inorganic Nanomedicines for Photothermal-Based Therapies,"Ling C, Wang X, Shen Y.",Int J Nanomedicine. 2021 Jan 22;16:493-513. doi: 10.2147/IJN.S285115. eCollection 2021.,Ling C,Int J Nanomedicine,2021,01-02-2021,PMC7837554,,10.2147/IJN.S285115
33515647,The potential of biomaterials for central nervous system cellular repair,"Jarrin S, Cabré S, Dowd E.",Neurochem Int. 2021 Mar;144:104971. doi: 10.1016/j.neuint.2021.104971. Epub 2021 Jan 28.,Jarrin S,Neurochem Int,2021,30-01-2021,,,10.1016/j.neuint.2021.104971
33515428,Intranasal Insulin for Alzheimer's Disease,Hallschmid M.,CNS Drugs. 2021 Jan;35(1):21-37. doi: 10.1007/s40263-020-00781-x. Epub 2021 Jan 30.,Hallschmid M,CNS Drugs,2021,30-01-2021,PMC7873098,,10.1007/s40263-020-00781-x
33514817,A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease,"El-Sappagh S, Alonso JM, Islam SMR, Sultan AM, Kwak KS.",Sci Rep. 2021 Jan 29;11(1):2660. doi: 10.1038/s41598-021-82098-3.,El-Sappagh S,Sci Rep,2021,30-01-2021,PMC7846613,,10.1038/s41598-021-82098-3
33513893,Influence of Imidazole-Dipeptides on Cognitive Status and Preservation in Elders: A Narrative Review,"Masuoka N, Lei C, Li H, Hisatsune T.",Nutrients. 2021 Jan 27;13(2):397. doi: 10.3390/nu13020397.,Masuoka N,Nutrients,2021,30-01-2021,PMC7912684,,10.3390/nu13020397
33509204,Multi-pathogen infections and Alzheimer's disease,"Vigasova D, Nemergut M, Liskova B, Damborsky J.",Microb Cell Fact. 2021 Jan 28;20(1):25. doi: 10.1186/s12934-021-01520-7.,Vigasova D,Microb Cell Fact,2021,29-01-2021,PMC7844946,,10.1186/s12934-021-01520-7
33505926,Adherence to Healthy Diet Can Delay Alzheimer's Diseases Development: A Systematic Review and Meta-Analysis,"Moradi S, Moloudi J, Moradinazar M, Sarokhani D, Nachvak SM, Samadi M.",Prev Nutr Food Sci. 2020 Dec 31;25(4):325-337. doi: 10.3746/pnf.2020.25.4.325.,Moradi S,Prev Nutr Food Sci,2020,28-01-2021,PMC7813603,,10.3746/pnf.2020.25.4.325
33504953,Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial,"Berk M, Agustini B, Woods RL, Nelson MR, Shah RC, Reid CM, Storey E, Fitzgerald SM, Lockery JE, Wolfe R, Mohebbi M, Dodd S, Murray AM, Stocks N, Fitzgerald PB, Mazza C, McNeil JJ.",Mol Psychiatry. 2021 Sep;26(9):5161-5170. doi: 10.1038/s41380-021-01020-5. Epub 2021 Jan 27.,Berk M,Mol Psychiatry,2021,28-01-2021,PMC8313623,NIHMS1661143,10.1038/s41380-021-01020-5
33498262,The Role of Natural Antioxidants in the Prevention of Dementia-Where Do We Stand and Future Perspectives,Jurcau A.,Nutrients. 2021 Jan 20;13(2):282. doi: 10.3390/nu13020282.,Jurcau A,Nutrients,2021,27-01-2021,PMC7909256,,10.3390/nu13020282
33483830,"Aspirin in people with dementia, long-term benefits, and harms: a systematic review","Davis KAS, Bishara D, Molokhia M, Mueller C, Perera G, Stewart RJ.",Eur J Clin Pharmacol. 2021 Jul;77(7):943-954. doi: 10.1007/s00228-021-03089-x. Epub 2021 Jan 22.,Davis KAS,Eur J Clin Pharmacol,2021,23-01-2021,PMC8184554,,10.1007/s00228-021-03089-x
33480232,Is granulovacuolar degeneration an essential pathological component of Alzheimer's disease? A review of the pathogenesis and histochemistry of old studies,"Kurdi M, Alghamdi B.",Folia Neuropathol. 2020;58(4):277-286. doi: 10.5114/fn.2020.102429.,Kurdi M,Folia Neuropathol,2020,22-01-2021,,,10.5114/fn.2020.102429
33472172,"Anserine, HClO-scavenger, protected against cognitive decline in individuals with mild cognitive impairment","Masuoka N, Lei C, Li H, Inamura N, Shiotani S, Yanai N, Sato K, Sakurai K, Hisatsune T.",Aging (Albany NY). 2021 Jan 20;13(2):1729-1741. doi: 10.18632/aging.202535. Epub 2021 Jan 20.,Masuoka N,Aging (Albany NY),2021,20-01-2021,PMC7880346,,10.18632/aging.202535
33470769,Sleep quality and cortical amyloid-β deposition in postmenopausal women of the Kronos early estrogen prevention study,"Zeydan B, Lowe VJ, Tosakulwong N, Lesnick TG, Senjem ML, Jack CR Jr, Fields JA, James TT, Gleason CE, Dowling NM, Miller VM, Kantarci K.",Neuroreport. 2021 Mar 3;32(4):326-331. doi: 10.1097/WNR.0000000000001592.,Zeydan B,Neuroreport,2021,20-01-2021,PMC7878341,NIHMS1657616,10.1097/WNR.0000000000001592
33464300,"Findings of Efficacy, Safety, and Biomarker Outcomes of Atabecestat in Preclinical Alzheimer Disease: A Truncated Randomized Phase 2b/3 Clinical Trial","Sperling R, Henley D, Aisen PS, Raman R, Donohue MC, Ernstrom K, Rafii MS, Streffer J, Shi Y, Karcher K, Raghavan N, Tymofyeyev Y, Bogert J, Brashear HR, Novak G, Thipphawong J, Saad ZS, Kolb H, Rofael H, Sanga P, Romano G.",JAMA Neurol. 2021 Mar 1;78(3):293-301. doi: 10.1001/jamaneurol.2020.4857.,Sperling R,JAMA Neurol,2021,19-01-2021,PMC7816119,,10.1001/jamaneurol.2020.4857
33460618,Antihypertensive Medication Classes and the Risk of Dementia: A Systematic Review and Network Meta-Analysis,"den Brok MGHE, van Dalen JW, Abdulrahman H, Larson EB, van Middelaar T, van Gool WA, Moll van Charante EP, Richard E.",J Am Med Dir Assoc. 2021 Jul;22(7):1386-1395.e15. doi: 10.1016/j.jamda.2020.12.019. Epub 2021 Jan 16.,den Brok MGHE,J Am Med Dir Assoc,2021,18-01-2021,,,10.1016/j.jamda.2020.12.019
33459706,Broader Insights into Understanding Tumor Necrosis Factor and Neurodegenerative Disease Pathogenesis Infer New Therapeutic Approaches,"Clark IA, Vissel B.",J Alzheimers Dis. 2021;79(3):931-948. doi: 10.3233/JAD-201186.,Clark IA,J Alzheimers Dis,2021,18-01-2021,PMC7990436,,10.3233/JAD-201186
33451358,Assessing individual-level change in dementia research: a review of methodologies,"Murray AL, Vollmer M, Deary IJ, Muniz-Terrera G, Booth T.",Alzheimers Res Ther. 2021 Jan 15;13(1):26. doi: 10.1186/s13195-021-00768-w.,Murray AL,Alzheimers Res Ther,2021,16-01-2021,PMC7811223,,10.1186/s13195-021-00768-w
33447926,Memantine in neurological disorders - schizophrenia and depression,"Czarnecka K, Chuchmacz J, Wójtowicz P, Szymański P.",J Mol Med (Berl). 2021 Mar;99(3):327-334. doi: 10.1007/s00109-020-01982-z. Epub 2021 Jan 14.,Czarnecka K,J Mol Med (Berl),2021,15-01-2021,PMC7900025,,10.1007/s00109-020-01982-z
33444615,Psychological Symptoms Among Surrogates of Critically Ill Patients During and Before the COVID-19 Pandemic,"Greenberg JA, Basapur S, Quinn TV, Bulger JL, Glover CM, Shah RC.",Chest. 2021 Jun;159(6):2318-2320. doi: 10.1016/j.chest.2020.12.056. Epub 2021 Jan 12.,Greenberg JA,Chest,2021,14-01-2021,PMC7832129,,10.1016/j.chest.2020.12.056
33444359,Effect of aerobic exercise on amyloid accumulation in preclinical Alzheimer's: A 1-year randomized controlled trial,"Vidoni ED, Morris JK, Watts A, Perry M, Clutton J, Van Sciver A, Kamat AS, Mahnken J, Hunt SL, Townley R, Honea R, Shaw AR, Johnson DK, Vacek J, Burns JM.",PLoS One. 2021 Jan 14;16(1):e0244893. doi: 10.1371/journal.pone.0244893. eCollection 2021.,Vidoni ED,PLoS One,2021,14-01-2021,PMC7808620,,10.1371/journal.pone.0244893
33441154,New approaches to symptomatic treatments for Alzheimer's disease,Cummings J.,Mol Neurodegener. 2021 Jan 13;16(1):2. doi: 10.1186/s13024-021-00424-9.,Cummings J,Mol Neurodegener,2021,14-01-2021,PMC7805095,,10.1186/s13024-021-00424-9
33435977,Non-genetic risk and protective factors and biomarkers for neurological disorders: a meta-umbrella systematic review of umbrella reviews,"Mentis AA, Dardiotis E, Efthymiou V, Chrousos GP.",BMC Med. 2021 Jan 13;19(1):6. doi: 10.1186/s12916-020-01873-7.,Mentis AA,BMC Med,2021,13-01-2021,PMC7805241,,10.1186/s12916-020-01873-7
33434704,"Mediterranean-DASH Intervention for Neurodegenerative Delay (MIND) study: Rationale, design and baseline characteristics of a randomized control trial of the MIND diet on cognitive decline","Liu X, Morris MC, Dhana K, Ventrelle J, Johnson K, Bishop L, Hollings CS, Boulin A, Laranjo N, Stubbs BJ, Reilly X, Carey VJ, Wang Y, Furtado JD, Marcovina SM, Tangney C, Aggarwal NT, Arfanakis K, Sacks FM, Barnes LL.",Contemp Clin Trials. 2021 Mar;102:106270. doi: 10.1016/j.cct.2021.106270. Epub 2021 Jan 9.,Liu X,Contemp Clin Trials,2021,12-01-2021,PMC8042655,NIHMS1679066,10.1016/j.cct.2021.106270
33430021,Benefits under the Sea: The Role of Marine Compounds in Neurodegenerative Disorders,"Catanesi M, Caioni G, Castelli V, Benedetti E, d'Angelo M, Cimini A.",Mar Drugs. 2021 Jan 8;19(1):24. doi: 10.3390/md19010024.,Catanesi M,Mar Drugs,2021,12-01-2021,PMC7827849,,10.3390/md19010024
33413488,Milk consumption and multiple health outcomes: umbrella review of systematic reviews and meta-analyses in humans,"Zhang X, Chen X, Xu Y, Yang J, Du L, Li K, Zhou Y.",Nutr Metab (Lond). 2021 Jan 7;18(1):7. doi: 10.1186/s12986-020-00527-y.,Zhang X,Nutr Metab (Lond),2021,08-01-2021,PMC7789627,,10.1186/s12986-020-00527-y
33412145,Astrocytes in heavy metal neurotoxicity and neurodegeneration,"Li B, Xia M, Zorec R, Parpura V, Verkhratsky A.",Brain Res. 2021 Feb 1;1752:147234. doi: 10.1016/j.brainres.2020.147234. Epub 2021 Jan 5.,Li B,Brain Res,2021,07-01-2021,PMC8999909,NIHMS1794173,10.1016/j.brainres.2020.147234
33410773,Carbamate group as structural motif in drugs: a review of carbamate derivatives used as therapeutic agents,"Matošević A, Bosak A.",Arh Hig Rada Toksikol. 2020 Dec 31;71(4):285-299. doi: 10.2478/aiht-2020-71-3466.,Matošević A,Arh Hig Rada Toksikol,2020,07-01-2021,PMC7968508,,10.2478/aiht-2020-71-3466
33407219,Prevalence of mild cognitive impairment in community-dwelling Chinese populations aged over 55 years: a meta-analysis and systematic review,"Lu Y, Liu C, Yu D, Fawkes S, Ma J, Zhang M, Li C.",BMC Geriatr. 2021 Jan 6;21(1):10. doi: 10.1186/s12877-020-01948-3.,Lu Y,BMC Geriatr,2021,07-01-2021,PMC7789349,,10.1186/s12877-020-01948-3
33406269,"Brain Activity of Benzoate, a D-Amino Acid Oxidase Inhibitor, in Patients With Mild Cognitive Impairment in a Randomized, Double-Blind, Placebo Controlled Clinical Trial","Lane HY, Tu CH, Lin WC, Lin CH.",Int J Neuropsychopharmacol. 2021 May 18;24(5):392-399. doi: 10.1093/ijnp/pyab001.,Lane HY,Int J Neuropsychopharmacol,2021,06-01-2021,PMC8130199,,10.1093/ijnp/pyab001
33403822,Quantifying dementia prevention potential in the FINGER randomized controlled trial using the LIBRA prevention index,"Deckers K, Köhler S, Ngandu T, Antikainen R, Laatikainen T, Soininen H, Strandberg T, Verhey F, Kivipelto M, Solomon A.",Alzheimers Dement. 2021 Jul;17(7):1205-1212. doi: 10.1002/alz.12281. Epub 2021 Jan 6.,Deckers K,Alzheimers Dement,2021,06-01-2021,PMC8359273,,10.1002/alz.12281
33401674,"Natural Molecules and Neuroprotection: Kynurenic Acid, Pantethine and α-Lipoic Acid","Tóth F, Cseh EK, Vécsei L.",Int J Mol Sci. 2021 Jan 2;22(1):403. doi: 10.3390/ijms22010403.,Tóth F,Int J Mol Sci,2021,06-01-2021,PMC7795784,,10.3390/ijms22010403
33400181,Formaldehyde and Brain Disorders: A Meta-Analysis and Bioinformatics Approach,"Rana I, Rieswijk L, Steinmaus C, Zhang L.",Neurotox Res. 2021 Jun;39(3):924-948. doi: 10.1007/s12640-020-00320-y. Epub 2021 Jan 5.,Rana I,Neurotox Res,2021,05-01-2021,PMC8102312,NIHMS1655669,10.1007/s12640-020-00320-y
33399511,Blood-Brain Barrier Opening with MRI-guided Focused Ultrasound Elicits Meningeal Venous Permeability in Humans with Early Alzheimer Disease,"Mehta RI, Carpenter JS, Mehta RI, Haut MW, Ranjan M, Najib U, Lockman P, Wang P, D'haese PF, Rezai AR.",Radiology. 2021 Mar;298(3):654-662. doi: 10.1148/radiol.2021200643. Epub 2021 Jan 5.,Mehta RI,Radiology,2021,05-01-2021,PMC7924515,,10.1148/radiol.2021200643
33397266,Nicotinamide as a Foundation for Treating Neurodegenerative Disease and Metabolic Disorders,Maiese K.,Curr Neurovasc Res. 2021;18(1):134-149. doi: 10.2174/1567202617999210104220334.,Maiese K,Curr Neurovasc Res,2021,05-01-2021,PMC8254823,NIHMS1661548,10.2174/1567202617999210104220334
33394237,Update and Potential Opportunities in CBP [Cyclic Adenosine Monophosphate (cAMP) Response Element-Binding Protein (CREB)-Binding Protein] Research Using Computational Techniques,"Akinsiku OE, Soremekun OS, Soliman MES.",Protein J. 2021 Feb;40(1):19-27. doi: 10.1007/s10930-020-09951-8. Epub 2021 Jan 4.,Akinsiku OE,Protein J,2021,04-01-2021,PMC7868315,,10.1007/s10930-020-09951-8
33393683,Environmental exposures and the etiopathogenesis of Alzheimer's disease: The potential role of BACE1 as a critical neurotoxic target,"Syeda T, Cannon JR.",J Biochem Mol Toxicol. 2021 Apr;35(4):e22694. doi: 10.1002/jbt.22694. Epub 2021 Jan 4.,Syeda T,J Biochem Mol Toxicol,2021,04-01-2021,PMC8049945,NIHMS1657903,10.1002/jbt.22694
33390807,Correlation between C9ORF72 mutation and neurodegenerative diseases: A comprehensive review of the literature,"Xu X, Su Y, Zou Z, Zhou Y, Yan J.",Int J Med Sci. 2021 Jan 1;18(2):378-386. doi: 10.7150/ijms.53550. eCollection 2021.,Xu X,Int J Med Sci,2021,04-01-2021,PMC7757155,,10.7150/ijms.53550
33383373,Alpiniae oxyphyllae Fructus and Alzheimer's disease: An update and current perspective on this traditional Chinese medicine,"Li J, Du Q, Li N, Du S, Sun Z.",Biomed Pharmacother. 2021 Mar;135:111167. doi: 10.1016/j.biopha.2020.111167. Epub 2020 Dec 29.,Li J,Biomed Pharmacother,2021,31-12-2020,,,10.1016/j.biopha.2020.111167
33378982,Zingiber officinale ameliorates Alzheimer's disease and Cognitive Impairments: Lessons from preclinical studies,"Talebi M, İlgün S, Ebrahimi V, Talebi M, Farkhondeh T, Ebrahimi H, Samarghandian S.",Biomed Pharmacother. 2021 Jan;133:111088. doi: 10.1016/j.biopha.2020.111088. Epub 2020 Dec 15.,Talebi M,Biomed Pharmacother,2021,31-12-2020,,,10.1016/j.biopha.2020.111088
33377138,Findings of Sequential Pilot Trials of Aliviado Dementia Care to Inform an Embedded Pragmatic Clinical Trial,"Lin SY, Schneider CE, Bristol AA, Clancy M, Sprague SA, Aldridge M, Cortes T, Goldfeld KS, Kutner JS, Mitchell SL, Shega JW, Wu B, Zhu CW, Brody AA.",Gerontologist. 2022 Feb 9;62(2):304-314. doi: 10.1093/geront/gnaa220.,Lin SY,Gerontologist,2022,30-12-2020,PMC8827334,,10.1093/geront/gnaa220
33375513,Curcumin and Its Derivatives as Theranostic Agents in Alzheimer's Disease: The Implication of Nanotechnology,"Shabbir U, Rubab M, Tyagi A, Oh DH.",Int J Mol Sci. 2020 Dec 27;22(1):196. doi: 10.3390/ijms22010196.,Shabbir U,Int J Mol Sci,2020,30-12-2020,PMC7795367,,10.3390/ijms22010196
33375448,"Is There Justification to Treat Neurodegenerative Disorders by Repurposing Drugs? The Case of Alzheimer's Disease, Lithium, and Autophagy","Damri O, Shemesh N, Agam G.",Int J Mol Sci. 2020 Dec 27;22(1):189. doi: 10.3390/ijms22010189.,Damri O,Int J Mol Sci,2020,30-12-2020,PMC7795249,,10.3390/ijms22010189
33374338,Neuroprotective Effects of Coffee Bioactive Compounds: A Review,"Socała K, Szopa A, Serefko A, Poleszak E, Wlaź P.",Int J Mol Sci. 2020 Dec 24;22(1):107. doi: 10.3390/ijms22010107.,Socała K,Int J Mol Sci,2020,30-12-2020,PMC7795778,,10.3390/ijms22010107
33374235,The Microbiota-Gut-Brain Axis and Alzheimer's Disease: Neuroinflammation Is to Blame?,"Megur A, Baltriukienė D, Bukelskienė V, Burokas A.",Nutrients. 2020 Dec 24;13(1):37. doi: 10.3390/nu13010037.,Megur A,Nutrients,2020,30-12-2020,PMC7824474,,10.3390/nu13010037
33371284,Fluorine-18-Labeled Fluorescent Dyes for Dual-Mode Molecular Imaging,"Munch M, Rotstein BH, Ulrich G.",Molecules. 2020 Dec 21;25(24):6042. doi: 10.3390/molecules25246042.,Munch M,Molecules,2020,29-12-2020,PMC7766373,,10.3390/molecules25246042
33368017,Potential Neuroregenerative and Neuroprotective Effects of Uridine/Choline-Enriched Multinutrient Dietary Intervention for Mild Cognitive Impairment: A Narrative Review,"Baumel BS, Doraiswamy PM, Sabbagh M, Wurtman R.",Neurol Ther. 2021 Jun;10(1):43-60. doi: 10.1007/s40120-020-00227-y. Epub 2020 Dec 26.,Baumel BS,Neurol Ther,2021,28-12-2020,PMC8139993,,10.1007/s40120-020-00227-y
33353228,Nutraceutical Approaches of Autophagy and Neuroinflammation in Alzheimer's Disease: A Systematic Review,"Gruendler R, Hippe B, Sendula Jengic V, Peterlin B, Haslberger AG.",Molecules. 2020 Dec 18;25(24):6018. doi: 10.3390/molecules25246018.,Gruendler R,Molecules,2020,23-12-2020,PMC7765980,,10.3390/molecules25246018
33352989,c-Jun N-Terminal Kinase Inhibitors as Potential Leads for New Therapeutics for Alzheimer's Diseases,"Hepp Rehfeldt SC, Majolo F, Goettert MI, Laufer S.",Int J Mol Sci. 2020 Dec 18;21(24):9677. doi: 10.3390/ijms21249677.,Hepp Rehfeldt SC,Int J Mol Sci,2020,23-12-2020,PMC7765872,,10.3390/ijms21249677
33351971,"First-in-man study to investigate safety, pharmacokinetics and exploratory pharmacodynamics of HTL0018318, a novel M(1) -receptor partial agonist for the treatment of dementias","Bakker C, Tasker T, Liptrot J, Hart EP, Klaassen ES, Prins S, van der Doef TF, Brown GA, Brown A, Congreve M, Weir M, Marshall FH, Cross DM, Groeneveld GJ, Nathan PJ.",Br J Clin Pharmacol. 2021 Jul;87(7):2945-2955. doi: 10.1111/bcp.14710. Epub 2021 Feb 5.,Bakker C,Br J Clin Pharmacol,2021,22-12-2020,PMC8359307,,10.1111/bcp.14710
33343442,Physical Activity for Executive Function and Activities of Daily Living in AD Patients: A Systematic Review and Meta-Analysis,"Zhu L, Li L, Wang L, Jin X, Zhang H.",Front Psychol. 2020 Dec 3;11:560461. doi: 10.3389/fpsyg.2020.560461. eCollection 2020.,Zhu L,Front Psychol,2020,21-12-2020,PMC7744293,,10.3389/fpsyg.2020.560461
33343293,Repositioning of Immunomodulators: A Ray of Hope for Alzheimer's Disease?,"Munafò A, Burgaletto C, Di Benedetto G, Di Mauro M, Di Mauro R, Bernardini R, Cantarella G.",Front Neurosci. 2020 Dec 4;14:614643. doi: 10.3389/fnins.2020.614643. eCollection 2020.,Munafò A,Front Neurosci,2020,21-12-2020,PMC7746859,,10.3389/fnins.2020.614643
33339351,Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer's Disease,"Kang YJ, Diep YN, Tran M, Cho H.",Int J Mol Sci. 2020 Dec 16;21(24):9591. doi: 10.3390/ijms21249591.,Kang YJ,Int J Mol Sci,2020,19-12-2020,PMC7766709,,10.3390/ijms21249591
33336232,Nutrition to Prevent or Treat Cognitive Impairment in Older Adults: A GRADE Recommendation,"Buckinx F, Aubertin-Leheudre M.",J Prev Alzheimers Dis. 2021;8(1):110-116. doi: 10.14283/jpad.2020.40.,Buckinx F,J Prev Alzheimers Dis,2021,18-12-2020,,,10.14283/jpad.2020.40
33336223,Prospective Associations between Plasma Amyloid-Beta 42/40 and Frailty in Community-Dwelling Older Adults,"Lu WH, Giudici KV, Rolland Y, Guyonnet S, Li Y, Bateman RJ, de Souto Barreto P, Vellas B.",J Prev Alzheimers Dis. 2021;8(1):41-47. doi: 10.14283/jpad.2020.60.,Lu WH,J Prev Alzheimers Dis,2021,18-12-2020,PMC9982745,NIHMS1847595,10.14283/jpad.2020.60
33333772,Palmitoylethanolamide: A Nutritional Approach to Keep Neuroinflammation within Physiological Boundaries-A Systematic Review,"Petrosino S, Schiano Moriello A.",Int J Mol Sci. 2020 Dec 15;21(24):9526. doi: 10.3390/ijms21249526.,Petrosino S,Int J Mol Sci,2020,18-12-2020,PMC7765232,,10.3390/ijms21249526
33331917,Assessment of Plasma Amyloid-β42/40 and Cognitive Decline Among Community-Dwelling Older Adults,"Giudici KV, de Souto Barreto P, Guyonnet S, Li Y, Bateman RJ, Vellas B; MAPT/DSA Group.",JAMA Netw Open. 2020 Dec 1;3(12):e2028634. doi: 10.1001/jamanetworkopen.2020.28634.,Giudici KV,JAMA Netw Open,2020,17-12-2020,PMC7747018,,10.1001/jamanetworkopen.2020.28634
33326819,Psychological comorbidity in gastrointestinal diseases: Update on the brain-gut-microbiome axis,"Person H, Keefer L.",Prog Neuropsychopharmacol Biol Psychiatry. 2021 Apr 20;107:110209. doi: 10.1016/j.pnpbp.2020.110209. Epub 2020 Dec 14.,Person H,Prog Neuropsychopharmacol Biol Psychiatry,2021,16-12-2020,PMC8382262,NIHMS1699330,10.1016/j.pnpbp.2020.110209
33325386,Pharmacological Strategies to Improve Dendritic Spines in Alzheimer's Disease,"Ettcheto M, Busquets O, Cano A, Sánchez-Lopez E, Manzine PR, Espinosa-Jimenez T, Verdaguer E, Sureda FX, Olloquequi J, Castro-Torres RD, Auladell C, Folch J, Casadesús G, Camins A.",J Alzheimers Dis. 2021;82(s1):S91-S107. doi: 10.3233/JAD-201106.,Ettcheto M,J Alzheimers Dis,2021,16-12-2020,PMC9853464,NIHMS1859295,10.3233/JAD-201106
33324194,Overview of Meta-Analyses of Five Non-pharmacological Interventions for Alzheimer's Disease,"Wang LY, Pei J, Zhan YJ, Cai YW.",Front Aging Neurosci. 2020 Nov 25;12:594432. doi: 10.3389/fnagi.2020.594432. eCollection 2020.,Wang LY,Front Aging Neurosci,2020,16-12-2020,PMC7723835,,10.3389/fnagi.2020.594432
33321511,Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials,"Tian Hui Kwan A, Arfaie S, Therriault J, Rosa-Neto P, Gauthier S.",Dement Geriatr Cogn Disord. 2020;49(4):334-348. doi: 10.1159/000511506. Epub 2020 Dec 15.,Tian Hui Kwan A,Dement Geriatr Cogn Disord,2020,15-12-2020,,,10.1159/000511506
33320477,[Diet as a risk factor for Alzheimer's disease],"Stępkowski D, Studnicki M, Woźniak G, Dębski K.",Postepy Biochem. 2020 Mar 20;66(1):19-22. doi: 10.18388/pb.2020_311. Print 2020 Mar 31.,Stępkowski D,Postepy Biochem,2020,15-12-2020,,,10.18388/pb.2020_311
33320335,Souvenaid for Alzheimer's disease,"Burckhardt M, Watzke S, Wienke A, Langer G, Fink A.",Cochrane Database Syst Rev. 2020 Dec 15;12(12):CD011679. doi: 10.1002/14651858.CD011679.pub2.,Burckhardt M,Cochrane Database Syst Rev,2020,15-12-2020,PMC8094446,,10.1002/14651858.CD011679.pub2
33313373,What does (low) education mean in terms of dementia risk? A systematic review and meta-analysis highlighting inconsistency in measuring and operationalising education,"Maccora J, Peters R, Anstey KJ.",SSM Popul Health. 2020 Aug 29;12:100654. doi: 10.1016/j.ssmph.2020.100654. eCollection 2020 Dec.,Maccora J,SSM Popul Health,2020,14-12-2020,PMC7721642,,10.1016/j.ssmph.2020.100654
33312780,The Impact of Low Hemoglobin Levels on Cognitive Brain Functions,"Gattas BS, Ibetoh CN, Stratulat E, Liu F, Wuni GY, Bahuva R, Shafiq MA, Gordon DK.",Cureus. 2020 Nov 8;12(11):e11378. doi: 10.7759/cureus.11378.,Gattas BS,Cureus,2020,14-12-2020,PMC7723430,,10.7759/cureus.11378
33311571,Cellular correlates of cortical thinning throughout the lifespan,"Vidal-Pineiro D, Parker N, Shin J, French L, Grydeland H, Jackowski AP, Mowinckel AM, Patel Y, Pausova Z, Salum G, Sørensen Ø, Walhovd KB, Paus T, Fjell AM; Alzheimer’s Disease Neuroimaging Initiative and the Australian Imaging Biomarkers and Lifestyle flagship study of ageing.",Sci Rep. 2020 Dec 11;10(1):21803. doi: 10.1038/s41598-020-78471-3.,Vidal-Pineiro D,Sci Rep,2020,14-12-2020,PMC7732849,,10.1038/s41598-020-78471-3
33310207,Adiponectin paradox as a therapeutic target of the cancer evolvability in aging,"Takamatsu Y, Ho G, Wada R, Inoue S, Hashimoto M.",Neoplasia. 2021 Jan;23(1):112-117. doi: 10.1016/j.neo.2020.11.008. Epub 2020 Dec 9.,Takamatsu Y,Neoplasia,2021,14-12-2020,PMC7726259,,10.1016/j.neo.2020.11.008
33309881,Current Clinical Applications of In Vivo Gene Therapy with AAVs,"Mendell JR, Al-Zaidy SA, Rodino-Klapac LR, Goodspeed K, Gray SJ, Kay CN, Boye SL, Boye SE, George LA, Salabarria S, Corti M, Byrne BJ, Tremblay JP.",Mol Ther. 2021 Feb 3;29(2):464-488. doi: 10.1016/j.ymthe.2020.12.007. Epub 2020 Dec 10.,Mendell JR,Mol Ther,2021,14-12-2020,PMC7854298,,10.1016/j.ymthe.2020.12.007
33297460,Modulation of Brain Hyperexcitability: Potential New Therapeutic Approaches in Alzheimer's Disease,"Toniolo S, Sen A, Husain M.",Int J Mol Sci. 2020 Dec 7;21(23):9318. doi: 10.3390/ijms21239318.,Toniolo S,Int J Mol Sci,2020,10-12-2020,PMC7730926,,10.3390/ijms21239318
33296631,[Caspase inhibition: From cellular biology and thanatology to potential clinical agents],Jacotot É.,Med Sci (Paris). 2020 Dec;36(12):1143-1154. doi: 10.1051/medsci/2020222. Epub 2020 Dec 9.,Jacotot É,Med Sci (Paris),2020,09-12-2020,,,10.1051/medsci/2020222
33281745,An Updated Review: Androgens and Cognitive Impairment in Older Men,"Cai Z, Li H.",Front Endocrinol (Lausanne). 2020 Nov 13;11:586909. doi: 10.3389/fendo.2020.586909. eCollection 2020.,Cai Z,Front Endocrinol (Lausanne),2020,07-12-2020,PMC7691320,,10.3389/fendo.2020.586909
33274192,Natural Cinnamaldehyde and Its Derivatives Ameliorate Neuroinflammatory Pathways in Neurodegenerative Diseases,"Hajinejad M, Ghaddaripouri M, Dabzadeh M, Forouzanfar F, Sahab-Negah S.",Biomed Res Int. 2020 Nov 14;2020:1034325. doi: 10.1155/2020/1034325. eCollection 2020.,Hajinejad M,Biomed Res Int,2020,04-12-2020,PMC7683109,,10.1155/2020/1034325
33271506,Few Structural Brain Changes Associated With Moderate-Intensity Interval Training and Low-Intensity Continuous Training in a Randomized Trial of Fitness and Older Adults,"Martin-Willett R, Ellingson JE, Fries J, Helmuth T, Karoly H, Giordano G, Calhoun VD, Bryan AD.",J Aging Phys Act. 2021 Jun 1;29(3):505-515. doi: 10.1123/japa.2019-0352. Epub 2020 Dec 2.,Martin-Willett R,J Aging Phys Act,2021,03-12-2020,PMC9092807,NIHMS1790923,10.1123/japa.2019-0352
33268824,New therapeutics beyond amyloid-β and tau for the treatment of Alzheimer's disease,"Zhang F, Zhong RJ, Cheng C, Li S, Le WD.",Acta Pharmacol Sin. 2021 Sep;42(9):1382-1389. doi: 10.1038/s41401-020-00565-5. Epub 2020 Dec 2.,Zhang F,Acta Pharmacol Sin,2021,03-12-2020,PMC8379190,,10.1038/s41401-020-00565-5
33260532,Hearing Loss in Alzheimer's Disease Is Associated with Altered Serum Lipidomic Biomarker Profiles,"Llano DA, Issa LK, Devanarayan P, Devanarayan V, Alzheimer's Disease Neuroimaging Initiative Adni.",Cells. 2020 Nov 28;9(12):2556. doi: 10.3390/cells9122556.,Llano DA,Cells,2020,02-12-2020,PMC7760745,,10.3390/cells9122556
33260151,rTMS modulates precuneus-hippocampal subregion circuit in patients with subjective cognitive decline,"Chen J, Ma N, Hu G, Nousayhah A, Xue C, Qi W, Xu W, Chen S, Rao J, Liu W, Zhang F, Zhang X.",Aging (Albany NY). 2020 Nov 30;13(1):1314-1331. doi: 10.18632/aging.202313. Epub 2020 Nov 30.,Chen J,Aging (Albany NY),2020,01-12-2020,PMC7835048,,10.18632/aging.202313
33256147,Cerebrospinal Fluid and Serum d-Serine Levels in Patients with Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Chang CH, Kuo HL, Ma WF, Tsai HC.",J Clin Med. 2020 Nov 26;9(12):3840. doi: 10.3390/jcm9123840.,Chang CH,J Clin Med,2020,01-12-2020,PMC7761499,,10.3390/jcm9123840
33254429,Melatonin regulates Aβ production/clearance balance and Aβ neurotoxicity: A potential therapeutic molecule for Alzheimer's disease,"Li Y, Zhang J, Wan J, Liu A, Sun J.",Biomed Pharmacother. 2020 Dec;132:110887. doi: 10.1016/j.biopha.2020.110887. Epub 2020 Nov 2.,Li Y,Biomed Pharmacother,2020,01-12-2020,,,10.1016/j.biopha.2020.110887
33253354,"BACE inhibition causes rapid, regional, and non-progressive volume reduction in Alzheimer's disease brain","Sur C, Kost J, Scott D, Adamczuk K, Fox NC, Cummings JL, Tariot PN, Aisen PS, Vellas B, Voss T, Mahoney E, Mukai Y, Kennedy ME, Lines C, Michelson D, Egan MF.",Brain. 2020 Dec 1;143(12):3816-3826. doi: 10.1093/brain/awaa332.,Sur C,Brain,2020,30-11-2020,PMC8453290,,10.1093/brain/awaa332
33243665,Same pollution sources for climate change might be hyperactivating the NLRP3 inflammasome and exacerbating neuroinflammation and SARS mortality,"Macias-Verde D, Lara PC, Burgos-Burgos J.",Med Hypotheses. 2021 Jan;146:110396. doi: 10.1016/j.mehy.2020.110396. Epub 2020 Nov 17.,Macias-Verde D,Med Hypotheses,2021,27-11-2020,PMC7963803,,10.1016/j.mehy.2020.110396
33239010,"The good, the bad, and the opportunities of the complement system in neurodegenerative disease","Schartz ND, Tenner AJ.",J Neuroinflammation. 2020 Nov 25;17(1):354. doi: 10.1186/s12974-020-02024-8.,Schartz ND,J Neuroinflammation,2020,26-11-2020,PMC7690210,,10.1186/s12974-020-02024-8
33233619,Sigma-2 Receptor-A Potential Target for Cancer/Alzheimer's Disease Treatment via Its Regulation of Cholesterol Homeostasis,"Yang K, Zeng C, Wang C, Sun M, Yin D, Sun T.",Molecules. 2020 Nov 20;25(22):5439. doi: 10.3390/molecules25225439.,Yang K,Molecules,2020,25-11-2020,PMC7699687,,10.3390/molecules25225439
33233502,Effects of Ketone Bodies on Brain Metabolism and Function in Neurodegenerative Diseases,"Jensen NJ, Wodschow HZ, Nilsson M, Rungby J.",Int J Mol Sci. 2020 Nov 20;21(22):8767. doi: 10.3390/ijms21228767.,Jensen NJ,Int J Mol Sci,2020,25-11-2020,PMC7699472,,10.3390/ijms21228767
33232931,Association between chronic stress and Alzheimer's disease: Therapeutic effects of Saffron,"Saeedi M, Rashidy-Pour A.",Biomed Pharmacother. 2021 Jan;133:110995. doi: 10.1016/j.biopha.2020.110995. Epub 2020 Nov 21.,Saeedi M,Biomed Pharmacother,2021,24-11-2020,,,10.1016/j.biopha.2020.110995
33228179,Can We Treat Neuroinflammation in Alzheimer's Disease?,"Sánchez-Sarasúa S, Fernández-Pérez I, Espinosa-Fernández V, Sánchez-Pérez AM, Ledesma JC.",Int J Mol Sci. 2020 Nov 19;21(22):8751. doi: 10.3390/ijms21228751.,Sánchez-Sarasúa S,Int J Mol Sci,2020,24-11-2020,PMC7699542,,10.3390/ijms21228751
33227157,Mindfulness in Motion and Dietary Approaches to Stop Hypertension (DASH) in Hypertensive African Americans,"Wright KD, Klatt MD, Adams IR, Nguyen CM, Mion LC, Tan A, Monroe TB, Rose KM, Scharre DW.",J Am Geriatr Soc. 2021 Mar;69(3):773-778. doi: 10.1111/jgs.16947. Epub 2020 Nov 23.,Wright KD,J Am Geriatr Soc,2021,23-11-2020,PMC8329944,NIHMS1721445,10.1111/jgs.16947
33219523,Treating disorders across the lifespan by modulating cholinergic signaling with galantamine,"Metz CN, Pavlov VA.",J Neurochem. 2021 Sep;158(6):1359-1380. doi: 10.1111/jnc.15243. Epub 2021 Jan 8.,Metz CN,J Neurochem,2021,21-11-2020,PMC10049459,NIHMS1673513,10.1111/jnc.15243
33213346,Cholinesterase Inhibitory Potential of Quercetin towards Alzheimer's Disease - A Promising Natural Molecule or Fashion of the Day? - A Narrowed Review,Orhan IE.,Curr Neuropharmacol. 2021;19(12):2205-2213. doi: 10.2174/1570159X18666201119153807.,Orhan IE,Curr Neuropharmacol,2021,20-11-2020,PMC9185776,,10.2174/1570159X18666201119153807
33211152,The positive effect of spermidine in older adults suffering from dementia : First results of a 3-month trial,"Pekar T, Bruckner K, Pauschenwein-Frantsich S, Gschaider A, Oppliger M, Willesberger J, Ungersbäck P, Wendzel A, Kremer A, Flak W, Wantke F, Jarisch R.",Wien Klin Wochenschr. 2021 May;133(9-10):484-491. doi: 10.1007/s00508-020-01758-y. Epub 2020 Nov 19.,Pekar T,Wien Klin Wochenschr,2021,19-11-2020,PMC8116233,,10.1007/s00508-020-01758-y
33210441,Bioengineering of Anti-Inflammatory Natural Products,"Winand L, Sester A, Nett M.",ChemMedChem. 2021 Mar 3;16(5):767-776. doi: 10.1002/cmdc.202000771. Epub 2020 Dec 16.,Winand L,ChemMedChem,2021,19-11-2020,PMC7986114,,10.1002/cmdc.202000771
33210212,"Recent Insights on the Role of PPAR-β/δ in Neuroinflammation and Neurodegeneration, and Its Potential Target for Therapy","Strosznajder AK, Wójtowicz S, Jeżyna MJ, Sun GY, Strosznajder JB.",Neuromolecular Med. 2021 Mar;23(1):86-98. doi: 10.1007/s12017-020-08629-9. Epub 2020 Nov 18.,Strosznajder AK,Neuromolecular Med,2021,19-11-2020,PMC7929960,,10.1007/s12017-020-08629-9
33207780,Efficacy of Sulforaphane in Neurodegenerative Diseases,"Schepici G, Bramanti P, Mazzon E.",Int J Mol Sci. 2020 Nov 16;21(22):8637. doi: 10.3390/ijms21228637.,Schepici G,Int J Mol Sci,2020,19-11-2020,PMC7698208,,10.3390/ijms21228637
33207662,Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration,"Sarparast M, Dattmore D, Alan J, Lee KSS.",Nutrients. 2020 Nov 16;12(11):3523. doi: 10.3390/nu12113523.,Sarparast M,Nutrients,2020,19-11-2020,PMC7696575,,10.3390/nu12113523
33203630,Treatment of hypertension reduces cognitive decline in older adults: a systematic review and meta-analysis,"Gupta A, Perdomo S, Billinger S, Beddhu S, Burns J, Gronseth G.",BMJ Open. 2020 Nov 17;10(11):e038971. doi: 10.1136/bmjopen-2020-038971.,Gupta A,BMJ Open,2020,18-11-2020,PMC7674095,,10.1136/bmjopen-2020-038971
33202839,Nano Carrier Drug Delivery Systems for the Treatment of Neuropsychiatric Disorders: Advantages and Limitations,"Zorkina Y, Abramova O, Ushakova V, Morozova A, Zubkov E, Valikhov M, Melnikov P, Majouga A, Chekhonin V.",Molecules. 2020 Nov 13;25(22):5294. doi: 10.3390/molecules25225294.,Zorkina Y,Molecules,2020,18-11-2020,PMC7697162,,10.3390/molecules25225294
33199752,"Effect of desalted Salicornia europaea L. ethanol extract (PM-EE) on the subjects complaining memory dysfunction without dementia: a 12 week, randomized, double-blind, placebo-controlled clinical trial","Lee WJ, Shin YW, Kim DE, Kweon MH, Kim M.",Sci Rep. 2020 Nov 16;10(1):19914. doi: 10.1038/s41598-020-76938-x.,Lee WJ,Sci Rep,2020,17-11-2020,PMC7670404,,10.1038/s41598-020-76938-x
33197235,Circulating plasma factors involved in rejuvenation,"Kang JS, Yang YR.",Aging (Albany NY). 2020 Nov 16;12(22):23394-23408. doi: 10.18632/aging.103933. Epub 2020 Nov 16.,Kang JS,Aging (Albany NY),2020,16-11-2020,PMC7746393,,10.18632/aging.103933
33194354,"A pilot feasibility randomized controlled trial on combining mind-body physical exercise, cognitive training, and nurse-led risk factor modification to reduce cognitive decline among older adults with mild cognitive impairment in primary care","Xu Z, Zhang D, Lee ATC, Sit RWS, Wong C, Lee EKP, Yip BHK, Tiu JYS, Lam LCW, Wong SYS.",PeerJ. 2020 Sep 7;8:e9845. doi: 10.7717/peerj.9845. eCollection 2020.,Xu Z,PeerJ,2020,16-11-2020,PMC7482623,,10.7717/peerj.9845
33190659,Effects of repetitive paired associative stimulation on brain plasticity and working memory in Alzheimer's disease: a pilot randomized double-blind-controlled trial,"Kumar S, Zomorrodi R, Ghazala Z, Goodman MS, Blumberger DM, Daskalakis ZJ, Fischer CE, Mulsant BH, Pollock BG, Rajji TK.",Int Psychogeriatr. 2023 Mar;35(3):143-155. doi: 10.1017/S1041610220003518. Epub 2020 Nov 16.,Kumar S,Int Psychogeriatr,2023,16-11-2020,,,10.1017/S1041610220003518
33189083,Pharmacotherapies for sleep disturbances in dementia,"McCleery J, Sharpley AL.",Cochrane Database Syst Rev. 2020 Nov 15;11(11):CD009178. doi: 10.1002/14651858.CD009178.pub4.,McCleery J,Cochrane Database Syst Rev,2020,14-11-2020,PMC8094738,,10.1002/14651858.CD009178.pub4
33189067,Traditional Chinese medicine compounds regulate autophagy for treating neurodegenerative disease: A mechanism review,"Wang ZY, Liu J, Zhu Z, Su CF, Sreenivasmurthy SG, Iyaswamy A, Lu JH, Chen G, Song JX, Li M.",Biomed Pharmacother. 2021 Jan;133:110968. doi: 10.1016/j.biopha.2020.110968. Epub 2020 Nov 11.,Wang ZY,Biomed Pharmacother,2021,14-11-2020,,,10.1016/j.biopha.2020.110968
33187212,Vitamins in Alzheimer's Disease-Review of the Latest Reports,"Mielech A, Puścion-Jakubik A, Markiewicz-Żukowska R, Socha K.",Nutrients. 2020 Nov 11;12(11):3458. doi: 10.3390/nu12113458.,Mielech A,Nutrients,2020,14-11-2020,PMC7696081,,10.3390/nu12113458
33187056,"""What Doesn't Kill You Makes You Stronger"": Future Applications of Amyloid Aggregates in Biomedicine","Abdelrahman S, Alghrably M, Lachowicz JI, Emwas AH, Hauser CAE, Jaremko M.",Molecules. 2020 Nov 11;25(22):5245. doi: 10.3390/molecules25225245.,Abdelrahman S,Molecules,2020,14-11-2020,PMC7696280,,10.3390/molecules25225245
33185677,Association Between Alzheimer Disease and Cancer With Evaluation of Study Biases: A Systematic Review and Meta-analysis,"Ospina-Romero M, Glymour MM, Hayes-Larson E, Mayeda ER, Graff RE, Brenowitz WD, Ackley SF, Witte JS, Kobayashi LC.",JAMA Netw Open. 2020 Nov 2;3(11):e2025515. doi: 10.1001/jamanetworkopen.2020.25515.,Ospina-Romero M,JAMA Netw Open,2020,13-11-2020,PMC7666424,,10.1001/jamanetworkopen.2020.25515
33185582,COVID-19 in age-related neurodegenerative diseases: is there a role for vitamin D3 as a possible therapeutic strategy?,"de Barros Viana M, Rosário BDA, de Fátima Santana de Nazaré M, Estadella D, Ribeiro DA, Socorro de Barros Viana G.",Rev Neurosci. 2020 Nov 12;32(2):235-247. doi: 10.1515/revneuro-2020-0074. Print 2021 Feb 23.,de Barros Viana M,Rev Neurosci,2020,13-11-2020,,,10.1515/revneuro-2020-0074
33179197,The Treatment of Sleep Dysfunction in Neurodegenerative Disorders,"Voysey ZJ, Barker RA, Lazar AS.",Neurotherapeutics. 2021 Jan;18(1):202-216. doi: 10.1007/s13311-020-00959-7. Epub 2020 Nov 11.,Voysey ZJ,Neurotherapeutics,2021,12-11-2020,PMC8116411,,10.1007/s13311-020-00959-7
33176653,Naturally Inspired Pyrimidines Analogues for Alzheimer's Disease,"Singh S, Dhanawat M, Gupta S, Kumar D, Kakkar S, Nair A, Verma I, Sharma P.",Curr Neuropharmacol. 2021;19(2):136-151. doi: 10.2174/1570159X18666201111110136.,Singh S,Curr Neuropharmacol,2021,12-11-2020,PMC8033975,,10.2174/1570159X18666201111110136
33176157,Using the Oxytosis/Ferroptosis Pathway to Understand and Treat Age-Associated Neurodegenerative Diseases,"Maher P, Currais A, Schubert D.",Cell Chem Biol. 2020 Dec 17;27(12):1456-1471. doi: 10.1016/j.chembiol.2020.10.010. Epub 2020 Nov 10.,Maher P,Cell Chem Biol,2020,11-11-2020,PMC7749085,NIHMS1640102,10.1016/j.chembiol.2020.10.010
33172069,Neurogranin and VILIP-1 as Molecular Indicators of Neurodegeneration in Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Dulewicz M, Kulczyńska-Przybik A, Mroczko B.",Int J Mol Sci. 2020 Nov 6;21(21):8335. doi: 10.3390/ijms21218335.,Dulewicz M,Int J Mol Sci,2020,11-11-2020,PMC7664397,,10.3390/ijms21218335
33171799,Shortcut Approaches to Substance Delivery into the Brain Based on Intranasal Administration Using Nanodelivery Strategies for Insulin,Tashima T.,Molecules. 2020 Nov 7;25(21):5188. doi: 10.3390/molecules25215188.,Tashima T,Molecules,2020,11-11-2020,PMC7664636,,10.3390/molecules25215188
33171772,Molecular Targets of Cannabidiol in Experimental Models of Neurological Disease,"Silvestro S, Schepici G, Bramanti P, Mazzon E.",Molecules. 2020 Nov 7;25(21):5186. doi: 10.3390/molecules25215186.,Silvestro S,Molecules,2020,11-11-2020,PMC7664437,,10.3390/molecules25215186
33167948,Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials,"Ayati Z, Yang G, Ayati MH, Emami SA, Chang D.",BMC Complement Med Ther. 2020 Nov 9;20(1):333. doi: 10.1186/s12906-020-03102-3.,Ayati Z,BMC Complement Med Ther,2020,10-11-2020,PMC7650148,,10.1186/s12906-020-03102-3
33146371,"ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV","Lubbe L, Cozier GE, Oosthuizen D, Acharya KR, Sturrock ED.",Clin Sci (Lond). 2020 Nov 13;134(21):2851-2871. doi: 10.1042/CS20200899.,Lubbe L,Clin Sci (Lond),2020,04-11-2020,PMC7642307,,10.1042/CS20200899
33123310,The Antiaggregative and Antiamyloidogenic Properties of Nanoparticles: A Promising Tool for the Treatment and Diagnostics of Neurodegenerative Diseases,"Pichla M, Bartosz G, Sadowska-Bartosz I.",Oxid Med Cell Longev. 2020 Oct 13;2020:3534570. doi: 10.1155/2020/3534570. eCollection 2020.,Pichla M,Oxid Med Cell Longev,2020,30-10-2020,PMC7582079,,10.1155/2020/3534570
33122694,Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression,"Noguchi-Shinohara M, Ono K, Hamaguchi T, Nagai T, Kobayashi S, Komatsu J, Samuraki-Yokohama M, Iwasa K, Yokoyama K, Nakamura H, Yamada M.",Sci Rep. 2020 Oct 29;10(1):18627. doi: 10.1038/s41598-020-73729-2.,Noguchi-Shinohara M,Sci Rep,2020,30-10-2020,PMC7596544,,10.1038/s41598-020-73729-2
33121510,Challenges and opportunities for improving the landscape for Lewy body dementia clinical trials,"Goldman JG, Forsberg LK, Boeve BF, Armstrong MJ, Irwin DJ, Ferman TJ, Galasko D, Galvin JE, Kaufer D, Leverenz J, Lippa CF, Marder K, Abler V, Biglan K, Irizarry M, Keller B, Munsie L, Nakagawa M, Taylor A, Graham T.",Alzheimers Res Ther. 2020 Oct 29;12(1):137. doi: 10.1186/s13195-020-00703-5.,Goldman JG,Alzheimers Res Ther,2020,30-10-2020,PMC7597002,,10.1186/s13195-020-00703-5
33117368,Protective Functions of Reactive Astrocytes Following Central Nervous System Insult,"Linnerbauer M, Rothhammer V.",Front Immunol. 2020 Sep 30;11:573256. doi: 10.3389/fimmu.2020.573256. eCollection 2020.,Linnerbauer M,Front Immunol,2020,29-10-2020,PMC7561408,,10.3389/fimmu.2020.573256
33114371,Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation,"Anfinogenova ND, Quinn MT, Schepetkin IA, Atochin DN.",Cells. 2020 Oct 24;9(11):2350. doi: 10.3390/cells9112350.,Anfinogenova ND,Cells,2020,29-10-2020,PMC7693759,,10.3390/cells9112350
33111259,Iron and Ferroptosis as Therapeutic Targets in Alzheimer's Disease,"Gleason A, Bush AI.",Neurotherapeutics. 2021 Jan;18(1):252-264. doi: 10.1007/s13311-020-00954-y. Epub 2020 Oct 27.,Gleason A,Neurotherapeutics,2021,28-10-2020,PMC8116360,,10.1007/s13311-020-00954-y
33110037,Cognitive complaints are associated with smaller right medial temporal gray-matter volume in younger postmenopausal women,"Conley AC, Albert KM, Boyd BD, Kim SG, Shokouhi S, McDonald BC, Saykin AJ, Dumas JA, Newhouse PA.",Menopause. 2020 Nov;27(11):1220-1227. doi: 10.1097/GME.0000000000001613.,Conley AC,Menopause,2020,28-10-2020,PMC9153070,NIHMS1802565,10.1097/GME.0000000000001613
33105637,Therapeutic Potential of Porcine Liver Decomposition Product: New Insights and Perspectives for Microglia-Mediated Neuroinflammation in Neurodegenerative Diseases,"Tsukahara T, Haniu H, Uemura T, Matsuda Y.",Biomedicines. 2020 Oct 22;8(11):446. doi: 10.3390/biomedicines8110446.,Tsukahara T,Biomedicines,2020,27-10-2020,PMC7690401,,10.3390/biomedicines8110446
33103819,A ketogenic drink improves cognition in mild cognitive impairment: Results of a 6-month RCT,"Fortier M, Castellano CA, St-Pierre V, Myette-Côté É, Langlois F, Roy M, Morin MC, Bocti C, Fulop T, Godin JP, Delannoy C, Cuenoud B, Cunnane SC.",Alzheimers Dement. 2021 Mar;17(3):543-552. doi: 10.1002/alz.12206. Epub 2020 Oct 26.,Fortier M,Alzheimers Dement,2021,26-10-2020,PMC8048678,,10.1002/alz.12206
33099465,Dietary interventions and cognition: A systematic review of clinical trials,"Gkotzamanis V, Panagiotakos D.",Psychiatriki. 2020 Jul-Sep;31(3):248-256. doi: 10.22365/jpsych.2020.313.248.,Gkotzamanis V,Psychiatriki,2020,25-10-2020,,,10.22365/jpsych.2020.313.248
33096898,"Use of Biodegradable, Chitosan-Based Nanoparticles in the Treatment of Alzheimer's Disease","Manek E, Darvas F, Petroianu GA.",Molecules. 2020 Oct 21;25(20):4866. doi: 10.3390/molecules25204866.,Manek E,Molecules,2020,24-10-2020,PMC7587961,,10.3390/molecules25204866
33096024,Emerging Microglia Biology Defines Novel Therapeutic Approaches for Alzheimer's Disease,"Lewcock JW, Schlepckow K, Di Paolo G, Tahirovic S, Monroe KM, Haass C.",Neuron. 2020 Dec 9;108(5):801-821. doi: 10.1016/j.neuron.2020.09.029. Epub 2020 Oct 22.,Lewcock JW,Neuron,2020,23-10-2020,,,10.1016/j.neuron.2020.09.029
33092396,"Dysfunction of the Microbiota-Gut-Brain Axis in Neurodegenerative Disease: The Promise of Therapeutic Modulation With Prebiotics, Medicinal Herbs, Probiotics, and Synbiotics",Peterson CT.,J Evid Based Integr Med. 2020 Jan-Dec;25:2515690X20957225. doi: 10.1177/2515690X20957225.,Peterson CT,J Evid Based Integr Med,2020,23-10-2020,PMC7586271,,10.1177/2515690X20957225
33089409,CRISPR-Cas9: A Promising Genome Editing Therapeutic Tool for Alzheimer's Disease-A Narrative Review,"Barman NC, Khan NM, Islam M, Nain Z, Roy RK, Haque A, Barman SK.",Neurol Ther. 2020 Dec;9(2):419-434. doi: 10.1007/s40120-020-00218-z. Epub 2020 Oct 21.,Barman NC,Neurol Ther,2020,22-10-2020,PMC7606404,,10.1007/s40120-020-00218-z
33081348,Copper Toxicity Links to Pathogenesis of Alzheimer's Disease and Therapeutics Approaches,"Ejaz HW, Wang W, Lang M.",Int J Mol Sci. 2020 Oct 16;21(20):7660. doi: 10.3390/ijms21207660.,Ejaz HW,Int J Mol Sci,2020,21-10-2020,PMC7589751,,10.3390/ijms21207660
33078369,Neurobiochemical Cross-talk Between COVID-19 and Alzheimer's Disease,"Rahman MA, Islam K, Rahman S, Alamin M.",Mol Neurobiol. 2021 Mar;58(3):1017-1023. doi: 10.1007/s12035-020-02177-w. Epub 2020 Oct 19.,Rahman MA,Mol Neurobiol,2021,20-10-2020,PMC7571527,,10.1007/s12035-020-02177-w
33076983,The impact of a multi-domain intervention on cerebral glucose metabolism: analysis from the randomized ancillary FDG PET MAPT trial,"Delrieu J, Voisin T, Saint-Aubert L, Carrie I, Cantet C, Vellas B, Payoux P, Andrieu S.",Alzheimers Res Ther. 2020 Oct 19;12(1):134. doi: 10.1186/s13195-020-00683-6.,Delrieu J,Alzheimers Res Ther,2020,20-10-2020,PMC7574215,,10.1186/s13195-020-00683-6
33074237,Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial,"Gibson GE, Luchsinger JA, Cirio R, Chen H, Franchino-Elder J, Hirsch JA, Bettendorff L, Chen Z, Flowers SA, Gerber LM, Grandville T, Schupf N, Xu H, Stern Y, Habeck C, Jordan B, Fonzetti P.",J Alzheimers Dis. 2020;78(3):989-1010. doi: 10.3233/JAD-200896.,Gibson GE,J Alzheimers Dis,2020,19-10-2020,PMC7880246,NIHMS1666597,10.3233/JAD-200896
33066585,Raloxifene as Treatment for Various Types of Brain Injuries and Neurodegenerative Diseases: A Good Start,Veenman L.,Int J Mol Sci. 2020 Oct 14;21(20):7586. doi: 10.3390/ijms21207586.,Veenman L,Int J Mol Sci,2020,17-10-2020,PMC7589740,,10.3390/ijms21207586
33066046,Radon Exposure and Neurodegenerative Disease,"Gómez-Anca S, Barros-Dios JM.",Int J Environ Res Public Health. 2020 Oct 13;17(20):7439. doi: 10.3390/ijerph17207439.,Gómez-Anca S,Int J Environ Res Public Health,2020,17-10-2020,PMC7600778,,10.3390/ijerph17207439
33063249,Effect of Sacubitril/Valsartan on Neurocognitive Function: Current Status and Future Directions,"Galo J, Celli D, Colombo R.",Am J Cardiovasc Drugs. 2021 May;21(3):267-270. doi: 10.1007/s40256-020-00445-7. Epub 2020 Oct 16.,Galo J,Am J Cardiovasc Drugs,2021,16-10-2020,PMC7561468,,10.1007/s40256-020-00445-7
33050383,"Relationship between Wine Consumption, Diet and Microbiome Modulation in Alzheimer's Disease","Moreno-Arribas MV, Bartolomé B, Peñalvo JL, Pérez-Matute P, Motilva MJ.",Nutrients. 2020 Oct 10;12(10):3082. doi: 10.3390/nu12103082.,Moreno-Arribas MV,Nutrients,2020,14-10-2020,PMC7600228,,10.3390/nu12103082
33048274,Psychosis in Alzheimer's Disease,"Ballard C, Kales HC, Lyketsos C, Aarsland D, Creese B, Mills R, Williams H, Sweet RA.",Curr Neurol Neurosci Rep. 2020 Oct 13;20(12):57. doi: 10.1007/s11910-020-01074-y.,Ballard C,Curr Neurol Neurosci Rep,2020,13-10-2020,PMC7554014,,10.1007/s11910-020-01074-y
33044487,"Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive Impairment","Insel PS, Hansson O, Mattsson-Carlgren N.",JAMA Neurol. 2021 Feb 1;78(2):229-235. doi: 10.1001/jamaneurol.2020.3780.,Insel PS,JAMA Neurol,2021,12-10-2020,PMC7551211,,10.1001/jamaneurol.2020.3780
33035532,Efficacy of acetylcholinesterase inhibitors in Alzheimer's disease,"Marucci G, Buccioni M, Ben DD, Lambertucci C, Volpini R, Amenta F.",Neuropharmacology. 2021 Jun 1;190:108352. doi: 10.1016/j.neuropharm.2020.108352. Epub 2020 Oct 6.,Marucci G,Neuropharmacology,2021,09-10-2020,,,10.1016/j.neuropharm.2020.108352
33033851,Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm,"Panoskaltsis N, McCarthy NE, Stagg AJ, Mummery CJ, Husni M, Arebi N, Greenstein D, Price CL, Al-Hassi HO, Koutinas M, Mantalaris A, Knight SC.",Cancer Immunol Immunother. 2021 Apr;70(4):1127-1142. doi: 10.1007/s00262-020-02725-2. Epub 2020 Oct 8.,Panoskaltsis N,Cancer Immunol Immunother,2021,09-10-2020,PMC7543968,,10.1007/s00262-020-02725-2
33032927,Preliminary Evidence That Cortical Amyloid Burden Predicts Poor Response to Antidepressant Medication Treatment in Cognitively Intact Individuals With Late-Life Depression,"Taylor WD, Boyd BD, Elson D, Andrews P, Albert K, Vega J, Newhouse PA, Woodward ND, Kang H, Shokouhi S.",Am J Geriatr Psychiatry. 2021 May;29(5):448-457. doi: 10.1016/j.jagp.2020.09.019. Epub 2020 Sep 28.,Taylor WD,Am J Geriatr Psychiatry,2021,09-10-2020,PMC8004530,NIHMS1636695,10.1016/j.jagp.2020.09.019
33024940,Race- and Sex-Based Disparities in Alzheimer's Disease Clinical Trial Enrollment in the United States and Canada: An Indigenous Perspective,"Olson NL, Albensi BC.",J Alzheimers Dis Rep. 2020 Aug 14;4(1):325-344. doi: 10.3233/ADR-200214.,Olson NL,J Alzheimers Dis Rep,2020,07-10-2020,PMC7504979,,10.3233/ADR-200214
33024239,The impact of cannabinoid type 2 receptors (CB2Rs) in neuroprotection against neurological disorders,"Xin Q, Xu F, Taylor DH, Zhao JF, Wu J.",Acta Pharmacol Sin. 2020 Dec;41(12):1507-1518. doi: 10.1038/s41401-020-00530-2. Epub 2020 Oct 6.,Xin Q,Acta Pharmacol Sin,2020,07-10-2020,PMC7921135,,10.1038/s41401-020-00530-2
33023920,"Linking the Mini-Mental State Examination, the Alzheimer's Disease Assessment Scale-Cognitive Subscale and the Severe Impairment Battery: evidence from individual participant data from five randomised clinical trials of donepezil","Levine SZ, Yoshida K, Goldberg Y, Samara M, Cipriani A, Efthimiou O, Iwatsubo T, Leucht S, Furukawa TA.",Evid Based Ment Health. 2021 May;24(2):56-61. doi: 10.1136/ebmental-2020-300184. Epub 2020 Oct 6.,Levine SZ,Evid Based Ment Health,2021,07-10-2020,PMC10231617,,10.1136/ebmental-2020-300184
33016914,Therapeutic Potential of TNF-α Inhibition for Alzheimer's Disease Prevention,"Torres-Acosta N, O'Keefe JH, O'Keefe EL, Isaacson R, Small G.",J Alzheimers Dis. 2020;78(2):619-626. doi: 10.3233/JAD-200711.,Torres-Acosta N,J Alzheimers Dis,2020,05-10-2020,PMC7739965,,10.3233/JAD-200711
33014276,The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases,"Jiao F, Gong Z.",Oxid Med Cell Longev. 2020 Sep 14;2020:6782872. doi: 10.1155/2020/6782872. eCollection 2020.,Jiao F,Oxid Med Cell Longev,2020,05-10-2020,PMC7519200,,10.1155/2020/6782872
33009542,The Gray Matters App Targeting Health Behaviors Associated with Alzheimer's Risk: Improvements in Intrinsic Motivation and Impact on Diet Quality and Physical Activity,"Schiwal AT, Fauth EB, Wengreen H, Norton M.",J Nutr Health Aging. 2020;24(8):893-899. doi: 10.1007/s12603-020-1421-5.,Schiwal AT,J Nutr Health Aging,2020,03-10-2020,,,10.1007/s12603-020-1421-5
33005040,Complement in neurological disorders and emerging complement-targeted therapeutics,"Dalakas MC, Alexopoulos H, Spaeth PJ.",Nat Rev Neurol. 2020 Nov;16(11):601-617. doi: 10.1038/s41582-020-0400-0. Epub 2020 Oct 1.,Dalakas MC,Nat Rev Neurol,2020,02-10-2020,PMC7528717,,10.1038/s41582-020-0400-0
33004235,One call makes a difference: An evaluation of the Alzheimer's Association National Helpline on dementia caregiver outcomes,"Hodgson NA, Petrovsky DV, Finegan K, Kallmyer BA, Pike J, Fazio S.",Patient Educ Couns. 2021 Apr;104(4):896-902. doi: 10.1016/j.pec.2020.09.026. Epub 2020 Sep 23.,Hodgson NA,Patient Educ Couns,2021,02-10-2020,PMC10001241,NIHMS1866619,10.1016/j.pec.2020.09.026
33002645,Enhancing cognitive training effects in Alzheimer's disease: rTMS as an add-on treatment,"Bagattini C, Zanni M, Barocco F, Caffarra P, Brignani D, Miniussi C, Defanti CA.",Brain Stimul. 2020 Nov-Dec;13(6):1655-1664. doi: 10.1016/j.brs.2020.09.010. Epub 2020 Sep 28.,Bagattini C,Brain Stimul,2020,01-10-2020,,,10.1016/j.brs.2020.09.010
32992601,Clinical Applications of Bee Venom Acupoint Injection,"Lin TY, Hsieh CL.",Toxins (Basel). 2020 Sep 27;12(10):618. doi: 10.3390/toxins12100618.,Lin TY,Toxins (Basel),2020,30-09-2020,PMC7601520,,10.3390/toxins12100618
32990494,"Transitioning to Long-Term Care: Family Caregiver Experiences of Dementia, Communities, and Counseling","Zmora R, Statz TL, Birkeland RW, McCarron HR, Finlay JM, Rosebush CE, Gaugler JE.",J Aging Health. 2021 Jan;33(1-2):133-146. doi: 10.1177/0898264320963588. Epub 2020 Sep 29.,Zmora R,J Aging Health,2021,29-09-2020,PMC7891851,NIHMS1664099,10.1177/0898264320963588
32981668,Physical Activity and Exercise in Mild Cognitive Impairment and Dementia: An Umbrella Review of Intervention and Observational Studies,"Demurtas J, Schoene D, Torbahn G, Marengoni A, Grande G, Zou L, Petrovic M, Maggi S, Cesari M, Lamb S, Soysal P, Kemmler W, Sieber C, Mueller C, Shenkin SD, Schwingshackl L, Smith L PhD, Veronese N; European Society of Geriatric Medicine Special Interest Group in Systematic Reviews and Meta-Analyses, Frailty, Sarcopenia, and Dementia.",J Am Med Dir Assoc. 2020 Oct;21(10):1415-1422.e6. doi: 10.1016/j.jamda.2020.08.031.,Demurtas J,J Am Med Dir Assoc,2020,28-09-2020,,,10.1016/j.jamda.2020.08.031
32979515,A dyadic approach for a remote physical activity intervention in adults with Alzheimer's disease and their caregivers: Rationale and design for an 18-month randomized trial,"Ptomey LT, Szabo-Reed AN, Vidoni ED, Washburn RA, Gorczyca AM, Little TD, Lee J, Helsel BC, Williams KN, Donnelly JE.",Contemp Clin Trials. 2020 Nov;98:106158. doi: 10.1016/j.cct.2020.106158. Epub 2020 Sep 23.,Ptomey LT,Contemp Clin Trials,2020,26-09-2020,PMC7686020,NIHMS1633400,10.1016/j.cct.2020.106158
32975796,Opioid Modulation of Neuronal Iron and Potential Contributions to NeuroHIV,"Nash B, Irollo E, Brandimarti R, Meucci O.",Methods Mol Biol. 2021;2201:139-162. doi: 10.1007/978-1-0716-0884-5_13.,Nash B,Methods Mol Biol,2021,25-09-2020,PMC7641316,NIHMS1637497,10.1007/978-1-0716-0884-5_13
32975632,Biomarkers of neuronal damage in saturation diving-a controlled observational study,"Rosén A, Gennser M, Oscarsson N, Kvarnström A, Sandström G, Blennow K, Seeman-Lodding H, Zetterberg H.",Eur J Appl Physiol. 2020 Dec;120(12):2773-2784. doi: 10.1007/s00421-020-04499-y. Epub 2020 Sep 25.,Rosén A,Eur J Appl Physiol,2020,25-09-2020,PMC7674315,,10.1007/s00421-020-04499-y
32969833,An Internet-Based Intervention Augmented With a Diet and Physical Activity Consultation to Decrease the Risk of Dementia in At-Risk Adults in a Primary Care Setting: Pragmatic Randomized Controlled Trial,"Anstey KJ, Cherbuin N, Kim S, McMaster M, D'Este C, Lautenschlager N, Rebok G, McRae I, Torres SJ, Cox KL, Pond CD.",J Med Internet Res. 2020 Sep 24;22(9):e19431. doi: 10.2196/19431.,Anstey KJ,J Med Internet Res,2020,24-09-2020,PMC7545332,,10.2196/19431
32969566,Microbiota modulation as preventative and therapeutic approach in Alzheimer's disease,"Bonfili L, Cecarini V, Gogoi O, Gong C, Cuccioloni M, Angeletti M, Rossi G, Eleuteri AM.",FEBS J. 2021 May;288(9):2836-2855. doi: 10.1111/febs.15571. Epub 2020 Oct 8.,Bonfili L,FEBS J,2021,24-09-2020,,,10.1111/febs.15571
32967303,Mitochondrial Calcium Deregulation in the Mechanism of Beta-Amyloid and Tau Pathology,"Esteras N, Abramov AY.",Cells. 2020 Sep 21;9(9):2135. doi: 10.3390/cells9092135.,Esteras N,Cells,2020,24-09-2020,PMC7564294,,10.3390/cells9092135
32967146,Classifications of Neurodegenerative Disorders Using a Multiplex Blood Biomarkers-Based Machine Learning Model,"Lin CH, Chiu SI, Chen TF, Jang JR, Chiu MJ.",Int J Mol Sci. 2020 Sep 21;21(18):6914. doi: 10.3390/ijms21186914.,Lin CH,Int J Mol Sci,2020,24-09-2020,PMC7555120,,10.3390/ijms21186914
32966585,"Nighttime Agitation and Restless Legs Syndrome in Persons With Alzheimer's Disease: Study Protocol for a Double-Blind, Placebo-Controlled, Randomized Trial (NightRest)","Richards K, Morrison J, Wang YY, Rangel A, Loera A, Hanlon A, Lozano A, Kovach C, Gooneratne N, Fry L, Allen R.",Res Gerontol Nurs. 2020 Nov 1;13(6):280-288. doi: 10.3928/19404921-20200918-01. Epub 2020 Sep 24.,Richards K,Res Gerontol Nurs,2020,23-09-2020,PMC9112187,NIHMS1787367,10.3928/19404921-20200918-01
32957534,The Role of Exosomes in Stemness and Neurodegenerative Diseases-Chemoresistant-Cancer Therapeutics and Phytochemicals,"Beeraka NM, Doreswamy SH, Sadhu SP, Srinivasan A, Pragada RR, Madhunapantula SV, Aliev G.",Int J Mol Sci. 2020 Sep 17;21(18):6818. doi: 10.3390/ijms21186818.,Beeraka NM,Int J Mol Sci,2020,22-09-2020,PMC7555629,,10.3390/ijms21186818
32953558,The role of nutraceuticals as a complementary therapy against various neurodegenerative diseases: A mini-review,"Chiu HF, Venkatakrishnan K, Wang CK.",J Tradit Complement Med. 2020 Apr 1;10(5):434-439. doi: 10.1016/j.jtcme.2020.03.008. eCollection 2020 Sep.,Chiu HF,J Tradit Complement Med,2020,21-09-2020,PMC7484964,,10.1016/j.jtcme.2020.03.008
32952859,Stem cell therapy for Alzheimer's disease,"Liu XY, Yang LP, Zhao L.",World J Stem Cells. 2020 Aug 26;12(8):787-802. doi: 10.4252/wjsc.v12.i8.787.,Liu XY,World J Stem Cells,2020,21-09-2020,PMC7477654,,10.4252/wjsc.v12.i8.787
32939050,Drug repositioning and repurposing for Alzheimer disease,"Ballard C, Aarsland D, Cummings J, O'Brien J, Mills R, Molinuevo JL, Fladby T, Williams G, Doherty P, Corbett A, Sultana J.",Nat Rev Neurol. 2020 Dec;16(12):661-673. doi: 10.1038/s41582-020-0397-4. Epub 2020 Sep 16.,Ballard C,Nat Rev Neurol,2020,17-09-2020,PMC8291993,NIHMS1718940,10.1038/s41582-020-0397-4
32930914,Alzheimer's disease: natural products as inhibitors of neuroinflammation,"Olajide OA, Sarker SD.",Inflammopharmacology. 2020 Dec;28(6):1439-1455. doi: 10.1007/s10787-020-00751-1. Epub 2020 Sep 15.,Olajide OA,Inflammopharmacology,2020,15-09-2020,PMC7572326,,10.1007/s10787-020-00751-1
32928279,A phase II randomized trial of sodium oligomannate in Alzheimer's dementia,"Wang T, Kuang W, Chen W, Xu W, Zhang L, Li Y, Li H, Peng Y, Chen Y, Wang B, Xiao J, Li H, Yan C, Du Y, Tang M, He Z, Chen H, Li W, Lin H, Shi S, Bi J, Zhou H, Cheng Y, Gao X, Guan Y, Huang Q, Chen K, Xin X, Ding J, Geng M, Xiao S.",Alzheimers Res Ther. 2020 Sep 14;12(1):110. doi: 10.1186/s13195-020-00678-3.,Wang T,Alzheimers Res Ther,2020,15-09-2020,PMC7489025,,10.1186/s13195-020-00678-3
32926630,"Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage","Farr AC, Xiong MP.",Mol Pharm. 2021 Feb 1;18(2):593-609. doi: 10.1021/acs.molpharmaceut.0c00474. Epub 2020 Oct 9.,Farr AC,Mol Pharm,2021,14-09-2020,PMC8819678,NIHMS1771611,10.1021/acs.molpharmaceut.0c00474
32925060,"Neuromodulation for Apathy in Alzheimer's Disease: A Double-Blind, Randomized, Sham-Controlled Pilot Study","Padala PR, Boozer EM, Lensing SY, Parkes CM, Hunter CR, Dennis RA, Caceda R, Padala KP.",J Alzheimers Dis. 2020;77(4):1483-1493. doi: 10.3233/JAD-200640.,Padala PR,J Alzheimers Dis,2020,14-09-2020,PMC7683089,,10.3233/JAD-200640
32925057,Anticoagulants for Treatment of Alzheimer's Disease,Grossmann K.,J Alzheimers Dis. 2020;77(4):1373-1382. doi: 10.3233/JAD-200610.,Grossmann K,J Alzheimers Dis,2020,14-09-2020,PMC7683055,,10.3233/JAD-200610
32925045,White Matter Changes on Diffusion Tensor Imaging in the FINGER Randomized Controlled Trial,"Stephen R, Solomon A, Ngandu T, Levälahti E, Rinne JO, Kemppainen N, Parkkola R, Antikainen R, Strandberg T, Kivipelto M, Soininen H, Liu Y; FINGER study group.",J Alzheimers Dis. 2020;78(1):75-86. doi: 10.3233/JAD-200423.,Stephen R,J Alzheimers Dis,2020,14-09-2020,PMC7683078,,10.3233/JAD-200423
32925028,"Real-World Treatment Patterns and Characteristics Among Patients with Agitation and Dementia in the United States: Findings from a Large, Observational, Retrospective Chart Review","Aigbogun MS, Cloutier M, Gauthier-Loiselle M, Guerin A, Ladouceur M, Baker RA, Grundman M, Duffy RA, Hartry A, Gwin K, Fillit H.",J Alzheimers Dis. 2020;77(3):1181-1194. doi: 10.3233/JAD-200127.,Aigbogun MS,J Alzheimers Dis,2020,14-09-2020,PMC7683079,,10.3233/JAD-200127
32924754,Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial,"Rymer JA, Mulder H, Smolderen KG, Hiatt WR, Conte MS, Berger JS, Norgren L, Mahaffey KW, Baumgartner I, Fowkes FG, Katona BG, Rockhold F, Jones WS, Patel MR.",J Am Heart Assoc. 2020 Oct 20;9(19):e016573. doi: 10.1161/JAHA.120.016573. Epub 2020 Sep 13.,Rymer JA,J Am Heart Assoc,2020,14-09-2020,PMC7792388,,10.1161/JAHA.120.016573
32920957,36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease,"Soininen H, Solomon A, Visser PJ, Hendrix SB, Blennow K, Kivipelto M, Hartmann T; LipiDiDiet clinical study group.",Alzheimers Dement. 2021 Jan;17(1):29-40. doi: 10.1002/alz.12172. Epub 2020 Sep 13.,Soininen H,Alzheimers Dement,2021,13-09-2020,PMC7821311,,10.1002/alz.12172
32920621,The Trial-Ready Cohort for Preclinical/Prodromal Alzheimer's Disease (TRC-PAD) Project: An Overview,"Aisen PS, Sperling RA, Cummings J, Donohue MC, Langford O, Jimenez-Maggiora GA, Rissman RA, Rafii MS, Walter S, Clanton T, Raman R.",J Prev Alzheimers Dis. 2020;7(4):208-212. doi: 10.14283/jpad.2020.45.,Aisen PS,J Prev Alzheimers Dis,2020,13-09-2020,PMC7735207,NIHMS1650580,10.14283/jpad.2020.45
32920022,Subgroup analysis of the ASPirin in Reducing Events in the Elderly randomized clinical trial suggests aspirin did not improve outcomes in older adults with chronic kidney disease,"Wolfe R, Wetmore JB, Woods RL, McNeil JJ, Gallagher H, Roderick P, Walker R, Nelson MR, Reid CM, Shah RC, Ernst ME, Lockery JE, Tonkin AM, Abhayaratna WP, Gibbs P, Wood EM, Mahady SE, Williamson JD, Donnan GA, Cloud GC, Murray AM, Polkinghorne KR.",Kidney Int. 2021 Feb;99(2):466-474. doi: 10.1016/j.kint.2020.08.011. Epub 2020 Sep 10.,Wolfe R,Kidney Int,2021,13-09-2020,PMC7957958,NIHMS1676962,10.1016/j.kint.2020.08.011
32913021,Effect of escitalopram dose and treatment duration on CSF Aβ levels in healthy older adults: A controlled clinical trial,"Sheline YI, Snider BJ, Beer JC, Seok D, Fagan AM, Suckow RF, Lee JM, Waligorska T, Korecka M, Aselcioglu I, Morris JC, Shaw LM, Cirrito JR.",Neurology. 2020 Nov 10;95(19):e2658-e2665. doi: 10.1212/WNL.0000000000010725. Epub 2020 Sep 10.,Sheline YI,Neurology,2020,11-09-2020,PMC7713735,,10.1212/WNL.0000000000010725
32908122,CHIP as a therapeutic target for neurological diseases,"Zhang S, Hu ZW, Mao CY, Shi CH, Xu YM.",Cell Death Dis. 2020 Sep 9;11(9):727. doi: 10.1038/s41419-020-02953-5.,Zhang S,Cell Death Dis,2020,10-09-2020,PMC7481199,,10.1038/s41419-020-02953-5
32902818,A geroscience perspective on immune resilience and infectious diseases: a potential case for metformin,"Justice JN, Gubbi S, Kulkarni AS, Bartley JM, Kuchel GA, Barzilai N.",Geroscience. 2021 Jun;43(3):1093-1112. doi: 10.1007/s11357-020-00261-6. Epub 2020 Sep 9.,Justice JN,Geroscience,2021,09-09-2020,PMC7479299,,10.1007/s11357-020-00261-6
32902313,"Satisfaction, utilization, and feasibility of a telehealth intervention for in-home dementia care support: A mixed methods study","Williams KN, Shaw CA, Perkhounkova Y, Hein M, Coleman CK.",Dementia (London). 2021 Jul;20(5):1565-1585. doi: 10.1177/1471301220957905. Epub 2020 Sep 9.,Williams KN,Dementia (London),2021,09-09-2020,PMC7940465,NIHMS1652249,10.1177/1471301220957905
32899606,The Role of HDL and HDL Mimetic Peptides as Potential Therapeutics for Alzheimer's Disease,"Chernick D, Zhong R, Li L.",Biomolecules. 2020 Sep 4;10(9):1276. doi: 10.3390/biom10091276.,Chernick D,Biomolecules,2020,09-09-2020,PMC7563116,,10.3390/biom10091276
32899357,Adiponectin: The Potential Regulator and Therapeutic Target of Obesity and Alzheimer's Disease,"Kim JY, Barua S, Jeong YJ, Lee JE.",Int J Mol Sci. 2020 Sep 3;21(17):6419. doi: 10.3390/ijms21176419.,Kim JY,Int J Mol Sci,2020,09-09-2020,PMC7504582,,10.3390/ijms21176419
32894821,Boosting the autophagy-lysosomal pathway by phytochemicals: A potential therapeutic strategy against Alzheimer's disease,"Nourbakhsh F, Read MI, Barreto GE, Sahebkar A.",IUBMB Life. 2020 Nov;72(11):2360-2281. doi: 10.1002/iub.2369. Epub 2020 Sep 7.,Nourbakhsh F,IUBMB Life,2020,07-09-2020,,,10.1002/iub.2369
32887591,Cost-effectiveness of the Namaste care family program for nursing home residents with advanced dementia in comparison with usual care: a cluster-randomized controlled trial,"El Alili M, Smaling HJA, Joling KJ, Achterberg WP, Francke AL, Bosmans JE, van der Steen JT.",BMC Health Serv Res. 2020 Sep 4;20(1):831. doi: 10.1186/s12913-020-05570-2.,El Alili M,BMC Health Serv Res,2020,05-09-2020,PMC7473814,,10.1186/s12913-020-05570-2
32887400,Memantine Derivatives as Multitarget Agents in Alzheimer's Disease,"Marotta G, Basagni F, Rosini M, Minarini A.",Molecules. 2020 Sep 2;25(17):4005. doi: 10.3390/molecules25174005.,Marotta G,Molecules,2020,05-09-2020,PMC7504780,,10.3390/molecules25174005
32884267,Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020),"Binda A, Murano C, Rivolta I.",Int J Nanomedicine. 2020 Aug 14;15:6113-6135. doi: 10.2147/IJN.S231480. eCollection 2020.,Binda A,Int J Nanomedicine,2020,05-09-2020,PMC7434571,,10.2147/IJN.S231480
32882995,Novel Multitarget Therapies for Lung Cancer and Respiratory Disease,"Yumura M, Nagano T, Nishimura Y.",Molecules. 2020 Sep 1;25(17):3987. doi: 10.3390/molecules25173987.,Yumura M,Molecules,2020,05-09-2020,PMC7504797,,10.3390/molecules25173987
32880220,Lessons from KEEPS: the Kronos Early Estrogen Prevention Study,"Miller VM, Taylor HS, Naftolin F, Manson JE, Gleason CE, Brinton EA, Kling JM, Cedars MI, Dowling NM, Kantarci K, Harman SM.",Climacteric. 2021 Apr;24(2):139-145. doi: 10.1080/13697137.2020.1804545. Epub 2020 Sep 3.,Miller VM,Climacteric,2021,04-09-2020,PMC8108428,NIHMS1679136,10.1080/13697137.2020.1804545
32877582,Trial of Sodium Phenylbutyrate-Taurursodiol for Amyotrophic Lateral Sclerosis,"Paganoni S, Macklin EA, Hendrix S, Berry JD, Elliott MA, Maiser S, Karam C, Caress JB, Owegi MA, Quick A, Wymer J, Goutman SA, Heitzman D, Heiman-Patterson T, Jackson CE, Quinn C, Rothstein JD, Kasarskis EJ, Katz J, Jenkins L, Ladha S, Miller TM, Scelsa SN, Vu TH, Fournier CN, Glass JD, Johnson KM, Swenson A, Goyal NA, Pattee GL, Andres PL, Babu S, Chase M, Dagostino D, Dickson SP, Ellison N, Hall M, Hendrix K, Kittle G, McGovern M, Ostrow J, Pothier L, Randall R, Shefner JM, Sherman AV, Tustison E, Vigneswaran P, Walker J, Yu H, Chan J, Wittes J, Cohen J, Klee J, Leslie K, Tanzi RE, Gilbert W, Yeramian PD, Schoenfeld D, Cudkowicz ME.",N Engl J Med. 2020 Sep 3;383(10):919-930. doi: 10.1056/NEJMoa1916945.,Paganoni S,N Engl J Med,2020,03-09-2020,PMC9134321,NIHMS1805149,10.1056/NEJMoa1916945
32867357,"Mangosteen Pericarp and Its Bioactive Xanthones: Potential Therapeutic Value in Alzheimer's Disease, Parkinson's Disease, and Depression with Pharmacokinetic and Safety Profiles","Do HTT, Cho J.",Int J Mol Sci. 2020 Aug 27;21(17):6211. doi: 10.3390/ijms21176211.,Do HTT,Int J Mol Sci,2020,02-09-2020,PMC7504283,,10.3390/ijms21176211
32865573,Risk of Chronic Cardiomyopathy Among Patients With the Acute Phase or Indeterminate Form of Chagas Disease: A Systematic Review and Meta-analysis,"Chadalawada S, Sillau S, Archuleta S, Mundo W, Bandali M, Parra-Henao G, Rodriguez-Morales AJ, Villamil-Gomez WE, Suárez JA, Shapiro L, Hotez PJ, Woc-Colburn L, DeSanto K, Rassi A Jr, Franco-Paredes C, Henao-Martínez AF.",JAMA Netw Open. 2020 Aug 3;3(8):e2015072. doi: 10.1001/jamanetworkopen.2020.15072.,Chadalawada S,JAMA Netw Open,2020,01-09-2020,PMC7489816,,10.1001/jamanetworkopen.2020.15072
32860945,"Obstructive Sleep Apnea and Its Treatment in Aging: Effects on Alzheimer's disease Biomarkers, Cognition, Brain Structure and Neurophysiology","Mullins AE, Kam K, Parekh A, Bubu OM, Osorio RS, Varga AW.",Neurobiol Dis. 2020 Nov;145:105054. doi: 10.1016/j.nbd.2020.105054. Epub 2020 Aug 27.,Mullins AE,Neurobiol Dis,2020,30-08-2020,PMC7572873,NIHMS1626475,10.1016/j.nbd.2020.105054
32860368,Therapeutic potentials of neural stem cells in Alzheimer's disease,"Wong RSY, Cheong SK.",Malays J Pathol. 2020 Aug;42(2):157-170.,Wong RSY,Malays J Pathol,2020,30-08-2020,,,
32859156,Rationale and protocol of the StayFitLonger study: a multicentre trial to measure efficacy and adherence of a home-based computerised multidomain intervention in healthy older adults,"Belleville S, Cuesta M, Bieler-Aeschlimann M, Giacomino K, Widmer A, Mittaz Hager AG, Perez-Marcos D, Cardin S, Boller B, Bier N, Aubertin-Leheudre M, Bherer L, Berryman N, Agrigoroaei S, Demonet JF.",BMC Geriatr. 2020 Aug 28;20(1):315. doi: 10.1186/s12877-020-01709-2.,Belleville S,BMC Geriatr,2020,30-08-2020,PMC7453698,,10.1186/s12877-020-01709-2
32854853,Ketotherapeutics for neurodegenerative diseases,"Norwitz NG, Jaramillo JG, Clarke K, Soto A.",Int Rev Neurobiol. 2020;155:141-168. doi: 10.1016/bs.irn.2020.02.003. Epub 2020 Aug 11.,Norwitz NG,Int Rev Neurobiol,2020,29-08-2020,PMC7418707,,10.1016/bs.irn.2020.02.003
32854372,"Saporin from Saponaria officinalis as a Tool for Experimental Research, Modeling, and Therapy in Neuroscience","Bolshakov AP, Stepanichev MY, Dobryakova YV, Spivak YS, Markevich VA.",Toxins (Basel). 2020 Aug 25;12(9):546. doi: 10.3390/toxins12090546.,Bolshakov AP,Toxins (Basel),2020,29-08-2020,PMC7551693,,10.3390/toxins12090546
32853472,Shared signaling pathways in Alzheimer's and metabolic disease may point to new treatment approaches,"Suresh J, Khor IW, Kaur P, Heng HL, Torta F, Dawe GS, Tai ES, Tolwinski NS.",FEBS J. 2021 Jun;288(12):3855-3873. doi: 10.1111/febs.15540. Epub 2020 Sep 10.,Suresh J,FEBS J,2021,28-08-2020,,,10.1111/febs.15540
32853175,ATP synthase and Alzheimer's disease: putting a spin on the mitochondrial hypothesis,"Ebanks B, Ingram TL, Chakrabarti L.",Aging (Albany NY). 2020 Aug 27;12(16):16647-16662. doi: 10.18632/aging.103867. Epub 2020 Aug 27.,Ebanks B,Aging (Albany NY),2020,28-08-2020,PMC7485717,,10.18632/aging.103867
32848775,Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: State of the Art and Future Progress,"Magierski R, Sobow T, Schwertner E, Religa D.",Front Pharmacol. 2020 Jul 31;11:1168. doi: 10.3389/fphar.2020.01168. eCollection 2020.,Magierski R,Front Pharmacol,2020,28-08-2020,PMC7413102,,10.3389/fphar.2020.01168
32848600,Targeting Amyloidogenic Processing of APP in Alzheimer's Disease,"Zhao J, Liu X, Xia W, Zhang Y, Wang C.",Front Mol Neurosci. 2020 Aug 4;13:137. doi: 10.3389/fnmol.2020.00137. eCollection 2020.,Zhao J,Front Mol Neurosci,2020,28-08-2020,PMC7418514,,10.3389/fnmol.2020.00137
32842530,Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders,"Sim TM, Tarini D, Dheen ST, Bay BH, Srinivasan DK.",Int J Mol Sci. 2020 Aug 23;21(17):6070. doi: 10.3390/ijms21176070.,Sim TM,Int J Mol Sci,2020,27-08-2020,PMC7503838,,10.3390/ijms21176070
32841101,Glycogen synthase kinase 3 (GSK-3) inhibitors: a patent update (2016-2019),"Roca C, Campillo NE.",Expert Opin Ther Pat. 2020 Nov;30(11):863-872. doi: 10.1080/13543776.2020.1815706. Epub 2020 Sep 14.,Roca C,Expert Opin Ther Pat,2020,26-08-2020,,,10.1080/13543776.2020.1815706
32833122,Ryanodine Receptors: A Potential Treatment Target in Various Neurodegenerative Disease,"Sun L, Wei H.",Cell Mol Neurobiol. 2021 Nov;41(8):1613-1624. doi: 10.1007/s10571-020-00936-w. Epub 2020 Aug 24.,Sun L,Cell Mol Neurobiol,2021,25-08-2020,PMC7902735,NIHMS1623186,10.1007/s10571-020-00936-w
32825138,"Merged Tacrine-Based, Multitarget-Directed Acetylcholinesterase Inhibitors 2015-Present: Synthesis and Biological Activity","Eckroat TJ, Manross DL, Cowan SC.",Int J Mol Sci. 2020 Aug 19;21(17):5965. doi: 10.3390/ijms21175965.,Eckroat TJ,Int J Mol Sci,2020,23-08-2020,PMC7504404,,10.3390/ijms21175965
32821251,The Effects of a Recollection-Based Occupational Therapy Program of Alzheimer's Disease: A Randomized Controlled Trial,Kim D.,Occup Ther Int. 2020 Jul 30;2020:6305727. doi: 10.1155/2020/6305727. eCollection 2020.,Kim D,Occup Ther Int,2020,22-08-2020,PMC7416254,,10.1155/2020/6305727
32813239,Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson's and Alzheimer's Diseases: a Review,"Cooray R, Gupta V, Suphioglu C.",Mol Neurobiol. 2020 Nov;57(11):4878-4890. doi: 10.1007/s12035-020-02054-6. Epub 2020 Aug 19.,Cooray R,Mol Neurobiol,2020,20-08-2020,PMC7515854,,10.1007/s12035-020-02054-6
32811586,Dementia-related psychosis and the potential role for pimavanserin,"Cummings JL, Devanand DP, Stahl SM.",CNS Spectr. 2022 Feb;27(1):7-15. doi: 10.1017/S1092852920001765. Epub 2020 Aug 19.,Cummings JL,CNS Spectr,2022,20-08-2020,PMC8318559,NIHMS1718936,10.1017/S1092852920001765
32810423,The proteostatic effects of traffic-derived air pollution on Alzheimer's disease risk,Kikis EA.,Open Biol. 2020 Aug;10(8):200146. doi: 10.1098/rsob.200146. Epub 2020 Aug 19.,Kikis EA,Open Biol,2020,19-08-2020,PMC7479932,,10.1098/rsob.200146
32809153,Towards early disease modification of Parkinson's disease: a review of lessons learned in the Alzheimer field,"Smedinga M, Darweesh SKL, Bloem BR, Post B, Richard E.",J Neurol. 2021 Feb;268(2):724-733. doi: 10.1007/s00415-020-10162-5. Epub 2020 Aug 18.,Smedinga M,J Neurol,2021,19-08-2020,PMC7880921,,10.1007/s00415-020-10162-5
32806612,"Alzheimer's Disease and Specialized Pro-Resolving Lipid Mediators: Do MaR1, RvD1, and NPD1 Show Promise for Prevention and Treatment?","Miyazawa K, Fukunaga H, Tatewaki Y, Takano Y, Yamamoto S, Mutoh T, Taki Y.",Int J Mol Sci. 2020 Aug 12;21(16):5783. doi: 10.3390/ijms21165783.,Miyazawa K,Int J Mol Sci,2020,19-08-2020,PMC7460933,,10.3390/ijms21165783
32805754,Nutritional supplements for neuropsychiatric symptoms in people with dementia: A systematic review and meta-analysis,"Haider S, Schwarzinger A, Stefanac S, Soysal P, Smith L, Veronese N, Dorner TE, Grabovac I.",Int J Geriatr Psychiatry. 2020 Nov;35(11):1285-1291. doi: 10.1002/gps.5407. Epub 2020 Aug 28.,Haider S,Int J Geriatr Psychiatry,2020,18-08-2020,PMC7692950,,10.1002/gps.5407
32805742,Expanded access: opening doors to personalized medicine for rare disease patients and patients with neurodegenerative diseases,Özdinler PH.,FEBS J. 2021 Mar;288(5):1457-1461. doi: 10.1111/febs.15529. Epub 2020 Sep 5.,Özdinler PH,FEBS J,2021,18-08-2020,PMC7887139,NIHMS1630508,10.1111/febs.15529
32804096,Collapsin Response Mediator Proteins: Novel Targets for Alzheimer's Disease,"Quach TT, Moutal A, Khanna R, Deems NP, Duchemin AM, Barrientos RM.",J Alzheimers Dis. 2020;77(3):949-960. doi: 10.3233/JAD-200721.,Quach TT,J Alzheimers Dis,2020,18-08-2020,PMC7579750,NIHMS1636501,10.3233/JAD-200721
32787971,"Aducanumab, gantenerumab, BAN2401, and ALZ-801-the first wave of amyloid-targeting drugs for Alzheimer's disease with potential for near term approval","Tolar M, Abushakra S, Hey JA, Porsteinsson A, Sabbagh M.",Alzheimers Res Ther. 2020 Aug 12;12(1):95. doi: 10.1186/s13195-020-00663-w.,Tolar M,Alzheimers Res Ther,2020,14-08-2020,PMC7424995,,10.1186/s13195-020-00663-w
32784855,Zinc Therapy in Early Alzheimer's Disease: Safety and Potential Therapeutic Efficacy,"Squitti R, Pal A, Picozza M, Avan A, Ventriglia M, Rongioletti MC, Hoogenraad T.",Biomolecules. 2020 Aug 9;10(8):1164. doi: 10.3390/biom10081164.,Squitti R,Biomolecules,2020,14-08-2020,PMC7466035,,10.3390/biom10081164
32784556,Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases,"Chen D, Zhang T, Lee TH.",Biomolecules. 2020 Aug 7;10(8):1158. doi: 10.3390/biom10081158.,Chen D,Biomolecules,2020,14-08-2020,PMC7464852,,10.3390/biom10081158
32783189,Autosomal dominant neuronal ceroid lipofuscinosis: Clinical features and molecular basis,"Naseri N, Sharma M, Velinov M.",Clin Genet. 2021 Jan;99(1):111-118. doi: 10.1111/cge.13829. Epub 2020 Aug 26.,Naseri N,Clin Genet,2021,13-08-2020,PMC7899141,NIHMS1670698,10.1111/cge.13829
32781559,Catechins as Tools to Understand the Molecular Basis of Neurodegeneration,"Martinez Pomier K, Ahmed R, Melacini G.",Molecules. 2020 Aug 6;25(16):3571. doi: 10.3390/molecules25163571.,Martinez Pomier K,Molecules,2020,13-08-2020,PMC7465241,,10.3390/molecules25163571
32777010,Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment,"Grill JD, Raman R, Ernstrom K, Sultzer DL, Burns JM, Donohue MC, Johnson KA, Aisen PS, Sperling RA, Karlawish J; A4 Study Team.",JAMA Neurol. 2020 Dec 1;77(12):1504-1513. doi: 10.1001/jamaneurol.2020.2734.,Grill JD,JAMA Neurol,2020,11-08-2020,PMC7418046,,10.1001/jamaneurol.2020.2734
32768885,Molecular mechanism-based therapeutic properties of honey,"Talebi M, Talebi M, Farkhondeh T, Samarghandian S.",Biomed Pharmacother. 2020 Oct;130:110590. doi: 10.1016/j.biopha.2020.110590. Epub 2020 Aug 5.,Talebi M,Biomed Pharmacother,2020,10-08-2020,,,10.1016/j.biopha.2020.110590
32758801,Imaging Alzheimer's genetic risk using diffusion MRI: A systematic review,"Harrison JR, Bhatia S, Tan ZX, Mirza-Davies A, Benkert H, Tax CMW, Jones DK.",Neuroimage Clin. 2020;27:102359. doi: 10.1016/j.nicl.2020.102359. Epub 2020 Jul 22.,Harrison JR,Neuroimage Clin,2020,08-08-2020,PMC7399253,,10.1016/j.nicl.2020.102359
32751991,P38α MAPK Signaling-A Robust Therapeutic Target for Rab5-Mediated Neurodegenerative Disease,"Germann UA, Alam JJ.",Int J Mol Sci. 2020 Jul 31;21(15):5485. doi: 10.3390/ijms21155485.,Germann UA,Int J Mol Sci,2020,06-08-2020,PMC7432772,,10.3390/ijms21155485
32751985,Is Memantine Effective as an NMDA-Receptor Antagonist in Adjunctive Therapy for Schizophrenia?,Kikuchi T.,Biomolecules. 2020 Jul 31;10(8):1134. doi: 10.3390/biom10081134.,Kikuchi T,Biomolecules,2020,06-08-2020,PMC7466074,,10.3390/biom10081134
32746921,Burden of Care in Caregivers of Iranian patients with chronic disorders: a systematic review and meta-analysis,"Rezaei H, Niksima SH, Ghanei Gheshlagh R.",Health Qual Life Outcomes. 2020 Aug 3;18(1):261. doi: 10.1186/s12955-020-01503-z.,Rezaei H,Health Qual Life Outcomes,2020,05-08-2020,PMC7398060,,10.1186/s12955-020-01503-z
32743317,Impact of Hypertension on Cognitive Decline and Dementia,"Naing HL, Teo SP.",Ann Geriatr Med Res. 2020 Mar;24(1):15-19. doi: 10.4235/agmr.19.0048. Epub 2020 Mar 18.,Naing HL,Ann Geriatr Med Res,2020,04-08-2020,PMC7370774,,10.4235/agmr.19.0048
32731418,Molecular Imaging of Fluorinated Probes for Tau Protein and Amyloid-β Detection,"Yeo SK, Shepelytskyi Y, Grynko V, Albert MS.",Molecules. 2020 Jul 28;25(15):3413. doi: 10.3390/molecules25153413.,Yeo SK,Molecules,2020,01-08-2020,PMC7435578,,10.3390/molecules25153413
32730766,Brain insulin resistance in Alzheimer's disease and related disorders: mechanisms and therapeutic approaches,"Kellar D, Craft S.",Lancet Neurol. 2020 Sep;19(9):758-766. doi: 10.1016/S1474-4422(20)30231-3. Epub 2020 Jul 27.,Kellar D,Lancet Neurol,2020,31-07-2020,PMC9661919,NIHMS1846555,10.1016/S1474-4422(20)30231-3
32730558,Mediterranean Diet and Telomere Length: A Systematic Review and Meta-Analysis,"Canudas S, Becerra-Tomás N, Hernández-Alonso P, Galié S, Leung C, Crous-Bou M, De Vivo I, Gao Y, Gu Y, Meinilä J, Milte C, García-Calzón S, Marti A, Boccardi V, Ventura-Marra M, Salas-Salvadó J.",Adv Nutr. 2020 Nov 16;11(6):1544-1554. doi: 10.1093/advances/nmaa079.,Canudas S,Adv Nutr,2020,31-07-2020,PMC7666892,,10.1093/advances/nmaa079
32728820,Exercise training improves vascular function in patients with Alzheimer's disease,"Pedrinolla A, Venturelli M, Fonte C, Tamburin S, Di Baldassarre A, Naro F, Varalta V, Giuriato G, Ghinassi B, Muti E, Smania N, Schena F.",Eur J Appl Physiol. 2020 Oct;120(10):2233-2245. doi: 10.1007/s00421-020-04447-w. Epub 2020 Jul 30.,Pedrinolla A,Eur J Appl Physiol,2020,31-07-2020,PMC7502067,,10.1007/s00421-020-04447-w
32719079,Association between metformin and neurodegenerative diseases of observational studies: systematic review and meta-analysis,"Ping F, Jiang N, Li Y.",BMJ Open Diabetes Res Care. 2020 Jul;8(1):e001370. doi: 10.1136/bmjdrc-2020-001370.,Ping F,BMJ Open Diabetes Res Care,2020,29-07-2020,PMC7390234,,10.1136/bmjdrc-2020-001370
32717806,Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer's Disease Therapy,"Zagórska A, Jaromin A.",Molecules. 2020 Jul 23;25(15):3337. doi: 10.3390/molecules25153337.,Zagórska A,Molecules,2020,29-07-2020,PMC7435667,,10.3390/molecules25153337
32716358,Baseline Prevalence of Polypharmacy in Older Hypertensive Study Subjects with Elevated Dementia Risk: Findings from the Risk Reduction for Alzheimer's Disease Study (rrAD),"Vidoni ED, Kamat A, Gahan WP, Ourso V, Woodard K, Kerwin DR, Binder EF, Burns JM, Cullum M, Hynan LS, Vongpatanasin W, Zhu DC, Zhang R, Keller JN.",J Alzheimers Dis. 2020;77(1):175-182. doi: 10.3233/JAD-200122.,Vidoni ED,J Alzheimers Dis,2020,28-07-2020,PMC8108402,NIHMS1693556,10.3233/JAD-200122
32715623,"A randomized, controlled clinical trial of plasma exchange with albumin replacement for Alzheimer's disease: Primary results of the AMBAR Study","Boada M, López OL, Olazarán J, Núñez L, Pfeffer M, Paricio M, Lorites J, Piñol-Ripoll G, Gámez JE, Anaya F, Kiprov D, Lima J, Grifols C, Torres M, Costa M, Bozzo J, Szczepiorkowski ZM, Hendrix S, Páez A.",Alzheimers Dement. 2020 Oct;16(10):1412-1425. doi: 10.1002/alz.12137. Epub 2020 Jul 27.,Boada M,Alzheimers Dement,2020,28-07-2020,PMC7984263,,10.1002/alz.12137
32715609,Safety and target engagement profile of two oxaloacetate doses in Alzheimer's patients,"Vidoni ED, Choi IY, Lee P, Reed G, Zhang N, Pleen J, Mahnken JD, Clutton J, Becker A, Sherry E, Bothwell R, Anderson H, Harris RA, Brooks W, Wilkins HM, Mosconi L, Burns JM, Swerdlow RH.",Alzheimers Dement. 2021 Jan;17(1):7-17. doi: 10.1002/alz.12156. Epub 2020 Jul 27.,Vidoni ED,Alzheimers Dement,2021,28-07-2020,PMC8084114,NIHMS1693488,10.1002/alz.12156
32715279,Phosphodiesterase Inhibitors for Alzheimer's Disease: A Systematic Review of Clinical Trials and Epidemiology with a Mechanistic Rationale,"Sanders O, Rajagopal L.",J Alzheimers Dis Rep. 2020 Jun 16;4(1):185-215. doi: 10.3233/ADR-200191.,Sanders O,J Alzheimers Dis Rep,2020,28-07-2020,PMC7369141,,10.3233/ADR-200191
32714977,Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations,"Maramai S, Benchekroun M, Gabr MT, Yahiaoui S.",Biomed Res Int. 2020 Jun 30;2020:5120230. doi: 10.1155/2020/5120230. eCollection 2020.,Maramai S,Biomed Res Int,2020,28-07-2020,PMC7354643,,10.1155/2020/5120230
32713125,A European Academy of Neurology guideline on medical management issues in dementia,"Frederiksen KS, Cooper C, Frisoni GB, Frölich L, Georges J, Kramberger MG, Nilsson C, Passmore P, Mantoan Ritter L, Religa D, Schmidt R, Stefanova E, Verdelho A, Vandenbulcke M, Winblad B, Waldemar G.",Eur J Neurol. 2020 Oct;27(10):1805-1820. doi: 10.1111/ene.14412. Epub 2020 Jul 26.,Frederiksen KS,Eur J Neurol,2020,27-07-2020,PMC7540303,,10.1111/ene.14412
32700462,Role of testosterone in cognition and mobility of aging men,"Kaufman JM, Lapauw B.",Andrology. 2020 Nov;8(6):1567-1579. doi: 10.1111/andr.12872. Epub 2020 Aug 31.,Kaufman JM,Andrology,2020,24-07-2020,,,10.1111/andr.12872
32700176,Brain angiotensin II and angiotensin IV receptors as potential Alzheimer's disease therapeutic targets,"Royea J, Hamel E.",Geroscience. 2020 Oct;42(5):1237-1256. doi: 10.1007/s11357-020-00231-y. Epub 2020 Jul 22.,Royea J,Geroscience,2020,24-07-2020,PMC7525853,,10.1007/s11357-020-00231-y
32698461,Royal Jelly-A Traditional and Natural Remedy for Postmenopausal Symptoms and Aging-Related Pathologies,"Bălan A, Moga MA, Dima L, Toma S, Elena Neculau A, Anastasiu CV.",Molecules. 2020 Jul 20;25(14):3291. doi: 10.3390/molecules25143291.,Bălan A,Molecules,2020,24-07-2020,PMC7397171,,10.3390/molecules25143291
32698354,Novel MRI Techniques Identifying Vascular Leak and Paravascular Flow Reduction in Early Alzheimer Disease,Joseph CR.,Biomedicines. 2020 Jul 20;8(7):228. doi: 10.3390/biomedicines8070228.,Joseph CR,Biomedicines,2020,24-07-2020,PMC7400582,,10.3390/biomedicines8070228
32696271,Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis,"Bascuñana P, Möhle L, Brackhan M, Pahnke J.",Drugs R D. 2020 Sep;20(3):197-207. doi: 10.1007/s40268-020-00316-1.,Bascuñana P,Drugs R D,2020,23-07-2020,PMC7419396,,10.1007/s40268-020-00316-1
32695312,New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer's disease: focus on brexpiprazole and pimavanserin,"Caraci F, Santagati M, Caruso G, Cannavò D, Leggio GM, Salomone S, Drago F.",F1000Res. 2020 Jul 8;9:F1000 Faculty Rev-686. doi: 10.12688/f1000research.22662.1. eCollection 2020.,Caraci F,F1000Res,2020,23-07-2020,PMC7344175,,10.12688/f1000research.22662.1
32691984,Comparative risk of cardiac arrhythmias associated with acetylcholinesterase inhibitors used in treatment of dementias - A narrative review,"Huang Y, Alsabbagh MW.",Pharmacol Res Perspect. 2020 Aug;8(4):e00622. doi: 10.1002/prp2.622.,Huang Y,Pharmacol Res Perspect,2020,22-07-2020,PMC7372915,,10.1002/prp2.622
32690803,Evidence-based prevention of Alzheimer's disease: systematic review and meta-analysis of 243 observational prospective studies and 153 randomised controlled trials,"Yu JT, Xu W, Tan CC, Andrieu S, Suckling J, Evangelou E, Pan A, Zhang C, Jia J, Feng L, Kua EH, Wang YJ, Wang HF, Tan MS, Li JQ, Hou XH, Wan Y, Tan L, Mok V, Tan L, Dong Q, Touchon J, Gauthier S, Aisen PS, Vellas B.",J Neurol Neurosurg Psychiatry. 2020 Nov;91(11):1201-1209. doi: 10.1136/jnnp-2019-321913. Epub 2020 Jul 20.,Yu JT,J Neurol Neurosurg Psychiatry,2020,22-07-2020,PMC7569385,,10.1136/jnnp-2019-321913
32690472,Brain delivery of supplemental docosahexaenoic acid (DHA): A randomized placebo-controlled clinical trial,"Arellanes IC, Choe N, Solomon V, He X, Kavin B, Martinez AE, Kono N, Buennagel DP, Hazra N, Kim G, D'Orazio LM, McCleary C, Sagare A, Zlokovic BV, Hodis HN, Mack WJ, Chui HC, Harrington MG, Braskie MN, Schneider LS, Yassine HN.",EBioMedicine. 2020 Sep;59:102883. doi: 10.1016/j.ebiom.2020.102883. Epub 2020 Jul 17.,Arellanes IC,EBioMedicine,2020,22-07-2020,PMC7502665,,10.1016/j.ebiom.2020.102883
32682954,Passive immunotherapies targeting Aβ and tau in Alzheimer's disease,"Plotkin SS, Cashman NR.",Neurobiol Dis. 2020 Oct;144:105010. doi: 10.1016/j.nbd.2020.105010. Epub 2020 Jul 16.,Plotkin SS,Neurobiol Dis,2020,20-07-2020,PMC7365083,,10.1016/j.nbd.2020.105010
32667654,Effect of Rotigotine vs Placebo on Cognitive Functions Among Patients With Mild to Moderate Alzheimer Disease: A Randomized Clinical Trial,"Koch G, Motta C, Bonnì S, Pellicciari MC, Picazio S, Casula EP, Maiella M, Di Lorenzo F, Ponzo V, Ferrari C, Scaricamazza E, Caltagirone C, Martorana A.",JAMA Netw Open. 2020 Jul 1;3(7):e2010372. doi: 10.1001/jamanetworkopen.2020.10372.,Koch G,JAMA Netw Open,2020,16-07-2020,PMC7364345,,10.1001/jamanetworkopen.2020.10372
32665410,Education Research: Online Alzheimer education for high school and college students: A randomized controlled trial,"Saif N, Niotis K, Dominguez M, Hodes JF, Woodbury M, Amini Y, Sadek G, Scheyer O, Caesar E, Hristov H, Knowlton N, Lee P, McInnis M, Isaacson RS.",Neurology. 2020 Oct 20;95(16):e2305-e2313. doi: 10.1212/WNL.0000000000009859. Epub 2020 Jul 14.,Saif N,Neurology,2020,16-07-2020,PMC7713789,,10.1212/WNL.0000000000009859
32664669,The Use of Antimicrobial and Antiviral Drugs in Alzheimer's Disease,"Iqbal UH, Zeng E, Pasinetti GM.",Int J Mol Sci. 2020 Jul 12;21(14):4920. doi: 10.3390/ijms21144920.,Iqbal UH,Int J Mol Sci,2020,16-07-2020,PMC7404195,,10.3390/ijms21144920
32664647,Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders,"Mitra S, Khatri SN, Maulik M, Bult-Ito A, Schulte M.",Int J Mol Sci. 2020 Jul 12;21(14):4918. doi: 10.3390/ijms21144918.,Mitra S,Int J Mol Sci,2020,16-07-2020,PMC7404387,,10.3390/ijms21144918
32663977,Combined treatment with escitalopram and memantine increases gray matter volume and cortical thickness compared to escitalopram and placebo in a pilot study of geriatric depression,"Krause-Sorio B, Siddarth P, Kilpatrick L, Laird KT, Milillo MM, Ercoli L, Narr KL, Lavretsky H.",J Affect Disord. 2020 Sep 1;274:464-470. doi: 10.1016/j.jad.2020.05.092. Epub 2020 May 24.,Krause-Sorio B,J Affect Disord,2020,16-07-2020,PMC7368564,NIHMS1599554,10.1016/j.jad.2020.05.092
32652024,Medium-Chain Triglycerides (8:0 and 10:0) Increase Mini-Mental State Examination (MMSE) Score in Frail Elderly Adults in a Randomized Controlled Trial,"Abe S, Ezaki O, Suzuki M.",J Nutr. 2020 Sep 1;150(9):2383-2390. doi: 10.1093/jn/nxaa186.,Abe S,J Nutr,2020,12-07-2020,,,10.1093/jn/nxaa186
32651327,Using a Timed Motor Task to Predict One-Year Functional Decline in Amnestic Mild Cognitive Impairment,"Schaefer SY, Hooyman A, Duff K.",J Alzheimers Dis. 2020;77(1):53-58. doi: 10.3233/JAD-200518.,Schaefer SY,J Alzheimers Dis,2020,12-07-2020,PMC7484390,NIHMS1618467,10.3233/JAD-200518
32651318,Heavy Metals Exposure and Alzheimer's Disease and Related Dementias,"Bakulski KM, Seo YA, Hickman RC, Brandt D, Vadari HS, Hu H, Park SK.",J Alzheimers Dis. 2020;76(4):1215-1242. doi: 10.3233/JAD-200282.,Bakulski KM,J Alzheimers Dis,2020,12-07-2020,PMC7454042,NIHMS1621361,10.3233/JAD-200282
32645824,Epigenetic Basis of Lead-Induced Neurological Disorders,"Wang T, Zhang J, Xu Y.",Int J Environ Res Public Health. 2020 Jul 7;17(13):4878. doi: 10.3390/ijerph17134878.,Wang T,Int J Environ Res Public Health,2020,11-07-2020,PMC7370007,,10.3390/ijerph17134878
32643187,"STXBP1 encephalopathies: Clinical spectrum, disease mechanisms, and therapeutic strategies","Abramov D, Guiberson NGL, Burré J.",J Neurochem. 2021 Apr;157(2):165-178. doi: 10.1111/jnc.15120. Epub 2020 Aug 4.,Abramov D,J Neurochem,2021,10-07-2020,PMC7812771,NIHMS1660710,10.1111/jnc.15120
32640331,Analysis of the intricate effects of polyunsaturated fatty acids and polyphenols on inflammatory pathways in health and disease,"Margină D, Ungurianu A, Purdel C, Nițulescu GM, Tsoukalas D, Sarandi E, Thanasoula M, Burykina TI, Tekos F, Buha A, Nikitovic D, Kouretas D, Tsatsakis AM.",Food Chem Toxicol. 2020 Sep;143:111558. doi: 10.1016/j.fct.2020.111558. Epub 2020 Jul 5.,Margină D,Food Chem Toxicol,2020,09-07-2020,PMC7335494,,10.1016/j.fct.2020.111558
32635400,Preventive Role of L-Carnitine and Balanced Diet in Alzheimer's Disease,"Kepka A, Ochocinska A, Borzym-Kluczyk M, Skorupa E, Stasiewicz-Jarocka B, Chojnowska S, Waszkiewicz N.",Nutrients. 2020 Jul 3;12(7):1987. doi: 10.3390/nu12071987.,Kepka A,Nutrients,2020,09-07-2020,PMC7400709,,10.3390/nu12071987
32630004,Natural Medicines and Their Underlying Mechanisms of Prevention and Recovery from Amyloid Β-Induced Axonal Degeneration in Alzheimer's Disease,"Kuboyama T, Yang X, Tohda C.",Int J Mol Sci. 2020 Jun 30;21(13):4665. doi: 10.3390/ijms21134665.,Kuboyama T,Int J Mol Sci,2020,08-07-2020,PMC7369795,,10.3390/ijms21134665
32627087,Application of PET Tracers in Molecular Imaging for Breast Cancer,"Boers J, de Vries EFJ, Glaudemans AWJM, Hospers GAP, Schröder CP.",Curr Oncol Rep. 2020 Jul 6;22(8):85. doi: 10.1007/s11912-020-00940-9.,Boers J,Curr Oncol Rep,2020,07-07-2020,PMC7335757,,10.1007/s11912-020-00940-9
32611994,Recent Strategies for Targeted Brain Drug Delivery,"Ogawa K, Kato N, Kawakami S.",Chem Pharm Bull (Tokyo). 2020;68(7):567-582. doi: 10.1248/cpb.c20-00041.,Ogawa K,Chem Pharm Bull (Tokyo),2020,03-07-2020,,,10.1248/cpb.c20-00041
32603894,Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease,"Sharma V, Kaur A, Singh TG.",Biomed Pharmacother. 2020 Sep;129:110373. doi: 10.1016/j.biopha.2020.110373. Epub 2020 Jun 27.,Sharma V,Biomed Pharmacother,2020,01-07-2020,,,10.1016/j.biopha.2020.110373
32603829,SARS-CoV-2 pathophysiology and assessment of coronaviruses in CNS diseases with a focus on therapeutic targets,"Vallamkondu J, John A, Wani WY, Ramadevi SP, Jella KK, Reddy PH, Kandimalla R.",Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165889. doi: 10.1016/j.bbadis.2020.165889. Epub 2020 Jun 27.,Vallamkondu J,Biochim Biophys Acta Mol Basis Dis,2020,01-07-2020,PMC7320676,,10.1016/j.bbadis.2020.165889
32597927,To Keto or Not to Keto? A Systematic Review of Randomized Controlled Trials Assessing the Effects of Ketogenic Therapy on Alzheimer Disease,"Grammatikopoulou MG, Goulis DG, Gkiouras K, Theodoridis X, Gkouskou KK, Evangeliou A, Dardiotis E, Bogdanos DP.",Adv Nutr. 2020 Nov 16;11(6):1583-1602. doi: 10.1093/advances/nmaa073.,Grammatikopoulou MG,Adv Nutr,2020,30-06-2020,PMC7666893,,10.1093/advances/nmaa073
32592177,Multi-angle development of therapeutic methods for Alzheimer's disease,Hoshi M.,Br J Pharmacol. 2021 Feb;178(4):770-783. doi: 10.1111/bph.15174. Epub 2020 Jul 16.,Hoshi M,Br J Pharmacol,2021,28-06-2020,,,10.1111/bph.15174
32591439,"Kidney Disease, Intensive Hypertension Treatment, and Risk for Dementia and Mild Cognitive Impairment: The Systolic Blood Pressure Intervention Trial","Kurella Tamura M, Gaussoin SA, Pajewski NM, Chelune GJ, Freedman BI, Gure TR, Haley WE, Killeen AA, Oparil S, Rapp SR, Rifkin DE, Supiano M, Williamson JD, Weiner DE; SPRINT Research Group*.",J Am Soc Nephrol. 2020 Sep;31(9):2122-2132. doi: 10.1681/ASN.2020010038. Epub 2020 Jun 26.,Kurella Tamura M,J Am Soc Nephrol,2020,28-06-2020,PMC7461687,,10.1681/ASN.2020010038
32588971,A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairment,"Lingler JH, Sereika SM, Butters MA, Cohen AD, Klunk WE, Knox ML, McDade E, Nadkarni NK, Roberts JS, Tamres LK, Lopez OL.",Alzheimers Dement. 2020 Sep;16(9):1330-1337. doi: 10.1002/alz.12129. Epub 2020 Jun 26.,Lingler JH,Alzheimers Dement,2020,27-06-2020,PMC7541680,NIHMS1614254,10.1002/alz.12129
32584672,Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical Trials,"Hung A, Schneider M, Lopez MH, McClellan M.",J Manag Care Spec Pharm. 2020 Jul;26(7):888-900. doi: 10.18553/jmcp.2020.26.7.888.,Hung A,J Manag Care Spec Pharm,2020,26-06-2020,PMC10391091,,10.18553/jmcp.2020.26.7.888
32581760,The Comparative Efficacy of Multiple Interventions for Mild Cognitive Impairment in Alzheimer's Disease: A Bayesian Network Meta-Analysis,"Lai X, Wen H, Li Y, Lu L, Tang C.",Front Aging Neurosci. 2020 Jun 5;12:121. doi: 10.3389/fnagi.2020.00121. eCollection 2020.,Lai X,Front Aging Neurosci,2020,26-06-2020,PMC7289916,,10.3389/fnagi.2020.00121
32580164,REducing SEDENTary Behavior Among Mild to Moderate Cognitively Impaired Assisted Living Residents: A Pilot Randomized Controlled Trial (RESEDENT Study),"Dillon K, Prapavessis H.",J Aging Phys Act. 2021 Feb 1;29(1):27-35. doi: 10.1123/japa.2019-0440. Epub 2020 Jun 23.,Dillon K,J Aging Phys Act,2021,25-06-2020,,,10.1123/japa.2019-0440
32579671,Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer's disease model,"Wang S, Mustafa M, Yuede CM, Salazar SV, Kong P, Long H, Ward M, Siddiqui O, Paul R, Gilfillan S, Ibrahim A, Rhinn H, Tassi I, Rosenthal A, Schwabe T, Colonna M.",J Exp Med. 2020 Sep 7;217(9):e20200785. doi: 10.1084/jem.20200785.,Wang S,J Exp Med,2020,25-06-2020,PMC7478730,,10.1084/jem.20200785
32568367,"Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial","Craft S, Raman R, Chow TW, Rafii MS, Sun CK, Rissman RA, Donohue MC, Brewer JB, Jenkins C, Harless K, Gessert D, Aisen PS.",JAMA Neurol. 2020 Sep 1;77(9):1099-1109. doi: 10.1001/jamaneurol.2020.1840.,Craft S,JAMA Neurol,2020,23-06-2020,PMC7309571,,10.1001/jamaneurol.2020.1840
32568200,Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease,"Lakey-Beitia J, Burillo AM, La Penna G, Hegde ML, Rao KS.",J Alzheimers Dis. 2021;82(s1):S335-S357. doi: 10.3233/JAD-200185.,Lakey-Beitia J,J Alzheimers Dis,2021,23-06-2020,PMC7809605,NIHMS1660360,10.3233/JAD-200185
32568196,"Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks","Guthrie H, Honig LS, Lin H, Sink KM, Blondeau K, Quartino A, Dolton M, Carrasco-Triguero M, Lian Q, Bittner T, Clayton D, Smith J, Ostrowitzki S.",J Alzheimers Dis. 2020;76(3):967-979. doi: 10.3233/JAD-200134.,Guthrie H,J Alzheimers Dis,2020,23-06-2020,PMC7505005,,10.3233/JAD-200134
32567070,Progress toward Alzheimer's disease treatment: Leveraging the Achilles' heel of Aβ oligomers?,"Fantini J, Chahinian H, Yahi N.",Protein Sci. 2020 Aug;29(8):1748-1759. doi: 10.1002/pro.3906. Epub 2020 Jul 13.,Fantini J,Protein Sci,2020,23-06-2020,PMC7380673,,10.1002/pro.3906
32565066,Genetic architecture of Alzheimer's disease,"Neuner SM, Tcw J, Goate AM.",Neurobiol Dis. 2020 Sep;143:104976. doi: 10.1016/j.nbd.2020.104976. Epub 2020 Jun 18.,Neuner SM,Neurobiol Dis,2020,23-06-2020,PMC7409822,NIHMS1607504,10.1016/j.nbd.2020.104976
32565008,Measuring Apathy in Alzheimer's Disease in the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2): A Comparison of Instruments,"Lanctôt KL, Scherer RW, Li A, Vieira D, Coulibaly H, Rosenberg PB, Herrmann N, Lerner AJ, Padala PR, Brawman-Mintzer O, van Dyck CH, Porsteinsson AP, Craft S, Levey A, Burke WJ, Mintzer JE.",Am J Geriatr Psychiatry. 2021 Jan;29(1):81-89. doi: 10.1016/j.jagp.2020.05.020. Epub 2020 May 27.,Lanctôt KL,Am J Geriatr Psychiatry,2021,23-06-2020,PMC7704818,NIHMS1605397,10.1016/j.jagp.2020.05.020
32564066,Does the Impact of Intensive Lifestyle Intervention on Cardiovascular Disease Risk Vary According to Frailty as Measured via Deficit Accumulation?,"Simpson FR, Pajewski NM, Beavers KM, Kritchevsky S, McCaffery J, Nicklas BJ, Wing RR, Bertoni A, Ingram F, Ojeranti D, Espeland MA.",J Gerontol A Biol Sci Med Sci. 2021 Jan 18;76(2):339-345. doi: 10.1093/gerona/glaa153.,Simpson FR,J Gerontol A Biol Sci Med Sci,2021,22-06-2020,PMC8444302,,10.1093/gerona/glaa153
32546992,"Effect of the Casein-Derived Peptide Met-Lys-Pro on Cognitive Function in Community-Dwelling Adults Without Dementia: A Randomized, Double-Blind, Placebo-Controlled Trial","Yuda N, Tanaka M, Yamauchi K, Abe F, Kakiuchi I, Kiyosawa K, Miyasaka M, Sakane N, Nakamura M.",Clin Interv Aging. 2020 May 27;15:743-754. doi: 10.2147/CIA.S253116. eCollection 2020.,Yuda N,Clin Interv Aging,2020,18-06-2020,PMC7266326,,10.2147/CIA.S253116
32546202,Safety of pharmacologic interventions for neuropsychiatric symptoms in dementia: a systematic review and network meta-analysis,"Watt JA, Goodarzi Z, Veroniki AA, Nincic V, Khan PA, Ghassemi M, Thompson Y, Lai Y, Treister V, Tricco AC, Straus SE.",BMC Geriatr. 2020 Jun 16;20(1):212. doi: 10.1186/s12877-020-01607-7.,Watt JA,BMC Geriatr,2020,18-06-2020,PMC7298771,,10.1186/s12877-020-01607-7
32545780,Can Physical Activity Support the Endocannabinoid System in the Preventive and Therapeutic Approach to Neurological Disorders?,"Charytoniuk T, Zywno H, Konstantynowicz-Nowicka K, Berk K, Bzdega W, Chabowski A.",Int J Mol Sci. 2020 Jun 13;21(12):4221. doi: 10.3390/ijms21124221.,Charytoniuk T,Int J Mol Sci,2020,18-06-2020,PMC7352563,,10.3390/ijms21124221
32543351,Role of antioxidants and a nutrient rich diet in Alzheimer's disease,"Veurink G, Perry G, Singh SK.",Open Biol. 2020 Jun;10(6):200084. doi: 10.1098/rsob.200084. Epub 2020 Jun 17.,Veurink G,Open Biol,2020,17-06-2020,PMC7333894,,10.1098/rsob.200084
32541134,Simultaneous exposure to noise and carbon monoxide increases the risk of Alzheimer's disease: a literature review,"Bagheri F, Rashedi V.",Med Gas Res. 2020 Apr-Jun;10(2):85-90. doi: 10.4103/2045-9912.285562.,Bagheri F,Med Gas Res,2020,17-06-2020,PMC7885712,,10.4103/2045-9912.285562
32534508,Crocus Sativus (Saffron): An Immunoregulatory Factor in the Autoimmune and Non-autoimmune Diseases,"Poursamimi J, Shariati-Sarabi Z, Tavakkol-Afshari J, Mohajeri SA, Mohammadi M.",Iran J Allergy Asthma Immunol. 2020 May 17;19(S1):27-42. doi: 10.18502/ijaai.v19i(s1.r1).2852.,Poursamimi J,Iran J Allergy Asthma Immunol,2020,15-06-2020,,,10.18502/ijaai.v19i(s1.r1).2852
32531260,Nerve growth factor in metabolic complications and Alzheimer's disease: Physiology and therapeutic potential,"Ding XW, Li R, Geetha T, Tao YX, Babu JR.",Biochim Biophys Acta Mol Basis Dis. 2020 Oct 1;1866(10):165858. doi: 10.1016/j.bbadis.2020.165858. Epub 2020 Jun 10.,Ding XW,Biochim Biophys Acta Mol Basis Dis,2020,13-06-2020,,,10.1016/j.bbadis.2020.165858
32528296,Different Doses of Pharmacological Treatments for Mild to Moderate Alzheimer's Disease: A Bayesian Network Meta-Analysis,"Zhang T, Liu N, Cao H, Wei W, Ma L, Li H.",Front Pharmacol. 2020 May 26;11:778. doi: 10.3389/fphar.2020.00778. eCollection 2020.,Zhang T,Front Pharmacol,2020,13-06-2020,PMC7264393,,10.3389/fphar.2020.00778
32525774,Protective Effects of Polydatin Against Dementia-Related Disorders,Tang KS.,Curr Neuropharmacol. 2021;19(2):127-135. doi: 10.2174/1570159X18666200611144825.,Tang KS,Curr Neuropharmacol,2021,12-06-2020,PMC8033983,,10.2174/1570159X18666200611144825
32523520,Non-invasive Brain Stimulation in Alzheimer's Disease and Mild Cognitive Impairment-A State-of-the-Art Review on Methodological Characteristics and Stimulation Parameters,"Holczer A, Németh VL, Vékony T, Vécsei L, Klivényi P, Must A.",Front Hum Neurosci. 2020 May 25;14:179. doi: 10.3389/fnhum.2020.00179. eCollection 2020.,Holczer A,Front Hum Neurosci,2020,12-06-2020,PMC7261902,,10.3389/fnhum.2020.00179
32520230,Resveratrol in Alzheimer's disease: a review of pathophysiology and therapeutic potential,"Sousa JCE, Santana ACF, MagalhÃes GJP.",Arq Neuropsiquiatr. 2020 Jun 8;78(8):501-511. doi: 10.1590/0004-282X20200010.,Sousa JCE,Arq Neuropsiquiatr,2020,11-06-2020,,,10.1590/0004-282X20200010
32512572,Translational Scoring of Candidate Treatments for Alzheimer's Disease: A Systematic Approach,Cummings JL.,Dement Geriatr Cogn Disord. 2020;49(1):22-37. doi: 10.1159/000507569. Epub 2020 Jun 8.,Cummings JL,Dement Geriatr Cogn Disord,2020,09-06-2020,,,10.1159/000507569
32508323,Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial,"Traini E, Carotenuto A, Fasanaro AM, Amenta F.",J Alzheimers Dis. 2020;76(1):317-329. doi: 10.3233/JAD-190623.,Traini E,J Alzheimers Dis,2020,09-06-2020,PMC7369051,,10.3233/JAD-190623
32506291,Alzheimer's Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials,Rafii MS.,CNS Drugs. 2020 Aug;34(8):785-794. doi: 10.1007/s40263-020-00740-6.,Rafii MS,CNS Drugs,2020,08-06-2020,PMC7395870,NIHMS1601692,10.1007/s40263-020-00740-6
32505710,Inter-individual differences in the responses to aerobic exercise in Alzheimer's disease: Findings from the FIT-AD trial,"Yu F, Salisbury D, Mathiason MA.",J Sport Health Sci. 2021 Jan;10(1):65-72. doi: 10.1016/j.jshs.2020.05.007. Epub 2020 Jun 4.,Yu F,J Sport Health Sci,2021,08-06-2020,PMC7858037,,10.1016/j.jshs.2020.05.007
32503473,The effect of physical activity on cognition relative to APOE genotype (PAAD-2): study protocol for a phase II randomized control trial,"Park KS, Ganesh AB, Berry NT, Mobley YP, Karper WB, Labban JD, Wahlheim CN, Williams TM, Wideman L, Etnier JL.",BMC Neurol. 2020 Jun 6;20(1):231. doi: 10.1186/s12883-020-01732-1.,Park KS,BMC Neurol,2020,07-06-2020,PMC7274941,,10.1186/s12883-020-01732-1
32492080,Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial,"Berk M, Woods RL, Nelson MR, Shah RC, Reid CM, Storey E, Fitzgerald S, Lockery JE, Wolfe R, Mohebbi M, Dodd S, Murray AM, Stocks N, Fitzgerald PB, Mazza C, Agustini B, McNeil JJ.",JAMA Psychiatry. 2020 Oct 1;77(10):1012-1020. doi: 10.1001/jamapsychiatry.2020.1214.,Berk M,JAMA Psychiatry,2020,04-06-2020,PMC7271558,,10.1001/jamapsychiatry.2020.1214
32486510,Copper Coordination Compounds as Biologically Active Agents,"Krasnovskaya O, Naumov A, Guk D, Gorelkin P, Erofeev A, Beloglazkina E, Majouga A.",Int J Mol Sci. 2020 May 31;21(11):3965. doi: 10.3390/ijms21113965.,Krasnovskaya O,Int J Mol Sci,2020,04-06-2020,PMC7312030,,10.3390/ijms21113965
32486409,Marine Biocompounds for Neuroprotection-A Review,"Bălașa AF, Chircov C, Grumezescu AM.",Mar Drugs. 2020 May 31;18(6):290. doi: 10.3390/md18060290.,Bălașa AF,Mar Drugs,2020,04-06-2020,PMC7344849,,10.3390/md18060290
32469698,Reversal of Calcium Dysregulation as Potential Approach for Treating Alzheimer's Disease,"Popugaeva E, Chernyuk D, Bezprozvanny I.",Curr Alzheimer Res. 2020;17(4):344-354. doi: 10.2174/1567205017666200528162046.,Popugaeva E,Curr Alzheimer Res,2020,30-05-2020,PMC8210816,NIHMS1678186,10.2174/1567205017666200528162046
32467879,Sildenafil for the Treatment of Alzheimer's Disease: A Systematic Review,Sanders O.,J Alzheimers Dis Rep. 2020 Apr 22;4(1):91-106. doi: 10.3233/ADR-200166.,Sanders O,J Alzheimers Dis Rep,2020,30-05-2020,PMC7242821,,10.3233/ADR-200166
32466248,S-Adenosine Methionine (SAMe) and Valproic Acid (VPA) as Epigenetic Modulators: Special Emphasis on their Interactions Affecting Nervous Tissue during Pregnancy,"Ornoy A, Becker M, Weinstein-Fudim L, Ergaz Z.",Int J Mol Sci. 2020 May 25;21(10):3721. doi: 10.3390/ijms21103721.,Ornoy A,Int J Mol Sci,2020,30-05-2020,PMC7279375,,10.3390/ijms21103721
32466216,Mitochondrial Dysfunctions: A Red Thread across Neurodegenerative Diseases,"Stanga S, Caretto A, Boido M, Vercelli A.",Int J Mol Sci. 2020 May 25;21(10):3719. doi: 10.3390/ijms21103719.,Stanga S,Int J Mol Sci,2020,30-05-2020,PMC7279270,,10.3390/ijms21103719
32463470,Bupropion for the Treatment of Apathy in Alzheimer Disease: A Randomized Clinical Trial,"Maier F, Spottke A, Bach JP, Bartels C, Buerger K, Dodel R, Fellgiebel A, Fliessbach K, Frölich L, Hausner L, Hellmich M, Klöppel S, Klostermann A, Kornhuber J, Laske C, Peters O, Priller J, Richter-Schmidinger T, Schneider A, Shah-Hosseini K, Teipel S, von Arnim CAF, Wiltfang J, Jessen F.",JAMA Netw Open. 2020 May 1;3(5):e206027. doi: 10.1001/jamanetworkopen.2020.6027.,Maier F,JAMA Netw Open,2020,29-05-2020,PMC7256670,,10.1001/jamanetworkopen.2020.6027
32461027,Neurobiologic Rationale for Treatment of Apathy in Alzheimer's Disease With Methylphenidate,"van Dyck CH, Arnsten AFT, Padala PR, Brawman-Mintzer O, Lerner AJ, Porsteinsson AP, Scherer RW, Levey AI, Herrmann N, Jamil N, Mintzer JE, Lanctôt KL, Rosenberg PB.",Am J Geriatr Psychiatry. 2021 Jan;29(1):51-62. doi: 10.1016/j.jagp.2020.04.026. Epub 2020 May 5.,van Dyck CH,Am J Geriatr Psychiatry,2021,29-05-2020,PMC7641967,NIHMS1598370,10.1016/j.jagp.2020.04.026
32459513,The dichotomous role of the gut microbiome in exacerbating and ameliorating neurodegenerative disorders,"Raval U, Harary JM, Zeng E, Pasinetti GM.",Expert Rev Neurother. 2020 Jul;20(7):673-686. doi: 10.1080/14737175.2020.1775585. Epub 2020 Jun 27.,Raval U,Expert Rev Neurother,2020,28-05-2020,PMC7387222,NIHMS1599754,10.1080/14737175.2020.1775585
32458360,Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer's Disease,"Fülöp T, Munawara U, Larbi A, Desroches M, Rodrigues S, Catanzaro M, Guidolin A, Khalil A, Bernier F, Barron AE, Hirokawa K, Beauregard PB, Dumoulin D, Bellenger JP, Witkowski JM, Frost E.",CNS Drugs. 2020 Jul;34(7):673-695. doi: 10.1007/s40263-020-00737-1.,Fülöp T,CNS Drugs,2020,28-05-2020,PMC9020372,NIHMS1789412,10.1007/s40263-020-00737-1
32452370,"[Alzheimer's disease, neuro-inflammation, and herpes viruses, a path that traces its way]",Epstein AL.,Med Sci (Paris). 2020 May;36(5):479-486. doi: 10.1051/medsci/2020090. Epub 2020 May 26.,Epstein AL,Med Sci (Paris),2020,27-05-2020,,,10.1051/medsci/2020090
32449919,Orthostatic Blood Pressure Recovery Is Associated With the Rate of Cognitive Decline and Mortality in Clinical Alzheimer's Disease,"de Heus RAA, de Jong DLK, Rijpma A, Lawlor BA, Olde Rikkert MGM, Claassen JAHR.",J Gerontol A Biol Sci Med Sci. 2020 Oct 15;75(11):2169-2176. doi: 10.1093/gerona/glaa129.,de Heus RAA,J Gerontol A Biol Sci Med Sci,2020,26-05-2020,PMC7566323,,10.1093/gerona/glaa129
32445136,Effects of saffron (Crocus sativus L.) on cognitive function. A systematic review of RCTs,"Avgerinos KI, Vrysis C, Chaitidis N, Kolotsiou K, Myserlis PG, Kapogiannis D.",Neurol Sci. 2020 Oct;41(10):2747-2754. doi: 10.1007/s10072-020-04427-0. Epub 2020 May 23.,Avgerinos KI,Neurol Sci,2020,24-05-2020,PMC7484083,NIHMS1597290,10.1007/s10072-020-04427-0
32444540,Tolcapone Treatment for Cognitive and Behavioral Symptoms in Behavioral Variant Frontotemporal Dementia: A Placebo-Controlled Crossover Study,"Fremont R, Manoochehri M, Armstrong NM, Mattay VS, Apud JA, Tierney MC, Devanand DP, Gazes Y, Habeck C, Wassermann EM, Grafman J, Huey ED.",J Alzheimers Dis. 2020;75(4):1391-1403. doi: 10.3233/JAD-191265.,Fremont R,J Alzheimers Dis,2020,24-05-2020,PMC10131251,NIHMS1890177,10.3233/JAD-191265
32442084,Approaches to Optimizing Dantrolene Neuroprotection for the Treatment of Alzheimer's Disease,"Abou MB, Sun L, Wei H.",Curr Alzheimer Res. 2020;17(4):324-328. doi: 10.2174/1567205017666200522204722.,Abou MB,Curr Alzheimer Res,2020,23-05-2020,PMC7705762,NIHMS1649301,10.2174/1567205017666200522204722
32435187,Effectiveness and Safety of Acupuncture for the Treatment of Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Wang YY, Yu SF, Xue HY, Li Y, Zhao C, Jin YH.",Front Aging Neurosci. 2020 May 6;12:98. doi: 10.3389/fnagi.2020.00098. eCollection 2020.,Wang YY,Front Aging Neurosci,2020,22-05-2020,PMC7218057,,10.3389/fnagi.2020.00098
32429787,Polygala tenuifolia: a source for anti-Alzheimer's disease drugs,"Deng X, Zhao S, Liu X, Han L, Wang R, Hao H, Jiao Y, Han S, Bai C.",Pharm Biol. 2020 Dec;58(1):410-416. doi: 10.1080/13880209.2020.1758732.,Deng X,Pharm Biol,2020,21-05-2020,PMC7301717,,10.1080/13880209.2020.1758732
32427314,Dietary Factors and Neurodegenerative Disorders: An Umbrella Review of Meta-Analyses of Prospective Studies,"Barbaresko J, Lellmann AW, Schmidt A, Lehmann A, Amini AM, Egert S, Schlesinger S, Nöthlings U.",Adv Nutr. 2020 Sep 1;11(5):1161-1173. doi: 10.1093/advances/nmaa053.,Barbaresko J,Adv Nutr,2020,20-05-2020,PMC7490166,,10.1093/advances/nmaa053
32423175,"Overview of Dual-Acting Drug Methotrexate in Different Neurological Diseases, Autoimmune Pathologies and Cancers","Koźmiński P, Halik PK, Chesori R, Gniazdowska E.",Int J Mol Sci. 2020 May 14;21(10):3483. doi: 10.3390/ijms21103483.,Koźmiński P,Int J Mol Sci,2020,20-05-2020,PMC7279024,,10.3390/ijms21103483
32421163,The Effects of Aerobic Exercise on Psychological Functioning in Family Caregivers: Secondary Analyses of a Randomized Controlled Trial,"Hives BA, Buckler EJ, Weiss J, Schilf S, Johansen KL, Epel ES, Puterman E.",Ann Behav Med. 2021 Feb 12;55(1):65-76. doi: 10.1093/abm/kaaa031.,Hives BA,Ann Behav Med,2021,19-05-2020,PMC7880222,,10.1093/abm/kaaa031
32419519,Natural compounds as inhibitors of transthyretin amyloidosis and neuroprotective agents: analysis of structural data for future drug design,"Ciccone L, Tonali N, Nencetti S, Orlandini E.",J Enzyme Inhib Med Chem. 2020 Dec;35(1):1145-1162. doi: 10.1080/14756366.2020.1760262.,Ciccone L,J Enzyme Inhib Med Chem,2020,19-05-2020,PMC7301710,,10.1080/14756366.2020.1760262
32417770,"The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction","VanDusen KW, Eleswarpu S, Moretti EW, Devinney MJ, Crabtree DM, Laskowitz DT, Woldorff MG, Roberts KC, Whittle J, Browndyke JN, Cooter M, Rockhold FW, Anakwenze O, Bolognesi MP, Easley ME, Ferrandino MN, Jiranek WA, Berger M; MARBLE Study Investigators.",J Alzheimers Dis. 2020;75(4):1319-1328. doi: 10.3233/JAD-191185.,VanDusen KW,J Alzheimers Dis,2020,18-05-2020,PMC7923142,NIHMS1672258,10.3233/JAD-191185
32414155,Improving Anti-Neurodegenerative Benefits of Acetylcholinesterase Inhibitors in Alzheimer's Disease: Are Irreversible Inhibitors the Future?,Moss DE.,Int J Mol Sci. 2020 May 13;21(10):3438. doi: 10.3390/ijms21103438.,Moss DE,Int J Mol Sci,2020,17-05-2020,PMC7279429,,10.3390/ijms21103438
32411323,Oxidative Stress and Dementia in Alzheimer's Patients: Effects of Synbiotic Supplementation,"Ton AMM, Campagnaro BP, Alves GA, Aires R, Côco LZ, Arpini CM, Guerra E Oliveira T, Campos-Toimil M, Meyrelles SS, Pereira TMC, Vasquez EC.",Oxid Med Cell Longev. 2020 Jan 13;2020:2638703. doi: 10.1155/2020/2638703. eCollection 2020.,Ton AMM,Oxid Med Cell Longev,2020,16-05-2020,PMC7201593,,10.1155/2020/2638703
32410694,"Long-term safety and tolerability of atabecestat (JNJ-54861911), an oral BACE1 inhibitor, in early Alzheimer's disease spectrum patients: a randomized, double-blind, placebo-controlled study and a two-period extension study","Novak G, Streffer JR, Timmers M, Henley D, Brashear HR, Bogert J, Russu A, Janssens L, Tesseur I, Tritsmans L, Van Nueten L, Engelborghs S.",Alzheimers Res Ther. 2020 May 14;12(1):58. doi: 10.1186/s13195-020-00614-5.,Novak G,Alzheimers Res Ther,2020,16-05-2020,PMC7227237,,10.1186/s13195-020-00614-5
32408634,Evidence of the Role of Omega-3 Polyunsaturated Fatty Acids in Brain Glucose Metabolism,"Pifferi F, Cunnane SC, Guesnet P.",Nutrients. 2020 May 12;12(5):1382. doi: 10.3390/nu12051382.,Pifferi F,Nutrients,2020,16-05-2020,PMC7285025,,10.3390/nu12051382
32399297,Low Vitamin D and Its Association with Cognitive Impairment and Dementia,"Sultan S, Taimuri U, Basnan SA, Ai-Orabi WK, Awadallah A, Almowald F, Hazazi A.",J Aging Res. 2020 Apr 30;2020:6097820. doi: 10.1155/2020/6097820. eCollection 2020.,Sultan S,J Aging Res,2020,14-05-2020,PMC7210535,,10.1155/2020/6097820
32394109,Behavioral and Psychological Symptoms that Predict Cognitive Decline or Impairment in Cognitively Normal Middle-Aged or Older Adults: a Meta-Analysis,"Hudon C, Escudier F, De Roy J, Croteau J, Cross N, Dang-Vu TT, Zomahoun HTV, Grenier S, Gagnon JF, Parent A, Bruneau MA, Belleville S; Consortium for the Early Identification of Alzheimer’s Disease – Quebec.",Neuropsychol Rev. 2020 Dec;30(4):558-579. doi: 10.1007/s11065-020-09437-5. Epub 2020 May 11.,Hudon C,Neuropsychol Rev,2020,13-05-2020,,,10.1007/s11065-020-09437-5
32389009,Anti-aging role of Chinese herbel medicine: an overview of scientific evidence from 2008 to 2018,"Zhao J, Lan X, Liu Y, Liu Y, Xian Y, Lin Z, Xu F.",Ann Palliat Med. 2020 May;9(3):1230-1248. doi: 10.21037/apm.2020.04.09. Epub 2020 Apr 28.,Zhao J,Ann Palliat Med,2020,12-05-2020,,,10.21037/apm.2020.04.09
32387399,Pleiotropic effects of statins on brain cells,"Sodero AO, Barrantes FJ.",Biochim Biophys Acta Biomembr. 2020 Sep 1;1862(9):183340. doi: 10.1016/j.bbamem.2020.183340. Epub 2020 May 6.,Sodero AO,Biochim Biophys Acta Biomembr,2020,11-05-2020,,,10.1016/j.bbamem.2020.183340
32386493,The Protective Roles and Molecular Mechanisms of Troxerutin (Vitamin P4) for the Treatment of Chronic Diseases: A Mechanistic Review,"Zamanian M, Bazmandegan G, Sureda A, Sobarzo-Sanchez E, Yousefi-Manesh H, Shirooie S.",Curr Neuropharmacol. 2021;19(1):97-110. doi: 10.2174/1570159X18666200510020744.,Zamanian M,Curr Neuropharmacol,2021,11-05-2020,PMC7903491,,10.2174/1570159X18666200510020744
32383964,Delirium Severity Trajectories and Outcomes in ICU Patients. Defining a Dynamic Symptom Phenotype,"Lindroth H, Khan BA, Carpenter JS, Gao S, Perkins AJ, Khan SH, Wang S, Jones RN, Boustani MA.",Ann Am Thorac Soc. 2020 Sep;17(9):1094-1103. doi: 10.1513/AnnalsATS.201910-764OC.,Lindroth H,Ann Am Thorac Soc,2020,09-05-2020,PMC7462321,,10.1513/AnnalsATS.201910-764OC
32380758,Combination Drug Therapy for the Management of Alzheimer's Disease,"Kabir MT, Uddin MS, Mamun AA, Jeandet P, Aleya L, Mansouri RA, Ashraf GM, Mathew B, Bin-Jumah MN, Abdel-Daim MM.",Int J Mol Sci. 2020 May 5;21(9):3272. doi: 10.3390/ijms21093272.,Kabir MT,Int J Mol Sci,2020,09-05-2020,PMC7246721,,10.3390/ijms21093272
32380145,Targeting tau: Clinical trials and novel therapeutic approaches,"VandeVrede L, Boxer AL, Polydoro M.",Neurosci Lett. 2020 Jul 13;731:134919. doi: 10.1016/j.neulet.2020.134919. Epub 2020 May 4.,VandeVrede L,Neurosci Lett,2020,08-05-2020,PMC9212860,NIHMS1814550,10.1016/j.neulet.2020.134919
32380022,Opportunities for multiscale computational modelling of serotonergic drug effects in Alzheimer's disease,"Joshi A, Wang DH, Watterson S, McClean PL, Behera CK, Sharp T, Wong-Lin K.",Neuropharmacology. 2020 Sep 1;174:108118. doi: 10.1016/j.neuropharm.2020.108118. Epub 2020 May 4.,Joshi A,Neuropharmacology,2020,08-05-2020,PMC7322519,,10.1016/j.neuropharm.2020.108118
32376818,"Dietary Melatonin Therapy Alleviates the Lamina Cribrosa Damages in Patients with Mild Cognitive Impairments: A Double-Blinded, Randomized Controlled Study","Xu L, Yu H, Sun H, Hu B, Geng Y.",Med Sci Monit. 2020 May 7;26:e923232. doi: 10.12659/MSM.923232.,Xu L,Med Sci Monit,2020,08-05-2020,PMC7233010,,10.12659/MSM.923232
32375872,The cholinergic system in subtypes of Alzheimer's disease: an in vivo longitudinal MRI study,"Machado A, Ferreira D, Grothe MJ, Eyjolfsdottir H, Almqvist PM, Cavallin L, Lind G, Linderoth B, Seiger Å, Teipel S, Wahlberg LU, Wahlund LO, Westman E, Eriksdotter M; Alzheimer’s Disease Neuroimaging Initiative.",Alzheimers Res Ther. 2020 May 6;12(1):51. doi: 10.1186/s13195-020-00620-7.,Machado A,Alzheimers Res Ther,2020,08-05-2020,PMC7203806,,10.1186/s13195-020-00620-7
32370538,SG1002 and Catenated Divalent Organic Sulfur Compounds as Promising Hydrogen Sulfide Prodrugs,"Gojon G, Morales GA.",Antioxid Redox Signal. 2020 Nov 10;33(14):1010-1045. doi: 10.1089/ars.2020.8060. Epub 2020 Jun 11.,Gojon G,Antioxid Redox Signal,2020,07-05-2020,PMC7578191,,10.1089/ars.2020.8060
32360477,"Tau immunotherapies: Lessons learned, current status and future considerations","Sandusky-Beltran LA, Sigurdsson EM.",Neuropharmacology. 2020 Sep 15;175:108104. doi: 10.1016/j.neuropharm.2020.108104. Epub 2020 Apr 28.,Sandusky-Beltran LA,Neuropharmacology,2020,04-05-2020,PMC7492435,NIHMS1603065,10.1016/j.neuropharm.2020.108104
32357528,Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia,Cacabelos R.,Int J Mol Sci. 2020 Apr 26;21(9):3059. doi: 10.3390/ijms21093059.,Cacabelos R,Int J Mol Sci,2020,03-05-2020,PMC7246738,,10.3390/ijms21093059
32352165,Aspirin and other non-steroidal anti-inflammatory drugs for the prevention of dementia,"Jordan F, Quinn TJ, McGuinness B, Passmore P, Kelly JP, Tudur Smith C, Murphy K, Devane D.",Cochrane Database Syst Rev. 2020 Apr 30;4(4):CD011459. doi: 10.1002/14651858.CD011459.pub2.,Jordan F,Cochrane Database Syst Rev,2020,01-05-2020,PMC7192366,,10.1002/14651858.CD011459.pub2
32348223,Current Status of Drug Targets and Emerging Therapeutic Strategies in the Management of Alzheimer's Disease,"Ghosh S, Durgvanshi S, Agarwal S, Raghunath M, Sinha JK.",Curr Neuropharmacol. 2020;18(9):883-903. doi: 10.2174/1570159X18666200429011823.,Ghosh S,Curr Neuropharmacol,2020,30-04-2020,PMC7569315,,10.2174/1570159X18666200429011823
32347461,Immunotherapies for Aging-Related Neurodegenerative Diseases-Emerging Perspectives and New Targets,"Kwon S, Iba M, Kim C, Masliah E.",Neurotherapeutics. 2020 Jul;17(3):935-954. doi: 10.1007/s13311-020-00853-2.,Kwon S,Neurotherapeutics,2020,30-04-2020,PMC7222955,,10.1007/s13311-020-00853-2
32340037,Benefits and Harms of Prescription Drugs and Supplements for Treatment of Clinical Alzheimer-Type Dementia,"Fink HA, Linskens EJ, MacDonald R, Silverman PC, McCarten JR, Talley KMC, Forte ML, Desai PJ, Nelson VA, Miller MA, Hemmy LS, Brasure M, Taylor BC, Ng W, Ouellette JM, Sheets KM, Wilt TJ, Butler M.",Ann Intern Med. 2020 May 19;172(10):656-668. doi: 10.7326/M19-3887. Epub 2020 Apr 28.,Fink HA,Ann Intern Med,2020,28-04-2020,,,10.7326/M19-3887
32337238,Relationship between Surgery under General Anesthesia and the Development of Dementia: A Systematic Review and Meta-Analysis,"Lee JJ, Choi GJ, Kang H, Baek CW, Jung YH, Shin HY, Park YH, Woo YC.",Biomed Res Int. 2020 Apr 2;2020:3234013. doi: 10.1155/2020/3234013. eCollection 2020.,Lee JJ,Biomed Res Int,2020,28-04-2020,PMC7165327,,10.1155/2020/3234013
32336738,A systematic review on anti-Alzheimer's disease activity of prescription Kangen-karyu,"Paudel P, Park CH, Jung HA, Yokozawa T, Choi JS.",Drug Discov Ther. 2020 May 6;14(2):61-66. doi: 10.5582/ddt.2020.03013. Epub 2020 Apr 24.,Paudel P,Drug Discov Ther,2020,28-04-2020,,,10.5582/ddt.2020.03013
32310162,Brain Perfusion Change in Patients with Mild Cognitive Impairment After 12 Months of Aerobic Exercise Training,"Thomas BP, Tarumi T, Sheng M, Tseng B, Womack KB, Cullum CM, Rypma B, Zhang R, Lu H.",J Alzheimers Dis. 2020;75(2):617-631. doi: 10.3233/JAD-190977.,Thomas BP,J Alzheimers Dis,2020,21-04-2020,PMC8062932,NIHMS1690389,10.3233/JAD-190977
32308807,Effects of Plant and Animal Natural Products on Mitophagy,"Shakeri F, Bianconi V, Pirro M, Sahebkar A.",Oxid Med Cell Longev. 2020 Mar 10;2020:6969402. doi: 10.1155/2020/6969402. eCollection 2020.,Shakeri F,Oxid Med Cell Longev,2020,21-04-2020,PMC7086453,,10.1155/2020/6969402
32308012,Advance Care Planning for African American Caregivers of Relatives With Dementias: Cluster Randomized Controlled Trial,"Bonner GJ, Freels S, Ferrans C, Steffen A, Suarez ML, Dancy BL, Watkins YJ, Collinge W, Hart AS, Aggarwal NT, Wilkie DJ.",Am J Hosp Palliat Care. 2021 Jun;38(6):547-556. doi: 10.1177/1049909120916127. Epub 2020 Apr 20.,Bonner GJ,Am J Hosp Palliat Care,2021,21-04-2020,PMC8443116,NIHMS1691554,10.1177/1049909120916127
32305689,"Cathepsin B in neurodegeneration of Alzheimer's disease, traumatic brain injury, and related brain disorders","Hook V, Yoon M, Mosier C, Ito G, Podvin S, Head BP, Rissman R, O'Donoghue AJ, Hook G.",Biochim Biophys Acta Proteins Proteom. 2020 Aug;1868(8):140428. doi: 10.1016/j.bbapap.2020.140428. Epub 2020 Apr 17.,Hook V,Biochim Biophys Acta Proteins Proteom,2020,20-04-2020,PMC7261628,NIHMS1588262,10.1016/j.bbapap.2020.140428
32301049,"Applying Antibodies Inside Cells: Principles and Recent Advances in Neurobiology, Virology and Oncology","Zhang C, Ötjengerdes RM, Roewe J, Mejias R, Marschall ALJ.",BioDrugs. 2020 Aug;34(4):435-462. doi: 10.1007/s40259-020-00419-w.,Zhang C,BioDrugs,2020,18-04-2020,PMC7391400,,10.1007/s40259-020-00419-w
32300799,"Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial","Kim CS, Cha L, Sim M, Jung S, Chun WY, Baik HW, Shin DM.",J Gerontol A Biol Sci Med Sci. 2021 Jan 1;76(1):32-40. doi: 10.1093/gerona/glaa090.,Kim CS,J Gerontol A Biol Sci Med Sci,2021,18-04-2020,PMC7861012,,10.1093/gerona/glaa090
32293314,The ResidentialCare Transition Module: a single-blinded randomized controlled evaluation of a telehealth support intervention for family caregivers of persons with dementia living in residential long-term care,"Gaugler JE, Statz TL, Birkeland RW, Louwagie KW, Peterson CM, Zmora R, Emery A, McCarron HR, Hepburn K, Whitlatch CJ, Mittelman MS, Roth DL.",BMC Geriatr. 2020 Apr 15;20(1):133. doi: 10.1186/s12877-020-01542-7.,Gaugler JE,BMC Geriatr,2020,16-04-2020,PMC7158110,,10.1186/s12877-020-01542-7
32291802,A pilot randomized controlled trial of hearing aids to improve mood and cognition in older adults,"Brewster KK, Pavlicova M, Stein A, Chen M, Chen C, Brown PJ, Roose SP, Kim AH, Golub JS, Brickman A, Galatioto J, Kuhlmey M, Rutherford BR.",Int J Geriatr Psychiatry. 2020 Aug;35(8):842-850. doi: 10.1002/gps.5311. Epub 2020 Apr 23.,Brewster KK,Int J Geriatr Psychiatry,2020,16-04-2020,PMC7656495,NIHMS1642434,10.1002/gps.5311
32290675,Alzheimer Drug Trials: Combination of Safe and Efficacious Biologicals to Break the Amyloidosis-Neuroinflammation Vicious Cycle,"Bartfai T, Lees GV.",ASN Neuro. 2020 Jan-Dec;12:1759091420918557. doi: 10.1177/1759091420918557.,Bartfai T,ASN Neuro,2020,16-04-2020,PMC7157973,,10.1177/1759091420918557
32285176,"Microbial acetylcholinesterase inhibitors for Alzheimer's therapy: recent trends on extraction, detection, irradiation-assisted production improvement and nano-structured drug delivery","Zaki AG, El-Sayed ER, Abd Elkodous M, El-Sayyad GS.",Appl Microbiol Biotechnol. 2020 Jun;104(11):4717-4735. doi: 10.1007/s00253-020-10560-9. Epub 2020 Apr 13.,Zaki AG,Appl Microbiol Biotechnol,2020,15-04-2020,PMC7223626,,10.1007/s00253-020-10560-9
32284421,Noninvasive hippocampal blood-brain barrier opening in Alzheimer's disease with focused ultrasound,"Rezai AR, Ranjan M, D'Haese PF, Haut MW, Carpenter J, Najib U, Mehta RI, Chazen JL, Zibly Z, Yates JR, Hodder SL, Kaplitt M.",Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9180-9182. doi: 10.1073/pnas.2002571117. Epub 2020 Apr 13.,Rezai AR,Proc Natl Acad Sci U S A,2020,15-04-2020,PMC7196825,,10.1073/pnas.2002571117
32283762,Dietary Supplementation with Curcumin Reduce Circulating Levels of Glycogen Synthase Kinase-3β and Islet Amyloid Polypeptide in Adults with High Risk of Type 2 Diabetes and Alzheimer's Disease,"Thota RN, Rosato JI, Dias CB, Burrows TL, Martins RN, Garg ML.",Nutrients. 2020 Apr 9;12(4):1032. doi: 10.3390/nu12041032.,Thota RN,Nutrients,2020,15-04-2020,PMC7230780,,10.3390/nu12041032
32281303,Quantitative amyloid PET in Alzheimer's disease: the AMYPAD prognostic and natural history study,"Lopes Alves I, Collij LE, Altomare D, Frisoni GB, Saint-Aubert L, Payoux P, Kivipelto M, Jessen F, Drzezga A, Leeuwis A, Wink AM, Visser PJ, van Berckel BNM, Scheltens P, Gray KR, Wolz R, Stephens A, Gismondi R, Buckely C, Gispert JD, Schmidt M, Ford L, Ritchie C, Farrar G, Barkhof F, Molinuevo JL; AMYPAD Consortium.",Alzheimers Dement. 2020 May;16(5):750-758. doi: 10.1002/alz.12069. Epub 2020 Apr 12.,Lopes Alves I,Alzheimers Dement,2020,14-04-2020,PMC7984341,,10.1002/alz.12069
32280093,Impact of 3-Day Combined Anodal Transcranial Direct Current Stimulation-Visuospatial Training on Object-Location Memory in Healthy Older Adults and Patients with Mild Cognitive Impairment,"de Sousa AVC, Grittner U, Rujescu D, Külzow N, Flöel A.",J Alzheimers Dis. 2020;75(1):223-244. doi: 10.3233/JAD-191234.,de Sousa AVC,J Alzheimers Dis,2020,14-04-2020,PMC7306891,,10.3233/JAD-191234
32280092,"Ca:Mg Ratio, APOE Cytosine Modifications, and Cognitive Function: Results from a Randomized Trial","Zhu X, Borenstein AR, Zheng Y, Zhang W, Seidner DL, Ness R, Murff HJ, Li B, Shrubsole MJ, Yu C, Hou L, Dai Q.",J Alzheimers Dis. 2020;75(1):85-98. doi: 10.3233/JAD-191223.,Zhu X,J Alzheimers Dis,2020,14-04-2020,PMC7737669,NIHMS1648781,10.3233/JAD-191223
32280091,Use of Immersive Virtual Reality in the Assessment and Treatment of Alzheimer's Disease: A Systematic Review,"Clay F, Howett D, FitzGerald J, Fletcher P, Chan D, Price A.",J Alzheimers Dis. 2020;75(1):23-43. doi: 10.3233/JAD-191218.,Clay F,J Alzheimers Dis,2020,14-04-2020,PMC7306888,,10.3233/JAD-191218
32280089,Concentration-Dependent Activity of Hydromethylthionine on Clinical Decline and Brain Atrophy in a Randomized Controlled Trial in Behavioral Variant Frontotemporal Dementia,"Shiells H, Schelter BO, Bentham P, Baddeley TC, Rubino CM, Ganesan H, Hammel J, Vuksanovic V, Staff RT, Murray AD, Bracoud L, Wischik DJ, Riedel G, Gauthier S, Jia J, Moebius HJ, Hardlund J, Kipps CM, Kook K, Storey JMD, Harrington CR, Wischik CM.",J Alzheimers Dis. 2020;75(2):501-519. doi: 10.3233/JAD-191173.,Shiells H,J Alzheimers Dis,2020,14-04-2020,PMC7306898,,10.3233/JAD-191173
32279541,Effectiveness of Dementia Care Mapping™ to reduce agitation in care home residents with dementia: an open-cohort cluster randomised controlled trial,"Surr CA, Holloway I, Walwyn REA, Griffiths AW, Meads D, Martin A, Kelley R, Ballard C, Fossey J, Burnley N, Chenoweth L, Creese B, Downs M, Garrod L, Graham EH, Lilley-Kelly A, McDermid J, McLellan V, Millard H, Perfect D, Robinson L, Robinson O, Shoesmith E, Siddiqi N, Stokes G, Wallace D, Farrin AJ.",Aging Ment Health. 2021 Aug;25(8):1410-1423. doi: 10.1080/13607863.2020.1745144. Epub 2020 Apr 13.,Surr CA,Aging Ment Health,2021,14-04-2020,,,10.1080/13607863.2020.1745144
32272780,Carnosine as a Possible Drug for Zinc-Induced Neurotoxicity and Vascular Dementia,"Kawahara M, Sadakane Y, Mizuno K, Kato-Negishi M, Tanaka KI.",Int J Mol Sci. 2020 Apr 7;21(7):2570. doi: 10.3390/ijms21072570.,Kawahara M,Int J Mol Sci,2020,11-04-2020,PMC7177235,,10.3390/ijms21072570
32266160,Fecal Microbiota Transplantation in Neurological Disorders,"Vendrik KEW, Ooijevaar RE, de Jong PRC, Laman JD, van Oosten BW, van Hilten JJ, Ducarmon QR, Keller JJ, Kuijper EJ, Contarino MF.",Front Cell Infect Microbiol. 2020 Mar 24;10:98. doi: 10.3389/fcimb.2020.00098. eCollection 2020.,Vendrik KEW,Front Cell Infect Microbiol,2020,09-04-2020,PMC7105733,,10.3389/fcimb.2020.00098
32264890,Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases,"Wu YY, Kuo HC.",J Biomed Sci. 2020 Apr 7;27(1):49. doi: 10.1186/s12929-020-00636-z.,Wu YY,J Biomed Sci,2020,09-04-2020,PMC7140545,,10.1186/s12929-020-00636-z
32260305,Lipids Nutrients in Parkinson and Alzheimer's Diseases: Cell Death and Cytoprotection,"Nury T, Lizard G, Vejux A.",Int J Mol Sci. 2020 Apr 3;21(7):2501. doi: 10.3390/ijms21072501.,Nury T,Int J Mol Sci,2020,09-04-2020,PMC7178281,,10.3390/ijms21072501
32251378,Biomarkers for Alzheimer's disease-preparing for a new era of disease-modifying therapies,"Zetterberg H, Bendlin BB.",Mol Psychiatry. 2021 Jan;26(1):296-308. doi: 10.1038/s41380-020-0721-9. Epub 2020 Apr 6.,Zetterberg H,Mol Psychiatry,2021,07-04-2020,PMC8172244,NIHMS1700789,10.1038/s41380-020-0721-9
32250301,Increased Cerebrospinal Fluid Amyloid-β During Sleep Deprivation in Healthy Middle-Aged Adults Is Not Due to Stress or Circadian Disruption,"Blattner MS, Panigrahi SK, Toedebusch CD, Hicks TJ, McLeland JS, Banks IR, Schaibley C, Ovod V, Mawuenyega KG, Bateman RJ, Wardlaw SL, Lucey BP.",J Alzheimers Dis. 2020;75(2):471-482. doi: 10.3233/JAD-191122.,Blattner MS,J Alzheimers Dis,2020,07-04-2020,PMC7246155,NIHMS1580393,10.3233/JAD-191122
32244729,"Gut Microbiota, Its Role in Induction of Alzheimer's Disease Pathology, and Possible Therapeutic Interventions: Special Focus on Anthocyanins","Khan MS, Ikram M, Park JS, Park TJ, Kim MO.",Cells. 2020 Apr 1;9(4):853. doi: 10.3390/cells9040853.,Khan MS,Cells,2020,05-04-2020,PMC7226756,,10.3390/cells9040853
32244496,Role of Vitamin D in Preventing and Treating Selected Extraskeletal Diseases-An Umbrella Review,"Maretzke F, Bechthold A, Egert S, Ernst JB, Melo van Lent D, Pilz S, Reichrath J, Stangl GI, Stehle P, Volkert D, Wagner M, Waizenegger J, Zittermann A, Linseisen J.",Nutrients. 2020 Mar 31;12(4):969. doi: 10.3390/nu12040969.,Maretzke F,Nutrients,2020,05-04-2020,PMC7231149,,10.3390/nu12040969
32230811,"Role of Alcohol Drinking in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis","Peng B, Yang Q, B Joshi R, Liu Y, Akbar M, Song BJ, Zhou S, Wang X.",Int J Mol Sci. 2020 Mar 27;21(7):2316. doi: 10.3390/ijms21072316.,Peng B,Int J Mol Sci,2020,02-04-2020,PMC7177420,,10.3390/ijms21072316
32228108,Army Liposome Formulation (ALF) family of vaccine adjuvants,"Alving CR, Peachman KK, Matyas GR, Rao M, Beck Z.",Expert Rev Vaccines. 2020 Mar;19(3):279-292. doi: 10.1080/14760584.2020.1745636. Epub 2020 Mar 31.,Alving CR,Expert Rev Vaccines,2020,02-04-2020,PMC7412170,NIHMS1608124,10.1080/14760584.2020.1745636
32369312,Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review,"Fink HA, Hemmy LS, Linskens EJ, Silverman PC, MacDonald R, McCarten JR, Talley KMC, Desai PJ, Forte ML, Miller MA, Brasure M, Nelson VA, Taylor BC, Ng W, Ouellette JM, Greer NL, Sheets KM, Wilt TJ, Butler M.",Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Apr. Report No.: 20-EHC003.,Fink HA,Diagnosis and Treatment of Clinical Alzheimer’s-Type Dementia: A Systematic Review,2020,01-04-2020,,,
32338849,"Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT","Howard R, Zubko O, Gray R, Bradley R, Harper E, Kelly L, Pank L, O’Brien J, Fox C, Tabet N, Livingston G, Bentham P, McShane R, Burns A, Ritchie C, Reeves S, Lovestone S, Ballard C, Noble W, Wilcock G, Nilforooshan R.",Southampton (UK): NIHR Journals Library; 2020 Apr.,Howard R,"Minocycline 200 mg or 400 mg versus placebo for mild Alzheimer’s disease: the MADE Phase II, three-arm RCT",2020,01-04-2020,,,10.3310/eme07020
32216870,Dementia Care Mapping™ to reduce agitation in care home residents with dementia: the EPIC cluster RCT,"Surr CA, Holloway I, Walwyn RE, Griffiths AW, Meads D, Kelley R, Martin A, McLellan V, Ballard C, Fossey J, Burnley N, Chenoweth L, Creese B, Downs M, Garrod L, Graham EH, Lilley-Kelley A, McDermid J, Millard H, Perfect D, Robinson L, Robinson O, Shoesmith E, Siddiqi N, Stokes G, Wallace D, Farrin AJ.",Health Technol Assess. 2020 Mar;24(16):1-172. doi: 10.3310/hta24160.,Surr CA,Health Technol Assess,2020,29-03-2020,PMC7132533,,10.3310/hta24160
32215172,Therapeutic Potential of Diosgenin and Its Major Derivatives against Neurological Diseases: Recent Advances,"Cai B, Zhang Y, Wang Z, Xu D, Jia Y, Guan Y, Liao A, Liu G, Chun C, Li J.",Oxid Med Cell Longev. 2020 Mar 6;2020:3153082. doi: 10.1155/2020/3153082. eCollection 2020.,Cai B,Oxid Med Cell Longev,2020,28-03-2020,PMC7079249,,10.1155/2020/3153082
32213642,Randomized placebo-controlled trial of the effects of aspirin on dementia and cognitive decline,"Ryan J, Storey E, Murray AM, Woods RL, Wolfe R, Reid CM, Nelson MR, Chong TTJ, Williamson JD, Ward SA, Lockery JE, Orchard SG, Trevaks R, Kirpach B, Newman AB, Ernst ME, McNeil JJ, Shah RC; ASPREE Investigator Group.",Neurology. 2020 Jul 21;95(3):e320-e331. doi: 10.1212/WNL.0000000000009277. Epub 2020 Mar 25.,Ryan J,Neurology,2020,28-03-2020,PMC7455352,,10.1212/WNL.0000000000009277
32208848,Grapes and their derivatives in modulation of cognitive decline: a critical review of epidemiological and randomized-controlled trials in humans,"Restani P, Fradera U, Ruf JC, Stockley C, Teissedre PL, Biella S, Colombo F, Lorenzo CD.",Crit Rev Food Sci Nutr. 2021;61(4):566-576. doi: 10.1080/10408398.2020.1740644. Epub 2020 Mar 25.,Restani P,Crit Rev Food Sci Nutr,2021,27-03-2020,,,10.1080/10408398.2020.1740644
32204380,The PERK-Dependent Molecular Mechanisms as a Novel Therapeutic Target for Neurodegenerative Diseases,"Rozpędek-Kamińska W, Siwecka N, Wawrzynkiewicz A, Wojtczak R, Pytel D, Diehl JA, Majsterek I.",Int J Mol Sci. 2020 Mar 19;21(6):2108. doi: 10.3390/ijms21062108.,Rozpędek-Kamińska W,Int J Mol Sci,2020,25-03-2020,PMC7139310,,10.3390/ijms21062108
32203086,Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases-focusing on FAAH/MAGL inhibitors,"Ren SY, Wang ZZ, Zhang Y, Chen NH.",Acta Pharmacol Sin. 2020 Oct;41(10):1263-1271. doi: 10.1038/s41401-020-0385-7. Epub 2020 Mar 18.,Ren SY,Acta Pharmacol Sin,2020,24-03-2020,PMC7608191,,10.1038/s41401-020-0385-7
32202623,Pathological Continuum From the Rise in Pulse Pressure to Impaired Neurovascular Coupling and Cognitive Decline,"de Montgolfier O, Thorin-Trescases N, Thorin E.",Am J Hypertens. 2020 Apr 29;33(5):375-390. doi: 10.1093/ajh/hpaa001.,de Montgolfier O,Am J Hypertens,2020,24-03-2020,PMC7188799,,10.1093/ajh/hpaa001
32202593,Association of Sleep-Disordered Breathing With Alzheimer Disease Biomarkers in Community-Dwelling Older Adults: A Secondary Analysis of a Randomized Clinical Trial,"André C, Rehel S, Kuhn E, Landeau B, Moulinet I, Touron E, Ourry V, Le Du G, Mézenge F, Tomadesso C, de Flores R, Bejanin A, Sherif S, Delcroix N, Manrique A, Abbas A, Marchant NL, Lutz A, Klimecki OM, Collette F, Arenaza-Urquijo EM, Poisnel G, Vivien D, Bertran F, de la Sayette V, Chételat G, Rauchs G; Medit-Ageing Research Group.",JAMA Neurol. 2020 Jun 1;77(6):716-724. doi: 10.1001/jamaneurol.2020.0311.,André C,JAMA Neurol,2020,24-03-2020,PMC7091393,,10.1001/jamaneurol.2020.0311
32200394,Impact of Air Pollution and Seasonal Haze on Neurological Conditions,"Rocha II, Narasimhalu K, De Silva DA.",Ann Acad Med Singap. 2020 Jan;49(1):26-36.,Rocha II,Ann Acad Med Singap,2020,23-03-2020,,,
32188096,Upregulation of Neuronal Rheb(S16H) for Hippocampal Protection in the Adult Brain,"Moon GJ, Shin M, Kim SR.",Int J Mol Sci. 2020 Mar 16;21(6):2023. doi: 10.3390/ijms21062023.,Moon GJ,Int J Mol Sci,2020,20-03-2020,PMC7139780,,10.3390/ijms21062023
32183348,Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's Disease,"Tanaka M, Saito S, Inoue T, Satoh-Asahara N, Ihara M.",Int J Mol Sci. 2020 Mar 14;21(6):1992. doi: 10.3390/ijms21061992.,Tanaka M,Int J Mol Sci,2020,19-03-2020,PMC7139812,,10.3390/ijms21061992
32183162,"Curcumin in Health and Diseases: Alzheimer's Disease and Curcumin Analogues, Derivatives, and Hybrids","Chainoglou E, Hadjipavlou-Litina D.",Int J Mol Sci. 2020 Mar 13;21(6):1975. doi: 10.3390/ijms21061975.,Chainoglou E,Int J Mol Sci,2020,19-03-2020,PMC7139886,,10.3390/ijms21061975
32183152,Prevention of Cognitive Decline in Alzheimer's Disease by Novel Antioxidative Supplements,"Tadokoro K, Ohta Y, Inufusa H, Loon AFN, Abe K.",Int J Mol Sci. 2020 Mar 13;21(6):1974. doi: 10.3390/ijms21061974.,Tadokoro K,Int J Mol Sci,2020,19-03-2020,PMC7139972,,10.3390/ijms21061974
32174828,Pimavanserin: A Novel Antipsychotic With Potentials to Address an Unmet Need of Older Adults With Dementia-Related Psychosis,"Yunusa I, El Helou ML, Alsahali S.",Front Pharmacol. 2020 Feb 26;11:87. doi: 10.3389/fphar.2020.00087. eCollection 2020.,Yunusa I,Front Pharmacol,2020,17-03-2020,PMC7054448,,10.3389/fphar.2020.00087
32170673,The Novel Role of PPAR Alpha in the Brain: Promising Target in Therapy of Alzheimer's Disease and Other Neurodegenerative Disorders,"Wójtowicz S, Strosznajder AK, Jeżyna M, Strosznajder JB.",Neurochem Res. 2020 May;45(5):972-988. doi: 10.1007/s11064-020-02993-5. Epub 2020 Mar 13.,Wójtowicz S,Neurochem Res,2020,15-03-2020,PMC7162839,,10.1007/s11064-020-02993-5
32170466,Rational approaches for the design of various GABA modulators and their clinical progression,"Bhagat K, Singh JV, Pagare PP, Kumar N, Sharma A, Kaur G, Kinarivala N, Gandu S, Singh H, Sharma S, Bedi PMS.",Mol Divers. 2021 Feb;25(1):551-601. doi: 10.1007/s11030-020-10068-4. Epub 2020 Mar 13.,Bhagat K,Mol Divers,2021,15-03-2020,PMC8422677,NIHMS1729658,10.1007/s11030-020-10068-4
32169093,"Comparison of Instrumental Activities of Daily Living assessment by face-to-face or telephone interviews: a randomized, crossover study","Dauphinot V, Boublay N, Moutet C, Achi S, Bathsavanis A, Krolak-Salmon P.",Alzheimers Res Ther. 2020 Mar 13;12(1):24. doi: 10.1186/s13195-020-00590-w.,Dauphinot V,Alzheimers Res Ther,2020,15-03-2020,PMC7068883,,10.1186/s13195-020-00590-w
32168835,Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer's Disease,"Uddin MS, Kabir MT, Niaz K, Jeandet P, Clément C, Mathew B, Rauf A, Rengasamy KRR, Sobarzo-Sánchez E, Ashraf GM, Aleya L.",Molecules. 2020 Mar 11;25(6):1267. doi: 10.3390/molecules25061267.,Uddin MS,Molecules,2020,15-03-2020,PMC7143946,,10.3390/molecules25061267
32165850,Current and Future Treatments in Alzheimer Disease: An Update,"Yiannopoulou KG, Papageorgiou SG.",J Cent Nerv Syst Dis. 2020 Feb 29;12:1179573520907397. doi: 10.1177/1179573520907397. eCollection 2020.,Yiannopoulou KG,J Cent Nerv Syst Dis,2020,14-03-2020,PMC7050025,,10.1177/1179573520907397
32165138,Effects of air pollution on the nervous system and its possible role in neurodevelopmental and neurodegenerative disorders,"Costa LG, Cole TB, Dao K, Chang YC, Coburn J, Garrick JM.",Pharmacol Ther. 2020 Jun;210:107523. doi: 10.1016/j.pharmthera.2020.107523. Epub 2020 Mar 9.,Costa LG,Pharmacol Ther,2020,14-03-2020,PMC7245732,NIHMS1582191,10.1016/j.pharmthera.2020.107523
32164678,Let's CHAT (community health approaches to) dementia in Aboriginal and Torres Strait Islander communities: protocol for a stepped wedge cluster randomised controlled trial,"Bradley K, Smith R, Hughson JA, Atkinson D, Bessarab D, Flicker L, Radford K, Smith K, Strivens E, Thompson S, Blackberry I, LoGiudice D.",BMC Health Serv Res. 2020 Mar 12;20(1):208. doi: 10.1186/s12913-020-4985-1.,Bradley K,BMC Health Serv Res,2020,14-03-2020,PMC7069169,,10.1186/s12913-020-4985-1
32159519,Efficacy of a Web App for Cognitive Training (MeMo) Regarding Cognitive and Behavioral Performance in People With Neurocognitive Disorders: Randomized Controlled Trial,"Robert P, Manera V, Derreumaux A, Ferrandez Y Montesino M, Leone E, Fabre R, Bourgeois J.",J Med Internet Res. 2020 Mar 11;22(3):e17167. doi: 10.2196/17167.,Robert P,J Med Internet Res,2020,12-03-2020,PMC7097721,,10.2196/17167
32155996,"Acetylcholinesterase: The ""Hub"" for Neurodegenerative Diseases and Chemical Weapons Convention","Cavalcante SFA, Simas ABC, Barcellos MC, de Oliveira VGM, Sousa RB, Cabral PAM, Kuča K, França TCC.",Biomolecules. 2020 Mar 7;10(3):414. doi: 10.3390/biom10030414.,Cavalcante SFA,Biomolecules,2020,12-03-2020,PMC7175162,,10.3390/biom10030414
32153388,An Updated Review of Randomized Clinical Trials Testing the Improvement of Cognitive Function of Ginkgo biloba Extract in Healthy People and Alzheimer's Patients,"Liu H, Ye M, Guo H.",Front Pharmacol. 2020 Feb 21;10:1688. doi: 10.3389/fphar.2019.01688. eCollection 2019.,Liu H,Front Pharmacol,2020,11-03-2020,PMC7047126,,10.3389/fphar.2019.01688
32139896,"Psychosis in Parkinson's disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges",Waddington JL.,Acta Pharmacol Sin. 2020 Apr;41(4):464-470. doi: 10.1038/s41401-020-0373-y. Epub 2020 Mar 5.,Waddington JL,Acta Pharmacol Sin,2020,07-03-2020,PMC7470778,,10.1038/s41401-020-0373-y
32131911,Managing depressive symptoms in people with mild cognitive impairment and mild dementia with a multicomponent psychotherapy intervention: a randomized controlled trial,"Tonga JB, Šaltytė Benth J, Arnevik EA, Werheid K, Korsnes MS, Ulstein ID.",Int Psychogeriatr. 2021 Mar;33(3):217-231. doi: 10.1017/S1041610220000216. Epub 2020 Mar 5.,Tonga JB,Int Psychogeriatr,2021,06-03-2020,,,10.1017/S1041610220000216
32126838,Postmortem Analysis in a Clinical Trial of AAV2-NGF Gene Therapy for Alzheimer's Disease Identifies a Need for Improved Vector Delivery,"Castle MJ, Baltanás FC, Kovacs I, Nagahara AH, Barba D, Tuszynski MH.",Hum Gene Ther. 2020 Apr;31(7-8):415-422. doi: 10.1089/hum.2019.367. Epub 2020 Mar 30.,Castle MJ,Hum Gene Ther,2020,05-03-2020,PMC7194314,,10.1089/hum.2019.367
32122378,Costs and economic evaluations of Quality Improvement Collaboratives in healthcare: a systematic review,"de la Perrelle L, Radisic G, Cations M, Kaambwa B, Barbery G, Laver K.",BMC Health Serv Res. 2020 Mar 2;20(1):155. doi: 10.1186/s12913-020-4981-5.,de la Perrelle L,BMC Health Serv Res,2020,04-03-2020,PMC7053095,,10.1186/s12913-020-4981-5
32122325,Effects of simultaneous cognitive and aerobic exercise training on dual-task walking performance in healthy older adults: results from a pilot randomized controlled trial,"Raichlen DA, Bharadwaj PK, Nguyen LA, Franchetti MK, Zigman EK, Solorio AR, Alexander GE.",BMC Geriatr. 2020 Mar 2;20(1):83. doi: 10.1186/s12877-020-1484-5.,Raichlen DA,BMC Geriatr,2020,04-03-2020,PMC7052975,,10.1186/s12877-020-1484-5
32121302,An Overview of Crucial Dietary Substances and Their Modes of Action for Prevention of Neurodegenerative Diseases,"Pogačnik L, Ota A, Ulrih NP.",Cells. 2020 Feb 28;9(3):576. doi: 10.3390/cells9030576.,Pogačnik L,Cells,2020,04-03-2020,PMC7140513,,10.3390/cells9030576
32120979,Is There a Future for PPARs in the Treatment of Neuropsychiatric Disorders?,"Tufano M, Pinna G.",Molecules. 2020 Feb 27;25(5):1062. doi: 10.3390/molecules25051062.,Tufano M,Molecules,2020,04-03-2020,PMC7179196,,10.3390/molecules25051062
32119976,"Characterization and preclinical evaluation of the cGMP grade DNA based vaccine, AV-1959D to enter the first-in-human clinical trials","Petrushina I, Hovakimyan A, Harahap-Carrillo IS, Davtyan H, Antonyan T, Chailyan G, Kazarian K, Antonenko M, Jullienne A, Hamer MM, Obenaus A, King O, Zagorski K, Blurton-Jones M, Cribbs DH, Lander H, Ghochikyan A, Agadjanyan MG.",Neurobiol Dis. 2020 Jun;139:104823. doi: 10.1016/j.nbd.2020.104823. Epub 2020 Feb 28.,Petrushina I,Neurobiol Dis,2020,03-03-2020,PMC8772258,NIHMS1765827,10.1016/j.nbd.2020.104823
32116250,"Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial","Tomaszewski N, He X, Solomon V, Lee M, Mack WJ, Quinn JF, Braskie MN, Yassine HN.",J Alzheimers Dis. 2020;74(3):975-990. doi: 10.3233/JAD-191017.,Tomaszewski N,J Alzheimers Dis,2020,03-03-2020,PMC7156328,NIHMS1572433,10.3233/JAD-191017
32113032,Advances in the In vitro and In vivo pharmacology of Alpha4beta2 nicotinic receptor positive allosteric modulators,"Wilkerson JL, Deba F, Crowley ML, Hamouda AK, McMahon LR.",Neuropharmacology. 2020 May 15;168:108008. doi: 10.1016/j.neuropharm.2020.108008. Epub 2020 Feb 12.,Wilkerson JL,Neuropharmacology,2020,01-03-2020,PMC7113117,NIHMS1570844,10.1016/j.neuropharm.2020.108008
32108738,One Year of Continuous Positive Airway Pressure Adherence Improves Cognition in Older Adults With Mild Apnea and Mild Cognitive Impairment,"Wang Y, Cheng C, Moelter S, Fuentecilla JL, Kincheloe K, Lozano AJ, Carter P, Gooneratne N, Richards KC.",Nurs Res. 2020 Mar/Apr;69(2):157-164. doi: 10.1097/NNR.0000000000000420.,Wang Y,Nurs Res,2020,29-02-2020,PMC7212768,NIHMS1549587,10.1097/NNR.0000000000000420
32107741,Psychotropic Drug-Associated Pneumonia in Older Adults,"Rajamaki B, Hartikainen S, Tolppanen AM.",Drugs Aging. 2020 Apr;37(4):241-261. doi: 10.1007/s40266-020-00754-1.,Rajamaki B,Drugs Aging,2020,29-02-2020,PMC7096389,,10.1007/s40266-020-00754-1
32098280,"PET Radiopharmaceuticals for Alzheimer's Disease and Parkinson's Disease Diagnosis, the Current and Future Landscape","Uzuegbunam BC, Librizzi D, Hooshyar Yousefi B.",Molecules. 2020 Feb 21;25(4):977. doi: 10.3390/molecules25040977.,Uzuegbunam BC,Molecules,2020,27-02-2020,PMC7070523,,10.3390/molecules25040977
32098256,CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration,"Carlini V, Verduci I, Cianci F, Cannavale G, Fenoglio C, Galimberti D, Mazzanti M.",Int J Mol Sci. 2020 Feb 21;21(4):1484. doi: 10.3390/ijms21041484.,Carlini V,Int J Mol Sci,2020,27-02-2020,PMC7073046,,10.3390/ijms21041484
32096539,Why a d-β-hydroxybutyrate monoester?,"Soto-Mota A, Norwitz NG, Clarke K.",Biochem Soc Trans. 2020 Feb 28;48(1):51-59. doi: 10.1042/BST20190240.,Soto-Mota A,Biochem Soc Trans,2020,26-02-2020,PMC7065286,,10.1042/BST20190240
32094485,MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice,"Sastre-Garriga J, Pareto D, Battaglini M, Rocca MA, Ciccarelli O, Enzinger C, Wuerfel J, Sormani MP, Barkhof F, Yousry TA, De Stefano N, Tintoré M, Filippi M, Gasperini C, Kappos L, Río J, Frederiksen J, Palace J, Vrenken H, Montalban X, Rovira À; MAGNIMS study group.",Nat Rev Neurol. 2020 Mar;16(3):171-182. doi: 10.1038/s41582-020-0314-x. Epub 2020 Feb 24.,Sastre-Garriga J,Nat Rev Neurol,2020,26-02-2020,PMC7054210,,10.1038/s41582-020-0314-x
32085610,Safety and Neuroprotective Efficacy of Palm Oil and Tocotrienol-Rich Fraction from Palm Oil: A Systematic Review,"Ismail M, Alsalahi A, Imam MU, Ooi J, Khaza'ai H, Aljaberi MA, Shamsudin MN, Idrus Z.",Nutrients. 2020 Feb 18;12(2):521. doi: 10.3390/nu12020521.,Ismail M,Nutrients,2020,23-02-2020,PMC7071496,,10.3390/nu12020521
32083095,Hypertension and the Risk of Dementia,Sierra C.,Front Cardiovasc Med. 2020 Jan 31;7:5. doi: 10.3389/fcvm.2020.00005. eCollection 2020.,Sierra C,Front Cardiovasc Med,2020,22-02-2020,PMC7005583,,10.3389/fcvm.2020.00005
32082137,Low-Density Lipoprotein Cholesterol and Alzheimer's Disease: A Systematic Review and Meta-Analysis,"Zhou Z, Liang Y, Zhang X, Xu J, Lin J, Zhang R, Kang K, Liu C, Zhao C, Zhao M.",Front Aging Neurosci. 2020 Jan 30;12:5. doi: 10.3389/fnagi.2020.00005. eCollection 2020.,Zhou Z,Front Aging Neurosci,2020,22-02-2020,PMC7002548,,10.3389/fnagi.2020.00005
32077057,Double-Blind Placebo-Controlled Pilot Investigation of the Safety of a Single Dose of Rapid-Acting Intranasal Insulin in Down Syndrome,"Rosenbloom M, Barclay T, Johnsen J, Erickson L, Svitak A, Pyle M, Frey W, Hanson LR.",Drugs R D. 2020 Mar;20(1):11-15. doi: 10.1007/s40268-020-00296-2.,Rosenbloom M,Drugs R D,2020,21-02-2020,PMC7067723,,10.1007/s40268-020-00296-2
32074412,Early Improvements of Individual Symptoms With Antipsychotics Predict Subsequent Treatment Response of Neuropsychiatric Symptoms in Alzheimer's Disease: A Re-Analysis of the CATIE-AD Study,"Nagata T, Shinagawa S, Yoshida K, Noda Y, Shigeta M, Mimura M, Nakajima S.",J Clin Psychiatry. 2020 Feb 11;81(2):19m12961. doi: 10.4088/JCP.19m12961.,Nagata T,J Clin Psychiatry,2020,20-02-2020,,,10.4088/JCP.19m12961
32072866,Effects of a Video-based Intervention on Caregiver Confidence for Managing Dementia Care Challenges: Findings from the FamTechCare Clinical Trial,"Shaw CA, Williams KN, Perkhounkova Y, Hein M, Coleman CK.",Clin Gerontol. 2020 Oct-Dec;43(5):508-517. doi: 10.1080/07317115.2020.1729917. Epub 2020 Feb 19.,Shaw CA,Clin Gerontol,2020,20-02-2020,PMC7434650,NIHMS1563810,10.1080/07317115.2020.1729917
32070025,Healthy Effects of Plant Polyphenols: Molecular Mechanisms,"Leri M, Scuto M, Ontario ML, Calabrese V, Calabrese EJ, Bucciantini M, Stefani M.",Int J Mol Sci. 2020 Feb 13;21(4):1250. doi: 10.3390/ijms21041250.,Leri M,Int J Mol Sci,2020,20-02-2020,PMC7072974,,10.3390/ijms21041250
32066716,Do nonpharmacological interventions prevent cognitive decline? a systematic review and meta-analysis,"Yao S, Liu Y, Zheng X, Zhang Y, Cui S, Tang C, Lu L, Xu N.",Transl Psychiatry. 2020 Jan 21;10(1):19. doi: 10.1038/s41398-020-0690-4.,Yao S,Transl Psychiatry,2020,19-02-2020,PMC7026127,,10.1038/s41398-020-0690-4
32063919,Heterogeneous Multi-Layered Network Model for Omics Data Integration and Analysis,"Lee B, Zhang S, Poleksic A, Xie L.",Front Genet. 2020 Jan 28;10:1381. doi: 10.3389/fgene.2019.01381. eCollection 2019.,Lee B,Front Genet,2020,18-02-2020,PMC6997577,,10.3389/fgene.2019.01381
32062613,"Efficacy of probiotics on cognition, and biomarkers of inflammation and oxidative stress in adults with Alzheimer's disease or mild cognitive impairment - a meta-analysis of randomized controlled trials","Den H, Dong X, Chen M, Zou Z.",Aging (Albany NY). 2020 Feb 15;12(4):4010-4039. doi: 10.18632/aging.102810. Epub 2020 Feb 15.,Den H,Aging (Albany NY),2020,17-02-2020,PMC7066922,,10.18632/aging.102810
32057125,Sleep Deprivation Affects Tau Phosphorylation in Human Cerebrospinal Fluid,"Barthélemy NR, Liu H, Lu W, Kotzbauer PT, Bateman RJ, Lucey BP.",Ann Neurol. 2020 May;87(5):700-709. doi: 10.1002/ana.25702. Epub 2020 Feb 27.,Barthélemy NR,Ann Neurol,2020,15-02-2020,PMC7289061,NIHMS1566002,10.1002/ana.25702
32054965,Rejuvenating the blood and bone marrow to slow aging-associated cognitive decline and Alzheimer's disease,"Kang S, Moser VA, Svendsen CN, Goodridge HS.",Commun Biol. 2020 Feb 13;3(1):69. doi: 10.1038/s42003-020-0797-4.,Kang S,Commun Biol,2020,15-02-2020,PMC7018752,,10.1038/s42003-020-0797-4
32054507,Tianzhi granule improves cognition and BPSD of vascular dementia: a randomized controlled trial,"Shi J, Wei M, Ni J, Sun F, Sun L, Wang J, Yu T, Wang K, Lv P, Wang Y, Zhang Y, Gao X, Gao X, Luo B, Mao S, Zhang B, Ren X, Yu F, Hu W, Yin P, Wu N, Liu X, Bi Q, Wang Y, Tian J; CHASE Study Group.",J Transl Med. 2020 Feb 13;18(1):76. doi: 10.1186/s12967-020-02232-z.,Shi J,J Transl Med,2020,15-02-2020,PMC7017567,,10.1186/s12967-020-02232-z
32043310,"US, EU, and Japanese Regulatory Guidelines for Development of Drugs for Treatment of Alzheimer's Disease: Implications for Global Drug Development","Morant AV, Vestergaard HT, Lassen AB, Navikas V.",Clin Transl Sci. 2020 Jul;13(4):652-664. doi: 10.1111/cts.12755. Epub 2020 Mar 3.,Morant AV,Clin Transl Sci,2020,12-02-2020,PMC7359941,,10.1111/cts.12755
32041110,Current Biomedical Use of Copper Chelation Therapy,"Baldari S, Di Rocco G, Toietta G.",Int J Mol Sci. 2020 Feb 6;21(3):1069. doi: 10.3390/ijms21031069.,Baldari S,Int J Mol Sci,2020,12-02-2020,PMC7037088,,10.3390/ijms21031069
32040141,Comparison of Integrated Outpatient Palliative Care With Standard Care in Patients With Parkinson Disease and Related Disorders: A Randomized Clinical Trial,"Kluger BM, Miyasaki J, Katz M, Galifianakis N, Hall K, Pantilat S, Khan R, Friedman C, Cernik W, Goto Y, Long J, Fairclough D, Sillau S, Kutner JS.",JAMA Neurol. 2020 May 1;77(5):551-560. doi: 10.1001/jamaneurol.2019.4992.,Kluger BM,JAMA Neurol,2020,11-02-2020,PMC7042842,,10.1001/jamaneurol.2019.4992
32039840,Individual Differences in the Effects of Physical Activity on Cognitive Function in People with Mild to Moderate Dementia,"Uijen IL, Aaronson JA, Karssemeijer EGA, Olde Rikkert MGM, Kessels RPC.",J Alzheimers Dis. 2020;74(2):435-439. doi: 10.3233/JAD-190606.,Uijen IL,J Alzheimers Dis,2020,11-02-2020,PMC7175929,,10.3233/JAD-190606
32037737,Examination of the influence of cedar fragrance on cognitive function and behavioral and psychological symptoms of dementia in Alzheimer type dementia,"Takahashi Y, Shindo S, Kanbayashi T, Takeshima M, Imanishi A, Mishima K.",Neuropsychopharmacol Rep. 2020 Mar;40(1):10-15. doi: 10.1002/npr2.12096. Epub 2020 Feb 9.,Takahashi Y,Neuropsychopharmacol Rep,2020,11-02-2020,PMC7292212,,10.1002/npr2.12096
32032732,Influence of Western diet and APOE genotype on Alzheimer's disease risk,Sullivan PM.,Neurobiol Dis. 2020 May;138:104790. doi: 10.1016/j.nbd.2020.104790. Epub 2020 Feb 4.,Sullivan PM,Neurobiol Dis,2020,08-02-2020,,,10.1016/j.nbd.2020.104790
32020875,Therapeutic use of cannabis and cannabinoids: an evidence mapping and appraisal of systematic reviews,"Montero-Oleas N, Arevalo-Rodriguez I, Nuñez-González S, Viteri-García A, Simancas-Racines D.",BMC Complement Med Ther. 2020 Jan 15;20(1):12. doi: 10.1186/s12906-019-2803-2.,Montero-Oleas N,BMC Complement Med Ther,2020,06-02-2020,PMC7076827,,10.1186/s12906-019-2803-2
32006534,Glycogen synthase kinase-3 signaling in Alzheimer's disease,"Lauretti E, Dincer O, Praticò D.",Biochim Biophys Acta Mol Cell Res. 2020 May;1867(5):118664. doi: 10.1016/j.bbamcr.2020.118664. Epub 2020 Jan 30.,Lauretti E,Biochim Biophys Acta Mol Cell Res,2020,02-02-2020,PMC7047718,NIHMS1556839,10.1016/j.bbamcr.2020.118664
32129963,Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force,"Patnode CD, Perdue LA, Rossom RC, Rushkin MC, Redmond N, Thomas RG, Lin JS.",Rockville (MD): Agency for Healthcare Research and Quality (US); 2020 Feb. Report No.: 19-05257-EF-1.,Patnode CD,Screening for Cognitive Impairment in Older Adults: An Evidence Update for the U.S. Preventive Services Task Force,2020,01-02-2020,,,
31981470,"""Amyloid-beta accumulation cycle"" as a prevention and/or therapy target for Alzheimer's disease","Rao CV, Asch AS, Carr DJJ, Yamada HY.",Aging Cell. 2020 Mar;19(3):e13109. doi: 10.1111/acel.13109. Epub 2020 Jan 25.,Rao CV,Aging Cell,2020,26-01-2020,PMC7059149,,10.1111/acel.13109
31979283,"Combined Treatment with Two Water Extracts of Eleutherococcus senticosus Leaf and Rhizome of Drynaria fortunei Enhances Cognitive Function: A Placebo-Controlled, Randomized, Double-Blind Study in Healthy Adults","Tohda C, Matsui M, Inada Y, Yang X, Kuboyama T, Kimbara Y, Watari H.",Nutrients. 2020 Jan 23;12(2):303. doi: 10.3390/nu12020303.,Tohda C,Nutrients,2020,26-01-2020,PMC7070741,,10.3390/nu12020303
31978826,Hippocampal plasticity underpins long-term cognitive gains from resistance exercise in MCI,"Broadhouse KM, Singh MF, Suo C, Gates N, Wen W, Brodaty H, Jain N, Wilson GC, Meiklejohn J, Singh N, Baune BT, Baker M, Foroughi N, Wang Y, Kochan N, Ashton K, Brown M, Li Z, Mavros Y, Sachdev PS, Valenzuela MJ.",Neuroimage Clin. 2020;25:102182. doi: 10.1016/j.nicl.2020.102182. Epub 2020 Jan 14.,Broadhouse KM,Neuroimage Clin,2020,25-01-2020,PMC6974789,,10.1016/j.nicl.2020.102182
31978378,Development of novel phosphodiesterase 5 inhibitors for the therapy of Alzheimer's disease,"Zuccarello E, Acquarone E, Calcagno E, Argyrousi EK, Deng SX, Landry DW, Arancio O, Fiorito J.",Biochem Pharmacol. 2020 Jun;176:113818. doi: 10.1016/j.bcp.2020.113818. Epub 2020 Jan 21.,Zuccarello E,Biochem Pharmacol,2020,25-01-2020,PMC7263960,NIHMS1558543,10.1016/j.bcp.2020.113818
31977846,Danggui-Shaoyao-San for dementia: A PRISMA-compliant systematic review and meta-analysis,"Kim Y, Cho SH.",Medicine (Baltimore). 2020 Jan;99(4):e18507. doi: 10.1097/MD.0000000000018507.,Kim Y,Medicine (Baltimore),2020,25-01-2020,PMC7004764,,10.1097/MD.0000000000018507
31976839,The Critical Period for Neuroprotection by Estrogen Replacement Therapy and the Potential Underlying Mechanisms,"Guo H, Liu M, Zhang L, Wang L, Hou W, Ma Y, Ma Y.",Curr Neuropharmacol. 2020;18(6):485-500. doi: 10.2174/1570159X18666200123165652.,Guo H,Curr Neuropharmacol,2020,25-01-2020,PMC7457406,,10.2174/1570159X18666200123165652
31969201,[(18)F]FDDNP PET binding predicts change in executive function in a pilot clinical trial of geriatric depression,"Krause-Sorio B, Siddarth P, Laird KT, Ercoli L, Narr K, Barrio JR, Small G, Lavretsky H.",Int Psychogeriatr. 2021 Feb;33(2):149-156. doi: 10.1017/S1041610219002047. Epub 2020 Jan 23.,Krause-Sorio B,Int Psychogeriatr,2021,24-01-2020,PMC7375908,NIHMS1545934,10.1017/S1041610219002047
31969177,Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease,"Yoshida K, Moein A, Bittner T, Ostrowitzki S, Lin H, Honigberg L, Jin JY, Quartino A.",Alzheimers Res Ther. 2020 Jan 22;12(1):16. doi: 10.1186/s13195-020-0580-2.,Yoshida K,Alzheimers Res Ther,2020,24-01-2020,PMC6977279,,10.1186/s13195-020-0580-2
31964153,NRF2 as a Therapeutic Target in Neurodegenerative Diseases,"Brandes MS, Gray NE.",ASN Neuro. 2020 Jan-Dec;12:1759091419899782. doi: 10.1177/1759091419899782.,Brandes MS,ASN Neuro,2020,23-01-2020,PMC6977098,,10.1177/1759091419899782
31962288,Approaches to develop therapeutics to treat frontotemporal dementia,"Elia LP, Reisine T, Alijagic A, Finkbeiner S.",Neuropharmacology. 2020 Apr;166:107948. doi: 10.1016/j.neuropharm.2020.107948. Epub 2020 Jan 8.,Elia LP,Neuropharmacology,2020,22-01-2020,PMC8101984,NIHMS1550408,10.1016/j.neuropharm.2020.107948
31961762,Elevated cerebrospinal fluid sodium in hypertensive human subjects with a family history of Alzheimer's disease,"Souza LAC, Trebak F, Kumar V, Satou R, Kehoe PG, Yang W, Wharton W, Feng Earley Y.",Physiol Genomics. 2020 Mar 1;52(3):133-142. doi: 10.1152/physiolgenomics.00093.2019. Epub 2020 Jan 21.,Souza LAC,Physiol Genomics,2020,22-01-2020,PMC7099411,,10.1152/physiolgenomics.00093.2019
31959733,An Altered Relationship between Soluble TREM2 and Inflammatory Markers in Young Adults with Down Syndrome: A Preliminary Report,"Weber GE, Koenig KA, Khrestian M, Shao Y, Tuason ED, Gramm M, Lal D, Leverenz JB, Bekris LM.",J Immunol. 2020 Mar 1;204(5):1111-1118. doi: 10.4049/jimmunol.1901166. Epub 2020 Jan 20.,Weber GE,J Immunol,2020,22-01-2020,PMC7033027,NIHMS1547076,10.4049/jimmunol.1901166
31952362,miRNAs as Influencers of Cell-Cell Communication in Tumor Microenvironment,"Conti I, Varano G, Simioni C, Laface I, Milani D, Rimondi E, Neri LM.",Cells. 2020 Jan 15;9(1):220. doi: 10.3390/cells9010220.,Conti I,Cells,2020,19-01-2020,PMC7016744,,10.3390/cells9010220
31949087,Risk of hemorrhagic and ischemic stroke in patients with Alzheimer disease: A synthesis of the literature,"Waziry R, Chibnik LB, Bos D, Ikram MK, Hofman A.",Neurology. 2020 Feb 11;94(6):265-272. doi: 10.1212/WNL.0000000000008924. Epub 2020 Jan 16.,Waziry R,Neurology,2020,18-01-2020,PMC7136067,,10.1212/WNL.0000000000008924
31944580,Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial,"Herring WJ, Ceesay P, Snyder E, Bliwise D, Budd K, Hutzelmann J, Stevens J, Lines C, Michelson D.",Alzheimers Dement. 2020 Mar;16(3):541-551. doi: 10.1002/alz.12035. Epub 2020 Jan 15.,Herring WJ,Alzheimers Dement,2020,17-01-2020,PMC7984350,,10.1002/alz.12035
31942969,Falls Risk in Relation to Activity Exposure in High-Risk Older Adults,"Del Din S, Galna B, Lord S, Nieuwboer A, Bekkers EMJ, Pelosin E, Avanzino L, Bloem BR, Olde Rikkert MGM, Nieuwhof F, Cereatti A, Della Croce U, Mirelman A, Hausdorff JM, Rochester L.",J Gerontol A Biol Sci Med Sci. 2020 May 22;75(6):1198-1205. doi: 10.1093/gerona/glaa007.,Del Din S,J Gerontol A Biol Sci Med Sci,2020,17-01-2020,PMC7243591,,10.1093/gerona/glaa007
31941000,Quercetin in Animal Models of Alzheimer's Disease: A Systematic Review of Preclinical Studies,"Zhang XW, Chen JY, Ouyang D, Lu JH.",Int J Mol Sci. 2020 Jan 13;21(2):493. doi: 10.3390/ijms21020493.,Zhang XW,Int J Mol Sci,2020,17-01-2020,PMC7014205,,10.3390/ijms21020493
31936521,Continuous Positive Airway Pressure Treatment in Patients with Alzheimer's Disease: A Systematic Review,"Perez-Cabezas V, Ruiz-Molinero C, Jimenez-Rejano JJ, Gonzalez-Medina G, Galan-Mercant A, Martin-Valero R.",J Clin Med. 2020 Jan 9;9(1):181. doi: 10.3390/jcm9010181.,Perez-Cabezas V,J Clin Med,2020,16-01-2020,PMC7019587,,10.3390/jcm9010181
31936134,Sterculic Acid: The Mechanisms of Action beyond Stearoyl-CoA Desaturase Inhibition and Therapeutic Opportunities in Human Diseases,"Peláez R, Pariente A, Pérez-Sala Á, Larráyoz IM.",Cells. 2020 Jan 7;9(1):140. doi: 10.3390/cells9010140.,Peláez R,Cells,2020,16-01-2020,PMC7016617,,10.3390/cells9010140
31930364,Safety and Efficacy of RimabotulinumtoxinB for Treatment of Sialorrhea in Adults: A Randomized Clinical Trial,"Isaacson SH, Ondo W, Jackson CE, Trosch RM, Molho E, Pagan F, Lew M, Dashtipour K, Clinch T, Espay AJ; MYSTICOL Study Group.",JAMA Neurol. 2020 Apr 1;77(4):461-469. doi: 10.1001/jamaneurol.2019.4565.,Isaacson SH,JAMA Neurol,2020,14-01-2020,PMC6990829,,10.1001/jamaneurol.2019.4565
31916847,Effect of Self-Efficacy on Quality of Life in People With Mild Cognitive Impairment and Mild Dementia: The Mediating Roles of Depression and Anxiety,"Tonga JB, Eilertsen DE, Solem IKL, Arnevik EA, Korsnes MS, Ulstein ID.",Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317519885264. doi: 10.1177/1533317519885264.,Tonga JB,Am J Alzheimers Dis Other Demen,2020,10-01-2020,PMC10623983,,10.1177/1533317519885264
31915189,Effects of acute sleep loss on diurnal plasma dynamics of CNS health biomarkers in young men,"Benedict C, Blennow K, Zetterberg H, Cedernaes J.",Neurology. 2020 Mar 17;94(11):e1181-e1189. doi: 10.1212/WNL.0000000000008866. Epub 2020 Jan 8.,Benedict C,Neurology,2020,10-01-2020,PMC7220231,,10.1212/WNL.0000000000008866
31912279,Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis,"Devos D, Cabantchik ZI, Moreau C, Danel V, Mahoney-Sanchez L, Bouchaoui H, Gouel F, Rolland AS, Duce JA, Devedjian JC; FAIRPARK-II and FAIRALS-II studygroups.",J Neural Transm (Vienna). 2020 Feb;127(2):189-203. doi: 10.1007/s00702-019-02138-1. Epub 2020 Jan 7.,Devos D,J Neural Transm (Vienna),2020,09-01-2020,,,10.1007/s00702-019-02138-1
31912155,Effect of a 2-year diet intervention with walnuts on cognitive decline. The Walnuts And Healthy Aging (WAHA) study: a randomized controlled trial,"Sala-Vila A, Valls-Pedret C, Rajaram S, Coll-Padrós N, Cofán M, Serra-Mir M, Pérez-Heras AM, Roth I, Freitas-Simoes TM, Doménech M, Calvo C, López-Illamola A, Bitok E, Buxton NK, Huey L, Arechiga A, Oda K, Lee GJ, Corella D, Vaqué-Alcázar L, Sala-Llonch R, Bartrés-Faz D, Sabaté J, Ros E.",Am J Clin Nutr. 2020 Mar 1;111(3):590-600. doi: 10.1093/ajcn/nqz328.,Sala-Vila A,Am J Clin Nutr,2020,09-01-2020,,,10.1093/ajcn/nqz328
31907026,"Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial","Pitchford LM, Driver PM, Fuller JC Jr, Akers WS, Abumrad NN, Amarnath V, Milne GL, Chen SC, Ye F, Roberts LJ 2nd, Shoemaker MB, Oates JA, Rathmacher JA, Boutaud O.",BMC Pharmacol Toxicol. 2020 Jan 6;21(1):3. doi: 10.1186/s40360-020-0382-y.,Pitchford LM,BMC Pharmacol Toxicol,2020,08-01-2020,PMC6945443,,10.1186/s40360-020-0382-y
31906949,Clinical trials of new drugs for Alzheimer disease,"Huang LK, Chao SP, Hu CJ.",J Biomed Sci. 2020 Jan 6;27(1):18. doi: 10.1186/s12929-019-0609-7.,Huang LK,J Biomed Sci,2020,08-01-2020,PMC6943903,,10.1186/s12929-019-0609-7
31892526,High density lipoprotein and its apolipoprotein-defined subspecies and risk of dementia,"Koch M, DeKosky ST, Goodman M, Sun J, Furtado JD, Fitzpatrick AL, Mackey RH, Cai T, Lopez OL, Kuller LH, Mukamal KJ, Jensen MK.",J Lipid Res. 2020 Mar;61(3):445-454. doi: 10.1194/jlr.P119000473. Epub 2019 Dec 31.,Koch M,J Lipid Res,2020,02-01-2020,PMC7053836,,10.1194/jlr.P119000473
31884472,An Exploratory Phase IIa Study of the PPAR delta/gamma Agonist T3D-959 Assessing Metabolic and Cognitive Function in Subjects with Mild to Moderate Alzheimer's Disease,"Chamberlain S, Gabriel H, Strittmatter W, Didsbury J.",J Alzheimers Dis. 2020;73(3):1085-1103. doi: 10.3233/JAD-190864.,Chamberlain S,J Alzheimers Dis,2020,30-12-2019,PMC7081093,,10.3233/JAD-190864
31883703,"A Phase I Study to Assess the Effect of Speed of Injection on Pain, Tolerability, and Pharmacokinetics After High-volume Subcutaneous Administration of Gantenerumab in Healthy Volunteers","Portron A, Jordan P, Draper K, Muenzer C, Dickerson D, van Iersel T, Hofmann C.",Clin Ther. 2020 Jan;42(1):108-120.e1. doi: 10.1016/j.clinthera.2019.11.015. Epub 2019 Dec 26.,Portron A,Clin Ther,2020,30-12-2019,,,10.1016/j.clinthera.2019.11.015
31870908,Medium Chain Triglycerides induce mild ketosis and may improve cognition in Alzheimer's disease. A systematic review and meta-analysis of human studies,"Avgerinos KI, Egan JM, Mattson MP, Kapogiannis D.",Ageing Res Rev. 2020 Mar;58:101001. doi: 10.1016/j.arr.2019.101001. Epub 2019 Dec 20.,Avgerinos KI,Ageing Res Rev,2020,25-12-2019,PMC7050425,NIHMS1547851,10.1016/j.arr.2019.101001
31868666,Comparative Cognitive Effects of Choreographed Exercise and Multimodal Physical Therapy in Older Adults with Amnestic Mild Cognitive Impairment: Randomized Clinical Trial,"Bisbe M, Fuente-Vidal A, López E, Moreno M, Naya M, de Benetti C, Milà R, Bruna O, Boada M, Alegret M.",J Alzheimers Dis. 2020;73(2):769-783. doi: 10.3233/JAD-190552.,Bisbe M,J Alzheimers Dis,2020,24-12-2019,PMC7029368,,10.3233/JAD-190552
31866419,Effectiveness of Powerful Tools for Caregivers on Caregiver Burden and on Care Recipient Behavioral and Psychological Symptoms of Dementia: A Randomized Controlled Trial,"Terracciano A, Artese A, Yeh J, Edgerton L, Granville L, Aschwanden D, Luchetti M, Glueckauf RL, Stephan Y, Sutin AR, Katz P.",J Am Med Dir Assoc. 2020 Aug;21(8):1121-1127.e1. doi: 10.1016/j.jamda.2019.11.011. Epub 2019 Dec 19.,Terracciano A,J Am Med Dir Assoc,2020,24-12-2019,PMC7302999,NIHMS1545436,10.1016/j.jamda.2019.11.011
31853557,"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","Family N, Maillet EL, Williams LTJ, Krediet E, Carhart-Harris RL, Williams TM, Nichols CD, Goble DJ, Raz S.",Psychopharmacology (Berl). 2020 Mar;237(3):841-853. doi: 10.1007/s00213-019-05417-7. Epub 2019 Dec 18.,Family N,Psychopharmacology (Berl),2020,20-12-2019,PMC7036065,,10.1007/s00213-019-05417-7
31841678,Advances and considerations in AD tau-targeted immunotherapy,"Bittar A, Bhatt N, Kayed R.",Neurobiol Dis. 2020 Feb;134:104707. doi: 10.1016/j.nbd.2019.104707. Epub 2019 Dec 10.,Bittar A,Neurobiol Dis,2020,17-12-2019,PMC6980703,NIHMS1548074,10.1016/j.nbd.2019.104707
31841599,"Nilotinib Effects on Safety, Tolerability, and Potential Biomarkers in Parkinson Disease: A Phase 2 Randomized Clinical Trial","Pagan FL, Hebron ML, Wilmarth B, Torres-Yaghi Y, Lawler A, Mundel EE, Yusuf N, Starr NJ, Anjum M, Arellano J, Howard HH, Shi W, Mulki S, Kurd-Misto T, Matar S, Liu X, Ahn J, Moussa C.",JAMA Neurol. 2020 Mar 1;77(3):309-317. doi: 10.1001/jamaneurol.2019.4200.,Pagan FL,JAMA Neurol,2020,17-12-2019,PMC6990742,,10.1001/jamaneurol.2019.4200
31835954,Cannabinoids for the Neuropsychiatric Symptoms of Dementia: A Systematic Review and Meta-Analysis,"Bahji A, Meyyappan AC, Hawken ER.",Can J Psychiatry. 2020 Jun;65(6):365-376. doi: 10.1177/0706743719892717. Epub 2019 Dec 13.,Bahji A,Can J Psychiatry,2020,15-12-2019,PMC7265608,,10.1177/0706743719892717
31828969,(-)-Phenserine tartrate (PhenT) as a treatment for traumatic brain injury,"Greig NH, Lecca D, Hsueh SC, Nogueras-Ortiz C, Kapogiannis D, Tweedie D, Glotfelty EJ, Becker RE, Chiang YH, Hoffer BJ.",CNS Neurosci Ther. 2020 Jun;26(6):636-649. doi: 10.1111/cns.13274. Epub 2019 Dec 11.,Greig NH,CNS Neurosci Ther,2020,13-12-2019,PMC7248544,,10.1111/cns.13274
31825466,Effects of Mirtazapine for Methamphetamine Use Disorder Among Cisgender Men and Transgender Women Who Have Sex With Men: A Placebo-Controlled Randomized Clinical Trial,"Coffin PO, Santos GM, Hern J, Vittinghoff E, Walker JE, Matheson T, Santos D, Colfax G, Batki SL.",JAMA Psychiatry. 2020 Mar 1;77(3):246-255. doi: 10.1001/jamapsychiatry.2019.3655.,Coffin PO,JAMA Psychiatry,2020,12-12-2019,PMC6990973,,10.1001/jamapsychiatry.2019.3655
31797405,PPARα serves as a new receptor of aspirin for neuroprotection,"Patel D, Roy A, Pahan K.",J Neurosci Res. 2020 Apr;98(4):626-631. doi: 10.1002/jnr.24561. Epub 2019 Dec 3.,Patel D,J Neurosci Res,2020,05-12-2019,PMC7015783,NIHMS1542530,10.1002/jnr.24561
31792940,Risks and Benefits of Screening for Dementia in Primary Care: The Indiana University Cognitive Health Outcomes Investigation of the Comparative Effectiveness of Dementia Screening (IU CHOICE)Trial,"Fowler NR, Perkins AJ, Gao S, Sachs GA, Boustani MA.",J Am Geriatr Soc. 2020 Mar;68(3):535-543. doi: 10.1111/jgs.16247. Epub 2019 Dec 2.,Fowler NR,J Am Geriatr Soc,2020,04-12-2019,PMC7187902,NIHMS1066400,10.1111/jgs.16247
31783330,A systematic review and meta-analysis of rTMS effects on cognitive enhancement in mild cognitive impairment and Alzheimer's disease,"Chou YH, Ton That V, Sundman M.",Neurobiol Aging. 2020 Feb;86:1-10. doi: 10.1016/j.neurobiolaging.2019.08.020. Epub 2019 Aug 27.,Chou YH,Neurobiol Aging,2020,30-11-2019,PMC6995441,NIHMS1538869,10.1016/j.neurobiolaging.2019.08.020
31782132,Pathophysiology and Therapeutic Perspectives of Oxidative Stress and Neurodegenerative Diseases: A Narrative Review,"Rekatsina M, Paladini A, Piroli A, Zis P, Pergolizzi JV, Varrassi G.",Adv Ther. 2020 Jan;37(1):113-139. doi: 10.1007/s12325-019-01148-5. Epub 2019 Nov 28.,Rekatsina M,Adv Ther,2020,30-11-2019,PMC6979458,,10.1007/s12325-019-01148-5
31764959,Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials,"Wessels AM, Tariot PN, Zimmer JA, Selzler KJ, Bragg SM, Andersen SW, Landry J, Krull JH, Downing AM, Willis BA, Shcherbinin S, Mullen J, Barker P, Schumi J, Shering C, Matthews BR, Stern RA, Vellas B, Cohen S, MacSweeney E, Boada M, Sims JR.",JAMA Neurol. 2020 Feb 1;77(2):199-209. doi: 10.1001/jamaneurol.2019.3988.,Wessels AM,JAMA Neurol,2020,26-11-2019,PMC6902191,,10.1001/jamaneurol.2019.3988
31753521,"Impact of the mental health and dynamic referral for oncology (MHADRO) program on oncology patient outcomes, health care utilization, and health provider behaviors: A multi-site randomized control trial","O'Hea E, Kroll-Desrosiers A, Cutillo AS, Michalak HR, Barton BA, Harralson T, Carmack C, McMahon C, Boudreaux ED.",Patient Educ Couns. 2020 Mar;103(3):607-616. doi: 10.1016/j.pec.2019.10.006. Epub 2019 Nov 5.,O'Hea E,Patient Educ Couns,2020,23-11-2019,PMC7061075,NIHMS1545324,10.1016/j.pec.2019.10.006
31753458,Association of oral health-related quality of life and Alzheimer disease: A systematic review,"Ming Y, Hsu SW, Yen YY, Lan SJ.",J Prosthet Dent. 2020 Aug;124(2):168-175. doi: 10.1016/j.prosdent.2019.08.015. Epub 2019 Nov 19.,Ming Y,J Prosthet Dent,2020,23-11-2019,,,10.1016/j.prosdent.2019.08.015
31738372,Minocycline at 2 Different Dosages vs Placebo for Patients With Mild Alzheimer Disease: A Randomized Clinical Trial,"Howard R, Zubko O, Bradley R, Harper E, Pank L, O'Brien J, Fox C, Tabet N, Livingston G, Bentham P, McShane R, Burns A, Ritchie C, Reeves S, Lovestone S, Ballard C, Noble W, Nilforooshan R, Wilcock G, Gray R; Minocycline in Alzheimer Disease Efficacy (MADE) Trialist Group.",JAMA Neurol. 2020 Feb 1;77(2):164-174. doi: 10.1001/jamaneurol.2019.3762.,Howard R,JAMA Neurol,2020,19-11-2019,PMC6865324,,10.1001/jamaneurol.2019.3762
31738191,"Local Health Jurisdiction Staff Deliver Health Promotion to Small Worksites, Washington","Harris JR, Hammerback K, Brown M, Ryan DE, Coe NB, Pike KJ, Santiago PM, Hannon PA.",J Public Health Manag Pract. 2021 Mar-Apr 01;27(2):117-124. doi: 10.1097/PHH.0000000000001105.,Harris JR,J Public Health Manag Pract,2021,19-11-2019,PMC7220816,NIHMS1540878,10.1097/PHH.0000000000001105
31710340,"Reactions to Multiple Ascending Doses of the Microtubule Stabilizer TPI-287 in Patients With Alzheimer Disease, Progressive Supranuclear Palsy, and Corticobasal Syndrome: A Randomized Clinical Trial","Tsai RM, Miller Z, Koestler M, Rojas JC, Ljubenkov PA, Rosen HJ, Rabinovici GD, Fagan AM, Cobigo Y, Brown JA, Jung JI, Hare E, Geldmacher DS, Natelson-Love M, McKinley EC, Luong PN, Chuu EL, Powers R, Mumford P, Wolf A, Wang P, Shamloo M, Miller BL, Roberson ED, Boxer AL.",JAMA Neurol. 2020 Feb 1;77(2):215-224. doi: 10.1001/jamaneurol.2019.3812.,Tsai RM,JAMA Neurol,2020,12-11-2019,PMC6865783,,10.1001/jamaneurol.2019.3812
31708380,"Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials","Grossberg GT, Kohegyi E, Mergel V, Josiassen MK, Meulien D, Hobart M, Slomkowski M, Baker RA, McQuade RD, Cummings JL.",Am J Geriatr Psychiatry. 2020 Apr;28(4):383-400. doi: 10.1016/j.jagp.2019.09.009. Epub 2019 Oct 1.,Grossberg GT,Am J Geriatr Psychiatry,2020,12-11-2019,,,10.1016/j.jagp.2019.09.009
31686629,Chinese Herbal Medicine Interventions in Neurological Disorder Therapeutics by Regulating Glutamate Signaling,"Liu Y, Wang S, Kan J, Zhang J, Zhou L, Huang Y, Zhang Y.",Curr Neuropharmacol. 2020;18(4):260-276. doi: 10.2174/1570159X17666191101125530.,Liu Y,Curr Neuropharmacol,2020,06-11-2019,PMC7327939,,10.2174/1570159X17666191101125530
31686182,From the prion-like propagation hypothesis to therapeutic strategies of anti-tau immunotherapy,"Colin M, Dujardin S, Schraen-Maschke S, Meno-Tetang G, Duyckaerts C, Courade JP, Buée L.",Acta Neuropathol. 2020 Jan;139(1):3-25. doi: 10.1007/s00401-019-02087-9. Epub 2019 Nov 4.,Colin M,Acta Neuropathol,2020,06-11-2019,PMC6942016,,10.1007/s00401-019-02087-9
31660655,Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases,"Coughlin DG, Hurtig HI, Irwin DJ.",Mov Disord. 2020 Jan;35(1):5-19. doi: 10.1002/mds.27867. Epub 2019 Oct 29.,Coughlin DG,Mov Disord,2020,30-10-2019,PMC7233798,NIHMS1572025,10.1002/mds.27867
31647950,Passive Immunotherapies Targeting Amyloid Beta and Tau Oligomers in Alzheimer's Disease,"Vander Zanden CM, Chi EY.",J Pharm Sci. 2020 Jan;109(1):68-73. doi: 10.1016/j.xphs.2019.10.024. Epub 2019 Oct 21.,Vander Zanden CM,J Pharm Sci,2020,25-10-2019,PMC6937375,NIHMS1543006,10.1016/j.xphs.2019.10.024
31628215,Predictive Value of (18)F-Florbetapir and (18)F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia,"Blazhenets G, Ma Y, Sörensen A, Schiller F, Rücker G, Eidelberg D, Frings L, Meyer PT; Alzheimer Disease Neuroimaging Initiative.",J Nucl Med. 2020 Apr;61(4):597-603. doi: 10.2967/jnumed.119.230797. Epub 2019 Oct 18.,Blazhenets G,J Nucl Med,2020,20-10-2019,PMC7198373,,10.2967/jnumed.119.230797
31604111,"Revisiting the intersection of amyloid, pathologically modified tau and iron in Alzheimer's disease from a ferroptosis perspective","Derry PJ, Hegde ML, Jackson GR, Kayed R, Tour JM, Tsai AL, Kent TA.",Prog Neurobiol. 2020 Jan;184:101716. doi: 10.1016/j.pneurobio.2019.101716. Epub 2019 Oct 8.,Derry PJ,Prog Neurobiol,2020,12-10-2019,PMC7850812,NIHMS1545368,10.1016/j.pneurobio.2019.101716
31595772,Is Benzodiazepine Use Associated With the Risk of Dementia and Cognitive Impairment-Not Dementia in Older Persons? The Canadian Study of Health and Aging,"Nafti M, Sirois C, Kröger E, Carmichael PH, Laurin D.",Ann Pharmacother. 2020 Mar;54(3):219-225. doi: 10.1177/1060028019882037. Epub 2019 Oct 9.,Nafti M,Ann Pharmacother,2020,10-10-2019,,,10.1177/1060028019882037
31585881,Insights from Drosophila melanogaster model of Alzheimer's disease,"Tue NT, Dat TQ, Ly LL, Anh VD, Yoshida H.",Front Biosci (Landmark Ed). 2020 Jan 1;25(1):134-146. doi: 10.2741/4798.,Tue NT,Front Biosci (Landmark Ed),2020,06-10-2019,,,10.2741/4798
31585875,Neuroprotective effects of resveratrol in Alzheimer's disease,"Rao YL, Ganaraja B, Joy T, Pai MM, Ullal SD, Murlimanju BV.",Front Biosci (Elite Ed). 2020 Jan 1;12(1):139-149. doi: 10.2741/E863.,Rao YL,Front Biosci (Elite Ed),2020,06-10-2019,,,10.2741/E863
31578055,Evaluation of the effect of aroma oil as a bath salt on cognitive function,"Kouzuki M, Kitao S, Kaju T, Urakami K.",Psychogeriatrics. 2020 Mar;20(2):163-171. doi: 10.1111/psyg.12481. Epub 2019 Oct 2.,Kouzuki M,Psychogeriatrics,2020,03-10-2019,PMC7079117,,10.1111/psyg.12481
31567873,Retrospective analysis of phytoSERM for management of menopause-associated vasomotor symptoms and cognitive decline: a pilot study on pharmacogenomic effects of mitochondrial haplogroup and APOE genotype on therapeutic efficacy,"Wang Y, Hernandez G, Mack WJ, Schneider LS, Yin F, Brinton RD.",Menopause. 2020 Jan;27(1):57-65. doi: 10.1097/GME.0000000000001418.,Wang Y,Menopause,2020,01-10-2019,PMC7100617,NIHMS1535157,10.1097/GME.0000000000001418
31535922,"The Effect of the ""Great Village"" on Psychological Outcomes, Burden, and Mastery in African American Caregivers of Persons Living With Dementia","Brewster GS, Epps F, Dye CE, Hepburn K, Higgins MK, Parker ML.",J Appl Gerontol. 2020 Oct;39(10):1059-1068. doi: 10.1177/0733464819874574. Epub 2019 Sep 19.,Brewster GS,J Appl Gerontol,2020,20-09-2019,PMC7080571,NIHMS1049089,10.1177/0733464819874574
31535641,Selective serotonin reuptake inhibitors and Alzheimer's disease,"Mdawar B, Ghossoub E, Khoury R.",Neural Regen Res. 2020 Jan;15(1):41-46. doi: 10.4103/1673-5374.264445.,Mdawar B,Neural Regen Res,2020,20-09-2019,PMC6862425,,10.4103/1673-5374.264445
31535640,Stem cell therapy for Parkinson's disease: safety and modeling,"Stoddard-Bennett T, Pera RR.",Neural Regen Res. 2020 Jan;15(1):36-40. doi: 10.4103/1673-5374.264446.,Stoddard-Bennett T,Neural Regen Res,2020,20-09-2019,PMC6862409,,10.4103/1673-5374.264446
31526767,Dopamine replacement improves motor learning of an upper extremity task in people with Parkinson disease,"Paul SS, Dibble LE, Olivier GN, Walter C, Duff K, Schaefer SY.",Behav Brain Res. 2020 Jan 13;377:112213. doi: 10.1016/j.bbr.2019.112213. Epub 2019 Sep 14.,Paul SS,Behav Brain Res,2020,19-09-2019,PMC7398159,NIHMS1606856,10.1016/j.bbr.2019.112213
31454800,Selenium and Other Trace Elements in the Etiology of Parkinson's Disease: A Systematic Review and Meta-Analysis of Case-Control Studies,"Adani G, Filippini T, Michalke B, Vinceti M.",Neuroepidemiology. 2020;54(1):1-23. doi: 10.1159/000502357. Epub 2019 Aug 27.,Adani G,Neuroepidemiology,2020,28-08-2019,,,10.1159/000502357
31414194,"Physical exercise improves quality of life, depressive symptoms, and cognition across chronic brain disorders: a transdiagnostic systematic review and meta-analysis of randomized controlled trials","Dauwan M, Begemann MJH, Slot MIE, Lee EHM, Scheltens P, Sommer IEC.",J Neurol. 2021 Apr;268(4):1222-1246. doi: 10.1007/s00415-019-09493-9. Epub 2019 Aug 14.,Dauwan M,J Neurol,2021,16-08-2019,PMC7990819,,10.1007/s00415-019-09493-9
31402066,Diagnostic performance of brief cognitive tests in cognitive impairment screening,"Carnero-Pardo C, Rego-García I, Mené Llorente M, Alonso Ródenas M, Vílchez Carrillo R.",Neurologia (Engl Ed). 2022 Jul-Aug;37(6):441-449. doi: 10.1016/j.nrl.2019.05.007. Epub 2019 Aug 8.,Carnero-Pardo C,Neurologia (Engl Ed),2022,13-08-2019,,,10.1016/j.nrl.2019.05.007
31288544,Immediate Benefit of Art on Pain and Well-Being in Community-Dwelling Patients with Mild Alzheimer's,"Pongan E, Delphin-Combe F, Krolak-Salmon P, Leveque Y, Tillmann B, Bachelet R, Getenet JC, Auguste N, Trombert B, Dorey JM, Laurent B, Rouch I.",Am J Alzheimers Dis Other Demen. 2020 Jan-Dec;35:1533317519859202. doi: 10.1177/1533317519859202. Epub 2019 Jul 9.,Pongan E,Am J Alzheimers Dis Other Demen,2020,11-07-2019,PMC10624084,,10.1177/1533317519859202
31276770,Neural regeneration therapies for Alzheimer's and Parkinson's disease-related disorders,"Reddy AP, Ravichandran J, Carkaci-Salli N.",Biochim Biophys Acta Mol Basis Dis. 2020 Apr 1;1866(4):165506. doi: 10.1016/j.bbadis.2019.06.020. Epub 2019 Jul 2.,Reddy AP,Biochim Biophys Acta Mol Basis Dis,2020,06-07-2019,,,10.1016/j.bbadis.2019.06.020
31233819,Beneficial microbiota. Probiotics and pharmaceutical products in functional nutrition and medicine,"Novik G, Savich V.",Microbes Infect. 2020 Jan-Feb;22(1):8-18. doi: 10.1016/j.micinf.2019.06.004. Epub 2019 Jun 21.,Novik G,Microbes Infect,2020,25-06-2019,,,10.1016/j.micinf.2019.06.004
31182663,Clinical and Technical Considerations for Brain PET Imaging for Dementia,"Acuff SN, Mathotaarachchi S, Zukotynski K, Osborne D, Subramaniam R; Alzheimer’s Disease Neuroimaging Initiative.",J Nucl Med Technol. 2020 Mar;48(1):5-8. doi: 10.2967/jnmt.118.220087. Epub 2019 Jun 10.,Acuff SN,J Nucl Med Technol,2020,12-06-2019,,,10.2967/jnmt.118.220087
31112605,Personality Moderates Intervention Effects on Cognitive Function: A 6-Week Conversation-Based Intervention,"Cerino ES, Hooker K, Goodrich E, Dodge HH.",Gerontologist. 2020 Jul 15;60(5):958-967. doi: 10.1093/geront/gnz063.,Cerino ES,Gerontologist,2020,22-05-2019,PMC7362618,,10.1093/geront/gnz063
31111428,Plasma Replacement Therapy for Alzheimer's Disease,"Ding XL, Lei P.",Neurosci Bull. 2020 Jan;36(1):89-90. doi: 10.1007/s12264-019-00394-5. Epub 2019 May 20.,Ding XL,Neurosci Bull,2020,22-05-2019,PMC6940398,,10.1007/s12264-019-00394-5
31067489,Mnemonic strategy training increases neocortical activation in healthy older adults and patients with mild cognitive impairment,"Hampstead BM, Stringer AY, Stilla RF, Sathian K.",Int J Psychophysiol. 2020 Aug;154:27-36. doi: 10.1016/j.ijpsycho.2019.04.011. Epub 2019 May 5.,Hampstead BM,Int J Psychophysiol,2020,09-05-2019,PMC7218756,NIHMS1529091,10.1016/j.ijpsycho.2019.04.011
30991105,Improvements of symptoms of Alzheimer`s disease by inhibition of the angiotensin system,"Quitterer U, AbdAlla S.",Pharmacol Res. 2020 Apr;154:104230. doi: 10.1016/j.phrs.2019.04.014. Epub 2019 Apr 13.,Quitterer U,Pharmacol Res,2020,17-04-2019,,,10.1016/j.phrs.2019.04.014
30862408,"Impact of androgen deprivation therapy on mood, cognition, and risk for AD","Cherrier MM, Higano CS.",Urol Oncol. 2020 Feb;38(2):53-61. doi: 10.1016/j.urolonc.2019.01.021. Epub 2019 Mar 9.,Cherrier MM,Urol Oncol,2020,14-03-2019,,,10.1016/j.urolonc.2019.01.021
30755135,Longitudinal evaluation of surrogates of regional cerebral blood flow computed from dynamic amyloid PET imaging,"Bilgel M, Beason-Held L, An Y, Zhou Y, Wong DF, Resnick SM.",J Cereb Blood Flow Metab. 2020 Feb;40(2):288-297. doi: 10.1177/0271678X19830537. Epub 2019 Feb 12.,Bilgel M,J Cereb Blood Flow Metab,2020,14-02-2019,PMC7370613,,10.1177/0271678X19830537
30569813,Parametric methods for [(18)F]flortaucipir PET,"Golla SS, Wolters EE, Timmers T, Ossenkoppele R, van der Weijden CW, Scheltens P, Schwarte L, Mintun MA, Devous MD Sr, Schuit RC, Windhorst AD, Lammertsma AA, Yaqub M, van Berckel BN, Boellaard R.",J Cereb Blood Flow Metab. 2020 Feb;40(2):365-373. doi: 10.1177/0271678X18820765. Epub 2018 Dec 20.,Golla SS,J Cereb Blood Flow Metab,2020,21-12-2018,PMC7044757,,10.1177/0271678X18820765
30304477,Translating an Evidence-based Multicomponent Intervention for Older Adults With Dementia and Caregivers,"Teri L, Logsdon RG, McCurry SM, Pike KC, McGough EL.",Gerontologist. 2020 Apr 2;60(3):548-557. doi: 10.1093/geront/gny122.,Teri L,Gerontologist,2020,11-10-2018,PMC7117621,,10.1093/geront/gny122
29504488,"""It's Like a Cyber-Security Blanket"": The Utility of Remote Activity Monitoring in Family Dementia Care","Mitchell LL, Peterson CM, Rud SR, Jutkowitz E, Sarkinen A, Trost S, Porta CM, Finlay JM, Gaugler JE.",J Appl Gerontol. 2020 Jan;39(1):86-98. doi: 10.1177/0733464818760238. Epub 2018 Mar 4.,Mitchell LL,J Appl Gerontol,2020,06-03-2018,PMC6353693,NIHMS938846,10.1177/0733464818760238
28986068,Effectiveness of omega-3 fatty acid supplementation in patients with Alzheimer disease: A systematic review and meta-analysis,"Araya-Quintanilla F, Gutiérrez-Espinoza H, Sánchez-Montoya U, Muñoz-Yañez MJ, Baeza-Vergara A, Petersen-Yanjarí M, Fernández-Lecaros L.",Neurologia (Engl Ed). 2020 Mar;35(2):105-114. doi: 10.1016/j.nrl.2017.07.009. Epub 2017 Oct 4.,Araya-Quintanilla F,Neurologia (Engl Ed),2020,08-10-2017,,,10.1016/j.nrl.2017.07.009
